PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Riaz, IB; Badgett, RG				Riaz, Irbaz Bin; Badgett, Robert G.			Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis	ANNALS OF INTERNAL MEDICINE			English	Letter									[Riaz, Irbaz Bin] Univ Arizona, Tucson, AZ USA; [Badgett, Robert G.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Arizona; University of Kansas; University of Kansas Medical Center	Riaz, IB (corresponding author), Univ Arizona, Tucson, AZ USA.		Badgett, Robert/AAD-3429-2021; Bin Riaz, Irbaz/ABB-3799-2020	Badgett, Robert/0000-0003-2888-3303; Bin Riaz, Irbaz/0000-0003-4249-0311				Ammendolia C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010712; Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; CUCKLER JM, 1985, J BONE JOINT SURG AM, V67A, P63, DOI 10.2106/00004623-198567010-00009; Koc Z, 2009, SPINE, V34, P985, DOI 10.1097/BRS.0b013e31819c0a6b; Manchikanti Laxmaiah, 2015, Anesth Pain Med, V5, pe23139, DOI 10.5812/aapm.23139	5	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					634	635		10.7326/L15-0567	http://dx.doi.org/10.7326/L15-0567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136218				2022-12-28	WOS:000375744000030
J	Oxenoid, K; Dong, Y; Cao, C; Cui, TX; Sancak, Y; Markhard, AL; Grabarek, Z; Kong, LL; Liu, ZJ; Ouyang, B; Cong, Y; Mootha, VK; Chou, JJ				Oxenoid, Kirill; Dong, Ying; Cao, Chan; Cui, Tanxing; Sancak, Yasemin; Markhard, Andrew L.; Grabarek, Zenon; Kong, Liangliang; Liu, Zhijun; Ouyang, Bo; Cong, Yao; Mootha, Vamsi K.; Chou, James J.			Architecture of the mitochondrial calcium uniporter	NATURE			English	Article							SINGLE-PARTICLE RECONSTRUCTIONS; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ION-CHANNEL; PROTEIN; CORA; MEMBRANE; RECEPTOR; TRANSPORTER; MECHANISMS	Mitochondria from many eukaryotic clades take up large amounts of calcium (Ca2+) via an inner membrane transporter called the uniporter. Transport by the uniporter is membrane potential dependent and sensitive to ruthenium red or its derivative Ru360 (ref. 1). Electrophysiological studies have shown that the uniporter is an ion channel with remarkably high conductance and selectivity(2). Ca2+ entry into mitochondria is also known to activate the tricarboxylic acid cycle and seems to be crucial for matching the production of ATP in mitochondria with its cytosolic demand(3). Mitochondrial calcium uniporter (MCU) is the pore-forming and Ca2+-conducting subunit of the uniporter holocomplex, but its primary sequence does not resemble any calcium channel studied to date. Here we report the structure of the pore domain of MCU from Caenorhabditis elegans, determined using nuclear magnetic resonance (NMR) and electron microscopy (EM). MCU is a homo-oligomer in which the second transmembrane helix forms a hydrophilic pore across the membrane. The channel assembly represents a new solution of ion channel architecture, and is stabilized by a coiled-coil motif protruding into the mitochondrial matrix. The critical DXXE motif forms the pore entrance, which features two carboxylate rings; based on the ring dimensions and functional mutagenesis, these rings appear to form the selectivity filter. To our knowledge, this is one of the largest membrane protein structures characterized by NMR, and provides a structural blueprint for understanding the function of this channel.	[Oxenoid, Kirill; Cao, Chan; Cui, Tanxing; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Dong, Ying; Kong, Liangliang; Liu, Zhijun; Ouyang, Bo; Cong, Yao; Chou, James J.] Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai 200031, Peoples R China; [Cao, Chan] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China; [Cao, Chan] Nankai Univ, Coll Chem, Tianjin 300071, Peoples R China; [Sancak, Yasemin; Markhard, Andrew L.; Grabarek, Zenon; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Sancak, Yasemin; Markhard, Andrew L.; Grabarek, Zenon; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nankai University; Nankai University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Chou, JJ (corresponding author), Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai 200031, Peoples R China.	james_chou@hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Cao, Chan/0000-0001-7023-8418; Grabarek, Zenon/0000-0002-3636-5701	NIH [P41 EB-002026, GM094608]; CAS [XDB08030301, XDB08030201]; China Scholarship Council; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608, R01GM116898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAS(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Balazs for helping with ITC measurement and data analysis and Y. Zhang and M. Cao from the EM facility of NCPSS for their assistance with EM data collection. The NMR data were collected at the NMR facility of NCPSS and MIT-Harvard CMR (supported by NIH grant P41 EB-002026). This work was supported by CAS grant XDB08030301 and NIH grant GM094608 to J.J.C. V.K.M. is an Investigator of the Howard Hughes Medical Institute. Y.C. is supported by CAS grant XDB08030201. C.C. is supported by the China Scholarship Council.	BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Cheng YF, 2006, J MOL BIOL, V355, P1048, DOI 10.1016/j.jmb.2005.11.021; Cong Y, 2005, J STRUCT BIOL, V152, P104, DOI 10.1016/j.jsb.2005.08.006; Cong Y, 2003, J STRUCT BIOL, V144, P51, DOI 10.1016/j.jsb.2003.09.017; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Guskov A, 2012, P NATL ACAD SCI USA, V109, P18459, DOI 10.1073/pnas.1210076109; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kay LE, 1990, J MAGN RESON, V213, P423, DOI DOI 10.1016/J.JMR.2011.09.004; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovacs-Bogdan E, 2014, P NATL ACAD SCI USA, V111, P8985, DOI 10.1073/pnas.1400514111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee Y., 2015, EMBO REP; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pfoh R, 2012, P NATL ACAD SCI USA, V109, P18809, DOI 10.1073/pnas.1209018109; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; SZYPERSKI T, 1992, J BIOMOL NMR, V2, P323, DOI 10.1007/BF01874811; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	42	218	222	7	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					269	+		10.1038/nature17656	http://dx.doi.org/10.1038/nature17656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27135929	Green Accepted, Green Submitted			2022-12-28	WOS:000376007200055
J	Willyard, C				Willyard, Cassandra			FUNDING Donor drugs	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S43	S45		10.1038/533S43a	http://dx.doi.org/10.1038/533S43a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144609	Bronze			2022-12-28	WOS:000375473900008
J	Allen, JI; Weinberg, DS				Allen, John I.; Weinberg, David S.			Update in Gastroenterology and Hepatology: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Allen, John I.] Yale Univ, Sch Med, 40 Temple St,Suite 1A, New Haven, CT 06510 USA; [Weinberg, David S.] Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA	Yale University; Fox Chase Cancer Center	Allen, JI (corresponding author), Yale Univ, Sch Med, 40 Temple St,Suite 1A, New Haven, CT 06510 USA.	john.i.allen@yale.edu							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W21	W26		10.7326/M16-0078	http://dx.doi.org/10.7326/M16-0078			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136227				2022-12-28	WOS:000375744000006
J	Salvo, F; Moore, N; Arnaud, M; Robinson, P; Raschi, E; De Ponti, F; Begaud, B; Pariente, A				Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, Fabrizio; Begaud, Bernard; Pariente, Antoine			Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TYPE-2 DIABETES-MELLITUS; DOUBLE-BLIND; EFFICACY; SAFETY; PLACEBO; LINAGLIPTIN; VILDAGLIPTIN; ALOGLIPTIN; ASSOCIATION; GLIMEPIRIDE	OBJECTIVE To quantify the risk of hypoglycaemia associated with the concomitant use of dipeptidyl peptidase-4 (DPP-4) inhibitors and sulphonylureas compared with placebo and sulphonylureas. DESIGN Systematic review and meta-analysis. Data sources Medline, ISI Web of Science, SCOPUS, Cochrane Central Register of Controlled Trials, and clinicaltrial. gov were searched without any language restriction. STUDY SELECTION Placebo controlled randomised trials comprising at least 50 participants with type 2 diabetes treated with DPP-4 inhibitors and sulphonylureas. Review methods Risk of bias in each trial was assessed using the Cochrane Collaboration tool. The risk ratio of hypoglycaemia with 95% confidence intervals was computed for each study and then pooled using fixed effect models (Mantel Haenszel method) or random effect models, when appropriate. Subgroup analyses were also performed (eg, dose of DPP-4 inhibitors). The number needed to harm (NNH) was estimated according to treatment duration. RESULTS 10 studies were included, representing a total of 6546 participants (4020 received DPP-4 inhibitors plus sulphonylureas, 2526 placebo plus sulphonylureas). The risk ratio of hypoglycaemia was 1.52 (95% confidence interval 1.29 to 1.80). The NNH was 17 (95% confidence interval 11 to 30) for a treatment duration of six months or less, 15 (9 to 26) for 6.1 to 12 months, and 8 (5 to 15) for more than one year. In subgroup analysis, no difference was found between full and low doses of DPP-4 inhibitors: the risk ratio related to full dose DPP-4 inhibitors was 1.66 (1.34 to 2.06), whereas the increased risk ratio related to low dose DPP-4 inhibitors did not reach statistical significance (1.33, 0.92 to 1.94). CONCLUSIONS Addition of DPP-4 inhibitors to sulphonylurea to treat people with type 2 diabetes is associated with a 50% increased risk of hypoglycaemia and to one excess case of hypoglycaemia for every 17 patients in the first six months of treatment. This highlights the need to respect recommendations for a decrease in sulphonylureas dose when initiating DPP-4 inhibitors and to assess the effectiveness of this risk minimisation strategy.	[Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Begaud, Bernard; Pariente, Antoine] Univ Bordeaux, UMR1219, F-33000 Bordeaux, France; [Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Begaud, Bernard; Pariente, Antoine] INSERM, Bordeaux Populat Hlth Res Ctr, Pharmacoepidemiol Team, UMR1219, Bordeaux, France; [Salvo, Francesco; Moore, Nicholas; Begaud, Bernard; Pariente, Antoine] CHU Bordeaux, Bordeaux, France; [Moore, Nicholas; Robinson, Philip] CIC Bordeaux CIC1401, Bordeaux, France; [Robinson, Philip] ADERA, Pessac, France; [Raschi, Emanuel; De Ponti, Fabrizio] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; University of Bologna	Salvo, F (corresponding author), Univ Bordeaux, UMR1219, F-33000 Bordeaux, France.; Salvo, F (corresponding author), INSERM, Bordeaux Populat Hlth Res Ctr, Pharmacoepidemiol Team, UMR1219, Bordeaux, France.; Salvo, F (corresponding author), CHU Bordeaux, Bordeaux, France.	francesco.salvo@u-bordeaux.fr	Raschi, Emanuel/H-8821-2019; Pariente, Antoine/S-9231-2019; De Ponti, Fabrizio/H-8701-2019; Salvo, Francesco/S-9254-2019	Raschi, Emanuel/0000-0003-0487-7996; Pariente, Antoine/0000-0002-7873-5483; De Ponti, Fabrizio/0000-0002-0367-9595; Salvo, Francesco/0000-0003-3210-7171; Moore, Nicholas/0000-0003-1212-2817				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS81, DOI [10.2337/dc12-s081, 10.2337/dc35-S081]; Amiel SA, 2015, DIABETES CARE, V38, P1583, DOI 10.2337/dc15-0279; AstraZeneca, SUMM PROD CHAR; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barnett AH, 2013, LANCET, V382, P1413, DOI 10.1016/S0140-6736(13)61500-7; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Campbell RK, 1998, ANN PHARMACOTHER, V32, P1044, DOI 10.1345/aph.17360; Cariou B, 2012, TRENDS ENDOCRIN MET, V23, P205, DOI 10.1016/j.tem.2012.03.001; Chacra AR, 2009, INT J CLIN PRACT, V63, P1395, DOI 10.1111/j.1742-1241.2009.02143.x; Cove DH, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1474; Cryer Philip E, 2013, Handb Clin Neurol, V117, P295, DOI 10.1016/B978-0-444-53491-0.00023-7; Cryer PE, 2013, NEW ENGL J MED, V369, P362, DOI 10.1056/NEJMra1215228; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Del Prato S, 2013, J DIABETES COMPLICAT, V27, P274, DOI 10.1016/j.jdiacomp.2012.11.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Forst T, 2015, CURR MED RES OPIN, V31, P1079, DOI 10.1185/03007995.2015.1039936; Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170; Garber AJ, 2008, DIABETES OBES METAB, V10, P1047, DOI 10.1111/j.1463-1326.2008.00859.x; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Gilbert RE, 2015, LANCET, V385, P2107, DOI 10.1016/S0140-6736(14)61402-1; Goto A, 2013, BMJ-BRIT MED J, V347, pf4533, DOI DOI 10.1136/BMJ.F4533; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Harrison TR, 1970, HARRISONS PRINCIPLES; HEMMINGSEN B, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD009008.PUB2; Hermansen K, 2007, DIABETES OBES METAB, V9, P733, DOI 10.1111/j.1463-1326.2007.00744.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoffman RP, 2007, CURR DIABETES REV, V3, P185; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Ingelheim B, SUMM PROD CHAR; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Karagiannis T, 2012, BMJ-BRIT MED J, V344, pe1369, DOI DOI 10.1136/BMJ.E1369; Keating GM, 2015, DRUGS, V75, P777, DOI 10.1007/s40265-015-0385-y; Kikuchi M, 2010, DIABETES RES CLIN PR, V89, P216, DOI 10.1016/j.diabres.2010.04.017; Kilbridge PM, 2006, J AM MED INFORM ASSN, V13, P372, DOI 10.1197/jamia.M2069; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Lewin AJ, 2012, CLIN THER, V34, P1909, DOI 10.1016/j.clinthera.2012.07.008; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lukashevich V, 2011, DIABETES OBES METAB, V13, P947, DOI 10.1111/j.1463-1326.2011.01467.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McIntosh CHS, 2005, REGUL PEPTIDES, V128, P159, DOI 10.1016/j.regpep.2004.06.001; Merck Sharp & Dohme, SUMM PROD CHAR; Novartis, SUMM PROD CHAR; Owens DR, 2011, DIABETIC MED, V28, P1352, DOI 10.1111/j.1464-5491.2011.03387.x; Pratley RE, 2009, DIABETES OBES METAB, V11, P167, DOI 10.1111/j.1463-1326.2008.01016.x; Richter B, 2008, Cochrane Database Syst Rev, pCD006739, DOI 10.1002/14651858.CD006739.pub2; Salvo F, 2014, LANCET, V383, P307, DOI 10.1016/S0140-6736(14)60103-3; Schopman JE, 2014, DIABETES-METAB RES, V30, P11, DOI 10.1002/dmrr.2470; Schunemann HJ, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.7314/APJCP.2014.15.14.5607; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seino Y, 2012, J DIABETES INVEST, V3, P517, DOI 10.1111/j.2040-1124.2012.00226.x; Sen Gupta P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d567; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	57	47	48	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2231	10.1136/bmj.i2231	http://dx.doi.org/10.1136/bmj.i2231			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27142267	Green Published, hybrid			2022-12-28	WOS:000375574000002
J	Li, SS; Zhu, A; Benes, V; Costea, PI; Hercog, R; Hildebrand, F; Huerta-Cepas, J; Nieuwdorp, M; Salojarvi, J; Voigt, AY; Zeller, G; Sunagawa, S; de Vos, WM; Bork, P				Li, Simone S.; Zhu, Ana; Benes, Vladimir; Costea, Paul I.; Hercog, Rajna; Hildebrand, Falk; Huerta-Cepas, Jaime; Nieuwdorp, Max; Salojarvi, Jarkko; Voigt, Anita Y.; Zeller, Georg; Sunagawa, Shinichi; de Vos, Willem M.; Bork, Peer			Durable coexistence of donor and recipient strains after fecal microbiota transplantation	SCIENCE			English	Article							BACTERIA	Fecal microbiota transplantation (FMT) has shown efficacy in treating recurrent Clostridium difficile infection and is increasingly being applied to other gastrointestinal disorders, yet the fate of native and introduced microbial strains remains largely unknown. To quantify the extent of donor microbiota colonization, we monitored strain populations in fecal samples from a recent FMT study on metabolic syndrome patients using single-nucleotide variants in metagenomes. We found extensive coexistence of donor and recipient strains, persisting 3 months after treatment. Colonization success was greater for conspecific strains than for new species, the latter falling within fluctuation levels observed in healthy individuals over a similar time frame. Furthermore, same-donor recipients displayed varying degrees of microbiota transfer, indicating individual patterns of microbiome resistance and donor-recipient compatibilities.	[Li, Simone S.; Zhu, Ana; Costea, Paul I.; Hildebrand, Falk; Huerta-Cepas, Jaime; Voigt, Anita Y.; Zeller, Georg; Sunagawa, Shinichi; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Li, Simone S.] Univ New S Wales, Sch Biotechnol & Bimolecular Sci, Sydney, NSW 2052, Australia; [Benes, Vladimir; Hercog, Rajna] European Mol Biol Lab, Genom Core Facil, D-69117 Heidelberg, Germany; [Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Nieuwdorp, Max] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, NL-1018 HV Amsterdam, Netherlands; [Nieuwdorp, Max] Univ Gothenburg, Wallenberg Lab, S-41345 Gothenburg, Sweden; [Salojarvi, Jarkko; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland; [Salojarvi, Jarkko] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [Voigt, Anita Y.] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, D-69120 Heidelberg, Germany; [Voigt, Anita Y.; Bork, Peer] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Voigt, Anita Y.; Bork, Peer] European Mol Biol Lab, D-69120 Heidelberg, Germany; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki 00014, Finland; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bork, Peer] Univ Wurzburg, Bioctr, Dept Bioinformat, D-97074 Wurzburg, Germany	European Molecular Biology Laboratory (EMBL); University of New South Wales Sydney; European Molecular Biology Laboratory (EMBL); University of Amsterdam; Vrije Universiteit Amsterdam; University of Gothenburg; University of Helsinki; University of Helsinki; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Wageningen University & Research; University of Helsinki; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg	Sunagawa, S; Bork, P (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.; de Vos, WM (corresponding author), Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland.; Bork, P (corresponding author), Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany.; Bork, P (corresponding author), European Mol Biol Lab, D-69120 Heidelberg, Germany.; de Vos, WM (corresponding author), Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands.; de Vos, WM (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki 00014, Finland.; Bork, P (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.; Bork, P (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, D-97074 Wurzburg, Germany.	sunagawa@embl.de; willem.devos@wur.nl; bork@embl.de	Zeller, Georg/M-6484-2013; Bork, Peer/F-1813-2013; Salojärvi, Jarkko/E-9103-2016; Huerta-Cepas, Jaime/H-5093-2013; Sunagawa, Shinichi/Q-5950-2019; Hildebrand, Falk/K-1914-2014	Zeller, Georg/0000-0003-1429-7485; Bork, Peer/0000-0002-2627-833X; Salojärvi, Jarkko/0000-0002-4096-6278; Huerta-Cepas, Jaime/0000-0003-4195-5025; Sunagawa, Shinichi/0000-0003-3065-0314; Voigt, Anita Yvonne/0000-0002-6794-0385; Hildebrand, Falk/0000-0002-0078-8948; Li, Simone S/0000-0002-0073-3656; Costea, Paul Igor/0000-0003-1645-3947	European Union [600375]; VIDI grant [016146327]; CVON grant (IN-CONTROL); European Research Council [268985, 250172]; Academy of Finland [141140, 2718324]; Netherlands Organization for Scientific Research [024.002.002]; Metagenomics in Cardiometabolic Diseases project [FP7-HEALTH-2012-INNOVATION-I-305312]; International Human Microbiome Standards project [HEALTH-F4-2010-261376]; Australian Postgraduate Award; EMBL Australia International Ph.D. Fellowship; AstraZeneca plc; Danone; Eli Lilly and Company	European Union(European Commission); VIDI grant; CVON grant (IN-CONTROL); European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Metagenomics in Cardiometabolic Diseases project; International Human Microbiome Standards project; Australian Postgraduate Award(Australian Government); EMBL Australia International Ph.D. Fellowship; AstraZeneca plc(AstraZeneca); Danone(Danone Nutricia); Eli Lilly and Company(Eli Lilly)	We thank M. R. Wilkins, A. Typas and members of the Bork group, as well as B. Klaus from the Centre for Statistical Data. Analysis at the Er ocean Molecular Biology Laboratory (EMBL) for helpful discussions. We acknowledge the EMBL Genomics Core Facility for sequencing support and Y. P. Yuan and the EMBL Information Technology Core Facility for support with high-performance computing. S.S.L. is the recipient of an Australian Postgraduate Award and EMBL Australia International Ph.D. Fellowship. F.H. received. funding through the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 600375 M.N. is supported by a VIDI 2013 grant (016146327) as well as a CVON 2012 grant (IN-CONTROL) This work hies received funding through the CancerBiorne and MicrobesInside projects (European Research Council project references 268985 and 250172), the Academy of Finland (grants 141140 and 2718324 the Netherlands Organization for Scientific Research (Spinoza Prize and SIAM Gravity grant 024.002.002), the Metagenomics in Cardiometabolic Disease project (FP7-HEALTH-2012-INNOVATION-I-305312) mm the International Human Microbiome Standards project (HEALTH-F4-2010-261376). M.N. and W.M.dV. are founders and. scientific advisory board. members of Caelus Health. M.N. and W.M.dV. are inventors on the patent application entitled "Method for preventing and/or treating insulin resistance" (WO 2013032328 also published as CA2851602A1, CN104244733A, EP2753187A1 US20140294774) filed. 30 August 2012 by Academic Medical Centre Amsterdam and Wageningen University. M.N. is a scientific advisory board member of Seres Therapeutics Inc., and has received, funds for speaking from AstraZeneca plc, Danone, and Eli Lilly and Company. Study sequence data reported in this paper are deposited in the European Nucleotide Archive under accession number PRJEB12357. Author contributions: P.B., S.S., and S.S.L. conceived and managed the project. S.S.L. and P.B. wrote the manuscript with input from all other authors. W.M.dV., M.N., and A.Y.V. designed study protocol, recruited subjects and obtained samples. R.H. and V.B. performed metagenomic shotgun sequencing. S.S.L., S.S., A.Z., P.I.C., IS., G.Z., F.H. and designed and performed data analysis.	Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; ANDERSON JD, 1973, J MED MICROBIOL, V6, P461, DOI 10.1099/00222615-6-4-461; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; de Vos WM, 2013, MICROB BIOTECHNOL, V6, P316, DOI 10.1111/1751-7915.12047; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; ROBINSBROWNE RM, 1981, AM J CLIN NUTR, V34, P514, DOI 10.1093/ajcn/34.4.514; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Seekatz AM, 2014, MBIO, V5, DOI 10.1128/mBio.00893-14; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Shin H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075729, 10.1371/journal.pone.0081330]; Smith MB, 2014, NATURE, V506, P290, DOI 10.1038/506290a; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Zhu A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0646-9	28	314	327	9	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					586	589		10.1126/science.aad8852	http://dx.doi.org/10.1126/science.aad8852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126044				2022-12-28	WOS:000374998600045
J	Virchow, JC; Backer, V; Kuna, P; Prieto, L; Nolte, H; Villesen, HH; Ljorring, C; Riis, B; de Blay, F				Virchow, J. Christian; Backer, Vibeke; Kuna, Piotr; Prieto, Luis; Nolte, Hendrik; Villesen, Hanne Hedegaard; Ljorring, Christian; Riis, Bente; de Blay, Frederic			Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GRASS-POLLEN IMMUNOTHERAPY; OF-LIFE QUESTIONNAIRE; RHINITIS; VALIDATION; CHILDREN; ALK	IMPORTANCE The house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet is a potential novel treatment option for HDM allergy-related asthma. OBJECTIVES To evaluate the efficacy and adverse events of the HDM SLIT tablet vs placebo for asthma exacerbations during an inhaled corticosteroid (ICS) reduction period. DESIGN, SETTINGS, AND PARTICIPANTS Double-blind, randomized, placebo-controlled trial conducted between August 2011 and April 2013 in 109 European trial sites. The trial included 834 adults with HDM allergy-related asthma not well controlled by ICS or combination products, and with HDM allergy-related rhinitis. Key exclusion criteria were FEV1 less than 70% of predicted value or hospitalization due to asthma within 3 months before randomization. Efficacy was assessed during the last 6 months of the trial when ICS was reduced by 50% for 3 months and then completely withdrawn for 3 months. INTERVENTIONS 1: 1: 1 randomization to once-daily treatment with placebo (n = 277) or HDM SLIT tablet (dosage groups: 6 SQ-HDM [n = 275] or 12 SQ-HDM [n = 282]) in addition to ICS and the short-acting beta(2)-agonist salbutamol. MAIN OUTCOMES AND MEASURES Primary outcome was time to first moderate or severe asthma exacerbation during the ICS reduction period. Secondary outcomes were deterioration in asthma symptoms, change in allergen-specific immunoglobulin G4 (IgG4), change in asthma control or asthma quality-of-life questionnaires, and adverse events. RESULTS Among 834 randomized patients (mean age, 33 years [range, 17-83]; women, 48%), 693 completed the study. The 6SQ-HDM and 12SQ-HDM doses both significantly reduced the risk of a moderate or severe asthma exacerbation compared with placebo (hazard ratio [HR]: 0.72 [95% CI, 0.52-0.99] for the 6SQ-HDM group, P = .045, and 0.69 [95% CI, 0.50-0.96] for the 12 SQ-HDM group, P = .03). The absolute risk differences based on the observed data (full analysis set) in the active groups vs the placebo group were 0.09 (95% CI, 0.01-0.15) for the 6SQ-HDM group and 0.10 (95% CI, 0.02-0.16) for the 12SQ-HDM group. There was no significant difference between the 2 active groups. Compared with placebo, there was a reduced risk of an exacerbation with deterioration in asthma symptoms (HR, 0.72 [95% CI, 0.49-1.02] for the 6SQ-HDM group, P = .11, and 0.64 [95% CI, 0.42-0.96] for the 12SQ-HDM group, P = .03) and a significant increase in allergen-specific IgG4. However, there was no significant difference for change in asthma control questionnaire or asthma quality-of-life questionnaire for either dose. There were no reports of severe systemic allergic reactions. The most frequent adverse events were mild to moderate oral pruritus (13% for the 6SQ-HDM group, 20% for the 12SQ-HDM group, and 3% for the placebo group), mouth edema, and throat irritation. CONCLUSIONS AND RELEVANCE Among adults with HDM allergy-related asthma not well controlled by ICS, the addition of HDM SLIT to maintenance medications improved time to first moderate or severe asthma exacerbation during ICS reduction, with an estimated absolute reduction at 6 months of 9 to 10 percentage points; the reduction was primarily due to an effect on moderate exacerbations. Treatment-related adverse events were common at both active doses. Further studies are needed to assess long-term efficacy and safety.	[Virchow, J. Christian] Univ Rostock, Dept Pulmonol Intens Care Med, Ernst Heydemannstr 6, D-18057 Rostock, Germany; [Backer, Vibeke] Bispebjerg Hosp, Dept Resp Med, Copenhagen, Denmark; [Kuna, Piotr] Med Univ Lodz, Div Internal Med Asthma & Allergy, Lodz, Poland; [Prieto, Luis] Univ Valencia, Dept Med, E-46003 Valencia, Spain; [Nolte, Hendrik] Merck Res Labs, White House Stn, NJ USA; [Villesen, Hanne Hedegaard; Ljorring, Christian; Riis, Bente] Global Clin Dev ALK, Horsholm, Denmark; [de Blay, Frederic] Strasbourg Univ, Univ Hosp Strasbourg, Chest Dis Dept, Strasbourg, France	University of Rostock; University of Copenhagen; Bispebjerg Hospital; Medical University Lodz; University of Valencia; Merck & Company; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Virchow, JC (corresponding author), Univ Rostock, Dept Pulmonol Intens Care Med, Ernst Heydemannstr 6, D-18057 Rostock, Germany.	jc.h.virchow@sunrise.ch	Backer, Vibeke/AAQ-9379-2021; Prieto, Luis Enrique/HFZ-7903-2022	Kuna, Piotr/0000-0003-2401-0070	ALK, Denmark	ALK, Denmark	This trial was sponsored by ALK, Denmark.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bateman ED, 2010, J ALLERGY CLIN IMMUN, V125, P600, DOI 10.1016/j.jaci.2009.11.033; Bergmann KC, 2014, J ALLERGY CLIN IMMUN, V133, P1608, DOI 10.1016/j.jaci.2013.11.012; Blumberga G, 2006, ALLERGY, V61, P843, DOI 10.1111/j.1398-9995.2006.01088.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Calderon MA, 2015, J ALLERGY CLIN IMMUN, V136, P38, DOI 10.1016/j.jaci.2014.10.012; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; de Blay F, 2014, RESP MED, V108, P1430, DOI 10.1016/j.rmed.2014.07.017; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Eifan AO, 2011, CURR OPIN ALLERGY CL, V11, P586, DOI 10.1097/ACI.0b013e32834cb994; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), ICH HARM TRIP GUID T; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Kocabas CN, 2005, PEDIATR PULM, V40, P235, DOI 10.1002/ppul.20247; Kupczyk M, 2004, ANN ALLERG ASTHMA IM, V92, P453, DOI 10.1016/S1081-1206(10)61782-6; Maneechotesuwan K, 2007, CHEST, V132, P98, DOI 10.1378/chest.06-2982; Meier U, 2006, PHARM STAT, V5, P253, DOI 10.1002/pst.210; Meltzer EO, 2012, EUR RESPIR J, V39, P279, DOI 10.1183/09031936.00020310; Mosbech H, 2015, ANN ALLERG ASTHMA IM, V114, P134, DOI 10.1016/j.anai.2014.11.015; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494; PLATTSMILLS TAE, 1991, INT ARCH ALLER A IMM, V94, P339, DOI 10.1159/000235398; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Ronborg S, 2016, J MED ECON, P1; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; Virchow J, 2011, ALLERGY, V66, P630; Virchow JC, 2015, RESP MED, V109, P547, DOI 10.1016/j.rmed.2015.01.012; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; World Medical Association, DECL HELS ETH PRINC; Zielen S, 2010, J ALLERGY CLIN IMMUN, V126, P942, DOI 10.1016/j.jaci.2010.06.002	35	240	247	3	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1715	1725		10.1001/jama.2016.3964	http://dx.doi.org/10.1001/jama.2016.3964			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115376	Green Published, Bronze			2022-12-28	WOS:000374759300019
J	Netea, MG; Joosten, LAB; Latz, E; Mills, KHG; Natoli, G; Stunnenberg, HG; O'Neill, LAJ; Xavier, RJ				Netea, Mihai G.; Joosten, Leo A. B.; Latz, Eicke; Mills, Kingston H. G.; Natoli, Gioacchino; Stunnenberg, Hendrik G.; O'Neill, Luke A. J.; Xavier, Ramnik J.			Trained immunity: A program of innate immune memory in health and disease	SCIENCE			English	Review							NATURAL-KILLER-CELLS; NK CELLS; CANDIDA-ALBICANS; BONE-MARROW; NONSPECIFIC PROTECTION; MACROPHAGE ACTIVATION; CYTOKINE PRODUCTION; CALMETTE-GUERIN; BCG VACCINATION; LOW-VIRULENCE	The general view that only adaptive immunity can build immunological memory has recently been challenged. In organisms lacking adaptive immunity, as well as in mammals, the innate immune system can mount resistance to reinfection, a phenomenon termed "trained immunity" or "innate immune memory." Trained immunity is orchestrated by epigenetic reprogramming, broadly defined as sustained changes in gene expression and cell physiology that do not involve permanent genetic changes such as mutations and recombination, which are essential for adaptive immunity. The discovery of trained immunity may open the door for novel vaccine approaches, new therapeutic strategies for the treatment of immune deficiency states, and modulation of exaggerated inflammation in autoinflammatory diseases.	[Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Latz, Eicke] Univ Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Mills, Kingston H. G.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Natoli, Gioacchino] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Med, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA	Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Trinity College Dublin; IRCCS European Institute of Oncology (IEO); Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Netea, MG (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	mihai.netea@radboudumc.nl	Latz, Eicke/H-3951-2014; Natoli, gioacchino/J-2100-2018; Netea, Mihai/N-5155-2014; Stunnenberg, Hendrik G./D-6875-2012; Mills, Kingston H/F-5684-2013; Joosten, Leo AB/H-3138-2015; Natoli, gioacchino/ABB-8679-2020	Latz, Eicke/0000-0003-1488-5666; Stunnenberg, Hendrik G./0000-0002-0066-1576; Mills, Kingston H/0000-0003-3646-8222; Joosten, Leo AB/0000-0001-6166-9830; Natoli, Gioacchino/0000-0003-0711-2411; O'Neill, Luke/0000-0002-4333-2748	Netherlands Organization for Scientific Research; European Research Council (ERC) [310372]; Deutsche Forschungsgemeinschaft; Excellence Cluster ImmunoSensation; ERC; Science Foundation Ireland [11/P1/1036]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster ImmunoSensation; ERC(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.G.N. is supported by a Vici grant from the Netherlands Organization for Scientific Research and a European Research Council (ERC) Consolidator Grant (310372). E.L. is supported by grants from the Deutsche Forschungsgemeinschaft and the Excellence Cluster ImmunoSensation and via an ERC Consolidator Grant. G.N.'s work on this topic was supported by an ERC grant (NORM). K.H.G.M. is supported by a PI grant from Science Foundation Ireland (11/P1/1036). We thank M. Gresnigt for the help with the figures. We apologize to the authors of studies that could not be cited due to space constraints.	Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Ataide MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003885; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bekkering S, 2015, CLIN THER, V37, P914, DOI 10.1016/j.clinthera.2015.01.008; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Benit P, 2014, BBA-BIOENERGETICS, V1837, P1330, DOI 10.1016/j.bbabio.2014.03.013; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; BISTONI F, 1988, J MED VET MYCOL, V26, P285; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485; Burgess SL, 2014, MBIO, V5, DOI 10.1128/mBio.01817-14; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Clarke TB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004506; DILUZIO NR, 1978, INFECT IMMUN, V20, P804, DOI 10.1128/IAI.20.3.804-810.1978; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grange JM, 2003, J ROY SOC MED, V96, P389, DOI 10.1258/jrsm.96.8.389; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Ifrim DC, 2015, CLIN EXP IMMUNOL, V181, P434, DOI 10.1111/cei.12642; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kachroo A, 2013, CURR OPIN PLANT BIOL, V16, P527, DOI 10.1016/j.pbi.2013.06.019; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; KRAHENBUHL JL, 1981, INFECT IMMUN, V31, P716, DOI 10.1128/IAI.31.2.716-722.1981; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Locht C, 2014, EXPERT REV VACCINES, V13, P1147, DOI 10.1586/14760584.2014.942222; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Luna E, 2012, PLANT SIGNAL BEHAV, V7, P615, DOI 10.4161/psb.20155; Mankad R, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0497-6; Marakalala MJ, 2013, MICROBES INFECT, V15, P511, DOI 10.1016/j.micinf.2013.03.002; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meyers PA, 2008, J CLIN ONCOL, V26, P633, DOI 10.1200/JCO.2008.14.0095; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Muramatsu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041399; Nabekura T, 2015, J IMMUNOL, V194, P5948, DOI 10.4049/jimmunol.1500424; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ng RLX, 2013, J IMMUNOL, V190, P5471, DOI 10.4049/jimmunol.1202786; Ng RLX, 2010, J IMMUNOL, V185, P7207, DOI 10.4049/jimmunol.1001693; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Ribes S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-14; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Stewart JH, 2011, EXPERT REV ANTICANC, V11, P1671, DOI [10.1586/ERA.11.163, 10.1586/era.11.163]; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; TRIBOULEY J, 1978, CR SOC BIOL, V172, P902; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; VECCHIARELLI A, 1989, CELL IMMUNOL, V124, P334, DOI 10.1016/0008-8749(89)90135-4; Villumsen M, 2009, VACCINE, V27, P6950, DOI 10.1016/j.vaccine.2009.08.103; Yanez A, 2013, EUR J IMMUNOL, V43, P2114, DOI 10.1002/eji.201343403; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida K, 2016, CELL CYCLE, V15, P3, DOI 10.1080/15384101.2015.1112687; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	111	1266	1295	39	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284							aaf1098	10.1126/science.aaf1098	http://dx.doi.org/10.1126/science.aaf1098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102489	Green Accepted			2022-12-28	WOS:000374479700037
J	Turajlic, S; Swanton, C				Turajlic, Samra; Swanton, Charles			Metastasis as an evolutionary process	SCIENCE			English	Review							COPY-NUMBER ALTERATION; INTRATUMOR HETEROGENEITY; GENOMIC INSTABILITY; SOMATIC MUTATIONS; CHROMOSOMAL INSTABILITY; BRANCHED EVOLUTION; THERAPY RESISTANCE; GENETIC EVOLUTION; BRAIN METASTASES; CLONAL EVOLUTION	Therapeutic advances in oncology have not fully translated to the treatment of metastatic disease, which remains largely incurable. Metastatic subclones can emerge both early and late in the life of the primary tumor. A better understanding of the genetic evolution of metastatic disease has the potential to reveal differences in the therapeutic vulnerabilities of primary and metastatic tumors, shed light on the temporal patterns of and routes to metastatic colonization, and provide insight into the biology of the metastatic process. Here we review recent comparative studies of primary and metastatic tumors, including data suggesting that macroevolutionary shifts (the onset of chromosomal instability) contribute to the evolution of metastatic disease. We also discuss the practical challenges associated with these studies and how they might be overcome.	[Turajlic, Samra; Swanton, Charles] Francis Crick Inst, 44 Lincolns Inn Fields, London WC2A 3LY2, England; [Turajlic, Samra] Royal Marsden Hosp, Renal Unit, London SW3 6JJ, England; [Turajlic, Samra] Royal Marsden Hosp, Skin Unit, London SW3 6JJ, England; [Swanton, Charles] Univ Coll London Hosp, Huntley St, London WC1, England; [Swanton, Charles] Canc Res UK Lung Canc Ctr Excellence, Inst Canc, Huntley St, London WC1, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; Cancer Research UK	Swanton, C (corresponding author), Francis Crick Inst, 44 Lincolns Inn Fields, London WC2A 3LY2, England.; Swanton, C (corresponding author), Univ Coll London Hosp, Huntley St, London WC1, England.; Swanton, C (corresponding author), Canc Res UK Lung Canc Ctr Excellence, Inst Canc, Huntley St, London WC1, England.	charles.swanton@crick.ac.uk		turajlic, samra/0000-0001-8846-136X; Swanton, Charles/0000-0002-4299-3018	Cancer Research UK [C50947/A18176]; National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital; Institute of Cancer Research [A109]; Cancer Research UK (TRACERx project); Rosetrees Trust; NovoNordisk Foundation [16584]; European Union [259303]; Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council; NIHR University College London Hospitals Biomedical Research Centre; Cancer Research UK [18176] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital; Institute of Cancer Research; Cancer Research UK (TRACERx project); Rosetrees Trust(Rosetrees Trust); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Prostate Cancer Foundation; Breast Cancer Research Foundation; European Research Council(European Research Council (ERC)European Commission); NIHR University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK(Cancer Research UK)	S.T. is a Cancer Research UK clinician scientist and is funded by Cancer Research UK (grant reference number C50947/A18176) and the National Institute for Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research (grant reference number A109). C.S. is a senior Cancer Research UK clinical research fellow and is funded by Cancer Research UK (TRACERx project), the Rosetrees Trust, the NovoNordisk Foundation (grant ID 16584), the European Union 7th Framework Programme for Research and Technological Development (projects PREDICT and RESPONSIFY; grant ID, 259303), the Prostate Cancer Foundation, the Breast Cancer Research Foundation, the European Research Council [THESEUS (Tumour Heterogeneity and Somatic Evolution of Unstable cancer genomes) project], and the NIHR University College London Hospitals Biomedical Research Centre. We thank N. McGranahan and M. Jamal-Hanjani for their helpful review of the manuscript. We apologize to those authors whose work we did not cite because of space constraints. C.S. is a paid advisor for Janssen, Boerhinger Ingelheim, Ventana, Novartis, Roche, Sequenom, Natera, GRAIL, Apogen Biotechnologies, Epic Biosciences, and the Sarah Cannon Research Institute, and he is a stockholder in Apogen Biotechnologies, Epic Sciences, and GRAIL.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Adamo B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3071; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brownlee PM, 2014, CELL REP, V6, P973, DOI 10.1016/j.celrep.2014.02.012; Butler TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136407; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Crockford A, 2014, J PATHOL, V232, P264, DOI 10.1002/path.4270; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Demicheli R, 1996, BREAST CANCER RES TR, V41, P177, DOI 10.1007/BF01807163; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Goswami RS, 2015, CLIN CANCER RES, V21, P2644, DOI 10.1158/1078-0432.CCR-14-2391; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Jesinghaus M, 2015, AM J SURG PATHOL, V39, P1140, DOI 10.1097/PAS.0000000000000423; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koivisto P, 1996, SCAND J CLIN LAB INV, V56, P57; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Lindberg J, 2015, EUR UROL, V67, P819, DOI 10.1016/j.eururo.2014.09.006; Lipsyc M, 2015, J GASTROINTEST ONCOL, V6, P645, DOI 10.3978/j.issn.2078-6891.2015.045; Maddipati R, 2015, CANCER DISCOV, V5, P1086, DOI 10.1158/2159-8290.CD-15-0120; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McCreery MQ, 2015, NAT MED, V21, P1514, DOI 10.1038/nm.3979; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Murtaza M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9760; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Naxerova K, 2015, NAT REV CLIN ONCOL, V12, P258, DOI 10.1038/nrclinonc.2014.238; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Niessner H, 2013, CANCER MED-US, V2, P76, DOI 10.1002/cam4.50; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; PATEL JK, 1978, AM J SURG, V135, P807, DOI 10.1016/0002-9610(78)90171-X; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sanborn JZ, 2015, P NATL ACAD SCI USA, V112, P10995, DOI 10.1073/pnas.1508074112; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Siravegna G, 2015, NAT MED, V21, P827, DOI 10.1038/nm0715-827b; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Sylvester BE, 2015, J GASTROINTEST ONCOL, V6, P668, DOI 10.3978/j.issn.2078-6891.2015.083; Turajlic S, 2014, ANN ONCOL, V25, P959, DOI 10.1093/annonc/mdu049; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vignot S, 2015, EUR J CANCER, V51, P791, DOI 10.1016/j.ejca.2015.02.012; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao ZM, 2016, P NATL ACAD SCI USA, V113, P2140, DOI 10.1073/pnas.1525677113	68	349	361	6	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					169	175		10.1126/science.aaf2784	http://dx.doi.org/10.1126/science.aaf2784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124450				2022-12-28	WOS:000373681600035
J	Marchalik, D; Jurecic, A				Marchalik, Daniel; Jurecic, Ann			Kazuo Ishiguro's uncanny science	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA; [Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08903 USA	Georgetown University; Rutgers State University New Brunswick	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1365	1365		10.1016/S0140-6736(16)30085-X	http://dx.doi.org/10.1016/S0140-6736(16)30085-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	27115806				2022-12-28	WOS:000373217500018
J	Song, ZR; Colla, CH				Song, Zirui; Colla, Carrie H.			Specialty-Based Global Payment A New Phase in Payment Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; MEDICARE; MODEL		[Song, Zirui] Massachusetts Gen Hosp, Dept Med, 55 Fruit St,Gray Bigelow 730, Boston, MA 02114 USA; [Song, Zirui] Harvard Univ, Sch Med, Boston, MA USA; [Colla, Carrie H.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Colla, Carrie H.] Geisel Sch Med Dartmouth, Hanover, NH USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dartmouth College; Dartmouth College	Song, ZR (corresponding author), Massachusetts Gen Hosp, Dept Med, 55 Fruit St,Gray Bigelow 730, Boston, MA 02114 USA.	zirui_song@post.harvard.edu			NCATS NIH HHS [KL2TR001088, KL2 TR001088, UL1 TR001086] Funding Source: Medline; NIA NIH HHS [F30 AG039175] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086, KL2TR001088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039175] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Centers for Medicare and Medicaid Services, ONC CAR MOD; Huckfeldt P, 2014, SPECIALTY PAYMENT MO; Kirkwood MK, 2015, J ONCOL PRACT, V11, P79, DOI 10.1200/JOP.2015.003772; Kline RM, 2015, J ONCOL PRACT, V11, P114, DOI 10.1200/JOP.2014.002337; Landon BE, 2013, JAMA-J AM MED ASSOC, V310, P371, DOI 10.1001/jama.2013.75247; Polite BN, 2015, J ONCOL PRACT, V11, P117, DOI 10.1200/JOP.2014.002899; Reinke T, CMS TAKES LEAD ONCOL; Rhoads KF, 2015, J CLIN ONCOL, V33, P854, DOI 10.1200/JCO.2014.56.8642	8	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2016	315	21					2271	2272		10.1001/jama.2016.4318	http://dx.doi.org/10.1001/jama.2016.4318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN6KO	27111885	Green Accepted			2022-12-28	WOS:000377183100011
J	Baron, E				Baron, Emmanuel			Liberte, egalite, fraternite ... sante	LANCET			English	Editorial Material									[Baron, Emmanuel] Epicentre, F-75011 Paris, France		Baron, E (corresponding author), Epicentre, F-75011 Paris, France.	emmanuel.baron@epicentre.msf.org						Atlani-Duault L, 2016, LANCET; Davies K, 2014, MIRROR MIRROR WALL P; Dourgnon P, 2012, EC PUBLIQUE, P123, DOI DOI 10.4000/ECONOMIEPUBLIQUE.8851; Haut Conseil de la Sante Publique, 2015, COLL AV RAPP; Hurel, 2016, RAPPORT POLITIQUE VA; Lang T, 2010, INEGALITES SOCIALES; Nay O, 2016, LANCET; Touraine M, 2014, LANCET, V383, P1101, DOI 10.1016/S0140-6736(14)60423-2; WHO, 2000, WORLD HLTH REP HLTH	9	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2179	2181		10.1016/S0140-6736(16)00656-5	http://dx.doi.org/10.1016/S0140-6736(16)00656-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145706				2022-12-28	WOS:000376820800014
J	Caracausi, A; Avice, G; Burnard, PG; Furi, E; Marty, B				Caracausi, Antonio; Avice, Guillaume; Burnard, Peter G.; Furi, Evelyn; Marty, Bernard			Chondritic xenon in the Earth's mantle	NATURE			English	Article							NOBLE-GASES; DIFFERENTIATION; ATMOSPHERE; RESERVOIRS; ACCRETION; VOLCANISM; ISOTOPES; PLUME; NEON; EVOLUTION	Noble gas isotopes are powerful tracers of the origins of planetary volatiles, and the accretion and evolution of the Earth. The compositions of magmatic gases provide insights into the evolution of the Earth's mantle and atmosphere(1-7). Despite recent analytical progress in the study of planetary materials(8,9) and mantle-derived gases(2-7), the possible dual origin(1,10) of the planetary gases in the mantle and the atmosphere remains unconstrained. Evidence relating to the relationship between the volatiles within our planet and the potential cosmochemical end-members is scarce(5). Here we show, using high-precision analysis of magmatic gas from the Eifel volcanic area (in Germany), that the light xenon isotopes identify a chondritic primordial component that differs from the precursor of atmospheric xenon. This is consistent with an asteroidal origin for the volatiles in the Earth's mantle, and indicates that the volatiles in the atmosphere and mantle originated from distinct cosmochemical sources. Furthermore, our data are consistent with the origin of Eifel magmatism being a deep mantle plume. The corresponding mantle source has been isolated from the convective mantle since about 4.45 billion years ago, in agreement with models that predict the early isolation of mantle domains(11). Xenon isotope systematics support a clear distinction between mid-ocean-ridge and continental or oceanic plume sources(6), with chemical heterogeneities dating back to the Earth's accretion(1,7). The deep reservoir now sampled by the Eifel gas had a lower volatile/refractory (iodine/plutonium) composition than the shallower mantle sampled by mid-ocean-ridge volcanism, highlighting the increasing contribution of volatile-rich material during the first tens of millions of years of terrestrial accretion.	[Caracausi, Antonio] Inst Nazl Geofis & Vulcanol, Sez Palermo, I-90146 Palermo, Italy; [Caracausi, Antonio; Avice, Guillaume; Burnard, Peter G.; Furi, Evelyn; Marty, Bernard] Univ Lorraine, CNRS, UMR 7358, Ctr Rech Petrograph & Geochim, F-54501 Vandoeuvre Les Nancy, France	Istituto Nazionale Geofisica e Vulcanologia (INGV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine	Caracausi, A (corresponding author), Inst Nazl Geofis & Vulcanol, Sez Palermo, I-90146 Palermo, Italy.; Caracausi, A (corresponding author), Univ Lorraine, CNRS, UMR 7358, Ctr Rech Petrograph & Geochim, F-54501 Vandoeuvre Les Nancy, France.	antonio.caracausi@ingv.it	Füri, Evelyn/N-7691-2016; Füri, Evelyn/AFT-7364-2022	Füri, Evelyn/0000-0002-7680-2478; Füri, Evelyn/0000-0002-7680-2478; Caracausi, Antonio/0000-0003-2510-2890; Avice, Guillaume/0000-0003-0962-0049	Instituto Nazionale di Geofisica e Vulcanologia; European Research Council under European Community [267255]; Deep Carbon Observatory	Instituto Nazionale di Geofisica e Vulcanologia; European Research Council under European Community(European Research Council (ERC)); Deep Carbon Observatory	This work is dedicated to Peter G. Burnard, who passed away after the submission of the manuscript. This study was supported by the Instituto Nazionale di Geofisica e Vulcanologia, by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 grant agreement no. 267255) and by the Deep Carbon Observatory. D. L. Hamilton helped in setting up the new mass spectrometry system at CRPG. This is CRPG contribution #2413.	Avice G, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0260; Ballentine CJ, 2005, NATURE, V433, P33, DOI 10.1038/nature03182; Ballentine CJ, 2001, NATURE, V409, P327, DOI 10.1038/35053046; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Brauer K, 2013, CHEM GEOL, V356, P193, DOI 10.1016/j.chemgeo.2013.08.013; Budweg M, 2006, GEOPHYS J INT, V166, P579, DOI 10.1111/j.1365-246X.2005.02778.x; Buikin A, 2005, EARTH PLANET SC LETT, V230, P143, DOI 10.1016/j.epsl.2004.11.001; Caffee MW, 1999, SCIENCE, V285, P2115, DOI 10.1126/science.285.5436.2115; Goes S, 1999, SCIENCE, V286, P1928, DOI 10.1126/science.286.5446.1928; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Harper CL, 1996, SCIENCE, V273, P1814, DOI 10.1126/science.273.5283.1814; HOERNLE K, 1995, NATURE, V374, P34, DOI 10.1038/374034a0; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; Holland G, 2009, SCIENCE, V326, P1522, DOI 10.1126/science.1179518; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; Hudson G.B., 1989, LUNAR PLANETARY SCI, V19, P547; MARTY B, 1989, EARTH PLANET SC LETT, V94, P45, DOI 10.1016/0012-821X(89)90082-4; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; Meshik A, 2014, GEOCHIM COSMOCHIM AC, V127, P326, DOI 10.1016/j.gca.2013.11.030; Ott U, 2014, CHEM ERDE-GEOCHEM, V74, P519, DOI 10.1016/j.chemer.2014.01.003; Parai R, 2015, GEOCHEM GEOPHY GEOSY, V16, P719, DOI 10.1002/2014GC005566; Pepin RO, 2006, EARTH PLANET SC LETT, V250, P470, DOI 10.1016/j.epsl.2006.08.014; Porcelli D, 2002, REV MINERAL GEOCHEM, V47, P411, DOI 10.2138/rmg.2002.47.11; Ritter J.R.R., 2007, MANTLE PLUMES MULTID, P379; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Takaoka N., 1972, J MASS SPECTROSC SOC, V20, P287; Touboul M, 2012, SCIENCE, V335, P1065, DOI 10.1126/science.1216351; Wedepohl KH, 1999, CONTRIB MINERAL PETR, V136, P225, DOI 10.1007/s004100050534	30	55	55	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					82	+		10.1038/nature17434	http://dx.doi.org/10.1038/nature17434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27111512				2022-12-28	WOS:000375473900043
J	Li, JH; Lu, E; Yi, TS; Cyster, JG				Li, Jianhua; Lu, Erick; Yi, Tangsheng; Cyster, Jason G.			EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells	NATURE			English	Article							FOLLICULAR HELPER-CELLS; GERMINAL CENTER; IMMUNE-RESPONSES; T-CELLS; LISTERIA-MONOCYTOGENES; ANTIBODY-RESPONSES; DIFFERENTIATION; INTERLEUKIN-2; EXPRESSION; GENERATION	T follicular helper (Tfh) cells are a subset of T cells carrying the CD4 antigen; they are important in supporting plasma cell and germinal centre responses(1,2). The initial induction of Tfh cell properties occurs within the first few days after activation by antigen recognition on dendritic cells, although how dendritic cells promote this cell-fate decision is not fully understood(1,2). Moreover, although Tfh cells are uniquely defined by expression of the follicle-homing receptor CXCR5 (refs 1, 2), the guidance receptor promoting the earlier localization of activated T cells at the interface of the B-cell follicle and T zone has been unclear(3-5). Here we show that the G-protein-coupled receptor EBI2 (GPR183) and its ligand 7 alpha,25-dihydroxycholesterol mediate positioning of activated CD4 T cells at the interface of the follicle and T zone. In this location they interact with activated dendritic cells and are exposed to Tfh-cell-promoting inducible co-stimulator (ICOS) ligand. Interleukin-2 (IL-2) is a cytokine that has multiple influences on T-cell fate, including negative regulation of Tfh cell differentiation(6-10). We demonstrate that activated dendritic cells in the outer T zone further augment Tfh cell differentiation by producing membrane and soluble forms of CD25, the IL-2 receptor alpha-chain, and quenching T-cell-derived IL-2. Mice lacking EBI2 in T cells or CD25 in dendritic cells have reduced Tfh cells and mount defective T-cell-dependent plasma cell and germinal centre responses. These findings demonstrate that distinct niches within the lymphoid organ T zone support distinct cell fate decisions, and they establish a function for dendritic-cell-derived CD25 in controlling IL-2 availability and T-cell differentiation.	[Li, Jianhua; Lu, Erick; Yi, Tangsheng; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Li, Jianhua; Lu, Erick; Yi, Tangsheng; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Li, Jianhua] Fudan Univ, Dept Med Microbiol, Sch Basic Med Sci, Key Lab Med Mol Virol,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yi, Tangsheng] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Fudan University; Roche Holding; Genentech	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Li, Jianhua/0000-0001-7329-5688; Lu, Erick/0000-0001-8175-5146	University of California, San Francisco, Biomedical Sciences (BMS) Graduate program; National Science Foundation [1144247]; National Institutes of Health [AI40098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098, T32AI007334] Funding Source: NIH RePORTER	University of California, San Francisco, Biomedical Sciences (BMS) Graduate program; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Allen, M. Ansel, T. Defranco, M. Muschen and S. Sanjabi for mice, J. An for help with the mouse colony, Y. Xu for help with quantitative PCR, and A. Abbas and M. Barnes for comments on the manuscript. J.G.C. is an investigator of the Howard Hughes Medical Institute. E.L. is supported by the University of California, San Francisco, Biomedical Sciences (BMS) Graduate program and the National Science Foundation (grant number 1144247). This work was supported in part by National Institutes of Health grant AI40098.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Carlsson F, 2009, SCAND J IMMUNOL, V70, P77, DOI 10.1111/j.1365-3083.2009.02274.x; Chistiakov DA, 2011, SCAND J IMMUNOL, V74, P496, DOI 10.1111/j.1365-3083.2011.02608.x; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Fukao T, 2000, EUR J IMMUNOL, V30, P1453, DOI 10.1002/(SICI)1521-4141(200005)30:5<1453::AID-IMMU1453>3.0.CO;2-W; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Liang DC, 2012, J IMMUNOL, V188, P5785, DOI 10.4049/jimmunol.1200109; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Logue EC, 2006, J IMMUNOL, V177, P2356, DOI 10.4049/jimmunol.177.4.2356; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Marczynska J, 2014, J IMMUNOL, V193, P2753, DOI 10.4049/jimmunol.1302893; Meli AP, 2015, METHODS MOL BIOL, V1291, P3, DOI 10.1007/978-1-4939-2498-1_1; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Popov A, 2008, J IMMUNOL, V181, P4976, DOI 10.4049/jimmunol.181.7.4976; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	36	166	172	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					110	+		10.1038/nature17947	http://dx.doi.org/10.1038/nature17947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27147029	Green Submitted, Green Accepted			2022-12-28	WOS:000375473900049
J	Li, D; Betzig, E				Li, Dong; Betzig, Eric			Response to Comment on "Extended-resolution structured illumination imaging of endocytic and cytoskeletal dynamics"	SCIENCE			English	Editorial Material							SUPERRESOLUTION MICROSCOPY; CELLS; FILAMENTS	Sahl et al. in their Comment raise criticisms of our work that fall into three classes: image artifacts, resolution criteria, and comparative performance on live cells. We explore each of these in turn.	[Li, Dong] Chinese Acad Sci, Inst Biophys, Natl Lab Biol Macromol, Beijing 100101, Peoples R China; [Li, Dong; Betzig, Eric] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute	Li, D (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biol Macromol, Beijing 100101, Peoples R China.; Li, D; Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	lidong@ibp.ac.cn; betzige@janelia.hhmi.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Burnette DT, 2014, J CELL BIOL, V205, P83, DOI 10.1083/jcb.201311104; Conduit PT, 2014, ELIFE, V3, DOI 10.7554/eLife.03399; Demmerle J, 2015, METHODS, V88, P3, DOI 10.1016/j.ymeth.2015.07.001; Hagen C, 2015, CELL, V163, P1692, DOI 10.1016/j.cell.2015.11.029; Hecht E., 2002, OPTICS, V5; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; Komis G, 2014, PLANT PHYSIOL, V165, P129, DOI 10.1104/pp.114.238477; Konig K, 1996, HUM REPROD, V11, P2162; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; PANTIN E, 2007, BIND IMAGE DECONVOLU, P277; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Sahl SJ, 2016, SCIENCE, V352, DOI 10.1126/science.aad7983; von Olshausen P, 2013, BIOPHYS J, V105, P1171, DOI 10.1016/j.bpj.2013.07.038; Waldchen S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15348	17	28	28	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285								10.1126/science.aad8396	http://dx.doi.org/10.1126/science.aad8396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126031				2022-12-28	WOS:000374998600029
J	Oliver, D				Oliver, David			David Oliver: Good medical leaders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Ham C, 2016, KINGS FUND BLOG 0418; Lees Peter, 2015, Future Hosp J, V2, P208, DOI 10.7861/futurehosp.2-3-208; Lees Peter, 2015, Future Hosp J, V2, P157, DOI 10.7861/futurehosp.2-3-157; Nath V., 2013, MED LEADERSHIP MOVIN; Newbold M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4082; NHS England, QUAL IMPR CLIN LEAD; Oliver D, 2013, HLTH SERV J; Press Association, 2016, AOL             0420; Royal College of Physicians, MED LEAD E LEARN COU; Smyth C, 2013, TIMES	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2369	10.1136/bmj.i2369	http://dx.doi.org/10.1136/bmj.i2369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129888	Green Published, Bronze			2022-12-28	WOS:000375484100002
J	Shahar, A; Schauble, EA; Caracas, R; Gleason, AE; Reagan, MM; Xiao, Y; Shu, J; Mao, W				Shahar, A.; Schauble, E. A.; Caracas, R.; Gleason, A. E.; Reagan, M. M.; Xiao, Y.; Shu, J.; Mao, W.			Pressure-dependent isotopic composition of iron alloys	SCIENCE			English	Article							FRACTIONATION FACTORS; LATTICE-PARAMETER; EARTHS CORE; HYDROGEN; MANTLE; CALIBRATION; ACCRETION; MINERALS; CARBON; WATER	Our current understanding of Earth's core formation is limited by the fact that this profound event is far removed from us physically and temporally. The composition of the iron metal in the core was a result of the conditions of its formation, which has important implications for our planet's geochemical evolution and physical history. We present experimental and theoretical evidence for the effect of pressure on iron isotopic composition, which we found to vary according to the alloy tested (FeO, FeHx, or Fe3C versus pure Fe). These results suggest that hydrogen or carbon is not the major light-element component in the core. The pressure dependence of iron isotopic composition provides an independent constraint on Earth's core composition.	[Shahar, A.; Shu, J.] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Schauble, E. A.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Caracas, R.] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, Lab Geol Lyon,UMR 5276, F-69364 Lyon 07, France; [Gleason, A. E.] Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA; [Reagan, M. M.; Mao, W.] Stanford Univ, Dept Geol Sci, Stanford, CA 94305 USA; [Xiao, Y.] Carnegie Inst Sci, HPCAT, Argonne, IL USA	Carnegie Institution for Science; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; United States Department of Energy (DOE); Los Alamos National Laboratory; Stanford University; Carnegie Institution for Science	Shahar, A (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	ashahar@carnegiescience.edu	Caracas, Razvan/C-8115-2012; Schauble, Edwin A/E-7812-2012	Gleason, Arianna/0000-0002-7736-5118; Caracas, Razvan/0000-0003-4586-776X	Stanford University Blaustein Fellowship; NSF [EAR1321858, EAR1464008, EAR1530306]; CNRS PICS grant [x2015106368]; Directorate For Geosciences [1530306] Funding Source: National Science Foundation	Stanford University Blaustein Fellowship; NSF(National Science Foundation (NSF)); CNRS PICS grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by a Stanford University Blaustein Fellowship during which this project developed, and NSF grant EAR1321858 (A.S.); NSF grant EAR1464008 (A.S. and W.M.); NSF grant EAR1530306 (E.A.S.), and CNRS PICS grant Carmelts and eDARI/CINES grant x2015106368 for computational resources (R.C.). The complete data tables for this study can be found on www.gl.ciw.edu/static/users/ashahar/shahar_nrixs/. We thank four anonymous reviewers for providing very helpful comments and suggestions.	Badro J, 2014, P NATL ACAD SCI USA, V111, P7542, DOI 10.1073/pnas.1316708111; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; BUSCHERT RC, 1988, PHYS REV B, V38, P5219, DOI 10.1103/PhysRevB.38.5219; Caracas R, 2015, GEOPHYS RES LETT, V42, P3780, DOI 10.1002/2015GL063478; Chen B, 2014, P NATL ACAD SCI USA, V111, P17755, DOI 10.1073/pnas.1411154111; CLAYTON RN, 1975, GEOCHIM COSMOCHIM AC, V39, P1197, DOI 10.1016/0016-7037(75)90062-9; Craddock PR, 2013, EARTH PLANET SC LETT, V365, P63, DOI 10.1016/j.epsl.2013.01.011; Dauphas N, 2012, GEOCHIM COSMOCHIM AC, V94, P254, DOI 10.1016/j.gca.2012.06.013; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gonze X, 2009, COMPUT PHYS COMMUN, V180, P2582, DOI 10.1016/j.cpc.2009.07.007; Herrero CP, 2001, J PHYS-CONDENS MAT, V13, P5127, DOI 10.1088/0953-8984/13/22/309; Hoering TC, 1961, CARNEGIE I WASHINGTO, V60, P201; Horita J, 1999, SCIENCE, V286, P1545, DOI 10.1126/science.286.5444.1545; JOY HW, 1960, J CHEM PHYS, V33, P1276, DOI 10.1063/1.1731392; Litasov KD, 2015, RUSS GEOL GEOPHYS+, V56, P164, DOI 10.1016/j.rgg.2015.01.010; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; MATSUHISA Y, 1979, GEOCHIM COSMOCHIM AC, V43, P1131, DOI 10.1016/0016-7037(79)90099-1; MATTHEWS A, 1983, GEOCHIM COSMOCHIM AC, V47, P631, DOI 10.1016/0016-7037(83)90284-3; Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Poitrasson F, 2009, EARTH PLANET SC LETT, V278, P376, DOI 10.1016/j.epsl.2008.12.025; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Polyakov VB, 1998, GEOCHIM COSMOCHIM AC, V62, P3077, DOI 10.1016/S0016-7037(98)00220-8; Polyakov VB, 2005, GEOCHIM COSMOCHIM AC, V69, P5531, DOI 10.1016/j.gca.2005.07.010; Polyakov VB, 2009, SCIENCE, V323, P912, DOI 10.1126/science.1166329; Rustad JR, 2009, NAT GEOSCI, V2, P514, DOI 10.1038/ngeo546; Sakamaki T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500802; Shahar A, 2015, GEOCHIM COSMOCHIM AC, V150, P253, DOI 10.1016/j.gca.2014.08.011; Siebert J, 2013, SCIENCE, V339, P1194, DOI 10.1126/science.1227923; Tschauner O, 2014, SCIENCE, V346, P1100, DOI 10.1126/science.1259369; Williams Q, 2001, ANNU REV EARTH PL SC, V29, P365, DOI 10.1146/annurev.earth.29.1.365; Wood BJ, 2013, REV MINERAL GEOCHEM, V75, P231, DOI 10.2138/rmg.2013.75.8	31	50	50	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					580	582		10.1126/science.aad9945	http://dx.doi.org/10.1126/science.aad9945			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126042				2022-12-28	WOS:000374998600043
J	Britton, J; Arnott, D; McNeill, A; Hopkinson, N				Britton, John; Arnott, Deborah; McNeill, Ann; Hopkinson, Nicholas		Royal Coll Phys	Nicotine without smoke-putting electronic cigarettes in context	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Britton, John; McNeill, Ann] Univ Nottingham, Div Epidemiol & Publ Hlth, Ctr Tobacco & Alcohol Studies, Nottingham NG5 1PB, England; [Arnott, Deborah] Act Smoking & Hlth, London, England; [McNeill, Ann] Kings Coll London, London WC2R 2LS, England; [Hopkinson, Nicholas] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	University of Nottingham; University of London; King's College London; Imperial College London	Britton, J (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Ctr Tobacco & Alcohol Studies, Nottingham NG5 1PB, England.	j.britton@outlook.com		Britton, John/0000-0001-6375-3841; McNeill, Ann/0000-0002-6223-4000	Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Action on Smoking and Health, 2015, SMOK STILL KILLS PRO; Action on Smoking and Health, 2016, EL CIG; [Anonymous], 1999, CURBING EPIDEMIC GOV; Britton J., 2014, ELECT CIGARETTES REP; Brose LS, 2015, DRUG ALCOHOL DEPEN, V157, P106, DOI 10.1016/j.drugalcdep.2015.10.014; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Health and Social Care Information Centre, 2015, STAT NHS STOP SMOK S; McNeill A., 2015, REPORT COMMISSIONED; National Institute for Health and Care Excellence, 2013, TOB HARM RED APPR SM; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Royal College of Physicians, 2010, PASS SMOK CHILDR REP; Royal College of Physicians, 1962, SMOKING HLTH REPORT; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Secretariat of the WHO Framework Convention on Tobacco Control, 2019, INF NOT CLASS NOV EM; Tobacco Advisory Group of the Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Tobacco Advisory Group of the Royal College of Physicians, 2007, HARM RED NIC ADD; Tobacco Advisory Group of the Royal College of Physicians, 2002, PROT SMOK SAV LIV CA; World Health Organisation (WHO), 2008, WHO FRAM CONV TOB CO; World Health Organization, 2008, WHO REP GLOB TOB EP	19	33	34	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i1745	10.1136/bmj.i1745	http://dx.doi.org/10.1136/bmj.i1745			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27122374	Green Published			2022-12-28	WOS:000375483300001
J	Ropers, C				Ropers, Claus			Electrons catch a terahertz wave	SCIENCE			English	Editorial Material									[Ropers, Claus] Univ Gottingen, Phys Inst 4, D-37077 Gottingen, Germany; [Ropers, Claus] Univ Gottingen, Int Ctr Adv Studies Energy Convers, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen	Ropers, C (corresponding author), Univ Gottingen, Phys Inst 4, D-37077 Gottingen, Germany.; Ropers, C (corresponding author), Univ Gottingen, Int Ctr Adv Studies Energy Convers, D-37077 Gottingen, Germany.	cropers@gwdg.de	Ropers, Claus/D-4843-2015	Ropers, Claus/0000-0002-9539-3817				Fabianska J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05645; Feist A, 2015, NATURE, V521, P200, DOI 10.1038/nature14463; Gulde M, 2014, SCIENCE, V345, P200, DOI 10.1126/science.1250658; Hemsing E, 2014, REV MOD PHYS, V86, P897, DOI 10.1103/RevModPhys.86.897; Hoffrogge J, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867185; de Abajo FJG, 2010, NANO LETT, V10, P1859, DOI 10.1021/nl100613s; Kealhofer C, 2016, SCIENCE, V352, P429, DOI 10.1126/science.aae0003; Miller RJD, 2014, SCIENCE, V343, P1108, DOI 10.1126/science.1248488; Muller M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6292; Nanni EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9486; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; van Oudheusden T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.264801; Wimmer L, 2014, NAT PHYS, V10, P432, DOI [10.1038/NPHYS2974, 10.1038/nphys2974]; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	14	5	5	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					410	411		10.1126/science.aaf6393	http://dx.doi.org/10.1126/science.aaf6393			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102465				2022-12-28	WOS:000374479700024
J	Wolynes, P				Wolynes, Peter			Moments of excitement	SCIENCE			English	Editorial Material									[Wolynes, Peter] Rice Univ, Dept Chem, POB 1892, Houston, TX 77251 USA	Rice University	Wolynes, P (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77251 USA.	pwolynes@rice.edu						BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Chaudhury S, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3459058; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Neupane K, 2016, SCIENCE, V352, P239, DOI 10.1126/science.aad0637; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185	6	7	7	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					150	151		10.1126/science.aaf6626	http://dx.doi.org/10.1126/science.aaf6626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI7LM	27124442				2022-12-28	WOS:000373681600025
J	Evans-Lacko, S; Ribeiro, W; Brietzke, E; Knapp, M; Mari, J; McDaid, D; Paula, CS; Romeo, R; Thornicroft, G; Wissow, L				Evans-Lacko, Sara; Ribeiro, Wagner; Brietzke, Elisa; Knapp, Martin; Mari, Jair; McDaid, David; Paula, Cristiane S.; Romeo, Renee; Thornicroft, Graham; Wissow, Lawrence			Lean economies and innovation in mental health systems	LANCET			English	Editorial Material							CARE; INTERVENTION; DEPRESSION; PEOPLE; IMPACT; TRIAL		[Evans-Lacko, Sara; Ribeiro, Wagner; Knapp, Martin; McDaid, David] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, Houghton St, London WC2A 2AE, England; [Evans-Lacko, Sara; Thornicroft, Graham] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London WC2R 2LS, England; [Brietzke, Elisa; Mari, Jair; Paula, Cristiane S.] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Paula, Cristiane S.] Univ Prebiteriana Mackenzie, Dev Disorder Program, Sao Paulo, Brazil; [Romeo, Renee] Kings Coll London, Kings Hlth Econ, London WC2R 2LS, England; [Wissow, Lawrence] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	University of London; London School Economics & Political Science; University of London; King's College London; Universidade Federal de Sao Paulo (UNIFESP); Universidade Presbiteriana Mackenzie; University of London; King's College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Evans-Lacko, S (corresponding author), Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, Houghton St, London WC2A 2AE, England.; Evans-Lacko, S (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London WC2R 2LS, England.	s.evans-lacko@lse.ac.uk	de Jesus Mari, Jair/A-7309-2008; Brietzke, Elisa/G-9559-2012; Paula, Cristiane Silvestre/D-8968-2017; McDaid, David/E-5959-2014; Ribeiro, Wagner Silva/O-2927-2018; Thornicroft, Graham/B-4027-2010; Evans-Lacko, Sara/A-8768-2011; /E-3261-2010	de Jesus Mari, Jair/0000-0002-5403-0112; Brietzke, Elisa/0000-0003-2697-1342; Paula, Cristiane Silvestre/0000-0003-0438-9407; McDaid, David/0000-0003-0744-2664; Ribeiro, Wagner Silva/0000-0001-6735-3861; Thornicroft, Graham/0000-0003-0662-0879; Evans-Lacko, Sara/0000-0003-4691-2630; Knapp, Martin/0000-0003-1427-0215; /0000-0003-3871-9697	National Institute for Health Research [NF-SI-0611-10053, NF-SI-0512-10158] Funding Source: researchfish; European Research Council [337673] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission)		Chatterjee S, 2014, LANCET, V383, P1385, DOI 10.1016/S0140-6736(13)62629-X; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-828; Clark F, 2014, LANCET, V383, P114, DOI 10.1016/S0140-6736(13)62706-3; Evans-Lacko S, 2012, PSYCHOL MED, V42, P1741, DOI 10.1017/S0033291711002558; Jenkins R, 2007, B WORLD HEALTH ORGAN, V85, P858, DOI 10.2471/BLT.06.039156; Lang M, 2013, HEALTH ECON, V22, P73, DOI 10.1002/hec.1816; Marmot M, 2010, FAIR SOC HLTH LIVES; Paula CS, 2012, REV BRAS PSIQUIATR, V34, P334, DOI 10.1016/j.rbp.2012.04.001; Petersen I, 2016, DIS CONTROL PRIORITI, P183; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Wahlbeck K, 2012, WORLD PSYCHIATRY, V11, P139; Wells KB, 2013, J GEN INTERN MED, V28, P1268, DOI 10.1007/s11606-013-2484-3; Wissow LS, 2016, PEDIATR CLIN N AM, V63, P97, DOI 10.1016/j.pcl.2015.08.005	13	13	13	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1356	1358		10.1016/S0140-6736(16)30090-3	http://dx.doi.org/10.1016/S0140-6736(16)30090-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI0WH	27115800	Green Submitted, Green Accepted			2022-12-28	WOS:000373217500011
J	Wenzel, S; Castro, M; Corren, J; Maspero, J; Wang, L; Zhang, BZ; Pirozzi, G; Sutherland, ER; Evans, RR; Joish, VN; Eckert, L; Graham, NMH; Stahl, N; Yancopoulos, GD; Louis-Tisserand, M; Teper, A				Wenzel, Sally; Castro, Mario; Corren, Jonathan; Maspero, Jorge; Wang, Lin; Zhang, Bingzhi; Pirozzi, Gianluca; Sutherland, E. Rand; Evans, Robert R.; Joish, Vijay N.; Eckert, Laurent; Graham, Neil M. H.; Stahl, Neil; Yancopoulos, George D.; Louis-Tisserand, Mariana; Teper, Ariel			Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta(2) agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial	LANCET			English	Article							QUALITY-OF-LIFE; EXACERBATIONS; INFLAMMATION; PREVALENCE; OMALIZUMAB	Background Dupilumab, a fully human anti-interleukin-4 receptor a monoclonal antibody, inhibits interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated inflammation. Adults with uncontrolled persistent asthma who are receiving medium-to-high-dose inhaled corticosteroids plus a long-acting beta(2) agonist require additional treatment options as add-on therapy. We aimed to assess the efficacy and safety of dupilumab as add-on therapy in patients with uncontrolled persistent asthma on medium-to-high-dose inhaled corticosteroids plus a long-acting beta(2) agonist, irrespective of baseline eosinophil count. Methods We did this randomised, double-blind, placebo-controlled, parallel-group, pivotal phase 2b clinical trial at 174 study sites across 16 countries or regions. Adults (aged >= 18 years) with an asthma diagnosis for 12 months or more based on the Global Initiative for Asthma 2009 Guidelines receiving treatment with medium-to-high-dose inhaled corticosteroids plus a long-acting beta(2) agonist were eligible for participation. Patients were randomly assigned (1:1:1:1:1) to receive subcutaneous dupilumab 200 mg or 300 mg every 2 weeks or every 4 weeks, or placebo, over a 24-week period. The primary endpoint was change from baseline at week 12 in forced expiratory volume in 1 s (FEV1 in L) in patients with baseline blood eosinophil counts of at least 300 eosinophils per mu L assessed in the intention-to-treat population. Safety outcomes were assessed in all patients that received at least one dose or part of a dose of study drug. This trial is registered at ClinicalTrials.gov, number NCT01854047, and with the EU Clinical Trials Register, EudraCT number 2013-000856-16. Findings 769 patients (158 in the placebo group and 611 in the dupilumab groups) received at least one dose of study drug. In the subgroup with at least 300 eosinophils per mu L, the greatest increases (200 mg every 2 weeks, p=0.0008; 300 mg every 2 weeks, p=0.0063) in FEV 1 compared with placebo were observed at week 12 with doses every 2 weeks in the 300 mg group (mean change 0.39 L [SE 0.05]; mean difference 0.21 [95% CI 0.06-0.36; p=0.0063]) and in the 200 mg group (mean change 0.43 L [SE 0.05]; mean difference 0.26 [0.11-0.40; p=0.0008]) compared with placebo (0.18 L [SE 0.05]). Similar significant increases were observed in the overall population and in the fewer than 300 eosinophils per mu L subgroup (overall population: 200 mg every 2 weeks, p< 0.0001; 300 mg every 2 weeks, p< 0.0001; < 300 eosinophils per mu L: 200 mg every 2 weeks, p=0.0034; 300 mg every 2 weeks, p=0.0086), and were maintained to week 24. Likewise, dupilumab every 2 weeks produced the greatest reductions in annualised rates of exacerbation in the overall population (70-70.5%), the subgroup with at least 300 eosinophils per mu L (71.2-80.7%), and the subgroup with fewer than 300 eosinophils per mu L (59.9-67.6%). The most common adverse events with dupilumab compared with placebo were upper respiratory tract infections (33-41% vs 35%) and injection-site reactions (13-26% vs 13%). Interpretation Dupilumab increased lung function and reduced severe exacerbations in patients with uncontrolled persistent asthma irrespective of baseline eosinophil count and had a favourable safety profile, and hence in addition to inhaled corticosteroids plus long-acting beta(2)-agonist therapy could improve the lives of patients with uncontrolled persistent asthma compared with standard therapy alone.	[Wenzel, Sally] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Castro, Mario] Washington Univ, Sch Med, St Louis, MO USA; [Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Maspero, Jorge] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Wang, Lin; Zhang, Bingzhi; Pirozzi, Gianluca; Sutherland, E. Rand; Louis-Tisserand, Mariana; Teper, Ariel] Sanofi, Bridgewater, MA USA; [Evans, Robert R.; Joish, Vijay N.; Graham, Neil M. H.; Stahl, Neil; Yancopoulos, George D.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Eckert, Laurent] Sanofi, Chilly Mazarin, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Sanofi-Aventis; Regeneron; Sanofi-Aventis; Sanofi France	Wenzel, S (corresponding author), Univ Pittsburgh, NW 931 Montefiore Hosp, Pittsburgh, PA 15213 USA.	wenzelse@upmc.edu		Wenzel, Sally/0000-0002-4242-0164	Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	This research was sponsored by Sanofi and Regeneron Pharmaceuticals. We thank the patients who participated in this study, the principal study investigators (appendix), and the following individuals from Sanofi and Regeneron Pharmaceuticals: Paul Cavanaugh, Jeffrey Cortez, Nicolas Duverger, Benjamin Ortiz, Franck Skobieranda, Brian Swanson, Pauline Wijnand (Sanofi), Judith Cusick, Rebecca Gall, Jaman Maroni, Jennifer Hamilton, Steven Weinstein, Linda Williams (Regeneron Pharmaceuticals). Editorial assistance with drafting the report following the authors' guidance, incorporating comments according to authors' feedback, and providing support with submission was provided by Marinella Calle, Xiomara Thomas, and Ronald van Olffen of Excerpta Medica, funded by Sanofi and Regeneron Pharmaceuticals.	Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bateman ED, 2015, J ALLERGY CLIN IMMUN, V135, P1457, DOI 10.1016/j.jaci.2014.08.015; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bingefors K, 2013, ACTA DERM-VENEREOL, V93, P438, DOI 10.2340/00015555-1522; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Chung KF, 2015, LANCET, V386, P1086, DOI 10.1016/S0140-6736(15)00157-9; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Forno E, 2012, CURR OPIN PULM MED, V18, P63, DOI 10.1097/MCP.0b013e32834db288; Gandhi NA, 2016, NAT REV DRUG DISCOV, V15, P35, DOI 10.1038/nrd4624; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Global Initiative for Asthma (GINA), 2015, GLOB STRAT ASTHM MAN; Global Strategy for Asthma Management and Prevention, 2009, GLOB STRAT ASTHM MAN; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Humbert M, 2014, J ALLER CL IMM-PRACT, V2, P525, DOI 10.1016/j.jaip.2014.03.010; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Katz Lynn E, 2014, Ann Am Thorac Soc, V11, P531, DOI 10.1513/AnnalsATS.201310-354OC; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Normansell R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub4; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	30	556	573	2	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					31	44		10.1016/S0140-6736(16)30307-5	http://dx.doi.org/10.1016/S0140-6736(16)30307-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27130691				2022-12-28	WOS:000378828400026
J	Sumpter, R; Sirasanagandla, S; Fernandez, AF; Wei, YJ; Dong, XN; Franco, L; Zou, ZJ; Marchal, C; Lee, MY; Clapp, DW; Hanenberg, H; Levine, B				Sumpter, Rhea, Jr.; Sirasanagandla, Shyam; Fernandez, Alvaro F.; Wei, Yongjie; Dong, Xiaonan; Franco, Luis; Zou, Zhongju; Marchal, Christophe; Lee, Ming Yeh; Clapp, D. Wade; Hanenberg, Helmut; Levine, Beth			Fanconi Anemia Proteins Function in Mitophagy and Immunity	CELL			English	Article							SIMPLEX-VIRUS TYPE-1; HUMAN-PAPILLOMAVIRUS; SELECTIVE AUTOPHAGY; OXIDATIVE STRESS; BONE-MARROW; IN-VITRO; CANCER; CELLS; GENE; DISEASE	Fanconi anemia (FA) pathway genes are important tumor suppressors whose best-characterized function is repair of damaged nuclear DNA. Here, we describe an essential role for FA genes in two forms of selective autophagy. Genetic deletion of Fancc blocks the autophagic clearance of viruses (virophagy) and increases susceptibility to lethal viral encephalitis. Fanconi anemia complementation group C (FANCC) protein interacts with Parkin, is required in vitro and in vivo for clearance of damaged mitochondria, and decreases mitochondrial reactive oxygen species (ROS) production and inflammasome activation. The mitophagy function of FANCC is genetically distinct from its role in genomic DNA damage repair. Moreover, additional genes in the FA pathway, including FANCA, FANCF, FANCL, FANCD2, BRCA1, and BRCA2, are required for mitophagy. Thus, members of the FA pathway represent a previously undescribed class of selective autophagy genes that function in immunity and organellar homeostasis. These findings have implications for understanding the pathogenesis of FA and cancers associated with mutations in FA genes.	[Sumpter, Rhea, Jr.; Sirasanagandla, Shyam; Fernandez, Alvaro F.; Wei, Yongjie; Dong, Xiaonan; Franco, Luis; Zou, Zhongju; Lee, Ming Yeh; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dept Internal Med, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Fernandez, Alvaro F.] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Marchal, Christophe; Clapp, D. Wade] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Univ Duisburg Essen, Dept Pediat 3, D-45122 Essen, Germany; [Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Indiana University System; Indiana University Bloomington; University of Duisburg Essen; Heinrich Heine University Dusseldorf	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dept Internal Med, Dallas, TX 75390 USA.; Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Sumpter, Jr., Rhea/N-8152-2018; Franco, Luis H/M-4636-2017; Fernández, Álvaro F./A-7375-2019	Franco, Luis H/0000-0002-8143-1384; Fernández, Álvaro F./0000-0002-7704-4285; Deldicque, Louise/0000-0003-3393-5278; Dong, Xiaonan/0000-0001-7967-2755	NIH [K08AI099150, CA155294, U19 AI109725, RO1 CA109618]; CPRIT grant [RP120718]; UTSW PRC Award; Burroughs Wellcome CAMS; Ministerio de Educacion of Spain; Lilly Foundation Physician/Scientist initiative; Walther Oncology Foundation; NATIONAL CANCER INSTITUTE [R01CA155294, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, K08AI099150, T32AI070116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT grant; UTSW PRC Award; Burroughs Wellcome CAMS(Burroughs Wellcome Fund); Ministerio de Educacion of Spain(Spanish Government); Lilly Foundation Physician/Scientist initiative; Walther Oncology Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. MacDonald, N. Mizushima, R. Thompson, and R. Youle for providing critical reagents; D. Chan, A. Orvedahl, and T. Ross for helpful discussions; L. Nguyen and S.L. Kelich for technical assistance; A. Bugde, P. Doss, R. Leidel, and A. Darehshouri for assistance with light and electron microscopy; and H. Smith for assistance with manuscript preparation. This work was supported by NIH grants K08AI099150 (R.S.), CA155294 (H.H.), U19 AI109725 (B.L.) and RO1 CA109618 (B.L), CPRIT grant RP120718 (B.L.), a UTSW PRC Award (R.S.), a Burroughs Wellcome CAMS (R.S.), a fellowship from Ministerio de Educacion of Spain (A.F.), the Lilly Foundation Physician/Scientist initiative (H. H.), and the Walther Oncology Foundation (H.H).	Bagby GC, 2006, SEMIN HEMATOL, V43, P147, DOI 10.1053/j.seminhematol.2006.04.005; Bogliolo M, 2015, CURR OPIN GENET DEV, V33, P32, DOI 10.1016/j.gde.2015.07.002; Chourasia AH, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0130-8; Comar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079683; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garbati MR, 2013, BLOOD, V122, P3197, DOI 10.1182/blood-2013-02-484816; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Haneline LS, 1998, BLOOD, V91, P4092; Hoskins EE, 2012, J VIROL, V86, P8131, DOI 10.1128/JVI.00408-12; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu GB, 2015, REV MED VIROL, V25, P345, DOI 10.1002/rmv.1834; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neveling K, 2009, MUTAT RES-FUND MOL M, V668, P73, DOI 10.1016/j.mrfmmm.2009.05.006; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Pagano G, 2013, FREE RADICAL BIO MED, V58, P118, DOI 10.1016/j.freeradbiomed.2013.01.015; Pang QS, 2001, BLOOD, V98, P1392, DOI 10.1182/blood.V98.5.1392; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Preobrazhenska O, 2002, ONCOGENE, V21, P5660, DOI 10.1038/sj.onc.1205732; PYLES RB, 1994, J VIROL, V68, P4514, DOI 10.1128/JVI.68.7.4514-4524.1994; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sauter SL, 2015, CANCER EPIDEM BIOMAR, V24, P864, DOI 10.1158/1055-9965.EPI-15-0097-T; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Xu L, 2014, J MOL MED, V92, P31, DOI 10.1007/s00109-013-1107-0; Yamashita T, 1996, BLOOD, V87, P4424, DOI 10.1182/blood.V87.10.4424.bloodjournal87104424; Yordy B, 2013, AUTOPHAGY, V9, P236, DOI 10.4161/auto.22506; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	46	163	165	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					867	881		10.1016/j.cell.2016.04.006	http://dx.doi.org/10.1016/j.cell.2016.04.006			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27133164	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000375800300015
J	Tarazona, OA; Slota, LA; Lopez, DH; Zhang, GJ; Cohn, MJ				Tarazona, Oscar A.; Slota, Leslie A.; Lopez, Davys H.; Zhang, GuangJun; Cohn, Martin J.			The genetic program for cartilage development has deep homology within Bilateria	NATURE			English	Article							II COLLAGEN; CHONDROCYTE DIFFERENTIATION; NEURAL CREST; EVOLUTION; SOX9; EXPRESSION; SEQUENCE; INSIGHTS; ANIMALS; LIMULUS	The evolution of novel cell types led to the emergence of new tissues and organs during the diversification of animals(1). The origin of the chondrocyte, the cell type that synthesizes cartilage matrix, was central to the evolution of the vertebrate endoskeleton. Cartilage-like tissues also exist outside the vertebrates, although their relationship to vertebrate cartilage is enigmatic. Here we show that protostome and deuterostome cartilage share structural and chemical properties, and that the mechanisms of cartilage development are extensively conserved-from induction of chondroprogenitor cells by Hedgehog and beta-catenin signalling, to chondrocyte differentiation and matrix synthesis by SoxE and SoxD regulation of clade A fibrillar collagen (ColA) genes-suggesting that the chondrogenic gene regulatory network evolved in the common ancestor of Bilateria. These results reveal deep homology of the genetic program for cartilage development in Bilateria and suggest that activation of this ancient core chondrogenic network underlies the parallel evolution of cartilage tissues in Ecdysozoa, Lophotrochozoa and Deuterostomia.	[Tarazona, Oscar A.; Cohn, Martin J.] Univ Florida, UF Genet Inst, Howard Hughes Med Inst, POB 103610, Gainesville, FL 32610 USA; [Tarazona, Oscar A.; Zhang, GuangJun; Cohn, Martin J.] Univ Florida, Dept Biol, POB 103610, Gainesville, FL 32610 USA; [Slota, Leslie A.; Lopez, Davys H.; Cohn, Martin J.] Univ Florida, Dept Mol Genet & Microbiol, Coll Med, POB 103610, Gainesville, FL 32610 USA; [Zhang, GuangJun] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, 625 Harrison St, W Lafayette, IN 47907 USA	Howard Hughes Medical Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cohn, MJ (corresponding author), Univ Florida, UF Genet Inst, Howard Hughes Med Inst, POB 103610, Gainesville, FL 32610 USA.; Cohn, MJ (corresponding author), Univ Florida, Dept Biol, POB 103610, Gainesville, FL 32610 USA.; Cohn, MJ (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Coll Med, POB 103610, Gainesville, FL 32610 USA.	mjcohn@ufl.edu		Zhang, GuangJun/0000-0002-0839-5161	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank B. Battelle and members of H. J. Brockmann's and David Julian's laboratories for Limulus eggs, N. Brown for sharing protocols and reagents, N. Patel and the Limulus genome consortium for access to sequence data, and M. Welten and F. Leal for assisting with optical projection tomography and luciferase assays, respectively. This project was supported by the Howard Hughes Medical Institute (to M.J.C.). O.A.T. was a Howard Hughes Medical Institute International Student Research Fellow.	Abzhanov A, 2004, DEV BIOL, V273, P134, DOI 10.1016/j.ydbio.2004.05.028; Abzhanov A., 2009, COLD SPRING HARBOR P, V2009; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Blackburn DC, 2008, DEV DYNAM, V237, P2209, DOI 10.1002/dvdy.21634; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Cole AG, 2004, ZOOLOGY, V107, P261, DOI 10.1016/j.zool.2004.05.001; Cole AG, 2004, ACTA ZOOL-STOCKHOLM, V85, P69, DOI 10.1111/j.0001-7272.2004.00159.x; COWDEN RR, 1967, HISTOCHEMISTRY, V9, P149, DOI 10.1007/BF00305859; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Grimaldi A, 2008, DEV DYNAM, V237, P659, DOI 10.1002/dvdy.21453; Hall BK, 2013, J ANAT, V222, P19, DOI 10.1111/j.1469-7580.2012.01495.x; Hall Brian K., 2005, P51, DOI 10.1016/B978-012319060-4/50006-3; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lauri A, 2014, SCIENCE, V345, P1365, DOI 10.1126/science.1253396; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1996, ANN NY ACAD SCI, V785, P284, DOI 10.1111/j.1749-6632.1996.tb56285.x; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; PERSON P, 1969, BIOL REV, V44, P1, DOI 10.1111/j.1469-185X.1969.tb00819.x; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P664, DOI 10.1101/pdb.prot5639; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P586, DOI 10.1101/pdb.top116; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Schaffer J., 1930, HDB MIKROSKOPISCHEN, P1; Sekiguchi K., 1982, Progress in Clinical and Biological Research, V81, P53; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Volpi N, 2003, BIOCHIMIE, V85, P619, DOI 10.1016/S0300-9084(03)00083-X; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P16829, DOI 10.1073/pnas.0605630103; Zhang GJ, 2009, CURR TOP DEV BIOL, V86, P15, DOI 10.1016/S0070-2153(09)01002-3	44	33	33	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					86	+		10.1038/nature17398	http://dx.doi.org/10.1038/nature17398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27111511				2022-12-28	WOS:000375473900044
J	Reuben, DB				Reuben, David B.			Update in Geriatric Medicine: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Reuben, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, 10945 Le Conte Ave, Los Angeles, CA 90095 USA.	dreuben@mednet.ucla.edu							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W27	W31		10.7326/M16-0216	http://dx.doi.org/10.7326/M16-0216			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136228	Green Published			2022-12-28	WOS:000375744000007
J	Kmietowicz, Z				Kmietowicz, Zosia			Petition urges GSK and Pfizer to lower price of pneumonia vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6131; Gulland A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h303	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2455	10.1136/bmj.i2455	http://dx.doi.org/10.1136/bmj.i2455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129726				2022-12-28	WOS:000375484100012
J	Greenland, S; Mansournia, MA; Altman, DG				Greenland, Sander; Mansournia, Mohammad Ali; Altman, Douglas G.			Sparse data bias: a problem hiding in plain sight	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOGISTIC-REGRESSION; SELECTION; MODEL; LIKELIHOOD; SIMULATION; REDUCTION; EVENTS; IMPACT; RISK	Effects of treatment or other exposure on outcome events are commonly measured by ratios of risks, rates, or odds. Adjusted versions of these measures are usually estimated by maximum likelihood regression (eg, logistic, Poisson, or Cox modelling). But resulting estimates of effect measures can have serious bias when the data lack adequate case numbers for some combination of exposure and outcome levels. This bias can occur even in quite large datasets and is hence often termed sparse data bias. The bias can arise or be worsened by regression adjustment for potentially confounding variables; in the extreme, the resulting estimates could be impossibly huge or even infinite values that are meaningless artefacts of data sparsity. Such estimate inflation might be obvious in light of background information, but is rarely noted let alone accounted for in research reports. We outline simple methods for detecting and dealing with the problem focusing especially on penalised estimation, which can be easily performed with common software packages.	[Greenland, Sander] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, POB 14155-6446, Tehran, Iran; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Tehran University of Medical Sciences; University of Oxford	Mansournia, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, POB 14155-6446, Tehran, Iran.	mansournia_ma@yahoo.com		Mansournia, Mohammad Ali/0000-0003-3343-2718				AbdelSalam H, 2012, J ARTHROPLASTY, V27, P720, DOI 10.1016/j.arth.2011.09.027; Agresti A, 2003, CATEGORICAL DATA ANA; Clayton D, 1993, STATISTICAL MODELS I; Discacciati A, 2015, STATA J, V15, P712, DOI 10.1177/1536867X1501500306; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Glymour M.M., 2008, MODERN EPIDEMIOLOGY, P183; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; GREENLAND S, 1989, STAT MED, V8, P669, DOI 10.1002/sim.4780080606; Greenland S, 1999, STAT SCI, V14, P29; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Greenland S, 2007, STAT MED, V26, P3578, DOI 10.1002/sim.2788; Greenland S, 2015, STAT MED, V34, P3133, DOI 10.1002/sim.6537; Greenland S, 2015, ANNU REV PUBL HEALTH, V36, P89, DOI 10.1146/annurev-publhealth-031914-122559; Greenland S, 2011, INT STAT REV, V79, P401, DOI 10.1111/j.1751-5823.2011.00158.x; Greenland S, 2010, AM STAT, V64, P340, DOI 10.1198/tast.2010.10006; Greenland S, 2009, INT J EPIDEMIOL, V38, P1662, DOI 10.1093/ije/dyp278; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hirji K., 2006, EXACT ANAL DISCRETE; HURVICH CM, 1990, AM STAT, V44, P214, DOI 10.2307/2685338; JEWELL NP, 1986, BIOMETRICS, V42, P351, DOI 10.2307/2531055; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; King G, 2016, WHY PROPENSITY SCORE; Lyles RH, 2012, J STAT PLAN INFER, V142, P3235, DOI 10.1016/j.jspi.2012.05.005; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rubin DB, 2006, MATCHED SAMPLING FOR CAUSAL EFFECTS, P1, DOI 10.2277/ 0521674360; Steyerberg E., 2009, CLIN PREDICTION MODE; Sullivan SG, 2013, INT J EPIDEMIOL, V42, P308, DOI 10.1093/ije/dys213; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	33	472	472	2	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i1981	10.1136/bmj.i1981	http://dx.doi.org/10.1136/bmj.i1981			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27121591	Green Published, Bronze			2022-12-28	WOS:000375483300002
J	Mayor, S				Mayor, Susan			Mediterranean diet reduces cardiovascular events in people with heart disease, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Stewart RAH, 2016, EUR HEART J, V37, P1993, DOI 10.1093/eurheartj/ehw125	1	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2348	10.1136/bmj.i2348	http://dx.doi.org/10.1136/bmj.i2348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27114468				2022-12-28	WOS:000375482000006
J	O'Brien, SF				O'Brien, Sheila F.			Transfusion-transmitted malaria: is hope around the corner?	LANCET			English	Editorial Material							PATHOGEN INACTIVATION		[O'Brien, Sheila F.] Canadian Blood Serv, Epidemiol & Surveillance, 1800 Alta Vista Dr, Ottawa, ON K1G 4J5, Canada; [O'Brien, Sheila F.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada	Canadian Blood Services; University of Ottawa	O'Brien, SF (corresponding author), Canadian Blood Serv, Epidemiol & Surveillance, 1800 Alta Vista Dr, Ottawa, ON K1G 4J5, Canada.; O'Brien, SF (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	sheila.obrien@blood.ca						Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X; Kleinman S, 2015, TRANSFUSION, V55, P2983, DOI 10.1111/trf.13259; O'Brien SF, 2015, TRANSFUS MED REV, V29, P162, DOI 10.1016/j.tmrv.2015.03.004; Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646; World Health Organization, WORLD MAL REP 2015	5	0	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1701	1703		10.1016/S0140-6736(16)30299-9	http://dx.doi.org/10.1016/S0140-6736(16)30299-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	27116262				2022-12-28	WOS:000374541900007
J	Fu, H				Fu, He			Growth can come in phases	SCIENCE			English	Editorial Material									[Fu, He] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fu, H (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.		Fu, He/P-8466-2019	Fu, He/0000-0001-6428-0716					0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					486	486		10.1126/science.352.6284.486	http://dx.doi.org/10.1126/science.352.6284.486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102487				2022-12-28	WOS:000374479700052
J	Lewis, SL				Lewis, Simon L.			The Paris Agreement has solved a troubling problem	NATURE			English	Editorial Material									[Lewis, Simon L.] UCL, Global Change Sci, London WC1E 6BT, England; [Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Leeds	Lewis, SL (corresponding author), UCL, Global Change Sci, London WC1E 6BT, England.; Lewis, SL (corresponding author), Univ Leeds, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851					0	19	21	3	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					283	283		10.1038/532283a	http://dx.doi.org/10.1038/532283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7WU	27111605	Green Submitted, Green Accepted			2022-12-28	WOS:000374424700004
J	Chopra, V; Edelson, DP; Saint, S				Chopra, Vineet; Edelson, Dana P.; Saint, Sanjay			Mentorship Malpractice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chopra, Vineet; Saint, Sanjay] Univ Michigan, Sch Med, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Chopra, Vineet; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Edelson, Dana P.] Univ Chicago Med, Dept Internal Med, Chicago, IL USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Chopra, V (corresponding author), Univ Michigan, Sch Med, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA.; Chopra, V (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA.	vineetc@umich.edu	Saint, Sanjay/AAF-5126-2019	Chopra, Vineet/0000-0001-8670-9376				Healy C. C., 1990, EDUC RESEARCHER, V19, P17, DOI [DOI 10.3102/0013189X019009017, 10.3102/0013189X019009017]; Humphrey HJ., 2010, MENTORING ACAD MED; Sackett DL, 2001, CLIN INVEST MED, V24, P94; Saha S, 1999, J GEN INTERN MED, V14, P745, DOI 10.1046/j.1525-1497.1999.12138.x	4	48	48	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1453	1454		10.1001/jama.2015.18884	http://dx.doi.org/10.1001/jama.2015.18884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115263	Green Published			2022-12-28	WOS:000373873800009
J	Rankin, EB; Giaccia, AJ				Rankin, Erinn B.; Giaccia, Amato J.			Hypoxic control of metastasis	SCIENCE			English	Review							INDUCIBLE FACTOR-I; BREAST-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR PROTEIN; PANCREATIC-CANCER; LYSYL OXIDASE; PROLYL HYDROXYLASE; E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; METABOLIC ZONATION	Metastatic disease is the leading cause of cancer-related deaths and involves critical interactions between tumor cells and the microenvironment. Hypoxia is a potent microenvironmental factor promoting metastatic progression. Clinically, hypoxia and the expression of the hypoxia-inducible transcription factors HIF-1 and HIF-2 are associated with increased distant metastasis and poor survival in a variety of tumor types. Moreover, HIF signaling in malignant cells influences multiple steps within the metastatic cascade. Here we review research focused on elucidating the mechanisms by which the hypoxic tumor microenvironment promotes metastatic progression. These studies have identified potential biomarkers and therapeutic targets regulated by hypoxia that could be incorporated into strategies aimed at preventing and treating metastatic disease.	[Rankin, Erinn B.; Giaccia, Amato J.] Stanford Univ, Med Ctr, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Rankin, Erinn B.] Stanford Univ, Med Ctr, Dept Obstet & Gynecol, Stanford, CA 94305 USA	Stanford University; Stanford University	Giaccia, AJ (corresponding author), Stanford Univ, Med Ctr, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	giaccia@stanford.edu		Rankin, Erinn/0000-0002-2045-2296	NIH [CA-198291, CA-67166, CA-197713]; Silicon Valley Foundation; Sydney Frank Foundation; Kimmelman Fund; Department of Defense Ovarian Cancer Research Academy [OC140611]; NATIONAL CANCER INSTITUTE [R01CA198291, P01CA067166, R35CA197713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silicon Valley Foundation; Sydney Frank Foundation; Kimmelman Fund; Department of Defense Ovarian Cancer Research Academy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grants CA-198291, CA-67166, and CA-197713, the Silicon Valley Foundation, the Sydney Frank Foundation, and the Kimmelman Fund (A.J.G.); and the Department of Defense Ovarian Cancer Research Academy OC140611 (E.B.R.). We apologize to those colleagues whose work we could not cite owing to space constraints.	Albrecht I, 2011, INT J DEV BIOL, V55, P483, DOI 10.1387/ijdb.103226ia; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Barsoum IB, 2011, CANCER RES, V71, P7433, DOI 10.1158/0008-5472.CAN-11-2104; Brown JM, 1998, CANCER RES, V58, P1408; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaturvedi P, 2014, P NATL ACAD SCI USA, V111, pE2120, DOI 10.1073/pnas.1406655111; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chou CC, 2015, ONCOTARGET, V6, P8271, DOI 10.18632/oncotarget.3186; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cox TR, 2016, CANCER RES, V76, P188, DOI 10.1158/0008-5472.CAN-15-2306; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Goto Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7153; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127229; Jones DT, 2006, CANCER RES, V66, P2749, DOI 10.1158/0008-5472.CAN-05-3857; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; JUNGERMANN K, 1988, SEMIN LIVER DIS, V8, P329, DOI 10.1055/s-2008-1040554; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaelin WG, 2005, CELL METAB, V1, P357, DOI 10.1016/j.cmet.2005.05.006; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]; Kim JJ, 2015, GENE DEV, V29, P2244, DOI 10.1101/gad.268128.115; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Kumar V, 2014, IMMUNOLOGY, V143, P512, DOI 10.1111/imm.12380; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5715; Lee YH, 2015, CLIN CANCER RES, V21, P1438, DOI 10.1158/1078-0432.CCR-14-1979; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Liu Y, 2014, TUMOR BIOL, V35, P5111, DOI 10.1007/s13277-014-1680-z; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Luan YJ, 2013, PATHOL RES PRACT, V209, P184, DOI 10.1016/j.prp.2012.10.017; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matsuo Y, 2014, J HEPATO-BIL-PAN SCI, V21, P105, DOI 10.1002/jhbp.6; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; Messai Y, 2014, CANCER RES, V74, P6820, DOI 10.1158/0008-5472.CAN-14-0303; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Noman MZ, 2011, CANCER RES, V71, P5976, DOI 10.1158/0008-5472.CAN-11-1094; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Ping W, 2014, TUMOR BIOL, V35, P4401, DOI 10.1007/s13277-013-1579-0; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HX, 2014, GENET MOL RES, V13, P2817, DOI 10.4238/2014.January.22.6; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Wilson C, 2014, CANCER RES, V74, P5878, DOI 10.1158/0008-5472.CAN-14-1009; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang HM, 2015, P NATL ACAD SCI USA, V112, pE6215, DOI 10.1073/pnas.1520032112; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	114	720	761	18	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					175	180		10.1126/science.aaf4405	http://dx.doi.org/10.1126/science.aaf4405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124451	Green Accepted			2022-12-28	WOS:000373681600036
J	Anderson, KB; Thomas, SJ; Endy, TP				Anderson, Kathryn B.; Thomas, Stephen J.; Endy, Timothy P.			The Emergence of Zika Virus A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							GUILLAIN-BARRE-SYNDROME; ENROLLING PREGNANT-WOMEN; SEXUAL TRANSMISSION; UNITED-STATES; WEST NILE; INFECTION; OUTBREAK; BRAZIL; FEVER; ISOLATIONS	Zika virus (ZIKV) is yet another arbovirus that is rapidly emerging on a global scale, on the heels of a chikungunya epidemic in the Americas that began in 2013. A ZIKV epidemic that began in Brazil in 2015 has now spread rapidly to more than 30 countries in the Americas and the Caribbean, infecting more than 2 million inhabitants. This epidemic currently continues unabated. The explosive nature of recent outbreaks and concerning links to Guillain-Barre syndrome and microcephaly are incompletely understood. Also unknown is the relative importance of sexual transmission of ZIKV and asymptomatic ZIKV infections to the overall burden of transmission. The limited understanding of ZIKV presents an enormous challenge for responses to this rapidly emerging threat to human health. This article reviews the existing literature on ZIKV and proposes critical questions for vaccine development and other areas of needed research.	Univ Minnesota, Minneapolis, MN USA; Walter Reed Army Inst Res, US Army Med Directorate, Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Thomas, Stephen J.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Anderson, Kathryn B.] Univ Minnesota, Dept Med, MMC 741,Mayo Bldg, Minneapolis, MN 55455 USA; [Endy, Timothy P.] SUNY Upstate Med Univ, Div Infect Dis, 750 East Adams St,CPOB Suite 304, Syracuse, NY 13210 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Anderson, KB (corresponding author), Univ Minnesota, Dept Med, MMC 741,Mayo Bldg, Minneapolis, MN 55455 USA.	ande7622@umn.edu	amsalu, ribka/G-8780-2019	Thomas, Stephen/0000-0002-8368-7682				ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6; Afifi A K, 1994, J Family Community Med, V1, P30; Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609; Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1; Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241; BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6; Besnard M, 2014, Euro Surveill, V19; Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Centers for Disease Control and Prevention, 2016, TRAV HLTH CDC ISS IN; Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P769; Cornblath DR, 2009, ANN NEUROL, V66, P569, DOI 10.1002/ana.21816; Dallas County Department of Health and Human Services, 2016, HLTH ADV SEX TRANSM; Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; EPPS RE, 1995, SEMIN DERMATOL, V14, P179, DOI 10.1016/S1085-5629(05)80016-1; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Foulkes MA, 2011, J WOMENS HEALTH, V20, P1429, DOI 10.1089/jwh.2011.3118; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323; Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194; Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1155; Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3; JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8; Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oehler E, 2014, Euro Surveill, V19; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1; Pan American Health Organization, 2016, EP UPD ZIK VIR INF; Pan American Health Organization, 2016, EP AL REP INCR CONG; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; SMITHBURN KC, 1952, J IMMUNOL, V69, P223; SMITHBURN KC, 1952, J IMMUNOL, V68, P441; Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	76	35	36	0	81	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					175	+		10.7326/M16-0617	http://dx.doi.org/10.7326/M16-0617			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27135717				2022-12-28	WOS:000380583300006
J	Baciu, A; Sharfstein, JM				Baciu, Alina; Sharfstein, Joshua M.			Population Health Case Reports From Clinic to Community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PUBLIC-HEALTH		[Baciu, Alina] Natl Acad Sci, 2101 Constitut Ave Nw, Washington, DC 20418 USA; [Baciu, Alina] Natl Acad Engn, Washington, DC 20418 USA; [Baciu, Alina] Natl Acad Med, Washington, DC USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,W1033D, Baltimore, MD 21205 USA	National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,W1033D, Baltimore, MD 21205 USA.	Joshua.Sharfstein@jhu.edu						Beitsch LM, 2005, AM J PREV MED, V29, P149, DOI 10.1016/j.amepre.2005.04.005; Galea S, 2016, JAMA-J AM MED ASSOC, V315, P655, DOI 10.1001/jama.2016.0198; Institute of Medicine, 2010, PUBL HLTH ROL MEAS A; Lavizzo-Mourey R, 2016, JAMA-J AM MED ASSOC, V315, P1335, DOI 10.1001/jama.2016.1732; Prybil L, IMPROVING COMMUNITY; Washington AE, 2016, JAMA-J AM MED ASSOC, V315, P459, DOI 10.1001/jama.2015.18550; Wong WF, 2015, JAMA-J AM MED ASSOC, V313, P1417, DOI 10.1001/jama.2015.2434; Zaza SBP, 2005, GUIDE COMMUNITY PREV, P431	8	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2016	315	24					2663	2664		10.1001/jama.2016.4932	http://dx.doi.org/10.1001/jama.2016.4932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP7WG	27135870				2022-12-28	WOS:000378709300013
J	Touraine, M				Touraine, Marisol			Tackling antimicrobial resistance in France	LANCET			English	Editorial Material									[Touraine, Marisol] Minist Social Affairs & Hlth, F-75350 Paris 07, SP, France		Touraine, M (corresponding author), Minist Social Affairs & Hlth, F-75350 Paris 07, SP, France.	marisol.touraine@sante.gouv.fr						Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail, 2015, SUIV VENT MED VET CO; ANSM, 2015, LIST ANT CRIT ACT; Carlet J, 2015, TOGETHER LETS SAVE A; European Centre for Disease Prevention and Control, 2015, ANN EP REP 2014 ANT; French Institute for Public Health Surveillance, 2013, SURV ANT CONS HOSP A; Joint Programming Initiative on Antimicrobial Resistance JPIAMR, STRAT RES AG; Ministry of Agriculture, 2012, PLAN ACT EC 2012 201; Ministry of Social Affairs and Health, 2015, PROGR NAT ACT PREV I; Ministry of Social Affairs and Health, PLAN NAT AL ANT; National Authority for Health (HAS), 2015, SCOP SANT; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	12	6	6	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2177	2179		10.1016/S0140-6736(16)30356-7	http://dx.doi.org/10.1016/S0140-6736(16)30356-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145702				2022-12-28	WOS:000376820800013
J	Freedman, SB; Willan, AR; Boutis, K; Schuh, S				Freedman, Stephen B.; Willan, Andrew R.; Boutis, Kathy; Schuh, Suzanne			Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL REHYDRATION SOLUTIONS; EMERGENCY-DEPARTMENT; DEHYDRATION SCALE; ACUTE DIARRHEA; INFANTS; VALIDATION; WATER; ONDANSETRON; TOO	IMPORTANCE Gastroenteritis is a common pediatric illness. Electrolyte maintenance solution is recommended to treat and prevent dehydration. Its advantage in minimally dehydrated children is unproven. OBJECTIVE To determine if oral hydration with dilute apple juice/preferred fluids is noninferior to electrolyte maintenance solution in children with mild gastroenteritis. DESIGN, SETTING, AND PARTICIPANTS Randomized, single-blind noninferiority trial conducted between the months of October and April during the years 2010 to 2015 in a tertiary care pediatric emergency department in Toronto, Ontario, Canada. Study participants were children aged 6 to 60 months with gastroenteritis and minimal dehydration. INTERVENTIONS Participants were randomly assigned to receive color-matched half-strength apple juice/preferred fluids (n=323) or apple-flavored electrolyte maintenance solution (n=324). Oral rehydration therapy followed institutional protocols. After discharge, the half-strength apple juice/preferred fluids group was administered fluids as desired; the electrolyte maintenance solution group replaced losses with electrolyte maintenance solution. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of treatment failure defined by any of the following occurring within 7 days of enrollment: intravenous rehydration, hospitalization, subsequent unscheduled physician encounter, protracted symptoms, crossover, and 3% or more weight loss or significant dehydration at in-person follow-up. Secondary outcomes included intravenous rehydration, hospitalization, and frequency of diarrhea and vomiting. The noninferiority margin was defined as a difference between groups of 7.5% for the primary outcome and was assessed with a 1-sided a=.025. If noninferiority was established, a 1-sided test for superiority was conducted. RESULTS Among 647 randomized children (mean age, 28.3 months; 331 boys [51.1%]; 441 (68.2%) without evidence of dehydration), 644 (99.5%) completed follow-up. Children who were administered dilute apple juice experienced treatment failure less often than those given electrolyte maintenance solution (16.7% vs 25.0%; difference, -8.3%; 97.5% CI, -infinity to -2.0%; P < .001 for inferiority and P = .006 for superiority). Fewer children administered apple juice/preferred fluids received intravenous rehydration (2.5% vs 9.0%; difference, -6.5%; 99% CI, -11.6% to -1.8%). Hospitalization rates and diarrhea and vomiting frequency were not significantly different between groups. CONCLUSIONS AND RELEVANCE Among children with mild gastroenteritis and minimal dehydration, initial oral hydration with dilute apple juice followed by their preferred fluids, compared with electrolyte maintenance solution, resulted in fewer treatment failures. In many high-income countries, the use of dilute apple juice and preferred fluids as desired may be an appropriate alternative to electrolyte maintenance fluids in children with mild gastroenteritis and minimal dehydration.	[Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Res Inst, 2888 Shaganappi Trail, Calgary, AB T3B 6A8, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Sect Pediat Emergency Med, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Gastroenterol Sect, Calgary, AB, Canada; [Willan, Andrew R.] Univ Toronto, Hosp Sick Children, Res Inst,Fac Med, Ontario Child Hlth Support Unit,Dalla Lana Sch Pu, Toronto, ON M5G 1X8, Canada; [Boutis, Kathy; Schuh, Suzanne] Hosp Sick Children, Div Pediat Emergency Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Boutis, Kathy; Schuh, Suzanne] Child Hlth Evaluat Sci, Toronto, ON, Canada; [Boutis, Kathy; Schuh, Suzanne] Univ Toronto, Hosp Sick Children, Res Inst, Dept Pediat,Fac Med, Toronto, ON M5G 1X8, Canada	Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Freedman, SB (corresponding author), Univ Calgary, Dept Pediat, Sect Emergency Med, 2888 Shaganappi Trail, Calgary, AB T3B 6A8, Canada.; Freedman, SB (corresponding author), Univ Calgary, Dept Pediat, Gastroenterol Sect, 2888 Shaganappi Trail, Calgary, AB T3B 6A8, Canada.; Freedman, SB (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, 2888 Shaganappi Trail, Calgary, AB T3B 6A8, Canada.	stephen.freedman@albertahealthservices.ca	Freedman, Stephen/H-9102-2012	Freedman, Stephen/0000-0003-2319-6192	Physician Services Incorporated Foundation [10q1011]; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness	Physician Services Incorporated Foundation; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness	This study was supported by a grant provided by the Physician Services Incorporated Foundation (grant 10q1011). Dr Freedman holds the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness.	American Academy of Pediatrics, 2004, PEDIATRICS, V114, P507, DOI [DOI 10.1542/PEDS.114.2.507, 10.1542/peds.114.2.507]; Bailey B, 2010, ACAD EMERG MED, V17, P583, DOI 10.1111/j.1553-2712.2010.00767.x; Briefel RR, 2004, J AM DIET ASSOC, V104, pS31, DOI 10.1016/j.jada.2003.10.020; Bruce RC, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.6.e4; Cheng A, 2011, PAED CHILD HEALT-CAN, V16, P177, DOI 10.1093/pch/16.3.177; COHEN MB, 1993, NEW ENGL J MED, V329, P211, DOI 10.1056/NEJM199307153290319; CPMP, 2001, BRIT J CLIN PHARMACO, V52, P223; Duggan C, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e29; Duggan C, 1996, J PEDIATR GASTR NUTR, V22, P56, DOI 10.1097/00005176-199601000-00009; FINBERG L, 1986, AM J DIS CHILD, V140, P524, DOI 10.1001/archpedi.1986.02140200034019; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Freedman SB, 2013, J PEDIATR GASTR NUTR, V57, P612, DOI 10.1097/MPG.0b013e3182a1dd93; Freedman SB, 2011, PEDIATRICS, V127, pE287, DOI 10.1542/peds.2010-2214; Freedman SB, 2010, ARCH PEDIAT ADOL MED, V164, P696, DOI 10.1001/archpediatrics.2010.129; Freedman SB, 2009, PEDIATRICS, V123, P841, DOI [10.1542/peds.2008-0113, 10.1542/peds.2008-1570]; Frifdman JN, 2004, J PEDIATR-US, V145, P201, DOI 10.1016/j.jpeds.2004.05.035; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; Gravel J, 2010, ARCH PEDIATRIE, V17, P1645, DOI 10.1016/j.arcped.2010.09.009; Guarino A, 2014, J PEDIATR GASTR NUTR, V59, P132, DOI 10.1097/MPG.0000000000000375; Hahn S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002847; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Karpas A, 2009, PEDIATR EMERG CARE, V25, P301, DOI 10.1097/PEC.0b013e3181a34144; Kharbanda AB, 2013, J PEDIATR-US, V163, P230, DOI 10.1016/j.jpeds.2012.12.013; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Leung A, 2006, PAED CHILD HEALT-CAN, V11, P527; Miyamoto K, 2012, ACTA PAEDIATR, V101, pE390, DOI 10.1111/j.1651-2227.2012.02765.x; National Institute for Health and Clinical Excellence, 2009, DIARRH VOM CAUS GAST; Ozuah PO, 2002, PEDIATRICS, V109, P259, DOI 10.1542/peds.109.2.259; Parkin PC, 2010, CLIN PEDIATR, V49, P235, DOI 10.1177/0009922809336670; Rao SSC, 2006, JPEN-PARENTER ENTER, V30, P433, DOI 10.1177/0148607106030005433; REIS EC, 1994, PEDIATRICS, V93, P708; Santucci KA, 1998, ARCH PEDIAT ADOL MED, V152, P142; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Tam RK, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-149; Teach SJ, 1997, CLIN PEDIATR, V36, P395, DOI 10.1177/000992289703600703; Valois S, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-23; World Health Organization, 2005, TREATM DIARRH MAN PH	40	32	33	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1966	1974		10.1001/jama.2016.5352	http://dx.doi.org/10.1001/jama.2016.5352			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	27131100	Bronze			2022-12-28	WOS:000375461100014
J	Brody, H				Brody, Herb			RESEARCH COMMERCIALIZATION	NATURE			English	Editorial Material																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S5	S5		10.1038/533S5a	http://dx.doi.org/10.1038/533S5a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27144611	Bronze			2022-12-28	WOS:000375473900058
J	Catano, JC; Villegas, SIG				Catano, Juan C.; Gomez Villegas, Sara Isabel			Cutaneous Actinomycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Catano, Juan C.; Gomez Villegas, Sara Isabel] Univ Antioquia, Antioquia, Colombia	Universidad de Antioquia	Catano, JC (corresponding author), Univ Antioquia, Antioquia, Colombia.	kataju@hotmail.com							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1773	1773		10.1056/NEJMicm1511213	http://dx.doi.org/10.1056/NEJMicm1511213			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144852				2022-12-28	WOS:000375341500010
J	Deyo, RA; Mirza, SK				Deyo, Richard A.; Mirza, Sohail K.			Herniated Lumbar Intervertebral Disk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BACK-PAIN; NONOPERATIVE TREATMENT; SPINAL MANIPULATION; BED REST; SCIATICA; SURGERY; TRIAL; RADICULOPATHY; STEROIDS; HISTORY	A 41-year-old man reports the sudden onset of low back and left leg pain. The symptoms began while he was doing yard work and pulling out large bushes. Since the onset of the pain 2 days ago, it has worsened, although he took a single dose of ibuprofen when the pain began. The patient has no clinically significant medical history, and the physical examination is normal other than severe pain in the left leg with a straight-leg-raising maneuver to 40 degrees. He says, "I'm sure I slipped a disk," and he requests magnetic resonance imaging (MRI) of the low back. What testing and treatment would you recommend?	[Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Mirza, Sohail K.] Dartmouth Geisel Sch Med, Dept Orthopaed Surg, Hanover, NH USA; [Mirza, Sohail K.] Dartmouth Geisel Sch Med, Dartmouth Inst, Hanover, NH USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Dartmouth College; Dartmouth College	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code FM, Portland, OR 97239 USA.	deyor@ohsu.edu			NuVasive from the International Society for the Study of the Lumbar Spine	NuVasive from the International Society for the Study of the Lumbar Spine	Dr. Deyo reports receiving a financial award from NuVasive as part of a lifetime achievement award from the International Society for the Study of the Lumbar Spine. No other potential conflict of interest relevant to this article was reported.	Al-Shoha A, 2012, SPINE, V37, pE1567, DOI 10.1097/BRS.0b013e318270280e; Andersson G, 2014, BURDEN MUSCULOSKELET; Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Bronfort G, 2014, ANN INTERN MED, V161, P381, DOI 10.7326/M14-0006; BUSH K, 1992, SPINE, V17, P1205, DOI 10.1097/00007632-199210000-00013; Carragee EJ, 1999, SPINE, V24, P2346, DOI 10.1097/00007632-199911150-00010; Chaparro LE, 2014, SPINE, V39, P556, DOI 10.1097/BRS.0000000000000249; Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Desai A, 2011, J NEUROSURG-SPINE, V14, P647, DOI 10.3171/2011.1.SPINE10426; DEYO RA, 1986, NEW ENGL J MED, V315, P1064, DOI 10.1056/NEJM198610233151705; Deyo RA, 2000, MED CARE, V38, P959, DOI 10.1097/00005650-200009000-00009; Fairbank Jeremy, 2011, Evid Based Spine Care J, V2, P27, DOI 10.1055/s-0031-1274754; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Fernandez M, 2015, SPINE, V40, P1457, DOI 10.1097/BRS.0000000000001036; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Goldberg H, 2015, JAMA-J AM MED ASSOC, V313, P1915, DOI 10.1001/jama.2015.4468; Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lurie JD, 2014, SPINE, V39, P3, DOI 10.1097/BRS.0000000000000088; Martin BI, 2012, SPINE J, V12, P89, DOI 10.1016/j.spinee.2011.11.010; Mixter W.J., 1934, NEW ENGL J MED, V211, P210, DOI [10.1056/NEJM193408022110506, DOI 10.1056/NEJM193408022110506]; Oliphant D, 2004, J MANIP PHYSIOL THER, V27, P197, DOI 10.1016/j.jmpt.2003.12.023; Osterman H, 2006, SPINE, V31, P2409; Overdevest GM, 2014, SPINE J, V14, P1817, DOI 10.1016/j.spinee.2013.07.456; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pinto RZ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e497; Rhee JM, 2006, J BONE JOINT SURG AM, V88A, P2070; Roncoroni C, 2011, RHEUMATOLOGY, V50, P1603, DOI 10.1093/rheumatology/ker151; Ropper AH, 2015, NEW ENGL J MED, V372, P1240, DOI 10.1056/NEJMra1410151; Santilli Valter, 2006, Spine J, V6, P131, DOI 10.1016/j.spinee.2005.08.001; Shriver MF, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15281; Smith JS, 2012, SPINE, V37, P1975, DOI 10.1097/BRS.0b013e318257fada; Sorensen IG, 2011, SPINE, V36, P1541, DOI 10.1097/BRS.0b013e3181f9b8d4; Suri P, 2012, ARCH PHYS MED REHAB, V93, P690, DOI 10.1016/j.apmr.2011.11.028; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; Verwoerd AJH, 2014, SPINE J, V14, P2028, DOI 10.1016/j.spinee.2013.11.049; Vroomen PCAJ, 2002, J NEUROL NEUROSUR PS, V72, P630, DOI 10.1136/jnnp.72.5.630; Vroomen PCAJ, 1999, NEW ENGL J MED, V340, P418, DOI 10.1056/NEJM199902113400602; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Webster BS, 2014, SPINE, V39, P1433, DOI 10.1097/BRS.0000000000000408; Wegner I, 2013, COCHRANE DB SYST REV, V8; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe	49	130	152	4	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1763	1772		10.1056/NEJMcp1512658	http://dx.doi.org/10.1056/NEJMcp1512658			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144851				2022-12-28	WOS:000375341500009
J	Zheng, Z; Jayaram, R; Jiang, LX; Emberson, J; Zhao, Y; Li, Q; Du, J; Guarguagli, S; Hill, M; Chen, ZM; Collins, R; Casadei, B				Zheng, Zhe; Jayaram, Raja; Jiang, Lixin; Emberson, Jonathan; Zhao, Yan; Li, Qi; Du, Juan; Guarguagli, Silvia; Hill, Michael; Chen, Zhengming; Collins, Rory; Casadei, Barbara			Perioperative Rosuvastatin in Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTOPERATIVE ATRIAL-FIBRILLATION; ENDOTHELIAL PROGENITOR CELLS; REDOX STATE; MYOCARDIAL INJURY; CORONARY SURGERY; ATORVASTATIN; PREVENTION; ASSOCIATION; SIMVASTATIN; INHIBITION	BACKGROUND Complications after cardiac surgery are common and lead to substantial increases in morbidity and mortality. Meta-analyses of small randomized trials have suggested that perioperative statin therapy can prevent some of these complications. METHODS We randomly assigned 1922 patients in sinus rhythm who were scheduled for elective cardiac surgery to receive perioperative rosuvastatin (at a dose of 20 mg daily) or placebo. The primary outcomes were postoperative atrial fibrillation within 5 days after surgery, as assessed by Holter electrocardiographic monitoring, and myocardial injury within 120 hours after surgery, as assessed by serial measurements of the cardiac troponin I concentration. Secondary outcomes included major in-hospital adverse events, duration of stay in the hospital and intensive care unit, left ventricular and renal function, and blood biomarkers. RESULTS The concentrations of low-density lipoprotein cholesterol and C-reactive protein after surgery were lower in patients assigned to rosuvastatin than in those assigned to placebo (P<0.001). However, the rate of postoperative atrial fibrillation did not differ significantly between the rosuvastatin group and the placebo group (21.1% and 20.5%, respectively; odds ratio 1.04; 95% confidence interval [CI], 0.84 to 1.30; P = 0.72), nor did the area under the troponin I-release curve (102 ng x hour per milliliter and 100 ng x hour per milliliter, respectively; between-group difference, 1%; 95% CI, -9 to 13; P = 0.80). Subgroup analyses did not indicate benefit in any category of patient. Rosuvastatin therapy did not result in beneficial effects on any of the secondary outcomes but was associated with a significant absolute (+/-SE) excess of 5.4+/-1.9 percentage points in the rate of postoperative acute kidney injury (P = 0.005). CONCLUSIONS In this trial, perioperative statin therapy did not prevent postoperative atrial fibrillation or perioperative myocardial damage in patients undergoing elective cardiac surgery. Acute kidney injury was more common with rosuvastatin.	[Zheng, Zhe; Jiang, Lixin; Zhao, Yan; Li, Qi; Du, Juan; Chen, Zhengming] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Natl Clin Res Ctr Cardiovasc Dis,Fuwai Hosp, Dept Cardiovasc Surg,State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China; [Zheng, Zhe; Jiang, Lixin; Zhao, Yan; Li, Qi; Du, Juan; Chen, Zhengming] Peking Union Med Coll, 167 Beilishi Rd, Beijing 100037, Peoples R China; [Jayaram, Raja; Guarguagli, Silvia; Casadei, Barbara] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, England; [Emberson, Jonathan; Hill, Michael; Chen, Zhengming; Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford OX3 9DU, England; [Emberson, Jonathan; Hill, Michael; Chen, Zhengming; Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 9DU, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Oxford; University of Oxford; University of Oxford	Zheng, Z (corresponding author), Peking Union Med Coll, 167 Beilishi Rd, Beijing 100037, Peoples R China.; Zheng, Z (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiovasc Surg, 167 Beilishi Rd, Beijing 100037, Peoples R China.; Casadei, B (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Div Cardiovasc Med, L6,West Wing, Oxford OX3 9DU, England.	zhengzhe@fuwai.com; barbara.casadei@cardiov.ox.ac.uk	Mahmoud, Ahmed Naguib/C-3239-2017; JAYARAM, RAJA/O-6068-2019; Elgendy, Islam Y/C-3900-2017	Mahmoud, Ahmed Naguib/0000-0003-2459-5195; Elgendy, Islam Y/0000-0001-9853-7591; Casadei, Barbara/0000-0002-6801-1617; JAYARAM, RAJA/0000-0002-7861-9546; Emberson, Jonathan/0000-0001-7792-9422	British Heart Foundation; British Heart Foundation [RG/11/15/29375] Funding Source: researchfish; Medical Research Council [MC_U137686855] Funding Source: researchfish; MRC [MC_U137686855] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the British Heart Foundation and others	Almansob MAS, 2012, ARTERIOSCL THROM VAS, V32, P2304, DOI 10.1161/ATVBAHA.112.252098; [Anonymous], 2010, EUROPACE, V12, P1360; Antoniades C, 2012, J AM COLL CARDIOL, V59, P60, DOI 10.1016/j.jacc.2011.08.062; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; Antoniades C, 2010, CIRCULATION, V122, pS66, DOI 10.1161/CIRCULATIONAHA.109.927376; Baran C, 2012, STEM CELL REV REP, V8, P963, DOI 10.1007/s12015-011-9321-z; Caorsi C, 2008, EUR CYTOKINE NETW, V19, P99, DOI 10.1684/ecn.2008.0124; Chello M, 2006, CRIT CARE MED, V34, P660, DOI 10.1097/01.CCM.0000201407.89977.EA; Chen WT, 2010, J THORAC CARDIOV SUR, V140, P364, DOI 10.1016/j.jtcvs.2010.02.042; Halonen J, 2007, JAMA-J AM MED ASSOC, V297, P1562, DOI 10.1001/jama.297.14.1562; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Imazio M, 2014, JAMA-J AM MED ASSOC, V312, P1016, DOI 10.1001/jama.2014.11026; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Ji Q, 2009, CIRC J, V73, P2244, DOI 10.1253/circj.CJ-09-0352; Kim YM, 2008, J AM COLL CARDIOL, V51, P68, DOI 10.1016/j.jacc.2007.07.085; Kuhn EW, 2014, EUR J CARDIO-THORAC, V45, P17, DOI 10.1093/ejcts/ezt181; Kuhn EW, 2015, COCHRANE DB SYST REV, V8; Lapar DJ, 2013, ANN THORAC SURG, V96, P1621, DOI 10.1016/j.athoracsur.2013.05.050; Lewicki M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010480.pub2; Li J, 2012, CHINESE MED J-PEKING, V125, P4361, DOI 10.3760/cma.j.issn.0366-6999.2012.24.008; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Maesen B, 2012, EUROPACE, V14, P159, DOI 10.1093/europace/eur208; Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pinho-Gomes AC, 2014, ANTIOXID REDOX SIGN, V20, P1268, DOI 10.1089/ars.2013.5542; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Roberts I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2463; Rubin DB, 1987, MULTIPLE IMPUTATION; Savarese G, 2013, INT J CARDIOL, V167, P2482, DOI 10.1016/j.ijcard.2012.05.010; Selvanayagam JB, 2005, J AM COLL CARDIOL, V45, P629, DOI 10.1016/j.jacc.2004.11.030; Song YB, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.200804.020; Spadaccio C, 2010, J CARDIOVASC PHARM, V55, P30, DOI 10.1097/FJC.0b013e3181c37d4d; Sun YF, 2011, INT HEART J, V52, P7, DOI 10.1536/ihj.52.7; Tamayo E, 2009, J CARDIOVASC SURG, V50, P687; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Vukovic PM, 2011, PERFUSION-UK, V26, P31, DOI 10.1177/0267659110385607	39	184	199	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1744	1753		10.1056/NEJMoa1507750	http://dx.doi.org/10.1056/NEJMoa1507750			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144849	Green Published, Bronze			2022-12-28	WOS:000375341500007
J	Woolston, C				Woolston, Chris			Take my advice	NATURE			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					531	533		10.1038/nj7600-531a	http://dx.doi.org/10.1038/nj7600-531a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27127824	Bronze			2022-12-28	WOS:000374815900054
J	Coombes, R				Coombes, Rebecca			DEBATE How to fix out of hours care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i2356	10.1136/bmj.i2356	http://dx.doi.org/10.1136/bmj.i2356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27122149				2022-12-28	WOS:000375483300006
J	Perry, DC; Metcalfe, D; Griffin, XL; Costa, ML				Perry, Daniel C.; Metcalfe, David; Griffin, Xavier L.; Costa, Matthew L.			Inequalities in use of total hip arthroplasty for hip fracture: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHORT-TERM MORTALITY; COMORBIDITY INDEX; REPLACEMENT; CARE; VOLUME; HEMIARTHROPLASTY; ASSOCIATION; CLINICIAN; SURGERY; RISK	OBJECTIVES To determine whether the use of total hip arthroplasty (THA) among individuals with a displaced intracapsular fracture of the femoral neck is based on national guidelines or if there are systematic inequalities. DESIGN Observational cohort study using the National Hip Fracture Database (NHFD). SETTING All hospitals that treat adults with hip fractures in England, Wales, and Northern Ireland. PARTICIPANTS Patients within the national database (all aged >= 60) who received operative treatment for a nonpathological displaced intracapsular hip fracture from 1 July 2011 to 31 April 2015. MAIN OUTCOME MEASURES Provision of THA to patients considered eligible under criteria published by the National Institute for Health and Care Excellence (NICE). RESULTS 114 119 patients with hip fracture were included, 11 683 (10.2%) of whom underwent THA. Of those who satisfied the NICE criteria, 32% (6780) received a THA. Of patients who underwent THA, 42% (4903) did not satisfy the NICE criteria. A recursive partitioning algorithm found that the NICE eligibility criteria did not optimally explain which patients underwent THA. A model with superior explanatory power drew distinctions that are not supported by NICE, which were an age cut off at 76 and a different ambulation cut off. Among patients who satisfied the NICE eligibility, the use of THA was less likely with higher age (odds ratio 0.88, 95% confidence interval 0.87 to 0.88), worsening abbreviated mental test scores (0.49 (0.41 to 0.58) for normal cognition v borderline cognitive impairment)), worsening American Society of Anesthesiologists score (0.74, 0.66 to 0.84), male sex (0.85, 0.77 to 0.93), worsening ambulatory status (0.32, 0.28 to 0.35 for walking with a stick v independent ambulation), and fifths of worsening socioeconomic area deprivation (0.76 (0.66 to 0.88) for least v most deprived fifth). Patients receiving treatment during the working week were more likely to receive THA than at the weekend (0.90, 0.83 to 0.98). CONCLUSIONS There are wide disparities in the use of THA among individuals with hip fractures, and compliance with NICE guidance is poor. Patients with higher levels of socioeconomic deprivation and those who require surgery at the weekend were less likely to receive THA. Inconsistent compliance with NICE recommendations means that the optimal treatment for older adults with hip fractures can depend on where and when they present to hospital.	[Perry, Daniel C.] Univ Liverpool, Inst Tradit Med, Liverpool L12 2AP, Merseyside, England; [Metcalfe, David] Harvard Univ, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Griffin, Xavier L.; Costa, Matthew L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kadoorie Ctr, Oxford OX3 9DU, England	University of Liverpool; Harvard University; Harvard Medical School; University of Oxford	Perry, DC (corresponding author), Univ Liverpool, Inst Tradit Med, Liverpool L12 2AP, Merseyside, England.	danperry@liverpool.ac.uk	Metcalfe, David/D-9699-2012; Griffin, Xavier/ABD-2354-2020	Metcalfe, David/0000-0003-1008-3105; Griffin, Xavier/0000-0003-2976-7523; Perry, Daniel/0000-0001-8420-8252	Academy of Medical Sciences (AMS) [AMS-SGCL10-Perry] Funding Source: researchfish; National Institute for Health Research [CS-2014-14-012, RP-DG-1210-10022, CL-2012-08-001, CL-2012-08-002] Funding Source: researchfish	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))		Abdus S, 2015, AM J PUBLIC HEALTH, V105, pS668, DOI 10.2105/AJPH.2015.302892; Avery PP, 2011, J BONE JOINT SURG BR, V93B, P1045, DOI 10.1302/0301-620X.93B8.27132; Bhandari M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006263; British Orthopedic Association and British Geriatrics Society, 2007, CAR PAT FRAG FRACT; Burge Rt, 2001, J MED ECON, V4, P51, DOI DOI 10.3111/200104051062; Dekker JWT, 2012, EJSO-EUR J SURG ONC, V38, P1071, DOI 10.1016/j.ejso.2012.04.017; Department of Health, 2011, GOVERNANCE ARRANGEME; Department of health, 2013, PAYM RES GUID 2013 1; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Haider AH, 2015, JAMA SURG, V150, P457, DOI 10.1001/jamasurg.2014.4038; Hedlundh U, 1996, J BONE JOINT SURG BR, V78B, P206, DOI 10.1302/0301-620X.78B2.0780206; Hopley C, 2010, BMJ-BRIT MED J, V340, pc2332, DOI DOI 10.1136/BMJ.C2332; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754; Kelly M, 2015, UNFALLCHIRURG; Keogh B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f621; Kleebauer Alistair, 2015, Nurs Manag (Harrow), V22, P6, DOI 10.7748/nm.22.3.6.s2; Lau TW, 2013, GERIATR ORTHOP SURG, V4, P3, DOI 10.1177/2151458513484759; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Losina E, 2004, ARTHRITIS RHEUM-US, V50, P1338, DOI 10.1002/art.20148; MacKenzie DM, 1996, PSYCHOL MED, V26, P427, DOI 10.1017/S0033291700034826; McLennan D., 2011, ENGLISH INDICES DEPR; National Institute for Health and Care Excellence, 2011, HIP FRACT MAN HIP FR, V124; National Institute for Health and Care Excellence (NICE), 2015, HIP FRACT MAN HIP FR; Neuburger J, 2015, MED CARE, V53, P686, DOI 10.1097/MLR.0000000000000383; Parker MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub4; Royal College of Physicians, 2014, NAT HIP FRACT DAT AN; Sahota O, 2008, AGE AGEING, V37, P128, DOI 10.1093/ageing/afn007; Street RL, 2008, ANN FAM MED, V6, P198, DOI 10.1370/afm.821; Tamayo-Sarver JH, 2003, ACAD EMERG MED, V10, P1239, DOI 10.1197/S1069-6563903)00494-9; Tan WP, 2013, J SURG RES, V184, P115, DOI 10.1016/j.jss.2013.05.039; Therneau TM., 2015, INTRO RECURSIVE PART; Vyawahare B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004182; Whitmore RG, 2014, SPINE J, V14, P31, DOI 10.1016/j.spinee.2013.03.011; Young L, 1997, GUIDELINES DIAGNOSIS; Yu LG, 2012, CLIN ORTHOP RELAT R, V470, P2235, DOI 10.1007/s11999-012-2293-8	36	51	51	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i2021	10.1136/bmj.i2021	http://dx.doi.org/10.1136/bmj.i2021			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27122469	hybrid, Green Published			2022-12-28	WOS:000375483300003
J	Lantos, PM; Auwaerter, PG; Nelson, CA				Lantos, Paul M.; Auwaerter, Paul G.; Nelson, Christina A.			Lyme Disease Serology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LABORATORIES		[Lantos, Paul M.] Duke Univ, Sch Med, Div Pediat Infect Dis, Durham, NC USA; [Lantos, Paul M.] Duke Univ, Sch Med, Div Gen Internal Med, Durham, NC USA; [Auwaerter, Paul G.] Johns Hopkins Univ, Sch Med, Sherrilyn & Ken Fisher Ctr Environm Infect Dis, Baltimore, MD USA; [Nelson, Christina A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd,Mail Stop P-02, Ft Collins, CO 80521 USA	Duke University; Duke University; Johns Hopkins University; Centers for Disease Control & Prevention - USA	Nelson, CA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd,Mail Stop P-02, Ft Collins, CO 80521 USA.	wje1@cdc.gov			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR001115] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Dattwyler RJ, 2014, CLIN INFECT DIS, V59, P1711, DOI 10.1093/cid/ciu705; ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Lantos PM, 2015, CLIN INFECT DIS, V61, P1374, DOI 10.1093/cid/civ584; Lantos PM, 2013, VECTOR-BORNE ZOONOT, V13, P877, DOI 10.1089/vbz.2013.1365; Molins CR, 2014, J CLIN MICROBIOL, V52, P3755, DOI 10.1128/JCM.01409-14; Nelson C, 2014, MMWR-MORBID MORTAL W, V63, P333; Nelson C, 2015, JAMA INTERN MED, V175, P132, DOI 10.1001/jamainternmed.2014.5426	9	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1780	1781		10.1001/jama.2016.4882	http://dx.doi.org/10.1001/jama.2016.4882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115380	Green Accepted			2022-12-28	WOS:000374759300025
J	Wise, J				Wise, Jacqui			No increased heart failure risk is reported with DPP-4 inhibitors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Toh S, 2016, ANN INTERN MED, V164, P705, DOI 10.7326/M15-2568	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2363	10.1136/bmj.i2363	http://dx.doi.org/10.1136/bmj.i2363			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27118534				2022-12-28	WOS:000375482500014
J	Jumde, RP; Lanza, F; Veenstra, MJ; Harutyunyan, SR				Jumde, Ravindra P.; Lanza, Francesco; Veenstra, Marieke J.; Harutyunyan, Syuzanna R.			Catalytic asymmetric addition of Grignard reagents to alkenyl-substituted aromatic N-heterocycles	SCIENCE			English	Article							CONJUGATE ADDITION; ACTIVATING GROUPS; 1,4-ADDITION; ALKYLATION	Catalytic asymmetric conjugate addition reactions represent a powerful strategy to access chiral molecules in contemporary organic synthesis. However, their applicability to conjugated alkenyl-N-heteroaromatic compounds, of particular interest in medicinal chemistry, has lagged behind applications to other substrates. We report a highly enantioselective and chemoselective catalytic transformation of a wide range of beta-substituted conjugated alkenyl-N-heteroaromatics to their corresponding chiral alkylated products. This operationally simple methodology can introduce linear, branched, and cyclic alkyl chains, as well as a phenyl group, at the beta-carbon position. The key to this success was enhancement of the reactivity of alkenyl-heteroaromatic substrates via Lewis acid activation, in combination with the use of readily available and highly reactive Grignard reagents and a copper catalyst coordinated by a chiral chelating diphosphine ligand.	[Jumde, Ravindra P.; Lanza, Francesco; Veenstra, Marieke J.; Harutyunyan, Syuzanna R.] Univ Groningen, Stratingh Inst Chem, NL-9747 AG Groningen, Netherlands	University of Groningen	Harutyunyan, SR (corresponding author), Univ Groningen, Stratingh Inst Chem, NL-9747 AG Groningen, Netherlands.	s.harutyunyan@rug.nl	Jumde, Ravindra P./AAD-8912-2020	Jumde, Ravindra P./0000-0002-2674-9605; Veenstra, Marieke/0000-0002-6858-4351	Netherlands Organization for Scientific Research NWO-Vidi grant; Netherlands Organization for Scientific Research NWO-ECHO grant; Ministry of Education, Culture and Science Gravity program [024.001.035]	Netherlands Organization for Scientific Research NWO-Vidi grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO-ECHO grant; Ministry of Education, Culture and Science Gravity program	Supported by Netherlands Organization for Scientific Research NWO-Vidi and ECHO grants (S.R.H.) and Ministry of Education, Culture and Science Gravity program grant 024.001.035 (S. R. H.). We thank J. T. A. de Jong, B. Macia, and J. F. Collados for helpful comments on the manuscript.	Alexakis A, 2008, CHEM REV, V108, P2796, DOI 10.1021/cr0683515; Alexakis A, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/9783527664573; Best D, 2014, J ORG CHEM, V79, P831, DOI 10.1021/jo402414k; Blacker J.A., 2011, PHARM PROCESS DEV CU; Farina V, 2006, CHEM REV, V106, P2734, DOI 10.1021/cr040700c; Friedman AA, 2013, ANGEW CHEM INT EDIT, V52, P9755, DOI 10.1002/anie.201303659; Gruttadauria M., 2011, CATALYTIC METHODS AS; Harutyunyan SR, 2008, CHEM REV, V108, P2824, DOI 10.1021/cr068424k; Harutyunyan SR, 2006, J AM CHEM SOC, V128, P9103, DOI 10.1021/ja0585634; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Houpis IN, 1998, TETRAHEDRON, V54, P1185, DOI 10.1016/S0040-4020(97)10217-4; Howell GP, 2012, ORG PROCESS RES DEV, V16, P1258, DOI 10.1021/op200381w; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Jerphagnon T, 2009, CHEM SOC REV, V38, P1039, DOI 10.1039/b816853a; Klumpp DA, 2012, SYNLETT, P1590, DOI 10.1055/s-0031-1290984; Marcantoni E., 2014, LEWID ACID PROMOTED, P344; Ojima I., 2010, CATALYTIC ASYMMETRIC; Pattison G, 2010, J AM CHEM SOC, V132, P14373, DOI 10.1021/ja106809p; Richey H.G., 1999, GRIGNARD REAGENTS NE; Rong JW, 2015, ANGEW CHEM INT EDIT, V54, P3038, DOI 10.1002/anie.201409815; Rupnicki L, 2009, J AM CHEM SOC, V131, P10386, DOI 10.1021/ja904365h; Saxena A, 2011, CHEM SCI, V2, P2326, DOI 10.1039/c1sc00521a; Wu G. G., 2012, COMPREHENSIVE CHIRAL, P147; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1-2; YAMAMOTO Y, 1982, J ORG CHEM, V47, P119, DOI 10.1021/jo00340a026; Yoshikai N, 2012, CHEM REV, V112, P2339, DOI 10.1021/cr200241f	26	70	70	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					433	437		10.1126/science.aaf1983	http://dx.doi.org/10.1126/science.aaf1983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102477	Green Submitted			2022-12-28	WOS:000374479700040
J	Robison, P; Caporizzo, MA; Ahmadzadeh, H; Bogush, AI; Chen, CYX; Margulies, KB; Shenoy, VB; Prosser, BL				Robison, Patrick; Caporizzo, Matthew A.; Ahmadzadeh, Hossein; Bogush, Alexey I.; Chen, Christina Yingxian; Margulies, Kenneth B.; Shenoy, Vivek B.; Prosser, Benjamin L.			Detyrosinated microtubules buckle and bear load in contracting cardiomyocytes	SCIENCE			English	Article							OVERLOAD CARDIAC-HYPERTROPHY; INTERMEDIATE-FILAMENTS; POSTTRANSLATIONAL MODIFICATIONS; TUBULIN; DYSFUNCTION; CELLS; VIMENTIN; MUSCLE; HEART; RAT	The microtubule (MT) cytoskeleton can transmit mechanical signals and resist compression in contracting cardiomyocytes. How MTs perform these roles remains unclear because of difficulties in observing MTs during the rapid contractile cycle. Here, we used high spatial and temporal resolution imaging to characterize MT behavior in beating mouse myocytes. MTs deformed under contractile load into sinusoidal buckles, a behavior dependent on posttranslational "detyrosination" of alpha-tubulin. Detyrosinated MTs associated with desmin at force-generating sarcomeres. When detyrosination was reduced, MTs uncoupled from sarcomeres and buckled less during contraction, which allowed sarcomeres to shorten and stretch with less resistance. Conversely, increased detyrosination promoted MT buckling, stiffened the myocyte, and correlated with impaired function in cardiomyopathy. Thus, detyrosinated MTs represent tunable, compression-resistant elements that may impair cardiac function in disease.	[Robison, Patrick; Bogush, Alexey I.; Chen, Christina Yingxian; Prosser, Benjamin L.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Dept Physiol, Philadelphia, PA 19104 USA; [Caporizzo, Matthew A.; Ahmadzadeh, Hossein; Shenoy, Vivek B.] Univ Penn, Sch Engn & Appl Sci, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Margulies, Kenneth B.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Prosser, BL (corresponding author), Univ Penn, Perelman Sch Med, Penn Muscle Inst, Dept Physiol, Philadelphia, PA 19104 USA.	bpros@mail.med.upenn.edu	Shenoy, Vivek/ABD-5075-2021; Chen, Christina Yingxian/O-5676-2016	Prosser, Benjamin/0000-0003-3696-9131; Chen, Christina Yingxian/0000-0002-8013-1515	National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIH) [T32AR053461-09, T32HL007954]; National Heart, Lung, and Blood Institute (NIH) [R00-HL114879]; NSF [DMR08-32802, CMMI-1312392]; NSF Polymers Program [DMR09-07493]; NIH [HL089847, HL105993]; National Institute of Biomedical Imaging and Bioengineering (NIH) [R01EB017753]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133080, R01HL105993, R00HL114879, R01HL089847, T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017753] Funding Source: NIH RePORTER	National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF(National Science Foundation (NSF)); NSF Polymers Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank C. W. Ward and E. L. Holzbaur for kindly providing TTL and EMTB-3xGFP plasmids, respectively, as well as for discussion; R. Bloch for providing desmin KO mice and littermate controls; Carl Zeiss Microscopy for Airyscan instrumentation use; IonOptix for technical support and cell holder materials; and Y. E. Goldman, E. L. Grishchuk, and R. J. Composto for discussion and guidance. B. L. P., P. R., M. A. C., A. I. B., and K. B. M. were responsible for experimental design; B. L. P., P. R., M. A. C., C. Y. C., and A. I. B. carried out experiments and analyzed data; H. A. and V. B. S. designed and executed the mathematical model. B. L. P. and P. R. cowrote the manuscript. All authors participated in the critical review and revision of the manuscript. This work was supported by funding from National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIH) (T32AR053461-09 to P. R. and T32HL007954 to M. A. C.) and from National Heart, Lung, and Blood Institute (NIH) (R00-HL114879 to B.L.P.). The VIVA experiments used shared experimental facilities from the Nano Science and Engineering Center on Molecular Function at the Nano-Bio Interface at the University of Pennsylvania supported by NSF under grant DMR08-32802. We thank R. Composto, who acknowledges the NSF Polymers Program under grant DMR09-07493. Procurement of human heart tissue was enabled by grants from NIH (HL089847 and HL105993) to K.B.M. H.A. and V.B.S. are supported by the National Institute of Biomedical Imaging and Bioengineering (NIH) under award number R01EB017753 and NSF grant CMMI-1312392. The data are included in the main manuscript and in the supplementary materials online.	Belmadani S, 2004, MOL CELL BIOCHEM, V258, P35, DOI 10.1023/B:MCBI.0000012834.43990.b6; Belmadani S, 2002, MOL CELL BIOCHEM, V237, P39, DOI 10.1023/A:1016554104209; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Cassimeris Lynne, 2010, Methods Cell Biol, V97, pxvii, DOI 10.1016/S0091-679X(10)97031-3; Cooper G 4th, 2000, Heart Fail Rev, V5, P187; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kerr JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9526; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Mehrbod M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025627; Nishimura S, 2006, CIRC RES, V98, P81, DOI 10.1161/01.RES.0000197785.51819.e8; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Prager-Khoutorsky M, 2014, NEURON, V83, P866, DOI 10.1016/j.neuron.2014.07.023; Prosser BL, 2013, CARDIOVASC RES, V98, P307, DOI 10.1093/cvr/cvt066; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Tagawa H, 1997, CIRC RES, V80, P281, DOI 10.1161/01.RES.80.2.281; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; White E, 2011, PFLUG ARCH EUR J PHY, V462, P177, DOI 10.1007/s00424-011-0963-0; Zile MR, 1999, J AM COLL CARDIOL, V33, P250, DOI 10.1016/S0735-1097(98)00550-6; Zile MR, 1998, CIRCULATION, V98, P567, DOI 10.1161/01.CIR.98.6.567	34	170	173	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284							aaf0659	10.1126/science.aaf0659	http://dx.doi.org/10.1126/science.aaf0659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102488	Green Accepted			2022-12-28	WOS:000374479700038
J	Krauss, BS; Krauss, BA; Green, SM				Krauss, Baruch S.; Krauss, Benjamin A.; Green, Steven M.			Managing Procedural Anxiety in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Krauss, Baruch S.] Boston Childrens Hosp, Div Emergency Med, 300 Long Wood Ave, Boston, MA 02115 USA; [Krauss, Benjamin A.] Univ Massachusetts, Boston, MA 02125 USA; [Green, Steven M.] Loma Linda Univ, Med Ctr, Dept Emergency Med, Loma Linda, CA 92350 USA; [Green, Steven M.] Childrens Hosp, Loma Linda, CA USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Boston; Loma Linda University; Children's Hospital Los Angeles	Krauss, BS (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Long Wood Ave, Boston, MA 02115 USA.	baruch.krauss@childrens.harvard.edu	Krauss, Baruch/U-6182-2019						0	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16								10.1056/NEJMvcm1411127	http://dx.doi.org/10.1056/NEJMvcm1411127			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	27096598				2022-12-28	WOS:000374383900009
J	Tuting, T; de Visser, KE				Tueting, Thomas; de Visser, Karin E.			How neutrophils promote metastasis	SCIENCE			English	Editorial Material									[Tueting, Thomas] Univ Hosp Magdeburg, Dept Dermatol, Magdeburg, Germany; [de Visser, Karin E.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	University Hospital Magdeburg; Netherlands Cancer Institute	de Visser, KE (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	k.d.visser@nki.nl	Tüting, Thomas/AAJ-3610-2021	Tüting, Thomas/0000-0001-7146-0934; de Visser, Karin/0000-0002-0293-868X				Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; El Rayes T, 2015, P NATL ACAD SCI USA, V112, P16000, DOI 10.1073/pnas.1507294112; Ferrucci PF, 2015, BRIT J CANCER, V112, P1904, DOI 10.1038/bjc.2015.180; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Gebhardt C, 2015, CLIN CANCER RES, V21, P5453, DOI 10.1158/1078-0432.CCR-15-0676; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140	14	61	63	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					145	146		10.1126/science.aaf7300	http://dx.doi.org/10.1126/science.aaf7300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124439				2022-12-28	WOS:000373681600022
J	Brechot, C				Brechot, Christian			The Institut Pasteur International Network: a century-old global public health powerhouse	LANCET			English	Editorial Material									[Brechot, Christian] Inst Pasteur, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brechot, C (corresponding author), Inst Pasteur, F-75724 Paris 15, France.	christian.brechot@pasteur.fr	BRECHOT, Christian/S-2011-2018					Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Atlani-Duault L, 2016, LANCET; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cauchemez S, 2016, LANCET; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; Institut Pasteur, 2014, I PAST I PAST DAK FR; Nicolle C, 1930, NAISSANCE VIE MORT M; Smithburn KC, 1956, VACCINATION ANTIAMAR; WHO, 2016, REP COMM EX BOARD ST; World Health Organization, 2013, DEP GLOB CAP AL RESP; World Organisation for Animal Health, 2015, INST PAST WORLD ORG	12	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2181	2183		10.1016/S0140-6736(16)00744-3	http://dx.doi.org/10.1016/S0140-6736(16)00744-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145701				2022-12-28	WOS:000376820800015
J	Nay, O; Bejean, S; Benamouzig, D; Bergeron, H; Castel, P; Ventelou, B				Nay, Olivier; Bejean, Sophie; Benamouzig, Daniel; Bergeron, Henri; Castel, Patrick; Ventelou, Bruno			Achieving universal health coverage in France: policy reforms and the challenge of inequalities	LANCET			English	Article							SOCIOECONOMIC INEQUALITIES; SOCIAL DETERMINANTS; PUBLIC-HEALTH	Since 1945, the provision of health care in France has been grounded in a social conception promoting universalism and equality. The French health-care system is based on compulsory social insurance funded by social contributions, co-administered by workers' and employers' organisations under State control and driven by highly redistributive financial transfers. This system is described frequently as the French model. In this paper, the first in The Lancet's Series on France, we challenge conventional wisdom about health care in France. First, we focus on policy and institutional transformations that have affected deeply the governance of health care over past decades. We argue that the health system rests on a diversity of institutions, policy mechanisms, and health actors, while its governance has been marked by the reinforcement of national regulation under the aegis of the State. Second, we suggest the redistributive mechanisms of the health insurance system are impeded by social inequalities in health, which remain major hindrances to achieving objectives of justice and solidarity associated with the conception of health care in France.	[Nay, Olivier] Univ Paris 01, F-75005 Paris, France; [Bejean, Sophie] Univ Dijon, F-21004 Dijon, France; [Benamouzig, Daniel; Bergeron, Henri] CNRS, Paris, France; [Benamouzig, Daniel; Bergeron, Henri] Sci Po, Paris, France; [Ventelou, Bruno] Aix Marseille Univ, Sch Econ, Marseille, France; [Ventelou, Bruno] INSERM, Paris, France	heSam Universite; Universite Pantheon-Sorbonne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Institut d'Etudes Politiques Paris (Sciences Po); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Nay, O (corresponding author), Univ Paris 01, UFR 11, F-75005 Paris, France.	onay@univ-paris1.fr	Béjean, Sophie/GZG-4552-2022		French National Research Agency (ANR; Investissements d'avenir programme) [ANR-11-LABX-0021-01-LipSTIC]; LabEx; region of Burgundy PARI funding programme	French National Research Agency (ANR; Investissements d'avenir programme)(French National Research Agency (ANR)); LabEx; region of Burgundy PARI funding programme(Region Bourgogne-Franche-Comte)	We acknowledge funding from the French National Research Agency (ANR; Investissements d'avenir programme, ANR-11-LABX-0021-01-LipSTIC), LabEx, and the region of Burgundy PARI funding programme.	Angels B, 2008, RETOUR EC DEPENSES P; Atlani-Duault L, 2016, LANCET; BELORGEY N, 2010, HOPITAL PRESSION ENQ; Benamouzig D, 2005, SOCIOL TRAV, V47, P301, DOI 10.1016/j.soctra.2005.06.001; Benamouzig D, 2012, SOCIOL TRAV S1, V54, pe32; Benamouzig D., 2012, ACTES RECHERCHE SCI, V193, P56; Benamouzig D, 2014, QUADERNI, V85, P68; Bergeron H., 2010, POLITIQUES PUBLIQUES, P79; Bergeron H, 2011, REV FR SCI POLIT, V61, P19; Bergeron H, 2012, J HEALTH POLIT POLIC, V37, P5, DOI 10.1215/03616878-1496002; Berlivet L., 2000, SANTE RISQUES ACTION; Bloch M.-A., 2014, COORDINATION PARCOUR; Bourgueil Y, 2012, QUESTIONS EC SANTE 1; Chevreul K, 2015, HLTH SYST TRANSIT, V17, P1; Cornilleau G, 2009, TRIBUNES SANTE, V4, P71; Couffinhal A, 2005, QUESTIONS EC SANTE 9; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; Deaton A, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.2.13; Delvallee C, 2004, OBS DIAGN EC, V4, P333; Deplaude MO, 2009, DYNAMIQUES ERREUR, P335; Devaux M, 2012, INCOME RELATED INEQU; Dourgnon P, 2008, QUESTIONS EC SANTE 1; Duval J, 2012, REDISTRIBUTION VERTI; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; ETILE F., 2013, OBESITE SANTE PUBLIQ; Guigner S, 2008, I ESPACE EUROPEEN SA; Hassenteufel P, 1997, MEDECINS FACE ETAT; Hassenteufel P, 2013, MEDECINS FACE REFORM; Immergut E., 1992, HLTH POLITICS INTERE; Jamous H, 1969, SOCIOLOGIE DECISION; Jusot F, 2012, EUR J AGEING, V9, P15, DOI 10.1007/s10433-011-0201-9; Leclerc A, 2006, SOC SCI MED, V62, P2035, DOI 10.1016/j.socscimed.2005.08.031; Leclerc A, 2008, INEGAUX FACE SANTE C; Marmot M, 2013, REV EPIDEMIOL SANTE, V61, pS127, DOI 10.1016/j.respe.2013.05.014; Marmot SM, 2009, GLOBAL HLTH PROMOT, V16, pS23; Mathieu-Fritz A, 2013, REV FR SOCIOL, V54, P303, DOI 10.3917/rfs.542.0303; Menvielle G., 2008, Bulletin Epidemiologique Hebdomadaire, P289; Ministere des Affaires sociales et de la Sante, COMPT NAT SANT 2012; Ministere des Affaires sociales et de la Sante, PAN ET SANT; Moatti JP, 2013, REV EPIDEMIOL SANTE, V61, pS123, DOI 10.1016/j.respe.2013.05.012; Morelle A, 1995, DEFAITE SANTE PUBLIQ; Nathanson C. A., 2007, DIS PREVENTION SOCIA; Or Z, 2009, REV ECON-FR, V60, P521, DOI 10.3917/reco.602.0521; Palier B, 2005, GOUVERNER SECURITE S; Paraponaris A, 2005, ECON HUM BIOL, V3, P241, DOI 10.1016/j.ehb.2005.06.001; Peretti-Watel P, 2013, REV EPIDEMIOL SANTE, V61, pS158, DOI 10.1016/j.respe.2013.05.019; Pickett K., 2011, SPIRIT LEVEL WHY GRE; Robelet M, 2005, REV FRANCAISE AFFAIR, V1, P233; Saliba B, 2007, HEALTH POLICY, V81, P166, DOI 10.1016/j.healthpol.2006.05.017; Sauze D, 2010, SANTE TRAVAIL EPREUV, P95; Serrier H, 2013, EUR J HEALTH ECON, V15, pS661; Tabuteau D., 2002, SECURITE SANITAIRE, V2nd; Touraine M, 2014, LANCET, V383, P1101, DOI 10.1016/S0140-6736(14)60423-2; Trannoy A, 2013, REV EPIDEMIOL SANTE, V61, pS153, DOI 10.1016/j.respe.2013.05.018; Wagstaff A, 1999, J PUBLIC ECON, V72, P73, DOI 10.1016/S0047-2727(98)00085-1; WHO, 2008, CLOS HLTH GAP GEN HL	56	56	56	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2236	2249		10.1016/S0140-6736(16)00580-8	http://dx.doi.org/10.1016/S0140-6736(16)00580-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145707	Green Submitted			2022-12-28	WOS:000376820800034
J	Tian, Y; Garcia, G; Bian, Q; Steffen, KK; Joe, L; Wolff, S; Meyer, BJ; Dillin, A				Tian, Ye; Garcia, Gilberto; Bian, Qian; Steffen, Kristan K.; Joe, Larry; Wolff, Suzanne; Meyer, Barbara J.; Dillin, Andrew			Mitochondrial Stress Induces Chromatin Reorganization to Promote Longevity and UPRmt	CELL			English	Article							GENE-EXPRESSION; EPIGENETIC MODIFICATIONS; NUCLEAR ARCHITECTURE; ELECTRON-TRANSPORT; ELEGANS; HETEROCHROMATIN; TRANSCRIPTION; IDENTIFICATION; METHYLATION; NUTRITION	Organisms respond to mitochondrial stress through the upregulation of an array of protective genes, often perpetuating an early response to metabolic dysfunction across a lifetime. We find that mitochondrial stress causes widespread changes in chromatin structure through histone H3K9 di-methylation marks traditionally associated with gene silencing. Mitochondrial stress response activation requires the di-methylation of histone H3K9 through the activity of the histone methyltransferase met-2 and the nuclear co-factor lin-65. While globally the chromatin becomes silenced by these marks, remaining portions of the chromatin open up, at which point the binding of canonical stress responsive factors such as DVE-1 occurs. Thus, a metabolic stress response is established and propagated into adulthood of animals through specific epigenetic modifications that allow for selective gene expression and lifespan extension.	[Tian, Ye; Garcia, Gilberto; Bian, Qian; Steffen, Kristan K.; Joe, Larry; Wolff, Suzanne; Meyer, Barbara J.; Dillin, Andrew] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA; [Tian, Ye; Garcia, Gilberto; Steffen, Kristan K.; Joe, Larry; Wolff, Suzanne; Dillin, Andrew] Univ Calif Berkeley, Glenn Ctr Aging Res, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dillin, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.; Dillin, A (corresponding author), Univ Calif Berkeley, Glenn Ctr Aging Res, Berkeley, CA 94720 USA.	dillin@berkeley.edu		Tian, Ye/0000-0002-7675-9270; Meyer, Barbara/0000-0002-6530-4588; Bian, Qian/0000-0001-7022-2213	NIH [S10RR029668, S10RR027303, R37 AG024365]; Gordon and Betty Moore Foundation; Glenn Foundation for Medical Research Postdoctoral Fellowship; Jane Coffin Childs Memorial Fund for Medical Research; Glenn Foundation for Medical Research; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027303, S10RR029668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Glenn Foundation for Medical Research Postdoctoral Fellowship; Jane Coffin Childs Memorial Fund for Medical Research; Glenn Foundation for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Caenorhabditis Genetic Center and Shohei Mitani of the National BioResource Project for providing strains. We also thank Dr. Robert Horvitz for providing the lin-65 cDNA plasmid. We are grateful to Tao Cai at NIBS for the help with whole genome deep sequencing data analyses. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. This work used the CRL Molecular Imaging Center, supported by Gordon and Betty Moore Foundation. Y.T. was supported by the Glenn Foundation for Medical Research Postdoctoral Fellowship. K.K.S. was supported by a grant from the Jane Coffin Childs Memorial Fund for Medical Research. S.W. received support from the Glenn Foundation for Medical Research. This work was also supported by the NIH (R37 AG024365) and Howard Hughes Medical Institute. A.D. is a founder of Proteostasis Therapeutics and Mitobridge, Inc. and declares no financial interest.	Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Anderson MZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004436; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Ceol CJ, 2006, GENETICS, V173, P709, DOI 10.1534/genetics.106.056465; Choi SW, 2010, ADV NUTR, V1, P8, DOI 10.3945/an.110.1004; Copeland J.M., 2009, EXTENSION DROSOPHILA; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dey SS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145704; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; Lavigne MD, 2015, CELL REP, V11, P1090, DOI 10.1016/j.celrep.2015.04.022; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Meister P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r123; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Vrachnis N, 2012, EXP DIABETES RES, DOI 10.1155/2012/538474; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055	43	194	200	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1197	1208		10.1016/j.cell.2016.04.011	http://dx.doi.org/10.1016/j.cell.2016.04.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27133166	Green Accepted, Bronze			2022-12-28	WOS:000376478200019
J	Henderson, JT; Patnode, CD; Fortmann, SP				Henderson, Jillian T.; Patnode, Carrie D.; Fortmann, Stephen P.			Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Pregnant Women Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Henderson, Jillian T.; Patnode, Carrie D.; Fortmann, Stephen P.] Kaiser Permanente Northwest, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA	Kaiser Permanente	Henderson, JT (corresponding author), Kaiser Permanente Northwest, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA.							Berlin I, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1622; Brose LS, 2013, DRUG ALCOHOL DEPEN, V132, P660, DOI 10.1016/j.drugalcdep.2013.04.017	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					638	638		10.7326/L15-0624	http://dx.doi.org/10.7326/L15-0624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136222				2022-12-28	WOS:000375744000036
J	Tilstra, SA; McNeil, MA				Tilstra, Sarah A.; McNeil, Melissa A.			Update in Women's Health: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VASOMOTOR; SYMPTOMS		[Tilstra, Sarah A.; McNeil, Melissa A.] Univ Pittsburgh, Sch Med, Med Ctr, Dept Med,Div Gen Internal Med, 200 Lothrop St,933 West MUH, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tilstra, SA (corresponding author), Univ Pittsburgh, Sch Med, Med Ctr, Dept Med,Div Gen Internal Med, 200 Lothrop St,933 West MUH, Pittsburgh, PA 15213 USA.	tilstrasa@upmc.edu	Tilstra, Sarah/AAF-5751-2020					Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Gartoulla P, 2015, MENOPAUSE, V22, P694, DOI 10.1097/GME.0000000000000383; Ozanne EM, 2011, BREAST CANCER RES TR, V129, P165, DOI 10.1007/s10549-011-1430-5; Sagara Y, 2015, JAMA SURG, V150, P739, DOI 10.1001/jamasurg.2015.0876	4	0	0	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W65	W69		10.7326/M16-0226	http://dx.doi.org/10.7326/M16-0226			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136235				2022-12-28	WOS:000375744000014
J	Addis-Jones, C				Addis-Jones, Clive			Margretta Eleanor Addis-Jones OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		ADDISJONES ME, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2421	10.1136/bmj.i2421	http://dx.doi.org/10.1136/bmj.i2421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130631				2022-12-28	WOS:000375484100007
J	Almond, J; Leslie, K; Bell, P				Almond, Janet; Leslie, Katie; Bell, Patricia			Francis Anthony Almond OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2424	10.1136/bmj.i2424	http://dx.doi.org/10.1136/bmj.i2424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130247				2022-12-28	WOS:000375484100009
J	Ash, C; Mueller, K				Ash, Caroline; Mueller, Kristen			MANIPULATING THE MICROBIOTA	SCIENCE			English	Editorial Material																			0	14	14	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					531	531		10.1126/science.352.6285.530	http://dx.doi.org/10.1126/science.352.6285.530			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126033				2022-12-28	WOS:000374998600031
J	Li, YI; van de Geijn, B; Raj, A; Knowles, DA; Petti, AA; Golan, D; Gilad, Y; Pritchard, JK				Li, Yang I.; van de Geijn, Bryce; Raj, Anil; Knowles, David A.; Petti, Allegra A.; Golan, David; Gilad, Yoav; Pritchard, Jonathan K.			RNA splicing is a primary link between genetic variation and disease	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION VARIATION; HUMANS; MECHANISMS	Noncoding variants play a central role in the genetics of complex traits, but we still lack a full understanding of the molecular pathways through which they act. We quantified the contribution of cis-acting genetic effects at all major stages of gene regulation from chromatin to proteins, in Yoruba lymphoblastoid cell lines (LCLs). About similar to 65% of expression quantitative trait loci (eQTLs) have primary effects on chromatin, whereas the remaining eQTLs are enriched in transcribed regions. Using a novel method, we also detected 2893 splicing QTLs, most of which have little or no effect on gene-level expression. These splicing QTLs are major contributors to complex traits, roughly on a par with variants that affect gene expression levels. Our study provides a comprehensive view of the mechanisms linking genetic variation to variation in human gene regulation.	[Li, Yang I.; Raj, Anil; Golan, David; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [van de Geijn, Bryce; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Knowles, David A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Knowles, David A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Petti, Allegra A.] Washington Univ, Genome Inst, St Louis, MO USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; University of Chicago; Stanford University; Stanford University; Washington University (WUSTL); Stanford University; Howard Hughes Medical Institute; Stanford University	Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Gilad, Y (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.; Pritchard, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	gilad@uchicago.edu; pritch@stanford.edu		Raj, Anil/0000-0003-4412-0883; Li, Yang/0000-0002-0736-251X	NIH [R01MH084703, R01MH101825, U01HG007036, U54CA149145]; Center for Computational, Evolutionary and Human Genomics Fellowship; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA149145] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101825, R01MH084703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Computational, Evolutionary and Human Genomics Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Prabhakar for early access to the H3K27ac data; J. Blischak for technical assistance with the 4sU experiments; the anonymous reviewers for helpful comments; and A. Battle, A Pai, N. Banovich, A. Fu, X. Lan, A Harpak, and other members of the Pritchard/Gilad Labs tor helpful discussions. This work was supported by NIH grants R01MH084703, R01MH101825, U01HG007036, and U54CA149145; by a Center for Computational, Evolutionary and Human Genomics Fellowship; and by the Howard Hughes Medical Institute. The 4SU-seq data have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession no. GSE75220; other accession numbers can be found in table S8.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; del Rosario RCH, 2015, NAT METHODS, V12, P458, DOI [10.1038/NMETH.3326, 10.1038/nmeth.3326]; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Ira E, 2013, J PSYCHIATR NEUROSCI, V38, P366, DOI 10.1503/jpn.120178; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806	23	291	295	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					600	604		10.1126/science.aad9417	http://dx.doi.org/10.1126/science.aad9417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126046	Green Accepted			2022-12-28	WOS:000374998600048
J	Mayor, S				Mayor, Susan			Research funds should be returned if findings can't be reproduced, proposes Merck chief	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rosenblatt M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5003	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2477	10.1136/bmj.i2477	http://dx.doi.org/10.1136/bmj.i2477			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129727				2022-12-28	WOS:000375484100021
J	Mayor, S				Mayor, Susan			Half of people seen at English hospitals after self harming do not receive mental health assessment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Geulayov G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010538	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2463	10.1136/bmj.i2463	http://dx.doi.org/10.1136/bmj.i2463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2RY	27129594				2022-12-28	WOS:000375484100015
J	Rimmer, A				Rimmer, Abi			Over half of qualified GPs are now women, show HSCIC data	BMJ-BRITISH MEDICAL JOURNAL			English	News Item												arimmer@bmj.com						Health and Social Care Information Centre, 2016, GEN PERS MED SERV EN; Iacobucci G, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2297	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2480	10.1136/bmj.i2480	http://dx.doi.org/10.1136/bmj.i2480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129482				2022-12-28	WOS:000375484100022
J	Yahia, M				Yahia, Mohammed			SAUDI ARABIA	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S1	S1		10.1038/532S1a	http://dx.doi.org/10.1038/532S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27135096	Bronze			2022-12-28	WOS:000374815900057
J	[Anonymous]				[Anonymous]			SightS Set on a central role	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S2	S3		10.1038/532S2a	http://dx.doi.org/10.1038/532S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI4ZN	27135097	Bronze			2022-12-28	WOS:000491114200001
J	Cao, YXL; Ryser, MD; Payne, S; Li, BC; Rao, CV; You, LC				Cao, Yangxiaolu; Ryser, Marc D.; Payne, Stephen; Li, Bochong; Rao, Christopher V.; You, Lingchong			Collective Space-Sensing Coordinates Pattern Scaling in Engineered Bacteria	CELL			English	Article							VERTEBRATE NEURAL-TUBE; MORPHOGEN GRADIENTS; ACTIVATION GRADIENT; GENE-EXPRESSION; SPATIAL-PATTERN; GROWTH; MECHANISM; BIOLOGY; DESIGN; UNDERSTAND	Scale invariance refers to the maintenance of a constant ratio of developing organ size to body size. Although common, its underlying mechanisms remain poorly understood. Here, we examined scaling in engineered Escherichia coli that can form self-organized core-ring patterns in colonies. We found that the ring width exhibits perfect scale invariance to the colony size. Our analysis revealed a collective space-sensing mechanism, which entails sequential actions of an integral feedback loop and an incoherent feedforward loop. The integral feedback is implemented by the accumulation of a diffusive chemical produced by a colony. This accumulation, combined with nutrient consumption, sets the timing for ring initiation. The incoherent feedforward is implemented by the opposing effects of the domain size on the rate and duration of ring maturation. This mechanism emphasizes a role of timing control in achieving robust pattern scaling and provides a new perspective in examining the phenomenon in natural systems.	[Cao, Yangxiaolu; Payne, Stephen; Li, Bochong; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Ryser, Marc D.] Duke Univ, Dept Math, Durham, NC 27708 USA; [Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [You, Lingchong] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC 27708 USA	Duke University; Duke University; University of Illinois System; University of Illinois Urbana-Champaign; Duke University	You, LC (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.; You, LC (corresponding author), Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC 27708 USA.	you@duke.edu		Payne, Stephen/0000-0001-9727-7409; cao, yangxiaolu/0000-0002-1993-2874	Office of Naval Research [N00014-12-1-0631]; National Science Foundation; Army Research Office [W911NF-14-1-0490]; NIH [1R01-GM098642, R01-GM096190]; Swiss National Science Foundation [P300P2_154583]; David and Lucile Packard Fellowship; Department of Homeland Security Graduate Fellowship; Duke Nano Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098642, R01GM110494, R01GM096190] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Army Research Office; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); Department of Homeland Security Graduate Fellowship(United States Department of Homeland Security (DHS)); Duke Nano Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H.R. Meredith, K. Zhu, A.J. Lee, R. Tsoi, F. Wu, T. Sysoeva, Z. Dai, C. Xu, R. Collopy, T. Hwa, D. Karig, G. Reeves, and S. Di Talia for discussions and comments; Duke GCB's DSCR for assistance with high-performance computations; J. Neu for insightful suggestions on the modeling framework; Y. Gao and S. Johnson for assistance with confocal microscopy; Duke Light Microscopy Core Facility (LMCF) for access to confocal microscopes and imaging software. This study was partially supported by the Office of Naval Research (N00014-12-1-0631), National Science Foundation (L.Y.), Army Research Office (L.Y., W911NF-14-1-0490), NIH (L.Y., 1R01-GM098642; M.D.R., R01-GM096190), Swiss National Science Foundation (M.D.R., P300P2_154583), a David and Lucile Packard Fellowship (L.Y.), a Department of Homeland Security Graduate Fellowship (S.P.), and a Duke Nano Fellowship (Y.C.).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Averbukh I, 2014, DEVELOPMENT, V141, P2150, DOI 10.1242/dev.107011; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Ben-Zvi D, 2011, CURR OPIN GENET DEV, V21, P704, DOI 10.1016/j.gde.2011.07.011; Ben-Zvi D, 2011, CURR BIOL, V21, P1391, DOI 10.1016/j.cub.2011.07.015; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Brawand D, 2008, PLOS BIOL, V6, P507, DOI 10.1371/journal.pbio.0060063; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; BULLOUGH WS, 1962, BIOL REV, V37, P307, DOI 10.1111/j.1469-185X.1962.tb01615.x; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Cohen DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007086; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dzialowski EM, 2004, J EXP BIOL, V207, P597, DOI 10.1242/jeb.00792; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Fried P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6077; Gamer LW, 2003, DEV CELL, V4, P143, DOI 10.1016/S1534-5807(03)00027-3; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kenkre VM, 2004, PHYSICA A, V342, P242, DOI 10.1016/j.physa.2004.04.084; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Lesne A, 2012, SCALE INVARIANCE: FROM PHASE TRANSITION TO TURBULENCE, P361, DOI 10.1007/978-3-642-15123-1_11; Liu CL, 2011, SCIENCE, V334, P238, DOI 10.1126/science.1209042; Maini PK, 2004, CR BIOL, V327, P225, DOI 10.1016/j.crvi.2003.05.006; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Murray JD, 1998, J FRANKLIN I, V335B, P303, DOI 10.1016/S0016-0032(97)00034-3; Pages F, 2000, TRENDS GENET, V16, P40, DOI 10.1016/S0168-9525(99)01880-6; Payne S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.55; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Roth S, 2012, CELL, V149, P511, DOI 10.1016/j.cell.2012.04.007; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J., 2001, MOL CLONING LAB MANU; Schaerli Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5905; SINERVO B, 1992, SCIENCE, V256, P1574, DOI 10.1126/science.256.5063.1574; Skataric M, 2015, IET SYST BIOL, V9, P1, DOI 10.1049/iet-syb.2014.0006; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Stano NM, 2004, J BIOL CHEM, V279, P16136, DOI 10.1074/jbc.M400139200; Stathopoulos A, 2013, DEVELOPMENT, V140, P4119, DOI 10.1242/dev.095141; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Weymouth FW, 1942, P SOC EXP BIOL MED, V49, P367, DOI 10.3181/00379727-49-13567; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yu TC, 2012, CURR OPIN BIOTECH, V23, P791, DOI 10.1016/j.copbio.2012.01.006	57	59	64	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					620	630		10.1016/j.cell.2016.03.006	http://dx.doi.org/10.1016/j.cell.2016.03.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104979	Green Accepted, Bronze			2022-12-28	WOS:000374636800020
J	Zanoni, I; Tan, YH; Di Gioia, M; Broggi, A; Ruan, JB; Shi, JJ; Donado, CA; Shao, F; Wu, H; Springstead, JR; Kagan, JC				Zanoni, Ivan; Tan, Yunhao; Di Gioia, Marco; Broggi, Achille; Ruan, Jianbin; Shi, Jianjin; Donado, Carlos A.; Shao, Feng; Wu, Hao; Springstead, James R.; Kagan, Jonathan C.			An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells	SCIENCE			English	Article							INFLAMMATORY CASPASES; OXIDIZED PHOSPHOLIPIDS; IMMUNE-SYSTEM; DANGER; ACTIVATION; PROTECTS; FAMILY; DEATH; LPS	Dendritic cells (DCs) use pattern recognition receptors to detect microorganisms and activate protective immunity. These cells and receptors are thought to operate in an all-or-nothing manner, existing in an immunologically active or inactive state. Here, we report that encounters with microbial products and self-encoded oxidized phospholipids (oxPAPC) induce an enhanced DC activation state, which we call "hyperactive." Hyperactive DCs induce potent adaptive immune responses and are elicited by caspase-11, an enzyme that binds oxPAPC and bacterial lipopolysaccharide (LPS). oxPAPC and LPS bind caspase-11 via distinct domains and elicit different inflammasome-dependent activities. Both lipids induce caspase-11-dependent interleukin-1 release, but only LPS induces pyroptosis. The cells and receptors of the innate immune system can therefore achieve different activation states, which may permit context-dependent responses to infection.	[Zanoni, Ivan; Tan, Yunhao; Di Gioia, Marco; Broggi, Achille; Donado, Carlos A.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA USA; [Zanoni, Ivan; Tan, Yunhao; Di Gioia, Marco; Broggi, Achille; Donado, Carlos A.; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Zanoni, Ivan] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Zanoni, Ivan] Humanitas Clin & Res Ctr, Unit Cell Signalling & Innate Immun, Milan, Italy; [Springstead, James R.] Western Michigan Univ, Dept Chem & Paper Engn, Kalamazoo, MI 49008 USA; [Shi, Jianjin; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Ruan, Jianbin; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Milano-Bicocca; Western Michigan University; National Institute of Biological Sciences, Beijing; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA.	jonathan.kagan@childrens.harvard.edu	Di Gioia, Marco/AAC-4192-2019; Broggi, Achille/AAC-2276-2019; Tan, Yunhao/K-7442-2016	Di Gioia, Marco/0000-0001-9499-5771; Broggi, Achille/0000-0002-7244-2401; Tan, Yunhao/0000-0002-5516-4980; Shi, Jianjin/0000-0001-8048-5180; Ruan, Jianbin/0000-0001-5843-8273	NIH [AI093589, AI072955, P30 DK34854, 1R15HL121770-01A1, 1R01AI121066-01A1]; Burroughs Wellcome Fund; Harvard Digestive Diseases Center [P30 DK34854]; Cariplo Foundation; Jane Coffin Childs Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL121770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955, R01AI093589, R01AI121066, K99AI072955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Digestive Diseases Center; Cariplo Foundation(Fondazione Cariplo); Jane Coffin Childs Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Kagan laboratory for helpful discussions. The results reported in this manuscript are tabulated in the main paper and in the supplementary materials. J.C.K. and Boston Children's Hospital have filed an international patent application (PCT/US2016/012994) that relates to the adjuvant activity of oxPAPC. J.C.K. is supported by NIH grants AI093589, AI072955, and P30 DK34854 and a gift from Mead Johnson & Company. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. I.Z. is supported by NIH grant 1R01AI121066-01A1, Harvard Digestive Diseases Center grant P30 DK34854, and the Cariplo Foundation. Y.T. is supported by a fellowship of the Jane Coffin Childs Fund (Merck Fellow). J.S. is supported by NIH grant 1R15HL121770-01A1. J.S. and F.S. performed the experiments in Fig. 3D but were not involved in the experimental design or interpretation of data.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pradeu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00287; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Springstead JR, 2012, J LIPID RES, V53, P1304, DOI 10.1194/jlr.M025320; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	23	295	306	6	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1232	1236		10.1126/science.aaf3036	http://dx.doi.org/10.1126/science.aaf3036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27103670	Green Accepted			2022-12-28	WOS:000377045700046
J	Qian, XY; Nguyen, HN; Song, MM; Hadiono, C; Ogden, SC; Hammack, C; Yao, B; Hamersky, GR; Jacob, F; Zhong, C; Yoon, KJ; Jeang, W; Lin, L; Li, YJ; Thakor, J; Berg, DA; Zhang, C; Kang, E; Chickering, M; Nauen, D; Ho, CY; Wen, ZX; Christian, KM; Shi, PY; Maher, BJ; Wu, H; Jin, P; Tang, HL; Song, HJ; Ming, GL				Qian, Xuyu; Ha Nam Nguyen; Song, Mingxi M.; Hadiono, Christopher; Ogden, Sarah C.; Hammack, Christy; Yao, Bing; Hamersky, Gregory R.; Jacob, Fadi; Zhong, Chun; Yoon, Ki-Jun; Jeang, William; Lin, Li; Li, Yujing; Thakor, Jai; Berg, Daniel A.; Zhang, Ce; Kang, Eunchai; Chickering, Michael; Nauen, David; Ho, Cheng-Ying; Wen, Zhexing; Christian, Kimberly M.; Shi, Pei-Yong; Maher, Brady J.; Wu, Hao; Jin, Peng; Tang, Hengli; Song, Hongjun; Ming, Guo-li			Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure	CELL			English	Article							SELF-ORGANIZATION; DIFFERENTIATION; TISSUE; CELLS; DYSREGULATION; NEURONS; RISK; MICE	Cerebral organoids, three-dimensional cultures that model organogenesis, provide a new platform to investigatehuman brain development. High cost, variability, and tissue heterogeneity limit their broad applications. Here, we developed a miniaturized spinning bioreactor (Spin Omega) to generate forebrain-specific organoids from human iPSCs. These organoids recapitulate key features of human cortical development, including progenitor zone organization, neurogenesis, gene expression, and, notably, a distinct human-specific outer radial glia cell layer. We also developed protocols for midbrain and hypothalamic organoids. Finally, we employed the forebrain organoid platform to model Zika virus (ZIKV) exposure. Quantitative analyses revealed preferential, productive infection of neural progenitors with either African or Asian ZIKV strains. ZIKV infection leads to increased cell death and reduced proliferation, resulting in decreased neuronal cell-layer volume resembling microcephaly. Together, our brain-region-specific organoids and Spin Omega provide an accessible and versatile platform for modeling human brain development and disease and for compound testing, including potential ZIKV antiviral drugs.	[Qian, Xuyu; Ha Nam Nguyen; Song, Mingxi M.; Hadiono, Christopher; Jacob, Fadi; Zhong, Chun; Yoon, Ki-Jun; Jeang, William; Thakor, Jai; Berg, Daniel A.; Zhang, Ce; Kang, Eunchai; Chickering, Michael; Nauen, David; Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA; [Ha Nam Nguyen; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Zhong, Chun; Yoon, Ki-Jun; Zhang, Ce; Kang, Eunchai; Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hamersky, Gregory R.; Maher, Brady J.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Nauen, David] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Maher, Brady J.; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Song, Mingxi M.] Riverhill High Sch, Clarksville, MD 21029 USA; [Hadiono, Christopher] Byram Hills High Sch, Armonk, NY 10504 USA; [Ogden, Sarah C.; Hammack, Christy; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Yao, Bing; Lin, Li; Li, Yujing; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Jeang, William] Clear Lake High Sch, Harris, TX 77058 USA; [Ho, Cheng-Ying] Childrens Natl Med Ctr, Div Pathol, Washington, DC 20010 USA; [Ho, Cheng-Ying] George Washington Univ, Pathol & Pediat, Washington, DC 20010 USA; [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University System of Florida; Florida State University; Emory University; Emory University; Rollins School Public Health; Children's National Health System; George Washington University; University of Texas System; University of Texas Medical Branch Galveston	Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.	shongju1@jhmi.edu; gming1@jhmi.edu	Ho, Cheng-Ying/AAA-5098-2019; Yoon, Ki-Jun/S-8170-2018; Berg, Daniel/DVZ-4324-2022; Wu, Hao/H-3899-2017; Li, yujing/GQA-4109-2022; Li, Yujing/AAJ-1411-2020; Maher, Brady/L-8314-2016; Maher, Brady/GPC-8697-2022; Wen, Zhexing/L-1228-2018; Qian, Xuyu/C-1240-2017	Wu, Hao/0000-0003-1269-7354; Li, Yujing/0000-0002-4363-2484; Maher, Brady/0000-0001-5930-885X; Wen, Zhexing/0000-0002-1518-3845; Qian, Xuyu/0000-0001-5944-3816; nauen, david/0000-0002-2652-9944; Yao, Bing/0000-0002-3205-8130; Jacob, Fadi/0000-0002-0094-8454; Thakor, Jai/0000-0001-7583-186X; Kang, Eunchai/0000-0001-6884-622X; Berg, Daniel/0000-0001-9595-2052; Yoon, Ki-Jun/0000-0003-2985-2541; Jeang, William/0000-0002-5401-8535; Ming, Guo-li/0000-0002-2517-6075	NIH [NS048271, MH105128, NS095348, NS047344, ES021957, AI119530, AI111250, NS051630, NS079625, MH102690, MH104593]; MSCRF; SFARI [308988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119530, R21AI111250, R01AI079150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102690, P20MH084018, R01MH105128, R56MH104593, T32MH015330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS047344, R01NS047344, R37NS047344, R01NS048271, R21NS095348, R01NS051630, R01NS079625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, P50AG005146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSCRF; SFARI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Hopkins WSE machine shop and Nathaniel Leon for help of 3D printing and members of the Ming and Song laboratories for discussion; L. Liu and Y. Cai for technical support; and Robert B. Tesh at UTMB and the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA) for the Cambodian strain ZIKV<SUP>C</SUP>. This work was supported by grants from NIH (NS048271, MH105128, and NS095348 to G.L.M.; NS047344 and ES021957 to H.S.; AI119530 and AI111250 to H.T.; NS051630, NS079625, and MH102690 to P.J.; and MH104593 to B.J.M.), MSCRF (to H.S.), and SFARI (308988 to H.S.).	Bayer A., 2016, CELL HOST MICROBE; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P361, DOI 10.1016/j.tins.2004.05.007; Blackshaw S, 2010, J NEUROSCI, V30, P14925, DOI 10.1523/JNEUROSCI.4499-10.2010; Calvet G, 2016, LANCET INFECT DIS; Cauchemez S, 2016, LANCET; Chung S, 2005, MOL CELL NEUROSCI, V28, P241, DOI 10.1016/j.mcn.2004.09.008; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Driggers R.W., 2016, N ENGL J MED; Faria NR, 2016, SCIENCE; Garcez P. P., 2016, SCIENCE; GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; JESSUP JM, 1993, J CELL BIOCHEM, V51, P290, DOI 10.1002/jcb.240510308; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lazear HM, 2016, CELL HOST MICROBE; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002; Tang H., 2016, CELL STEM CELL; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011	36	1122	1150	36	282	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1238	1254		10.1016/j.cell.2016.04.032	http://dx.doi.org/10.1016/j.cell.2016.04.032			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27118425	Bronze, Green Accepted			2022-12-28	WOS:000376478200022
J	Suzuki, Y; Cardone, G; Restrepo, D; Zavattieri, PD; Baker, TS; Tezcan, FA				Suzuki, Yuta; Cardone, Giovanni; Restrepo, David; Zavattieri, Pablo D.; Baker, Timothy S.; Tezcan, F. Akif			Self-assembly of coherently dynamic, auxetic, two-dimensional protein crystals	NATURE			English	Article							ELECTRON-MICROSCOPY; POISSONS RATIO; IMAGE-ANALYSIS; GRAPHENE; MEMBRANE; POLYMER; DIFFRACTION; RESOLUTION; DESIGN; ARRAYS	Two-dimensional (2D) crystalline materials possess unique structural, mechanical and electronic properties(1,2) that make them highly attractive in many applications(3-5). Although there have been advances in preparing 2D materials that consist of one or a few atomic or molecular layers(6,7), bottom-up assembly of 2D crystalline materials remains a challenge and an active area of development(8-10). More challenging is the design of dynamic 2D lattices that can undergo large-scale motions without loss of crystallinity. Dynamic behaviour in porous three-dimensional (3D) crystalline solids has been exploited for stimuli-responsive functions and adaptive behaviour(11-13). As in such 3D materials, integrating flexibility and adaptiveness into crystalline 2D lattices would greatly broaden the functional scope of 2D materials. Here we report the self-assembly of unsupported, 2D protein lattices with precise spatial arrangements and patterns using a readily accessible design strategy. Three single-or double-point mutants of the C4-symmetric protein RhuA were designed to assemble via different modes of intermolecular interactions (single-disulfide, double-disulfide and metal-coordination) into crystalline 2D arrays. Owing to the flexibility of the single-disulfide interactions, the lattices of one of the variants ((C98)RhuA) are essentially defect-free and undergo substantial, but fully correlated, changes in molecular arrangement, yielding coherently dynamic 2D molecular lattices. (C98)RhuA lattices display a Poisson's ratio of -1-the lowest thermodynamically possible value for an isotropic material-making them auxetic.	[Suzuki, Yuta; Cardone, Giovanni; Baker, Timothy S.; Tezcan, F. Akif] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Restrepo, David; Zavattieri, Pablo D.] Purdue Univ, Sch Civil Engn, W Lafayette, IN 47907 USA; [Baker, Timothy S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego	Tezcan, FA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tezcan@ucsd.edu	Restrepo, David/AAM-6817-2020; Suzuki, Yuta/U-3992-2019	Restrepo, David/0000-0001-5462-5434; , Timothy/0000-0001-6543-8968; Cardone, Giovanni/0000-0003-4712-1451; Zavattieri, Pablo/0000-0003-4953-150X	US Department of Energy (DOE) (Division of Materials Sciences, Office of Basic Energy Sciences) [DE-FG02-10ER46677]; Air Force Office of Scientific Research (AFOSR) [BRI FA9550-12-1-0414]; NIH [1S10 RR-020016, GM-033050]; Agouron Foundation; UCSD; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033050] Funding Source: NIH RePORTER	US Department of Energy (DOE) (Division of Materials Sciences, Office of Basic Energy Sciences); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agouron Foundation; UCSD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Sailor, H. Gray, R. Alberstein and F. Paesani for discussions, N. Olson and J. Bouwer for assistance with TEM measurements, and N. Gianneschi for the use of AFM and DLS instrumentation. This work was primarily supported by the US Department of Energy (DOE) (Division of Materials Sciences, Office of Basic Energy Sciences, Award DE-FG02-10ER46677 to F.A.T.). Y.S. and F.A.T. were partially supported (for EM measurements) by a grant from the Air Force Office of Scientific Research (AFOSR, BRI FA9550-12-1-0414). The EM facilities used in this work are supported by funding to T.S.B. from the NIH (1S10 RR-020016 and GM-033050), the Agouron Foundation and UCSD.	Baughman RH, 2003, NATURE, V425, P667, DOI 10.1038/425667a; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; CHOI JB, 1992, J MATER SCI, V27, P5375, DOI 10.1007/BF02403846; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9; Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/NMAT3134, 10.1038/nmat3134]; Grima JN, 2005, PHYS STATUS SOLIDI B, V242, P561, DOI 10.1002/pssb.200460376; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Kissel P, 2014, NAT CHEM, V6, P774, DOI 10.1038/nchem.2008; Kory MJ, 2014, NAT CHEM, V6, P779, DOI [10.1038/nchem.2007, 10.1038/NCHEM.2007]; Kroemer M, 2002, ACTA CRYSTALLOGR D, V58, P824, DOI 10.1107/S0907444902004614; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Mas-Balleste R, 2011, NANOSCALE, V3, P20, DOI 10.1039/c0nr00323a; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabone J, 2010, SCIENCE, V329, P1053, DOI 10.1126/science.1190672; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Saboe PO, 2014, ADV MATER, V26, P7064, DOI 10.1002/adma.201402375; Scarpa F, 2004, SMART MATER STRUCT, V13, P49, DOI 10.1088/0964-1726/13/1/006; Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serre C, 2007, SCIENCE, V315, P1828, DOI 10.1126/science.1137975; Shimomura S, 2010, NAT CHEM, V2, P633, DOI [10.1038/NCHEM.684, 10.1038/nchem.684]; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Sleytr UB, 2014, FEMS MICROBIOL REV, V38, P823, DOI 10.1111/1574-6976.12063; Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445	42	200	201	10	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					369	+		10.1038/nature17633	http://dx.doi.org/10.1038/nature17633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27135928	Green Accepted			2022-12-28	WOS:000376004300043
J	Manchikanti, L; Kaye, AD; Hirsch, JA				Manchikanti, Laxmaiah; Kaye, Alan David; Hirsch, Joshua A.			Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis	ANNALS OF INTERNAL MEDICINE			English	Letter							METAANALYSIS		[Manchikanti, Laxmaiah] Univ Louisville, Louisville, KY 40292 USA; [Manchikanti, Laxmaiah] Pain Management Ctr Paducah, Paducah, KY USA; [Kaye, Alan David] Louisiana State Univ, Sch Med, New Orleans, LA USA; [Hirsch, Joshua A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hirsch, Joshua A.] Harvard Univ, Sch Med, Boston, MA USA	University of Louisville; Pain Management Center of Paducah; Louisiana State University System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Manchikanti, L (corresponding author), Univ Louisville, Louisville, KY 40292 USA.; Manchikanti, L (corresponding author), Pain Management Ctr Paducah, Paducah, KY USA.							Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; Manchikanti Laxmaiah, 2015, Anesth Pain Med, V5, pe23139, DOI 10.5812/aapm.23139; Manchikanti Laxmaiah, 2015, Surg Neurol Int, V6, pS194, DOI 10.4103/2152-7806.156598; Manchikanti L, 2015, CLIN ORTHOP RELAT R, V473, P1940, DOI 10.1007/s11999-014-3490-4; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564	5	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					633	633		10.7326/L15-0566	http://dx.doi.org/10.7326/L15-0566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136215				2022-12-28	WOS:000375744000028
J	Peixoto, AJ				Peixoto, Aldo J.			Update in Nephrology and Hypertension: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Peixoto, Aldo J.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Peixoto, AJ (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Boardman Nephrol 114, 330 Cedar St, New Haven, CT 06520 USA.	aldo.peixoto@yale.edu						Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Perkovic V, 2015, NEW ENGL J MED, V373, P2175, DOI 10.1056/NEJMe1513301; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88	3	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W42	W47		10.7326/M16-0243	http://dx.doi.org/10.7326/M16-0243			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136231				2022-12-28	WOS:000375744000010
J	Landolt, HP; Holst, SC				Landolt, Hans-Peter; Holst, Sebastian C.			Ionic control of sleep and wakefulness	SCIENCE			English	Editorial Material									[Landolt, Hans-Peter; Holst, Sebastian C.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Landolt, Hans-Peter; Holst, Sebastian C.] Univ Zurich, Zurich Ctr interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University of Zurich	Landolt, HP (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.; Landolt, HP (corresponding author), Univ Zurich, Zurich Ctr interdisciplinary Sleep Res, Zurich, Switzerland.	landolt@pharma.uzh.ch	Landolt, Hans-Peter/H-6951-2016; Holst, Sebastian C/V-4930-2017	Landolt, Hans-Peter/0000-0003-0887-9403; Holst, Sebastian C/0000-0003-3657-4535				BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Cloetta M, 1934, N-S ARCH EX PATH PH, V174, P589, DOI 10.1007/BF01878396; Demole V, 1927, N-S ARCH EX PATH PH, V120, P229, DOI 10.1007/BF01861262; Ding FF, 2016, SCIENCE, V352, P550, DOI 10.1126/science.aad4821; Holst SC, 2014, J NEUROSCI, V34, P566, DOI 10.1523/JNEUROSCI.4128-13.2014; Kleitman N, 1963, SLEEP WAKEFULNESS, P195; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Seigneur J, 2006, CEREB CORTEX, V16, P655, DOI 10.1093/cercor/bhj011; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017	11	4	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					517	518		10.1126/science.aaf8178	http://dx.doi.org/10.1126/science.aaf8178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126024	Green Accepted			2022-12-28	WOS:000374998600021
J	Rogers, KC; Whitney, M; D'Emic, M; Bagley, B				Rogers, Kristina Curry; Whitney, Megan; D'Emic, Michael; Bagley, Brian			Precocity in a tiny titanosaur from the Cretaceous of Madagascar	SCIENCE			English	Article							LONG-BONE HISTOLOGY; GROWTH RATE; DINOSAURS; ARCHOSAURS; STARVATION; CARTILAGE; PATTERNS; SAUROPOD; PLATE	Sauropod dinosaurs exhibit the largest ontogenetic size range among terrestrial vertebrates, but a dearth of very young individuals has hindered understanding of the beginning of their growth trajectory. A new specimen of Rapetosaurus krausei sheds light on early life in the smallest stage of one of the largest dinosaurs. Bones record rapid growth rates and hatching lines, indicating that this individual weighed similar to 3.4 kilograms at hatching. Just several weeks later, when it likely succumbed to starvation in a drought-stressed ecosystem, it had reached a mass of similar to 40 kilograms and was similar to 35 centimeters tall at the hip. Unexpectedly, Rapetosaurus limb bones grew isometrically throughout their development. Cortical remodeling, limb isometry, and thin calcified hypertrophic metaphyseal cartilages indicate an active, precocial growth strategy.	[Rogers, Kristina Curry] Macalester Coll, Biol & Geol Dept, St Paul, MN 55105 USA; [Whitney, Megan] Univ Washington, Dept Biol, Seattle, WA 98185 USA; [D'Emic, Michael] Adelphi Univ, Dept Biol, Garden City, NY 11530 USA; [Bagley, Brian] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA	Macalester College; University of Washington; University of Washington Seattle; Adelphi University; University of Minnesota System; University of Minnesota Twin Cities	Rogers, KC (corresponding author), Macalester Coll, Biol & Geol Dept, St Paul, MN 55105 USA.	rogersk@macalester.edu		Whitney, Megan/0000-0002-6671-5127; Bagley, Brian/0000-0001-6632-2035	National Science Foundation [EAR-0955716]; Directorate For Geosciences [1528273] Funding Source: National Science Foundation; Division Of Earth Sciences [1664432, 0955716] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Research was supported by the National Science Foundation (EAR-0955716). Higher-resolution images and XRCT .mpg files are archived at MorphoBank (http://morphobank.org/permalink/?P2326). Original fossil material will be permanently reposited in the paleontology collection at the Universite d'Antananarivo, with exact replicas (casts) housed at the Denver Museum of Nature and Science and at Macalester College. We thank the people of Berivotra and the Mahajanga Basin Project. R. Rogers, P. O'Connor, and three reviewers provided insightful comments. We thank J. Groenke and V. Heisey for preparation, J. Thole for photos, and T. Keillor, R. Martin, and D. Vital for artwork.	ACHESON RM, 1958, BRIT J EXP PATHOL, V39, P37; ACHESON RM, 1959, J ANAT, V93, P123; Apanius V., 1998, AVIAN GROWTH DEV EVO; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Bonnan MF, 2007, ANAT REC, V290, P1089, DOI 10.1002/ar.20578; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; Carrier DR, 1996, PHYSIOL ZOOL, V69, P467, DOI 10.1086/physzool.69.3.30164211; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Curtin AJ, 2012, J VERTEBR PALEONTOL, V32, P939, DOI 10.1080/02724634.2012.672388; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Francillon-Viellot H., 1993, BONE, V7; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Hugi J, 2012, J HERPETOL, V46, P312, DOI 10.1670/11-071; Martin RB, 2003, CALCIFIED TISSUE INT, V73, P101, DOI 10.1007/s00223-002-1059-9; Montes L, 2005, J ANAT, V206, P445, DOI 10.1111/j.1469-7580.2005.00410.x; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Rogers RR, 2007, J VERTEBR PALEONTOL, V27, P21, DOI 10.1671/0272-4634(2007)27[21:PAPOMC]2.0.CO;2; Rogers RR, 2005, GEOLOGY, V33, P297, DOI 10.1130/G21036.1; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Stern T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002212; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245	29	38	39	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					450	453		10.1126/science.aaf1509	http://dx.doi.org/10.1126/science.aaf1509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102482				2022-12-28	WOS:000374479700045
J	Lee, JM; Hirschfeld, E; Wedding, J				Lee, Joyce M.; Hirschfeld, Emily; Wedding, James			A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes Promise and Challenges for a New Era in Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXCHANGE CLINIC REGISTRY		[Lee, Joyce M.] Univ Michigan, Endocrinol Child Hlth Evaluat & Res Unit, 300 NIB,Room 6E14,Campus Box 5456, Ann Arbor, MI 48109 USA; [Hirschfeld, Emily] Univ Michigan, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Wedding, James] Nightscout Fdn, Mckinney, TX USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, JM (corresponding author), Univ Michigan, Endocrinol Child Hlth Evaluat & Res Unit, 300 NIB,Room 6E14,Campus Box 5456, Ann Arbor, MI 48109 USA.							Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; OpenAPS.org, WEARENOTWAITING RED; Patient-Centered Outcomes Research Institute, CREAT RES COLL INN N; Sparling K, WE ARE NOT WAITING 1; The Nightscout Project, NIGHTSC WEARENOTWAIT; Torrance AW, RIGHT INNOVATE; Wong JC, 2014, DIABETES CARE, V37, P2702, DOI 10.2337/dc14-0303	7	48	48	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1447	1448		10.1001/jama.2016.1903	http://dx.doi.org/10.1001/jama.2016.1903			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115262				2022-12-28	WOS:000373873800006
J	Baier, S; Mark, MJ; Petter, D; Aikawa, K; Chomaz, L; Cai, Z; Baranov, M; Zoller, P; Ferlaino, F				Baier, S.; Mark, M. J.; Petter, D.; Aikawa, K.; Chomaz, L.; Cai, Z.; Baranov, M.; Zoller, P.; Ferlaino, F.			Extended Bose-Hubbard models with ultracold magnetic atoms	SCIENCE			English	Article							OPTICAL LATTICES; MOTT-INSULATOR; QUANTUM; TRANSITION; SUPERFLUID; GAS	The Hubbard model underlies our understanding of strongly correlated materials. Whereas its standard form only comprises interactions between particles at the same lattice site, extending it to encompass long-range interactions is predicted to profoundly alter the quantum behavior of the system. We realize the extended Bose-Hubbard model for an ultracold gas of strongly magnetic erbium atoms in a three-dimensional optical lattice. Controlling the orientation of the atomic dipoles, we reveal the anisotropic character of the onsite interaction and hopping dynamics and their influence on the superfluid-to-Mott insulator quantum phase transition. Moreover, we observe nearest-neighbor interactions, a genuine consequence of the long-range nature of dipolar interactions. Our results lay the groundwork for future studies of exotic many-body quantum phases.	[Baier, S.; Mark, M. J.; Petter, D.; Aikawa, K.; Chomaz, L.; Ferlaino, F.] Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria; [Mark, M. J.; Chomaz, L.; Cai, Z.; Baranov, M.; Zoller, P.; Ferlaino, F.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Zoller, P.] Univ Innsbruck, Inst Theoret Phys, Technikerstr 21A, A-6020 Innsbruck, Austria; [Aikawa, K.] Tokyo Inst Technol, Dept Phys, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528550, Japan	University of Innsbruck; Austrian Academy of Sciences; University of Innsbruck; Tokyo Institute of Technology	Ferlaino, F (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.; Ferlaino, F (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria.	francesca.ferlaino@uibk.ac.at	Zoller, Peter/O-1639-2014; Ferlaino, Francesca/E-6726-2012; Chomaz, Lauriane/AAF-1092-2021; Baier, Simon/AAV-7185-2021; Cai, Zi/D-8017-2017; Mark, Manfred J/E-4286-2010; Baier, Simon/B-3559-2018	Zoller, Peter/0000-0003-4014-1505; Ferlaino, Francesca/0000-0002-3020-6291; Chomaz, Lauriane/0000-0001-7196-5721; Baier, Simon/0000-0002-2840-5590; Mark, Manfred J/0000-0001-8157-4716; Baier, Simon/0000-0002-2840-5590	Austrian Ministry of Science and Research (BMWF); Austrian Science Fund (FWF) through START grant [Y479-N20]; European Research Council (ERC) [259435]; Lise-Meitner program of the FWF; Special Research Programme (SFB) FoQuS; ERC Synergy Grant UQUAM; EU FET Proactive Initiative SIQS; Austrian Science Fund (FWF) [Y 479] Funding Source: researchfish	Austrian Ministry of Science and Research (BMWF); Austrian Science Fund (FWF) through START grant; European Research Council (ERC)(European Research Council (ERC)); Lise-Meitner program of the FWF(Austrian Science Fund (FWF)); Special Research Programme (SFB) FoQuS; ERC Synergy Grant UQUAM; EU FET Proactive Initiative SIQS; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank F. Meinert and H.-C. Nagerl for fruitful discussions. The Innsbruck experimental group is supported by the Austrian Ministry of Science and Research (BMWF) and the Austrian Science Fund (FWF) through a START grant under project Y479-N20 and by the European Research Council (ERC) under project 259435. K.A. has been supported within the Lise-Meitner program of the FWF. The Innsbruck theory group is supported by the Special Research Programme (SFB) FoQuS, by the ERC Synergy Grant UQUAM, and by the EU FET Proactive Initiative SIQS. The data leading to the histograms of Fig. 3D are presented in (27).	Aikawa K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.010404; Aikawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210401; Auerbach A., 2012, INTERACTING ELECT QU; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; Capogrosso-Sansone B, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.125301; Clark SR, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/160; De Gennes, 1995, PHYS LIQUID CRYSTALS; de Paz A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185305; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dutta O, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066001; Frisch A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.203201; Frisch A, 2014, NATURE, V507, P475, DOI 10.1038/nature13137; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; Jurgensen O, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.193003; Kollath C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050402; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lu MW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215301; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; Luhmann DS, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033021; Mark MJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175301; Mazzarella G, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.013625; MICNAS R, 1990, REV MOD PHYS, V62, P113, DOI 10.1103/RevModPhys.62.113; Muller S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053601; Nascimbene S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.140401; Naylor B, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.011603; Ospelkaus S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.180403; Pollet L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.125302; Rosensweig RE, 1998, FERROHYDRODYNAMICS; SCALETTAR RT, 1995, PHYS REV B, V51, P8467, DOI 10.1103/PhysRevB.51.8467; Scarola VW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033003; Schauss P, 2015, SCIENCE, V347, P1455, DOI 10.1126/science.1258351; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Trefzger C, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/19/193001; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Wall ML, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123005; Wessel S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.127205; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Yi S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.260405; Yi W, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073015; Zaanen J, 1999, PHYSICA C, V317, P217, DOI 10.1016/S0921-4534(99)00062-3	41	202	202	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					201	205		10.1126/science.aac9812	http://dx.doi.org/10.1126/science.aac9812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124454	Green Submitted			2022-12-28	WOS:000373681600040
J	Bernard, CL; Brandeau, ML; Humphreys, K; Bendavid, E; Holodniy, M; Weyant, C; Owens, DK; Goldhaber-Fiebert, JD				Bernard, Cora L.; Brandeau, Margaret L.; Humphreys, Keith; Bendavid, Eran; Holodniy, Mark; Weyant, Christopher; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							REDUCING HETEROSEXUAL TRANSMISSION; BEHAVIORAL SURVEILLANCE SYSTEM; ANTIRETROVIRAL PROPHYLAXIS; SUBSTITUTION TREATMENT; TESTING BEHAVIORS; RISK BEHAVIORS; US CITIES; PREVENTION; INFECTION; MEN	Background: The total population health benefits and costs of HIV preexposure prophylaxis (PrEP) for people who inject drugs (PWID) in the United States are unclear. Objective: To evaluate the cost-effectiveness and optimal delivery conditions of PrEP for PWID. Design: Empirically calibrated dynamic compartmental model. Data Sources: Published literature and expert opinion. Target Population: Adult U.S. PWID. Time Horizon: 20 years and lifetime. Intervention: PrEP alone, PrEP with frequent screening (PrEP+screen), and PrEP+screen with enhanced provision of antiretroviral therapy (ART) for individuals who become infected (PrEP+screen+ART). All scenarios are considered at 25% coverage. Outcome Measures: Infections averted, deaths averted, change in HIV prevalence, discounted costs (in 2015 U.S. dollars), discounted quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: PrEP+screen+ART dominates other strategies, averting 26 700 infections and reducing HIV prevalence among PWID by 14% compared with the status quo. Achieving these benefits costs $253 000 per QALY gained. At current drug prices, total expenditures for PrEP+screen+ART could be as high as $44 billion over 20 years. Results of Sensitivity Analysis: Cost-effectiveness of the intervention is linear in the annual cost of PrEP and is dependent on PrEP drug adherence, individual transmission risks, and community HIV prevalence. Limitation: Data on risk stratification and achievable PrEP efficacy levels for U.S. PWID are limited. Conclusion: PrEP with frequent screening and prompt treatment for those who become infected can reduce HIV burden among PWID and provide health benefits for the entire U.S. population, but, at current drug prices, it remains an expensive intervention both in absolute terms and in cost per QALY gained.	[Bernard, Cora L.; Brandeau, Margaret L.; Weyant, Christopher] Stanford Univ, Dept Management Sci & Engn, Huang Engn Ctr, 475 Via Ortega, Stanford, CA 94305 USA; [Humphreys, Keith] Stanford Sch Med, Dept Psychiat, 401 N Quarry Rd,Room C-305, Stanford, CA 94305 USA; [Bendavid, Eran; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care & Outcomes Res, Ctr Hlth Policy, 117 Encina Commons,Room 204, Stanford, CA 94305 USA; [Holodniy, Mark] VA Palo Alto Hlth Care Syst, AIDS Res Ctr, 3801 Miranda Ave 132, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Bernard, CL (corresponding author), Stanford Univ, Dept Management Sci & Engn, Huang Engn Ctr, 475 Via Ortega, Stanford, CA 94305 USA.	clb210@stanford.edu		Holodniy, Mark/0000-0002-6655-7982; Bernard, Cora/0000-0002-1967-6356; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	National Institute on Drug Abuse [R01-DA15612]; PAC-CAR Inc. Stanford Graduate Fellowship; National Science Foundation Graduate Fellowship [DGE-114747]; Stanford Department of Management Science and Engineering Graduate Fellowship; Department of Veterans Affairs; Career Development Award from the National Institute on Aging [K01AG037593-01A1]; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); PAC-CAR Inc. Stanford Graduate Fellowship; National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); Stanford Department of Management Science and Engineering Graduate Fellowship; Department of Veterans Affairs(US Department of Veterans Affairs); Career Development Award from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: By grant R01-DA15612 from the National Institute on Drug Abuse. Ms. Bernard was supported by a PAC-CAR Inc. Stanford Graduate Fellowship and a National Science Foundation Graduate Fellowship (DGE-114747). Christopher Weyant was supported by a Stanford Department of Management Science and Engineering Graduate Fellowship and a National Science Foundation Graduate Fellowship (DGE-114747). Drs. Owens, Humphreys, and Holodniy were supported by the Department of Veterans Affairs. Dr. Goldhaber-Fiebert was supported by a Career Development Award (K01AG037593-01A1) from the National Institute on Aging.	Alistar SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086584; Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barnett PG, 2014, AM J MANAG CARE, V20, pE129; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540; Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bellis David J., 1993, Journal of Addictive Diseases, V12, P7, DOI 10.1300/J069v12n01_02; Blankenship KM, 2005, J HEALTH CARE POOR U, V16, P140, DOI 10.1353/hpu.2005.0110; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S, V17; Centers for Disease Control and Prevention, 2015, HIV SURV REP 2013, V25; Centers for Disease Control and Prevention, 2015, HIV AIDS INF POST; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P133; Central Intelligence Agency, WORLD FACTB US; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cipriano LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045176; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Gold M, 1996, MED CARE, V34, pDS197; Goldhaber-Fiebert Jeremy D, 2007, Popul Health Metr, V5, P11, DOI 10.1186/1478-7954-5-11; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hall HI, 2010, JAIDS-J ACQ IMM DEF, V55, P271, DOI 10.1097/QAI.0b013e3181e8f90c; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1998, J ACQ IMMUN DEF SYND, V18, pS133, DOI 10.1097/00042560-199802001-00022; JUUSOLA JL, 2012, ANN INTERN MED, V156, P541, DOI DOI 10.1059/0003-4819-156-8-201204170-00001; Kapadia F, 2007, DRUG ALCOHOL DEPEN, V91, pS56, DOI 10.1016/j.drugalcdep.2007.01.004; Karnon J, 2011, PHARMACOECONOMICS, V29, P51, DOI 10.2165/11584610-000000000-00000; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Lehman DA, 2015, J INFECT DIS, V211, P1211, DOI 10.1093/infdis/jiu677; Livoti C., 2013, FINANCIAL TIMES; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery JP, 2003, AIDS CARE, V15, P829, DOI 10.1080/09540120310001618676; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; New York State Department of Health, 2012, PREEXP PROPH PREP PR; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pollack HA, 2010, J SUBST ABUSE TREAT, V38, P307, DOI 10.1016/j.jsat.2009.12.004; Public Health Agency of Canada, 2013, HIV TRANSM RISK SUMM; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Semaan S, 2010, DRUG ALCOHOL DEPEN, V106, P7, DOI 10.1016/j.drugalcdep.2009.07.015; Sionean C, 2014, MMWR SURVEILL SUMM, V63, P1; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Spiller MW, 2015, MMWR-MORBID MORTAL W, V64, P270; Spire B, 2007, INT J DRUG POLICY, V18, P262, DOI 10.1016/j.drugpo.2006.12.014; Stinnett AA, 1997, MED DECIS MAKING, V17, P483, DOI 10.1177/0272989X9701700414; Sullivan LE, 2008, J SUBST ABUSE TREAT, V35, P87, DOI 10.1016/j.jsat.2007.08.004; Supervie V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00185; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; The Henry J Kaiser Family Foundation, 2015, US FED FUND HIV AIDS; US Bureau of Labor Statistics, 2014, CONS PRIC IND; US Public Health Service, 2014, PREEXP PROPH PREV HI; Wada N, 2014, AIDS, V28, P257, DOI 10.1097/QAD.0000000000000078; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878; Westergaard RP, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-10; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zule WA, 2009, J URBAN HEALTH, V86, pS48, DOI 10.1007/s11524-009-9366-3	69	36	36	2	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					10	+		10.7326/M15-2634	http://dx.doi.org/10.7326/M15-2634			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ5AD	27110953	Green Accepted			2022-12-28	WOS:000379215800003
J	Nik-Zainal, S; Davies, H; Staaf, J; Ramakrishna, M; Dominik,; Zou, XQ; Martincorena, I; Alexandrov, LB; Martin, S; Wedge, DC; Van Loo, P; Ju, YS; Smid, M; Brinkman, AB; Morganella, S; Aure, MR; Lingjaerde, OC; Langerod, A; Ringner, M; Ahn, SM; Boyault, S; Brock, JE; Broeks, A; Butler, A; Desmedt, C; Dirix, L; Dronov, S; Fatima, A; Foekens, JA; Gerstung, M; Hooijer, GKJ; Jang, SJ; Jones, DR; Kim, HY; King, TA; Krishnamurthy, S; Lee, HJ; Lee, JY; Li, YL; McLaren, S; Menzies, A; Mustonen, V; O'Meara, S; Pauporte, I; Pivot, X; Purdie, CA; Raine, K; Ramakrishnan, K; Rodriguez-Gonzalez, FG; Romieu, G; Sieuwerts, AM; Simpson, PT; Shepherd, R; Stebbings, L; Stefansson, OA; Teague, J; Tommasi, S; Treilleux, I; Van den Eynden, GG; Vermeulen, P; Vincent-Salomon, A; Yates, L; Caldas, C; van't Veer, L; Tutt, A; Knappskog, S; Tan, BKT; Jonkers, J; Borg, A; Ueno, NT; Sotiriou, C; Viari, A; Futreal, PA; Campbell, PJ; Span, PN; Van Laere, S; Lakhani, SR; Eyfjord, JE; Thompson, AM; Birney, E; Stunnenberg, HG; Van De Vijver, MJ; Martens, JWM; Borresen-Dale, AL; Richardson, AL; Kong, G; Thomas, G; Stratton, MR				Nik-Zainal, Serena; Davies, Helen; Staaf, Johan; Ramakrishna, Manasa; Glodzik, Dominik; Zou, Xueqing; Martincorena, Inigo; Alexandrov, Ludmil B.; Martin, Sancha; Wedge, David C.; Van Loo, Peter; Ju, Young Seok; Smid, Marcel; Brinkman, Arie B.; Morganella, Sandro; Aure, Miriam R.; Lingjaerde, Ole Christian; Langerod, Anita; Ringner, Markus; Ahn, Sung-Min; Boyault, Sandrine; Brock, Jane E.; Broeks, Annegien; Butler, Adam; Desmedt, Christine; Dirix, Luc; Dronov, Serge; Fatima, Aquila; Foekens, John A.; Gerstung, Moritz; Hooijer, Gerrit K. J.; Jang, Se Jin; Jones, David R.; Kim, Hyung-Yong; King, Tari A.; Krishnamurthy, Savitri; Lee, Hee Jin; Lee, Jeong-Yeon; Li, Yilong; McLaren, Stuart; Menzies, Andrew; Mustonen, Ville; O'Meara, Sarah; Pauporte, Iris; Pivot, Xavier; Purdie, Colin A.; Raine, Keiran; Ramakrishnan, Kamna; Rodriguez-Gonzalez, F. German; Romieu, Gilles; Sieuwerts, Anieta M.; Simpson, Peter T.; Shepherd, Rebecca; Stebbings, Lucy; Stefansson, Olafur A.; Teague, Jon; Tommasi, Stefania; Treilleux, Isabelle; Van den Eynden, Gert G.; Vermeulen, Peter; Vincent-Salomon, Anne; Yates, Lucy; Caldas, Carlos; van't Veer, Laura; Tutt, Andrew; Knappskog, Stian; Tan, Benita Kiat Tee; Jonkers, Jos; Borg, Ake; Ueno, Naoto T.; Sotiriou, Christos; Viari, Alain; Futreal, P. Andrew; Campbell, Peter J.; Span, Paul N.; Van Laere, Steven; Lakhani, Sunil R.; Eyfjord, Jorunn E.; Thompson, Alastair M.; Birney, Ewan; Stunnenberg, Hendrik G.; van de Vijver, Marc J.; Martens, John W. M.; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Kong, Gu; Thomas, Gilles; Stratton, Michael R.			Landscape of somatic mutations in 560 breast cancer whole-genome sequences	NATURE			English	Article							TERT PROMOTER MUTATIONS; INVERTED REPEATS; GENE FUSIONS; COPY NUMBER; DNA-REPAIR; SIGNATURES; TUMORS; CARCINOMAS; DISCOVERY; HETEROZYGOSITY	We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer.	[Nik-Zainal, Serena; Davies, Helen; Ramakrishna, Manasa; Glodzik, Dominik; Zou, Xueqing; Martincorena, Inigo; Alexandrov, Ludmil B.; Martin, Sancha; Wedge, David C.; Van Loo, Peter; Ju, Young Seok; Butler, Adam; Dronov, Serge; Gerstung, Moritz; Jones, David R.; Li, Yilong; McLaren, Stuart; Menzies, Andrew; Mustonen, Ville; O'Meara, Sarah; Raine, Keiran; Ramakrishnan, Kamna; Shepherd, Rebecca; Stebbings, Lucy; Teague, Jon; Yates, Lucy; Futreal, P. Andrew; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Nik-Zainal, Serena] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge CB2 9NB, England; [Staaf, Johan; Ringner, Markus; Borg, Ake] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, SE-22381 Lund, Sweden; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Theoret Biol & Biophys T6, POB 1663, Los Alamos, NM 87545 USA; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Ctr Nonlinear Studies, POB 1663, Los Alamos, NM 87545 USA; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Smid, Marcel; Foekens, John A.; Rodriguez-Gonzalez, F. German; Sieuwerts, Anieta M.; Martens, John W. M.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, NL-3015 CN Rotterdam, Netherlands; [Smid, Marcel; Foekens, John A.; Rodriguez-Gonzalez, F. German; Sieuwerts, Anieta M.; Martens, John W. M.] Erasmus Univ, Med Ctr, Canc Genom Netherlands, NL-3015 CN Rotterdam, Netherlands; [Brinkman, Arie B.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Morganella, Sandro; Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Aure, Miriam R.; Langerod, Anita; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Canc Genet, N-0310 Oslo, Norway; [Aure, Miriam R.; Lingjaerde, Ole Christian; Langerod, Anita; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0310 Oslo, Norway; [Lingjaerde, Ole Christian] Univ Oslo, Dept Comp Sci, Oslo, Norway; [Ahn, Sung-Min] Gachon Univ, Gil Med Ctr, Gachon Inst Genome Med & Sci, Inchon, South Korea; [Boyault, Sandrine] Ctr Leon Berard, Translat Res Lab, 28 Rue Laennec, F-69373 Lyon 08, France; [Brock, Jane E.; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Broeks, Annegien; van't Veer, Laura; Jonkers, Jos] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Desmedt, Christine; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Bd Waterloo 121, B-1000 Brussels, Belgium; [Dirix, Luc; Van den Eynden, Gert G.; Vermeulen, Peter; Van Laere, Steven] Univ Antwerp, Fac Med & Hlth Sci, Oncol Res Ctr, Translat Canc Res Unit, B-2020 Antwerp, Belgium; [Fatima, Aquila; Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Hooijer, Gerrit K. J.; van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Jang, Se Jin; Lee, Hee Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Ulsan 680749, South Korea; [Kim, Hyung-Yong; Kong, Gu] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [King, Tari A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA; [Krishnamurthy, Savitri; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, 1515 Holcombe Boulevard, Houston, TX 77030 USA; [Lee, Jeong-Yeon] Hanyang Univ, IBBR, Seoul 133791, South Korea; [Pauporte, Iris] Natl Canc Inst, Div Res, Dept Clin Res, 52 Ave Morizet, F-92513 Boulogne, France; [Pivot, Xavier] Univ Hosp Minjoz, INSERM UMR 1098, Bd Fleming, F-25000 Besancon, France; [Purdie, Colin A.; Thompson, Alastair M.] Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Scotland; [Romieu, Gilles] ICM Inst Reg Canc, Oncol Senol, Montpellier, France; [Simpson, Peter T.; Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4029, Australia; [Simpson, Peter T.; Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld 4029, Australia; [Stefansson, Olafur A.; Eyfjord, Jorunn E.] Univ Iceland, Fac Med, Canc Res Lab, IS-101 Reykjavik, Iceland; [Tommasi, Stefania] IRCCS Ist Tumori Giovanni Paolo II, Bari, Italy; [Treilleux, Isabelle] Ctr Leon Berard, Dept Pathol, 28 Rue Laennec, F-69373 Lyon 08, France; [Van den Eynden, Gert G.; Vermeulen, Peter] GZA Hosp Sint Augustinus, Dept Pathol, Antwerp, Belgium; [Vincent-Salomon, Anne] Paris Sci Lettres Univ, Inst Curie, Dept Pathol, 26 Rue Ulm, F-75248 Paris 05, France; [Vincent-Salomon, Anne] INSERM U934, 26 Rue Ulm, F-75248 Paris 05, France; [Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England; [Tutt, Andrew] Kings Coll London, Breast Canc Now Res Unit, London SE1 9RT, England; [Tutt, Andrew] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London SW3 6JB, England; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, N-5020 Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Tan, Benita Kiat Tee] Natl Canc Ctr Singapore, 11 Hosp Dr, Singapore 169610, Singapore; [Tan, Benita Kiat Tee] Singapore Gen Hosp, Outram Rd, Singapore 169608, Singapore; [Viari, Alain] INRIA Grenoble Rhone Alpes, Equipe Erable, 655 Ave Europe, F-38330 Montbonnot St Martin, France; [Viari, Alain; Thomas, Gilles] Ctr Leon Berard, Synergie Lyon Canc, 28 Rue Laennec, F-69373 Lyon 08, France; [Futreal, P. Andrew] UT MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77230 USA; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld 4029, Australia; [Thompson, Alastair M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, 1400 Pressler St, Houston, TX 77030 USA	Wellcome Trust Sanger Institute; University of Cambridge; Lund University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; KU Leuven; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Oslo; University of Oslo; University of Oslo; Gachon University; UNICANCER; Centre Leon Berard; Harvard University; Brigham & Women's Hospital; Netherlands Cancer Institute; Institut Jules Bordet; Universite Libre de Bruxelles; University of Antwerp; Harvard University; Dana-Farber Cancer Institute; University of Amsterdam; University of Ulsan; Asan Medical Center; Hanyang University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Hanyang University; Institut National du Cancer (INCA) France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; University of Dundee; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of Queensland; University of Queensland; University of Iceland; IRCCS Istituto Tumori Bari Giovanni Paolo II; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Bergen; University of Bergen; Haukeland University Hospital; National Cancer Centre Singapore (NCCS); Singapore General Hospital; UNICANCER; Centre Leon Berard; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Royal Brisbane & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center	Nik-Zainal, S; Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.; Nik-Zainal, S (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge CB2 9NB, England.; Kong, G (corresponding author), Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea.; Viari, A (corresponding author), INRIA Grenoble Rhone Alpes, Equipe Erable, 655 Ave Europe, F-38330 Montbonnot St Martin, France.; Viari, A (corresponding author), Ctr Leon Berard, Synergie Lyon Canc, 28 Rue Laennec, F-69373 Lyon 08, France.	snz@sanger.ac.uk; Alain.Viari@inria.fr; gkong@hanyang.ac.kr; mrs@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Brinkman, Arie/V-1533-2018; Desmedt, Christine/P-7438-2017; Span, Paul/G-4710-2012; Simpson, Peter/F-1225-2010; Ju, Young Seok/E-1324-2012; Mustonen, Ville/J-1155-2018; Jonkers, Jos/AAG-3246-2019; Caldas, Carlos/U-7250-2019; Wedge, David/AAC-4977-2021; Van Laere, Steven/GQA-8872-2022; Nik-Zainal, Serena/ABD-4437-2020; Dirix, Luc/AAI-8880-2020; Ringnér, Markus/G-3641-2011; Stunnenberg, Hendrik G./D-6875-2012; Mustonen, Ville/X-1599-2019; Lakhani, Sunil R/I-1970-2018; Tommasi, Stefania/J-6732-2012	Alexandrov, Ludmil/0000-0003-3596-4515; Brinkman, Arie/0000-0002-9875-1835; Desmedt, Christine/0000-0002-5223-5579; Span, Paul/0000-0002-1930-6638; Simpson, Peter/0000-0002-4816-8289; Ju, Young Seok/0000-0002-5514-4189; Mustonen, Ville/0000-0002-7270-1792; Jonkers, Jos/0000-0002-9264-9792; Caldas, Carlos/0000-0003-3547-1489; Van Laere, Steven/0000-0002-2640-0040; Ringnér, Markus/0000-0001-5469-8940; Stunnenberg, Hendrik G./0000-0002-0066-1576; Mustonen, Ville/0000-0002-7270-1792; Lakhani, Sunil R/0000-0003-4067-2760; Purdie, Colin/0000-0002-1258-4010; Smid, Marcel/0000-0003-0605-1901; Ahn, Sung-Min/0000-0002-5031-1929; van de Vijver, Marc/0000-0002-0385-4787; Raine, Keiran/0000-0002-5634-1539; Ramakrishnan, Kamna/0000-0002-2507-4722; Rodriguez Gonzalez, Francisco G/0000-0002-8509-0804; Zou, Xueqing/0000-0003-1143-1028; Hooijer, Gerrit Karel Jan/0000-0002-8993-7101; Knappskog, Stian/0000-0002-4153-1655; Wedge, David/0000-0002-7572-3196; Nik-Zainal, Serena/0000-0001-5054-1727; Martincorena, Inigo/0000-0003-1122-4416; Tutt, Andrew/0000-0001-8715-2901; Gerstung, Moritz/0000-0001-6709-963X; Yates, Lucy/0000-0003-4519-7794; Glodzik, Dominik/0000-0001-8112-9073; Van Loo, Peter/0000-0003-0292-1949; Birney, Ewan/0000-0001-8314-8497; Martin, Sancha/0000-0001-6213-5259; Tommasi, Stefania/0000-0002-2157-2978	ICGC Breast Cancer Working group by the Breast Cancer Somatic Genetics Study (BASIS), a European research project - European Community's Seventh Framework Programme [242006]; Triple Negative project - Wellcome Trust [077012/Z/05/Z]; HER2+ project - Institut National du Cancer (INCa) in France [226-2009, 02-2011, 41-2012, 144-2008, 06-2012]; Korean Health Technology R& D Project, Ministry of Health and Welfare, Republic of Korea [A111218-SC01]; BASIS; ICGC breast cancer projects; CRUK; University of Dundee; Chief Scientist Office; Breast Cancer Campaign; Wellcome Trust [WT100183MA]; Los Alamos National Laboratory; Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer [NIH/NCI 5 P50 CA168504-02]; EU-FP7-SUPPRESSTEM project; Cancer Genomics Netherlands through a grant from the Netherlands Organisation of Scientific research (NWO); EU-FP7-DDR response project; Breast Cancer Research Foundation; EMBL; FNRS (Fonds National de la Recherche Scientifique); Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Republic Korea [NRF 2011-0030105]; National Research Foundation of Korea (NRF) - Korean government [NRF 2015R1A2A1A10052578]; ERC Advanced grant [322737]; US Department of Energy National Nuclear Security Administration [DE-AC52-06NA25396]; National Nuclear Security Administration of the United States Department of Energy; Cancer Research UK [16942, 20952] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154, NF-SI-0515-10090] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA168504, P30CA008748] Funding Source: NIH RePORTER	ICGC Breast Cancer Working group by the Breast Cancer Somatic Genetics Study (BASIS), a European research project - European Community's Seventh Framework Programme; Triple Negative project - Wellcome Trust; HER2+ project - Institut National du Cancer (INCa) in France; Korean Health Technology R& D Project, Ministry of Health and Welfare, Republic of Korea; BASIS; ICGC breast cancer projects; CRUK(Cancer Research UK); University of Dundee; Chief Scientist Office; Breast Cancer Campaign; Wellcome Trust(Wellcome Trust); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer; EU-FP7-SUPPRESSTEM project; Cancer Genomics Netherlands through a grant from the Netherlands Organisation of Scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU-FP7-DDR response project; Breast Cancer Research Foundation; EMBL; FNRS (Fonds National de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Republic Korea(National Research Foundation of Korea); National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea); ERC Advanced grant(European Research Council (ERC)); US Department of Energy National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); National Nuclear Security Administration of the United States Department of Energy(National Nuclear Security Administration); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded through the ICGC Breast Cancer Working group by the Breast Cancer Somatic Genetics Study (BASIS), a European research project funded by the European Community's Seventh Framework Programme (FP7/2010-2014) under the grant agreement number 242006; the Triple Negative project funded by the Wellcome Trust (grant reference 077012/Z/05/Z) and the HER2+ project funded by Institut National du Cancer (INCa) in France (grant numbers 226-2009, 02-2011, 41-2012, 144-2008, 06-2012). The ICGC Asian Breast Cancer Project was funded through a grant of the Korean Health Technology R& D Project, Ministry of Health and Welfare, Republic of Korea (A111218-SC01). Personally funded by grants above: F.G.R.-G., S.M., K.R., S.M. were funded by BASIS. Recruitment was performed under the auspices of the ICGC breast cancer projects run by the UK, France and Korea. For contributions towards instruments, specimens and collections: Tayside Tissue Bank (funded by CRUK, University of Dundee, Chief Scientist Office & Breast Cancer Campaign), Asan Bio-Resource Center of the Korea Biobank Network, Seoul, South Korea, OSBREAC consortium, The Icelandic Centre for Research (RANNIS), The Swedish Cancer Society and the Swedish Research Council, and Fondation Jean Dausset-Centre d'Etudes du polymorphisme humain. Icelandic Cancer Registry, The Brisbane Breast Bank (The University of Queensland, The Royal Brisbane and Women's Hospital and QIMR Berghofer), Breast Cancer Tissue and Data Bank at KCL and NIHR Biomedical Research Centre at Guy's and St Thomas's Hospitals. Breakthrough Breast Cancer and Cancer Research UK Experimental Cancer Medicine Centre at KCL. For pathology review: The Mouse Genome Project and Department of Pathology, Cambridge University Hospitals NHS Foundation Trust for microscopes. A. Richardson, A. Ehinger, A. Vincent-Salomon, C. Van Deurzen, C. Purdie, D. Larsimont, D. Giri, D. Grabau, E. Provenzano, G. MacGrogan, G. Van den Eynden, I. Treilleux, J. E. Brock, J. Jacquemier, J. Reis-Filho, L. Arnould, L. Jones, M. van de Vijver, O. Garred, R. Salgado, S. Pinder, S. R. Lakhani, T. Sauer, V. Barbashina. Illumina UK Ltd for input on optimization of sequencing throughout this project. Wellcome Trust Sanger Institute Sequencing Core Facility, Core IT Facility and Cancer Genome Project Core IT team and Cancer Genome Project Core Laboratory team for general support. Personal funding: S.N.-Z. is a Wellcome Beit Fellow and personally funded by a Wellcome Trust Intermediate Fellowship (WT100183MA). L.B.A. is supported through a J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory. A.L.R. is partially supported by the Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer (NIH/NCI 5 P50 CA168504-02). D.G. was supported by the EU-FP7-SUPPRESSTEM project. A. S. was supported by Cancer Genomics Netherlands through a grant from the Netherlands Organisation of Scientific research (NWO). M.S. was supported by the EU-FP7-DDR response project. C.S. and C.D. are supported by a grant from the Breast Cancer Research Foundation. E.B. was funded by EMBL. C.S. is funded by FNRS (Fonds National de la Recherche Scientifique). S. J. J. is supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Republic Korea (NRF 2011-0030105). G.K. is supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (NRF 2015R1A2A1A10052578). J.F. received funding from an ERC Advanced grant (no. 322737).; For general contribution and administrative support: Fondation Synergie Lyon Cancer in France. J. G. Jonasson, Department of Pathology, University Hospital & Faculty of Medicine, University of Iceland. K. Ferguson, Tissue Bank Manager, Brisbane Breast Bank and The Breast Unit, The Royal Brisbane and Women's Hospital, Brisbane, Australia. The Oslo Breast Cancer Consortium of Norway (OSBREAC). Angelo Paradiso, IRCCS Istituto Tumori "Giovanni Paolo II", Bari Italy. A. Vines for administratively supporting to identifying the samples, organizing the bank, and sending out the samples. M. Schlooz-Vries, J. Tol, H. van Laarhoven, F. Sweep, P. Bult in Nijmegen for contributions in Nijmegen. This research used resources provided by the Los Alamos National Laboratory Institutional Computing Program, which is supported by the US Department of Energy National Nuclear Security Administration under contract no. DE-AC52-06NA25396. Research performed at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the United States Department of Energy. N. Miller (in memoriam) for her contribution in setting up the clinical database. Finally, we would like to acknowledge all members of the ICGC Breast Cancer Working Group and ICGC Asian Breast Cancer Project.	Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Birkbak NJ, 2012, CANCER DISCOV, V2, P366, DOI 10.1158/2159-8290.CD-11-0206; Ching HC, 2011, INT J ONCOL, V39, P621, DOI 10.3892/ijo.2011.1081; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fang M, 2011, CANCER-AM CANCER SOC, V117, P2024, DOI 10.1002/cncr.25770; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Giacomini CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003464; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kalyana-Sundaram S, 2012, NEOPLASIA, V14, P702, DOI 10.1593/neo.12914; Karlsson J, 2015, CANCER LETT, V357, P498, DOI 10.1016/j.canlet.2014.11.057; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu S, 2015, CELL REP, V10, P1674, DOI 10.1016/j.celrep.2015.02.039; Morganella S. A., 2016, NATURE COMMUN; Natrajan R, 2014, J PATHOL, V232, P553, DOI 10.1002/path.4325; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Tubio JMC, 2015, BRIEF FUNCT GENOMICS, V14, P339, DOI 10.1093/bfgp/elv016; Turner N, 2005, CURR OPIN PHARMACOL, V5, P388, DOI 10.1016/j.coph.2005.03.006; Ussery DW, 2004, MICROBIOL-SGM, V150, P3519, DOI 10.1099/mic.0.27628-0; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wojcik EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051064; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244	57	1181	1214	8	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					47	+		10.1038/nature17676	http://dx.doi.org/10.1038/nature17676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27135926	Green Submitted, Green Accepted			2022-12-28	WOS:000376962300031
J	Delfraissy, JF; Yazdanpanah, Y; Levy, Y				Delfraissy, Jean-Francois; Yazdanpanah, Yazdan; Levy, Yves			REACTing: the French response to infectious disease crises	LANCET			English	Editorial Material							VIRUS		[Delfraissy, Jean-Francois] Inst Immunol Inflammat Infectiol & Microbiol AVIE, F-75013 Paris, France; [Delfraissy, Jean-Francois] ANRS, F-75013 Paris, France; [Yazdanpanah, Yazdan; Levy, Yves] INSERM, REACTing, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Delfraissy, JF (corresponding author), Inst Immunol Inflammat Infectiol & Microbiol AVIE, F-75013 Paris, France.; Delfraissy, JF (corresponding author), ANRS, F-75013 Paris, France.	jf.delfraissy@inserm.fr						Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Davey RT, 2016, 2016 C RETR OPP INF, p77LD; Etard J-F, 2016, 2016 C RETR OPP INF, p73LB; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Jacobsen KH, 2016, ECOHEALTH, V13, P200, DOI 10.1007/s10393-016-1100-5; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Murgue B, 2012, VIROLOGIE, V16, P3, DOI 10.1684/vir.2012.0434; Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236; Simon F, 2015, NEW ENGL J MED, V373, P93, DOI 10.1056/NEJMc1505501; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	13	12	12	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2183	2185		10.1016/S0140-6736(16)30059-9	http://dx.doi.org/10.1016/S0140-6736(16)30059-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145708	Green Published, Bronze			2022-12-28	WOS:000376820800016
J	Iglehart, JK				Iglehart, John K.			Decriminalizing Mental Illness - The Miami Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Eleventh Judicial Circuit, 2016, 11 JUD CRIM MENT HLT; Leifman S, 2014, MIAMI HERALD    0529; Robert Wood Johnson Foundation, COUNT HLTH RANK ROAD; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761	4	10	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1701	1703		10.1056/NEJMp1602959	http://dx.doi.org/10.1056/NEJMp1602959			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL0RY	27144845				2022-12-28	WOS:000375341500001
J	Yamada, T; Ogawa, A; Freire, M				Yamada, Tadataka; Ogawa, Ayano; Freire, Maria			Security spending must cover disease outbreaks	NATURE			English	Editorial Material									[Yamada, Tadataka] Global Hlth Risk Framework Commiss, Seattle, WA USA; [Yamada, Tadataka] Frazier Healthcare Partners, Seattle, WA USA; [Ogawa, Ayano] US Natl Acad Med, Global Hlth Risk Framework Commiss, Washington, DC USA; [Freire, Maria] Global Hlth Risk Framework Commiss, Bethesda, MD USA; [Freire, Maria] NIH, Bldg 10, Bethesda, MD 20892 USA	National Academies of Sciences, Engineering & Medicine; National Institutes of Health (NIH) - USA	Yamada, T (corresponding author), Global Hlth Risk Framework Commiss, Seattle, WA USA.; Yamada, T (corresponding author), Frazier Healthcare Partners, Seattle, WA USA.	tachi.yamada@gmail.com		Ogawa, Victoria Ayano/0000-0001-6225-7264				Boddie C, 2015, HEALTH SECUR, V13, P186, DOI 10.1089/hs.2015.0017; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR; Lee JW, 2008, LEARNING SARS PREPAR, P92; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Office of the Under Secretary of Defense (Comptroller) Chief Financial Officer, 2015, US DEP DEF FISC YEAR; United Nations Development Group-Western and Central Africa (UNDG-WCA), 2015, SOC EC IMP EB VIR DI, DOI [10.13140/RG.2.2.29620.04481, DOI 10.13140/RG.2.2.29620.04481]; US Department of Homeland Security, 2015, BUDG IN BRIEF; Ward A, 2016, FINANCIAL TIMES	8	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					29	31		10.1038/533029a	http://dx.doi.org/10.1038/533029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27147017	Bronze			2022-12-28	WOS:000375473900023
J	McHardy, R				McHardy, Ross			Valentine Urie McHardy OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353									10.1136/bmj.i2540	http://dx.doi.org/10.1136/bmj.i2540			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27146912				2022-12-28	WOS:000375575500018
J	Beyerlein, A; Donnachie, E; Jergens, S; Ziegler, AG				Beyerlein, Andreas; Donnachie, Ewan; Jergens, Sibille; Ziegler, Anette-Gabriele			Infections in Early Life and Development of Type 1 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ENTEROVIRUS INFECTION; RISK		[Beyerlein, Andreas; Jergens, Sibille; Ziegler, Anette-Gabriele] Helmholtz Zentrum Munchen, Diabet Res Inst, Munich, Germany; [Donnachie, Ewan] Bavarian Assoc Statutory Hlth Insurance Phys, Kassenarztliche Vereinigung Bayern, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ziegler, AG (corresponding author), Helmholtz Zentrum Munchen, Diabet Res Inst, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	g.ziegler@helmholtz-muenchen.de	Ziegler, Anette-Gabriele/M-4614-2014; Beyerlein, Andreas/I-7504-2019; Donnachie, Ewan/E-3912-2019	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Beyerlein, Andreas/0000-0001-6603-5036; Donnachie, Ewan/0000-0002-0668-0049				Beyerlein A, 2013, JAMA PEDIATR, V167, P800, DOI 10.1001/jamapediatrics.2013.158; Lin HC, 2015, DIABETOLOGIA, V58, P79, DOI 10.1007/s00125-014-3400-z; Swart E, 2015, GESUNDHEITSWESEN, V77, DOI [10.1055/s-0035-1562981, 10.1055/s-0034-1396815]; von Herrath M, 2009, NATURE, V459, P518, DOI 10.1038/459518a; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	6	54	55	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1899	1901		10.1001/jama.2016.2181	http://dx.doi.org/10.1001/jama.2016.2181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139064	Bronze			2022-12-28	WOS:000375284400020
J	Huth, AG; de Heer, WA; Griffiths, TL; Theunissen, FE; Gallant, JL				Huth, Alexander G.; de Heer, Wendy A.; Griffiths, Thomas L.; Theunissen, Frederic E.; Gallant, Jack L.			Natural speech reveals the semantic maps that tile human cerebral cortex	NATURE			English	Article							HUMAN BRAIN; REPRESENTATION; SPACE; ORGANIZATION; KNOWLEDGE; CONCRETE; SYSTEMS; OBJECT; AREAS	The meaning of language is represented in regions of the cerebral cortex collectively known as the 'semantic system'. However, little of the semantic system has been mapped comprehensively, and the semantic selectivity of most regions is unknown. Here we systematically map semantic selectivity across the cortex using voxel-wise modelling of functional MRI (fMRI) data collected while subjects listened to hours of narrative stories. We show that the semantic system is organized into intricate patterns that seem to be consistent across individuals. We then use a novel generative model to create a detailed semantic atlas. Our results suggest that most areas within the semantic system represent information about specific semantic domains, or groups of related concepts, and our atlas shows which domains are represented in each area. This study demonstrates that data-driven methods-commonplace in studies of human neuroanatomy and functional connectivity-provide a powerful and efficient means for mapping functional representations in the brain.	[Huth, Alexander G.; Griffiths, Thomas L.; Theunissen, Frederic E.; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [de Heer, Wendy A.; Griffiths, Thomas L.; Theunissen, Frederic E.; Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.; Gallant, JL (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	gallant@berkeley.edu		Griffiths, Thomas/0000-0002-5138-7255; Theunissen, Frederic/0000-0001-8980-0650	National Science Foundation (NSF) [IIS1208203]; National Eye Institute [EY019684]; Center for Science of Information (CSoI), an NSF Science and Technology Center [CCF-0939370]; William Orr Dingwall Neurolinguistics Fellowship; Direct For Computer & Info Scie & Enginr [1208203] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY019684] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Center for Science of Information (CSoI), an NSF Science and Technology Center; William Orr Dingwall Neurolinguistics Fellowship; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Science Foundation (NSF; IIS1208203), the National Eye Institute (EY019684), and from the Center for Science of Information (CSoI), an NSF Science and Technology Center, under grant agreement CCF-0939370. A.G.H. was also supported by the William Orr Dingwall Neurolinguistics Fellowship. We thank J. Sohl-Dickstein and K. Crane for technical discussions about PrAGMATiC, J. Nguyen for assistance transcribing and aligning stimuli, B. Griffin for segmenting and flattening cortical surfaces, and N. Bilenko, J. Gao, M. Lescroart and A. Nunez-Elizalde for general comments and discussions.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Boersma P., 2014, PRAAT DOING PHONETIC; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caramazza A, 2006, COGN NEUROPSYCHOL, V23, P13, DOI 10.1080/02643290542000021; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Caspers S, 2013, CEREB CORTEX, V23, P615, DOI 10.1093/cercor/bhs048; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; DeWitt I, 2012, P NATL ACAD SCI USA, V109, pE505, DOI 10.1073/pnas.1113427109; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Gao JS, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00023; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Huth A. G., 2015, PREPRINT; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jones E., 2001, SCIPY OPEN SOURCE SC; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010; Oliphant T, 2006, A GUIDE TO NUMPY; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Riesenhuber M, 2007, NEURON, V55, P341, DOI 10.1016/j.neuron.2007.07.017; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Wehbe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112575; Yuan J., 2008, P AC	38	568	584	11	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					453	+		10.1038/nature17637	http://dx.doi.org/10.1038/nature17637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27121839	Green Accepted, Green Submitted			2022-12-28	WOS:000374815900037
J	Iacobucci, G				Iacobucci, Gareth			Hunt offers to meet BMA chair to try to avert all-out strike by junior doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Alexander H, 2016, COMMUNICATION; Hunt J., 2016, COMMUNICATION; Porter M, 2016, COMMUNICATION	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2362	10.1136/bmj.i2362	http://dx.doi.org/10.1136/bmj.i2362			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27112836				2022-12-28	WOS:000375482000010
J	Pan, JY				Pan, Jingyan			Xianming Wang OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		WANG X, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2110	10.1136/bmj.i2110	http://dx.doi.org/10.1136/bmj.i2110			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106242				2022-12-28	WOS:000374999700002
J	Pershing, AJ; Alexander, MA; Hernandez, CM; Kerr, LA; Le Bris, A; Mills, KE; Nye, JA; Record, NR; Scannell, HA; Scott, JD; Sherwood, GD; Thomas, AC				Pershing, Andrew J.; Alexander, Michael A.; Hernandez, Christina M.; Kerr, Lisa A.; Le Bris, Arnault; Mills, Katherine E.; Nye, Janet A.; Record, Nicholas R.; Scannell, Hillary A.; Scott, James D.; Sherwood, Graham D.; Thomas, Andrew C.			Response to Comments on "Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery"	SCIENCE			English	Editorial Material							TEMPERATURE; CLIMATE	Palmer et al. and Swain et al. suggest that our "extra mortality" time series is spurious. In response, we show that including temperature-dependent mortality improves abundance estimates and that warming waters reduce growth rates in Gulf of Maine cod. Far from being spurious, temperature effects on this stock are clear, and continuing to ignore them puts the stock in jeopardy.	[Pershing, Andrew J.; Kerr, Lisa A.; Le Bris, Arnault; Mills, Katherine E.; Sherwood, Graham D.] Gulf Maine Res Inst, 350 Commercial St, Portland, ME 04101 USA; [Alexander, Michael A.; Scott, James D.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Hernandez, Christina M.] Woods Hole Oceanog Inst, 86 Water St, Woods Hole, MA 02543 USA; [Nye, Janet A.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Record, Nicholas R.] Bigelow Lab Ocean Sci, 60 Bigelow Dr, East Boothbay, ME 04544 USA; [Scannell, Hillary A.] Univ Washington, Sch Oceanog, 1503 Northeast Boat St, Seattle, WA 98105 USA; [Scott, James D.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Thomas, Andrew C.] Univ Maine, Sch Marine Sci, 5706 Aubert Hall, Orono, ME 04469 USA	Gulf of Maine Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; Woods Hole Oceanographic Institution; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Maine System; University of Maine Orono	Pershing, AJ (corresponding author), Gulf Maine Res Inst, 350 Commercial St, Portland, ME 04101 USA.	apershing@gmri.org	Hernández, Christina/GMW-8402-2022; Alexander, Michael A/A-7097-2013	Alexander, Michael A/0000-0001-9646-6427; Nye, Janet/0000-0001-8554-2084; Scott, James D/0000-0002-8709-8594				Brooks EN, 2015, CAN J FISH AQUAT SCI, V72, P634, DOI 10.1139/cjfas-2014-0231; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Mohn R, 1999, ICES J MAR SCI, V56, P473, DOI 10.1006/jmsc.1999.0481; Northeast Fisheries Science Center, 2013, 55 NE REG STOCK ASS; Palmer M. C., 2014, 2014 ASSESSMENT UPDA; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; PETERSON I, 1984, CAN J FISH AQUAT SCI, V41, P1117, DOI 10.1139/f84-131; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Swain Douglas P, 2016, Science, V352, P423, DOI 10.1126/science.aad9346; Swain DP, 2016, SCIENCE, V352, DOI [10.1126/science.aad9346, 10.1126/science.aad9674]; TAYLOR C. C., 1958, JOUR CONS PERM INTERNATL EXPLOR MER, V23, P366	13	10	10	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284								10.1126/science.aae0463	http://dx.doi.org/10.1126/science.aae0463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102475				2022-12-28	WOS:000374479700036
J	Amarenco, P; Lavallee, PC; Labreuche, J; Albers, GW; Bornstein, NM; Canhao, P; Caplan, LR; Donnan, GA; Ferro, JM; Hennerici, MG; Molina, C; Rothwell, PM; Sissani, L; Skoloudik, D; Steg, PG; Touboul, PJ; Uchiyama, S; Vicaut, E; Wong, LKS				Amarenco, Pierre; Lavallee, Philippa C.; Labreuche, Julien; Albers, Gregory W.; Bornstein, Natan M.; Canhao, Patricia; Caplan, Louis R.; Donnan, Geoffrey A.; Ferro, Jose M.; Hennerici, Michael G.; Molina, Carlos; Rothwell, Peter M.; Sissani, Leila; Skoloudik, David; Steg, Philippe Gabriel; Touboul, Pierre-Jean; Uchiyama, Shinichiro; Vicaut, Eric; Wong, Lawrence K. S.		TIAregistry Org Investigators	One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ABCD(2) SCORE; TIME; TIA	BACKGROUND Previous studies conducted between 1997 and 2003 estimated that the risk of stroke or an acute coronary syndrome was 12 to 20% during the first 3 months after a transient ischemic attack (TIA) or minor stroke. The TIAregistry.org project was designed to describe the contemporary profile, etiologic factors, and outcomes in patients with a TIA or minor ischemic stroke who receive care in health systems that now offer urgent evaluation by stroke specialists. METHODS We recruited patients who had had a TIA or minor stroke within the previous 7 days. Sites were selected if they had systems dedicated to urgent evaluation of patients with TIA. We estimated the 1-year risk of stroke and of the composite outcome of stroke, an acute coronary syndrome, or death from cardiovascular causes. We also examined the association of the ABCD(2) score for the risk of stroke (range, 0 [lowest risk] to 7 [highest risk]), findings on brain imaging, and cause of TIA or minor stroke with the risk of recurrent stroke over a period of 1 year. RESULTS From 2009 through 2011, we enrolled 4789 patients at 61 sites in 21 countries. A total of 78.4% of the patients were evaluated by stroke specialists within 24 hours after symptom onset. A total of 33.4% of the patients had an acute brain infarction, 23.2% had at least one extracranial or intracranial stenosis of 50% or more, and 10.4% had atrial fibrillation. The Kaplan-Meier estimate of the 1-year event rate of the composite cardiovascular outcome was 6.2% (95% confidence interval, 5.5 to 7.0). Kaplan-Meier estimates of the stroke rate at days 2, 7, 30, 90, and 365 were 1.5%, 2.1%, 2.8%, 3.7%, and 5.1%, respectively. In multivariable analyses, multiple infarctions on brain imaging, large-artery atherosclerosis, and an ABCD(2) score of 6 or 7 were each associated with more than a doubling of the risk of stroke. CONCLUSIONS We observed a lower risk of cardiovascular events after TIA than previously reported. The ABCD(2) score, findings on brain imaging, and status with respect to large-artery atherosclerosis helped stratify the risk of recurrent stroke within 1 year after a TIA or minor stroke.	[Amarenco, Pierre; Lavallee, Philippa C.; Labreuche, Julien; Sissani, Leila; Touboul, Pierre-Jean] Hop Xavier Bichat, AP HP, Dept Neurol, Paris, France; [Steg, Philippe Gabriel] Hop Xavier Bichat, AP HP, Dept Cardiol, Paris, France; [Amarenco, Pierre; Lavallee, Philippa C.; Labreuche, Julien; Sissani, Leila; Touboul, Pierre-Jean] Hop Xavier Bichat, AP HP, Stroke Ctr, Paris, France; [Vicaut, Eric] Univ Paris Diderot, Fernand Widal Hosp, AP HP, Dept Biostat,Sorbonne Paris Cite, Paris, France; [Labreuche, Julien] Univ Lille, CHU Lille, Sante Publ Epidemiol & Qualite Soins, Lille, France; [Albers, Gregory W.] Stanford Univ, Med Ctr, Stanford Stroke Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Bornstein, Natan M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Canhao, Patricia; Ferro, Jose M.] Univ Lisbon, Hosp Santa Maria, Dept Neurosci, P-1699 Lisbon, Portugal; [Caplan, Louis R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Cerebrovasc Dis Serv, Boston, MA 02215 USA; [Donnan, Geoffrey A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Hennerici, Michael G.] Heidelberg Univ, Univ Med Mannheim, Dept Neurol, Heidelberg, Germany; [Molina, Carlos] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Stroke Unit, Dept Neurol, E-08193 Barcelona, Spain; [Rothwell, Peter M.] Univ Oxford, Stroke Prevent Res Unit, Nuffield Dept Clin Neurosci, Oxford, England; [Steg, Philippe Gabriel] Royal Brompton Hosp, Inst Cardiovasc Med & Sci, Natl Heart & Lung Inst Imperial Coll, London SW3 6LY, England; [Skoloudik, David] Palacky Univ, Dept Nursing, CR-77147 Olomouc, Czech Republic; [Uchiyama, Shinichiro] Int Univ Hlth & Welf, Sanno Hosp, Ctr Brain & Cerebral Vessels, Clin Res Ctr, Tokyo, Japan; [Uchiyama, Shinichiro] Sanno Med Ctr, Tokyo, Japan; [Wong, Lawrence K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Stanford University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Universidade de Lisboa; Hospital Santa Maria; Harvard University; Beth Israel Deaconess Medical Center; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Ruprecht Karls University Heidelberg; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Oxford; Imperial College London; Royal Brompton Hospital; Palacky University Olomouc; International University of Health & Welfare; Chinese University of Hong Kong; Prince of Wales Hospital	Amarenco, P (corresponding author), Hop Xavier Bichat, Dept Neurol, 46 Rue Henri Huchard, F-75018 Paris, France.; Amarenco, P (corresponding author), Hop Xavier Bichat, Stroke Ctr, 46 Rue Henri Huchard, F-75018 Paris, France.	pierre.amarenco@aphp.fr	Buchan, Alastair M/B-9095-2009; Fonseca, Ana Catarina/J-3127-2013; Purroy, Francisco/D-4538-2009; Rothwell, Peter/ABE-5913-2020; Toni, Danilo/K-3151-2016; STEG, Philippe Gabriel/Z-1567-2019; Wong, Ka Sing Lawrence/N-3434-2015; Ferro, José/ABA-1779-2021; anticoli, sabrina/X-4458-2019; Merwick, Aine/L-9754-2013	Buchan, Alastair M/0000-0002-2918-5200; Fonseca, Ana Catarina/0000-0001-6913-5526; Purroy, Francisco/0000-0002-1808-5968; Rothwell, Peter/0000-0001-9739-9211; Toni, Danilo/0000-0003-2735-8427; Wong, Ka Sing Lawrence/0000-0002-2031-9866; anticoli, sabrina/0000-0003-4401-1695; Albers, Gregory/0000-0003-0263-4632; STEG, Philippe Gabriel/0000-0001-6896-2941; Touboul, Pierre-Jean/0000-0002-8872-9917; Merwick, Aine/0000-0001-7533-0117; Ferro, Jose/0000-0002-2343-9097	Sanofi; Bristol-Myers Squibb; National Institute for Health Research [NF-SI-0514-10168] Funding Source: researchfish	Sanofi(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Sanofi and Bristol-Myers Squibb	Amarenco P, 2012, STROKE, V43, P863, DOI 10.1161/STROKEAHA.111.636506; Amarenco P, 2009, STROKE, V40, P3091, DOI 10.1161/STROKEAHA.109.552042; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Giles MF, 2011, NEUROLOGY, V77, P1222, DOI 10.1212/WNL.0b013e3182309f91; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Giles MF, 2010, STROKE, V41, P667, DOI 10.1161/STROKEAHA.109.571174; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hyafil F, 2014, CIRCULATION, V129, P130, DOI 10.1161/CIRCULATIONAHA.112.000467; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; National Institute for Health and Care Excellence, 2008, STROK TRANS ISCH ATT; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	21	334	348	7	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1533	1542		10.1056/NEJMoa1412981	http://dx.doi.org/10.1056/NEJMoa1412981			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7IA	27096581	Green Published, Bronze			2022-12-28	WOS:000374383900006
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			The straitjacket	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1607	1607		10.1016/S0140-6736(16)30206-9	http://dx.doi.org/10.1016/S0140-6736(16)30206-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	27116059				2022-12-28	WOS:000374145100013
J	Kesselheim, AS; Woloshin, S; Eddings, W; Franklin, JM; Ross, KM; Schwartz, LM				Kesselheim, Aaron S.; Woloshin, Steven; Eddings, Wesley; Franklin, Jessica M.; Ross, Kathryn M.; Schwartz, Lisa M.			Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kesselheim, Aaron S.; Eddings, Wesley; Franklin, Jessica M.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH USA; [Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Ross, Kathryn M.] Amer Board Internal Med, Philadelphia, PA USA	Harvard University; Brigham & Women's Hospital; Dartmouth College; Dartmouth College; American Board of Internal Medicine	Kesselheim, AS (corresponding author), 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Krishnamurti T, 2015, JAMA INTERN MED, V175, P1856, DOI 10.1001/jamainternmed.2015.5355; Medscape, ID ZYD APPR CLL LYMP; Pfizer, TRUMENBA MEN GROUP B; US Food and Drug Administration, BREAKTHR THER	4	38	38	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1516	1518		10.1001/jama.2015.16984	http://dx.doi.org/10.1001/jama.2015.16984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115269	Bronze			2022-12-28	WOS:000373873800019
J	Mac Sweeney, R; McAuley, DF				Mac Sweeney, Rob; McAuley, Daniel F.			Acute respiratory distress syndrome	LANCET			English	Review							ACUTE LUNG INJURY; TIDAL-VOLUME VENTILATION; END-EXPIRATORY PRESSURE; HIGH-FREQUENCY OSCILLATION; CONTROLLED CLINICAL-TRIAL; CARE-UNIT MORTALITY; PULMONARY-ARTERY; MECHANICAL VENTILATION; RECRUITMENT MANEUVERS; PRONE POSITION	Acute respiratory distress syndrome presents as hypoxia and bilateral pulmonary infiltrates on chest imaging in the absence of heart failure sufficient to account for this clinical state. Management is largely supportive, and is focused on protective mechanical ventilation and the avoidance of fluid overload. Patients with severe hypoxaemia can be managed with early short-term use of neuromuscular blockade, prone position ventilation, or extracorporeal membrane oxygenation. The use of inhaled nitric oxide is rarely indicated and both beta(2) agonists and late corticosteroids should be avoided. Mortality remains at approximately 30%.	[Mac Sweeney, Rob; McAuley, Daniel F.] Royal Victoria Hosp, Reg Intens Care Unit, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland	Queens University Belfast	McAuley, DF (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	d.f.mcauley@qub.ac.uk		McAuley, Daniel/0000-0002-3283-1947	GlaxoSmithKline; Bayer; Peptinnovate; SOBI; Medical Research Council [G0701690, MC_G1002460] Funding Source: researchfish; Public Health Agency [EAT/4908/13, EAT/4210/09, COM/4700/12] Funding Source: researchfish; MRC [MC_G1002460, G0701690] Funding Source: UKRI	GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG); Peptinnovate; SOBI; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DM reports fees for consultancy from GlaxoSmithKline, Bayer, Peptinnovate, and SOBI. His institution has received funds for his undertaking of bronchoscopy as part of a clinical trial funded by GlaxoSmithKline. He is also a named inventor on a patent for a pharmacotherapy for the treatment of acute respiratory distress syndrome held by his institution. RMS declares no competing interests.	ABERLE DR, 1988, RADIOLOGY, V168, P73, DOI 10.1148/radiology.168.1.3380985; Acosta-Herrera M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00020; Adhikari NKJ, 2014, CRIT CARE MED, V42, P404, DOI 10.1097/CCM.0b013e3182a27909; Agarwal R, 2010, RESP CARE, V55, P1653; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; ASHBAUGH DG, 1967, LANCET, V2, P319; Avila Maria Olinda Nogueira, 2014, J Bras Nefrol, V36, P379; Barbas Carmen Sílvia Valente, 2014, Rev. bras. ter. intensiva, V26, P215, DOI 10.5935/0103-507X.20140034; Barbas Carmen Sílvia Valente, 2014, Rev. bras. ter. intensiva, V26, P89, DOI 10.5935/0103-507X.20140017; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Baumann HJ, 2008, SURGERY, V143, P426, DOI 10.1016/j.surg.2007.06.003; Bein T, 2013, INTENS CARE MED, V39, P847, DOI 10.1007/s00134-012-2787-6; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bihari S, 2013, SHOCK, V40, P28, DOI 10.1097/SHK.0b013e31829727f1; Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown LM, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-25; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Cardinal-Fernandez P, 2015, CHEST, V147, P7, DOI 10.1378/chest.14-0874; Chacko B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008807.pub2; Charbonney E, 2009, J CRIT CARE, V24, P122, DOI 10.1016/j.jcrc.2008.01.008; Claesson J, 2015, ACTA ANAESTH SCAND, V59, P286, DOI 10.1111/aas.12449; Copetti R, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-16; Craig TR, 2010, CRIT CARE MED, V38, P114, DOI 10.1097/CCM.0b013e3181b43050; Curley G, 2011, CRIT CARE, V15, DOI 10.1186/cc9994; Dasenbrook EC, 2011, RESP CARE, V56, P568, DOI 10.4187/respcare.01011; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; de Hemptinne Q, 2009, CHEST, V135, P944, DOI 10.1378/chest.08-1741; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Duggal A, 2015, MINERVA ANESTESIOL, V81, P567; Enghard P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0756-5; Esteban A, 2004, ANN INTERN MED, V141, P440, DOI 10.7326/0003-4819-141-6-200409210-00009; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Ferguson ND, 2004, INTENS CARE MED, V30, P1111, DOI 10.1007/s00134-004-2163-2; Ferguson ND, 2005, CRIT CARE MED, V33, P2228, DOI 10.1097/01.CCM.0000181529.08630.49; Ferguson ND, 2005, J CRIT CARE, V20, P147, DOI 10.1016/j.jcrc.2005.03.001; Ferguson ND, 2002, INTENS CARE MED, V28, P1073, DOI 10.1007/s00134-002-1354-y; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Figueroa-Casas JB, 2013, J CRIT CARE, V28, P352, DOI 10.1016/j.jcrc.2012.12.002; Frank JA, 2005, CRIT CARE MED, V33, P181, DOI 10.1097/01.CCM.0000150663.45778.C4; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Frohlich S, 2013, BRIT J ANAESTH, V111, P696, DOI 10.1093/bja/aet165; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 2010, MINERVA ANESTESIOL, V76, P448; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; Gowda MS, 1997, CRIT CARE MED, V25, P41, DOI 10.1097/00003246-199701000-00010; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; Guerin C, 2015, INTENS CARE MED, V41, P222, DOI 10.1007/s00134-014-3583-2; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Guerin C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-9; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Hoste EA, 2014, BRIT J ANAESTH, V113, P740, DOI 10.1093/bja/aeu300; IBERTI TJ, 1994, CRIT CARE MED, V22, P1674; IBERTI TJ, 1990, JAMA-J AM MED ASSOC, V264, P2928, DOI 10.1001/jama.264.22.2928; Kao KC, 2006, CRIT CARE, V10, DOI 10.1186/cc4981; KOMADINA KH, 1991, CHEST, V100, P1647, DOI 10.1378/chest.100.6.1647; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kumar A, 2004, CRIT CARE MED, V32, P691, DOI 10.1097/01.CCM.0000114996.68110.C9; Li JT, 2015, J IMMUNOL, V195, P87, DOI 10.4049/jimmunol.1500054; Linko R, 2009, INTENS CARE MED, V35, P1352, DOI 10.1007/s00134-009-1519-z; Liu C, 2014, J TRANSL INTERN MED, V2, P107, DOI 10.4103/2224-4018.141831; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC; Marik PE, 2013, CRIT CARE MED, V41, P1774, DOI 10.1097/CCM.0b013e31828a25fd; Martin GS, 2002, CRIT CARE MED, V30, P2175, DOI 10.1097/00003246-200210000-00001; MARTIN TR, 1989, J CLIN INVEST, V84, P1609, DOI 10.1172/JCI114338; Martinez O, 2009, ARCH BRONCONEUMOL, V45, P291, DOI 10.1016/j.arbres.2008.05.010; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; McAuley DF, 2002, INTENS CARE MED, V28, P414, DOI 10.1007/s00134-002-1248-z; McAuley DF, 2004, CRIT CARE MED, V32, P1470, DOI 10.1097/01.CCM.0000129489.34416.0E; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Meade MO, 2000, AM J RESP CRIT CARE, V161, P85, DOI 10.1164/ajrccm.161.1.9809003; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Messika J, 2015, RESP CARE, V60, P162, DOI 10.4187/respcare.03423; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Modrykamien A, 2011, CLEV CLIN J MED, V78, P101, DOI 10.3949/ccjm.78a.10032; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; MUIR AL, 1975, J APPL PHYSIOL, V38, P786, DOI 10.1152/jappl.1975.38.5.786; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; NASH G, 1967, NEW ENGL J MED, V276, P368, DOI 10.1056/NEJM196702162760702; Needham DM, 2015, AM J RESP CRIT CARE, V191, P177, DOI 10.1164/rccm.201409-1598OC; Needham DM, 2013, AM J RESP CRIT CARE, V188, P567, DOI 10.1164/rccm.201304-0651OC; Needham DM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2124; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; Papazian L, 2007, CRIT CARE MED, V35, P755, DOI 10.1097/01.CCM.0000257325.88144.30; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Patel SR, 2004, CHEST, V125, P197, DOI 10.1378/chest.125.1.197; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Perkins GD, 2008, THORAX, V63, P215, DOI 10.1136/thx.2007.080382; Perkins GD, 2007, THORAX, V62, P36, DOI 10.1136/thx.2006.059410; Pinheiro Bruno Valle, 2007, J. bras. pneumol., V33, P423, DOI 10.1590/S1806-37132007000400011; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Preiser JC, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0737-8; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reilly John P, 2014, Ann Am Thorac Soc, V11, P728, DOI 10.1513/AnnalsATS.201308-280OC; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Ruan SY, 2014, CRIT CARE, V18, DOI 10.1186/cc13819; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 1999, CHEST, V116, P1347, DOI 10.1378/chest.116.5.1347; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Seeley E, 2008, THORAX, V63, P994, DOI 10.1136/thx.2007.093658; Shari G, 2011, RESP CARE, V56, P576, DOI 10.4187/respcare.00901; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Shyamsundar M, 2013, CRIT CARE, V17, DOI 10.1186/cc12710; Sigurdsson MI, 2013, ACTA ANAESTH SCAND, V57, P37, DOI 10.1111/aas.12001; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Stapleton RD, 2011, CRIT CARE MED, V39, P1655, DOI 10.1097/CCM.0b013e318218669d; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Sud S, 2008, CAN MED ASSOC J, V178, P1153, DOI 10.1503/cmaj.071802; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Thille AW, 2013, LANCET RESP MED, V1, P395, DOI 10.1016/S2213-2600(13)70053-5; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Vargas M, 2014, SCI WORLD J, DOI 10.1155/2014/852356; Villar J, 2007, AM J RESP CRIT CARE, V176, P795, DOI 10.1164/rccm.200610-1534OC; Villar J, 2015, CRIT CARE MED, V43, P346, DOI 10.1097/CCM.0000000000000703; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Wang CY, 2014, INTENS CARE MED, V40, P388, DOI 10.1007/s00134-013-3186-3; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Zhan QY, 2012, CRIT CARE MED, V40, P455, DOI 10.1097/CCM.0b013e318232d75e; Zhu DJ, 2014, INTENS CARE MED, V40, P504, DOI 10.1007/s00134-014-3244-5	152	230	267	5	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2016	388	10058					2416	2430		10.1016/S0140-6736(16)00578-X	http://dx.doi.org/10.1016/S0140-6736(16)00578-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB5RB	27133972	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000387436900029
J	Walensky, RP				Walensky, Rochelle P.			Investing in People Who Inject Drugs: A PrEPonderance of Opportunities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COST-EFFECTIVENESS; PROPHYLAXIS; USERS		[Walensky, Rochelle P.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	rwalensky@partners.org		Walensky, Rochelle P./0000-0002-8795-379X				Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Behavioral Health Coordinating Committee P. D. A. S., 2013, ADDR PRESCR DRUG AB; Bernard CL, 2016, ANN INTERN MED, V165, P10, DOI 10.7326/M15-2634; Centers for Disease Control and Prevention, PREEXP PROPH PREV HI; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coffin PO, 2013, ANN INTERN MED, V158, P1, DOI 10.7326/0003-4819-158-1-201301010-00003; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; National Center for HIV/AIDS, 2013, HIV SURV EP HIV INF	9	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					63	64		10.7326/M16-0788	http://dx.doi.org/10.7326/M16-0788			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27111241				2022-12-28	WOS:000379215800013
J	Khullar, D; Chokshi, DA				Khullar, Dhruv; Chokshi, Dave A.			Toward an Integrated Federal Health System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Khullar, Dhruv] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chokshi, Dave A.] New York City Hlth Hosp, New York, NY USA; [Chokshi, Dave A.] NYU Langone Med Ctr, Dept Populat Hlth, 125 Worth St,Room 410, New York, NY 10013 USA	Harvard University; Massachusetts General Hospital; NYU Langone Medical Center	Chokshi, DA (corresponding author), NYU Langone Med Ctr, New York City Hlth Hosp, 125 Worth St,Room 410, New York, NY 10013 USA.	dave.chokshi@nychhc.org		Chokshi, Dave/0000-0001-7467-4591				McKinsey & Co Inc, 2015, IND ASS HLTH CAR DEL; Trivedi AN, 2012, JAMA-J AM MED ASSOC, V308, P67, DOI 10.1001/jama.2012.7115	2	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2016	315	23					2521	2522		10.1001/jama.2016.4641	http://dx.doi.org/10.1001/jama.2016.4641			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2GQ	27123569				2022-12-28	WOS:000378306700012
J	Sidibe, M				Sidibe, Michel			Democratising the global health agenda: why we need France	LANCET			English	Editorial Material									[Sidibe, Michel] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Sidibe, M (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland.	sidibem@unaids.org						Atlani-Duault L, 2016, LANCET; Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8; France Diplomatie, 2014, FRANC GLOB HLTH GOV; Hawkes S, 2016, INT J HLTH POLICY MA, V5, P1; Medecins Sans Frontieres, 2011, MAL 10 YEARS AG MSF; Nay O, 2016, LANCET; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Schaferhoff M, 2015, RETHINKING GLOBAL HL; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2014, FRANC GLOB FUND	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2176	2177		10.1016/S0140-6736(16)30060-5	http://dx.doi.org/10.1016/S0140-6736(16)30060-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145704				2022-12-28	WOS:000376820800012
J	Anagnostou, E; John, EH; Edgar, KM; Foster, GL; Ridgwell, A; Inglis, GN; Pancost, RD; Lunt, DJ; Pearson, PN				Anagnostou, Eleni; John, Eleanor H.; Edgar, Kirsty M.; Foster, Gavin L.; Ridgwell, Andy; Inglis, Gordon N.; Pancost, Richard D.; Lunt, Daniel J.; Pearson, Paul N.			Changing atmospheric CO2 concentration was the primary driver of early Cenozoic climate	NATURE			English	Article							BORON ISOTOPIC COMPOSITION; CARBON-DIOXIDE; PLANKTONIC-FORAMINIFERA; SEAWATER PH; STABLE-ISOTOPES; KILWA GROUP; OXYGEN; SEA; PALEOGENE; EVOLUTION	The Early Eocene Climate Optimum (EECO, which occurred about 51 to 53 million years ago)(1), was the warmest interval of the past 65 million years, with mean annual surface air temperature over ten degrees Celsius warmer than during the pre-industrial period(2-4). Subsequent global cooling in the middle and late Eocene epoch, especially at high latitudes, eventually led to continental ice sheet development in Antarctica in the early Oligocene epoch (about 33.6 million years ago). However, existing estimates place atmospheric carbon dioxide (CO2) levels during the Eocene at 500-3,000 parts per million(5-7), and in the absence of tighter constraints carbon-climate interactions over this interval remain uncertain. Here we use recent analytical and methodological developments(8-11) to generate a new high-fidelity record of CO2 concentrations using the boron isotope (delta B-11) composition of well preserved planktonic foraminifera from the Tanzania Drilling Project, revising previous estimates(6). Although species-level uncertainties make absolute values difficult to constrain, CO2 concentrations during the EECO were around 1,400 parts per million. The relative decline in CO2 concentration through the Eocene is more robustly constrained at about fifty per cent, with a further decline into the Oligocene(12). Provided the latitudinal dependency of sea surface temperature change for a given climate forcing in the Eocene was similar to that of the late Quaternary period(13), this CO2 decline was sufficient to drive the well documented high-and low-latitude cooling that occurred through the Eocene(14). Once the change in global temperature between the pre-industrial period and the Eocene caused by the action of all known slow feedbacks (apart from those associated with the carbon cycle) is removed(2-4), both the EECO and the late Eocene exhibit an equilibrium climate sensitivity relative to the pre-industrial period of 2.1 to 4.6 degrees Celsius per CO2 doubling (66 per cent confidence), which is similar to the canonical range (1.5 to 4.5 degrees Celsius(15)), indicating that a large fraction of the warmth of the early Eocene greenhouse was driven by increased CO2 concentrations, and that climate sensitivity was relatively constant throughout this period.	[Anagnostou, Eleni; Foster, Gavin L.] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Waterfront Campus, Southampton SO14 3ZH, Hants, England; [John, Eleanor H.; Edgar, Kirsty M.; Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Pk Pl, Cardiff CF10 3AT, S Glam, Wales; [Edgar, Kirsty M.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Ridgwell, Andy; Lunt, Daniel J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Ridgwell, Andy; Lunt, Daniel J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Inglis, Gordon N.; Pancost, Richard D.] Univ Bristol, Sch Chem, Organ Geochem Unit, Cantocks Close, Bristol BS8 1TS, Avon, England; [Inglis, Gordon N.; Pancost, Richard D.] Univ Bristol, Cabot Inst, Bristol BS8 1UJ, Avon, England; [John, Eleanor H.] Univ S Pacific, Sch Geog Earth Sci & Environm, Suva, Fiji; [Edgar, Kirsty M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	NERC National Oceanography Centre; University of Southampton; Cardiff University; University of Bristol; University of Bristol; University of California System; University of California Riverside; University of Bristol; University of Bristol; University of the South Pacific; University of Birmingham	Anagnostou, E (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Waterfront Campus, Southampton SO14 3ZH, Hants, England.	e.anagnostou@noc.soton.ac.uk	Foster, Gavin/CAF-4654-2022; Lunt, Daniel J/G-9451-2011; Edgar, Kirsty/AAR-9052-2021; Foster, Gavin/W-5968-2019; anagnostou, eleni/AAH-2618-2021; Ridgwell, Andy/AAD-9487-2021	Foster, Gavin/0000-0003-3688-9668; Lunt, Daniel J/0000-0003-3585-6928; Edgar, Kirsty/0000-0001-7587-9951; Ridgwell, Andy/0000-0003-2333-0128; Anagnostou, Eleni/0000-0002-7200-4794; Inglis, Gordon/0000-0002-0032-4668; Pancost, Richard/0000-0003-0298-4026	NERC [NE/H017356/1, NE/I005595/1, NE/H016457/1]; UK NERC [NE/I005595/1]; Royal Society Wolfson Research Merit Award; Advanced ERC Grant T-GRES [340923]; Tanzania Petroleum Development Corporation; Tanzania Commission for Science and Technology; Tanzania Drilling Project field team; NERC [NE/I005870/1, NE/I005714/1] Funding Source: UKRI; Natural Environment Research Council [NE/I005870/1, NE/H017356/1, NE/I005595/1, NE/H016457/1, NE/I005714/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Advanced ERC Grant T-GRES; Tanzania Petroleum Development Corporation; Tanzania Commission for Science and Technology; Tanzania Drilling Project field team; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was provided by NERC grants (NE/H017356/1 and NE/I005595/1 to G.L.F. and P.N.P.) and by a NERC Post Doctoral Research Fellowship (NE/H016457/1 to K.M.E.). G.N.I. thanks the UK NERC for supporting his PhD studentship (via NE/I005595/1) and R.D.P. acknowledges the Royal Society Wolfson Research Merit Award. R.D.P. and G.N.I. also acknowledge the Advanced ERC Grant T-GRES (340923). We thank the Tanzania Petroleum Development Corporation, the Tanzania Commission for Science and Technology and the Tanzania Drilling Project field team for support. We also acknowledge A. Milton and S. Nederbraght for technical assistance, and we are grateful to M. Huber for discussions on drivers of Eocene warmth.	Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; BATTINO R, 1983, J PHYS CHEM REF DATA, V12, P163, DOI 10.1063/1.555680; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; BENYAAKOV S, 1973, DEEP-SEA RES, V20, P87, DOI 10.1016/0011-7471(73)90044-2; BERGER WH, 1978, OCEANOL ACTA, V1, P203; Birch H, 2013, MAR MICROPALEONTOL, V101, P127, DOI 10.1016/j.marmicro.2013.02.002; Bohaty SM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001676; Bown PR, 2008, GEOL SOC AM BULL, V120, P3, DOI 10.1130/B26261.1; Byrne B, 2014, GEOPHYS RES LETT, V41, P152, DOI 10.1002/2013GL058456; Caballero R, 2013, P NATL ACAD SCI USA, V110, P14162, DOI 10.1073/pnas.1303365110; Coggon RM, 2010, SCIENCE, V327, P1114, DOI 10.1126/science.1182252; Cramer BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007255; CROWELL JC, 1970, AM J SCI, V268, P193, DOI 10.2475/ajs.268.3.193; Demicco RV, 2003, GEOLOGY, V31, P793, DOI 10.1130/G19727.1; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Edgar KM, 2013, GEOLOGY, V41, P15, DOI 10.1130/G33388.1; Edgar KM, 2015, GEOCHIM COSMOCHIM AC, V166, P189, DOI 10.1016/j.gca.2015.06.018; FAIRBANKS RG, 1980, SCIENCE, V207, P61, DOI 10.1126/science.207.4426.61; Foster GL, 2008, EARTH PLANET SC LETT, V271, P254, DOI 10.1016/j.epsl.2008.04.015; Foster GL, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003201; Foster GL, 2013, CHEM GEOL, V358, P1, DOI 10.1016/j.chemgeo.2013.08.027; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Franks PJ, 2014, GEOPHYS RES LETT, V41, P4685, DOI 10.1002/2014GL060457; Goyet C., 2000, ORNLCDIAC127 US DEP; Henehan MJ, 2013, EARTH PLANET SC LETT, V364, P111, DOI 10.1016/j.epsl.2012.12.029; HERSHEY JP, 1986, GEOCHIM COSMOCHIM AC, V50, P143, DOI 10.1016/0016-7037(86)90059-1; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Honisch B, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001026; Honisch B, 2003, MAR MICROPALEONTOL, V49, P87, DOI 10.1016/S0377-8398(03)00030-6; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Hull PM, 2011, LIMNOL OCEANOGR, V56, P562, DOI 10.4319/lo.2011.56.2.0562; Inglis GN, 2015, PALEOCEANOGRAPHY, V30, P1000, DOI 10.1002/2014PA002723; IPCC, 2018, SUMMARY POLICYMAKERS; Jagniecki EA, 2015, GEOLOGY, V43, P1075, DOI 10.1130/G36886.1; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; John EH, 2014, PALAEOGEOGR PALAEOCL, V413, P158, DOI 10.1016/j.palaeo.2014.05.019; John EH, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0099; Kent P. E., 1971, 6 I GEOL SCI MAJ STA, P1; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Klochko K, 2006, EARTH PLANET SC LETT, V248, P276, DOI 10.1016/j.epsl.2006.05.034; Kroon D., 2010, TROPICAL TEMPERATURE; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; Loptson CA, 2014, CLIM PAST, V10, P419, DOI 10.5194/cp-10-419-2014; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Lunt DJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0146; Lunt DJ, 2010, GEOLOGY, V38, P875, DOI 10.1130/G31184.1; Martinez-Boti MA, 2015, NATURE, V518, P219, DOI 10.1038/nature14155; Martinez-Boti MA, 2015, NATURE, V518, P49, DOI 10.1038/nature14145; McCorkle DC, 1997, DEEP-SEA RES PT I, V44, P983, DOI 10.1016/S0967-0637(97)00004-6; Millero FJ, 1998, AQUAT GEOCHEM, V4, P153, DOI 10.1023/A:1009656023546; Nicholas CJ, 2006, J AFR EARTH SCI, V45, P431, DOI 10.1016/j.jafrearsci.2006.04.003; Palike H, 2012, NATURE, V488, P609, DOI 10.1038/nature11360; Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; PALAEOSENS Project Members, 2013, NATURE, V494, P130; Pearson P.N, 2012, PALEONTOL SOC PAPERS, V18, P1; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pearson PN, 2006, J AFR EARTH SCI, V45, P279, DOI 10.1016/j.jafrearsci.2006.02.005; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; PEARSON PN, 1993, J FORAMIN RES, V23, P123, DOI 10.2113/gsjfr.23.2.123; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Penman DE, 2014, PALEOCEANOGRAPHY, V29, P357, DOI 10.1002/2014PA002621; Rae JWB, 2011, EARTH PLANET SC LETT, V302, P403, DOI 10.1016/j.epsl.2010.12.034; Raitzsch M, 2013, GEOLOGY, V41, P591, DOI 10.1130/G34031.1; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Rink S, 1998, MAR BIOL, V131, P583, DOI 10.1007/s002270050350; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Rohling EJ, 2012, J CLIMATE, V25, P1635, DOI 10.1175/2011JCLI4078.1; Sanyal A, 1996, PALEOCEANOGRAPHY, V11, P513, DOI 10.1029/96PA01858; Sanyal A, 1999, PALEOCEANOGRAPHY, V14, P753, DOI 10.1029/1999PA900036; Sanyal A, 2001, PALEOCEANOGRAPHY, V16, P515, DOI 10.1029/2000PA000547; Sarmiento J.L., 2006, OCEAN BIOGEOCHEMICAL, VVolume 1015, P1, DOI [DOI 10.1515/9781400849079, 10.1515/9781400849079]; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Sexton PF, 2006, MAR MICROPALEONTOL, V60, P1, DOI 10.1016/j.marmicro.2006.02.006; SPERO HJ, 1988, NATURE, V335, P717, DOI 10.1038/335717a0; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tindall J, 2010, EARTH PLANET SC LETT, V292, P265, DOI 10.1016/j.epsl.2009.12.049; Tyrrell T, 2004, GEOCHIM COSMOCHIM AC, V68, P3521, DOI 10.1016/j.gca.2004.02.018; van Dongen BE, 2006, ORG GEOCHEM, V37, P539, DOI 10.1016/j.orggeochem.2006.01.003; Wade BS, 2008, MAR MICROPALEONTOL, V68, P244, DOI 10.1016/j.marmicro.2008.04.002; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Yu JM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001571; Yu JM, 2013, PALEOCEANOGRAPHY, V28, P237, DOI 10.1002/palo.20024; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266; Zeebe RE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000881; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	95	240	244	17	307	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					380	+		10.1038/nature17423	http://dx.doi.org/10.1038/nature17423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27111509	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000376004300045
J	Merkwirth, C; Jovaisaite, V; Durieux, J; Matilainen, O; Jordan, SD; Quiros, PM; Steffen, KK; Williams, EG; Mouchiroud, L; Tronnes, SU; Murillo, V; Wolff, SC; Shaw, RJ; Auwerx, J; Dillin, A				Merkwirth, Carsten; Jovaisaite, Virginija; Durieux, Jenni; Matilainen, Olli; Jordan, Sabine D.; Quiros, Pedro M.; Steffen, Kristan K.; Williams, Evan G.; Mouchiroud, Laurent; Tronnes, Sarah U.; Murillo, Virginia; Wolff, Suzanne C.; Shaw, Reuben J.; Auwerx, Johan; Dillin, Andrew			Two Conserved Histone Demethylases Regulate Mitochondrial Stress-Induced Longevity	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; LIFE-SPAN; ELECTRON-TRANSPORT; PHF8; TRANSCRIPTION; METHYLATION; DETERMINANT; METABOLISM; REPRESSION; GENETICS	Across eukaryotic species, mild mitochondrial stress can have beneficial effects on the lifespan of organisms. Mitochondrial dysfunction activates an unfolded protein response (UPRmt), a stress signaling mechanism designed to ensure mitochondrial homeostasis. Perturbation of mitochondria during larval development in C. elegans not only delays aging but also maintains UPRmt signaling, suggesting an epigenetic mechanism that modulates both longevity and mitochondrial proteostasis throughout life. We identify the conserved histone lysine demethylases jmjd-1.2/PHF8 and jmjd-3.1/JMJD3 as positive regulators of lifespan in response to mitochondrial dysfunction across species. Reduction of function of the demethylases potently suppresses longevity and UPRmt induction, while gain of function is sufficient to extend lifespan in a UPRmt-dependent manner. A systems genetics approach in the BXD mouse reference population further indicates conserved roles of the mammalian orthologs in longevity and UPRmt signaling. These findings illustrate an evolutionary conserved epigenetic mechanism that determines the rate of aging downstream of mitochondrial perturbations.	[Merkwirth, Carsten; Durieux, Jenni; Jordan, Sabine D.; Steffen, Kristan K.; Tronnes, Sarah U.; Wolff, Suzanne C.; Dillin, Andrew] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Merkwirth, Carsten; Durieux, Jenni; Jordan, Sabine D.; Steffen, Kristan K.; Tronnes, Sarah U.; Wolff, Suzanne C.; Dillin, Andrew] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Merkwirth, Carsten; Murillo, Virginia; Shaw, Reuben J.] Salk Inst Biol Studies, Glenn Ctr Res Aging, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Merkwirth, Carsten; Durieux, Jenni; Jordan, Sabine D.; Steffen, Kristan K.; Tronnes, Sarah U.; Wolff, Suzanne C.; Dillin, Andrew] Univ Calif Berkeley, Paul F Glenn Ctr Aging Res, Berkeley, CA 94720 USA; [Jovaisaite, Virginija; Matilainen, Olli; Quiros, Pedro M.; Williams, Evan G.; Mouchiroud, Laurent; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Interfaculty Inst Bioengn, CH-1015 Lausanne, Switzerland; [Jordan, Sabine D.] Scripps Res Inst, Dept Chem Physiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Salk Institute; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Scripps Research Institute	Dillin, A (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Dillin, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Dillin, A (corresponding author), Univ Calif Berkeley, Paul F Glenn Ctr Aging Res, Berkeley, CA 94720 USA.; Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Interfaculty Inst Bioengn, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch; dillin@berkeley.edu	Auwerx, Johan/ABE-9307-2021; Williams, Evan/M-7539-2017; Merkwirth, Carsten/H-5992-2012; Quiros, Pedro M/L-3186-2017	Williams, Evan/0000-0002-9746-376X; Merkwirth, Carsten/0000-0001-8895-3495; Quiros, Pedro M/0000-0002-7793-6291; Auwerx, Johan/0000-0002-5065-5393; Matilainen, Olli/0000-0001-9939-4828	NIH [P40 OD010440, S10RR029668, S10RR027303, R01 ES021667, R01AG043930]; Glenn Center for Research on Aging at the Salk Institute for Biological Studies; American Heart Association [15POST22510020]; Jane Coffin Childs Memorial Fund for Medical Research; Howard Hughes Medical Institute (HHMI); Glenn Foundation for Medical Research; EPFL; SwissCancerLeague [KFS-3082-02-2013]; Systems X [SySX.ch 2013/153]; SNSF [31003A-140780]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Center for Research on Aging at the Salk Institute for Biological Studies; American Heart Association(American Heart Association); Jane Coffin Childs Memorial Fund for Medical Research; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Glenn Foundation for Medical Research; EPFL; SwissCancerLeague; Systems X; SNSF(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Y. Tian for help with reporter crosses, L. Joe for help with preparing the RNA-seq libraries, and Drs. C. Riera, P. Douglas, and N. Baird for scientific insight. We thank F. Lorbeer for help with data analysis and E. Ralston for help with gamma irradiation. We are grateful to Drs. A. Salcini, A. Carrano, M. Hansen, R. O'Sullivan, and C. Holmberg for reagents. Some of the nematode strains used in this work were provided by the Japanese National BioResource Project and the CGC, which is supported by the NIH-Officer of Research Infrastructure Programs (P40 OD010440). This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants (S10RR029668 and S10RR027303). C. M. was supported by a postdoctoral fellowship from the Glenn Center for Research on Aging at the Salk Institute for Biological Studies. S.D.J was supported by an American Heart Association grant (15POST22510020). K.K.S. was supported by a grant from the Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by the Howard Hughes Medical Institute (HHMI), NIH (R01 ES021667) (to A.D.), the Glenn Foundation for Medical Research (to C. M. and S.C.W.), the EPFL, NIH (R01AG043930), SwissCancerLeague (KFS-3082-02-2013), Systems X (SySX.ch 2013/153), and the SNSF (31003A-140780) (to J. A.). J. A. is the Nestle Chair in Energy Metabolism at the EPFL and a cofounder of Mitobridge, Inc. and declares no financial interest related to this work. A.D. is a cofounder of Proteostasis Therapeutics, Inc. and Mitobridge, Inc. and declares no financial interest related to this work.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Baird NA, 2014, SCIENCE, V346, P360, DOI 10.1126/science.1253168; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirchman PA, 1999, GENETICS, V152, P179; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	51	204	208	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1209	1223		10.1016/j.cell.2016.04.012	http://dx.doi.org/10.1016/j.cell.2016.04.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27133168	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000376478200020
J	Eisenstein, M				Eisenstein, Michael			ASSESSMENT Academic return	NATURE			English	Editorial Material																		Azoulay P., 2015, 16056 NBER PUBL R D; Health Economics Research Group Office of Health Economics RAND Europe, 2008, MED RES WHATS IT WOR; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Salter AJ, 2001, RES POLICY, V30, P509, DOI 10.1016/S0048-7333(00)00091-3	4	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S20	S21		10.1038/533S20a	http://dx.doi.org/10.1038/533S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144604	Bronze			2022-12-28	WOS:000375473900003
J	Horn, EJ; Rosen, BR; Chen, Y; Tang, JZ; Chen, K; Eastgate, MD; Baran, PS				Horn, Evan J.; Rosen, Brandon R.; Chen, Yong; Tang, Jiaze; Chen, Ke; Eastgate, Martin D.; Baran, Phil S.			Scalable and sustainable electrochemical allylic C-H oxidation	NATURE			English	Article							PHTHALIMIDE-N-OXYL; ANODIC ELECTROCHEMISTRY; HYDROXYPHTHALIMIDE; FUNCTIONALIZATION; CATALYSIS; MEDIATOR; OLEFINS; ENONES	New methods and strategies for the direct functionalization of C-H bonds are beginning to reshape the field of retrosynthetic analysis, affecting the synthesis of natural products, medicines and materials(1). The oxidation of allylic systems has played a prominent role in this context as possibly the most widely applied C-H functionalization, owing to the utility of enones and allylic alcohols as versatile intermediates, and their prevalence in natural and unnatural materials(2). Allylic oxidations have featured in hundreds of syntheses, including some natural product syntheses regarded as "classics"(3). Despite many attempts to improve the efficiency and practicality of this transformation, the majority of conditions still use highly toxic reagents (based around toxic elements such as chromium or selenium) or expensive catalysts (such as palladium or rhodium)(2). These requirements are problematic in industrial settings; currently, no scalable and sustainable solution to allylic oxidation exists. This oxidation strategy is therefore rarely used for large-scale synthetic applications, limiting the adoption of this retrosynthetic strategy by industrial scientists. Here we describe an electrochemical C-H oxidation strategy that exhibits broad substrate scope, operational simplicity and high chemoselectivity. It uses inexpensive and readily available materials, and represents a scalable allylic C-H oxidation (demonstrated on 100 grams), enabling the adoption of this C-H oxidation strategy in large-scale industrial settings without substantial environmental impact.	[Horn, Evan J.; Rosen, Brandon R.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Chen, Yong; Tang, Jiaze] Tianjin Econ Technol Dev Zone, Asymchem Life Sci Tianjin, Tianjin 300457, Peoples R China; [Chen, Ke; Eastgate, Martin D.] Bristol Myers Squibb Co, Chem Dev, New Brunswick, NJ 08903 USA	Scripps Research Institute; Bristol-Myers Squibb	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu			NSF; National Institute of General Medical Sciences [GM-097444]; Asymchem; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118176, R01GM073949, R01GM097444] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Asymchem; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF predoctoral fellowship (B.R.R.), National Institute of General Medical Sciences grant GM-097444, Asymchem and Bristol-Myers Squibb. We thank D.-H. Huang and L. Pasternack for assistance with NMR spectroscopy; A. L. Rheingold, C. E. Moore and M. A. Galella for X-ray crystallographic analysis; and D. G. Blackmond, O. Luca, T. Paschkewitz, Y. Ishihara and T. Razler for discussions.	Anastas P. T., 1998, GREEN CHEM THEORY PR; Cai Y, 2005, J ORG CHEM, V70, P238, DOI 10.1021/jo048418t; Campbell AN, 2012, ACCOUNTS CHEM RES, V45, P851, DOI 10.1021/ar2002045; Foricher J., 1991, US patent, Patent No. [5,030,739, 5030739]; Francke R, 2014, CHEM SOC REV, V43, P2492, DOI 10.1039/c3cs60464k; Frankowski KJ, 2015, ANGEW CHEM INT EDIT, V54, P10555, DOI 10.1002/anie.201504775; Frey DA, 1996, TETRAHEDRON LETT, V37, P8317, DOI 10.1016/0040-4039(96)01946-6; Gutz C, 2015, ORG PROCESS RES DEV, V19, P1428, DOI 10.1021/acs.oprd.5b00272; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Harre M, 1998, ORG PROCESS RES DEV, V2, P100, DOI 10.1021/op9700587; ISHII Y, 1995, J ORG CHEM, V60, P3934, DOI 10.1021/jo00118a002; Marwah P., 2002, Patent No. [US6384251 B1, 6384251]; MASUI M, 1983, CHEM PHARM BULL, V31, P4209; MASUI M, 1985, CHEM PHARM BULL, V33, P4798; Michaudel Q, 2014, ANGEW CHEM INT EDIT, V53, P12091, DOI 10.1002/anie.201407016; Miller RA, 1996, TETRAHEDRON LETT, V37, P3429, DOI 10.1016/0040-4039(96)00586-2; Modzelewska Aneta, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P477, DOI 10.2174/1568011054866973; Moeller KD, 2000, TETRAHEDRON, V56, P9527, DOI 10.1016/S0040-4020(00)00840-1; Mudryk B, 2014, ORG PROCESS RES DEV, V18, P520, DOI 10.1021/op500031z; Nakamura A, 2013, SYNTHESIS-STUTTGART, V45, P1421, DOI 10.1055/s-0033-1338426; Osterberg PM, 2015, ORG PROCESS RES DEV, V19, P1537, DOI 10.1021/op500328f; Recupero F, 2007, CHEM REV, V107, P3800, DOI 10.1021/cr040170k; Sequeira CAC, 2009, J BRAZIL CHEM SOC, V20, P387, DOI 10.1590/S0103-50532009000300002; SHONO T, 1972, J AM CHEM SOC, V94, P7892, DOI 10.1021/ja00777a036; SHONO T, 1968, TETRAHEDRON LETT, P6207; Sperry JB, 2006, CHEM SOC REV, V35, P605, DOI 10.1039/b512308a; Steckchan E., 1988, ELECTROCHEMISTRY, VIII, P1; UEDA C, 1987, CHEM PHARM BULL, V35, P1372; Weidmann V, 2013, SYNTHESIS-STUTTGART, V45, P2201, DOI 10.1055/s-0033-1338491; Yoshida J, 2008, CHEM REV, V108, P2265, DOI 10.1021/cr0680843	30	426	431	23	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					77	81		10.1038/nature17431	http://dx.doi.org/10.1038/nature17431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096371	Green Accepted			2022-12-28	WOS:000375473900042
J	Jais, A; Solas, M; Backes, H; Chaurasia, B; Kleinridders, A; Theurich, S; Mauer, J; Steculorum, SM; Hampel, B; Goldau, J; Alber, J; Forster, CY; Eming, SA; Schwaninger, M; Ferrara, N; Karsenty, G; Bruning, JC				Jais, Alexander; Solas, Maite; Backes, Heiko; Chaurasia, Bhagirath; Kleinridders, Andre; Theurich, Sebastian; Mauer, Jan; Steculorum, Sophie M.; Hampel, Brigitte; Goldau, Julia; Alber, Jens; Foerster, Carola Y.; Eming, Sabine A.; Schwaninger, Markus; Ferrara, Napoleone; Karsenty, Gerard; Bruening, Jens C.			Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity	CELL			English	Article							INDUCED INSULIN-RESISTANCE; ENDOTHELIAL GROWTH-FACTOR; ENERGY HOMEOSTASIS; ALZHEIMERS-DISEASE; IMMUNE-SYSTEM; IN-VIVO; MACROPHAGES; TRANSPORTER; BARRIER; CNS	High-fat diet (HFD) feeding induces rapid reprogramming of systemic metabolism. Here, we demonstrate that HFD feeding of mice downregulates glucose transporter (GLUT)-1 expression in blood-brain barrier (BBB) vascular endothelial cells (BECs) and reduces brain glucose uptake. Upon prolonged HFD feeding, GLUT1 expression is restored, which is paralleled by increased expression of vascular endothelial growth factor (VEGF) in macrophages at the BBB. In turn, inducible reduction of GLUT1 expression specifically in BECs reduces brain glucose uptake and increases VEGF serum concentrations in lean mice. Conversely, myeloid-cell-specific deletion of VEGF in VEGF Dmyel mice impairs BBB-GLUT1 expression, brain glucose uptake, and memory formation in obese, but not in lean mice. Moreover, obese VEGF Dmyel mice exhibit exaggerated progression of cognitive decline and neuroinflammation on an Alzheimer's disease background. These experiments reveal that transient, HFD-elicited reduction of brain glucose uptake initiates a compensatory increase of VEGF production and assign obesity-associated macrophage activation a homeostatic role to restore cerebral glucose metabolism, preserve cognitive function, and limit neurodegeneration in obesity.	[Jais, Alexander; Solas, Maite; Backes, Heiko; Chaurasia, Bhagirath; Kleinridders, Andre; Theurich, Sebastian; Mauer, Jan; Steculorum, Sophie M.; Hampel, Brigitte; Goldau, Julia; Alber, Jens; Bruening, Jens C.] Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany; [Jais, Alexander; Solas, Maite; Theurich, Sebastian; Mauer, Jan; Steculorum, Sophie M.; Hampel, Brigitte; Goldau, Julia; Alber, Jens; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50924 Cologne, Germany; [Jais, Alexander; Solas, Maite; Theurich, Sebastian; Mauer, Jan; Steculorum, Sophie M.; Hampel, Brigitte; Goldau, Julia; Alber, Jens; Eming, Sabine A.; Bruening, Jens C.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Jais, Alexander; Solas, Maite; Theurich, Sebastian; Mauer, Jan; Steculorum, Sophie M.; Hampel, Brigitte; Goldau, Julia; Alber, Jens; Eming, Sabine A.; Bruening, Jens C.] Univ Cologne, Ctr Mol Med Cologne CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Kleinridders, Andre] German Inst Human Nutr Potsdam Rehbrucke, Cent Regulat Metab, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany; [Kleinridders, Andre; Bruening, Jens C.] Natl Ctr Diabet Res DZD, Ingolstadter Land Str 1, D-85764 Neuherberg, Germany; [Foerster, Carola Y.] Univ Wurzburg, Dept Anaesthesia & Crit Care, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany; [Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Schwaninger, Markus] Med Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Ratzeburger Allee 160, D-23562 Lubeck, Germany; [Ferrara, Napoleone] Univ Calif San Diego, Moores Canc Ctr, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA; [Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA	University of Cologne; University of Cologne; University of Cologne; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Wurzburg; University of Cologne; University of Lubeck; University of California System; University of California San Diego; Columbia University	Bruning, JC (corresponding author), Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany.; Bruning, JC (corresponding author), Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50924 Cologne, Germany.; Bruning, JC (corresponding author), Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Bruning, JC (corresponding author), Univ Cologne, Ctr Mol Med Cologne CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Bruning, JC (corresponding author), Natl Ctr Diabet Res DZD, Ingolstadter Land Str 1, D-85764 Neuherberg, Germany.	bruening@sf.mpg.de	Solas, Maite/O-7845-2016; Jais, Alexander/AAQ-9102-2021; Theurich, Sebastian/C-9995-2018; Theurich, Sebastian/AAB-2855-2022; Steculorum, Sophie/R-2704-2017	Solas, Maite/0000-0001-7670-3237; Jais, Alexander/0000-0002-9897-4983; Theurich, Sebastian/0000-0001-5706-8258; Mauer, Jan/0000-0002-0189-5876; Schwaninger, Markus/0000-0002-4510-9718; Steculorum, Sophie/0000-0002-5665-2732; Kleinridders, Andre/0000-0002-4248-6366; Karsenty, Gerard/0000-0002-9253-7627	DFG [BR 1492/7-1, TRR134, KL2399-3/1]; CMMC; Excellence Initiative by German Federal Government; Excellence Initiative by German State Government; Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Networking Fund of the Helmholtz Association; European Union [266408]; Humboldt-Bayer program of the Alexander Von Humboldt foundation; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD); Medical Faculty of the University of Cologne [3/2014]; National Institute on Aging (NIA) [1R01DK104727-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104727] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); CMMC; Excellence Initiative by German Federal Government; Excellence Initiative by German State Government; Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Networking Fund of the Helmholtz Association; European Union(European Commission); Humboldt-Bayer program of the Alexander Von Humboldt foundation(Alexander von Humboldt Foundation); Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD); Medical Faculty of the University of Cologne; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the DFG (BR 1492/7-1) to J.C.B., and received funding by the DFG within the framework of the TRR134 and within the CMMC and the Excellence Initiative by German Federal and State Governments (CECAD). This work was funded (in part) by the Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Networking Fund of the Helmholtz Association. Moreover, the research leading to these results has received funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement 266408. S.M.S. was funded by the Humboldt-Bayer program of the Alexander Von Humboldt foundation and received a grant from the Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD). A.K. was supported by a DFG fellowship KL2399-3/1. S.T. was funded by a scholarship-program (Gerok-Rotationsstelle, No. 3/2014) of the Medical Faculty of the University of Cologne. G.K. was funded by the National Institute on Aging (NIA) grant 1R01DK104727-01A1. [18F]FDG was provided by B. Neumaier and the radiochemistry department of the Max Planck Institute for Metabolism Research.	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gong CX, 2006, J ALZHEIMERS DIS, V9, P1; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kalin S, 2015, NAT REV ENDOCRINOL, V11, P339, DOI 10.1038/nrendo.2015.48; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Macauley SL, 2015, J CLIN INVEST, V125, P2463, DOI 10.1172/JCI79742; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Mani N, 2003, J CEREBR BLOOD F MET, V23, P1420, DOI 10.1097/01.WCB.0000090620.86921.9C; PEKALA P, 1990, J BIOL CHEM, V265, P18051; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Schlich R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/982458; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Steinbusch L, 2015, TRENDS ENDOCRIN MET, V26, P455, DOI 10.1016/j.tem.2015.06.005; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tovar S, 2013, CELL METAB, V18, P445, DOI 10.1016/j.cmet.2013.08.006; Tsaousidou E, 2014, CELL REP, V9, P1495, DOI 10.1016/j.celrep.2014.10.045; VANNUCCI SJ, 1994, AM J PHYSIOL-ENDOC M, V267, pE605, DOI 10.1152/ajpendo.1994.267.4.E605; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; Wang D, 2006, HUM MOL GENET, V15, P1169, DOI 10.1093/hmg/ddl032; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Yi CX, 2012, MOL METAB, V1, P95, DOI 10.1016/j.molmet.2012.08.004; Yi CX, 2012, DIS MODEL MECH, V5, P686, DOI 10.1242/dmm.009464; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	53	118	120	6	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					882	895		10.1016/j.cell.2016.03.033	http://dx.doi.org/10.1016/j.cell.2016.03.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27133169	Bronze, Green Published			2022-12-28	WOS:000375800300016
J	MacFarlane, L; Osman, N; Ritter, S; Miller, AL; Loscalzo, J				MacFarlane, Lindsey; Osman, Nora; Ritter, Susan; Miller, Amy L.; Loscalzo, Joseph			Eye of the Beholder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLAMMATORY MYOPATHIES; JUVENILE DERMATOMYOSITIS; POLYMYOSITIS; DISEASES; TRIAL; ADULT		Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021					Amato AA, 2009, J NEUROL NEUROSUR PS, V80, P1060, DOI 10.1136/jnnp.2008.169375; Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; Dimachkie MM, 2014, NEUROL CLIN, V32, P595, DOI 10.1016/j.ncl.2014.04.007; Narazaki M, 2011, RHEUMATOLOGY, V50, P1344, DOI 10.1093/rheumatology/ker152; Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754; Shah AA, 2015, ARTHRITIS RHEUMATOL, V67, P317, DOI 10.1002/art.38928; Studynkova JT, 2007, RHEUMATOLOGY, V46, P1174, DOI 10.1093/rheumatology/kem088; Tansley SL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4198; Trallero-Araguas E, 2012, ARTHRITIS RHEUM-US, V64, P523, DOI 10.1002/art.33379; Yamasaki Y, 2007, RHEUMATOLOGY, V46, P124, DOI 10.1093/rheumatology/kel112; Zong M, 2014, ANN RHEUM DIS, V73, P913, DOI 10.1136/annrheumdis-2012-202857	12	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1775	1780		10.1056/NEJMcps1509470	http://dx.doi.org/10.1056/NEJMcps1509470			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144853				2022-12-28	WOS:000375341500012
J	Perkel, JM				Perkel, Jeffrey M.			THE STRUGGLE WITH IMAGE GLUT	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008				Amat F, 2015, NAT PROTOC, V10, P1679, DOI 10.1038/nprot.2015.111; Egelman EH, 2014, ELIFE, V3, DOI 10.7554/eLife.04969; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489	4	2	2	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					131	132		10.1038/533131a	http://dx.doi.org/10.1038/533131a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27147030	hybrid			2022-12-28	WOS:000375473900056
J	Yamano, T; Nishimasu, H; Zetsche, B; Hirano, H; Slaymaker, IM; Li, YQ; Fedorova, I; Nakane, T; Makarova, KS; Koonin, EV; Ishitani, R; Zhang, F; Nureki, O				Yamano, Takashi; Nishimasu, Hiroshi; Zetsche, Bernd; Hirano, Hisato; Slaymaker, Ian M.; Li, Yinqing; Fedorova, Iana; Nakane, Takanori; Makarova, Kira S.; Koonin, Eugene V.; Ishitani, Ryuichiro; Zhang, Feng; Nureki, Osamu			Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA	CELL			English	Article							CRISPR-CAS9 NUCLEASES; DUAL-RNA; CAS9; ENDONUCLEASE; IMMUNITY; SYSTEM; SERVER	Cpf1 is an RNA-guided endonuclease of a type V CRISPR-Cas system that has been recently harnessed for genome editing. Here, we report the crystal structure of Acidaminococcus sp. Cpf1 (AsCpf1) in complex with the guide RNA and its target DNA at 2.8 angstrom resolution. AsCpf1 adopts a bilobed architecture, with the RNA-DNA heteroduplex bound inside the central channel. The structural comparison of AsCpf1 with Cas9, a type II CRISPR-Cas nuclease, reveals both striking similarity and major differences, thereby explaining their distinct functionalities. AsCpf1 contains the RuvC domain and a putative novel nuclease domain, which are responsible for cleaving the non-target and target strands, respectively, and for jointly generating staggered DNA double-strand breaks. AsCpf1 recognizes the 50-TTTN-30 protospacer adjacent motif by base and shape readout mechanisms. Our findings provide mechanistic insights into RNA-guided DNA cleavage by Cpf1 and establish a framework for rational engineering of the CRISPR-Cpf1 toolbox.	[Yamano, Takashi; Nishimasu, Hiroshi; Hirano, Hisato; Nakane, Takanori; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan; [Nishimasu, Hiroshi] JST, PRESTO, Tokyo 1130032, Japan; [Zetsche, Bernd; Slaymaker, Ian M.; Li, Yinqing; Fedorova, Iana; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zetsche, Bernd; Slaymaker, Ian M.; Li, Yinqing; Fedorova, Iana; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd; Slaymaker, Ian M.; Li, Yinqing; Fedorova, Iana; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Zetsche, Bernd; Slaymaker, Ian M.; Li, Yinqing; Fedorova, Iana; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zetsche, Bernd] Bonn Med Sch, Inst Pathol, Dept Dev Pathol, D-53127 Bonn, Germany; [Fedorova, Iana] Peter Great St Petersburg Polytech Univ, St Petersburg 195251, Russia; [Fedorova, Iana] Skolkovo Inst Sci & Technol, Skolkovo 143026, Russia; [Makarova, Kira S.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	University of Tokyo; Japan Science & Technology Agency (JST); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Bonn; Peter the Great St. Petersburg Polytechnic University; Skolkovo Institute of Science & Technology; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan.; Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org; nureki@bs.s.u-tokyo.ac.jp	Fedorova, Iana/A-6804-2014; Macrae, Rhiannon/AAX-1536-2020; NUREKI, OSAMU/G-4960-2014	Fedorova, Iana/0000-0001-6144-173X; Nakane, Takanori/0000-0003-2697-2767; Yamano, Takashi/0000-0001-5998-4532; Li, Yinqing/0000-0002-9096-8482	JST; PRESTO; JSPS KAKENHI [26291010, 15H01463]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; US Department of Health and Human Services; NIH through the NIMH [5DP1-MH100706, 1R01-MH110049]; Waterman Award from the National Science Foundation; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED; Council for Science; Grants-in-Aid for Scientific Research [16J08032] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	JST(Japan Science & Technology Agency (JST)); PRESTO; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; US Department of Health and Human Services; NIH through the NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Waterman Award from the National Science Foundation; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Council for Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Arisa Kurabayashi for assistance with vector construction. We thank the beamline scientists at PXI X06SA at the Swiss Light Source and BL41XU at SPring-8 for assistance with data collection. H.N. is supported by JST, PRESTO, JSPS KAKENHI (26291010 and 15H01463), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology. K.S.M. and E.V.K. are supported by intramural funds of the US Department of Health and Human Services (to the National Library of Medicine). F.Z. is supported by the NIH through the NIMH (5DP1-MH100706 and 1R01-MH110049); a Waterman Award from the National Science Foundation; the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. F.Z. is a founder of Editas Medicine and a scientific advisor for Editas Medicine and Horizon Discovery. O.N. is supported by the Basic Science and Platform Technology Program for Innovative Biological Medicine from the Japan Agency for Medical Research and Development, AMED, the Council for Science, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Waterman D. G., 2013, CCP4 NEWSLETTER; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	42	359	456	16	201	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					949	962		10.1016/j.cell.2016.04.003	http://dx.doi.org/10.1016/j.cell.2016.04.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27114038	Green Accepted, Bronze			2022-12-28	WOS:000375800300021
J	Braillon, A; Bewley, S				Braillon, Alain; Bewley, Susan			Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Pregnant Women	ANNALS OF INTERNAL MEDICINE			English	Letter							NICOTINE		[Braillon, Alain] Univ Hosp, Amiens, France; [Bewley, Susan] Kings Coll London, London WC2R 2LS, England	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of London; King's College London	Braillon, A (corresponding author), Univ Hosp, Amiens, France.							Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Berlin I, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1622; Brose LS, 2013, DRUG ALCOHOL DEPEN, V132, P660, DOI 10.1016/j.drugalcdep.2013.04.017; Koren G, 2008, THER DRUG MONIT, V30, P246, DOI 10.1097/FTD.0b013e318167d05b; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171	5	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					637	637		10.7326/L15-0625	http://dx.doi.org/10.7326/L15-0625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136221				2022-12-28	WOS:000375744000035
J	Hughes, HJJ; Kluzek, S				Hughes, Henry James Jonathon; Kluzek, Stefan			An amateur runner with hip pain and antalgic gait	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hughes, Henry James Jonathon] Univ Oxford, Oxford Univ Med Sch, Oxford, England; [Kluzek, Stefan] Univ Oxford, Arthritis Res UK Ctr Sport Exercise & Osteoarthri, Oxford, England	University of Oxford; University of Oxford	Hughes, HJJ (corresponding author), Univ Oxford, Oxford Univ Med Sch, Oxford, England.	henry.hughes@magd.ox.ac.uk	Hughes, Henry/AAM-5600-2020	Hughes, Henry/0000-0002-9498-7138; Kluzek, Stefan/0000-0002-0696-7541				Behrens SB, 2013, SPORTS HEALTH, V5, P165, DOI 10.1177/1941738112467423; Clough TM, 2002, BRIT J SPORT MED, V36, P308, DOI 10.1136/bjsm.36.4.308; Gurney B, 2006, J ORTHOP SPORT PHYS, V36, P80, DOI 10.2519/jospt.2006.36.2.80; Polacek Martin, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.02.2010.2749	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2400	10.1136/bmj.i2400	http://dx.doi.org/10.1136/bmj.i2400			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27143403	Green Published			2022-12-28	WOS:000375574000004
J	Cohen, L; Gurun, UG; Kominers, SD				Cohen, Lauren; Gurun, Umit G.; Kominers, Scott Duke			The growing problem of patent trolling	SCIENCE			English	Editorial Material							ASSERTION ENTITIES		[Cohen, Lauren; Kominers, Scott Duke] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Cohen, Lauren; Gurun, Umit G.; Kominers, Scott Duke] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Gurun, Umit G.] Univ Texas Dallas, Richardson, TX 75080 USA; [Kominers, Scott Duke] Harvard Univ, Dept Econ, Ctr Res Computat & Soc, Ctr Math Sci & Applicat,Soc Fellows, Cambridge, MA 02138 USA; [Kominers, Scott Duke] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Harvard University; National Bureau of Economic Research; University of Texas System; University of Texas Dallas; Harvard University; Harvard University	Cohen, L; Kominers, SD (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.; Cohen, L; Gurun, UG; Kominers, SD (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Gurun, UG (corresponding author), Univ Texas Dallas, Richardson, TX 75080 USA.; Kominers, SD (corresponding author), Harvard Univ, Dept Econ, Ctr Res Computat & Soc, Ctr Math Sci & Applicat,Soc Fellows, Cambridge, MA 02138 USA.; Kominers, SD (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	lcohen@hbs.edu; umit.gurun@utdallas.edu; kominers@fas.harvard.edu		Kominers, Scott/0000-0002-7608-6619				Allison J. R., 2015, WORKING PAPER; Allison JR, 2014, TEX LAW REV, V92, P1769; American Intellectual Property Law Association, 2013, AIPLA REP EC SURV 20; Anderson JJ, 2015, U PENN LAW REV, V163, P631; Bessen J.E., 2011, REGULATION, V34, P26; Bessen J, 2014, CORNELL LAW REV, V99, P387; Catherine ETucker, 2014, WORKING PAPER; Chien C., 2014, STANF TECHNOL LAW RE, V17, P461; Cohen Lauren, 2015, 15002 HARV BUS SCH, P4; Cotropia CA, 2014, MINN LAW REV, V99, P649; Feldman R., 2013, UCLA J LAW TECHNOL, V18, P1; Feldman R., 2015, STANFORD TECHNOLOGY, V19, P52; Feldman R, 2015, IOWA LAW REV, V101, P137; Kiebzak S, 2016, RES POLICY, V45, P218, DOI 10.1016/j.respol.2015.07.002; Lanjouw JO, 2004, J LAW ECON, V47, P45, DOI 10.1086/380476; Leychkis Y., 2007, YALE J LAW TECHNOL, V9; Miller S.P., 2012, VIRGINIA J LAW TECHN, V18, P1; Morton FMS, 2014, ANTITRUST LAW J, V79, P463; Mullin Joe, 2016, ARS TECHNICA; Smeets R., 2014, WORKING PAPER	20	35	37	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					521	522		10.1126/science.aad2686	http://dx.doi.org/10.1126/science.aad2686			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126027				2022-12-28	WOS:000374998600024
J	Dustin, ML; Muller, J				Dustin, Michael L.; Muller, James			Liquidity in immune cell signaling	SCIENCE			English	Editorial Material							ACTIVATION		[Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Dustin, Michael L.; Muller, James] NYU, Sch Med, Skirball Inst, New York, NY USA	University of Oxford; New York University	Dustin, ML (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.; Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst, New York, NY USA.	michael.dustin@kennedy.ox.ac.uk	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010	9	7	7	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					516	517		10.1126/science.aaf8179	http://dx.doi.org/10.1126/science.aaf8179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126023	Green Submitted			2022-12-28	WOS:000374998600020
J	Trigg, J; Trigg, H; Trigg, C; Trigg, M				Trigg, Jennifer; Trigg, Hilary; Trigg, Cecilia; Trigg, Miles			Kenneth Haddon Trigg OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		TRIGG KH, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2420	10.1136/bmj.i2420	http://dx.doi.org/10.1136/bmj.i2420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130492				2022-12-28	WOS:000375484100006
J	Rimmer, A				Rimmer, Abi			Government abused power as sole employer of junior doctors, says BMA chair	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2362; Rimmer A., 2016, BMJ CAREERS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2382	10.1136/bmj.i2382	http://dx.doi.org/10.1136/bmj.i2382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27116972				2022-12-28	WOS:000375482500017
J	Gulland, A				Gulland, Anne			Staff shortages are putting UK breast cancer screening "at risk," survey finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		The Royal College of Radiologists, 2016, BREAST IM DIAGN WORK	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2350	10.1136/bmj.i2350	http://dx.doi.org/10.1136/bmj.i2350			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27114480				2022-12-28	WOS:000375482000007
J	Chan, K; Mandeville, KL				Chan, Kenneth; Mandeville, Kate L.			Improving access to NCD medicines through collaboration	LANCET			English	Editorial Material									[Chan, Kenneth] UCL, Royal Free Hosp, London NW3 2PF, England; [Mandeville, Kate L.] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; London School of Hygiene & Tropical Medicine	Chan, K (corresponding author), UCL, Royal Free Hosp, London NW3 2PF, England.	kennethchan1@nhs.net	chan, Kenneth/GSN-8133-2022	Chan, Kenneth/0000-0002-5571-7549; Mandeville, Kate/0000-0002-5525-1574				Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; Hargreaves JR, 2011, LANCET, V378, P1885, DOI 10.1016/S0140-6736(11)60687-9; International Federation of Pharmaceutical Manufacturers and Associations, DEV WORLD HLTH PARTN; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; UN, 2015, SUST DEV GOALS GOALS; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2016, GLOB REP PSOR; WHO, 2010, DIFF PRIC PHARM REV; World Health Organization, 2011, WORLD MED SIT 2011 M; World Health Organization, 2015, MOD LIST ESS MED 19	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1704	1705		10.1016/S0140-6736(16)00275-0	http://dx.doi.org/10.1016/S0140-6736(16)00275-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	27116264				2022-12-28	WOS:000374541900009
J	Sowton, T				Sowton, Tim			John Victor Sowton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2306	10.1136/bmj.i2306	http://dx.doi.org/10.1136/bmj.i2306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106506				2022-12-28	WOS:000374999700010
J	Monath, TP; Woodall, JP; Gubler, DJ; Yuill, TM; Mackenzie, JS; Martins, RM; Reiter, P; Heymann, DL				Monath, Thomas P.; Woodall, Jack P.; Gubler, Duane J.; Yuill, Thomas M.; Mackenzie, John S.; Martins, Reinaldo M.; Reiter, Paul; Heymann, David L.			Yellow fever vaccine supply: a possible solution	LANCET			English	Editorial Material							EPIDEMIC; NIGERIA		[Monath, Thomas P.] NewLink Genet Corp, Devens, MA USA; [Woodall, Jack P.] Int Soc Infect Dis, ProMED, Brookline, MA USA; [Gubler, Duane J.] Duke NUS Grad Med Sch, Dept Trop Med, Singapore, Singapore; [Yuill, Thomas M.] Univ Wisconsin, Pathobiol Sci Forest & Wildlife Ecol, Madison, WI USA; [Mackenzie, John S.] Curtin Univ, Trop Infect Dis, Perth, WA 6845, Australia; [Martins, Reinaldo M.] Biomanguinhos Fiocruz, Rio De Janeiro, RJ, Brazil; [Reiter, Paul] Inst Pasteur, Paris, France; [Heymann, David L.] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England	National University of Singapore; University of Wisconsin System; University of Wisconsin Madison; Curtin University; Fundacao Oswaldo Cruz; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	david.heymann@lshtm.ac.uk	/S-4986-2019; Martins, Reinaldo/I-3413-2015	/0000-0002-5918-2190; Martins, Reinaldo/0000-0002-0667-532X				Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391; DECOCK KM, 1988, LANCET, V1, P630; Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264; Hickling J, 2013, YELLOW FEVER VACCINA, P118; Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982; Monath T.P., 2013, VACCINES-BASEL, V6e, P870; NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X; The Lancet, 2016, LANCET, V387, P1348; WHO, 2019, DENG SEV DENG; WHO, YELL FEV VACC GLOB P; WHO, DIS OUTBR NEWS 6 APR; WHO, 2016, DENG CONTR CHIK; WHO Regional Office for South-East Asia, 2011, INF EXP CONS YELL FE, P39; Wold Health Organization, 2016, WHO EM US ASS LIST P; World Health Organization (WHO), 2016, EM PREP RESP YELL FE	15	34	37	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1599	1600		10.1016/S0140-6736(16)30195-7	http://dx.doi.org/10.1016/S0140-6736(16)30195-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	27116054				2022-12-28	WOS:000374145100008
J	Dar, D; Shamir, M; Mellin, JR; Koutero, M; Stern-Ginossar, N; Cossart, P; Sorek, R				Dar, Daniel; Shamir, Maya; Mellin, J. R.; Koutero, Mikael; Stern-Ginossar, Noam; Cossart, Pascale; Sorek, Rotem			Term-seq reveals abundant ribo-regulation of antibiotics resistance in bacteria	SCIENCE			English	Article							CONTROLS GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; ATTENUATION; RIBOSWITCHES; ANTITERMINATION; TRANSCRIPTOMICS; TERMINATION; MECHANISM	Riboswitches and attenuators are cis-regulatory RNA elements, most of which control bacterial gene expression via metabolite-mediated, premature transcription termination. We developed an unbiased experimental approach for genome-wide discovery of such ribo-regulators in bacteria. We also devised an experimental platform that quantitatively measures the in vivo activity of all such regulators in parallel and enables rapid screening for ribo-regulators that respond to metabolites of choice. Using this approach, we detected numerous antibioticresponsive ribo-regulators that control antibiotic resistance genes in pathogens and in the human microbiome. Studying one such regulator in Listeria monocytogenes revealed an attenuation mechanism mediated by antibiotic-stalled ribosomes. Our results expose broad roles for conditional termination in regulating antibiotic resistance and provide a tool for discovering riboswitches and attenuators that respond to previously unknown ligands.	[Dar, Daniel; Shamir, Maya; Stern-Ginossar, Noam; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mellin, J. R.; Koutero, Mikael; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mellin, J. R.; Koutero, Mikael; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Mellin, J. R.; Koutero, Mikael; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France	Weizmann Institute of Science; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rotem.sorek@weizmann.ac.il		Voichek, Maya/0000-0002-0508-0682; Dar, Daniel/0000-0002-6650-5488; , Noam/0000-0003-3583-5932	Israel Science Foundation [1303/12]; Israel Science Foundation (I-CORE) [1796/12]; European Research Council (ERC) [260432]; Human Frontier Science Program [RGP0011/2013]; Abisch-Frenkel foundation; Pasteur-Weizmann council; Minerva Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft; ERC [670823]	Israel Science Foundation(Israel Science Foundation); Israel Science Foundation (I-CORE); European Research Council (ERC)(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Abisch-Frenkel foundation; Pasteur-Weizmann council; Minerva Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	We thank O. Wurtzel, I. Karunker, S. Doron, G. Amitai, G. Ofir, A. Millman, Y. Voichek, S. Melamed, and R. Nir-Paz for insightful discussion. R. S. was supported, in part, by the Israel Science Foundation (personal grant 1303/12 and I-CORE grant 1796/12), the European Research Council (ERC)-Starting Grants program (grant 260432), Human Frontier Science Program (grant RGP0011/2013 to R. S. and P.C), the Abisch-Frenkel foundation, the Pasteur-Weizmann council grant (to R. S and P.C), the Minerva Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, and by a Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft. P.C was supported by an ERC-Advanced Grants grant (BacCellEpi, #670823). Reference IRB for the microbiome analysis is 0315-15-HMO. Sequencing data was deposited in the European Nucleotide Database (ENA), accession no. PRJEB12568. D.D. and R. S. are inventors on U.S. provisional patent application 62/200,662.	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Balestrino D, 2010, APPL ENVIRON MICROB, V76, P3625, DOI 10.1128/AEM.02612-09; Benenson Y, 2012, CURR OPIN CHEM BIOL, V16, P278, DOI 10.1016/j.cbpa.2012.05.192; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Burke TP, 2014, J BACTERIOL, V196, P3756, DOI 10.1128/JB.02053-14; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chesneau O, 2005, ANTIMICROB AGENTS CH, V49, P973, DOI 10.1128/AAC.49.3.973-980.2005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Douthwaite S, 2004, J MOL BIOL, V337, P1073, DOI 10.1016/j.jmb.2004.02.030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fowler CC, 2010, CHEM BIOL, V17, P756, DOI 10.1016/j.chembiol.2010.05.025; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; HOLMBERG C, 1992, MOL MICROBIOL, V6, P2931, DOI 10.1111/j.1365-2958.1992.tb01752.x; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; KWAK JH, 1991, J BACTERIOL, V173, P4725, DOI 10.1128/jb.173.15.4725-4735.1991; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Naville M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r97; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Ohki R, 2005, J BACTERIOL, V187, P5946, DOI 10.1128/JB.187.17.5946-5954.2005; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Reilman E, 2014, NUCLEIC ACIDS RES, V42, P11393, DOI 10.1093/nar/gku832; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TURNER RJ, 1994, J BACTERIOL, V176, P3708, DOI 10.1128/JB.176.12.3708-3722.1994; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; Zhao QX, 1998, ANTIMICROB AGENTS CH, V42, P2225, DOI 10.1128/AAC.42.9.2225	58	191	195	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282							aad9822	10.1126/science.aad9822	http://dx.doi.org/10.1126/science.aad9822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27120414	Green Accepted			2022-12-28	WOS:000373681600037
J	Dalbeth, N; Merriman, TR; Stamp, LK				Dalbeth, Nicola; Merriman, Tony R.; Stamp, Lisa K.			Gout	LANCET			English	Review							SERUM URIC-ACID; 3RD NATIONAL-HEALTH; QUALITY-OF-LIFE; MENDELIAN RANDOMIZATION ANALYSIS; POSTMENOPAUSAL HORMONE USE; URATE CRYSTAL DEPOSITION; US GENERAL-POPULATION; PURINE-RICH FOODS; DOUBLE-BLIND; AMERICAN-COLLEGE	Gout is a chronic disease of deposition of monosodium urate crystals, which form in the presence of increased urate concentrations. Although environmental factors contribute to hyperuricaemia, renal and gut excretion of urate is central to regulation of serum urate, and genetic factors are important. Activation of the NLRP3 inflammasome and release of interleukin 1 beta have key roles in initiation of acute gout flares. A "treat to target serum urate" approach is essential for effective gout management; long-term lowering of serum urate to less than 360 mu mol/L leads to crystal dissolution and ultimately to suppression of flares. An allopurinol dose-escalation strategy is frequently effective for achieving treatment targets, and several new urate-lowering drugs are also available. Worldwide, rates of initiation and continuation of urate-lowering therapy are very low, and, consequently, achievement of serum urate targets is infrequent. Strategies to improve quality of gout care are needed.	[Dalbeth, Nicola] Univ Auckland, Dept Med, Private Bag 92019,85 Pk Rd, Auckland, New Zealand; [Merriman, Tony R.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Stamp, Lisa K.] Univ Otago, Dept Med, Christchurch, New Zealand	University of Auckland; University of Otago; University of Otago	Dalbeth, N (corresponding author), Univ Auckland, Dept Med, Private Bag 92019,85 Pk Rd, Auckland, New Zealand.	n.dalbeth@auckland.ac.nz		Merriman, Tony/0000-0003-0844-8726	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	We are supported by the Health Research Council of New Zealand. We thank Sarah Stewart, Anna Gosling, Ashika Chhana, and Rhian Miranda for assistance with images.	Aati O, 2015, ANN RHEUM DIS, V74, P2144, DOI 10.1136/annrheumdis-2014-205671; Aati O, 2014, JCR-J CLIN RHEUMATOL, V20, P251, DOI 10.1097/RHU.0000000000000127; AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andres Mariano, 2014, Cochrane Database Syst Rev, pCD010156, DOI 10.1002/14651858.CD010156.pub2; Batt C, 2014, ANN RHEUM DIS, V73, P2101, DOI 10.1136/annrheumdis-2013-203600; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2013, ANN RHEUM DIS, V72, P1469, DOI 10.1136/annrheumdis-2012-201795; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Becker MA, 2009, J RHEUMATOL, V36, P1041, DOI 10.3899/jrheum.071229; BELLAMY N, 1987, BRIT J CLIN PHARMACO, V24, P33, DOI 10.1111/j.1365-2125.1987.tb03132.x; Bhole V, 2010, ARTHRITIS RHEUM-US, V62, P1069, DOI 10.1002/art.27338; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Chandratre P, 2013, RHEUMATOLOGY, V52, P2031, DOI 10.1093/rheumatology/ket265; Chhana A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0762-4; Choi HK, 2009, ANN RHEUM DIS, V68, P1609, DOI 10.1136/ard.2008.099713; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Choi HK, 2007, ARTHRITIS RHEUM, V56, P2049, DOI 10.1002/art.22712; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P816, DOI 10.1002/art.22762; Choi HK, 2015, ARTHRITIS RHEUMATOL, V67, P555, DOI 10.1002/art.38917; Choi HK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8190; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Cottrell E, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-170; Cronstein BN, 2013, JCR-J CLIN RHEUMATOL, V19, P19, DOI 10.1097/RHU.0b013e31827d8790; Czegley C, 2014, GOUT HYPERURICEMIA, V1, P88; Dalbeth N, 2009, ANN RHEUM DIS, V68, P1290, DOI 10.1136/ard.2008.094201; Dalbeth N, 2013, HYPERURICEMIA GOUT O; Dalbeth N, 2015, ANN RHEUM DIS, V74, P908, DOI 10.1136/annrheumdis-2014-206397; Dalbeth N, 2014, ANN RHEUM DIS, V73, P1598, DOI 10.1136/annrheumdis-2014-205304; Dalbeth N, 2014, ANN RHEUM DIS, V73, P797, DOI 10.1136/annrheumdis-2013-203970; Dalbeth N, 2013, ANN RHEUM DIS, V72, P1868, DOI 10.1136/annrheumdis-2012-202732; Dalbeth N, 2012, ANN RHEUM DIS, V71, P929, DOI 10.1136/annrheumdis-2011-200156; Dalbeth N, 2010, ARTHRITIS RHEUM-US, V62, P1549, DOI 10.1002/art.27356; Daoussis D, 2013, JOINT BONE SPINE, V80, P291, DOI 10.1016/j.jbspin.2012.09.009; De Vera MA, 2014, ARTHRIT CARE RES, V66, P1551, DOI 10.1002/acr.22336; Dubreuil M, 2013, AM J MED, V126, P1138, DOI 10.1016/j.amjmed.2013.06.026; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Flynn TJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0661-8; Forbess LJ, 2012, SEMIN ARTHRITIS RHEU, V42, P146, DOI 10.1016/j.semarthrit.2012.03.007; Getting SJ, 2002, ARTHRITIS RHEUM, V46, P2765, DOI 10.1002/art.10526; Goldfien RD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003627; GRAHAME R, 1970, ANN RHEUM DIS, V29, P461, DOI 10.1136/ard.29.5.461; Grassi W, 2006, SEMIN ARTHRITIS RHEU, V36, P197, DOI 10.1016/j.semarthrit.2006.08.001; Hak AE, 2010, ANN RHEUM DIS, V69, P1305, DOI 10.1136/ard.2009.109884; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Hench PS, 1941, J AMER MED ASSOC, V116, P453, DOI 10.1001/jama.1941.02820060001001; Hershfield MS, 2013, CLIN PHARMACOL THER, V93, P153, DOI 10.1038/clpt.2012.209; Hill EM, 2015, JCR-J CLIN RHEUMATOL, V21, P120, DOI 10.1097/RHU.0000000000000235; Holland R, 2015, INTERN MED J, V45, P189, DOI 10.1111/imj.12661; Hong JY, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0642-1; Howard RG, 2011, ARTHRIT CARE RES, V63, P1456, DOI 10.1002/acr.20527; Hughes K, 2014, KIDNEY INT, V85, P344, DOI 10.1038/ki.2013.353; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Janssens HJEM, 2006, ANN RHEUM DIS, V65, P1080, DOI 10.1136/ard.2005.040360; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Janssens HJEM, 2010, ARCH INTERN MED, V170, P1120, DOI 10.1001/archinternmed.2010.196; Johnson RJ, 2011, SEMIN NEPHROL, V31, P394, DOI 10.1016/j.semnephrol.2011.08.002; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Juraschek SP, 2011, ARTHRIT CARE RES, V63, P1295, DOI 10.1002/acr.20519; Jutkowitz E, 2014, ANN INTERN MED, V161, P617, DOI 10.7326/M14-0227; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Khanna PP, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-117; Kienhorst LBE, 2015, RHEUMATOLOGY, V54, P609, DOI 10.1093/rheumatology/keu378; Kleber ME, 2015, J AM SOC NEPHROL, V26, P2831, DOI 10.1681/ASN.2014070660; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Latourte A, 2014, RHEUMATOLOGY, V53, P1920, DOI 10.1093/rheumatology/keu157; Lee KH, 2015, J KOREAN MED SCI, V30, P700, DOI 10.3346/jkms.2015.30.6.700; Li CG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8041; LIEBER CS, 1962, J CLIN INVEST, V41, P1863, DOI 10.1172/JCI104643; Lipsky PE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4497; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Logan JA, 1997, ANN RHEUM DIS, V56, P696, DOI 10.1136/ard.56.11.696a; Lu N, 2016, ANN RHEUM DIS, V75, P547, DOI 10.1136/annrheumdis-2014-206917; Lyngdoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039321; Mallamaci F, 2015, AM J KIDNEY DIS, V65, P294, DOI 10.1053/j.ajkd.2014.07.021; Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matsuo H, 2016, ANN RHEUM DIS, V75, P652, DOI 10.1136/annrheumdis-2014-206191; MCCARTY DJ, 1961, ANN INTERN MED, V54, P452, DOI 10.7326/0003-4819-54-3-452; McKinney C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0802-3; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Moi JHY, 2014, J RHEUMATOL, V41, P26, DOI 10.3899/jrheum.140459; Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254; Ogdie A, 2015, ANN RHEUM DIS, V74, P1868, DOI 10.1136/annrheumdis-2014-205431; Pakpoor J, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0273-9; Palmer TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4262; Pascual E, 2005, BEST PRACT RES CL RH, V19, P371, DOI 10.1016/j.berh.2005.01.004; Pascual E, 1999, ANN INTERN MED, V131, P756, DOI 10.7326/0003-4819-131-10-199911160-00007; Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P610, DOI 10.1002/art.10792; Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P356, DOI 10.1002/art.10511; Perez-Ruiz F, 2016, ANN RHEUM DIS, V75, P1074, DOI 10.1136/annrheumdis-2015-207919; Perez-Ruiz F, 2009, RHEUMATOLOGY, V48, P9, DOI 10.1093/rheumatology/kep087; Perrin CM, 2011, CRYSTENGCOMM, V13, P1111, DOI 10.1039/c0ce00737d; Phipps-Green AJ, 2016, ANN RHEUM DIS, V75, P124, DOI 10.1136/annrheumdis-2014-205877; Pui K, 2013, J RHEUMATOL, V40, P872, DOI 10.3899/jrheum.121301; Qing YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064845; Ramasamy SN, 2013, DRUG SAFETY, V36, P953, DOI 10.1007/s40264-013-0084-0; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Robinson PC, 2015, J RHEUMATOL, V42, P1702, DOI 10.3899/jrheum.150310; Rodriguez G, 2010, ANN RHEUM DIS, V69, P2090, DOI 10.1136/ard.2010.130013; ROSEFF R, 1987, J RHEUMATOL, V14, P974; Saag KG, 2014, ARTHRITIS RHEUMATOL, V66, P3533; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schlesinger N, 2002, J RHEUMATOL, V29, P331; Schlesinger N, 2012, ANN RHEUM DIS, V71, P1839, DOI 10.1136/annrheumdis-2011-200908; Schlesinger N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3297; Schlesinger N, 2011, ANN RHEUM DIS, V70, P1264, DOI 10.1136/ard.2010.144063; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Schumacher HR, 2012, ARTHRIT CARE RES, V64, P1462, DOI 10.1002/acr.21690; Seth R, 2014, J RHEUMATOL, V41, P42, DOI 10.3899/jrheum.140461; Shibagaki Y, 2014, HYPERTENS RES, V37, P919, DOI 10.1038/hr.2014.107; Singh JA, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0624-3; Singh JA, 2014, JCR-J CLIN RHEUMATOL, V20, P172, DOI 10.1097/RHU.0000000000000091; Singh JA, 2011, CURR OPIN RHEUMATOL, V23, P192, DOI 10.1097/BOR.0b013e3283438e13; Sluijs I, 2015, DIABETES, V64, P3028, DOI 10.2337/db14-0742; Smith E, 2014, ANN RHEUM DIS, V73, P1470, DOI 10.1136/annrheumdis-2013-204647; Stamp L, 2016, ARTHRITIS RHEUM, V63, P412; Stamp LK, 2016, NAT REV RHEUMATOL, V12, P235, DOI 10.1038/nrrheum.2015.132; Stamp LK, 2013, ARTHRITIS RHEUM-US, V65, P1636, DOI 10.1002/art.37925; Stamp LK, 2012, ARTHRITIS RHEUM-US, V64, P2529, DOI 10.1002/art.34488; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]; Taylor TH, 2012, AM J MED, V125, P1126, DOI 10.1016/j.amjmed.2012.05.025; Taylor WJ, 2015, ARTHRIT CARE RES, V67, P1304, DOI 10.1002/acr.22585; Terkeltaub Robert, 2013, Evid Based Med, V18, P230, DOI 10.1136/eb-2012-101211; Terkeltaub RA, 2011, ARTHRITIS RHEUM-US, V63, P2226, DOI 10.1002/art.30389; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Testa A, 2014, CLIN J AM SOC NEPHRO, V9, P1059, DOI 10.2215/CJN.11041013; Thiele RG, 2007, RHEUMATOLOGY, V46, P1116, DOI 10.1093/rheumatology/kem058; Urano W, 2013, J RHEUMATOL, V40, P1374, DOI 10.3899/jrheum.121244; Van Durme C, 2014, COCHRANE DB SYST REV, V9; Wang WQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006843; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; WERNICK R, 1992, ARCH INTERN MED, V152, P873, DOI 10.1001/archinte.152.4.873; White J, 2016, LANCET DIABETES ENDO, V4, P327, DOI 10.1016/S2213-8587(15)00386-1; Winnard D, 2012, RHEUMATOLOGY, V51, P901, DOI 10.1093/rheumatology/ker361; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang Yuqing, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2006.01.020; Zhang YQ, 2012, ANN RHEUM DIS, V71, P1448, DOI 10.1136/annrheumdis-2011-201215; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zhu YY, 2010, RHEUMATOLOGY, V49, P2391, DOI 10.1093/rheumatology/keq256	153	570	623	25	277	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					2039	2052		10.1016/S0140-6736(16)00346-9	http://dx.doi.org/10.1016/S0140-6736(16)00346-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27112094				2022-12-28	WOS:000385954800033
J	Zhang, HB; Ryu, D; Wu, YB; Gariani, K; Wang, X; Luan, PL; D'Amico, D; Ropelle, ER; Lutolf, MP; Aebersold, R; Schoonjans, K; Menzies, KJ; Auwerx, J				Zhang, Hongbo; Ryu, Dongryeol; Wu, Yibo; Gariani, Karim; Wang, Xu; Luan, Peiling; D'Amico, Davide; Ropelle, Eduardo R.; Lutolf, Matthias P.; Aebersold, Ruedi; Schoonjans, Kristina; Menzies, Keir J.; Auwerx, Johan			NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice	SCIENCE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; METABOLISM; SENESCENCE; ADULT; DIFFERENTIATION; QUIESCENCE; NICHE; REJUVENATION; MAINTENANCE	Adult stem cells (SCs) are essential for tissue maintenance and regeneration yet are susceptible to senescence during aging. We demonstrate the importance of the amount of the oxidized form of cellular nicotinamide adenine dinucleotide (NAD(+)) and its effect on mitochondrial activity as a pivotal switch to modulate muscle SC (MuSC) senescence. Treatment with the NAD(+) precursor nicotinamide riboside (NR) induced the mitochondrial unfolded protein response and synthesis of prohibitin proteins, and this rejuvenated MuSCs in aged mice. NR also prevented MuSC senescence in the mdx (C57BL/10ScSn-Dmd(mdx)/J) mouse model of muscular dystrophy. We furthermore demonstrate that NR delays senescence of neural SCs and melanocyte SCs and increases mouse life span. Strategies that conserve cellular NAD(+) may reprogram dysfunctional SCs and improve life span in mammals.	[Zhang, Hongbo; Ryu, Dongryeol; Gariani, Karim; Wang, Xu; Luan, Peiling; D'Amico, Davide; Ropelle, Eduardo R.; Menzies, Keir J.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Wu, Yibo; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Ropelle, Eduardo R.] Univ Estadual Campinas, Sch Appl Sci, Lab Mol Biol Exercise, BR-13484350 Sao Paulo, Brazil; [Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Lab Stem Cell Bioengn, CH-1015 Lausanne, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Metab Signaling, CH-1015 Lausanne, Switzerland; [Menzies, Keir J.] Univ Ottawa, Brain & Mind Res Inst, Interdisciplinary Sch Hlth Sci, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Estadual de Campinas; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Ottawa	Menzies, KJ; Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.; Menzies, KJ (corresponding author), Univ Ottawa, Brain & Mind Res Inst, Interdisciplinary Sch Hlth Sci, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	kmenzies@uottawa.ca; admin.auwerx@epfl.ch	Wu, Yibo/AAK-8294-2020; Auwerx, Johan/ABE-9307-2021; Ryu, Dongryeol/AAQ-3642-2020; Wang, Xu/T-8608-2017; Wu, Yibo/AAW-7121-2020; D'Amico, Davide/AAY-6183-2021; Ropelle, Eduardo R/C-3977-2012	Wu, Yibo/0000-0002-8256-3901; Ryu, Dongryeol/0000-0001-5905-6760; Wang, Xu/0000-0002-9267-8278; Wu, Yibo/0000-0002-8256-3901; D'Amico, Davide/0000-0002-8499-9514; Ropelle, Eduardo R/0000-0003-1655-9557; Auwerx, Johan/0000-0002-5065-5393; Menzies, Keir J/0000-0002-1873-8500; Zhang, Hongbo/0000-0002-4081-5752; Schoonjans, Kristina/0000-0003-1247-4265	China Scholarship Council; CARIGEST SA; Associazione Italiana per la Ricerca sul Cancro; University of Ottawa; Heart and Stroke Foundation of Canada; EPFL; NIH [R01AG043930]; Krebsforschung Schweiz/SwissCancerLeague [KFS-3082-02-2013]; Systems X [SySX.ch 2013/153]; Swiss National Science Foundation [31003A-140780]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); CARIGEST SA; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); University of Ottawa; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); EPFL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krebsforschung Schweiz/SwissCancerLeague; Systems X; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	H.Z., D.R., K.J.M., J.A., and the EPFL have filed a provisional patent application on the use of NAD boosting to enhance SC function. We thank T. Lange for sharing the Phb plasmids; S. Wang and M. Knobloch for technical help in McSC and NSC experiments; H. Li, L. Mouchiroud, P. Moral Quires, and all members of We Auwerx and Schoonjans groups for helpful discussions; and We EPFL histology and flow cytometry core facilities for technical assistance. H.Z. is the recipient of a doctoral scholarship from the China Scholarship Council and a fellowship from CARIGEST SA. D.D. was supported by a fellowship from Associazione Italiana per la Ricerca sul Cancro. K.J.M. is supported by the University of Ottawa and the Heart and Stroke Foundation of Canada. J.A. is the Nestle Chair in Energy Metabolism, and his research is supported by EPFL, the NIH (grant R01AG043930), Krebsforschung Schweiz/SwissCancerLeague (grant KFS-3082-02-2013), Systems X (grant SySX.ch 2013/153) and the Swiss National Science Foundation (grant 31003A-140780).	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Hara E, 1996, MOL CELL BIOL, V16, P859; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Quinn KP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03432; Rimmele P, 2015, EMBO REP, V16, P1164, DOI 10.15252/embr.201439704; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; SARTORE S, 1982, NATURE, V298, P294, DOI 10.1038/298294a0; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	43	630	650	21	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2016	352	6292					1436	1443		10.1126/science.aaf2693	http://dx.doi.org/10.1126/science.aaf2693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7PV	27127236				2022-12-28	WOS:000377975400043
J	Atlani-Duault, L; Dozon, JP; Wilson, A; Delfraissy, JF; Moatti, JP				Atlani-Duault, Latitia; Dozon, Jean-Pierre; Wilson, Andrew; Delfraissy, Jean-Francois; Moatti, Jean-Paul			State humanitarian verticalism versus universal health coverage: a century of French international health assistance revisited	LANCET			English	Article							RURAL DISTRICT HOSPITALS; LOW-INCOME COUNTRIES; ANTIRETROVIRAL TREATMENT; HIV-INFECTION; CARE FINANCE; AFRICA; DELIVERY; ACCESS; INSURANCE; CAMEROON	The French contribution to global public health over the past two centuries has been marked by a fundamental tension between two approaches: State-provided universal free health care and what we propose to call State humanitarian verticalism. Both approaches have historical roots in French colonialism and have led to successes and failures that continue until the present day. In this paper, the second in The Lancet's Series on France, we look at how this tension has evolved. During the French colonial period (1890s to 1950s), the Indigenous Medical Assistance structure was supposed to bring metropolitan France's model of universal and free public health care to the colonies, and French State imperial humanitarianism crystallised in vertical programmes inspired by Louis Pasteur, while vying with early private humanitarian activism in health represented by Albert Schweitzer. From decolonisation to the end of the Cold War (1960-99), French assistance to newly independent states was affected by sans frontierisme, Health for All, and the AIDS pandemic. Since 2000, France has had an active role in development of global health initiatives and favoured multilateral action for health assistance. Today, with adoption of the 2030 Sustainable Development Goals and the challenges of non-communicable diseases, economic inequality, and climate change, French international health assistance needs new direction. In the context of current debate over global health as a universal goal, understanding and acknowledging France's history could help strengthen advocacy in favour of universal health coverage and contribute to advancing global equity through income redistribution, from healthy populations to people who are sick and from wealthy individuals to those who are poor.	[Atlani-Duault, Latitia] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA; [Atlani-Duault, Latitia] Univ Paris, CNRS, French Natl Inst Dev Res IRD INSERM AMU, UMR 912, F-75252 Paris, France; [Atlani-Duault, Latitia] Univ Paris, CNRS, Lab Ethnol & Sociol Comparat, F-75252 Paris, France; [Dozon, Jean-Pierre] Inst Mondes Africains, Paris, France; [Dozon, Jean-Pierre] Ecole Hautes Etud Sci Sociales, Paris, France; [Wilson, Andrew] Fdn Maison Sci Homme, Paris, France; [Delfraissy, Jean-Francois] ANRS French Natl Agcy AIDS Res, Paris, France; [Delfraissy, Jean-Francois] INSERM, I3M Immunol Inflammat Infectiol & Microbiol, Paris, France; [Moatti, Jean-Paul] French Natl Inst Dev Res IRD, Marseille, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Atlani-Duault, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA.	lae2617@cumc.columbia.edu						Abu-Zaineh M, 2014, HEALTH POLICY PLANN, V29, P433, DOI 10.1093/heapol/czt029; Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; Amble J, 1991, FRENCH WELFARE STATE; Atlani-Duault L., 2011, ETHNOLOGIE FRANCAISE, V41, P393; Atlani-Duault Laetitia., 2005, BONHEUR AUTRES ANTHR; AtlaniDuault L, 2007, CENT ASIAN STUD SER, P1; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Atun R, 2009, JAIDS-J ACQ IMM DEF, V52, pS67, DOI 10.1097/QAI.0b013e3181bbcd58; Audibert M, 2004, Med Trop (Mars), V64, P552; Aye M, 2002, SOC SCI MED, V55, P1929, DOI 10.1016/S0277-9536(01)00322-7; Bado Jean-Paul, 1996, MED COLONIALE GRANDE; Banerjee V, 2005, HDB EC GROWTH, V1a, P474; Barnett M.N., 2011, EMPIRE OF HUMANITY; Bennett S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001001; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; Bortolotti Dan, 2004, HOPE HELL INSIDE WOR; Boulle C, 2013, JAIDS-J ACQ IMM DEF, V62, P569, DOI 10.1097/QAI.0b013e318285f7b6; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Brabazon James, 2000, A SCHWEITZER BIOGRAP; Brauman R., 2009, MED HUMANITAIRE; BROWN RE, 1969, TROP GEOGR MED, V21, P348; Brunet-Jailly J, 2000, AFRIQUE CONT, V195, P191; Bynum H, 2002, SUCCESS AFRICA ONCHO; Cisse B, 2004, REV FR EC, V4, P111; Cisse B, 2007, HEALTH POLICY, V80, P51, DOI 10.1016/j.healthpol.2006.02.011; COLLIGNON R, 1978, PSYCHOPATHOL AFR, V14, P133; Collignon R, 2002, AUTRE CLIN CULT SOC, V5, P455, DOI [10.3917/lautr.009.0455, DOI 10.3917/LAUTR.009.0455]; Conklin Alice L., 1997, MISSION CIVILIZE REP; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Davies JB, 2009, 15508 NBER; Dedet JP, 2001, I PASTEURS OUTRE MER; Dozon J.P., 2001, CRITIQUE SANTE PUBLI; Dozon J. P., 1991, CAHIERS DETUDES AFRC, V31, P135; Dozon Jean-Pierre, 1991, I PASTEUR CONTRIBUTI, P269; Dufourcq E, 1993, AVENTURIERES DIEU; Duriez M, 1996, SYSTEME SANTE FRANCE; Dutton P.V., 2002, ORIGINS FRENCH WELFA; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Ewald F., 1986, ETAT PROVIDENCE; Expertise France, LIN 5; Fanon Frantz., 2008, BLACK SKIN WHITE MAS; Fieldhouse D. K., 1966, COLONIAL EMPIRES COM; Fox R.C., 2014, DOCTORS BORDERS HUMA; French Ministry of Foreign and European Aff airs, 2015, EV CONJ INT MAEDI AF; French Ministry of Foreign and European Affairs, 2012, FRANC STRAT INT HLTH; Dozon J P, 1985, Sci Soc Sante, V3, P27; Gillam S, 2008, BMJ-BRIT MED J, V336, P536, DOI 10.1136/bmj.39469.432118.AD; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Gire K, 2012, ANSWERING CALL DOCTO; Glassman A, 2013, GLOB POLICY, V4, P1, DOI 10.1111/j.1758-5899.2012.00176.x; Hardon A., 1990, HLTH POLICY PLAN, V5, P186, DOI [10.1093/heapol/5.2.186, DOI 10.1093/HEAPOL/5.2.186]; Hardoon D., 2016, EC 1 PRIVILEGE POWER; Hayter T, 1966, FRENCH AID; Headrick DR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002772; I-8 Group, 2009, INN FIN DEV; IFFIm, OV; Jamot E, 1929, ARCH CTR MURAZ BOBO; Kanbur R, 2012, J INT DEV, V24, P686, DOI 10.1002/jid.2861; Katzenstein D, 2003, AIDS, V17, pS1, DOI 10.1097/00002030-200317003-00001; Kouchner B, 1991, MALHEUR AUTRES; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lapeyssonnie L., 1988, MED COLONIALE MYTHES; Latour B., 1984, MICROBES GUERRE PAIX; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Letourmy A, 2008, CR BIOL, V331, P952, DOI 10.1016/j.crvi.2008.08.013; Lyons Maryinez, 1992, COLONIAL DIS SOCIAL; Marshall George, 1971, SCHWEITZER BIOGRAPHY; Martino P, 1989, PSYCHIAT FR, V2, P41; Mathis Constant, 1946, OEUVRE PASTORIENS AF; Mathonnat J, 2008, CR BIOL, V331, P942, DOI 10.1016/j.crvi.2008.08.008; McKnight G, 1964, VERDICT SCHWEITZER M; Moatti JP, 2003, NAT MED, V9, P1449, DOI 10.1038/nm1203-1449; Monteillet N, 2006, POLIT AFR, V3, P127; Nay O, 2016, LANCET; Nolan B., 1995, COST RECOVERY PUBLIC; OECD, 2013, STRENGTH NAT STAT SY; Orsi F, 2007, AIDS, V21, P1997, DOI 10.1097/QAD.0b013e328273bbe4; Picht W, 1964, LIFE THOUGHT A SCHWE; Redfield P, 2005, CULT ANTHROPOL, V20, P328, DOI 10.1525/can.2005.20.3.328; Republique Francaise, 2014, PPOL FRANC FAV DEV D; Ridde V, 2003, B WORLD HEALTH ORGAN, V81, P532; Salomon-Bayet C., 1986, PASTEUR REVOLUTION P; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sastry S, 2012, HEALTH COMMUN, V27, P519, DOI 10.1080/10410236.2011.616626; Schweitzer A, 1979, PAIX RESPECT VIE; Schweitzer A, 1923, OREE FORET VIERGE RE; Seaver G, 1955, A SCHWEITZER MAN HIS; Senate French, 2014, RAPP GEN FAIT NOM CO; Senghor L.S., 1979, PSYCHOPATHOL AFR, V15, P137; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; Taithe B, 2014, J IMP COMMONW HIST, V42, P912, DOI 10.1080/03086534.2014.959719; Taithe Bertrand, 2004, MOD CONTEMP FR, V12, P147, DOI DOI 10.1080/09639480410001693025; The PLOS Medicine Editors, 2014, PLOS MED, V11; United Nations, 2015, MILL DEV GOALS IND; Ventelou B, 2008, AIDS, V22, P107, DOI 10.1097/QAD.0b013e3282f1d49f; Vidal L., 2005, PROFESSIONNELS SANTE; Wang S, 1994, MED AFRIQUE NOIRE, V41, P74; Weber Olivier, 1995, FRENCH DOCTORS EPOPE; WEISS JH, 1983, FR HIST STUD, V13, P47, DOI 10.2307/286593; WHO, 2010, WOR HEALT REP, P1; WHO, 2015, WORLD HLTH REP EX SU; World Health Organization, 1978, DECL ALM ALT INT C P; Yameogo L, 2003, 30 YEARS ONCHOCERCIA	104	3	3	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2250	2262		10.1016/S0140-6736(16)00379-2	http://dx.doi.org/10.1016/S0140-6736(16)00379-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145710				2022-12-28	WOS:000376820800035
J	Casasuss, B				Casasuss, Barbara			Research Focus Profile: Institut Pasteur, Paris, France	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2190	2190		10.1016/S0140-6736(16)30406-8	http://dx.doi.org/10.1016/S0140-6736(16)30406-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27145703	Bronze			2022-12-28	WOS:000376820800020
J	Lin, YF; Schulz, AM; Pellegrino, MW; Lu, Y; Shaham, S; Haynes, CM				Lin, Yi-Fan; Schulz, Anna M.; Pellegrino, Mark W.; Lu, Yun; Shaham, Shai; Haynes, Cole M.			Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response	NATURE			English	Article							C-ELEGANS; DNA DELETIONS; SKELETAL-MUSCLE; CELLS; MTDNA; HETEROPLASMY; ACTIVATION; MITOPHAGY; PARKIN; ACCUMULATION	Mitochondrial genomes (mitochondrial DNA, mtDNA) encode essential oxidative phosphorylation (OXPHOS) components. Because hundreds of mtDNAs exist per cell, a deletion in a single mtDNA has little impact. However, if the deletion genome is enriched, OXPHOS declines, resulting in cellular dysfunction. For example, Kearns-Sayre syndrome is caused by a single heteroplasmic mtDNA deletion. More broadly, mtDNA deletion accumulation has been observed in individual muscle cells(1) and dopaminergic neurons(2) during ageing. It is unclear how mtDNA deletions are tolerated or how they are propagated in somatic cells. One mechanism by which cells respond to OXPHOS dysfunction is by activating the mitochondrial unfolded protein response (UPRmt), a transcriptional response mediated by the transcription factor ATFS-1 that promotes the recovery and regeneration of defective mitochondria(3,4). Here we investigate the role of ATFS-1 in the maintenance and propagation of a deleterious mtDNA in a heteroplasmic Caenorhabditis elegans strain that stably expresses wild-type mtDNA and mtDNA with a 3.1-kilobase deletion (Delta mtDNA) lacking four essential genes(5). The heteroplasmic strain, which has 60% Delta mtDNA, displays modest mitochondrial dysfunction and constitutive UPRmt activation. ATFS-1 impairment reduced the Delta mtDNA nearly tenfold, decreasing the total percentage to 7%. We propose that in the context of mtDNA heteroplasmy, UPRmt activation caused by OXPHOS defects propagates or maintains the deleterious mtDNA in an attempt to recover OXPHOS activity by promoting mitochondrial biogenesis and dynamics.	[Lin, Yi-Fan; Schulz, Anna M.; Pellegrino, Mark W.; Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA; [Haynes, Cole M.] Weill Cornell Med Coll, BCMB Allied Program, 1300 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University	Haynes, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.; Haynes, CM (corresponding author), Weill Cornell Med Coll, BCMB Allied Program, 1300 York Ave, New York, NY 10065 USA.	haynesc@mskcc.org			NIH Office of Research 362 Infrastructure Programs [P40 OD010440]; Genomics and Bioinformatics Facilities at Memorial Sloan Kettering Cancer Center; National Institutes of Health [R01AG040061, R01AG047182, R01HD078703, R01NS081490]; Parkinson's Disease Foundation [PDF-FBS-1314]; Deutsche Forschungsgemeinschaft (DFG) [SCHU 3023/1-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047182, R01AG040061, R37AG047182] Funding Source: NIH RePORTER	NIH Office of Research 362 Infrastructure Programs; Genomics and Bioinformatics Facilities at Memorial Sloan Kettering Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Lemire, the National Bioresource Project and the Caenorhabditis Genetics Center for providing C. elegans strains (funded by NIH Office of Research 362 Infrastructure Programs (P40 OD010440), and the Genomics and Bioinformatics Facilities at Memorial Sloan Kettering Cancer Center). This work was supported by National Institutes of Health grants (R01AG040061 and R01AG047182) to C.M.H. and (R01HD078703 and R01NS081490) to S.S., and a Parkinson's Disease Foundation grant (PDF-FBS-1314) to Y.-F.L. and Deutsche Forschungsgemeinschaft (DFG, SCHU 3023/1-1) to A.M.S.	Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lamech LT, 2015, J CELL BIOL, V209, P781, DOI 10.1083/jcb.201503107; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Schieber M, 2014, CELL REP, V9, P9, DOI 10.1016/j.celrep.2014.08.075; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	28	168	173	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					416	+		10.1038/nature17989	http://dx.doi.org/10.1038/nature17989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27135930	Green Accepted			2022-12-28	WOS:000376004300053
J	Qin, T; Cornella, J; Li, C; Malins, LR; Edwards, JT; Kawamura, S; Maxwell, BD; Eastgate, MD; Baran, PS				Qin, Tian; Cornella, Josep; Li, Chao; Malins, Lara R.; Edwards, Jacob T.; Kawamura, Shuhei; Maxwell, Brad D.; Eastgate, Martin D.; Baran, Phil S.			A general alkyl-alkyl cross-coupling enabled by redox-active esters and alkylzinc reagents	SCIENCE			English	Article							GRIGNARD-REAGENTS; CATALYZED REACTION; ALKYLMAGNESIUM HALIDES; BETA-HYDROGENS; MECHANISM	Alkyl carboxylic acids are ubiquitous in all facets of chemical science, from natural products to polymers, and represent an ideal starting material with which to forge new connections. This study demonstrates how the same activating principles used for decades to make simple C-N (amide) bonds from carboxylic acids with loss of water can be used to make C-C bonds through coupling with dialkylzinc reagents and loss of carbon dioxide. This disconnection strategy benefits from the use of a simple, inexpensive nickel catalyst and exhibits a remarkably broad scope across a range of substrates (> 70 examples).	[Qin, Tian; Cornella, Josep; Li, Chao; Malins, Lara R.; Edwards, Jacob T.; Kawamura, Shuhei; Baran, Phil S.] Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Maxwell, Brad D.] Bristol Myers Squibb Co, Discovery Chem Platforms Radiochem, POB 4000, Princeton, NJ USA; [Eastgate, Martin D.] Bristol Myers Squibb Co, Chem Dev, One Squibb Dr, New Brunswick, NJ 08903 USA	Scripps Research Institute; Bristol-Myers Squibb; Bristol-Myers Squibb	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Malins, Lara R/U-3851-2018	Malins, Lara R/0000-0002-7691-6432; Cornella, Josep/0000-0003-4152-7098	Bristol-Myers Squibb; Catalan Government; U.S. Department of Defense (National Defense Science and Engineering Graduate fellowship); NIH [F32GM117816]; China Scholarship Council; National Institute of General Medical Sciences [GM106210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118176, F32GM117816, R01GM106210] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Catalan Government; U.S. Department of Defense (National Defense Science and Engineering Graduate fellowship); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by Bristol-Myers Squibb, the Catalan Government (postdoctoral fellowship to J.C.), the U.S. Department of Defense (National Defense Science and Engineering Graduate fellowship to J.T.E.), NIH (F32GM117816 postdoctoral fellowship to L.R.M.), the China Scholarship Council (postdoctoral fellowship to C.L.), and the National Institute of General Medical Sciences (GM106210). We thank D.-H. Huang and L. Pasternack for assistance with nuclear magnetic resonance spectroscopy; M. Collins for providing samples of atorvastatin, cetirizine, and pregabalin; R. Mills for experimental assistance; A. Rheingold, C. E. Moore, and M. A. Galella for x-ray crystallographic analysis; M. R. Ghadiri for providing access to preparative HPLC equipment; and K. Chen for helpful discussions. Metrical parameters for the structures of 11 and 73 are available free of charge from the Cambridge Crystallographic Data Center under reference nos. CCDC-1457710 and CCDC-1457711, respectively.	Arnott JA, 2012, EXPERT OPIN DRUG DIS, V7, P863, DOI 10.1517/17460441.2012.714363; Boutureira O, 2015, CHEM REV, V115, P2174, DOI 10.1021/cr500399p; Cornella J, 2016, J AM CHEM SOC, V138, P2174, DOI 10.1021/jacs.6b00250; Devasagayaraj A, 1995, ANGEW CHEM INT EDIT, V34, P2723; Diederich F., 1998, METAL CATALYZED CROS; Frisch AC, 2005, ANGEW CHEM INT EDIT, V44, P674, DOI 10.1002/anie.200461432; Huihui KMM, 2016, J AM CHEM SOC, V138, P5016, DOI 10.1021/jacs.6b01533; Ishihara Y., 2013, PORTABLE CHEM CONSUL; ISHIYAMA T, 1992, CHEM LETT, P691, DOI 10.1246/cl.1992.691; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Jolibois P, 1912, CR HEBD ACAD SCI, V155, P213; KHARASCH MS, 1959, J ORG CHEM, V24, P303, DOI 10.1021/jo01085a003; Kritzer JA, 2010, NAT CHEM BIOL, V6, P566, DOI 10.1038/nchembio.407; Lau YH, 2015, CHEM SOC REV, V44, P91, DOI 10.1039/c4cs00246f; Musser M. T, 2000, ULLMANNS ENCY IND CH; Netherton MR, 2004, ADV SYNTH CATAL, V346, P1525, DOI 10.1002/adsc.200404223; Netherton MR, 2001, J AM CHEM SOC, V123, P10099, DOI 10.1021/ja011306o; Ogliaruso M.A., 1991, SYNTHESIS CARBOXYLIC; OKADA K, 1988, J AM CHEM SOC, V110, P8736, DOI 10.1021/ja00234a047; PARKER VD, 1964, J AM CHEM SOC, V86, P1112, DOI 10.1021/ja01060a031; PARKER VD, 1964, J AM CHEM SOC, V86, P1110, DOI 10.1021/ja01060a030; Rodriguez N, 2011, CHEM SOC REV, V40, P5030, DOI 10.1039/c1cs15093f; Rudolph A, 2009, ANGEW CHEM INT EDIT, V48, P2656, DOI 10.1002/anie.200803611; Sheehan J. C., 1982, ENCHANTED RING UNTOL; Spath E., 1913, MONATSH, V34, P1965; TAMURA M, 1971, J AM CHEM SOC, V93, P1483; Tamura M., 1970, J AM CHEM SOC, V93, P1485; Terao J, 2002, J AM CHEM SOC, V124, P4222, DOI 10.1021/ja025828v; Tsuji T, 2002, ANGEW CHEM INT EDIT, V41, P4137, DOI 10.1002/1521-3773(20021104)41:21<4137::AID-ANIE4137>3.0.CO;2-0; Urkalan KB, 2009, J AM CHEM SOC, V131, P18042, DOI 10.1021/ja908545b; Waddell S. T., 2004, Patent No. [US 20040133011, 20040133011]; Zhang L, 2016, SCIENCE, V351, P70, DOI 10.1126/science.aad6080	32	433	434	14	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					801	805		10.1126/science.aaf6123	http://dx.doi.org/10.1126/science.aaf6123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27103669	Green Accepted			2022-12-28	WOS:000375663000034
J	Zhang, SY; Chang, LF; Alfieri, C; Zhang, ZG; Yang, J; Maslen, S; Skehel, M; Barford, D				Zhang, Suyang; Chang, Leifu; Alfieri, Claudio; Zhang, Ziguo; Yang, Jing; Maslen, Sarah; Skehel, Mark; Barford, David			Molecular mechanism of APC/C activation by mitotic phosphorylation	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; CYCLIN-UBIQUITIN LIGASE; CRYO-EM; MASS-SPECTROMETRY; CELL-CYCLE; PROTEIN; CYCLOSOME; COMPLEX/CYCLOSOME; RECOGNITION; BINDING	In eukaryotes, the anaphase-promoting complex (APC/C, also known as the cyclosome) regulates the ubiquitin-dependent proteolysis of specific cell-cycle proteins to coordinate chromosome segregation in mitosis and entry into the G1 phase(1,2). The catalytic activity of the APC/C and its ability to specify the destruction of particular proteins at different phases of the cell cycle are controlled by its interaction with two structurally related coactivator subunits, Cdc20 and Cdh1. Coactivators recognize substrate degrons(3), and enhance the affinity of the APC/C for its cognate E2 (refs 4-6). During mitosis, cyclin-dependent kinase (Cdk) and polo-like kinase (Plk) control Cdc20- and Cdh1-mediated activation of the APC/C. Hyperphosphorylation of APC/C subunits, notably Apc1 and Apc3, is required for Cdc20 to activate the APC/C7-12, whereas phosphorylation of Cdh1 prevents its association with the APC/C-9,C-13,C-14. Since both coactivators associate with the APC/C through their common C-box(15) and Ile-Arg tail motifs(16,17), the mechanism underlying this differential regulation is unclear, as is the role of specific APC/C phosphorylation sites. Here, using cryo-electron microscopy and biochemical analysis, we define the molecular basis of how phosphorylation of human APC/C allows for its control by Cdc20. An auto-inhibitory segment of Apc1 acts as a molecular switch that in apo unphosphorylated APC/C interacts with the C-box binding site and obstructs engagement of Cdc20. Phosphorylation of the auto-inhibitory segment displaces it from the C-box-binding site. Efficient phosphorylation of the auto-inhibitory segment, and thus relief of auto-inhibition, requires the recruitment of Cdk-cyclin in complex with a Cdk regulatory subunit (Cks) to a hyperphosphorylated loop of Apc3. We also find that the small-molecule inhibitor, tosyl-l-arginine methyl ester, preferentially suppresses APC/C-Cdc20 rather than APC/CCdh1, and interacts with the binding sites of both the C-box and Ile-Arg tail motifs. Our results reveal the mechanism for the regulation of mitotic APC/C by phosphorylation and provide a rationale for the development of selective inhibitors of this state.	[Zhang, Suyang; Chang, Leifu; Alfieri, Claudio; Zhang, Ziguo; Yang, Jing; Maslen, Sarah; Skehel, Mark; Barford, David] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		Yang, Jing/0000-0002-8984-4503; Alfieri, Claudio/0000-0003-3215-1607; Zhang, Suyang/0000-0002-2322-9276; Barford, David/0000-0001-8810-950X; Zhang, Ziguo/0000-0002-7268-9631	MRC Laboratory of Molecular Biology; Cancer Research UK; Gates Cambridge Scholarship; Boehringer Ingelheim Fonds; MRC [MC_UP_1201/6] Funding Source: UKRI; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish	MRC Laboratory of Molecular Biology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Gates Cambridge Scholarship; Boehringer Ingelheim Fonds(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the MRC Laboratory of Molecular Biology and a Cancer Research UK grant to D.B. PhD funding for S.Z. was from the Gates Cambridge Scholarship and Boehringer Ingelheim Fonds. C.A. is an EMBO Fellow. We are grateful to members of the Barford group for discussion; S. Chen, C. Savva and G. McMullan for EM facilities; J. Grimmet and T. Darling for computing; K. Zhang for advice on data processing; G. Murshudov for help with REFMAC and S. Aibara for advice on cloning.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Herzog F, 2005, METHOD ENZYMOL, V398, P231, DOI 10.1016/S0076-6879(05)98019-1; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Izawa D, 2012, J CELL BIOL, V199, P27, DOI 10.1083/jcb.201205170; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; LAHAVBARATZ S, 1995, P NATL ACAD SCI USA, V92, P9303, DOI 10.1073/pnas.92.20.9303; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V260, P193, DOI 10.1006/bbrc.1999.0884; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V257, P12, DOI 10.1006/bbrc.1999.0409; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Sudakin V, 1997, J BIOL CHEM, V272, P18051, DOI 10.1074/jbc.272.29.18051; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Van Voorhis VA, 2014, CURR BIOL, V24, P1556, DOI 10.1016/j.cub.2014.05.052; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamaguchi M, 2015, J MOL BIOL, V427, P1748, DOI 10.1016/j.jmb.2014.11.020; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374	45	120	121	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					260	+		10.1038/nature17973	http://dx.doi.org/10.1038/nature17973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27120157	Green Accepted			2022-12-28	WOS:000376007200053
J	Nogrady, B				Nogrady, Bianca			AUSTRALIA Engagement upgrade	NATURE			English	Editorial Material																		Dutta S., 2015, GLOBAL INNOVATION IN	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S22	S23		10.1038/533S22a	http://dx.doi.org/10.1038/533S22a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144605	Bronze			2022-12-28	WOS:000375473900004
J	Vatanen, T; Kostic, AD; d'Hennezel, E; Siljander, H; Franzosa, EA; Yassour, M; Kolde, R; Vlamakis, H; Arthur, TD; Hamalainen, AM; Peet, A; Tillmann, V; Uibo, R; Mokurov, S; Dorshakova, N; Ilonen, J; Virtanen, SM; Szabo, SJ; Porter, JA; Lahdesmaki, H; Huttenhower, C; Gevers, D; Cullen, TW; Knip, M; Xavier, RJ				Vatanen, Tommi; Kostic, Aleksandar D.; d'Hennezel, Eva; Siljander, Heli; Franzosa, Eric A.; Yassour, Moran; Kolde, Raivo; Vlamakis, Hera; Arthur, Timothy D.; Hamalainen, Anu-Maaria; Peet, Aleksandr; Tillmann, Vallo; Uibo, Raivo; Mokurov, Sergei; Dorshakova, Natalya; Ilonen, Jorma; Virtanen, Suvi M.; Szabo, Susanne J.; Porter, Jeffrey A.; Lahdesmaki, Harri; Huttenhower, Curtis; Gevers, Dirk; Cullen, Thomas W.; Knip, Mikael; Xavier, Ramnik J.		DIABIMMUNE Study Grp	Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans	CELL			English	Article							INFANT GUT MICROBIOME; MILK OLIGOSACCHARIDES; NEWBORN-INFANTS; RUSSIAN KARELIA; CELIAC-DISEASE; LIPOPOLYSACCHARIDE; SENSITIZATION; CHILDREN; SUSCEPTIBILITY; REACTIVITY	According to the hygiene hypothesis, the increasing incidence of autoimmune diseases in western countries may be explained by changes in early microbial exposure, leading to altered immune maturation. We followed gut microbiome development from birth until age three in 222 infants in Northern Europe, where early-onset autoimmune diseases are common in Finland and Estonia but are less prevalent in Russia. We found that Bacteroides species are lowly abundant in Russians but dominate in Finnish and Estonian infants. Therefore, their lipopolysaccharide (LPS) exposures arose primarily from Bacteroides rather than from Escherichia coli, which is a potent innate immune activator. We show that Bacteroides LPS is structurally distinct from E. coli LPS and inhibits innate immune signaling and endotoxin tolerance; furthermore, unlike LPS from E. coli, B. dorei LPS does not decrease incidence of autoimmune diabetes in non-obese diabetic mice. Early colonization by immunologically silencing microbiota may thus preclude aspects of immune education.	[Vatanen, Tommi; Kostic, Aleksandar D.; Franzosa, Eric A.; Yassour, Moran; Vlamakis, Hera; Arthur, Timothy D.; Huttenhower, Curtis; Gevers, Dirk; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Vatanen, Tommi; Lahdesmaki, Harri] Aalto Univ, Dept Comp Sci, Sch Sci, Espoo 02150, Finland; [Kostic, Aleksandar D.; Kolde, Raivo; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Kostic, Aleksandar D.; Kolde, Raivo; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kostic, Aleksandar D.; Franzosa, Eric A.; Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [d'Hennezel, Eva; Szabo, Susanne J.; Porter, Jeffrey A.; Cullen, Thomas W.] Novartis Inst Biomed Res Inc, Cambridge, MA 02139 USA; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Childrens Hosp, Stenbackinkatu 11, FIN-00290 Helsinki, Finland; [Siljander, Heli; Knip, Mikael] Helsinki Univ Hosp, Helsinki 00290, Finland; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Res Programs Unit, Diabet & Obes Res Program, FIN-00290 Helsinki, Finland; [Siljander, Heli; Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere 33521, Finland; [Hamalainen, Anu-Maaria] Helsinki Univ Hosp, Jorvi Hosp, Dept Pediat, Espoo 02740, Finland; [Peet, Aleksandr; Tillmann, Vallo] Univ Tartu, Dept Pediat, Tartu 51014, Estonia; [Peet, Aleksandr; Tillmann, Vallo] Tartu Univ Hosp, Tartu 51014, Estonia; [Uibo, Raivo] Univ Tartu, Ctr Excellence Translat Med, Inst Biomed & Translat Med, Dept Immunol, Tartu 50411, Estonia; [Mokurov, Sergei] Minist Hlth & Social Dev, Lenin St 6, Petrozavodsk 185035, Russia; [Dorshakova, Natalya] Petrozavodsk State Univ, Dept Family Med, Lenin St 33, Petrozavodsk 185910, Russia; [Ilonen, Jorma] Univ Turku, Immunogenet Lab, FIN-20520 Turku, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio 70211, Finland; [Virtanen, Suvi M.] Natl Inst Hlth & Welf, Dept Hlth, Helsinki 00271, Finland; [Virtanen, Suvi M.] Univ Tampere, Sch Hlth Sci, Tampere 33014, Finland; [Virtanen, Suvi M.] Tampere Univ Hosp, Pirkanmaa Hosp Dist, Sci Ctr, Tampere 33521, Finland; [Virtanen, Suvi M.] Tampere Univ Hosp, Res Ctr Child Hlth, Sci Ctr, Tampere 33521, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki 00290, Finland; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Aalto University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Novartis; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Tartu; University of Tartu; Ministry of Health of the Russian Federation; Petrozavodsk State University; University of Turku; University of Eastern Finland; Finland National Institute for Health & Welfare; Tampere University; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Folkhalsan Research Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	xavier@molbio.mgh.harvard.edu	Tillmann, Vallo/G-8118-2012; Virtanen, Suvi/AAP-1922-2021; Yassour, Moran/ABE-7415-2020; Gevers, Dirk/C-1451-2009; Vatanen, Tommi/J-5458-2018; Knip, Mikael/AAL-3773-2020; Peet, Aleksandr/H-6114-2018; Kolde, Raivo/AAB-8149-2022	Tillmann, Vallo/0000-0002-5279-4493; Yassour, Moran/0000-0002-7344-5188; Vatanen, Tommi/0000-0003-0949-1291; Kolde, Raivo/0000-0003-2886-6298; Arthur, Timothy/0000-0002-3393-1691; Knip, Mikael/0000-0003-0474-0033; Dorshakova, Natalia/0000-0003-1072-9164; Uibo, Raivo/0000-0002-2298-1300; Kostic, Aleksandar/0000-0002-0837-4360; Ilonen, Jorma/0000-0002-9973-2062; Virtanen, Suvi/0000-0001-8928-0878	JDRF; Hecse (Helsinki Doctoral Programme in Computer Science); Academy of Finland Center of Excellence in Systems Immunology and Physiology Research; European Union [202063]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research [250114]; NIH [U54 DK102557, R01 DK092405, P30 DK043351]; Leona M. and Harry B. Helmsley Charitable Trust; Center for Microbiome Informatics and Therapeutics at MIT; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092405, P30DK043351, U54DK102557] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); Hecse (Helsinki Doctoral Programme in Computer Science); Academy of Finland Center of Excellence in Systems Immunology and Physiology Research(Academy of Finland); European Union(European Commission); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Center for Microbiome Informatics and Therapeutics at MIT; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Tiffany Poon and Scott Steelman (Broad Institute) for help in sequence production and sample management, Leon Murphy (Novartis) for help with experimental design, Katriina Koski and Matti Koski (University of Helsinki) for the coordination and database work in the DIABIMMUNE study, Chengwei Luo (Broad Institute) for help in the strain analysis, and Natalia Nedelsky (Massachusetts General Hospital) for editorial help in writing and figure generation. T.V. was supported by funding from JDRF and Hecse (Helsinki Doctoral Programme in Computer Science). H.L. and T.V. were supported by funding from the Academy of Finland Center of Excellence in Systems Immunology and Physiology Research. A.D.K received support as the Merck Fellow of the Helen Hay Whitney Foundation and as the Lawrence H. Summers Fellow of the Broad Institute. M.K. was supported by the European Union Seventh Framework Programme FP7/2007-2013 (202063) and the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (250114). R.J.X. was supported by funding from JDRF, grants from the NIH (U54 DK102557, R01 DK092405, and P30 DK043351), funding from the Leona M. and Harry B. Helmsley Charitable Trust, and funding from the Center for Microbiome Informatics and Therapeutics at MIT.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Bach JF, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007799; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Davis-Richardson AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00678; Gulden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075385; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOFSTAD T, 1977, ACTA PATH MICRO IM B, V85, P262; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Kallionpaa H, 2014, CLIN IMMUNOL, V155, P136, DOI 10.1016/j.clim.2014.09.009; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kondrashova A, 2008, ANN MED, V40, P223, DOI 10.1080/07853890701678689; Kondrashova A, 2008, J CLIN ENDOCR METAB, V93, P729, DOI 10.1210/jc.2007-1644; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Larizza D, 2012, AUTOIMMUNITY, V45, P470, DOI 10.3109/08916934.2012.697594; LoCascio RG, 2009, MICROB BIOTECHNOL, V2, P333, DOI 10.1111/j.1751-7915.2008.00072.x; Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Peet A, 2012, DIABETES-METAB RES, V28, P455, DOI 10.1002/dmrr.2303; Sai P, 1996, DIABETES METAB, V22, P341; Seiskari T, 2007, CLIN EXP IMMUNOL, V148, P47, DOI 10.1111/j.1365-2249.2007.03333.x; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Teeaar T, 2010, PEDIATR DIABETES, V11, P107, DOI 10.1111/j.1399-5448.2009.00535.x; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Voor T, 2005, CLIN EXP ALLERGY, V35, P153, DOI 10.1111/j.1365-2222.2005.02157.x; WATSON DW, 1963, J EXP MED, V118, P425, DOI 10.1084/jem.118.3.425; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600	42	574	587	19	197	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					842	853		10.1016/j.cell.2016.04.007	http://dx.doi.org/10.1016/j.cell.2016.04.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27133167	Green Accepted, Bronze			2022-12-28	WOS:000375800300013
J	Crampton, J				Crampton, John			Philip Edward Jones OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		JONES PE, PUBLICATION LIST, P6687	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353									10.1136/bmj.i2538	http://dx.doi.org/10.1136/bmj.i2538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27147279				2022-12-28	WOS:000375575500017
J	Merten, M				Merten, Martina			India, Pakistan, and polio	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												info@martina-merten.de						Rotary International's India National PolioPlus Society, ROT END POL NOW CAMP, P8; The United Nations Children's Fund (UNICEF), 2014, IND STOR TRIUMPH POL, P6	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353								i2417	10.1136/bmj.i2417	http://dx.doi.org/10.1136/bmj.i2417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27146842				2022-12-28	WOS:000375575500004
J	Hu, LT				Hu, Linden T.			Lyme Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; TICK BITES; ANTIBIOTIC-TREATMENT; PERSISTENT SYMPTOMS; COST-EFFECTIVENESS; ORAL DOXYCYCLINE; CONTROLLED-TRIAL; PREVENTION; PROPHYLAXIS						Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558				AGRE F, 1993, AM J DIS CHILD, V147, P945, DOI 10.1001/archpedi.1993.02160330035013; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Bremell D, 2014, EUR J NEUROL, V21, P1162, DOI 10.1111/ene.12420; Burke GS, 2005, EMERG INFECT DIS, V11, P36; CAMPBELL GL, 1995, J INFECT DIS, V172, P470, DOI 10.1093/infdis/172.2.470; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; COSTELLO CM, 1989, J INFECT DIS, V159, P136, DOI 10.1093/infdis/159.1.136; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Felz MW, 1999, ARCH DERMATOL, V135, P1317, DOI 10.1001/archderm.135.11.1317; Hinckley AF, 2016, J INFECT DIS; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Kaplan RF, 2003, NEUROLOGY, V60, P1916, DOI 10.1212/01.WNL.0000068030.26992.25; Kirkland KB, 1997, ARCH INTERN MED, V157, P2635, DOI 10.1001/archinte.157.22.2635; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Ljostad U, 2008, LANCET NEUROL, V7, P690, DOI 10.1016/S1474-4422(08)70119-4; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; Nadelman RB, 2012, NEW ENGL J MED, V367, P1883, DOI 10.1056/NEJMoa1114362; Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Piesman J, 2012, TICKS TICK-BORNE DIS, V3, P193, DOI 10.1016/j.ttbdis.2012.01.001; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Pritt BS, 2016, LANCET INFECT DIS; Ramsey AH, 2004, ANN FAM MED, V2, P341, DOI 10.1370/afm.117; Schutzer SE, 2013, EMERG INFECT DIS, V19, P815, DOI 10.3201/eid1905.120796; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; SHAPIRO ED, 1992, NEW ENGL J MED, V327, P1769, DOI 10.1056/NEJM199212173272501; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Tugwell P, 1997, ANN INTERN MED, V127, P1109, DOI 10.7326/0003-4819-127-12-199712150-00011; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wang TJ, 2000, CLIN INFECT DIS, V31, P1149, DOI 10.1086/317465; Warshafsky S, 1996, J GEN INTERN MED, V11, P329, DOI 10.1007/BF02600042; Wormser GP, 2008, CLIN INFECT DIS, V47, P910, DOI 10.1086/591529; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2013, J CLIN MICROBIOL, V51, P4045, DOI 10.1128/JCM.01853-13	49	23	23	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					ITC65	ITC79		10.7326/AITC201605030	http://dx.doi.org/10.7326/AITC201605030			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136224				2022-12-28	WOS:000375744000003
J	Tate, M; Dubrey, S				Tate, Mathew; Dubrey, Simon			What is the diagnosis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tate, Mathew; Dubrey, Simon] Hillingdon Hosp, Dept Cardiol, Uxbridge, Middx, England		Dubrey, S (corresponding author), Hillingdon Hosp, Dept Cardiol, Uxbridge, Middx, England.	simon.dubrey@thh.nhs.uk						Berger FH, 2015, RADIOL MED, V120, P118, DOI 10.1007/s11547-014-0458-0; Pinto A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130500; Rousset P, 2013, EUR RADIOL, V23, P2146, DOI 10.1007/s00330-013-2798-x; Schulz B, 2014, CLIN RADIOL, V69, pE525, DOI 10.1016/j.crad.2014.08.019	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2394	10.1136/bmj.i2394	http://dx.doi.org/10.1136/bmj.i2394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130627				2022-12-28	WOS:000375484100004
J	El-Showk, S				El-Showk, Sedeer			A 21ST CENTURY TRANSFORMATION	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S4	S9		10.1038/532S4a	http://dx.doi.org/10.1038/532S4a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27135098	Bronze			2022-12-28	WOS:000374815900001
J	Vera-Kellet, C; Del Barrio-Diaz, P				Vera-Kellet, Cristian; Del Barrio-Diaz, Pablo			Oral Amalgam Tattoo Mimicking Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vera-Kellet, Cristian; Del Barrio-Diaz, Pablo] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile	Pontificia Universidad Catolica de Chile	Vera-Kellet, C (corresponding author), Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile.	cvera@med.puc.cl	Vera, Cristian/ABB-9454-2021	Vera, Cristian/0000-0001-8697-9245					0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					E21	E21		10.1056/NEJMicm1510216	http://dx.doi.org/10.1056/NEJMicm1510216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	27119254				2022-12-28	WOS:000374843400001
J	[Anonymous]				[Anonymous]			A GUIDE TO THE NATURE INDEX	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S24	S24						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27135103				2022-12-28	WOS:000374815900006
J	Palmer, MC; Deroba, JJ; Legault, CM; Brooks, EN				Palmer, Michael C.; Deroba, Jonathan J.; Legault, Christopher M.; Brooks, Elizabeth N.			Comment on "Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery'	SCIENCE			English	Editorial Material								Pershing et al. (Reports, 13 November, p. 809) concluded that failure to account for temperature in the assessment and management of Gulf of Maine Atlantic cod caused overfishing. We argue that the "extra mortality" calculation driving this conclusion is an artifact. Environmental factors affect all stocks, but attribution of additional mortality to temperature alone by Pershing et al. is unsupported by the data.	[Palmer, Michael C.; Deroba, Jonathan J.; Legault, Christopher M.; Brooks, Elizabeth N.] Northeast Fisheries Sci Ctr, Populat Dynam Branch, 166 Water St, Woods Hole, MA 02543 USA		Palmer, MC (corresponding author), Northeast Fisheries Sci Ctr, Populat Dynam Branch, 166 Water St, Woods Hole, MA 02543 USA.	michael.palmer@noaa.gov	Brooks, ELIZABETH/AAD-2502-2020	Legault, Christopher/0000-0002-0328-1376; Cadigan, Noel/0000-0002-5922-1014; Brooks, Elizabeth N/0000-0002-9142-4372				Brooks EN, 2015, CAN J FISH AQUAT SCI, V72, P634, DOI 10.1139/cjfas-2014-0231; MILLER RG, 1974, BIOMETRIKA, V61, P1; NOAA Fisheries Toolbox, 2008, NOAA FISHERIES TOOLB; Palmer M. C., 2014, 2014 ASSESSMENT UPDA; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; WALTERS CJ, 1988, CAN J FISH AQUAT SCI, V45, P1848, DOI 10.1139/f88-217	6	13	13	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284								10.1126/science.aad9674	http://dx.doi.org/10.1126/science.aad9674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102473				2022-12-28	WOS:000374479700034
J	Schmied, R; Bancal, JD; Allard, B; Fadel, M; Scarani, V; Treutlein, P; Sangouard, N				Schmied, Roman; Bancal, Jean-Daniel; Allard, Baptiste; Fadel, Matteo; Scarani, Valerio; Treutlein, Philipp; Sangouard, Nicolas			Bell correlations in a Bose-Einstein condensate	SCIENCE			English	Article							ATOM-CHIP; ENTANGLEMENT; STATES; INEQUALITY; NONLOCALITY; PHYSICS; THEOREM	Characterizing many-body systems through the quantum correlations between their constituent particles is a major goal of quantum physics. Although entanglement is routinely observed in many systems, we report here the detection of stronger correlations-Bell correlations-between the spins of about 480 atoms in a Bose-Einstein condensate. We derive a Bell correlation witness from a many-particle Bell inequality involving only one-and two-body correlation functions. Our measurement on a spin-squeezed state exceeds the threshold for Bell correlations by 3.8 standard deviations. Our work shows that the strongest possible nonclassical correlations are experimentally accessible in many-body systems and that they can be revealed by collective measurements.	[Schmied, Roman; Allard, Baptiste; Fadel, Matteo; Treutlein, Philipp] Univ Basel, Dept Phys, Quantum Atom Opt Lab, Klingelbergstr 82, CH-4056 Basel, Switzerland; [Bancal, Jean-Daniel; Scarani, Valerio] Natl Univ Singapore, Ctr Quantum Technol, 3 Sci Dr 2, Singapore 117543, Singapore; [Scarani, Valerio] Natl Univ Singapore, Dept Phys, 2 Sci Dr 3, Singapore 117542, Singapore; [Bancal, Jean-Daniel; Sangouard, Nicolas] Univ Basel, Dept Phys, Quantum Opt Theory Grp, Klingelbergstr 82, CH-4056 Basel, Switzerland	University of Basel; National University of Singapore; National University of Singapore; University of Basel	Treutlein, P (corresponding author), Univ Basel, Dept Phys, Quantum Atom Opt Lab, Klingelbergstr 82, CH-4056 Basel, Switzerland.; Sangouard, N (corresponding author), Univ Basel, Dept Phys, Quantum Opt Theory Grp, Klingelbergstr 82, CH-4056 Basel, Switzerland.	philipp.treutlein@unibas.ch; nicolas.sangouard@unibas.ch	Scarani, Valerio/G-1109-2012; Treutlein, Philipp/H-6158-2012	Scarani, Valerio/0000-0001-5594-5616; Treutlein, Philipp/0000-0001-9025-9574; Schmied, Roman/0000-0001-5713-5262	Spain's Ministerio de Economia y Competitividad [MAT2013-41636-P, CSD2010-00024, PCIN-2015-030, FIS2013-47328, FIS2012-37549-C05-03]; European Union structural funds; Comunidad de Madrid MAD2D-CM program [S2013/MIT-3007, P2013/MIT-2850]; Generalitat Valenciana [PROMETEO/2012/011]; CNRS PICS [6182]; European Union [604391]; FLAG-ERA programs	Spain's Ministerio de Economia y Competitividad(Spanish Government); European Union structural funds(European Commission); Comunidad de Madrid MAD2D-CM program(Comunidad de Madrid); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CNRS PICS(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); FLAG-ERA programs	We thank V. Cherkez (Institut NEEL, CNRS, and Universite Grenoble Alpes) for his help with the fabrication of samples of graphene grown on SiC, and we thank D. Wong (University of California-Berkeley) for his careful reading of the manuscript. This work was supported by Spain's Ministerio de Economia y Competitividad under grant nos. MAT2013-41636-P, CSD2010-00024, PCIN-2015-030, FIS2013-47328, and FIS2012-37549-C05-03; the European Union structural funds and the Comunidad de Madrid MAD2D-CM program under grant nos. S2013/MIT-3007 and P2013/MIT-2850; the Generalitat Valenciana under grant no. PROMETEO/2012/011; THE CNRS PICS (Projets Internationaux de Cooperation Scientifique) program under grant no. 6182; and the European Union FP7 (7th Framework Programme for Research and Technological Development) Graphene Flagship (grant 604391) and FLAG-ERA programs. The authors acknowledge the computer resources and assistance provided by the Centro de Computacion Cientifica of the Universidad Autonoma de Madrid.	Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Bancal JD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.250404; Bancal JD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090503; Bell J. S., 1990, SCI TECHNOL; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bohi P, 2009, NAT PHYS, V5, P592, DOI 10.1038/NPHYS1329; Brunner N, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.419; Curchod FJ, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.012121; DRUMMOND PD, 1983, PHYS REV LETT, V50, P1407, DOI 10.1103/PhysRevLett.50.1407; Eibl M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.200403; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; Hyllus P, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012337; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Lanyon BP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.100403; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.250801; Louchet-Chauvet A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065032; Ockeloen CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.143001; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Pironio S, 2010, NATURE, V464, P1021, DOI 10.1038/nature09008; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Scarani V, 2012, ACTA PHYS SLOVACA, V62, P347, DOI 10.2478/v10155-012-0003-4; Schmied R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/065019; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; SVETLICHNY G, 1987, PHYS REV D, V35, P3066, DOI 10.1103/PhysRevD.35.3066; Tura J, 2014, SCIENCE, V344, P1256, DOI 10.1126/science.1247715; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; Zhao Z, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.180401; Zukowski M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.210401	31	107	107	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					441	444		10.1126/science.aad8665	http://dx.doi.org/10.1126/science.aad8665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102479	Green Submitted			2022-12-28	WOS:000374479700042
J	Basiri, ML; Stuber, GD				Basiri, Marcus L.; Stuber, Garret D.			Multimodal Signal Integration for Feeding Control	CELL			English	Editorial Material							DROSOPHILA; TASTE; MAMMALS; BRAIN	Feeding is arguably one of the most well-conserved and important adaptive behaviors across all species. In this issue of Cell, Yapici et al. use a novel real-time feeding assay in Drosophila flies to identify a neural circuit that integrates gustatory input and hunger state to modulate food ingestion.	[Basiri, Marcus L.; Stuber, Garret D.] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA.; Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.; Stuber, GD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Stuber, GD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855				Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Yapici N, 2016, CELL, V165, P715, DOI 10.1016/j.cell.2016.02.061; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	10	2	3	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					522	523		10.1016/j.cell.2016.04.022	http://dx.doi.org/10.1016/j.cell.2016.04.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104975	Bronze			2022-12-28	WOS:000374636800012
J	Hillman, SC; Stokes-Lampard, H; Kilby, MD				Hillman, Sarah C.; Stokes-Lampard, Helen; Kilby, Mark D.			EASILY MISSED? Intrahepatic cholestasis of pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OBSTETRIC CHOLESTASIS; URSODEOXYCHOLIC ACID; MANAGEMENT; SERIES		[Hillman, Sarah C.; Kilby, Mark D.] Univ Birmingham, Coll Med Sci, Inst Metab & Syst Res, Ctr Womens & New Born Hlth, Birmingham B15 2TT, W Midlands, England; [Hillman, Sarah C.; Stokes-Lampard, Helen] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Kilby, Mark D.] Birmingham Womens Fdn Trust, Fetal Med Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Hillman, SC (corresponding author), Univ Birmingham, Coll Med Sci, Inst Metab & Syst Res, Ctr Womens & New Born Hlth, Birmingham B15 2TT, W Midlands, England.; Hillman, SC (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	sarahchillman@hotmail.com	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; hillman, sarah/0000-0002-3560-2074				Ambros-Rudolph CM, 2007, ARCH DERMATOL, V143, P757, DOI 10.1001/archderm.143.6.757; Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Kenyon AP, 2002, BJOG-INT J OBSTET GY, V109, P282, DOI 10.1111/j.1471-0528.2002.01368.x; Kenyon AP, 2001, BRIT J OBSTET GYNAEC, V108, P1190, DOI 10.1111/j.1471-0528.2003.00281.x; L Brouwers, 2015, PLOS MED, V212, pe1, DOI DOI 10.1016/J.AJ0G.2014.07.026.25046809; Lammert F, 2000, J HEPATOL, V33, P1012, DOI 10.1016/S0168-8278(00)80139-7; Lee RH, 2008, AM J PERINAT, V25, P341, DOI 10.1055/s-2008-1078756; Marschall HU, 2013, HEPATOLOGY, V58, P1385, DOI 10.1002/hep.26444; Royal College of Obstetricians and Gynaecologists, 2011, OBST CHOL GREEN TOP	12	3	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2016	353								i1236	10.1136/bmj.i1236	http://dx.doi.org/10.1136/bmj.i1236			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZJ	27103313				2022-12-28	WOS:000374999500001
J	Marjanovic, G; Hoeppner, J				Marjanovic, Goran; Hoeppner, Jens			Esophagogastric Bypass in Motion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marjanovic, Goran; Hoeppner, Jens] Univ Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany	University of Freiburg	Marjanovic, G (corresponding author), Univ Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	goran.marjanovic@uniklinik-freiburg.de		Hoeppner, Jens/0000-0002-3485-7446					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					E20	E20		10.1056/NEJMicm1509754	http://dx.doi.org/10.1056/NEJMicm1509754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	27096599				2022-12-28	WOS:000374383900011
J	Rajasethupathy, P; Ferenczi, E; Deisseroth, K				Rajasethupathy, Priyamvada; Ferenczi, Emily; Deisseroth, Karl			Targeting Neural Circuits	CELL			English	Review							DEEP-BRAIN-STIMULATION; PRIMARY SOMATOSENSORY CORTEX; IN-VIVO; OPTOGENETIC CONTROL; CELLULAR-RESOLUTION; FOCUSED ULTRASOUND; NEURONAL-ACTIVITY; CHLORIDE CHANNEL; INTACT-TISSUE; MOUSE-BRAIN	Optogenetic methodology enables direct targeting of specific neural circuit elements for inhibition or excitation while spanning timescales from the acute (milliseconds) to the chronic (many days or more). Although the impact of this temporal versatility and cellular specificity has been greater for basic science than clinical research, it is natural to ask whether the dynamic patterns of neural circuit activity discovered to be causal in adaptive or maladaptive behaviors could become targets for treatment of neuropsychiatric diseases. Here, we consider the landscape of ideas related to therapeutic targeting of circuit dynamics. Specifically, we highlight optical, ultrasonic, and magnetic concepts for the targeted control of neural activity, preclinical/clinical discovery opportunities, and recently reported optogenetically guided clinical outcomes.	[Rajasethupathy, Priyamvada; Ferenczi, Emily; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	deissero@stanford.edu			NIMH; NIDA; NSF; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Defense Advanced Research Projects Agency [W911NF-14-2-0013]; US Army Research Laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH109652] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Deisseroth lab for discussions and Lief Fenno for helpful comments on the manuscript. P.R. is an Ellison Fellow of the Life Sciences Foundation, and E.F. is a Gerald J Lieberman fellow. K.D. was supported by NIMH, NIDA, NSF, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H.L. Snyder Medical Foundation, the Samuel and Betsy Reeves Fund, and the US Army Research Laboratory and Defense Advanced Research Projects Agency (Cooperative Agreement Number W911NF-14-2-0013); nothing in this material represents official views or policies of our funders. K.D. is a founder and Scientific Advisory Board member for Circuit Therapeutics, a startup company seeking to develop optogenetic and pharmacological strategies for controlling chronic pain and other nervous system disease states, with intellectual property relating to clinical interventions. All tools and reagents described above generated by the authors are freely available upon request (www.optogenetics.org).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2015, SCIENCE, V349, P590, DOI 10.1126/science.aac7889; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Blumenfeld Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121067; Brittain JS, 2013, CURR BIOL, V23, P436, DOI 10.1016/j.cub.2013.01.068; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cosentino C, 2015, SCIENCE, V348, P707, DOI 10.1126/science.aaa2787; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Ferenczi E, 2016, NAT NEUROSCI, V19, P414, DOI 10.1038/nn.4232; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Fontaine D, 2013, J ALZHEIMERS DIS, V34, P315, DOI 10.3233/JAD-121579; Gerits A, 2012, CURR BIOL, V22, P1722, DOI 10.1016/j.cub.2012.07.023; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hodgson K, 2016, EUR NEUROPSYCHOPHARM, V26, P105, DOI 10.1016/j.euroneuro.2015.10.009; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; Ibsen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9264; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jeong JW, 2015, CELL, V162, P662, DOI 10.1016/j.cell.2015.06.058; Khraiche ML, 2008, IEEE ENG MED BIO, P4246, DOI 10.1109/IEMBS.2008.4650147; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; King RL, 2013, ULTRASOUND MED BIOL, V39, P312, DOI 10.1016/j.ultrasmedbio.2012.09.009; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Koester SE, 2016, MOL PSYCHIATR, V21, P448, DOI 10.1038/mp.2015.226; Krook-Magnuson E, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0005-14.2014; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Le Clerc S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.97; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08743; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Long XY, 2015, SCI BULL, V60, P2107, DOI 10.1007/s11434-015-0902-0; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; Meister M., 2016, ARXIV160401359V1; Menz MD, 2013, J NEUROSCI, V33, P4550, DOI 10.1523/JNEUROSCI.3521-12.2013; Montgomery KL, 2015, NAT METHODS, V12, P969, DOI [10.1038/NMETH.3536, 10.1038/nmeth.3536]; Moore ME, 2015, NEUROSCI LETT, V604, P183, DOI 10.1016/j.neulet.2015.07.024; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Peterson SC, 2015, CELL STEM CELL, V16, P400, DOI 10.1016/j.stem.2015.02.006; Qin SY, 2016, NAT MATER, V15, P217, DOI [10.1038/NMAT4484, 10.1038/nmat4484]; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schulz D, 2011, NAT METHODS, V8, P347, DOI [10.1038/nmeth.1582, 10.1038/NMETH.1582]; Shen Y., 2016, BIOL PSYCHIAT; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stanley SA, 2016, NATURE, V531, P647, DOI 10.1038/nature17183; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Stopczynski RE, 2014, CANCER RES, V74, P1718, DOI 10.1158/0008-5472.CAN-13-2050; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Sylwestrak EL, 2016, CELL, V164, P792, DOI 10.1016/j.cell.2016.01.038; Terraneo A, 2016, EUR NEUROPSYCHOPHARM, V26, P37, DOI 10.1016/j.euroneuro.2015.11.011; Tomer R, 2015, CELL, V163, P1796, DOI 10.1016/j.cell.2015.11.061; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Trivedi MH, 2016, J PSYCHIATR RES, V78, P11, DOI 10.1016/j.jpsychires.2016.03.001; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Wheeler M. A., 2016, NAT NEUROSCI; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058; Zalocusky KA, 2016, NATURE, V531, P642, DOI 10.1038/nature17400; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	102	101	105	11	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					524	534		10.1016/j.cell.2016.03.047	http://dx.doi.org/10.1016/j.cell.2016.03.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104976	Green Accepted, Bronze			2022-12-28	WOS:000374636800013
J	Stein, SL; Cifu, AS				Stein, Sarah L.; Cifu, Adam S.			Management of Atopic Dermatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ECZEMA PREVALENCE; TOPICAL THERAPIES; HEALTH		[Stein, Sarah L.] Univ Chicago, Dermatol Sect, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Sect Gen Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Ashcroft DM, 2005, BMJ-BRIT MED J, V330, P516, DOI 10.1136/bmj.38376.439653.D3; Callen J, 2007, BRIT J DERMATOL, V156, P203, DOI 10.1111/j.1365-2133.2006.07538.x; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031	9	12	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1510	1511		10.1001/jama.2016.1459	http://dx.doi.org/10.1001/jama.2016.1459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115267				2022-12-28	WOS:000373873800017
J	Zawertailo, L				Zawertailo, Laurie			Safety of smoking cessation drugs for mentally ill patients	LANCET			English	Editorial Material							VARENICLINE		[Zawertailo, Laurie] Univ Toronto, Ctr Addict & Mental Hlth, Dept Pharmacol & Toxicol, Fac Med, 175 Coll St, Toronto, ON MST 1P7, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Zawertailo, L (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Dept Pharmacol & Toxicol, Fac Med, 175 Coll St, Toronto, ON MST 1P7, Canada.	laurie.zawertailo@camh.ca	Zawertailo, Laurie/L-2809-2019					Anthenelli RM, 2016, LANCET, V387, P2507, DOI 10.1016/S0140-6736(16)30272-0; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hurt RD, 1996, JAMA-J AM MED ASSOC, V275, P1097, DOI 10.1001/jama.275.14.1097; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Pfizer Canada Inc, 2016, PROD MON CHAMP VAR T; Thomas KH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1109; US Food and Drug Administration, 2014, CHANT SER NEUR ADV E; Valeant Canada, 2016, PROD MON ZYB BUPR HC; Wu Q, 2016, ADDICTION, V111, P1554, DOI 10.1111/add.13415	11	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2481	2482		10.1016/S0140-6736(16)30294-X	http://dx.doi.org/10.1016/S0140-6736(16)30294-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27116919				2022-12-28	WOS:000377947200004
J	Kracher, D; Scheiblbrandner, S; Felice, AKG; Breslmayr, E; Preims, M; Ludwicka, K; Haltrich, D; Eijsink, VGH; Ludwig, R				Kracher, Daniel; Scheiblbrandner, Stefan; Felice, Alfons K. G.; Breslmayr, Erik; Preims, Marita; Ludwicka, Karolina; Haltrich, Dietmar; Eijsink, Vincent G. H.; Ludwig, Roland			Extracellular electron transfer systems fuel cellulose oxidative degradation	SCIENCE			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASE; CELL WALL DEGRADATION; NEUROSPORA-CRASSA; CELLOBIOSE DEHYDROGENASE; BROWN-ROT; LIGNIN; BIOMASS; METALLOENZYME; CELLULASES; MECHANISMS	Ninety percent of lignocellulose-degrading fungi contain genes encoding lytic polysaccharide monooxygenases (LPMOs). These enzymes catalyze the initial oxidative cleavage of recalcitrant polysaccharides after activation by an electron donor. Understanding the source of electrons is fundamental to fungal physiology and will also help with the exploitation of LPMOs for biomass processing. Using genome data and biochemical methods, we characterized and compared different extracellular electron sources for LPMOs: cellobiose dehydrogenase, phenols procured from plant biomass or produced by fungi, and glucose-methanol-choline oxidoreductases that regenerate LPMO-reducing diphenols. Our data demonstrate that all three of these electron transfer systems are functional and that their relative importance during cellulose degradation depends on fungal lifestyle. The availability of extracellular electron donors is required to activate fungal oxidative attack on polysaccharides.	[Kracher, Daniel; Scheiblbrandner, Stefan; Felice, Alfons K. G.; Breslmayr, Erik; Preims, Marita; Ludwicka, Karolina; Haltrich, Dietmar; Ludwig, Roland] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria; [Ludwicka, Karolina] Lodz Univ Technol, Inst Tech Biochem, Stefanowskiego 4-10, PL-90924 Lodz, Poland; [Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Natural Resources & Life Sciences, Vienna; Lodz University of Technology; Norwegian University of Life Sciences	Ludwig, R (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria.	roland.ludwig@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Kracher, Daniel/H-6667-2019; Ludwicka, Karolina/M-3610-2018	Haltrich, Dietmar/0000-0002-8722-8176; Kracher, Daniel/0000-0002-3856-3170; Ludwicka, Karolina/0000-0001-5403-7640; Ludwig, Roland/0000-0002-5058-5874; Scheiblbrandner, Stefan/0000-0002-9858-1637; Breslmayr, Erik/0000-0002-4601-5895	European Commission [FP7-KBBE-2013-7-613549]; Austrian Science Fund (project BioToP) [FWF W1224]; BMWFW (Austrian Federal Ministry of Science, Research and Economy) IGS BioNanoTech; Austrian Academy of Sciences	European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (project BioToP)(Austrian Science Fund (FWF)); BMWFW (Austrian Federal Ministry of Science, Research and Economy) IGS BioNanoTech; Austrian Academy of Sciences	This work was supported by the European Commission (project INDOX FP7-KBBE-2013-7-613549). D.K., M.P., and E.B. acknowledge support from the Austrian Science Fund (project BioToP; grant FWF W1224); S.S. acknowledges support from the BMWFW (Austrian Federal Ministry of Science, Research and Economy) IGS BioNanoTech; and A.K.G.F. acknowledges support from the Austrian Academy of Sciences (doctoral grant recipient). We thank C. Lorenz for technical assistance, M. Ravber for his generous gift of beech wood (hot water) extracts, and C. Keuschnig for discussing statistical topics. Data are available in the Knowledge Network for Biocomplexity data repository at http://doi.org/10.5063/F1086389.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Arantes V, 2014, ACS SYM SER, V1158, P3; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Cannella D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11134; Cragg SM, 2015, CURR OPIN CHEM BIOL, V29, P108, DOI 10.1016/j.cbpa.2015.10.018; Dimarogona M, 2012, BIORESOURCE TECHNOL, V110, P480, DOI 10.1016/j.biortech.2012.01.116; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; GREEN TR, 1977, NATURE, V268, P78, DOI 10.1038/268078a0; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Makela MR, 2015, ADV APPL MICROBIOL, V91, P63, DOI 10.1016/bs.aambs.2014.12.001; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Phillips CM, 2011, J PROTEOME RES, V10, P4177, DOI 10.1021/pr200329b; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Suzuki MR, 2006, ENVIRON MICROBIOL, V8, P2214, DOI 10.1111/j.1462-2920.2006.01160.x; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Takeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115722; Tan TC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8542; Thomson R. H., 1971, NATURALLY OCCURRING, P1; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561; WOOD PM, 1994, FEMS MICROBIOL REV, V13, P313, DOI 10.1016/0168-6445(94)90088-4; Yoshida M, 2005, APPL ENVIRON MICROB, V71, P4548, DOI 10.1128/AEM.71.8.4548-4555.2005	32	243	247	20	502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1098	1101		10.1126/science.aaf3165	http://dx.doi.org/10.1126/science.aaf3165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27127235				2022-12-28	WOS:000376480800038
J	Rialdi, A; Campisi, L; Zhao, N; Lagda, AC; Pietzsch, C; Ho, JSY; Martinez-Gil, L; Fenouil, R; Chen, XT; Edwards, M; Metreveli, G; Jordan, S; Peralta, Z; Munoz-Fontela, C; Bouvier, N; Merad, M; Jin, J; Weirauch, M; Heinz, S; Benner, C; Van Bakel, H; Basler, C; Garcia-Sastre, A; Bukreyev, A; Marazzi, I				Rialdi, Alex; Campisi, Laura; Zhao, Nan; Lagda, Arvin Cesar; Pietzsch, Colette; Ho, Jessica Sook Yuin; Martinez-Gil, Luis; Fenouil, Romain; Chen, Xiaoting; Edwards, Megan; Metreveli, Giorgi; Jordan, Stefan; Peralta, Zuleyma; Munoz-Fontela, Cesar; Bouvier, Nicole; Merad, Miriam; Jin, Jian; Weirauch, Matthew; Heinz, Sven; Benner, Chris; Van Bakel, Harm; Basler, Christopher; Garcia-Sastre, Adolfo; Bukreyev, Alexander; Marazzi, Ivan			Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation	SCIENCE			English	Article							RNA-POLYMERASE-II; CPG ISLANDS; RIG-I; TRANSCRIPTION; VIRUS; CAMPTOTHECIN; INFLUENZA; EXPRESSION; DISEASE; BROMODOMAINS		[Rialdi, Alex; Campisi, Laura; Zhao, Nan; Lagda, Arvin Cesar; Martinez-Gil, Luis; Edwards, Megan; Metreveli, Giorgi; Bouvier, Nicole; Basler, Christopher; Garcia-Sastre, Adolfo; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Rialdi, Alex; Campisi, Laura; Zhao, Nan; Lagda, Arvin Cesar; Metreveli, Giorgi; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Pietzsch, Colette; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol Microbiol & Immunol, Galveston, TX 77555 USA; [Ho, Jessica Sook Yuin] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Methyltransferases Dev & Dis, 10 Kent Ridge Crescent, Singapore 117548, Singapore; [Martinez-Gil, Luis] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Fenouil, Romain; Peralta, Zuleyma; Van Bakel, Harm] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Chen, Xiaoting; Weirauch, Matthew] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Chen, Xiaoting; Weirauch, Matthew] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Chen, Xiaoting; Weirauch, Matthew] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Jordan, Stefan; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Jordan, Stefan; Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, Dept Oncol Sci, New York, NY 10029 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Heinz, Sven] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Heinz, Sven; Benner, Chris] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Valencia; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Heinrich Pette Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; Salk Institute	Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.	ivan.marazzi@mssm.edu	Jordan, Stefan/G-6243-2011; van Bakel, Harm/N-9561-2017; Campisi, Laura/AAL-2064-2021; Weirauch, Matthew/M-5459-2019; Jordan, Stefan/AAH-8261-2021; Basler, Christopher/AAG-8346-2019; ZHAO, NAN/H-7633-2017; Martinez-Gil, Luis/M-7422-2014; Jordan, Stefan/AAI-1073-2021	Jordan, Stefan/0000-0001-9330-1715; van Bakel, Harm/0000-0002-1376-6916; Campisi, Laura/0000-0003-4173-4521; Jordan, Stefan/0000-0001-9330-1715; Basler, Christopher/0000-0003-4195-425X; Martinez-Gil, Luis/0000-0002-9076-7760; Jordan, Stefan/0000-0001-9330-1715; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Munoz-Fontela, Cesar/0000-0002-7725-2586; marazzi, ivan/0000-0003-3376-0922; Benner, Christopher/0000-0002-4618-0719; Ho, Jessica Sook Yuin/0000-0003-2234-2602; Heinz, Sven/0000-0002-4665-1007; Rialdi, Alexander/0000-0001-5393-9247	Center for Research on Influenza Pathogenesis (CRIP) [HHSN272201400008C]; Center of Excellence for Influenza Research and Surveillance (CEIRS) - National Institute of Allergy and Infectious Diseases; Public Health Service Institutional Research Training Award [AI07647]; Department of Defense [W911NF-14-1-0353]; NIH [U19AI106754, 1R01AN3663134, U19AI109945, U19AI109664, 1R56AI114770-01A1]; NATIONAL CANCER INSTITUTE [R01CA154947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109945, U19AI106754, R01AI113186, U19AI109664, T32AI007647, R56AI114770] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Center for Research on Influenza Pathogenesis (CRIP); Center of Excellence for Influenza Research and Surveillance (CEIRS) - National Institute of Allergy and Infectious Diseases; Public Health Service Institutional Research Training Award; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Palese for the FF-luciferase construct, chromatized cells, and Sendai virus; F. Kramer for the H3N2 virus; R. Cadagan for help with virus propagations; T. Kraus for use of the Luminex 100/200 plate reader; M. Schotsaert for help with co-infection experiments; S. Tripathi for providing IRF3 dependency data; the genomics facility at Icahn School of Medicine at Mount Sinai; Bioproximity LLC for proteomics work; J. K. Gregory for help with computer graphics; and H. Nakano for discussion about the history of Top1 inhibitors. I. Marazzi and M. Byun designed the graphical abstract illustration of the "the Vitruvian automaton"; the illustration is our homage to Marcus Vitruvius Pollio, Leonardo da Vinci, and the history of automata. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Sequencing data are available in GEO, GSE80132, and linked superseries. Supported by HHSN272201400008C-Center for Research on Influenza Pathogenesis (CRIP), a Center of Excellence for Influenza Research and Surveillance (CEIRS) funded by the National Institute of Allergy and Infectious Diseases (A.G.-S., G.M., H.v.B., and I. M.); Public Health Service Institutional Research Training Award AI07647 (A. R.); Department of Defense grant W911NF-14-1-0353 (I. M.); NIH grants U19AI106754 (I. M. and A.G.-S.), 1R01AN3663134 (I. M. and H.v.B.), U19AI109945 (A.B. and C. Basler), U19AI109664 (A.B. and C. Basler), and 1R56AI114770-01A1 (I. M.); and the computational resources and staff of the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. A patent application (62/267,608) was filed by Mount Sinai related to treatment of inflammatory diseases with Top1 inhibitors.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Atherton K. T., 1975, J GEN VIROL, V41; ATHERTON KT, 1975, J GEN VIROL, V29, P297, DOI 10.1099/0022-1317-29-3-297; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Beretta GL, 2013, CURR MED CHEM, V20, P1541; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Bray M, 2003, J INFECT DIS, V188, P1613, DOI 10.1086/379727; Chen Y, 2014, CHEM-BIOL INTERACT, V216, P17, DOI 10.1016/j.cbi.2014.03.010; Chiou WF, 2001, LIFE SCI, V69, P625, DOI 10.1016/S0024-3205(01)01154-7; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hyz K, 2010, MAGN RESON CHEM, V48, P575, DOI 10.1002/mrc.2625; Kim HK, 2014, J IMMUNOL METHODS, V410, P88, DOI 10.1016/j.jim.2014.04.007; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kohn KW, 2000, ANN NY ACAD SCI, V922, P11; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kubo I, 2010, NAT PROD COMMUN, V5, P85; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Loo YM, 2007, NATURE, V445, P267, DOI 10.1038/445267a; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Martinez-Gil L, 2013, J VIROL, V87, P1290, DOI 10.1128/JVI.02338-12; Martinez-Gil L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049049; Martinez-Sobrido L, 2010, J VIROL, V84, P2157, DOI 10.1128/JVI.01433-09; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; Miller MS, 2015, NAT IMMUNOL, V16, P485, DOI 10.1038/ni.3132; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Portales-Casamar E, 2009, NUCLEIC ACIDS RES, V37, pD54, DOI 10.1093/nar/gkn783; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Regal KM, 2014, CHEM RES TOXICOL, V27, P2044, DOI 10.1021/tx500245m; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Smith NA, 2014, BIOCHEMISTRY-US, V53, P3229, DOI 10.1021/bi500421q; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Strahle L, 2003, J VIROL, V77, P7903, DOI 10.1128/JVI.77.14.7903-7913.2003; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	70	103	108	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289							aad7993	10.1126/science.aad7993	http://dx.doi.org/10.1126/science.aad7993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27127234	Green Accepted			2022-12-28	WOS:000376480800031
J	Ahalt, C; Williams, B				Ahalt, Cyrus; Williams, Brie			Reforming Solitary-Confinement Policy - Heeding a Presidential Call to Action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ahalt, Cyrus; Williams, Brie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ahalt, C (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Ahalt C, 2015, ANN INTERN MED, V162, P345, DOI 10.7326/M14-2161; American Medical Association, PRINC MED ETH; [Anonymous], 2011, INT REP SPEC RAPP HU; Beck AJ., 2015, USE RESTRICTIVE HOUS; Shalev S., 2015, CAN J HUM RIGHTS, V4, P143	5	8	8	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1704	1706		10.1056/NEJMp1601399	http://dx.doi.org/10.1056/NEJMp1601399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL0RY	27144846	Green Published			2022-12-28	WOS:000375341500002
J	von der Wense, L; Seiferle, B; Laatiaoui, M; Neumayr, JB; Maier, HJ; Wirth, HF; Mokry, C; Runke, J; Eberhardt, K; Dullmann, CE; Trautmann, NG; Thirolf, PG				von der Wense, Lars; Seiferle, Benedict; Laatiaoui, Mustapha; Neumayr, Juergen B.; Maier, Hans-Joerg; Wirth, Hans-Friedrich; Mokry, Christoph; Runke, Joerg; Eberhardt, Klaus; Duellmann, Christoph E.; Trautmann, Norbert G.; Thirolf, Peter G.			Direct detection of the Th-229 nuclear clock transition	NATURE			English	Article							ENERGY; SEARCH; DECAY; SPECTROSCOPY; EFFICIENCY; LEVEL	Today's most precise time and frequency measurements are performed with optical atomic clocks. However, it has been proposed that they could potentially be outperformed by a nuclear clock, which employs a nuclear transition instead of an atomic shell transition. There is only one known nuclear state that could serve as a nuclear clock using currently available technology, namely, the isomeric first excited state of Th-229 (denoted Th-229m). Here we report the direct detection of this nuclear state, which is further confirmation of the existence of the isomer and lays the foundation for precise studies of its decay parameters. On the basis of this direct detection, the isomeric energy is constrained to between 6.3 and 18.3 electronvolts, and the half-life is found to be longer than 60 seconds for Th-229m(2+). More precise determinations appear to be within reach, and would pave the way to the development of a nuclear frequency standard.	[von der Wense, Lars; Seiferle, Benedict; Neumayr, Juergen B.; Maier, Hans-Joerg; Wirth, Hans-Friedrich; Thirolf, Peter G.] Univ Munich, D-85748 Garching, Germany; [Laatiaoui, Mustapha; Runke, Joerg; Duellmann, Christoph E.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Laatiaoui, Mustapha; Mokry, Christoph; Eberhardt, Klaus; Duellmann, Christoph E.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Mokry, Christoph; Runke, Joerg; Eberhardt, Klaus; Duellmann, Christoph E.; Trautmann, Norbert G.] Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany	University of Munich; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz	von der Wense, L (corresponding author), Univ Munich, D-85748 Garching, Germany.	L.Wense@physik.uni-muenchen.de	Laatiaoui, Mustapha/Q-6295-2016; Düllmann, Christoph E/L-3401-2017	Laatiaoui, Mustapha/0000-0003-0105-8303; Düllmann, Christoph E/0000-0002-1194-0423	DFG [Th956/3-1]; European Union [664732]; LMU department of Medical Physics via the Maier-Leibnitz Laboratory	DFG(German Research Foundation (DFG)); European Union(European Commission); LMU department of Medical Physics via the Maier-Leibnitz Laboratory	We acknowledge discussions with D. Habs, T. W. Hansch, T. Udem, T. Lamour, J. Weitenberg, A. Ozawa, E. Peters, J. Schreiber, P. Hilz, T. Schumm, S. Stellmer, F. Allegretti, P. Feulner, J. Crespo, M. Schwarz, L. Schmoger, P. Micke, C. Weber, P. Bolton and K. Parodi. We thank T. Lauer for the Ti sputtering of the Si wafers and the MPQ for the temporary loan of the MCP detector. We thank I. Cortrie, L. Black and J. Soll for graphic design support. This work was supported by DFG (Th956/3-1), by the European Union's Horizon 2020 research and innovation programme under grant agreement 664732 "nuClock" and by the LMU department of Medical Physics via the Maier-Leibnitz Laboratory.	Barci V, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.034329; BAY HL, 1992, APPL PHYS A-MATER, V55, P274, DOI 10.1007/BF00348397; Beck BR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.142501; Beck B. R., 2009, LLNLPROC415170; Brubaker W.M., 1968, ADV MASS SPECTROM, V4, P293; Burke DG, 2008, NUCL PHYS A, V809, P129, DOI 10.1016/j.nuclphysa.2008.06.009; BURKE DG, 1990, PHYS REV C, V42, pR499, DOI 10.1103/PhysRevC.42.R499; Burvenich TJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.142501; Campbell CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120802; Campbell CJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.223001; Flambaum VV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.092502; GORUGANTHU RR, 1984, REV SCI INSTRUM, V55, P2030, DOI 10.1063/1.1137709; Grossmann R, 1997, NUCL INSTRUM METH A, V397, P39, DOI 10.1016/S0168-9002(97)00758-4; Haettner E., 2011, THESIS U GIESSEN; Hayes AC, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.024311; HELMER RG, 1994, PHYS REV C, V49, P1845, DOI 10.1103/PhysRevC.49.1845; Hotop H., 1996, EXPT METHODS PHYSI B, V29B, P191; Irwin GM, 1997, PHYS REV LETT, V79, P990, DOI 10.1103/PhysRevLett.79.990; Jeet J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.253001; JONGMA RT, 1995, J CHEM PHYS, V102, P1925, DOI 10.1063/1.468758; Karpeshin FF, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054313; Kazakov GA, 2014, NUCL INSTRUM METH A, V735, P229, DOI 10.1016/j.nima.2013.09.012; Kazakov GA, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083019; Kramida A., NIST ATOMIC SPECTRA; KROGER LA, 1976, NUCL PHYS A, V259, P29, DOI 10.1016/0375-9474(76)90494-2; Liao WT, 2011, PHYS LETT B, V705, P134, DOI 10.1016/j.physletb.2011.09.107; Litvinova E, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.064303; MAIER HJ, 1991, NUCL INSTRUM METH B, V56-7, P926, DOI 10.1016/0168-583X(91)95064-K; MARTENSSON N, 1994, J ELECTRON SPECTROSC, V70, P117, DOI 10.1016/0368-2048(94)02224-N; Matinyan S, 1998, PHYS REP, V298, P200; Neumayr JB, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2213154; Neumayr J. B., 2004, THESIS U MUNICH; Nicholson TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7896; PALMBERG PW, 1968, APPL PHYS LETT, V13, P183, DOI 10.1063/1.1652562; Peik E, 2003, EUROPHYS LETT, V61, P181, DOI 10.1209/epl/i2003-00210-x; Peik E, 2009, PROCEEDINGS OF THE 7TH SYMPOSIUM FREQUENCY STANDARDS AND METROLOGY, P532; Peik E, 2015, CR PHYS, V16, P516, DOI 10.1016/j.crhy.2015.02.007; Peik E, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.018901; Plass WR, 2008, NUCL INSTRUM METH B, V266, P4560, DOI 10.1016/j.nimb.2008.05.079; POOLE RT, 1975, PHYS REV B, V11, P5179, DOI 10.1103/PhysRevB.11.5179; Raeder S, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/16/165005; Rellergert WG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.200802; Richardson DS, 1998, PHYS REV LETT, V80, P3206, DOI 10.1103/PhysRevLett.80.3206; Rispoli R, 2012, PROC SPIE, V8450, DOI 10.1117/12.926185; Ruchowska E, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.044326; Sakharov SL, 2010, PHYS ATOM NUCL+, V73, P1, DOI 10.1134/S1063778810010011; Schwarz M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4742770; Sonnenschein V, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12052-3; Stellmer S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15580; Swanberg E., 2012, THESIS U CALIFORNIA; Tkalya EV, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054324; Tkalya EV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.162501; Tkalya EV, 2003, PHYS-USP+, V46, P315, DOI 10.1070/PU2003v046n03ABEH001379; Tkalya EV, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.064308; Tuli J.K., 2011, NUCL WALLET CARDS; Utter SB, 1999, PHYS REV LETT, V82, P505, DOI 10.1103/PhysRevLett.82.505; Von der Wense L, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/03/P03005; Vascon A, 2012, NUCL INSTRUM METH A, V696, P180, DOI 10.1016/j.nima.2012.08.072; Von der Wense L, 2015, EUR PHYS J A, V51, DOI 10.1140/epja/i2015-15029-8; WIZA JL, 1979, NUCL INSTRUM METHODS, V162, P587, DOI 10.1016/0029-554X(79)90734-1; Yamaguchi A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/053053; Yamakita Y, 2000, REV SCI INSTRUM, V71, P3042, DOI 10.1063/1.1305819; Zhao XX, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160801; Zimmermann K., 2010, THESIS U HANNOVER	64	134	135	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					47	+		10.1038/nature17669	http://dx.doi.org/10.1038/nature17669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27147026	Green Submitted			2022-12-28	WOS:000375473900036
J	Jafar, A				Jafar, Amer			Ihsan Raouf Al-Bahrani	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353								i2509	10.1136/bmj.i2509	http://dx.doi.org/10.1136/bmj.i2509			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27147557				2022-12-28	WOS:000375575500012
J	Shah, R; Rashid, A; Mizeracki, A				Shah, Rahman; Rashid, Abdul; Mizeracki, Adam			An Elderly Unresponsive Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							J-WAVE; HYPOTHERMIA		[Shah, Rahman; Mizeracki, Adam] Univ Tennessee, Sch Med, Cardiol Sect, Memphis, TN USA; [Shah, Rahman; Mizeracki, Adam] Vet Affairs Med Ctr, 1030 Jefferson Ave, Memphis, TN 38104 USA; [Rashid, Abdul] Univ Tennessee, Jackson Clin, Jackson, TN USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Shah, R (corresponding author), Vet Affairs Med Ctr, 1030 Jefferson Ave, Memphis, TN 38104 USA.	shahcardiology@yahoo.com	shah, Rahman/AAR-3354-2020					[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Aslam AF, 2006, AM J MED, V119, P297, DOI 10.1016/j.amjmed.2005.09.062; GUSSAK I, 1995, J ELECTROCARDIOL, V28, P49, DOI 10.1016/S0022-0736(05)80007-X; OSBORN JJ, 1953, AM J PHYSIOL, V175, P389, DOI 10.1152/ajplegacy.1953.175.3.389; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; Wira CR, 2008, RESUSCITATION, V78, P21, DOI 10.1016/j.resuscitation.2008.01.025	8	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1896	1897		10.1001/jama.2016.4462	http://dx.doi.org/10.1001/jama.2016.4462			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139063				2022-12-28	WOS:000375284400019
J	Rupprecht, JF; Prost, J				Rupprecht, Jean-Francois; Prost, Jacques			PHYSICAL BIOLOGY A fresh eye on nonequilibrium systems	SCIENCE			English	Editorial Material									[Rupprecht, Jean-Francois; Prost, Jacques] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Prost, Jacques] PSL Res Univ, Lab Phys Chim Curie, Inst Curie, CNRS, F-75005 Paris, France; [Prost, Jacques] Univ Paris 06, Sorbonne Univ, Lab Phys Chim Curie, CNRS, F-75005 Paris, France	National University of Singapore; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Prost, J (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.; Prost, J (corresponding author), PSL Res Univ, Lab Phys Chim Curie, Inst Curie, CNRS, F-75005 Paris, France.; Prost, J (corresponding author), Univ Paris 06, Sorbonne Univ, Lab Phys Chim Curie, CNRS, F-75005 Paris, France.	jacques.prost@curie.fr		Rupprecht, Jean-Francois/0000-0001-8904-5878				Battle C, 2016, SCIENCE, V352, P604, DOI 10.1126/science.aac8167; Bustamante C, 2005, PHYS TODAY, V58, P43, DOI 10.1063/1.2012462; Egolf DA, 2000, SCIENCE, V287, P101, DOI 10.1126/science.287.5450.101; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Feynman R. P., 2018, STAT MECH SET LECT; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Turlier H, 2016, NAT PHYS, V12, P513, DOI [10.1038/nphys3621, 10.1038/NPHYS3621]; Verley G, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012111	11	18	18	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					514	+		10.1126/science.aaf4611	http://dx.doi.org/10.1126/science.aaf4611			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126022	Green Submitted			2022-12-28	WOS:000374998600019
J	Biard, T; Stemmann, L; Picheral, M; Mayot, N; Vandromme, P; Hauss, H; Gorsky, G; Guidi, L; Kiko, R; Not, F				Biard, Tristan; Stemmann, Lars; Picheral, Marc; Mayot, Nicolas; Vandromme, Pieter; Hauss, Helena; Gorsky, Gabriel; Guidi, Lionel; Kiko, Rainer; Not, Fabrice			In situ imaging reveals the biomass of giant protists in the global ocean	NATURE			English	Article							PLANKTONIC SARCODINES ACANTHARIA; SURFACE WATERS; ZOOPLANKTON; RADIOLARIA; PHOTOSYNTHESIS; PHYTOPLANKTON; FORAMINIFERA; ABUNDANCE; PACIFIC	Planktonic organisms play crucial roles in oceanic food webs and global biogeochemical cycles(1,2). Most of our knowledge about the ecological impact of large zooplankton stems from research on abundant and robust crustaceans, and in particular copepods(3,4). A number of the other organisms that comprise planktonic communities are fragile, and therefore hard to sample and quantify, meaning that their abundances and effects on oceanic ecosystems are poorly understood. Here, using data from a worldwide in situ imaging survey of plankton larger than 600 mu m, we show that a substantial part of the biomass of this size fraction consists of giant protists belonging to the Rhizaria, a super-group of mostly fragile unicellular marine organisms that includes the taxa Phaeodaria and Radiolaria ( for example, orders Collodaria and Acantharia). Globally, we estimate that rhizarians in the top 200 m of world oceans represent a standing stock of 0.089 Pg carbon, equivalent to 5.2% of the total oceanic biota carbon reservoir(5). In the vast oligotrophic intertropical open oceans, rhizarian biomass is estimated to be equivalent to that of all other mesozooplankton ( plankton in the size range 0.2-20 mm). The photosymbiotic association of many rhizarians with microalgae may be an important factor in explaining their distribution. The previously overlooked importance of these giant protists across the widest ecosystem on the planet(6) changes our understanding of marine planktonic ecosystems.	[Biard, Tristan; Not, Fabrice] Univ Paris 06, Sorbonne Univ, Lab Adaptat & Divers Milieu Marin, CNRS,UMR7144,Stn Biol Roscoff, F-29688 Roscoff, France; [Biard, Tristan; Stemmann, Lars; Picheral, Marc; Mayot, Nicolas; Gorsky, Gabriel; Guidi, Lionel] Univ Paris 06, Sorbonne Univ, Observ Oceanol, CNRS,LOV,UMR7093, F-06230 Villefranche Sur Mer, France; [Vandromme, Pieter; Hauss, Helena; Kiko, Rainer] GEOMAR Helmholtz Ctr Ocean Res Kiel, Wischhofstr 1-3, D-24148 Kiel, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Not, F (corresponding author), Univ Paris 06, Sorbonne Univ, Lab Adaptat & Divers Milieu Marin, CNRS,UMR7144,Stn Biol Roscoff, F-29688 Roscoff, France.; Stemmann, L (corresponding author), Univ Paris 06, Sorbonne Univ, Observ Oceanol, CNRS,LOV,UMR7093, F-06230 Villefranche Sur Mer, France.	stemmann@obs-vlfr.fr; not@sb-roscoff.fr	Biard, Tristan/AAW-8013-2020; stemmann, lars/Q-8458-2019; Guidi, Lionel/B-3977-2012; stemmann, lars/E-6899-2011; Hauss, Helena M/S-1718-2018; Mayot, Nicolas/S-1319-2017; Biard, Tristan/E-8966-2017	Biard, Tristan/0000-0001-7052-6022; stemmann, lars/0000-0001-8935-4531; Guidi, Lionel/0000-0002-6669-5744; Hauss, Helena M/0000-0002-0754-3388; Mayot, Nicolas/0000-0003-4255-5939; Gorsky, Gabriel/0000-0002-1099-8711; Kiko, Rainer/0000-0002-7851-9107	U.S. National Science Foundation; DESIR project Emergence-UPMC from Universite Pierre et Marie Curie; JST-CNRS exchange program; CHAIRE CNRS/UPMC Vision; Investissements d'Avenir' programmes OCEANOMICS [ANR-11-BTBR-0008]; DFG [SFB754]; Future Ocean (Kiel University); Future Ocean (GEOMAR)	U.S. National Science Foundation(National Science Foundation (NSF)); DESIR project Emergence-UPMC from Universite Pierre et Marie Curie; JST-CNRS exchange program; CHAIRE CNRS/UPMC Vision; Investissements d'Avenir' programmes OCEANOMICS(French National Research Agency (ANR)); DFG(German Research Foundation (DFG)); Future Ocean (Kiel University); Future Ocean (GEOMAR)	Thanks to J.-O. Irisson for help with the R language and statistical analysis and I. Probert and J. Dolan for comments and English proofreading. The following people were involved in cruise organization: T. Moutin (BOUM), M. Landry and M. Ohman (CCE LTER), S. Blain (KEOPS II), V. Smetacek and W. Naqvi (LOHAFEX), J. Karstensen (M96), M. Babin (Malina), L. Coppola (Moose GE), P. Brandt (MSM22) and M. Visbeck (MSM23). The following people were involved in plankton image sorting: L. Burdorf (CNRS LOV), C. Desnos (CNRS LOV), A. Forest (Tackuvit), G. IdAoud (CNRS LOV), M. P. Jouandet (MIO Pytheas), J. Poulain (CEA), J. Baptiste Romagnan (CNRS LOV), F. Roullier (CNRS LOV), S. Searson (CNRS LOV), B. Serranito (EBMA-PROTEE) and N. Vasset (CNRS LOV). This study is a contribution from the CCE-LTER program, supported by the U.S. National Science Foundation. For the Tara Oceans expedition we thank the CNRS (in particular Groupement de Recherche GDR3280), European Molecular Biology Laboratory (EMBL), Genoscope/CEA, VIB, Stazione Zoologica Anton Dohrn, UNIMIB, Fund for Scientific Research - Flanders, Rega Institute, KU Leuven and the French Ministry of Research. We also thank A. Bourgois and E. Bourgois, the Veolia Environment Foundation, Region Bretagne, Lorient Agglomeration, World Courier, Illumina, the EDF Foundation, FRB, the Prince Albert II de Monaco Foundation, the Tara schooner and its captains and crew. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries who granted sampling permission. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). The authors further declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations in whose waters the Tara Oceans expedition sampled. Data described herein are available at PANGAEA (http://doi.pangaea.de/10.1594/PANGAEA.842227), and the data release policy regarding future public release of Tara Oceans data is described in ref. 29. Funding was from DESIR project Emergence-UPMC from Universite Pierre et Marie Curie, JST-CNRS exchange program, CHAIRE CNRS/UPMC Vision, Investissements d'Avenir' programmes OCEANOMICS (ANR-11-BTBR-0008), DFG through SFB754 (GEOMAR and Kiel University) and Future Ocean (Kiel University and GEOMAR). This article is contribution number 38 from Tara Oceans.	Anderson O., 1983, RADIOLARIA; [Anonymous], 2014, R LANG ENV STAT COMP; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Beaugrand G, 2010, P NATL ACAD SCI USA, V107, P10120, DOI 10.1073/pnas.0913855107; Beers J. R, 1970, Bull. Scripps Instn Oceanogr. tech. Ser., V17, P67; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Biard T., 2016, PANGAEA; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Buitenhuis E, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002511; Buitenhuis ET, 2013, EARTH SYST SCI DATA, V5, P227, DOI 10.5194/essd-5-227-2013; Burki F, 2014, CURR BIOL, V24, pR103, DOI 10.1016/j.cub.2013.12.025; CARON DA, 1995, J PLANKTON RES, V17, P103, DOI 10.1093/plankt/17.1.103; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; De Wever P., 2001, RADIOLARIANS SEDIMEN; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fontanez KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00469; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Guidi L., NATURE IN PRESS; Herndl GJ, 2013, NAT GEOSCI, V6, P718, DOI [10.1038/ngeo1921, 10.1038/NGEO1921]; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P1253, DOI 10.4319/lo.1985.30.6.1253; Lampitt RS, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003221; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; MICHAELS AF, 1995, J PLANKTON RES, V17, P131, DOI 10.1093/plankt/17.1.131; MICHAELS AF, 1988, MAR BIOL, V97, P559, DOI 10.1007/BF00391052; Morel A, 2007, REMOTE SENS ENVIRON, V111, P69, DOI 10.1016/j.rse.2007.03.012; Moriarty R, 2013, EARTH SYST SCI DATA, V5, P45, DOI 10.5194/essd-5-45-2013; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Remsen A, 2004, DEEP-SEA RES PT I, V51, P129, DOI 10.1016/j.dsr.2003.09.008; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Suzuki N., 2015, MARINE PROTISTS, P179, DOI DOI 10.1007/978-4-431-55130-0_8; Taylor F.J.R., 1990, P323; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson SE, 2013, LIMNOL OCEANOGR, V58, P881, DOI 10.4319/lo.2013.58.3.0881	43	131	133	9	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					504	+		10.1038/nature17652	http://dx.doi.org/10.1038/nature17652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27096373	Green Submitted			2022-12-28	WOS:000374815900048
J	Kamcev, J; Freeman, BD				Kamcev, Jovan; Freeman, Benny D.			Cracks help membranes to stay hydrated	NATURE			English	Editorial Material							POLYMERS; PERFORMANCE		[Kamcev, Jovan; Freeman, Benny D.] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78758 USA; [Kamcev, Jovan; Freeman, Benny D.] Univ Texas Austin, Ctr Energy Environm Resources, Austin, TX 78758 USA; [Kamcev, Jovan; Freeman, Benny D.] Univ Texas Austin, Texas Mat Inst, Austin, TX 78758 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Kamcev, J; Freeman, BD (corresponding author), Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78758 USA.; Kamcev, J; Freeman, BD (corresponding author), Univ Texas Austin, Ctr Energy Environm Resources, Austin, TX 78758 USA.; Kamcev, J; Freeman, BD (corresponding author), Univ Texas Austin, Texas Mat Inst, Austin, TX 78758 USA.	jkamcev@utexas.edu; freeman@che.utexas.edu	Freeman, Benny/G-5405-2016; Kamcev, Jovan/S-3505-2018	Freeman, Benny/0000-0003-2779-7788; Kamcev, Jovan/0000-0003-0379-5171				Chen YB, 2010, NAT CHEM, V2, P503, DOI [10.1038/NCHEM.629, 10.1038/nchem.629]; Edwards EJ, 2006, AM NAT, V167, P777, DOI 10.1086/504605; Hong JG, 2015, J MEMBRANE SCI, V486, P71, DOI 10.1016/j.memsci.2015.02.039; Kamcev J, 2016, PHYS CHEM CHEM PHYS, V18, P6021, DOI 10.1039/c5cp06747b; Li QF, 2009, PROG POLYM SCI, V34, P449, DOI 10.1016/j.progpolymsci.2008.12.003; Park CH, 2016, NATURE, V532, P480, DOI 10.1038/nature17634; ROBESON LM, 1994, POLYMER, V35, P4970, DOI 10.1016/0032-3861(94)90651-3; Sata T., 2004, ION EXCHANGE MEMBRAN	8	5	5	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					445	446		10.1038/532445a	http://dx.doi.org/10.1038/532445a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121835				2022-12-28	WOS:000374815900031
J	Gulland, A				Gulland, Anne			Government must follow the evidence before implementing seven day GP services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							ACCESS											Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3279; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5949	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2308	10.1136/bmj.i2308	http://dx.doi.org/10.1136/bmj.i2308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27114474				2022-12-28	WOS:000375482000004
J	Urrutia, J; Porteny, T; Daniels, N				Urrutia, Julian; Porteny, Thalia; Daniels, Norman			What does it mean to put new hepatitis C drugs on a list of essential medicines?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIRECT-ACTING ANTIVIRALS; COST-EFFECTIVENESS; ACCESS; ACCOUNTABILITY; REASONABLENESS		[Urrutia, Julian; Porteny, Thalia] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Daniels, Norman] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Urrutia, J (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA.	jurrutia@fas.harvard.edu	Urrutia, Julian/HII-8237-2022	Urrutia, Julian/0000-0001-9708-2353	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000055] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2015, NY TIMES; Bazargani YT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1583-4; Beyer P, 2014, INCREASING ACCESS HI; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1850; Daniels N, 2015, HEALTH SYST REFORM, V1, P229, DOI 10.1080/23288604.2014.1002705; Ford N, 2015, INT J DRUG POLICY, V26, P1088, DOI 10.1016/j.drugpo.2015.05.004; GLOBOCAN, 2012, EST CANC INC MORT PR; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hill A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009586; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hill A, 2013, CURR OPIN HIV AIDS, V8, P34, DOI 10.1097/COH.0b013e32835b7f28; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; [Infectious Diseases Society of America American Association for the Study of Liver Diseases], 2016, REC TEST MAN TREAT H; Kirby J, 2015, PEDIATR BLOOD CANCER, V62, P204, DOI 10.1002/pbc.25273; Medecins Sans Frontieres, 2014, UNT WEB ANT PRIC RED; Norheim OF, 2014, MAKING FAIR CHOICES; REICH MR, 1987, HEALTH POLICY, V8, P39, DOI 10.1016/0168-8510(87)90129-1; Rein DB, 2015, CLIN INFECT DIS, V61, P157, DOI 10.1093/cid/civ220; [Servicios Sociales e Igualdad Ministerio de Sanidad], 2015, PLAN ESTR AB HEP C S; UNAIDS, GLOB REP UNAIDS REP; van de Ven N, 2015, HEPATOLOGY, V61, P1174, DOI 10.1002/hep.27641; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; WHO, DAT PROC HIV HEP PRO; WHO, 2001, WHO MED STRAT REV PR; WHO, 2013, UN HLTH COV SUPP COU; WHO, 2015, ESS MED; WHO, 2015, PAT SIT KEY PROD TRE; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; World Bank, HLTH DAT; World Health Organization, 2015, 20 EXP COMM SEL US E	33	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2035	10.1136/bmj.i2035	http://dx.doi.org/10.1136/bmj.i2035			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106956				2022-12-28	WOS:000374999700001
J	Egan, PJ; Mullin, M				Egan, Patrick J.; Mullin, Megan			Recent improvement and projected worsening of weather in the United States	NATURE			English	Article							CLIMATE VARIABILITY; TEMPERATURE; TRENDS; BELIEF; CMIP5; FREQUENCY; HUMIDITY	As climate change unfolds, weather systems in the United States have been shifting in patterns that vary across regions and seasons(1-7). Climate science research typically assesses these changes by examining individual weather indicators, such as temperature or precipitation, in isolation, and averaging their values across the spatial surface. As a result, little is known about population exposure to changes in weather and how people experience and evaluate these changes considered together. Here we show that in the United States from 1974 to 2013, the weather conditions experienced by the vast majority of the population improved. Using previous research on how weather affects local population growth(8-14) to develop an index of people's weather preferences, we find that 80% of Americans live in counties that are experiencing more pleasant weather than they did four decades ago. Virtually all Americans are now experiencing the much milder winters that they typically prefer, and these mild winters have not been offset by markedly more uncomfortable summers or other negative changes. Climate change models predict that this trend is temporary, however, because US summers will eventually warm more than winters. Under a scenario in which greenhouse gas emissions proceed at an unabated rate (Representative Concentration Pathway 8.5), we estimate that 88% of the US public will experience weather at the end of the century that is less preferable than weather in the recent past. Our results have implications for the public's understanding of the climate change problem, which is shaped in part by experiences with local weather(15-20). Whereas weather patterns in recent decades have served as a poor source of motivation for Americans to demand a policy response to climate change, public concern may rise once people's everyday experiences of climate change effects start to become less pleasant.	[Egan, Patrick J.] NYU, Wilf Family Dept Polit, 550 1St Ave, New York, NY 10012 USA; [Mullin, Megan] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	New York University; Duke University	Egan, PJ (corresponding author), NYU, Wilf Family Dept Polit, 550 1St Ave, New York, NY 10012 USA.	patrick.egan@nyu.edu						Alder J, 2013, USGS NATL CLIMATE CH; Barreca AI, 2012, J ENVIRON ECON MANAG, V63, P19, DOI 10.1016/j.jeem.2011.07.004; Brown PJ, 2013, J APPL METEOROL CLIM, V52, P147, DOI 10.1175/JAMC-D-12-035.1; Cragg MI, 1999, REG SCI URBAN ECON, V29, P519, DOI 10.1016/S0166-0462(98)00046-5; Deryugina T, 2013, CLIMATIC CHANGE, V118, P397, DOI 10.1007/s10584-012-0615-1; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Dutch Ministry of Infrastructure and Environment, 2015, KNMI CLIM CHANG ATL; Egan PJ, 2012, J POLIT, V74, P796, DOI 10.1017/S0022381612000448; Gaffen DJ, 1998, NATURE, V396, P529, DOI 10.1038/25030; Glaeser E.L., 2001, JOURNALOF EC GEOGRAP, V1, P27, DOI [10.2139/ssrn.237462, DOI 10.1093/JEG/1.1.27]; Glaeser EL, 2005, J ECON GEOGR, V5, P119, DOI 10.1093/jnlecg/lbh058; Glaeser EL, 2003, J REGIONAL SCI, V43, P139, DOI 10.1111/1467-9787.00293; Hanigan Ivan, 2006, Int J Health Geogr, V5, P38, DOI 10.1186/1476-072X-5-38; Howe PD, 2013, NAT CLIM CHANGE, V3, P352, DOI [10.1038/NCLIMATE1768, 10.1038/nclimate1768]; Hubbard KG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027069; Joireman J, 2010, J ENVIRON PSYCHOL, V30, P358, DOI 10.1016/j.jenvp.2010.03.004; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Kumar S, 2013, J CLIMATE, V26, P3511, DOI 10.1175/JCLI-D-12-00535.1; Kunkel K. E., 2013, REGIONAL CLIMATE T 9; Lehner F, 2015, NAT CLIM CHANGE, V5, P731, DOI 10.1038/NCLIMATE2660; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; McGranahan D.A., 1999, NATURAL AMENITIES DR; McKibben B, 2014, NEW YORK REV BOOKS, V61, P46; Menne, 2015, US HIST CLIMATOLOGY; Menne MJ, 2009, B AM METEOROL SOC, V90, P993, DOI 10.1175/2008BAMS2613.1; Minnesota Population Center, 2011, NAT HIST GEOGR INF S; MUESER PR, 1995, J URBAN ECON, V37, P176, DOI 10.1006/juec.1995.1010; National Oceanic and Atmospheric Administration, 2014, GLOB SURF SUMM DAY; New M, 2001, INT J CLIMATOL, V21, P1899, DOI 10.1002/joc.680; Oswald EM, 2014, J APPL METEOROL CLIM, V53, P565, DOI 10.1175/JAMC-D-13-071.1; Partridge MD, 2010, PAP REG SCI, V89, P513, DOI 10.1111/j.1435-5957.2010.00315.x; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; QUAYLE RG, 1991, B AM METEOROL SOC, V72, P1718, DOI 10.1175/1520-0477(1991)072<1718:EORTCI>2.0.CO;2; Rappaport J, 2007, REG SCI URBAN ECON, V37, P375, DOI 10.1016/j.regsciurbeco.2006.11.004; Ruggles S., 2014, INTEGRATED PUBLIC US; Sheffield J, 2013, J CLIMATE, V26, P9209, DOI 10.1175/JCLI-D-12-00592.1; Stull R. B., 2000, METEOROLOGY SCI ENG; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wanielista M.P., 1997, HYDROLOGY WATER QUAN; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093	43	27	32	2	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					357	+		10.1038/nature17441	http://dx.doi.org/10.1038/nature17441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27127821				2022-12-28	WOS:000374424700030
J	Hsu, A; Cheng, YP; Weinfurter, A; Xu, KY; Yick, C				Hsu, Angel; Cheng, Yaping; Weinfurter, Amy; Xu, Kaiyang; Yick, Cameron			Track climate pledges of cities and companies	NATURE			English	Editorial Material									[Hsu, Angel] Yale NUS Coll, Singapore, Singapore; [Hsu, Angel] Yale Sch Forestry & Environm Studies, Singapore, Singapore; [Cheng, Yaping; Weinfurter, Amy; Xu, Kaiyang; Yick, Cameron] Yale Data Driven Environm Solut Grp, New Haven, CT USA	Yale NUS College	Hsu, A (corresponding author), Yale NUS Coll, Singapore, Singapore.; Hsu, A (corresponding author), Yale Sch Forestry & Environm Studies, Singapore, Singapore.	angel.hsu@yale.edu						Ecofys & University of Cambridge Institute for Sustainability Leadership, 2015, BETT PARTN UND INCR; Espey J., 2015, DATA DEV NEEDS ASSES; Heede R, 2014, CLIMATIC CHANGE, V122, P229, DOI 10.1007/s10584-013-0986-y; Hoffmann M. J., 2011, CLIMATE GOVERNANCE C; SCHUCKING H., 2011, BANKROLLING CLIMATE; US Department of State, 2015, 2 US DEP STAT; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110	7	42	42	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					303	306		10.1038/532303a	http://dx.doi.org/10.1038/532303a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7WU	27111615	Bronze			2022-12-28	WOS:000374424700013
J	Benson, J				Benson, Jemma			My mother's tongue	LANCET			English	Editorial Material									[Benson, Jemma] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA	Columbia University	Benson, J (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	jrb2232@cumc.columbia.edu							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1368	1369		10.1016/S0140-6736(16)30087-3	http://dx.doi.org/10.1016/S0140-6736(16)30087-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI0WH	27115808				2022-12-28	WOS:000373217500019
J	Elborn, JS				Elborn, J. Stuart			Cystic fibrosis	LANCET			English	Review							PSEUDOMONAS-AERUGINOSA INFECTION; SWEAT CHLORIDE CONCENTRATION; LUNG-FUNCTION DECLINE; QUALITY-OF-LIFE; SOCIETY STANDARDS; CFTR POTENTIATOR; CIGARETTE-SMOKE; DOUBLE-BLIND; PULMONARY EXACERBATIONS; AIRWAY INFLAMMATION	Cystic fibrosis is a common life-limiting autosomal recessive genetic disorder, with highest prevalence in Europe, North America, and Australia. The disease is caused by mutation of a gene that encodes a chloride-conducting transmembrane channel called the cystic fibrosis transmembrane conductance regulator (CFTR), which regulates anion transport and mucociliary clearance in the airways. Functional failure of CFTR results in mucus retention and chronic infection and subsequently in local airway inflammation that is harmful to the lungs. CFTR dysfunction mainly affects epithelial cells, although there is evidence of a role in immune cells. Cystic fibrosis affects several body systems, and morbidity and mortality is mostly caused by bronchiectasis, small airways obstruction, and progressive respiratory impairment. Important comorbidities caused by epithelial cell dysfunction occur in the pancreas (malabsorption), liver (biliary cirrhosis), sweat glands (heat shock), and vas deferens (infertility). The development and delivery of drugs that improve the clearance of mucus from the lungs and treat the consequent infection, in combination with correction of pancreatic insufficiency and undernutrition by multidisciplinary teams, have resulted in remarkable improvements in quality of life and clinical outcomes in patients with cystic fibrosis, with median life expectancy now older than 40 years. Innovative and transformational therapies that target the basic defect in cystic fibrosis have recently been developed and are effective in improving lung function and reducing pulmonary exacerbations. Further small molecule and gene-based therapies are being developed to restore CFTR function; these therapies promise to be disease modifying and to improve the lives of people with cystic fibrosis.	[Elborn, J. Stuart] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Hlth Sci Bldg,97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland; [Elborn, J. Stuart] Belfast City Hosp, Belfast, Antrim, North Ireland	Queens University Belfast; Belfast City Hospital	Elborn, JS (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Hlth Sci Bldg,97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	s.elborn@qub.ac.uk		elborn, joseph/0000-0002-2323-442X	MRC; European Commission Framework 7 grants; Vertex; PTC; Novartis; Gilead; Celtaxsys	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission Framework 7 grants; Vertex(Vertex Pharmaceuticals); PTC; Novartis(Novartis); Gilead(Gilead Sciences); Celtaxsys	I am supported by the MRC and European Commission Framework 7 grants. Queen's University Belfast has been paid for clinical trial-related work by Vertex, PTC, Novartis, Gilead, and Celtaxsys. I have undertaken consultancy work for Vertex, PTC, Novartis, Gilead, Raptor, and Corbus. All payments for these activities were made to Queen's University Belfast.	Abbott J, 2015, J CYST FIBROS, V14, P533, DOI 10.1016/j.jcf.2014.12.015; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Bartlett JR, 2009, JAMA-J AM MED ASSOC, V302, P1076, DOI 10.1001/jama.2009.1295; Bell SC, 1996, THORAX, V51, P126, DOI 10.1136/thx.51.2.126; Bell SC, 2015, PHARMACOL THERAPEUT, V145, P19, DOI 10.1016/j.pharmthera.2014.06.005; Blackman SM, 2013, DIABETES, V62, P3627, DOI 10.2337/db13-0510; Bodewes FAJA, 2015, J CYST FIBROS, V14, P169, DOI 10.1016/j.jcf.2015.01.006; Boucher RC, 2010, AM J RESP CRIT CARE, V181, P1017, DOI 10.1164/rccm.201002-0284ED; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Boyle MP, 2013, LANCET RESP MED, V1, P158, DOI 10.1016/S2213-2600(12)70057-7; Bradley JM, 2012, J CYST FIBROS, V11, P387, DOI 10.1016/j.jcf.2012.03.004; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Burgel PR, 2015, EUR RESPIR J, V46, P133, DOI 10.1183/09031936.00196314; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Castellani C, 2014, J CYST FIBROS, V13, pS1, DOI 10.1016/j.jcf.2014.03.008; Castellani C, 2009, J CYST FIBROS, V8, P153, DOI 10.1016/j.jcf.2009.01.004; Chmiel James F, 2014, Ann Am Thorac Soc, V11, P1120, DOI 10.1513/AnnalsATS.201402-050AS; Chmiel JF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009779; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Cohen-Cymberknoh M, 2013, THORAX, V68, P1157, DOI 10.1136/thoraxjnl-2013-203204; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; Collawn JF, 2014, AM J PHYSIOL-LUNG C, V307, pL917, DOI 10.1152/ajplung.00326.2014; Conway S, 2014, J CYST FIBROS, V13, pS3, DOI 10.1016/j.jcf.2014.03.009; Corris PA, 2013, SEMIN RESP CRIT CARE, V34, P297, DOI 10.1055/s-0033-1348469; Courville CA, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-25; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Davies J, 2013, LANCET RESP MED, V1, P630, DOI 10.1016/S2213-2600(13)70182-6; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Davis PB, 2015, NEW ENGL J MED, V373, P274, DOI 10.1056/NEJMe1504059; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; De Boeck K, 2014, J CYST FIBROS, V13, P403, DOI 10.1016/j.jcf.2013.12.003; De Boeck K, 2013, EUR RESPIR J, V41, P203, DOI 10.1183/09031936.00057512; De Boeck K, 2014, J CYST FIBROS, V13, P674, DOI 10.1016/j.jcf.2014.09.005; de Boer K, 2011, THORAX, V66, P680, DOI 10.1136/thx.2011.161117; Dill EJ, 2013, CHEST, V144, P981, DOI 10.1378/chest.12-1404; Doering G, 2007, J CYST FIBROS, V6, P85, DOI 10.1016/j.jcf.2007.02.001; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Floto RA, 2015, J CYST FIBROS, V14, P1, DOI 10.1016/j.jcf.2014.12.002; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Fodor Anthony A, 2012, PLoS One, V7, pe45001, DOI 10.1371/journal.pone.0045001; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Gilligan PH, 2014, CLIN LAB MED, V34, P197, DOI 10.1016/j.cll.2014.02.001; Graeber SY, 2013, AM J RESP CELL MOL, V49, P410, DOI 10.1165/rcmb.2013-0050OC; Habib AR, 2015, ANN AM THORAC SOC, V12, P420, DOI 10.1513/AnnalsATS.201408-393OC; Haller W, 2014, J GASTROEN HEPATOL, V29, P1344, DOI 10.1111/jgh.12546; Haworth CS, 2011, J CYST FIBROS, V10, P470, DOI 10.1016/j.jcf.2011.07.007; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Hirche TO, 2014, PULM MED, V2014, DOI 10.1155/2014/621342; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Keiser NW, 2015, AM J RESP CELL MOL, V52, P683, DOI 10.1165/rcmb.2014-0250OC; Kelly A, 2013, J CYST FIBROS, V12, P318, DOI 10.1016/j.jcf.2013.02.008; Kent L, 2014, J CYST FIBROS, V13, P123, DOI 10.1016/j.jcf.2013.09.005; Kerem E, 2014, J CYST FIBROS; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Knibbs LD, 2014, THORAX, V69, P740, DOI 10.1136/thoraxjnl-2014-205213; Ledder O, 2014, J GASTROEN HEPATOL, V29, P1954, DOI 10.1111/jgh.12785; Levy H, 2015, J PEDIATR-US, V166, P1337, DOI 10.1016/j.jpeds.2015.03.042; Linnemann RW, 2016, J CYST FIBROS, V15, P90, DOI 10.1016/j.jcf.2015.03.005; Mall MA, 2014, AM J RESP CRIT CARE, V190, P126, DOI 10.1164/rccm.201405-0935ED; Mayell SJ, 2009, J CYST FIBROS, V8, P71, DOI 10.1016/j.jcf.2008.09.005; McCloskey M, 2000, RESPIRATION, V67, P402, DOI 10.1159/000029538; McCormick J, 2010, LANCET, V375, P1007, DOI 10.1016/S0140-6736(09)62161-9; McCourt F, 2015, J CYST FIBROS, V14, P90, DOI 10.1016/j.jcf.2014.06.007; McIlwaine MP, 2013, THORAX, V68, P746, DOI 10.1136/thoraxjnl-2012-202915; McKone EF, 2015, J CYST FIBROS, V14, P580, DOI 10.1016/j.jcf.2015.01.005; McKone EF, 2014, LANCET RESP MED, V2, P902, DOI [10.1016/S2213-2600(14)70218-8, 10.1016/s2213-2600(14)70218-8]; Mogayzel Jr PJ, 2014, ANN AM THORAC SOC; Mogayzel PJ, 2013, AM J RESP CRIT CARE, V187, P680, DOI 10.1164/rccm.201207-1160OE; Moss RB, 2015, LANCET RESP MED, V3, P524, DOI 10.1016/S2213-2600(15)00201-5; Nick JA, 2010, AM J RESP CRIT CARE, V182, P614, DOI 10.1164/rccm.201001-0092OC; O'Neill K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126980; Ode KL, 2013, LANCET DIABETES ENDO, V1, P52, DOI 10.1016/S2213-8587(13)70015-9; Olivier AK, 2015, AM J PHYSIOL-GASTR L, V308, pG459, DOI 10.1152/ajpgi.00146.2014; Paganin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124348; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Parkins Michael D, 2011, Ther Adv Respir Dis, V5, P105, DOI 10.1177/1753465810386051; Plant BJ, 2013, LANCET RESP MED, V1, P164, DOI 10.1016/S2213-2600(13)70025-0; Prayle A, 2010, CURR OPIN PULM MED, V16, P604, DOI 10.1097/MCP.0b013e32833eebfd; Proesmans M, 2013, J CYST FIBROS, V12, P29, DOI 10.1016/j.jcf.2012.06.001; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; Quittner AL, 2016, THORAX, V71, P26, DOI 10.1136/thoraxjnl-2015-207488; Quittner AL, 2014, THORAX, V69, P1090, DOI 10.1136/thoraxjnl-2014-205983; Rab A, 2013, AM J PHYSIOL-LUNG C, V305, pL530, DOI 10.1152/ajplung.00039.2013; Raju SV, 2013, AM J RESP CRIT CARE, V188, P1321, DOI 10.1164/rccm.201304-0733OC; Ramsay KA, 2013, J CLIN MICROBIOL, V51, P3975, DOI 10.1128/JCM.01360-13; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ramsey KA, 2014, AM J RESP CRIT CARE, V190, P1111, DOI 10.1164/rccm.201407-1277OC; Ratjen F, 2010, THORAX, V65, P286, DOI 10.1136/thx.2009.121657; Robinson WM, 2009, CURR OPIN PULM MED, V15, P621, DOI 10.1097/MCP.0b013e3283304c29; Rosenow T, 2015, AM J RESP CRIT CARE, V191, P1158, DOI 10.1164/rccm.201501-0061OC; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Sagel SD, 2015, J CYST FIBROS, V14, P164, DOI 10.1016/j.jcf.2014.12.004; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Sands D, 2011, J CYST FIBROS, V10, pS37, DOI 10.1016/S1569-1993(11)60007-6; Schaffer K, 2015, J HOSP INFECT, V89, P309, DOI 10.1016/j.jhin.2015.02.005; Sermet-Gaudelus I, 2011, J CYST FIBROS, V10, pS16, DOI 10.1016/S1569-1993(11)60004-0; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Sherrard LJ, 2014, LANCET, V384, P703, DOI 10.1016/S0140-6736(14)61137-5; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Sims EJ, 2007, LANCET, V369, P1187, DOI 10.1016/S0140-6736(07)60565-0; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Somaraju UR, 2015, PAEDIATR RESPIR REV, V16, P108, DOI 10.1016/j.prrv.2014.11.001; Somaraju UR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008227.pub2; Sosnay PR, 2014, THORAX, V69, P295, DOI 10.1136/thoraxjnl-2013-204903; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stalvey MS, 2013, CURR OPIN ENDOCRINOL, V20, P547, DOI 10.1097/01.med.0000436191.87727.ec; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Stern M, 2014, J CYST FIBROS, V13, pS43, DOI 10.1016/j.jcf.2014.03.011; Stoltz DA, 2015, NEW ENGL J MED, V372, P1574, DOI 10.1056/NEJMc1502191; Taccetti G, 2012, THORAX, V67, P853, DOI 10.1136/thoraxjnl-2011-200832; Thauvin-Robinet C, 2013, J MED GENET, V50, P220, DOI 10.1136/jmedgenet-2012-101427; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Waters V, 2015, J CYST FIBROS, V14, P551, DOI 10.1016/j.jcf.2015.02.005; Waters V, 2012, EUR RESPIR J, V40, P61, DOI 10.1183/09031936.00159111; WILSCHANSKI M, 1995, J PEDIATR-US, V127, P705, DOI 10.1016/S0022-3476(95)70157-5; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	135	890	924	19	430	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2519	2531		10.1016/S0140-6736(16)00576-6	http://dx.doi.org/10.1016/S0140-6736(16)00576-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC5IA	27140670				2022-12-28	WOS:000388166300030
J	Tajima, N; Karakas, E; Grant, T; Simorowski, N; Diaz-Avalos, R; Grigorieff, N; Furukawa, H				Tajima, Nami; Karakas, Erkan; Grant, Timothy; Simorowski, Noriko; Diaz-Avalos, Ruben; Grigorieff, Nikolaus; Furukawa, Hiro			Activation of NMDA receptors and the mechanism of inhibition by ifenprodil	NATURE			English	Article							AMINO-TERMINAL DOMAIN; SPINAL-CORD NEURONS; SUBUNIT ARRANGEMENT; STRUCTURAL MECHANISM; GLUTAMATE RECEPTORS; BINDING; KAINATE; SOFTWARE; KINETICS; CHANNELS	The physiology of N-methyl-D-aspartate (NMDA) receptors is fundamental to brain development and function. NMDA receptors are ionotropic glutamate receptors that function as heterotetramers composed mainly of GluN1 and GluN2 subunits. Activation of NMDA receptors requires binding of neurotransmitter agonists to a ligand-binding domain (LBD) and structural rearrangement of an amino-terminal domain (ATD). Recent crystal structures of GluN1-GluN2B NMDA receptors bound to agonists and an allosteric inhibitor, ifenprodil, represent the allosterically inhibited state. However, how the ATD and LBD move to activate the NMDA receptor ion channel remains unclear. Here we applied X-ray crystallography, single-particle electron cryomicroscopy and electrophysiology to rat NMDA receptors to show that, in the absence of ifenprodil, the bi-lobed structure of GluN2 ATD adopts an open conformation accompanied by rearrangement of the GluN1-GluN2 ATD heterodimeric interface, altering subunit orientation in the ATD and LBD and forming an active receptor conformation that gates the ion channel.	[Tajima, Nami; Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Grant, Timothy; Diaz-Avalos, Ruben; Grigorieff, Nikolaus] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Furukawa, H (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA.; Grigorieff, N (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	grigorieffn@janelia.hhmi.org; furukawa@cshl.edu		Grant, Tim/0000-0002-4855-8703; Grigorieff, Nikolaus/0000-0002-1506-909X	National Institutes of Health [MH085926, GM105730]; Stanley Institute of Cognitive Genomics; Burroughs Wellcome Fund Collaborative Research Travel Grant; Robertson Research Fund of Cold Spring Harbor Laboratory; Japan Society for the Promotion of Science; Visiting Scientist program of the Janelia Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Institute of Cognitive Genomics; Burroughs Wellcome Fund Collaborative Research Travel Grant(Burroughs Wellcome Fund); Robertson Research Fund of Cold Spring Harbor Laboratory; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Visiting Scientist program of the Janelia Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank staff at the 23-ID beamlines at the Advanced Photon System in the Argonne National Laboratory. We are grateful to Z. Yu, C. Hong and R. Huang at the Janelia Research Center/HHMI EM facility for their support. This work was supported by the National Institutes of Health (MH085926 and GM105730), the Stanley Institute of Cognitive Genomics, Burroughs Wellcome Fund Collaborative Research Travel Grant, the Robertson Research Fund of Cold Spring Harbor Laboratory (all to H.F.), Japan Society for the Promotion of Science (to N.T.) and the Visiting Scientist program of the Janelia Research Center to allow H.F. to conduct cryo-EM work.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BENVENISTE M, 1991, BRIT J PHARMACOL, V104, P207, DOI 10.1111/j.1476-5381.1991.tb12409.x; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Granger AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0136; Grant T, 2015, J STRUCT BIOL, V192, P204, DOI 10.1016/j.jsb.2015.08.006; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karakas E, 2015, TRENDS BIOCHEM SCI, V40, P328, DOI 10.1016/j.tibs.2015.04.002; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2004, NEUROSCIENTIST, V10, P192, DOI 10.1177/1073858404263483; Regan MC, 2015, CURR OPIN STRUC BIOL, V33, P68, DOI 10.1016/j.sbi.2015.07.012; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sirrieh RE, 2015, J GEN PHYSIOL, V146, P173, DOI 10.1085/jgp.201511422; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhu SJ, 2015, CURR OPIN PHARMACOL, V20, P14, DOI 10.1016/j.coph.2014.10.009	45	132	136	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2016	534	7605					63	+		10.1038/nature17679	http://dx.doi.org/10.1038/nature17679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN3LB	27135925	Green Submitted, Green Accepted			2022-12-28	WOS:000376962300033
J	Nacu, E; Gromberg, E; Oliveira, CR; Drechsel, D; Tanaka, EM				Nacu, Eugeniu; Gromberg, Elena; Oliveira, Catarina R.; Drechsel, David; Tanaka, Elly M.			FGF8 and SHH substitute for anterior-posterior tissue interactions to induce limb regeneration	NATURE			English	Article							SONIC HEDGEHOG; FEEDBACK LOOP; NOTOPHTHALMUS-VIRIDESCENS; SUPERNUMERARY LIMBS; VERTEBRATE LIMB; DOUBLE-HALF; AXOLOTL; CELLS; BUD; BLASTEMA	In salamanders, grafting of a left limb blastema onto a right limb stump yields regeneration of three limbs, the normal limb and two 'supernumerary' limbs(1-4). This experiment and other research have shown that the juxtaposition of anterior and posterior limb tissue plus innervation are necessary and sufficient to induce complete limb regeneration in salamanders(5-10). However, the cellular and molecular basis of the requirement for anterior-posterior tissue interactions were unknown. Here we have clarified the molecular basis of the requirement for both anterior and posterior tissue during limb regeneration and supernumerary limb formation in axolotls (Ambystoma mexicanum). We show that the two tissues provide complementary cross-inductive signals that are required for limb outgrowth. A blastema composed solely of anterior tissue normally regresses rather than forming a limb, but activation of hedgehog (HH) signalling was sufficient to drive regeneration of an anterior blastema to completion owing to its ability to maintain fibroblast growth factor (FGF) expression, the key signalling activity responsible for blastema outgrowth. In blastemas composed solely of posterior tissue, HH signalling was not sufficient to drive regeneration; however, ectopic expression of FGF8 together with endogenous HH signalling was sufficient. In axolotls, FGF8 is expressed only in the anterior mesenchyme and maintenance of its expression depends on sonic hedgehog (SHH) signalling from posterior tissue. Together, our findings identify key anteriorly and posteriorly localized signals that promote limb regeneration and show that these single factors are sufficient to drive non-regenerating blastemas to complete regeneration with full elaboration of skeletal elements.	[Nacu, Eugeniu; Gromberg, Elena; Oliveira, Catarina R.; Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Nacu, Eugeniu; Gromberg, Elena; Drechsel, David; Tanaka, Elly M.] Max Planck Inst Mol Zellbiol & Genet, D-01307 Dresden, Germany; [Oliveira, Catarina R.] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal	Technische Universitat Dresden; Max Planck Society; Universidade do Porto	Nacu, E; Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, D-01307 Dresden, Germany.; Nacu, E; Tanaka, EM (corresponding author), Max Planck Inst Mol Zellbiol & Genet, D-01307 Dresden, Germany.	eugeniu_nacu@harvard.edu; elly.tanaka@crt-dresden.de	Tanaka, Elly M/F-8572-2010	Tanaka, Elly/0000-0003-4240-2158	CRTD; MPI-CBG; ERC Advanced Investigator grant; Portuguese Foundation for Science and Technology (FCT)	CRTD; MPI-CBG; ERC Advanced Investigator grant; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	We thank B. Gruhl, S. Moegel, M. Armstead, H. Goers, A. Wagner and S. Kaudel for animal care, H. Q. Le and K. Goehler for assistance, C. Cannistraci for advice on statistical analysis, C. Antos, D. Knapp, W. Masselink, T. Sugiura and Y. Taniguchi for advice on the manuscript, K. Crawford for discussion, S. Eaton for providing us with the plasmid with human SHH, K. Airenne, S. Yla-Herttuala, and M. Kaikonnen for the plasmid with VSV-GED, members of the MPI-CBG protein facility for assistance in baculovirus preparation, and members of the MPI-CBG antibody facility for the anti-MHC antibody. This work was supported by central funds from the CRTD and MPI-CBG and an ERC Advanced Investigator grant to E.M.T. C.R.O. was supported by the Portuguese Foundation for Science and Technology (FCT). Schematic illustrations of axolotl limbs were redrawn based on illustrations from ref. 10 under copyright transfer agreement to E.N. and E.M.T. as authors.	Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; BRYANT SV, 1978, J EXP ZOOL, V204, P307, DOI 10.1002/jez.1402040302; BRYANT SV, 1976, NATURE, V263, P676, DOI 10.1038/263676a0; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Kaikkonen MU, 2006, GENE THER, V13, P304, DOI 10.1038/sj.gt.3302657; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; MADEN M, 1980, NATURE, V286, P803, DOI 10.1038/286803a0; MADEN M, 1982, AM ZOOL, V22, P131; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P115; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; STOCUM DL, 1978, SCIENCE, V200, P790, DOI 10.1126/science.644323; STOCUM DL, 1982, J EMBRYOL EXP MORPH, V71, P193; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	33	98	98	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					407	+		10.1038/nature17972	http://dx.doi.org/10.1038/nature17972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27120163				2022-12-28	WOS:000376004300051
J	Pinto, C; Middleton, MJ; Fabian, AC				Pinto, Ciro; Middleton, Matthew J.; Fabian, Andrew C.			Resolved atomic lines reveal outflows in two ultraluminous X-ray sources	NATURE			English	Article							REFLECTION GRATING SPECTROMETER; PHOTON IMAGING CAMERA; BLACK-HOLE WINDS; XMM-NEWTON; ACCRETION DISK; SPECTROSCOPY; EVOLUTION; EMISSION; GALAXIES; FEEDBACK	Ultraluminous X-ray sources are extragalactic, off-nucleus, point sources in galaxies, and have X-ray luminosities in excess of 3 x 10(39) ergs per second. They are thought to be powered by accretion onto a compact object. Possible explanations include accretion onto neutron stars with strong magnetic fields(1), onto stellar-mass black holes (of up to 20 solar masses) at or in excess of the classical Eddington limit(2-4), or onto intermediate-mass black holes (10(3)-10(5) solar masses)(5). The lack of sufficient energy resolution in previous analyses has prevented an unambiguous identification of any emission or absorption lines in the X-ray band, thereby precluding a detailed analysis of the accretion flow(6-8). Here we report the presence of X-ray emission lines arising from highly ionized iron, oxygen and neon with a cumulative significance in excess of five standard deviations, together with blueshifted (about 0.2 times light velocity) absorption lines of similar significance, in the high-resolution X-ray spectra of the ultraluminous X-ray sources NGC 1313 X-1 and NGC 5408 X-1. The blueshifted absorption lines must occur in a fast-outflowing gas, whereas the emission lines originate in slow-moving gas around the source. We conclude that the compact object in each source is surrounded by powerful winds with an outflow velocity of about 0.2 times that of light, as predicted by models of accreting supermassive black holes and hyper-accreting stellar-mass black holes(9,10).	[Pinto, Ciro; Middleton, Matthew J.; Fabian, Andrew C.] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England	University of Cambridge	Pinto, C (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	cpinto@ast.cam.ac.uk	Pinto, Ciro/CAH-0295-2022	Pinto, Ciro/0000-0003-2532-7379	European Research Council [340492]; STFC; ESA Member States; NASA; STFC [ST/M005283/1, ST/M005283/2] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ESA Member States(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank A. Lohfink for help with the use of photoionization emission codes. A.C.F. acknowledges support from the European Research Council through Advanced Grant on Feedback 340492. M.J.M. appreciates support from an STFC advanced fellowship. This work is based on observations with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA. This research has also made use of data obtained from NASA's Chandra satellite. All codes used are publicly available.	Bachetti M, 2014, NATURE, V514, P202, DOI 10.1038/nature13791; Bachetti M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/163; COOKE BA, 1978, NATURE, V273, P645, DOI 10.1038/273645a0; den Herder JW, 2001, ASTRON ASTROPHYS, V365, pL7, DOI 10.1051/0004-6361:20000058; Gladstone JC, 2009, MON NOT R ASTRON SOC, V397, P1836, DOI 10.1111/j.1365-2966.2009.15123.x; Goad MR, 2006, MON NOT R ASTRON SOC, V365, P191, DOI 10.1111/j.1365-2966.2005.09702.x; Kaastra JS, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201116870; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Kaspi S, 2002, ASTROPHYS J, V574, P643, DOI 10.1086/341113; King AL, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/103; King A, 2016, MON NOT R ASTRON SOC, V455, P1211, DOI 10.1093/mnras/stv2347; King A, 2015, ANNU REV ASTRON ASTR, V53, P115, DOI 10.1146/annurev-astro-082214-122316; King AR, 2001, ASTROPHYS J, V552, pL109, DOI 10.1086/320343; Lodders K., 2009, METEORIT PLANET SC S, V72, P5154; Marshall HL, 2002, ASTROPHYS J, V564, P941, DOI 10.1086/324398; Middleton MJ, 2015, MON NOT R ASTRON SOC, V454, P3134, DOI 10.1093/mnras/stv2214; Middleton MJ, 2014, MON NOT R ASTRON SOC, V438, pL51, DOI 10.1093/mnrasl/slt157; Miller JM, 2008, ASTROPHYS J, V680, P1359, DOI 10.1086/588521; Nomoto K, 2006, NUCL PHYS A, V777, P424, DOI 10.1016/j.nuclphysa.2006.05.008; Oskinova LM, 2005, MON NOT R ASTRON SOC, V361, P679, DOI 10.1111/j.1365-2966.2005.09229.x; Pakull M. W., 2002, PREPRINT; Pasham DR, 2014, NATURE, V513, P74, DOI 10.1038/nature13710; Pinto C, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220481; Ponti G, 2012, MON NOT R ASTRON SOC, V422, pL11, DOI 10.1111/j.1745-3933.2012.01224.x; Poutanen J, 2007, MON NOT R ASTRON SOC, V377, P1187, DOI 10.1111/j.1365-2966.2007.11668.x; Roberts TP, 2006, MON NOT R ASTRON SOC, V371, P1877, DOI 10.1111/j.1365-2966.2006.10821.x; Schulz NS, 2001, ASTROPHYS J, V563, P941, DOI 10.1086/323988; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Stobbart AM, 2006, MON NOT R ASTRON SOC, V368, P397, DOI 10.1111/j.1365-2966.2006.10112.x; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Swartz DA, 2004, ASTROPHYS J SUPPL S, V154, P519, DOI 10.1086/422842; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087	32	143	144	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					64	+		10.1038/nature17417	http://dx.doi.org/10.1038/nature17417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120159	Green Submitted, Green Accepted			2022-12-28	WOS:000375473900039
J	Caron, DA				Caron, David A.			The rise of Rhizaria	NATURE			English	Editorial Material							PLANKTONIC SARCODINES ACANTHARIA; SURFACE WATERS; COLONIAL RADIOLARIA; FORAMINIFERA; BERMUDA		[Caron, David A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Caron, DA (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	dcaron@usc.edu						Anderson O., 1983, RADIOLARIA; Biard T, 2016, NATURE, V532, P504, DOI 10.1038/nature17652; CARON DA, 1995, J PLANKTON RES, V17, P103, DOI 10.1093/plankt/17.1.103; Decelle J., 2015, MARINE PROTISTS, P465, DOI [10.1007/978-4-431-55130-0_19, DOI 10.1007/978-4-431-55130-0_19]; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; Haeckel E., 1887, REPORTS SCI RESULTS, V18, P1; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; MICHAELS AF, 1995, J PLANKTON RES, V17, P131, DOI 10.1093/plankt/17.1.131; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; SWANBERG NR, 1983, LIMNOL OCEANOGR, V28, P655, DOI 10.4319/lo.1983.28.4.0655	12	11	11	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					444	445		10.1038/nature17892	http://dx.doi.org/10.1038/nature17892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27096370				2022-12-28	WOS:000374815900030
J	Moreau, P; Masszi, T; Grzasko, N; Bahlis, NJ; Hansson, M; Pour, L; Sandhu, I; Ganly, P; Baker, BW; Jackson, SR; Stoppa, AM; Simpson, DR; Gimsing, P; Palumbo, A; Garderet, L; Cavo, M; Kumar, S; Touzeau, C; Buadi, FK; Laubach, JP; Berg, DT; Lin, J; Di Bacco, A; Hui, AM; van de Velde, H; Richardson, PG				Moreau, P.; Masszi, T.; Grzasko, N.; Bahlis, N. J.; Hansson, M.; Pour, L.; Sandhu, I.; Ganly, P.; Baker, B. W.; Jackson, S. R.; Stoppa, A. -M.; Simpson, D. R.; Gimsing, P.; Palumbo, A.; Garderet, L.; Cavo, M.; Kumar, S.; Touzeau, C.; Buadi, F. K.; Laubach, J. P.; Berg, D. T.; Lin, J.; Di Bacco, A.; Hui, A. -M.; van de Velde, H.; Richardson, P. G.		TOURMALINE-MM1 Study Grp	Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEASOME INHIBITOR MLN9708; QUALITY-OF-LIFE; RANDOMIZED PHASE-3; ANTITUMOR-ACTIVITY; BORTEZOMIB; THALIDOMIDE; THERAPY; TRANSPLANTATION; CARFILZOMIB; SUPERIORITY	BACKGROUND Ixazomib is an oral proteasome inhibitor that is currently being studied for the treatment of multiple myeloma. METHODS In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned 722 patients who had relapsed, refractory, or relapsed and refractory multiple myeloma to receive ixazomib plus lenalidomide-dexamethasone (ixazomib group) or placebo plus lenalidomide-dexamethasone (placebo group). The primary end point was progression-free survival. RESULTS Progression-free survival was significantly longer in the ixazomib group than in the placebo group at a median follow-up of 14.7 months (median progression-free survival, 20.6 months vs. 14.7 months; hazard ratio for disease progression or death in the ixazomib group, 0.74; P=0.01); a benefit with respect to progression-free survival was observed with the ixazomib regimen, as compared with the placebo regimen, in all prespecified patient subgroups, including in patients with high-risk cytogenetic abnormalities. The overall rates of response were 78% in the ixazomib group and 72% in the placebo group, and the corresponding rates of complete response plus very good partial response were 48% and 39%. The median time to response was 1.1 months in the ixazomib group and 1.9 months in the placebo group, and the corresponding median duration of response was 20.5 months and 15.0 months. At a median follow-up of approximately 23 months, the median overall survival has not been reached in either study group, and follow-up is ongoing. The rates of serious adverse events were similar in the two study groups (47% in the ixazomib group and 49% in the placebo group), as were the rates of death during the study period (4% and 6%, respectively); adverse events of at least grade 3 severity occurred in 74% and 69% of the patients, respectively. Thrombocytopenia of grade 3 and grade 4 severity occurred more frequently in the ixazomib group (12% and 7% of the patients, respectively) than in the placebo group (5% and 4% of the patients, respectively). Rash occurred more frequently in the ixazomib group than in the placebo group (36% vs. 23% of the patients), as did gastrointestinal adverse events, which were predominantly low grade. The incidence of peripheral neuropathy was 27% in the ixazomib group and 22% in the placebo group (grade 3 events occurred in 2% of the patients in each study group). Patient-reported quality of life was similar in the two study groups. CONCLUSIONS The addition of ixazomib to a regimen of lenalidomide and dexamethasone was associated with significantly longer progression-free survival; the additional toxic effects with this all-oral regimen were limited.	[Moreau, P.; Touzeau, C.] Univ Hosp Hotel Dieu, F-44093 Nantes 01, France; [Stoppa, A. -M.] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France; [Garderet, L.] Hosp St Antoine, Dept Hematol & Cell Therapy, Paris, France; [Masszi, T.] Semmelweis Univ, Dept Internal Med 3, St Istvan & St Laszlo Hosp, Dept Haematol & Stem Cell Transplantat, H-1085 Budapest, Hungary; [Grzasko, N.] Med Univ Lublin, Dept Haematooncol & Bone Marrow Transplantat, Lublin, Poland; [Grzasko, N.] St Johns Canc Ctr, Lublin, Poland; [Bahlis, N. J.] Univ Calgary, Southern Alberta Canc Res Inst, Calgary, AB, Canada; [Sandhu, I.] Univ Alberta, Dept Med, Div Hematol, Edmonton, AB, Canada; [Hansson, M.] Lund Univ, Dept Hematol, Skane Univ Hosp, Lund, Sweden; [Pour, L.] Univ Hosp Brno, Hematol & Oncol, Brno, Czech Republic; [Ganly, P.] Christchurch Hosp, Dept Haematol, Christchurch, New Zealand; [Baker, B. W.] Palmerston North Hosp, Dept Haematol, Palmerston North, Manawatu, New Zealand; [Jackson, S. R.] Middlemore Hosp, Dept Haematol, Auckland 6, New Zealand; [Simpson, D. R.] North Shore Hosp, Dept Haematol, Auckland, New Zealand; [Gimsing, P.] Univ Copenhagen Hosp, Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Palumbo, A.] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy; [Cavo, M.] Univ Bologna, St Orsola Malpighi Univ Hosp, Sch Med, Seragnoli Inst Haematol, Bologna, Italy; [Kumar, S.; Buadi, F. K.] Mayo Clin, Div Hematol, Rochester, MN USA; [Laubach, J. P.; Richardson, P. G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Berg, D. T.; Lin, J.; Di Bacco, A.; Hui, A. -M.; van de Velde, H.] Millennium Pharmaceut Inc, Cambridge, MA USA	Nantes Universite; CHU de Nantes; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Semmelweis University; Medical University of Lublin; University of Calgary; University of Alberta; Lund University; Skane University Hospital; University Hospital Brno; Christchurch Hospital New Zealand; Rigshospitalet; University of Copenhagen; University of Turin; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Moreau, P (corresponding author), Univ Hosp Hotel Dieu, F-44093 Nantes 01, France.	philippe.moreau@chu-nantes.fr	Ganly, Peter/B-8355-2008; Hajek, Roman/I-6639-2017; Kumar, Shaji K/A-9853-2008; Blimark, Cecilie Hveding/AAZ-6423-2021; Greil, Richard F/C-7673-2017; CAVO, MICHELE/AAK-8274-2020; Kim, Kihyun/D-5175-2013	Hajek, Roman/0000-0001-6955-6267; Kumar, Shaji K/0000-0001-5392-9284; Blimark, Cecilie Hveding/0000-0003-3297-6019; Greil, Richard F/0000-0002-4462-3694; CAVO, MICHELE/0000-0003-4514-3227; Masszi, Tamas/0000-0003-2322-9863; Ganly, Peter/0000-0003-0335-2063; Kim, Kihyun/0000-0002-5878-8895; nahi, hareth/0000-0003-4711-5094; sandhu, irwindeep/0000-0001-9407-6265; Grzasko, Norbert/0000-0001-7727-4307; moreau, philippe/0000-0003-1780-8746; Touzeau, Cyrille/0000-0003-0275-2575; Hari, Parameswaran/0000-0002-8800-297X	Millennium Pharmaceuticals	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Funded by Millennium Pharmaceuticals; TOURMALINE-MM1 ClinicalTrials.gov number, NCT01564537.	Anderson KC, 2011, CLIN CANCER RES, V17, P1225, DOI 10.1158/1078-0432.CCR-10-3366; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Center for Drug Evaluation and Research, 2009, GUID IND PAT REP OUT; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; Durie B, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.25.25; Garderet L, 2012, J CLIN ONCOL, V30, P2475, DOI 10.1200/JCO.2011.37.4918; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kumar SK, 2014, LANCET ONCOL, V15, P1503, DOI 10.1016/S1470-2045(14)71125-8; Kumar SK, 2014, BLOOD, V124, P1047, DOI 10.1182/blood-2014-01-548941; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Laubach J, 2016, LEUKEMIA, V30, P1005, DOI 10.1038/leu.2015.356; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Lonial S, 2005, BLOOD, V106, P3777, DOI 10.1182/blood-2005-03-1173; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Lonial S, 2011, CLIN CANCER RES, V17, P1264, DOI 10.1158/1078-0432.CCR-10-1805; Manier S, 2015, BLOOD, V126; Millennium Pharmaceuticals, 2015, NINLARO IX CAPS OR U; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Osborne TR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-496; Osborne TR, 2012, EUR J HAEMATOL, V89, P437, DOI 10.1111/ejh.12012; Palumbo A, 2014, J CLIN ONCOL, V32, P634, DOI 10.1200/JCO.2013.52.0023; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Richardson PG, 2012, LEUKEMIA, V26, P595, DOI 10.1038/leu.2011.346; Richardson PG, 2014, BLOOD, V124, P1038, DOI 10.1182/blood-2014-01-548826; Rollig C, 2015, LANCET, V385, P2197, DOI 10.1016/S0140-6736(14)60493-1; Rosinol L, 2012, BLOOD, V120, P1589, DOI 10.1182/blood-2012-02-408922; Ross FM, 2012, HAEMATOL-HEMATOL J, V97, P1272, DOI 10.3324/haematol.2011.056176; Siegel D, 2013, HAEMATOLOGICA, V98, P1753, DOI 10.3324/haematol.2013.089334; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321	33	695	722	2	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1621	1634		10.1056/NEJMoa1516282	http://dx.doi.org/10.1056/NEJMoa1516282			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	27119237	Green Published, Bronze			2022-12-28	WOS:000374843400006
J	Rentas, S; Holzapfel, NT; Belew, MS; Pratt, GA; Voisin, V; Wilhelm, BT; Bader, GD; Yeo, GW; Hope, KJ				Rentas, Stefan; Holzapfel, Nicholas T.; Belew, Muluken S.; Pratt, Gabriel A.; Voisin, Veronique; Wilhelm, Brian T.; Bader, Gary D.; Yeo, Gene W.; Hope, Kristin J.			Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells	NATURE			English	Article							CORD BLOOD; EXPRESSION PROFILES; GENOMIC FEATURES; CHIP-SEQ; RNA; POPULATIONS; REGULATOR; MICE; ULTRAFAST; DATASETS	Umbilical cord blood-derived haematopoietic stem cells (HSCs) are essential for many life-saving regenerative therapies. However, despite their advantages for transplantation, their clinical use is restricted because HSCs in cord blood are found only in small numbers(1). Small molecules that enhance haematopoietic stem and progenitor cell (HSPC) expansion in culture have been identified(2,3), but in many cases their mechanisms of action or the nature of the pathways they impinge on are poorly understood. A greater understanding of the molecular circuitry that underpins the selfrenewal of human HSCs will facilitate the development of targeted strategies that expand HSCs for regenerative therapies. Whereas transcription factor networks have been shown to influence the self-renewal and lineage decisions of human HSCs4,5, the posttranscriptional mechanisms that guide HSC fate have not been closely investigated. Here we show that overexpression of the RNA-binding protein Musashi-2 (MSI2) induces multiple pro-self-renewal phenotypes, including a 17-fold increase in short-term repopulating cells and a net 23-fold ex vivo expansion of long-term repopulating HSCs. By performing a global analysis of MSI2-RNA interactions, we show that MSI2 directly attenuates aryl hydrocarbon receptor (AHR) signalling through post-transcriptional downregulation of canonical AHR pathway components in cord blood HSPCs. Our study gives mechanistic insight into RNA networks controlled by RNA-binding proteins that underlie self-renewal and provides evidence that manipulating such networks ex vivo can enhance the regenerative potential of human HSCs.	[Rentas, Stefan; Holzapfel, Nicholas T.; Belew, Muluken S.; Hope, Kristin J.] McMaster Univ, Dept Biochem & Biomed Sci, Stem Cell & Canc Res Inst, Hamilton, ON L8S 4K1, Canada; [Pratt, Gabriel A.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Pratt, Gabriel A.; Yeo, Gene W.] Univ Calif San Diego, Bioinformat Grad Program, La Jolla, CA 92037 USA; [Voisin, Veronique; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Wilhelm, Brian T.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Yeo, Gene W.] Natl Univ Singapore, Dept Physiol, Singapore 138632, Singapore; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore 138632, Singapore	McMaster University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; Universite de Montreal; National University of Singapore; Agency for Science Technology & Research (A*STAR)	Hope, KJ (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Stem Cell & Canc Res Inst, Hamilton, ON L8S 4K1, Canada.; Yeo, GW (corresponding author), Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92037 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Bioinformat Grad Program, La Jolla, CA 92037 USA.; Yeo, GW (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 138632, Singapore.; Yeo, GW (corresponding author), ASTAR, Mol Engn Lab, Singapore 138632, Singapore.	geneyeo@ucsd.edu; kristin@mcmaster.ca	Bader, Gary/C-1176-2009; Yeo, Gene/AAE-7676-2019	Bader, Gary/0000-0003-0185-8861; Yeo, Gene/0000-0002-0799-6037; Hope, Kristin/0000-0003-1449-4948	Ontario Institute for Cancer Research New Investigator Award [IA-033]; Ontario Institute for Cancer Research Cancer Stem Cell Program Team Grant [P.CSC.005]; Canadian Institutes of Health Research [MOP-126030]; CIHR MD/PhD Studentship; NSERC Alexander Graham Bell Doctoral Fellowship; Canadian Blood Services Graduate Fellowship; Health Canada; National Institute of Health [HG004659, NS075449]; California Institute of Regenerative Medicine [RB3-05219]; National Science Graduate Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	Ontario Institute for Cancer Research New Investigator Award; Ontario Institute for Cancer Research Cancer Stem Cell Program Team Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR MD/PhD Studentship(Canadian Institutes of Health Research (CIHR)); NSERC Alexander Graham Bell Doctoral Fellowship; Canadian Blood Services Graduate Fellowship; Health Canada; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Graduate Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Lechman and P. Van Galen for experimental advice and for providing H1 and pSMALB vectors. The MA overexpression vector was a gift from L. Naldini. We also thank the SCC-RI core flow cytometry staff, the Obstetrics and Gynecology Unit at McMaster Children's Hospital for cord blood, B. Doble and M. Bhatia for critical assessment of this work and all members of the Hope laboratory for experimental support and advice. This work was supported by an Ontario Institute for Cancer Research New Investigator Award (IA-033), an Ontario Institute for Cancer Research Cancer Stem Cell Program Team Grant (P.CSC.005) and a Canadian Institutes of Health Research (MOP-126030) grant to K.J.H. N.T.H was supported in part by a CIHR MD/PhD Studentship. M.S.B. was supported by an NSERC Alexander Graham Bell Doctoral Fellowship. S.R. is supported by a Canadian Blood Services Graduate Fellowship and Health Canada. The views expressed herein do not necessarily represent the view of the federal government of Canada. This work was partially supported by grants from the National Institute of Health (HG004659 and NS075449) and the California Institute of Regenerative Medicine (RB3-05219) to G.W.Y. G.P. was supported by a National Science Graduate Fellowship. G.W.Y. is an Alfred P. Sloan Research Fellow. We thank the UCSD Institute for Genomic Medicine's Genomics Center for providing access to high-throughput sequencing facilities.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bagger FO, 2013, NUCLEIC ACIDS RES, V41, pD1034, DOI 10.1093/nar/gks1021; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; CAROW CE, 1993, BLOOD, V81, P942; Cashman JD, 1999, BLOOD, V93, P481, DOI 10.1182/blood.V93.2.481.402k20_481_487; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Darnell Robert, 2012, Cold Spring Harb Protoc, V2012, P1146, DOI 10.1101/pdb.prot072132; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lo R, 2012, TOXICOL SCI, V130, P349, DOI 10.1093/toxsci/kfs253; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Miller PH, 2013, CURR OPIN HEMATOL, V20, P257, DOI 10.1097/MOH.0b013e328360aaf6; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545	37	74	80	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					508	+		10.1038/nature17665	http://dx.doi.org/10.1038/nature17665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121842	Green Accepted			2022-12-28	WOS:000374815900049
J	Mackay, LK; Minnich, M; Kragten, NAM; Liao, Y; Nota, B; Seillet, C; Zaid, A; Man, K; Preston, S; Freestone, D; Braun, A; Wynne-Jones, E; Behr, FM; Stark, R; Pellicci, DG; Godfrey, DI; Belz, GT; Pellegrini, M; Gebhardt, T; Busslinger, M; Shi, W; Carbone, FR; van Lier, RAW; Kallies, A; van Gisbergen, KPJM				Mackay, Laura K.; Minnich, Martina; Kragten, Natasja A. M.; Liao, Yang; Nota, Benjamin; Seillet, Cyril; Zaid, Ali; Man, Kevin; Preston, Simon; Freestone, David; Braun, Asolina; Wynne-Jones, Erica; Behr, Felix M.; Stark, Regina; Pellicci, Daniel G.; Godfrey, Dale I.; Belz, Gabrielle T.; Pellegrini, Marc; Gebhardt, Thomas; Busslinger, Meinrad; Shi, Wei; Carbone, Francis R.; van Lier, Rene A. W.; Kallies, Axel; van Gisbergen, Klaas P. J. M.			Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes	SCIENCE			English	Article							MEMORY T-CELLS; PERIPHERAL-TISSUES; DIFFERENTIATION; INFECTION; IMMUNITY; INNATE; SKIN; BET; PATHWAY; TRIGGER	Tissue-resident memory T (Trm) cells permanently localize to portals of pathogen entry, where they provide immediate protection against reinfection. To enforce tissue retention, Trm cells up-regulate CD69 and down-regulate molecules associated with tissue egress; however, a Trm-specific transcriptional regulator has not been identified. Here, we show that the transcription factor Hobit is specifically up-regulated in Trm cells and, together with related Blimp1, mediates the development of Trm cells in skin, gut, liver, and kidney in mice. The Hobit-Blimp1 transcriptional module is also required for other populations of tissue-resident lymphocytes, including natural killer T (NKT) cells and liver-resident NK cells, all of which share a common transcriptional program. Our results identify Hobit and Blimp1 as central regulators of this universal program that instructs tissue retention in diverse tissue-resident lymphocyte populations.	[Mackay, Laura K.; Zaid, Ali; Freestone, David; Braun, Asolina; Wynne-Jones, Erica; Pellicci, Daniel G.; Godfrey, Dale I.; Gebhardt, Thomas; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Mackay, Laura K.; Pellicci, Daniel G.; Godfrey, Dale I.] Univ Melbourne, ARC, Ctr Excellence Adv Mol Imaging, Melbourne, Vic, Australia; [Minnich, Martina; Busslinger, Meinrad] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Kragten, Natasja A. M.; Behr, Felix M.; Stark, Regina; van Lier, Rene A. W.; van Gisbergen, Klaas P. J. M.] Univ Amsterdam, Acad Med Ctr, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Liao, Yang; Seillet, Cyril; Man, Kevin; Preston, Simon; Behr, Felix M.; Belz, Gabrielle T.; Pellegrini, Marc; Shi, Wei; Kallies, Axel; van Gisbergen, Klaas P. J. M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Liao, Yang; Seillet, Cyril; Man, Kevin; Preston, Simon; Behr, Felix M.; Belz, Gabrielle T.; Pellegrini, Marc; Kallies, Axel; van Gisbergen, Klaas P. J. M.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Nota, Benjamin; Kallies, Axel; van Gisbergen, Klaas P. J. M.] Univ Amsterdam, AMC, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Behr, Felix M.; van Gisbergen, Klaas P. J. M.] AMC, Dept Expt Immunol, Amsterdam, Netherlands; [Shi, Wei; van Gisbergen, Klaas P. J. M.] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Amsterdam; Academic Medical Center Amsterdam; Walter & Eliza Hall Institute; University of Melbourne; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Melbourne	Mackay, LK (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Mackay, LK (corresponding author), Univ Melbourne, ARC, Ctr Excellence Adv Mol Imaging, Melbourne, Vic, Australia.; van Gisbergen, KPJM (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.; Kallies, A; van Gisbergen, KPJM (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.; Kallies, A; van Gisbergen, KPJM (corresponding author), Univ Amsterdam, AMC, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands.; van Gisbergen, KPJM (corresponding author), Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia.		Busslinger, Meinrad J./J-1249-2016; Seillet, Cyril/AAF-1888-2019; Pellicci, Daniel/AAX-8539-2020; Mackay, Laura K/HGC-6580-2022; Carbone, Francis/ABF-2141-2020; Belz, Gabrielle T/C-9350-2013	Busslinger, Meinrad J./0000-0002-9111-9351; Seillet, Cyril/0000-0002-0941-8679; Mackay, Laura K/0000-0002-8496-6632; Belz, Gabrielle T/0000-0002-9660-9587; Godfrey, Dale/0000-0002-3009-5472; Stark, Regina/0000-0001-7693-799X; Nota, Benjamin/0000-0001-7500-5760; Pellicci, Daniel/0000-0001-5305-2398; Gebhardt, Thomas/0000-0002-3768-9468; van Gisbergen, Klaas/0000-0003-3623-7555; Braun, Asolina/0000-0002-2646-5362; , Yang/0000-0002-9746-2839; Man, Kevin/0000-0002-6585-9532; Zaid, Ali/0000-0002-2528-2783; Wynne-Jones, Erica/0000-0003-2661-6981; Behr, Felix M./0000-0002-1158-5011; Kallies, Axel/0000-0002-6312-6968; Pellegrini, Marc/0000-0003-3627-3126; Preston, Simon/0000-0001-8969-8297	ARC [DE140100432]; National Health and Medical Research Council of Australia (NHMRC) [1083685]; Boehringer Ingelheim; European Research Council from the European Community [291740-LymphoControl]; German Research Foundation; Alexander von Humboldt Foundation; NHMRC [1023454, 1054431, 1020770, 1042582, 637345]; Landsteiner Foundation of Blood Transfusion Research [1136]; ARC; Sylvia and Charles Viertel Foundation; Vidi from The Netherlands Organization of Scientific Research [917.13.338]; Victorian State Government; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme	ARC(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Boehringer Ingelheim(Boehringer Ingelheim); European Research Council from the European Community(European Research Council (ERC)); German Research Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Landsteiner Foundation of Blood Transfusion Research; ARC(Australian Research Council); Sylvia and Charles Viertel Foundation; Vidi from The Netherlands Organization of Scientific Research; Victorian State Government; Australian Government NHMRC Independent Research Institute Infrastructure Support scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia)	We wish to thank L. Mackiewicz and R. Gloury for technical support and M. Jaritz for bioinformatics support. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. RNA and ChIP sequencing data have been made available under accession numbers GSE70813 and GSE79339 at GEO. Blimp1-Bio mice are available from M.B. under a material transfer agreement (MTA) with IMP, Blimp1 KO, Blimp1-GFP and Blimp1 x Hobit DKO mice are available from A.K. under an MTA with The Walter and Eliza Hall Institute and Hobit KO and Blimp1 x Hobit DKO mice are available from K.P.J.M.v.G. under an MTA with Sanquin Research. L.K.M. was supported by grant DE140100432 from the ARC and grant 1083685 from the National Health and Medical Research Council of Australia (NHMRC). M.M. and M.B. were supported by the Boehringer Ingelheim and a European Research Council Advanced Grant (291740-LymphoControl) from the European Community's Seventh Framework Programme. A.B. was funded by a Fellowship from the German Research Foundation. R.S. was supported by a Fellowship from the Alexander von Humboldt Foundation. W.S. was supported by grant 1023454 from the NHMRC. N.A.M.K. and R.A.W.v.L. were supported by grant 1136 of the Landsteiner Foundation of Blood Transfusion Research. D.G.P. was supported by an NHMRC Early Career Fellowship (1054431), and D.I.G. was supported by an NHMRC Senior Principal Research Fellowship (1020770). G.T.B. was supported by a fellowship from the ARC and grant 1042582 from the NHMRC. A.K. was supported by a fellowship from the Sylvia and Charles Viertel Foundation and a project grant (637345) from the NHMRC. F.M.B. and K.P.J.M.v.G. were supported by Vidi grant 917.13.338 from The Netherlands Organization of Scientific Research. This work was supported by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; van Gisbergen KPJM, 2012, NAT IMMUNOL, V13, P864, DOI 10.1038/ni.2393; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	30	524	530	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					459	463		10.1126/science.aad2035	http://dx.doi.org/10.1126/science.aad2035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102484				2022-12-28	WOS:000374479700047
J	Lipton, SA; Nordstedt, C				Lipton, Stuart A.; Nordstedt, Christer			Partnering with Big Pharma-What Academics Need to Know	CELL			English	Editorial Material								Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development-pharmacodynamics, pharmacokinetics, and toxicity studies-which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.	[Lipton, Stuart A.] Scintillon Inst, San Diego, CA 92121 USA; [Lipton, Stuart A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Lipton, Stuart A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Nordstedt, Christer] Eli Lilly & Co, Indianapolis, IN 46285 USA	Scripps Research Institute; University of California System; University of California San Diego; Eli Lilly	Lipton, SA (corresponding author), Scintillon Inst, San Diego, CA 92121 USA.; Lipton, SA (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.; Lipton, SA (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	slipton@ucsd.edu		Lipton, Stuart/0000-0002-3490-1259				Dahlin JL, 2015, NAT REV DRUG DISCOV, V14, P279, DOI 10.1038/nrd4578; Rosier JA, 2014, ULLA POSTGRAD PHARM, P1, DOI 10.1002/9781118414873	2	8	8	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					512	515		10.1016/j.cell.2016.04.021	http://dx.doi.org/10.1016/j.cell.2016.04.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104971	Bronze			2022-12-28	WOS:000374636800008
J	Watts, G				Watts, Geoff			Andrew Herxheimer Obituary	LANCET			English	Biographical-Item																		HERXHEIMER A, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1612	1612		10.1016/S0140-6736(16)30210-0	http://dx.doi.org/10.1016/S0140-6736(16)30210-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3ZL	27116063	Bronze			2022-12-28	WOS:000374145100015
J	Cavalcanti, AB; Bozza, FA; Machado, FR; Salluh, JIF; Campagnucci, VP; Vendramim, P; Guimaraes, HP; Normilio-Silva, K; Damiani, LP; Romano, E; Carrara, F; de Souza, JLD; Silva, AR; Ramos, GV; Teixeira, C; da Silva, NB; Chang, CCH; Angus, DC; Berwanger, O				Cavalcanti, Alexandre B.; Bozza, Fernando Augusto; Machado, Flavia R.; Salluh, Jorge I. F.; Campagnucci, Valquiria Pelisser; Vendramim, Patricia; Guimaraes, Helio Penna; Normilio-Silva, Karina; Damiani, Lucas Petri; Romano, Edson; Carrara, Fernanda; Diniz de Souza, Juliana Lubarino; Silva, Aline Reis; Ramos, Grazielle Viana; Teixeira, Cassiano; da Silva, Nilton Brandao; Chang, Chung-Chou H.; Angus, Derek C.; Berwanger, Otavio		Writing Grp CHECKLIST-ICU; Brazilian Res Intensive Care	Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE UNITS; SAFETY CHECKLISTS; CRITERIA; OUTCOMES	IMPORTANCE The effectiveness of checklists, daily goal assessments, and clinician prompts as quality improvement interventions in intensive care units (ICUs) is uncertain. OBJECTIVE To determine whether a multifaceted quality improvement intervention reduces the mortality of critically ill adults. DESIGN, SETTING, AND PARTICIPANTS This study had 2 phases. Phase 1 was an observational study to assess baseline data on work climate, care processes, and clinical outcomes, conducted between August 2013 and March 2014 in 118 Brazilian ICUs. Phase 2 was a cluster randomized trial conducted between April and November 2014 with the same ICUs. The first 60 admissions of longer than 48 hours per ICU were enrolled in each phase. INTERVENTIONS Intensive care units were randomized to a quality improvement intervention, including a daily checklist and goal setting during multidisciplinary rounds with follow-up clinician prompting for 11 care processes, or to routine care. MAIN OUTCOMES AND MEASURES In-hospital mortality truncated at 60 days (primary outcome) was analyzed using a random-effects logistic regression model, adjusted for patients' severity and the ICU's baseline standardized mortality ratio. Exploratory secondary outcomes included adherence to care processes, safety climate, and clinical events. RESULTS A total of 6877 patients (mean age, 59.7 years; 3218 [46.8%] women) were enrolled in the baseline (observational) phase and 6761 (mean age, 59.6 years; 3098 [45.8%] women) in the randomized phase, with 3327 patients enrolled in ICUs (n = 59) assigned to the intervention group and 3434 patients in ICUs (n = 59) assigned to routine care. There was no significant difference in in-hospital mortality between the intervention group and the usual care group, with 1096 deaths (32.9%) and 1196 deaths (34.8%), respectively (odds ratio, 1.02; 95% CI, 0.82-1.26; P = .88). Among 20 prespecified secondary outcomes not adjusted for multiple comparisons, 6 were significantly improved in the intervention group (use of low tidal volumes, avoidance of heavy sedation, use of central venous catheters, use of urinary catheters, perception of team work, and perception of patient safety climate), whereas there were no significant differences between the intervention group and the control group for 14 outcomes (ICU mortality, central line-associated bloodstream infection, ventilator-associated pneumonia, urinary tract infection, mean ventilator-free days, mean ICU length of stay, mean hospital length of stay, bed elevation to >= 30 degrees, venous thromboembolism prophylaxis, diet administration, job satisfaction, stress reduction, perception of management, and perception of working conditions). CONCLUSIONS AND RELEVANCE Among critically ill patients treated in ICUs in Brazil, implementation of a multifaceted quality improvement intervention with daily checklists, goal setting, and clinician prompting did not reduce in-hospital mortality.	[Cavalcanti, Alexandre B.; Guimaraes, Helio Penna; Normilio-Silva, Karina; Damiani, Lucas Petri; Romano, Edson; Berwanger, Otavio] HCor Hosp Coracao, Res Inst, Rua Abilio Soares 250,12th Floor, BR-04005000 Sao Paulo, SP, Brazil; [Bozza, Fernando Augusto; Salluh, Jorge I. F.; Silva, Aline Reis; Ramos, Grazielle Viana] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Bozza, Fernando Augusto] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Machado, Flavia R.; Carrara, Fernanda; Diniz de Souza, Juliana Lubarino] Latin Amer Sepsis Inst, Sao Paulo, Brazil; [Campagnucci, Valquiria Pelisser; Vendramim, Patricia] Hosp Samaritano, Sao Paulo, Brazil; [Teixeira, Cassiano; da Silva, Nilton Brandao] Hosp Moinhos Vento, Porto Alegre, RS, Brazil; [Chang, Chung-Chou H.; Angus, Derek C.] Univ Pittsburgh, Pittsburgh, PA USA	Hospital do Coracao - HCor; IDOR - Instituto D'Or de Ensino e Pesquisa; Fundacao Oswaldo Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cavalcanti, AB (corresponding author), HCor Hosp Coracao, Res Inst, Rua Abilio Soares 250,12th Floor, BR-04005000 Sao Paulo, SP, Brazil.	abiasi@hcor.com.br	Salluh, Jorge/AAF-2682-2021; Angus, Derek C/E-9671-2012; Borges, Marcos Carvalho/A-3585-2014; Bozza, Fernando A/A-2618-2013; de Carvalho, Frederico Bruzzi/ABB-3911-2020; Teixeira, Cassiano/V-8764-2019; dantas, vicente c souza/L-2648-2013; Guimaraes, Helio Penna/AAD-8681-2019; Cavalcanti, Alexandre/K-5529-2013; Damiani, Lucas/F-8576-2015; Ho, Yeh-Li/A-7197-2013	Salluh, Jorge/0000-0002-8164-1453; Borges, Marcos Carvalho/0000-0001-6280-0714; Bozza, Fernando A/0000-0003-4878-0256; de Carvalho, Frederico Bruzzi/0000-0002-9752-5625; Azevedo Randi, Bruno/0000-0002-6312-6669; Pereira da Silva, Eliane/0000-0002-3364-5046; Schilling Rosenfeld, Ricardo/0000-0002-4144-3372; Cavalcanti, Alexandre/0000-0003-2798-6263; Damiani, Lucas/0000-0002-5836-3379; Ho, Yeh-Li/0000-0001-8719-2508	Brazilian Health Surveillance Agency (ANVISA); PROADI; Brazilian Development Bank (BNDES); D'Or Institute for Research and Education	Brazilian Health Surveillance Agency (ANVISA); PROADI; Brazilian Development Bank (BNDES); D'Or Institute for Research and Education	This study was conducted as part of the Program to Support Institutional Development of Universal Health System (PROADI) from the Brazilian Ministry of Health. It was funded mainly by the Brazilian Health Surveillance Agency (ANVISA), PROADI, and Brazilian Development Bank (BNDES). D'Or Institute for Research and Education also contributed with additional funding.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; BROWMAN GP, 1995, J CLIN ONCOL, V13, P502, DOI 10.1200/JCO.1995.13.2.502; CARVALHO REE, 2011, ADAPTACAO TRANSCULTU; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Damiani LP, 2015, CRIT CARE RESUSC, V17, P113; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dondorpa AM, 2014, T ROY SOC TROP MED H, V108, P453, DOI 10.1093/trstmh/tru099; DuBose J, 2010, J TRAUMA, V69, P855, DOI 10.1097/TA.0b013e3181c4526f; Finkelstein A, 2015, SCIENCE, V347, P720, DOI 10.1126/science.aaa2362; Giraudeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040436; Rigobello MCG, 2012, ACTA PAUL ENFERM, V25, P728, DOI 10.1590/S0103-21002012000500013; Harhay MO, 2014, AM J RESP CRIT CARE, V189, P1469, DOI 10.1164/rccm.201401-0056CP; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Klompas M, 2014, INFECT CONT HOSP EP, V35, P915, DOI [10.1017/S0899823X00193894, 10.1086/677144]; Ko HCH, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-211; Leon AC, 2005, J BIOPHARM STAT, V15, P839, DOI 10.1081/BIP-200067922; Marsteller JA, 2012, CRIT CARE MED, V40, P2933, DOI 10.1097/CCM.0b013e31825fd4d8; Minkov M., 2010, CULTURES ORG SOFTWAR, V3; Niel-Weise BS, 2011, CRIT CARE, V15, DOI 10.1186/cc10135; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Russ S, 2013, ANN SURG, V258, P856, DOI 10.1097/SLA.0000000000000206; Scales DC, 2011, JAMA-J AM MED ASSOC, V305, P363, DOI 10.1001/jama.2010.2000; Sexton JB, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-44; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vincent JL, 2005, CRIT CARE MED, V33, P1225, DOI 10.1097/01.CCM.0000165962.16682.46; Walsh TS, 2004, BRIT J ANAESTH, V92, P793, DOI 10.1093/bja/aeh139; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC; [No title captured]; [No title captured]	37	94	100	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1480	1490		10.1001/jama.2016.3463	http://dx.doi.org/10.1001/jama.2016.3463			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115264	Bronze			2022-12-28	WOS:000373873800014
J	[Anonymous]				[Anonymous]			Safety of Testosterone Replacement Therapy (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 58, pg 33, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							MEN; METAANALYSIS; EVENTS											Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Boyle P, 2016, BJU INT, V118, P731, DOI 10.1111/bju.13417; Corona G, 2014, EXPERT OPIN DRUG SAF, V13, P1327, DOI 10.1517/14740338.2014.950653; Michaud JE, 2015, THER ADV UROL, V7, P378, DOI 10.1177/1756287215597633; Morgentaler A, 2015, MAYO CLIN PROC, V90, P224, DOI 10.1016/j.mayocp.2014.10.011; Sharma R, 2015, EUR HEART J, V36, P2706, DOI 10.1093/eurheartj/ehv346; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108; 2016, MED LETT DRUGS THER, V58, P33	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1512	1513		10.1001/jama.2016.3450	http://dx.doi.org/10.1001/jama.2016.3450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115268				2022-12-28	WOS:000373873800018
J	Broockman, D; Kalla, J				Broockman, David; Kalla, Joshua			Durably reducing transphobia: A field experiment on door-to-door canvassing	SCIENCE			English	Article							PREJUDICE; ATTITUDES; CONTACT	Existing research depicts intergroup prejudices as deeply ingrained, requiring intense intervention to lastingly reduce. Here, we show that a single approximately 10-minute conversation encouraging actively taking the perspective of others can markedly reduce prejudice for at least 3 months. We illustrate this potential with a door-to-door canvassing intervention in South Florida targeting antitransgender prejudice. Despite declines in homophobia, transphobia remains pervasive. For the intervention, 56 canvassers went door to door encouraging active perspective-taking with 501 voters at voters' doorsteps. A randomized trial found that these conversations substantially reduced transphobia, with decreases greater than Americans' average decrease in homophobia from 1998 to 2012. These effects persisted for 3 months, and both transgender and nontransgender canvassers were effective. The intervention also increased support for a nondiscrimination law, even after exposing voters to counterarguments.	[Broockman, David] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Kalla, Joshua] Univ Calif Berkeley, Dept Polit Sci, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	Broockman, D (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	dbroockman@stanford.edu			Gill Foundation; National Science Foundation Graduate Research Fellowship Program	Gill Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	The authors acknowledge funding from the Gill Foundation for this research. D.B. acknowledges the National Science Foundation Graduate Research Fellowship Program for support while conducting this research. Replication data and code are available at http://dx.doi.org/10.7910/DVN/WKR39N. Neither of the authors is affiliated with the Los Angeles LGBT Center or SAVE or received compensation for this research. A preanalysis plan was filed after the data were collected but before they were analyzed with the treatment indicator, and revised preanalysis plans were also filed before the 3-week and 6-week surveys. These are available at the Evidence in Governance and Politics site (www.egap.org), ID 20150707AA. This research was approved by the University of California-Berkeley Committee for the Protection of Human Subjects, Protocol ID 2015-04-7508.	Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; Cook S.W., 1969, NEBRASKA S MOTIVATIO, V17, P179; Enos RD, 2014, P NATL ACAD SCI USA, V111, P3699, DOI 10.1073/pnas.1317670111; Fernandez Manny, 2015, NY TIMES, pTexas; Finkel EJ, 2013, PSYCHOL SCI, V24, P1595, DOI 10.1177/0956797612474938; Flores AR, 2015, POLIT GROUPS IDENTIT, V3, P398, DOI 10.1080/21565503.2015.1050414; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Gehlbach H., 2012, TEACH COLL REC, V114, P226; Gerber AS, 2011, AM POLIT SCI REV, V105, P135, DOI 10.1017/S000305541000047X; Han Hahrie, 2014, ORG DEV ACTIVISTS CI; Hill SJ, 2013, POLIT COMMUN, V30, P521, DOI 10.1080/10584609.2013.828143; Ku G, 2015, RES ORGAN BEHAV, V35, P79, DOI 10.1016/j.riob.2015.07.003; LaCour MJ, 2014, SCIENCE, V346, P1366, DOI 10.1126/science.1256151; McGee H., 2015, IRISH TIMES 0514; MCNUTT M, 2015, SCIENCE, V348, P1100; Nickerson DW, 2010, PSYCHOL SCI, V21, P194, DOI 10.1177/0956797609359326; Nickerson DW, 2005, POLIT ANAL, V13, P233, DOI 10.1093/pan/mpi015; Paluck EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138610; Paluck EL, 2009, J PERS SOC PSYCHOL, V96, P574, DOI 10.1037/a0011989; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Panagopoulos C, 2016, PARTY POLIT, V22, P179, DOI 10.1177/1354068815605676; Pettigrew TF, 1998, ANNU REV SOCIOL, V24, P77, DOI 10.1146/annurev.soc.24.1.77; Petty R. E., 1995, ATTITUDE STRENGTH AN, P93; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Sherrill K, 1996, PS, V29, P469, DOI 10.2307/420826; Skocpol T, 2003, DIMINISHED DEMOCRACY; Tesler M, 2015, AM J POLIT SCI, V59, P806, DOI 10.1111/ajps.12157; Todd AR, 2014, SOC PERSONAL PSYCHOL, V8, P374, DOI 10.1111/spc3.12116; Van Laar C, 2005, J EXP SOC PSYCHOL, V41, P329, DOI 10.1016/j.jesp.2004.08.002; Yang AS, 1997, PUBLIC OPIN QUART, V61, P477, DOI 10.1086/297810; Zaller JohnR., 1992, NATURE ORIGINS MASS	31	258	259	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					220	224		10.1126/science.aad9713	http://dx.doi.org/10.1126/science.aad9713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI7LM	27124458	Green Published			2022-12-28	WOS:000373681600045
J	Geraedts, SD; Zaletel, MP; Mong, RSK; Metlitski, MA; Vishwanath, A; Motrunich, OI				Geraedts, Scott D.; Zaletel, Michael P.; Mong, Roger S. K.; Metlitski, Max A.; Vishwanath, Ashvin; Motrunich, Olexei I.			The half-filled Landau level: The case for Dirac composite fermions	SCIENCE			English	Article							LIQUID-LIKE STATE; QUANTUM HALL; SURFACE; ENERGY; CONDUCTANCE; NU=1/2; SYSTEM	In a two-dimensional electron gas under a strong magnetic field, correlations generate emergent excitations distinct from electrons. It has been predicted that "composite fermions"-bound states of an electron with two magnetic flux quanta-can experience zero net magnetic field and form a Fermi sea. Using infinite-cylinder density matrix renormalization group numerical simulations, we verify the existence of this exotic Fermi sea, but find that the phase exhibits particle-hole symmetry. This is self-consistent only if composite fermions are massless Dirac particles, similar to the surface of a topological insulator. Exploiting this analogy, we observe the suppression of 2kF backscattering, a characteristic of Dirac particles. Thus, the phenomenology of Dirac fermions is also relevant to two-dimensional electron gases in the quantum Hall regime.	[Geraedts, Scott D.; Mong, Roger S. K.; Motrunich, Olexei I.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Geraedts, Scott D.; Mong, Roger S. K.; Motrunich, Olexei I.] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Zaletel, Michael P.] Microsoft Res, Stn Q, Santa Barbara, CA 93106 USA; [Mong, Roger S. K.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Mong, Roger S. K.; Motrunich, Olexei I.] CALTECH, Walter Burke Inst Theoret Phys, Pasadena, CA 91125 USA; [Metlitski, Max A.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Metlitski, Max A.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Vishwanath, Ashvin] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Vishwanath, Ashvin] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	California Institute of Technology; California Institute of Technology; Microsoft; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Institute of Technology; Perimeter Institute for Theoretical Physics; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Motrunich, OI (corresponding author), CALTECH, Dept Phys, Pasadena, CA 91125 USA.; Motrunich, OI (corresponding author), CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA.; Motrunich, OI (corresponding author), CALTECH, Walter Burke Inst Theoret Phys, Pasadena, CA 91125 USA.	motrunch@caltech.edu	Vishwanath, Ashvin/AAO-6878-2020		National Science Engineering Research Council of Canada; U.S. Department of Energy BES [de-sc0002140]; Sherman Fairchild Foundation; U.S. Army Research Office [W911NF-14-1-0379]; Simons Investigator Award; NSF [PHY11-25915, DMR 1206096]; Caltech Institute for Quantum Information and Matter; NSF Physics Frontiers Center; Division Of Materials Research [1206096] Funding Source: National Science Foundation	National Science Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy BES(United States Department of Energy (DOE)); Sherman Fairchild Foundation; U.S. Army Research Office; Simons Investigator Award; NSF(National Science Foundation (NSF)); Caltech Institute for Quantum Information and Matter; NSF Physics Frontiers Center(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We enjoyed conversations with M. Barkeshli, M. Fisher, D. Haldane, R. Mishmash, C. Nayak, N. Read, E. Rezayi, D. Son, and T. Senthil. We particularly thank M. Barkeshli for first bringing the enigma of PH symmetry to our attention. R. M. and A.V. acknowledge KITP for hospitality. Supported by the National Science Engineering Research Council of Canada and U.S. Department of Energy BES grant de-sc0002140 (S.G.), the Sherman Fairchild Foundation (R. M.), U.S. Army Research Office grant W911NF-14-1-0379 (M. M.), a Simons Investigator Award (A.V.), NSF grant PHY11-25915 (R. M. and A.V.), NSF grant DMR 1206096 (S.G. and O.I.M.), and the Caltech Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation. During the completion of this work, reference (53) appeared, which also provides a theoretical discussion of the PH-symmetric CFL.	ALTSHULER BL, 1994, PHYS REV B, V50, P14048, DOI 10.1103/PhysRevB.50.14048; Barkeshli M, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.165125; Calabrese P, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/50/504005; Son DT, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031027; Fidkowski L, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041016; GOLDMAN VJ, 1994, PHYS REV LETT, V72, P2065, DOI 10.1103/PhysRevLett.72.2065; HALPERIN BI, 1993, PHYS REV B, V47, P7312, DOI 10.1103/PhysRevB.47.7312; HALPERIN BI, 1983, HELV PHYS ACTA, V56, P75; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Kamburov D, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.196801; KANG W, 1993, PHYS REV LETT, V71, P3850, DOI 10.1103/PhysRevLett.71.3850; KIM YB, 1994, PHYS REV B, V50, P17917, DOI 10.1103/PhysRevB.50.17917; Kivelson SA, 1997, PHYS REV B, V55, P15552, DOI 10.1103/PhysRevB.55.15552; Kukushkin IV, 1999, PHYS REV LETT, V82, P3665, DOI 10.1103/PhysRevLett.82.3665; Lee DH, 1998, PHYS REV LETT, V80, P4745, DOI 10.1103/PhysRevLett.80.4745; Lee SS, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165102; Li H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.010504; LOPEZ A, 1991, PHYS REV B, V44, P5246, DOI 10.1103/PhysRevB.44.5246; LUTTINGER JM, 1960, PHYS REV, V119, P1153, DOI 10.1103/PhysRev.119.1153; Metlitski MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075127; Metlitski MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075128; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Morf RH, 1998, PHYS REV LETT, V80, P1505, DOI 10.1103/PhysRevLett.80.1505; Mross DF, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011011; Mross DF, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045121; Murthy G, 2003, REV MOD PHYS, V75, P1101, DOI 10.1103/RevModPhys.75.1101; NAYAK C, 1994, NUCL PHYS B, V430, P534, DOI 10.1016/0550-3213(94)90158-9; NAYAK C, 1994, NUCL PHYS B, V417, P359, DOI 10.1016/0550-3213(94)90477-4; Papic Z, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.266806; POLCHINSKI J, 1994, NUCL PHYS B, V422, P617, DOI 10.1016/0550-3213(94)90449-9; Pollmann F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.255701; Read N, 1998, PHYS REV B, V58, P16262, DOI 10.1103/PhysRevB.58.16262; REZAYI E, 1994, PHYS REV LETT, V72, P900, DOI 10.1103/PhysRevLett.72.900; Rezayi EH, 2000, PHYS REV LETT, V84, P4685, DOI 10.1103/PhysRevLett.84.4685; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Smet JH, 1996, PHYS REV LETT, V77, P2272, DOI 10.1103/PhysRevLett.77.2272; Tagliacozzo L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024410; Varjas D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.155314; Wang C, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.085110; Wang C, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041031; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776; WILLETT RL, 1993, PHYS REV LETT, V71, P3846, DOI 10.1103/PhysRevLett.71.3846; Zaletel MP, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.045115; Zhang T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266803	47	105	105	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					197	201		10.1126/science.aad4302	http://dx.doi.org/10.1126/science.aad4302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124453	Green Accepted, Green Submitted			2022-12-28	WOS:000373681600039
J	Chaturvedi, S; McCrae, KR				Chaturvedi, Shruti; McCrae, Keith R.			Treatment of chronic immune thrombocytopenia in children with romiplostim	LANCET			English	Editorial Material							CONTROLLED-TRIAL; ELTROMBOPAG; ITP; MULTICENTER; MANAGEMENT; REMISSION; EFFICACY; SAFETY		[Chaturvedi, Shruti] Vanderbilt Univ, Med Ctr, Div Hematol & Oncol, Dept Med, Nashville, TN USA; [McCrae, Keith R.] Cleveland Clin, Dept Hematol & Oncol, Cleveland, OH 44195 USA; [McCrae, Keith R.] Cleveland Clin, Cellular & Mol Med, Cleveland, OH 44195 USA	Vanderbilt University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	McCrae, KR (corresponding author), Cleveland Clin, Dept Hematol & Oncol, Cleveland, OH 44195 USA.; McCrae, KR (corresponding author), Cleveland Clin, Cellular & Mol Med, Cleveland, OH 44195 USA.	mccraek@ccf.org						Boyle S, 2013, BLOOD, V121, P4782, DOI 10.1182/blood-2012-12-467068; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; Bussel JB, 2015, LANCET HAEMATOL, V2, pE315, DOI 10.1016/S2352-3026(15)00114-3; Bussel JB, 2015, PEDIATR BLOOD CANCER, V62, P208, DOI 10.1002/pbc.25136; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Cines DB, 2015, INT J HEMATOL, V102, P259, DOI 10.1007/s12185-015-1837-6; Cooper N, 2014, BRIT J HAEMATOL, V165, P756, DOI 10.1111/bjh.12889; Gernsheimer TB, 2010, J THROMB HAEMOST, V8, P1372, DOI 10.1111/j.1538-7836.2010.03830.x; Grainger JD, 2015, LANCET, V386, P1649, DOI 10.1016/S0140-6736(15)61107-2; Gonzalez-Lopez TJ, 2015, AM J HEMATOL, V90, pE40, DOI 10.1002/ajh.23900; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Newland A, 2016, BRIT J HAEMATOL, V172, P262, DOI 10.1111/bjh.13827; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Tarantino MDB, 2016, LANCET	15	1	1	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					4	6		10.1016/S0140-6736(16)00589-4	http://dx.doi.org/10.1016/S0140-6736(16)00589-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27103125				2022-12-28	WOS:000378828400005
J	Anthenelli, RM; Benowitz, NL; West, R; St Aubin, L; McRae, T; Lawrence, D; Ascher, J; Russ, C; Krishen, A; Evins, AE				Anthenelli, Robert M.; Benowitz, Neal L.; West, Robert; St Aubin, Lisa; McRae, Thomas; Lawrence, David; Ascher, John; Russ, Cristina; Krishen, Alok; Evins, A. Eden			Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial	LANCET			English	Article							SMOKING-CESSATION; ADVERSE EVENTS; RISK; SCHIZOPHRENIA; DEPRESSION; ABSTINENCE; SUICIDE	Background Substantial concerns have been raised about the neuropsychiatric safety of the smoking cessation medications varenicline and bupropion. Their efficacy relative to nicotine patch largely relies on indirect comparisons, and there is limited information on safety and efficacy in smokers with psychiatric disorders. We compared the relative neuropsychiatric safety risk and efficacy of varenicline and bupropion with nicotine patch and placebo in smokers with and without psychiatric disorders. Methods We did a randomised, double-blind, triple-dummy, placebo-controlled and active-controlled (nicotine patch; 21 mg per day with taper) trial of varenicline (1 mg twice a day) and bupropion (150 mg twice a day) for 12 weeks with 12-week non-treatment follow-up done at 140 centres (clinical trial centres, academic centres, and outpatient clinics) in 16 countries between Nov 30, 2011, and Jan 13, 2015. Participants were motivated-to-quit smokers with and without psychiatric disorders who received brief cessation counselling at each visit. Randomisation was computer generated (1: 1: 1: 1 ratio). Participants, investigators, and research personnel were masked to treatment assignments. The primary endpoint was the incidence of a composite measure of moderate and severe neuropsychiatric adverse events. The main efficacy endpoint was biochemically confirmed continuous abstinence for weeks 9-12. All participants randomly assigned were included in the efficacy analysis and those who received treatment were included in the safety analysis. The trial is registered at ClinicalTrials.gov (number NCT01456936) and is now closed. Findings 8144 participants were randomly assigned, 4116 to the psychiatric cohort (4074 included in the safety analysis) and 4028 to the non-psychiatric cohort (3984 included in the safety analysis). In the non-psychiatric cohort, 13 (1.3%) of 990 participants reported moderate and severe neuropsychiatric adverse events in the varenicline group, 22 (2.2%) of 989 in the bupropion group, 25 (2.5%) of 1006 in the nicotine patch group, and 24 (2.4%) of 999 in the placebo group. The varenicline-placebo and bupropion-placebo risk differences (RDs) for moderate and severe neuropsychiatric adverse events were -1.28 (95% CI -2.40 to -0.15) and -0.08 (-1.37 to 1.21), respectively; the RDs for comparisons with nicotine patch were -1.07 (-2.21 to 0.08) and 0.13 (-1.19 to 1.45), respectively. In the psychiatric cohort, moderate and severe neuropsychiatric adverse events were reported in 67 (6.5%) of 1026 participants in the varenicline group, 68 (6.7%) of 1017 in the bupropion group, 53 (5.2%) of 1016 in the nicotine patch group, and 50 (4.9%) of 1015 in the placebo group. The varenicline-placebo and bupropion-placebo RDs were 1.59 (95% CI -0.42 to 3.59) and 1.78 (-0.24 to 3.81), respectively; the RDs versus nicotine patch were 1.22 (-0.81 to 3.25) and 1.42 (-0.63 to 3.46), respectively. Varenicline-treated participants achieved higher abstinence rates than those on placebo (odds ratio [OR] 3.61, 95% CI 3.07 to 4.24), nicotine patch (1.68, 1.46 to 1.93), and bupropion (1.75, 1.52 to 2.01). Those on bupropion and nicotine patch achieved higher abstinence rates than those on placebo (OR 2.07 [1.75 to 2.45] and 2.15 [1.82 to 2.54], respectively). Across cohorts, the most frequent adverse events by treatment group were nausea (varenicline, 25% [511 of 2016 participants]), insomnia (bupropion, 12% [245 of 2006 participants]), abnormal dreams (nicotine patch, 12% [251 of 2022 participants]), and headache (placebo, 10% [199 of 2014 participants]). Efficacy treatment comparison did not differ by cohort. Interpretation The study did not show a significant increase in neuropsychiatric adverse events attributable to varenicline or bupropion relative to nicotine patch or placebo. Varenicline was more effective than placebo, nicotine patch, and bupropion in helping smokers achieve abstinence, whereas bupropion and nicotine patch were more effective than placebo.	[Anthenelli, Robert M.] Univ Calif San Diego, San Diego, CA 92103 USA; [Benowitz, Neal L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [West, Robert] UCL, London, England; [St Aubin, Lisa; McRae, Thomas; Lawrence, David; Russ, Cristina] Pfizer, New York, NY USA; [Ascher, John] GSK, Res Triangle Pk, NC USA; [Krishen, Alok] GSK, PAREXEL Int, Res Triangle Pk, NC USA; [Evins, A. Eden] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Evins, A. Eden] Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; University of London; University College London; Pfizer; GlaxoSmithKline; GlaxoSmithKline; Parexel International; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Anthenelli, RM (corresponding author), Univ Calif San Diego, Dept Psychiat, Hlth Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ranthenelli@ucsd.edu	West, Robert/B-5414-2009	West, Robert/0000-0001-6398-0921	Pfizer; Cancer Research UK [14135] Funding Source: researchfish	Pfizer(Pfizer); Cancer Research UK(Cancer Research UK)	We thank the investigators and study site personnel involved in the study. They or their institutions were compensated for their contributions by Pfizer and GlaxoSmithKline. Editorial support (in the form of creating tables and figures, formatting references, collating review comments, and proofing and formatting for submission) was provided by Anne Jakobsen and Abegale Templar (Engage Scientific, Horsham, UK) and funded by Pfizer.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890420249, DOI 10.1176/APPI.BOOKS.9780890420249]; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Baker TB, 2016, JAMA-J AM MED ASSOC, V315, P371, DOI 10.1001/jama.2015.19284; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Cinciripini PM, 2013, JAMA PSYCHIAT, V70, P522, DOI 10.1001/jamapsychiatry.2013.678; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Fiore MC, 2008, TREATING TOBACCO USE; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Freedman R, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07020326; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Institute for Safe Medication Practices, 2014, QUART WATCH MON FDA; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; Kotz D, 2015, LANCET RESP MED, V3, P761, DOI 10.1016/S2213-2600(15)00320-3; Molero Y, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2388; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Pasternak B, 2013, ADDICTION, V108, P1336, DOI 10.1111/add.12165; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Smith AL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007301; Thomas KH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1109; Thomas KH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5704; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; US Food and Drug Administration, 2014, JOINT M PSYCH DRUGS; US Food and Drug Administration, 2009, FDA DRUG SAFETY NEWS, V2; World Medical Association, 2008, WORLD MED ASS DECL H; Yousefi M. K., 2011, J ADDICT RES THER, pS4; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	519	533	5	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2016	387	10037					2507	2520		10.1016/S0140-6736(16)30272-0	http://dx.doi.org/10.1016/S0140-6736(16)30272-0			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO7FG	27116918	Green Submitted, Green Published			2022-12-28	WOS:000377947200028
J	Shaw, MH; Shurtleff, VW; Terrett, JA; Cuthbertson, JD; MacMillan, DWC				Shaw, Megan H.; Shurtleff, Valerie W.; Terrett, Jack A.; Cuthbertson, James D.; MacMillan, David W. C.			Native functionality in triple catalytic cross-coupling: sp(3) C-H bonds as latent nucleophiles	SCIENCE			English	Article							PHOTOREDOX CATALYSIS; C(SP(3))-H ARYLATION; ALPHA-ARYLATION; ARYL HALIDES; OXIDATION; STRATEGY; AMINES; ACIDS	The use of sp(3) C-H bonds-which are ubiquitous in organic molecules-as latent nucleophile equivalents for transition metal-catalyzed cross-coupling reactions has the potential to substantially streamline synthetic efforts in organic chemistry while bypassing substrate activation steps. Through the combination of photoredox-mediated hydrogen atom transfer (HAT) and nickel catalysis, we have developed a highly selective and general C-H arylation protocol that activates a wide array of C-H bonds as native functional handles for cross-coupling. This mild approach takes advantage of a tunable HAT catalyst that exhibits predictable reactivity patterns based on enthalpic and bond polarity considerations to selectively functionalize a-amino and a-oxy sp(3) C-H bonds in both cyclic and acyclic systems.	[Shaw, Megan H.; Shurtleff, Valerie W.; Terrett, Jack A.; Cuthbertson, James D.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Cuthbertson, James/0000-0003-3820-6816	NIH National Institute of General Medical Sciences [R01 GM078201-05]; Bristol-Myers Squibb; Marie Curie Actions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Marie Curie Actions(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for financial support provided by the NIH National Institute of General Medical Sciences (R01 GM078201-05) and gifts from Merck and AbbVie. V.W.S. and J.A.T. thank Bristol-Myers Squibb for graduate fellowships. J.D.C. thanks Marie Curie Actions for an International Outgoing Fellowship.	Anka-Lufford LL, 2012, J ORG CHEM, V77, P9989, DOI 10.1021/jo302086g; Beller M., 2004, TRANSITION METALS OR, V1; Campos KR, 2006, J AM CHEM SOC, V128, P3538, DOI 10.1021/ja0605265; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cuthbertson JD, 2015, NATURE, V519, P74, DOI 10.1038/nature14255; DE MEIJERE A, 1994, ANGEW CHEM INT EDIT, V33, P2379, DOI 10.1002/anie.199423791; Diederich F., 2004, METAL CATALYZED CROS, V1; Durandetti M, 1996, NEW J CHEM, V20, P659; Goossen LJ, 2006, SCIENCE, V313, P662, DOI 10.1126/science.1128684; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; Jeffrey JL, 2015, SCIENCE, V349, P1532, DOI 10.1126/science.aac8555; Jin J, 2015, NATURE, V525, P87, DOI 10.1038/nature14885; Lee M, 2015, J AM CHEM SOC, V137, P12796, DOI 10.1021/jacs.5b09099; Lewis JC, 2011, CHEM SOC REV, V40, P2003, DOI 10.1039/c0cs00067a; Liu D, 2015, ORG LETT, V17, P998, DOI 10.1021/acs.orglett.5b00104; Liu D, 2013, ANGEW CHEM INT EDIT, V52, P4453, DOI 10.1002/anie.201300459; Lo JCL, 2014, NATURE, V516, P343, DOI 10.1038/nature14006; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Luo Y.-R., 2003, HDB BOND DISSOCIATIO; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; Pastine SJ, 2006, J AM CHEM SOC, V128, P14220, DOI 10.1021/ja064481j; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; Rodriguez N, 2011, CHEM SOC REV, V40, P5030, DOI 10.1039/c1cs15093f; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Terrett JA, 2015, NATURE, V524, P330, DOI 10.1038/nature14875; Topczewski JJ, 2016, NATURE, V531, P220, DOI 10.1038/nature16957; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Zaitsev VG, 2005, J AM CHEM SOC, V127, P13154, DOI 10.1021/ja054549f; Zhang FL, 2016, SCIENCE, V351, P252, DOI 10.1126/science.aad7893; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	35	382	385	20	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2016	352	6291					1304	1308		10.1126/science.aaf6635	http://dx.doi.org/10.1126/science.aaf6635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO7ON	27127237	Green Accepted			2022-12-28	WOS:000377972000037
J	de Mestral, C				de Mestral, Charles			Simple pharmacological prophylaxis for post-ERCP pancreatitis	LANCET			English	Editorial Material							RECTAL INDOMETHACIN		[de Mestral, Charles] Univ Toronto, Toronto Gen Hosp, Dept Surg, 100 Coll St, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	de Mestral, C (corresponding author), Univ Toronto, Toronto Gen Hosp, Dept Surg, 100 Coll St, Toronto, ON M5G 2C4, Canada.	charles.demestral@mail.utoronto.ca						Dobronte Z, 2014, WORLD J GASTROENTERO, V20, P10151, DOI 10.3748/wjg.v20.i29.10151; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; Andrade-Davila VF, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0314-2; Kochar B, 2015, GASTROINTEST ENDOSC, V81, P143, DOI 10.1016/j.gie.2014.06.045; Levenick JM, 2016, GASTROENTEROLOGY, V150, P911, DOI 10.1053/j.gastro.2015.12.040; Luo H, 2016, LANCET, V387, P2293, DOI 10.1016/S0140-6736(16)30310-5; Puig I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092922; Yaghoobi M, 2013, ALIMENT PHARM THER, V38, P995, DOI 10.1111/apt.12488	8	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2265	2266		10.1016/S0140-6736(16)30312-9	http://dx.doi.org/10.1016/S0140-6736(16)30312-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27133970				2022-12-28	WOS:000376969100004
J	Luo, H; Zhao, LN; Leung, J; Zhang, RC; Liu, ZG; Wang, XP; Wang, BL; Nie, ZG; Lei, T; Li, X; Zhou, WC; Zhang, LG; Wang, Q; Li, M; Zhou, Y; Liu, Q; Sun, H; Wang, Z; Liang, SH; Guo, XY; Tao, Q; Wu, KC; Pan, YL; Guo, XG; Fan, DM				Luo, Hui; Zhao, Lina; Leung, Joseph; Zhang, Rongchun; Liu, Zhiguo; Wang, Xiangping; Wang, Biaoluo; Nie, Zhanguo; Lei, Ting; Li, Xun; Zhou, Wence; Zhang, Lingen; Wang, Qi; Li, Ming; Zhou, Yi; Liu, Qian; Sun, Hao; Wang, Zheng; Liang, Shuhui; Guo, Xiaoyang; Tao, Qin; Wu, Kaichun; Pan, Yanglin; Guo, Xuegang; Fan, Daiming			Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ERCP PANCREATITIS; RISK-FACTORS; CLINICAL-TRIAL; COMPLICATIONS; METAANALYSIS; SOMATOSTATIN; DICLOFENAC; PLACEBO; REDUCE	Background Rectal indometacin decreases the occurrence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, the population most at risk and the optimal timing of administration require further investigation. We aimed to assess whether pre-procedural administration of rectal indometacin in all patients is more effective than post-procedural use in only high-risk patients to prevent post-ERCP pancreatitis. Methods We did a multicentre, single-blinded, randomised controlled trial at six centres in China. Eligible patients with native papilla undergoing ERCP were randomly assigned in a 1: 1 ratio (with a computer-generated list) to universal pre-procedural indometacin or post-procedural indometacin in only high-risk patients, with stratification by trial centres and block size of ten. In the universal indometacin group, all patients received a single dose (100 mg) of rectal indometacin within 30 min before ERCP. In the risk-stratified, post-procedural indometacin group, only patients at predicted high risk received rectal indometacin, immediately after ERCP. Investigators, but not patients, were masked to group allocation. The primary outcome was overall ocurrence of post-ERCP pancreatitis. The analysis followed the intention-to-treat principle. This study was registered with ClinicalTrials.gov, number NCT02002650. Findings Between Dec 15, 2013, and Sept 21, 2015, 2600 patients were randomly assigned to universal, pre-procedural indometacin (n= 1297) or risk-stratified, post-procedural indometacin (n= 1303). Overall, post-ERCP pancreatitis occurred in 47 (4%) of 1297 patients assigned to universal indometacin and 100 (8%) of 1303 patients assigned to risk-stratified indometacin (relative risk 0 . 47; 95% CI 0.34-0.66; p< 0.0001). Post-ERCP pancreatitis occurred in 18 (6%) of 305 high-risk patients in the universal group and 35 (12%) of 281 high-risk patients in the risk-stratified group (p= 0 . 0057). Post-ERCP pancreatitis was also less frequent in average-risk patients in the universal group (3% [29/992]), in which they received indometacin, than in the risk-stratified group (6% [65/1022]), in which they did not receive the drug (p= 0.0003). Other than pancreatitis, adverse events occurred in 41 (3%; two severe) patients in the universal indometacin group and 48 (4%; one severe) patients in the risk-stratified group. The most common adverse events were biliary infection (22 [2%] patients vs 33 [3%] patients) and gastrointestinal bleeding (13 [1%] vs ten [1%]). Interpretation Compared with a risk-stratified, post-procedural strategy, pre-procedural administration of rectal indometacin in unselected patients reduced the overall occurrence of post-ERCP pancreatitis without increasing risk of bleeding. Our results favour the routine use of rectal indometacin in patients without contraindications before ERCP.	[Luo, Hui; Zhang, Rongchun; Liu, Zhiguo; Wang, Xiangping; Wang, Biaoluo; Liang, Shuhui; Guo, Xiaoyang; Tao, Qin; Wu, Kaichun; Pan, Yanglin; Guo, Xuegang; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Zhao, Lina] Fourth Mil Med Univ, Xijing Hosp, Dept Radiotherapy, Xian 710032, Peoples R China; [Leung, Joseph] VANCHCS, Sacramento VA Med Ctr, Gastroenterol, Mather, CA USA; [Leung, Joseph] Univ Calif Davis, Med Ctr, Sacramento, CA USA; [Nie, Zhanguo; Lei, Ting] Urumqi Gen Hosp Lanzhou Mil Reg, Dept Gastroenterol, Urumqi, Peoples R China; [Li, Xun; Zhou, Wence; Zhang, Lingen] Lanzhou Univ, Hosp 1, Dept Gen Surg 2, Lanzhou 730000, Peoples R China; [Wang, Qi; Li, Ming] Ningxia Med Univ, Gen Hosp, Dept Hepatobiliary Surg, Yinchuan, Peoples R China; [Zhou, Yi; Liu, Qian] 451 Mil Hosp, Dept Gastroenterol, Xian, Peoples R China; [Sun, Hao; Wang, Zheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; University of California System; University of California Davis; Lanzhou University; Ningxia Medical University; Xi'an Jiaotong University	Pan, YL; Guo, XG (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China.	yanglinpan@hotmail.com; xuegangguo@gmail.com		Ye, Cheng/0000-0001-9180-6648; Zhao, Lina/0000-0002-0011-6471; Wang, Qi/0000-0003-2108-3266	National Key Technology R&D Program, National Natural Science Foundation of China	National Key Technology R&D Program, National Natural Science Foundation of China	National Key Technology R&D Program, National Natural Science Foundation of China.	Akbar A, 2013, CLIN GASTROENTEROL H, V11, P778, DOI 10.1016/j.cgh.2012.12.043; Andriulli A, 2007, AM J GASTROENTEROL, V102, P1781, DOI 10.1111/j.1572-0241.2007.01279.x; Bai Y, 2015, ENDOSCOPY, V47, P415, DOI 10.1055/s-0034-1391227; Bailey AA, 2010, GASTROINTEST ENDOSC, V71, P266, DOI 10.1016/j.gie.2009.09.024; Baron TH, 2014, CLIN GASTROENTEROL H, V12, P187, DOI 10.1016/j.cgh.2013.05.020; Baron TH, 2012, NEW ENGL J MED, V367, P277, DOI 10.1056/NEJMc1205928; Cheon YK, 2007, GASTROINTEST ENDOSC, V66, P1126, DOI 10.1016/j.gie.2007.04.012; Choksi NS, 2015, GASTROINTEST ENDOSC, V81, P150, DOI 10.1016/j.gie.2014.07.033; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Cotton PB, 2009, GASTROINTEST ENDOSC, V70, P80, DOI 10.1016/j.gie.2008.10.039; Ding XW, 2012, GASTROINTEST ENDOSC, V76, P1152, DOI 10.1016/j.gie.2012.08.021; Dobronte Z, 2014, WORLD J GASTROENTERO, V20, P10151, DOI 10.3748/wjg.v20.i29.10151; Doebroente Zoltan, 2012, Orvosi Hetilap, V153, P990, DOI 10.1556/OH.2012.29403; Dumonceau JM, 2014, ENDOSCOPY, V46, P798, DOI 10.1055/s-0034-1377875; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; Andrade-Davila VF, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0314-2; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; He QB, 2015, J DIGEST DIS, V16, P471, DOI 10.1111/1751-2980.12258; Kapral C, 2012, EUR J GASTROEN HEPAT, V24, P1447, DOI 10.1097/MEG.0b013e3283583c6f; Katsinelos P, 2012, ENDOSCOPY, V44, P53, DOI 10.1055/s-0031-1291440; Klibansky David A, 2012, Gastroenterology, V143, P1387, DOI 10.1053/j.gastro.2012.09.024; Kubiliun NM, 2015, CLIN GASTROENTEROL H, V13, P1231, DOI 10.1016/j.cgh.2014.11.038; Levenick JM, 2016, GASTROENTEROLOGY, V150, P911, DOI 10.1053/j.gastro.2015.12.040; Li ZS, 2007, AM J GASTROENTEROL, V102, P46, DOI 10.1111/j.1572-0241.2006.00959.x; Loza AM, 2007, REV ESP ENFERM DIG, V99, P330; Masci E, 2003, ENDOSCOPY, V35, P830; Masci E, 2001, AM J GASTROENTEROL, V96, P417; Pan YL, 2015, ENDOSCOPY, V47, P688, DOI 10.1055/s-0034-1391564; Patai A, 2015, J CLIN GASTROENTEROL, V49, P429, DOI 10.1097/MCG.0000000000000168; Poon RTP, 2003, GUT, V52, P1768, DOI 10.1136/gut.52.12.1768; Puig I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092922; Rustagi T, 2015, PANCREAS, V44, P859, DOI 10.1097/MPA.0000000000000326; Sethi S, 2014, PANCREAS, V43, P190, DOI 10.1097/MPA.0000000000000090; Sotoudehmanesh R, 2007, AM J GASTROENTEROL, V102, P978, DOI 10.1111/j.1572-0241.2007.01165.x; Sun HL, 2014, SURG-J R COLL SURG E, V12, P141, DOI 10.1016/j.surge.2013.10.010; Veitch AM, 2016, GUT, V65, P374, DOI 10.1136/gutjnl-2015-311110; Wang P, 2009, AM J GASTROENTEROL, V104, P31, DOI 10.1038/ajg.2008.5; Williams EJ, 2007, ENDOSCOPY, V39, P793, DOI 10.1055/s-2007-966723; Yokoe M, 2015, J HEPATO-BIL-PAN SCI, V22, P405, DOI 10.1002/jhbp.259	39	116	136	3	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2293	2301		10.1016/S0140-6736(16)30310-5	http://dx.doi.org/10.1016/S0140-6736(16)30310-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27133971				2022-12-28	WOS:000376969100032
J	Davis, J; Davis, LC; Correll, RN; Makarewich, CA; Schwanekamp, JA; Moussavi-Harami, F; Wang, D; York, AJ; Wu, HD; Houser, SR; Seidman, CE; Seidman, JG; Regnier, M; Metzger, JM; Wu, JC; Molkentin, JD				Davis, Jennifer; Davis, L. Craig; Correll, Robert N.; Makarewich, Catherine A.; Schwanekamp, Jennifer A.; Moussavi-Harami, Farid; Wang, Dan; York, Allen J.; Wu, Haodi; Houser, Steven R.; Seidman, Christine E.; Seidman, Jonathan G.; Regnier, Michael; Metzger, Joseph M.; Wu, Joseph C.; Molkentin, Jeffery D.			A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy	CELL			English	Article							CARDIAC TROPONIN-C; RESTRICTIVE CARDIOMYOPATHY; MOUSE MODEL; CONTRACTION; MUTATIONS; MUSCLE; DISEASE; DYSREGULATION; DYSFUNCTION; MECHANISMS	The heart either hypertrophies or dilates in response to familial mutations in genes encoding sarcomeric proteins, which are responsible for contraction and pumping. These mutations typically alter calcium-dependent tension generation within the sarcomeres, but how this translates into the spectrum of hypertrophic versus dilated cardiomyopathy is unknown. By generating a series of cardiac-specific mouse models that permit the systematic tuning of sarcomeric tension generation and calcium fluxing, we identify a significant relationship between the magnitude of tension developed over time and heart growth. When formulated into a computational model, the integral of myofilament tension development predicts hypertrophic and dilated cardiomyopathies in mice associated with essentially any sarcomeric gene mutations, but also accurately predicts human cardiac phenotypes from data generated in induced-pluripotent-stem-cell-derived myocytes from familial cardiomyopathy patients. This tension-based model also has the potential to inform pharmacologic treatment options in cardiomyopathy patients.	[Davis, Jennifer; Moussavi-Harami, Farid; Wang, Dan; Regnier, Michael] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Davis, L. Craig] 10244 Normandy Dr, Plymouth, MI 48170 USA; [Correll, Robert N.; Schwanekamp, Jennifer A.; York, Allen J.; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45247 USA; [Makarewich, Catherine A.; Houser, Steven R.] Temple Univ, Dept Physiol, Philadelphia, PA 19122 USA; [Wu, Haodi; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Seidman, Christine E.; Seidman, Jonathan G.] Harvard Univ, Sch Med, Dept Genet, Div Cardiovasc Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45247 USA	University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45247 USA.; Molkentin, JD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45247 USA.	jeff.molkentin@cchmc.org	WU, HAODI/G-7659-2019; Moussavi-Harami, Farid/AAD-4608-2020; Wu, Joseph/H-1067-2013	Moussavi-Harami, Farid/0000-0002-0189-7214; DAVIS, JENNIFER/0000-0003-2380-1321; Schwanekamp, Jennifer/0000-0002-0329-5786; Molkentin, Jeffery/0000-0002-3558-6529; Wu, Joseph/0000-0002-6068-8041	National Institutes of Health; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the National Institutes of Health (J.D.M., M.R., S.R.H., C.E.S., J.G.S., J.M.M, J.C.W., and J.D) and by the Howard Hughes Medical Institute (to J.D. M. and C.E.S.).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; Davis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009140; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Feest ER, 2014, J MOL CELL CARDIOL, V72, P219, DOI 10.1016/j.yjmcc.2014.03.015; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hamada M, 2014, J CARDIOL, V64, P1, DOI 10.1016/j.jjcc.2014.02.022; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Houser SR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125pe31; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Kalyva A, 2014, J MUSCLE RES CELL M, V35, P161, DOI 10.1007/s10974-014-9382-0; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; LeWinter MM, 2013, CIRCULATION, V127, P938, DOI 10.1161/CIRCULATIONAHA.112.139717; Luckey SW, 2009, J MOL CELL CARDIOL, V46, P739, DOI 10.1016/j.yjmcc.2009.02.010; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; Negroni JA, 2008, J MOL CELL CARDIOL, V45, P300, DOI 10.1016/j.yjmcc.2008.04.012; Ostman-Smith I, 2010, FUND CLIN PHARMACOL, V24, P637, DOI 10.1111/j.1472-8206.2010.00869.x; Parvatiyar MS, 2010, J BIOL CHEM, V285, P27785, DOI 10.1074/jbc.M110.112326; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Spoladore R, 2012, EUR HEART J, V33, P1724, DOI 10.1093/eurheartj/ehs150; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Tardiff JC, 2015, CARDIOVASC RES, V105, P457, DOI 10.1093/cvr/cvv023; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Wang D, 2012, BIOCHEMISTRY-US, V51, P4473, DOI 10.1021/bi3003007	36	121	122	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1147	1159		10.1016/j.cell.2016.04.002	http://dx.doi.org/10.1016/j.cell.2016.04.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27114035	Green Accepted, Bronze			2022-12-28	WOS:000376478200015
J	Deglincerti, A; Croft, GF; Pietila, LN; Zernicka-Goetz, M; Siggia, ED; Brivanlou, AH				Deglincerti, Alessia; Croft, Gist F.; Pietila, Lauren N.; Zernicka-Goetz, Magdalena; Siggia, Eric D.; Brivanlou, Ali H.			Self-organization of the in vitro attached human embryo	NATURE			English	Article							HUMAN BLASTOCYST; STEM-CELLS; MOUSE; IMPLANTATION	Implantation of the blastocyst is a developmental milestone in mammalian embryonic development. At this time, a coordinated program of lineage diversification, cell-fate specification, and morphogenetic movements establishes the generation of extra-embryonic tissues and the embryo proper, and determines the conditions for successful pregnancy and gastrulation. Despite its basic and clinical importance, this process remains mysterious in humans. Here we report the use of a novel in vitro system(1,2) to study the post-implantation development of the human embryo. We unveil the self-organizing abilities and autonomy of in vitro attached human embryos. We find human-specific molecular signatures of early cell lineage, timing, and architecture. Embryos display key landmarks of normal development, including epiblast expansion, lineage segregation, bi-laminar disc formation, amniotic and yolk sac cavitation, and trophoblast diversification. Our findings highlight the species-specificity of these developmental events and provide a new understanding of early human embryonic development beyond the blastocyst stage. In addition, our study establishes a new model system relevant to early human pregnancy loss. Finally, our work will also assist in the rational design of differentiation protocols of human embryonic stem cells to specific cell types for disease modelling and cell replacement therapy.	[Deglincerti, Alessia; Croft, Gist F.; Pietila, Lauren N.; Brivanlou, Ali H.] Rockefeller Univ, Lab Stem Cell Biol & Mol Embryol, New York, NY 10065 USA; [Zernicka-Goetz, Magdalena] Univ Cambridge, Dept Physiol Dev & Neurosci, Physiol Bldg,Downing St, Cambridge CB2 3DY, England; [Siggia, Eric D.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA	Rockefeller University; University of Cambridge; Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Lab Stem Cell Biol & Mol Embryol, New York, NY 10065 USA.	brvnlou@rockefeller.edu		Croft, Gist/0000-0002-9721-0148; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	STARR Foundation [2013-026]; Rockefeller Private funds; Sohn Conference Foundation	STARR Foundation; Rockefeller Private funds; Sohn Conference Foundation	We thank the members of the Brivanlou laboratory for their advice and criticisms, in particular C. Nchako, S. Tse for technical assistance, and members of the Zernicka-Goetz laboratory for their advice on how to culture embryos through attachment. We also thank A.K. Hadjantonakis for discussions, A. Wilkerson for support, and A. Brivanlou and P. Carleton-Evans for their comments on the manuscript. This work was supported by a STARR Foundation grant (number 2013-026) and Rockefeller Private funds. Images were obtained using instrumentation in The Rockefeller University Bio-Imaging Resource Center purchased with grant funds from the Sohn Conference Foundation. The Carnegie stage images are used with permission from the Virtual Human Embryo Project (http://virtualhumanembryo.lsuhsc.edu). We give special thanks for technical advice on imaging to A. North, K. Thomas, and P. Ariel, and on image analysis and rendering to T. Tong. This work would not have been possible without the generosity of the people who consented to donate their embryos to research, to whom we are indebted.	Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; *INT SOC STEM CELL, 2006, GUID COND HUM EMBR S; Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155; National Research Council Human Embryonic Stem Cell Research Advisory Committee Board on Life Sciences Board on Health Sciences Policy National Research Council and Institute of Medicine, 2010, FIN REP NAT AC HUM E; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Schrode N, 2014, DEV CELL, V29, P454, DOI 10.1016/j.devcel.2014.04.011; Shakiba N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8329	15	383	393	13	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					251	+		10.1038/nature17948	http://dx.doi.org/10.1038/nature17948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144363				2022-12-28	WOS:000376007200051
J	Oren-Suissa, M; Bayer, EA; Hobert, O				Oren-Suissa, Meital; Bayer, Emily A.; Hobert, Oliver			Sex-specific pruning of neuronal synapses in Caenorhabditis elegans	NATURE			English	Article							C. ELEGANS; MATING-BEHAVIOR; NEMATODE; GENETICS	Whether and how neurons that are present in both sexes of the same species can differentiate in a sexually dimorphic manner is not well understood. A comparison of the connectomes of the Caenorhabditis elegans hermaphrodite and male nervous systems reveals the existence of sexually dimorphic synaptic connections between neurons present in both sexes. Here we demonstrate sex-specific functions of these sex-shared neurons and show that many neurons initially form synapses in a hybrid manner in both the male and hermaphrodite pattern before sexual maturation. Sex-specific synapse pruning then results in the sex-specific maintenance of subsets of these connections. Reversal of the sexual identity of either the pre- or postsynaptic neuron alone transforms the patterns of synaptic connectivity to that of the opposite sex. A dimorphically expressed and phylogenetically conserved transcription factor is both necessary and sufficient to determine sex-specific connectivity patterns. Our studies reveal new insights into sex-specific circuit development.	[Oren-Suissa, Meital; Bayer, Emily A.; Hobert, Oliver] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Oren-Suissa, Meital; Bayer, Emily A.; Hobert, Oliver] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Oren-Suissa, Meital; Bayer, Emily A.; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Oren-Suissa, M; Hobert, O (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.; Oren-Suissa, M; Hobert, O (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.; Oren-Suissa, M; Hobert, O (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA.	meitals@gmail.com; or38@columbia.edu	Oren-Suissa, Meital/GXG-0736-2022	Oren-Suissa, Meital/0000-0001-9937-8326; Bayer, Emily/0000-0002-5254-9199	EMBO; HFSP; NIH [2R37NS039996]; HHMI; Weizmann Institute of Science, National Postdoctoral Award Program for Advancing Women in Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039996, F31NS096863] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Weizmann Institute of Science, National Postdoctoral Award Program for Advancing Women in Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for generating transgenic strains; J. White, J. Sulston and LMB/MRC for sharing their annotated electron microscopy images to D. Hall for curation, and http://www.wormimage.org where these annotated images have been made available by D. Hall; E. Yemini for advice on tracking experiments; S. Cook for help with Elegance software; M. Zhen for communicating unpublished results; P. Sengupta, I. Greenwald and members of the Hobert lab for comments on the manuscript. This work was supported by postdoctoral fellowships from the EMBO and HFSP (to M.O.-S.), the NIH (2R37NS039996) and the HHMI. M.O.-S. is an Awardee of the Weizmann Institute of Science, National Postdoctoral Award Program for Advancing Women in Science.	Bond SR, 2012, NUCLEIC ACIDS RES, V40, pW209, DOI 10.1093/nar/gks396; BRENNER S, 1974, GENETICS, V77, P71; Desbois M, 2015, GENETICS, V200, P697, DOI 10.1534/genetics.115.177006; DURBIN RM, 1987, THESIS U CAMBRIDGE; Emmons SW, 2014, WIRES DEV BIOL, V3, P239, DOI 10.1002/wdev.136; Fang-Yen C, 2012, METHOD CELL BIOL, V107, P177, DOI 10.1016/B978-0-12-394620-1.00006-0; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Gordus A, 2015, CELL, V161, P215, DOI 10.1016/j.cell.2015.02.018; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hutter H, 2003, DEVELOPMENT, V130, P5307, DOI 10.1242/dev.00727; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; Mowrey WR, 2014, J NEUROSCI, V34, P1579, DOI 10.1523/JNEUROSCI.4352-13.2014; Murphy MW, 2015, NAT STRUCT MOL BIOL, V22, P442, DOI 10.1038/nsmb.3032; Peden EM, 2005, CURR BIOL, V15, P394, DOI 10.1016/j.cub.2004.12.073; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Portman DS, 2007, ADV GENET, V59, P1, DOI 10.1016/S0065-2660(07)59001-2; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Sammut M, 2015, NATURE, V526, P385, DOI 10.1038/nature15700; Serrano-Saiz E, 2013, CELL, V155, P659, DOI 10.1016/j.cell.2013.09.052; Sherlekar AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060597; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1985, TRENDS NEUROSCI, V8, P277, DOI 10.1016/0166-2236(85)90102-X; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054050; Yang CF, 2014, NEURON, V82, P261, DOI 10.1016/j.neuron.2014.03.029; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]	38	69	71	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					206	+		10.1038/nature17977	http://dx.doi.org/10.1038/nature17977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144354	Green Accepted			2022-12-28	WOS:000376007200041
J	Gautam, R; Nishimura, Y; Pegu, A; Nason, MC; Klein, F; Gazumyan, A; Golijanin, J; Buckler-White, A; Sadjadpour, R; Wang, KY; Mankoff, Z; Schmidt, SD; Lifson, JD; Mascola, JR; Nussenzweig, MC; Martin, MA				Gautam, Rajeev; Nishimura, Yoshiaki; Pegu, Amarendra; Nason, Martha C.; Klein, Florian; Gazumyan, Anna; Golijanin, Jovana; Buckler-White, Alicia; Sadjadpour, Reza; Wang, Keyun; Mankoff, Zachary; Schmidt, Stephen D.; Lifson, Jeffrey D.; Mascola, John R.; Nussenzweig, Michel C.; Martin, Malcolm A.			A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges	NATURE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; BROADLY NEUTRALIZING ANTIBODY; HIV-1/SIV CHIMERIC VIRUS; MONOCLONAL-ANTIBODIES; IMPROVES PROTECTION; PASSIVE TRANSFER; POTENT; MACAQUES; INFECTION; TRANSMISSION	Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in generating an effective HIV-1 vaccine. Although passive transfer of anti-HIV-1 broadly neutralizing antibodies can protect mice or macaques against a single high-dose challenge with HIV or simian/human (SIV/HIV) chimaeric viruses (SHIVs) respectively(1-8), the long-term efficacy of a passive antibody transfer approach for HIV-1 has not been examined. Here we show, on the basis of the relatively long-term protection conferred by hepatitis A immune globulin, the efficacy of a single injection (20 mg kg(-1)) of four anti-HIV-1-neutralizing monoclonal antibodies (VRC01, VRC01-LS, 3BNC117, and 10-1074 (refs 9-12)) in blocking repeated weekly low-dose virus challenges of the clade B SHIVAD8. Compared with control animals, which required two to six challenges (median = 3) for infection, a single broadly neutralizing antibody infusion prevented virus acquisition for up to 23 weekly challenges. This effect depended on antibody potency and half-life. The highest levels of plasma-neutralizing activity and, correspondingly, the longest protection were found in monkeys administered the more potent antibodies 3BNC117 and 10-1074 (median = 13 and 12.5 weeks, respectively). VRC01, which showed lower plasma-neutralizing activity, protected for a shorter time (median = 8 weeks). The introduction of a mutation that extends antibody half-life into the crystallizable fragment (Fc) domain of VRC01 increased median protection from 8 to 14.5 weeks. If administered to populations at high risk of HIV-1 transmission, such an immunoprophylaxis regimen could have a major impact on virus transmission.	[Gautam, Rajeev; Nishimura, Yoshiaki; Buckler-White, Alicia; Sadjadpour, Reza; Martin, Malcolm A.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Pegu, Amarendra; Wang, Keyun; Mankoff, Zachary; Schmidt, Stephen D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Klein, Florian; Gazumyan, Anna; Golijanin, Jovana; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Klein, Florian] Univ Cologne, Lab Expt Immunol, CMMC, D-50931 Cologne, Germany; [Klein, Florian] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 1, D-50937 Cologne, Germany; [Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, Leidos Biomed Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rockefeller University; University of Cologne; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Martin, MA (corresponding author), NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA.	malm@nih.gov	Nussenzweig, Michel/AAE-7292-2019; Pegu, Amarendra/X-1361-2019; Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019	Pegu, Amarendra/0000-0003-3564-6453; 	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH; National Cancer Institute, NIH [HHSN261200800001E]; Bill and Melinda Gates Foundation [OPP1033115, OPP1092074]; NIH [AI-100148, UM1 AI100663-01]; Robertson Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000415, ZIAAI001213, ZIAAI005009, UM1AI100663, P01AI100148] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Plishka, A. Peach, and T. Lewis for determining plasma viral RNA loads, and K. Rice, R. Engel, R. Petros, and S. Fong for assisting in the maintenance of animals and assisting with procedures. We also thank R. Schwartz for clinical-grade VRC01 and VRC01-LS, and X. Chen for protein reagents for ELISA. We thank the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program for TZM-bl cells. We thank R. Fast for ultrasensitive plasma SIV RNA assays and W. Bosche and M Hull for ultrasensitive peripheral blood mononuclear cell SIV RNA/DNA assays. This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH and, in part, with federal funds from the National Cancer Institute, NIH, under contract number HHSN261200800001E (to J.D.L.). The research was also funded in part by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grants OPP1033115 and OPP1092074 (to M.C.Nu.), by the NIH under award numbers AI-100148, UM1 AI100663-01. M.C.Nu. is supported by the Robertson Foundation and the The Howard Hughes Medical Institute.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Graham BS, 2015, CURR OPIN HIV AIDS, V10, P129, DOI 10.1097/COH.0000000000000154; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	33	232	234	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					105	+		10.1038/nature17677	http://dx.doi.org/10.1038/nature17677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120156	Green Accepted			2022-12-28	WOS:000375473900048
J	Lee, KS; Huang, XY; Fitzpatrick, D				Lee, Kuo-Sheng; Huang, Xiaoying; Fitzpatrick, David			Topology of ON and OFF inputs in visual cortex enables an invariant columnar architecture	NATURE			English	Article							SIMPLE RECEPTIVE-FIELDS; SHREW STRIATE CORTEX; TREE SHREW; SIMPLE CELLS; ORIENTATION SELECTIVITY; SPATIAL STRUCTURE; OCULAR DOMINANCE; ORGANIZATION; ARRANGEMENT; CONNECTIONS	Circuits in the visual cortex integrate the information derived from separate ON (light-responsive) and OFF (dark-responsive) pathways to construct orderly columnar representations of stimulus orientation and visual space(1-7). How this transformation is achieved to meet the specific topographic constraints of each representation remains unclear. Here we report several novel features of ON-OFF convergence visualized by mapping the receptive fields of layer 2/3 neurons in the tree shrew (Tupaia belangeri) visual cortex using two-photon imaging of GCaMP6 calcium signals. We show that the spatially separate ON and OFF subfields of simple cells in layer 2/3 exhibit topologically distinct relationships with the maps of visual space and orientation preference. The centres of OFF subfields for neurons in a given region of cortex are confined to a compact region of visual space and display a smooth visuotopic progression. By contrast, the centres of the ON subfields are distributed over a wider region of visual space, display substantial visuotopic scatter, and have an orientation-specific displacement consistent with orientation preference map structure. As a result, cortical columns exhibit an invariant aggregate receptive field structure: an OFF-dominated central region flanked by ON-dominated subfields. This distinct arrangement of ON and OFF inputs enables continuity in the mapping of both orientation and visual space and the generation of a columnar map of absolute spatial phase.	[Lee, Kuo-Sheng; Huang, Xiaoying; Fitzpatrick, David] Max Planck Florida Inst Neurosci, Dept Funct Architecture & Dev Cerebral Cortex, Jupiter, FL 33458 USA; [Lee, Kuo-Sheng] Florida Atlantic Univ, Integrat Biol & Neurosci Grad Program, Boca Raton, FL 33431 USA	Max Planck Society; State University System of Florida; Florida Atlantic University	Fitzpatrick, D (corresponding author), Max Planck Florida Inst Neurosci, Dept Funct Architecture & Dev Cerebral Cortex, Jupiter, FL 33458 USA.	david.fitzpatrick@mpfi.org	Huang, Xiao-Ying/E-5994-2011; Lee, Kuo-Sheng/A-7653-2017	Huang, Xiao-Ying/0000-0002-3514-216X; Lee, Kuo-Sheng/0000-0002-2256-4283	US National Institutes of Health; Max Planck Florida Institute for Neuroscience; Max Planck Society; NATIONAL EYE INSTITUTE [R01EY006821] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Florida Institute for Neuroscience; Max Planck Society(Max Planck Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Fitzpatrick laboratory for discussions and comments, D. Ouimet and K. Diah for animal technical support, T. Walker for technical assistance, A. Jacob for histology assistance, D. Wilson for advice on two-photon imaging, and D. Whitney for advice on epi-fluorescence imaging. This work was supported by grants from the US National Institutes of Health and funding from Max Planck Florida Institute for Neuroscience and Max Planck Society to D.F.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Huang XY, 2014, J NEUROSCI, V34, P4976, DOI 10.1523/JNEUROSCI.4116-13.2014; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; KRETZ R, 1986, J COMP NEUROL, V251, P135, DOI 10.1002/cne.902510110; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; MILLER KD, 1994, J NEUROSCI, V14, P409; MULY EC, 1992, J NEUROSCI, V12, P1319; Nauhaus I, 2012, NAT NEUROSCI, V15, P1683, DOI 10.1038/nn.3255; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Sage D., 2012, MIJ MAKING INTEROPER; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Smith GB, 2015, NEURON, V88, P805, DOI 10.1016/j.neuron.2015.10.019; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Van Hooser SD, 2013, J NEUROSCI, V33, P11494, DOI 10.1523/JNEUROSCI.1464-13.2013; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wang YS, 2015, NAT NEUROSCI, V18, P97, DOI 10.1038/nn.3878; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106	40	73	74	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					90	+		10.1038/nature17941	http://dx.doi.org/10.1038/nature17941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120162	Green Accepted			2022-12-28	WOS:000375473900045
J	Makary, MA; Daniel, M				Makary, Martin A.; Daniel, Michael			Medical error-the third leading cause of death in the US	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; MORTALITY		[Makary, Martin A.; Daniel, Michael] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA	Johns Hopkins University	Makary, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA.	mmakary1@jhmi.edu	Callahan, Charles D/L-1641-2013					American Hospital Association, 2015, FAST FACTS US HOSP; [Anonymous], 2004, HEALTHGRADES QUALITY; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Department of Health and Human Services, 2010, ADV EV HOSP NAT INC; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Grober ED, 2005, CAN J SURG, V48, P39; Institute of Medicine of the National Academies, 2011, CONT IMPR INN HLTH H; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Moriyama IM, 2011, HIST STAT CLASSIFICA; Office for National Statistics' Death Certification Advisory Group, 2010, GUID DOCT COMPL MED; Provenzano A, 2015, BMJ QUAL SAF, V24, P31, DOI 10.1136/bmjqs-2014-003120; Reason J., 1990, HUMAN ERROR, DOI [10.1017/CBO9781139062367, DOI 10.1017/CBO9781139062367]; Reason JT, 2001, BRIT MED J, P9; Statistics Canada, CAN VIT STAT DEATH D; Thomas EJ, 1999, INQUIRY-J HEALTH CAR, V36, P255; World Health Organization, INT CLASS DIS	21	1461	1507	15	148	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2139	10.1136/bmj.i2139	http://dx.doi.org/10.1136/bmj.i2139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27143499				2022-12-28	WOS:000375574000001
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Welfare is not a dirty word	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, WRITT EV PARL; [Anonymous], 2016, DISP GREAT BEN ROW; [Anonymous], 2016, CONTR OUT HLTH DIS A; Brewer M, 2008, DOES WELFARE REFORM; Perkins A., 2016, TELEGRAPH; Quigley A., 2014, MAINTAINING PRIDE NH; Thomson J., 2016, PSYCHOL COMMENT 0114	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2447	10.1136/bmj.i2447	http://dx.doi.org/10.1136/bmj.i2447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27142416	Bronze, Green Published			2022-12-28	WOS:000375574000011
J	Wojciechowski, A; Skowronek, P				Wojciechowski, Artur; Skowronek, Pawel			Aortocoronary Saphenous-Vein-Graft Aneurysms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wojciechowski, Artur] St Georges Univ Hosp NHS Fdn Trust, London, England; [Skowronek, Pawel] Jan Kochanowski Univ Humanities & Sci, Kielce, Poland	Jan Kochanowski University	Wojciechowski, A (corresponding author), St Georges Univ Hosp NHS Fdn Trust, London, England.	artur.radiology@gmail.com							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1670	1670		10.1056/NEJMicm1508440	http://dx.doi.org/10.1056/NEJMicm1508440			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	27119239				2022-12-28	WOS:000374843400010
J	Cowper, A				Cowper, Andy			Junior doctors' strike: which side's reach exceeds its grasp?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andycowper@hotmail.com						[Anonymous], 2016, BMJ, V353, pi2238; Browning R, ANDREA DEL SARTO; Campbell D, 2016, GUARDIAN; Campbell D., 2015, GUARDIAN; Clover B, 2016, HLTH SERVICES J; Darzi A, 2016, TELEGRAPH; Torjesen Ingrid, 2016, BMJ, V353, pi2255, DOI 10.1136/bmj.i2255; YouGov, 2016, PUBLIC SUPPORT FOR D	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2016	353								i2237	10.1136/bmj.i2237	http://dx.doi.org/10.1136/bmj.i2237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZJ	27103592				2022-12-28	WOS:000374999500005
J	Berhane, K; Chang, CC; McConnell, R; Gauderman, WJ; Avol, E; Rapapport, E; Urman, R; Lurmann, F; Gilliland, F				Berhane, Kiros; Chang, Chih-Chieh; McConnell, Rob; Gauderman, W. James; Avol, Edward; Rapapport, Ed; Urman, Robert; Lurmann, Fred; Gilliland, Frank			Association of Changes in Air Quality With Bronchitic Symptoms in Children in California, 1993-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYMPTOMS; CHILDHOOD ASTHMA; DIFFERING LEVELS; POLLUTION; HEALTH; COMMUNITIES; DECLINE	IMPORTANCE Childhood bronchitic symptoms are significant public and clinical health problems that produce a substantial burden of disease. Ambient air pollutants are important determinants of bronchitis occurrence. OBJECTIVE To determine whether improvements in ambient air quality in Southern California were associated with reductions in bronchitic symptoms in children. DESIGN, SETTING, AND PARTICIPANTS A longitudinal study involving 4602 children (age range, 5-18 years) from 3 cohorts was conducted during the 1993-2001, 1996-2004, and 2003-2012 years in 8 Southern California communities. A multilevel logistic model was used to estimate the association of changes in pollution levels with bronchitic symptoms. EXPOSURES Average concentrations of nitrogen dioxide, ozone, particulate matter with an aerodynamic diameter of less than 10 mu m (PM10) and less than 2.5 mu m (PM2.5). MAIN OUTCOMES AND MEASURES Annual age-specific prevalence of bronchitic symptoms during the previous 12 months based on the parent's or child's report of a daily cough for 3 months in a row, congestion or phlegm other than when accompanied by a cold, or bronchitis. RESULTS The 3 cohorts included a total of 4602 children (mean age at baseline, 8.0 years; 2268 girls [49.3%]; 2081 Hispanic white [45.2%]) who had data from 2 or more annual questionnaires. Among these children, 892 (19.4%) had asthma at age 10 years. For nitrogen dioxide, the odds ratio (OR) for bronchitic symptoms among children with asthma at age 10 years was 0.79 (95% CI, 0.67-0.94) for a median reduction of 4.9 ppb, with absolute decrease in prevalence of 10.1%. For ozone, the OR was 0.66 (95% CI, 0.50-0.86) for a median reduction of 3.6 ppb, with an absolute decrease in prevalence of 16.3%. For PM10, the OR was 0.61 (95% CI, 0.48-0.78) for a median reduction of 5.8 mu g/m(3), with an absolute decrease in prevalence of 18.7%. For PM2.5, the OR was 0.68 (95% CI, 0.53-0.86) for a median reduction of 6.8 mu g/m(3), with absolute decrease in prevalence of 15.4%. Among children without asthma (n = 3710), the ORs were 0.84 (95% CI, 0.76-0.92) for nitrogen dioxide, 0.85 (95% CI, 0.74-0.97) for ozone, 0.80 (95% CI, 0.70-0.92) for PM10, and 0.79 (95% CI, 0.69-0.91) for PM2.5; with absolute decrease in prevalence of 1.8% for nitrogen dioxide, 1.7% for ozone, 2.2% for PM10, and 2.3% for PM2.5. The associations were similar or slightly stronger at age 15 years. CONCLUSIONS AND RELEVANCE Decreases in ambient pollution levels were associated with statistically significant decreases in bronchitic symptoms in children. Although the study design does not establish causality, the findings support potential benefit of air pollution reduction on asthma control.	[Berhane, Kiros; Chang, Chih-Chieh; McConnell, Rob; Gauderman, W. James; Avol, Edward; Rapapport, Ed; Urman, Robert; Gilliland, Frank] Univ So Calif, Dept Prevent Med, 2001 Soto St,202-G, Los Angeles, CA 90089 USA; [Lurmann, Fred] Sonoma Technol Inc, Petaluma, CA USA	University of Southern California	Berhane, K (corresponding author), Univ So Calif, Dept Prevent Med, 2001 Soto St,202-G, Los Angeles, CA 90089 USA.	kiros@usc.edu			Health Effects Institute [4910-RFA11-1/12-4]; National Institute of Environmental Health Sciences [ES011627, ES07048, ES022719, ES023262]; FOGARTY INTERNATIONAL CENTER [U01TW010094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011627, P30ES007048, R01ES023262, R03ES022719] Funding Source: NIH RePORTER	Health Effects Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a contract 4910-RFA11-1/12-4 from the Health Effects Institute and grants ES011627, ES07048, ES022719, and ES023262 from the National Institute of Environmental Health Sciences.	Aalto P, 2005, J AIR WASTE MANAGE, V55, P1064, DOI 10.1080/10473289.2005.10464702; Bayer-Oglesby L, 2005, ENVIRON HEALTH PERSP, V113, P1632, DOI 10.1289/ehp.8159; Berhane K, 2004, STAT SCI, V19, P414, DOI 10.1214/088342304000000413; Brandt S, 2014, J ALLERGY CLIN IMMUN, V134, P1028, DOI 10.1016/j.jaci.2014.09.029; Brandt SJ, 2012, EUR RESPIR J, V40, P363, DOI 10.1183/09031936.00157811; BraunFahrlander C, 1997, AM J RESP CRIT CARE, V155, P1042, DOI 10.1164/ajrccm.155.3.9116984; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; Dockery DW, 1996, ENVIRON HEALTH PERSP, V104, P500, DOI 10.2307/3432990; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Heinrich J, 2003, EUR RESPIR J, V21, p64S, DOI 10.1183/09031936.03.00402603; Heinrich J, 2000, AM J RESP CRIT CARE, V161, P1930, DOI 10.1164/ajrccm.161.6.9906105; Jedrychowski W, 1998, EUR RESPIR J, V11, P1312, DOI 10.1183/09031936.98.11061312; Kunzli N, 1997, ENVIRON HEALTH PERSP, V105, P1078, DOI 10.2307/3433849; Leonardi GS, 2002, EUR RESPIR J, V20, P890, DOI 10.1183/09031936.02.00260802; Lurmann F, 2015, J AIR WASTE MANAGE, V65, P324, DOI 10.1080/10962247.2014.991856; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McConnell R, 2003, AM J RESP CRIT CARE, V168, P790, DOI 10.1164/rccm.200304-466OC; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P1910, DOI 10.1289/ehp.8548; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; POPE CA, 1991, ARCH ENVIRON HEALTH, V46, P90, DOI 10.1080/00039896.1991.9937434; South Coast Air Quality Management District, 2013, FINAL 2012 AIR QUAL; VERHEIJ T, 1995, SCAND J PRIM HEALTH, V13, P8, DOI 10.3109/02813439508996728; Zeger SL, 1994, ANAL LONGITUDINAL DA	25	76	80	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1491	1501		10.1001/jama.2016.3444	http://dx.doi.org/10.1001/jama.2016.3444			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115265	Green Accepted, Bronze			2022-12-28	WOS:000373873800015
J	Chassaing, B; Koren, O; Goodrich, JK; Poole, AC; Srinivasan, S; Ley, RE; Gewirtz, AT				Chassaing, Benoit; Koren, Omry; Goodrich, Julia K.; Poole, Angela C.; Srinivasan, Shanthi; Ley, Ruth E.; Gewirtz, Andrew T.			Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome (vol 519, pg 92, 2015)	NATURE			English	Correction													Goodrich, Julia/ABD-8368-2021; Koren, Omry/A-5222-2016; Ley, Ruth E/M-8542-2014; Chassaing, Benoit/R-3819-2017	Koren, Omry/0000-0002-7738-1337; Ley, Ruth E/0000-0002-9087-1672; Chassaing, Benoit/0000-0002-4285-769X; Poole, Angela/0000-0003-0278-7655				Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232	1	16	17	6	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615								10.1038/nature18000	http://dx.doi.org/10.1038/nature18000			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UG	27144359	Bronze			2022-12-28	WOS:000452218700002
J	El-Toukhy, T; Campo, R; Khalaf, Y; Tabanelli, C; Gianaroli, L; Gordts, SS; Gordts, S; Mestdagh, G; Mardesic, T; Voboril, J; Marchino, GL; Benedetto, C; Al-Shawaf, T; Sabatini, L; Seed, PT; Gergolet, M; Grimbizis, G; Harb, H; Coomarasamy, A				El-Toukhy, Tarek; Campo, Rudi; Khalaf, Yacoub; Tabanelli, Carla; Gianaroli, Luca; Gordts, Sylvie S.; Gordts, Stephan; Mestdagh, Greet; Mardesic, Tonko; Voboril, Jan; Marchino, Gian L.; Benedetto, Chiara; Al-Shawaf, Talha; Sabatini, Luca; Seed, Paul T.; Gergolet, Marco; Grimbizis, Grigoris; Harb, Hoda; Coomarasamy, Arri			Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial	LANCET			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IMPLANTATION FAILURE; ENDOMETRIAL INJURY; DIAGNOSTIC HYSTEROSCOPY; UTERINE CAVITY; WOMEN	Background The success rate of in-vitro fertilisation (IVF) remains low and many women undergo multiple treatment cycles. A previous meta-analysis suggested hysteroscopy could improve outcomes in women who have had recurrent implantation failure; however, studies were of poor quality and a definitive randomised trial was needed. In the TROPHY trial we aimed to assess whether hysteroscopy improves the livebirth rate following IVF treatment in women with recurrent failure of implantation. Methods We did a multicentre, randomised controlled trial in eight hospitals in the UK, Belgium, Italy, and the Czech Republic. We recruited women younger than 38 years who had normal ultrasound of the uterine cavity and history of two to four unsuccessful IVF cycles. We used an independent web-based trial management system to randomly assign (1: 1) women to receive outpatient hysteroscopy (hysteroscopy group) or no hysteroscopy (control group) in the month before starting a treatment cycle of IVF (with or without intracytoplasmic sperm injection). A computer-based algorithm minimised for key prognostic variables: age, body-mass index, basal follicle-stimulating hormone concentration, and the number of previous failed IVF cycles. The order of group assignment was masked to the researchers at the time of recruitment and randomisation. Embryologists involved in the embryo transfer were masked to group allocation, but physicians doing the procedure knew of group assignment and had hysteroscopy findings accessible. Participants were not masked to their group assignment. The primary outcome was the livebirth rate (proportion of women who had a live baby beyond 24 weeks of gestation) in the intention-to-treat population. The trial was registered with the ISRCTN Registry, ISRCTN35859078. Findings Between Jan 1, 2010, and Dec 31, 2013, we randomly assigned 350 women to the hysteroscopy group and 352 women to the control group. 102 (29%) of women in the hysteroscopy group had a livebirth after IVF compared with 102 (29%) women in the control group (risk ratio 1.0, 95% CI 0.79-1.25; p = 0.96). No hysteroscopy-related adverse events were reported. Interpretation Outpatient hysteroscopy before IVF in women with a normal ultrasound of the uterine cavity and a history of unsuccessful IVF treatment cycles does not improve the livebirth rate. Further research into the effectiveness of surgical correction of specific uterine cavity abnormalities before IVF is warranted.	[El-Toukhy, Tarek; Khalaf, Yacoub] Guys & St Thomas Hosp NHS Fdn Trust, Assisted Concept Unit, London, England; [Campo, Rudi; Mestdagh, Greet] Ziekenhuis Oost Limburg, Assisted Concept Unit, Genk, Belgium; [Tabanelli, Carla; Gianaroli, Luca] SISMER, Assisted Concept Unit, Bologna, Italy; [Gordts, Sylvie S.; Gordts, Stephan] Leuven Inst Fertil & Embryol, Tiensevest, Leuven, Belgium; [Mardesic, Tonko; Voboril, Jan] Sanat Pronatal, Assisted Concept Unit, Prague, Czech Republic; [Marchino, Gian L.; Benedetto, Chiara] Univ Turin, Dept Obstet & Gynaecol, Turin, Italy; [Al-Shawaf, Talha; Sabatini, Luca] Barts Hlth NHS Trust, Ctr Reprod Med, London, England; [Seed, Paul T.] Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr, London WC2R 2LS, England; [Seed, Paul T.] St Thomas Hosp, Kings Hlth Partners, London, England; [Gergolet, Marco] European Soc Human Reprod & Embryol, Reprod Surg Special Interest Grp, Brussels, Belgium; [Grimbizis, Grigoris] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol, GR-54006 Thessaloniki, Greece; [Harb, Hoda; Coomarasamy, Arri] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Harb, Hoda; Coomarasamy, Arri] Univ Birmingham, Tommys Natl Ctr Miscarriage Care & Res, Birmingham, W Midlands, England	Guy's & St Thomas' NHS Foundation Trust; East Limburg Hospital; KU Leuven; University of Turin; Barts Health NHS Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Aristotle University of Thessaloniki; University of Birmingham; University of Birmingham	El-Toukhy, T (corresponding author), Guys Hosp, Assisted Concept Unit, London SE1 9RT, England.	tarek.el-toukhy@gstt.nhs.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Gergolet, Marco/0000-0002-2280-5809	European Society of Human Reproduction and Embryology; European Society for Gynaecological Endoscopy (ESGE)	European Society of Human Reproduction and Embryology; European Society for Gynaecological Endoscopy (ESGE)	This study was partly funded by the the European Society of Human Reproduction and Embryology and the European Society for Gynaecological Endoscopy (ESGE) provided funding for trial coordination and meetings. Karl Storz Company provided the hysteroscopy equipment for all centres and Tristel Solutions Limited (Snailwell, Cambridgeshire, UK) provided the equipment disinfecting systems for five of the eight participating centres. We thank all of the women who participated in this study and the following investigators for supervising recruitment and randomisation at study centres: Jyotsna Pundir, Jean Bvumbe, Madhurima Rajkhowa, Spyridon Chouliaras, Yves Van Belle at The European Academy of Gynaecological Surgery, and Rhona O'Flaherty at the ESGE Central Office. We also thank all TROPHY research nurses who assisted data collection. We are grateful to Peter Braude and Annette Briley for chairing the data monitoring committee, to Justin Clark for advice and assistance to design the study, and to Helen Williams at the University of Birmingham for assistance with the final preparation of the manuscript. Finally, we thank all those not otherwise mentioned above who have contributed to the TROPHY study.	Agresti A, 2013, CATEGORICAL DATA ANA; Bosteels J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009461.pub3; Campo R, 1999, HUM REPROD UPDATE, V5, P73, DOI 10.1093/humupd/5.1.73; Campo R, 2014, FACTS VIEWS VIS OBGY, V6, P235; Carneiro Marcia Mendonca, 2014, Surg Res Pract, V2014, P105412, DOI 10.1155/2014/105412; Cenksoy P, 2013, ARCH GYNECOL OBSTET, V287, P357, DOI 10.1007/s00404-012-2627-5; Coughlan C, 2014, INT J GYNECOL OBSTET, V124, P143, DOI 10.1016/j.ijgo.2013.08.006; Cutting Rachel, 2008, Hum Fertil (Camb), V11, P131, DOI 10.1080/14647270802302629; DICKER D, 1992, FERTIL STERIL, V58, P833; El-Toukhy T, 2008, REPROD BIOMED ONLINE, V16, P712, DOI 10.1016/S1472-6483(10)60486-5; El-Toukhy Tarek, 2009, Reprod Health, V6, P20, DOI 10.1186/1742-4755-6-20; Fatemi HM, 2010, HUM REPROD, V25, P1959, DOI 10.1093/humrep/deq150; Galliano D, 2015, HUM REPROD UPDATE, V21, P13, DOI 10.1093/humupd/dmu047; GOLAN A, 1992, HUM REPROD, V7, P1433, DOI 10.1093/oxfordjournals.humrep.a137589; Grimbizis GF, 2013, GYNECOL SURG, V10, P199, DOI 10.1007/s10397-013-0800-x; Kasius JC, 2011, HUM REPROD, V26, P801, DOI 10.1093/humrep/der003; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; La Sala GB, 1998, FERTIL STERIL, V70, P378, DOI 10.1016/S0015-0282(98)00147-2; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P289, DOI 10.1016/0197-2456(88)90045-1; Moini A, 2012, INT J FERTIL STERIL, V6, P27; Nastri CO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009517.pub3; Panagiotopoulou N, 2015, EUR J OBSTET GYN R B, V193, P27, DOI 10.1016/j.ejogrb.2015.06.026; Papathanasiou A, 2015, SEMIN REPROD MED, V33, P65, DOI 10.1055/s-0035-1545364; Polanski LT, 2014, REPROD BIOMED ONLINE, V28, P409, DOI 10.1016/j.rbmo.2013.12.006; Potdar N, 2012, REPROD BIOMED ONLINE, V25, P561, DOI 10.1016/j.rbmo.2012.08.005; Setti PEL, 2004, ANN NY ACAD SCI, V1034, P184, DOI 10.1196/annals.1335.021; Sunderam S, 2013, MMWR SURVEILL SUMM, V62, P1; Sunkara SK, 2014, FERTIL STERIL, V101, P147, DOI 10.1016/j.fertnstert.2013.09.035; Yeung TWY, 2014, HUM REPROD, V29, P2474, DOI 10.1093/humrep/deu213; Zeyneloglu HB, 2014, SEMIN REPROD MED, V32, P297, DOI 10.1055/s-0034-1375182	30	67	73	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2614	2621		10.1016/S0140-6736(16)00258-0	http://dx.doi.org/10.1016/S0140-6736(16)00258-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27132053	Green Submitted			2022-12-28	WOS:000378390500029
J	Sebe-Pedros, A; Ballare, C; Parra-Acero, H; Chiva, C; Tena, JJ; Sabido, E; Gomez-Skarmeta, JL; Di Croce, L; Ruiz-Trillo, I				Sebe-Pedros, Arnau; Ballare, Cecilia; Parra-Acero, Helena; Chiva, Cristina; Tena, Juan J.; Sabido, Eduard; Gomez-Skarmeta, Jose Luis; Di Croce, Luciano; Ruiz-Trillo, Inaki			The Dynamic Regulatory Genome of Capsaspora and the Origin of Animal Multicellularity	CELL			English	Article							CTD CODE; TRANSCRIPTIONAL REGULATION; FUNCTIONAL IMPLICATIONS; NUCLEOSOME POSITION; FISSION YEAST; EVOLUTION; CHROMATIN; ENHANCERS; NETWORKS; ORGANIZATION	The unicellular ancestor of animals had a complex repertoire of genes linked to multicellular processes. This suggests that changes in the regulatory genome, rather than in gene innovation, were key to the origin of animals. Here, we carry out multiple functional genomic assays in Capsaspora owczarzaki, the unicellular relative of animals with the largest known gene repertoire for transcriptional regulation. We show that changing chromatin states, differential lincRNA expression, and dynamic cis-regulatory sites are associated with life cycle transitions in Capsaspora. Moreover, we demonstrate conservation of animal developmental transcription-factor networks and extensive network interconnection in this premetazoan organism. In contrast, however, Capsaspora lacks animal promoter types, and its regulatory sites are small, proximal, and lack signatures of animal enhancers. Overall, our results indicate that the emergence of animal multicellularity was linked to a major shift in genome cis-regulatory complexity, most notably the appearance of distal enhancer regulation.	[Sebe-Pedros, Arnau; Parra-Acero, Helena; Ruiz-Trillo, Inaki] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Passeig Maritim de la Barceloneta 37-49, Barcelona 08003, Spain; [Ballare, Cecilia; Chiva, Cristina; Sabido, Eduard; Di Croce, Luciano] Ctr Genom Regulat, Doctor Aiguader 88, Barcelona 08003, Spain; [Ballare, Cecilia; Chiva, Cristina; Sabido, Eduard; Di Croce, Luciano] Univ Pompeu Fabra, Doctor Aiguader 88, Barcelona 08003, Spain; [Tena, Juan J.; Gomez-Skarmeta, Jose Luis] Univ Pablo de Olavide Junta de Andalucia, CSIC, CABD, Carretera Utrera Km1, Seville 41013, Spain; [Di Croce, Luciano; Ruiz-Trillo, Inaki] Inst Catalana Recerca & Estudis Avancats, Pg Lluis Co 23, Barcelona 08010, Spain; [Ruiz-Trillo, Inaki] Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; [Sebe-Pedros, Arnau] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); ICREA; University of Barcelona; Weizmann Institute of Science	Sebe-Pedros, A; Ruiz-Trillo, I (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Passeig Maritim de la Barceloneta 37-49, Barcelona 08003, Spain.; Ruiz-Trillo, I (corresponding author), Inst Catalana Recerca & Estudis Avancats, Pg Lluis Co 23, Barcelona 08010, Spain.; Ruiz-Trillo, I (corresponding author), Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain.; Sebe-Pedros, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	arnau.sebe-pedros@weizmann.ac.il; inaki.ruiz@ibe.upf-csic.es	Ruiz-Trillo, Iñaki/H-3217-2019; Sebé-Pedrós, Arnau/B-9268-2011; Tena, Juan J./Q-5995-2019; Tena, Juan J/M-2265-2014; Gomez-Skarmeta, Jose Luis/B-5268-2014; Ballare, Cecilia/F-2593-2016; RODRIGUEZ, CRISTINA CHIVA/AAH-7862-2020; Sabido, Eduard/F-7914-2015; Di Croce, Luciano/E-7759-2015	Ruiz-Trillo, Iñaki/0000-0001-6547-5304; Sebé-Pedrós, Arnau/0000-0002-9896-9746; Tena, Juan J./0000-0001-8165-7984; Tena, Juan J/0000-0001-8165-7984; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Ballare, Cecilia/0000-0002-9442-807X; RODRIGUEZ, CRISTINA CHIVA/0000-0001-8150-6203; Sabido, Eduard/0000-0001-6506-7714; Di Croce, Luciano/0000-0003-3488-6228	Institucio Catalana de Recerca i Estudis Avancats contract; European Research Council Consolidator Grant [ERC-2012-Co-616960]; Ministerio de Economia y Competitividad (MINECO) [BFU-2011-23434]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014 SGR 619]; Spanish "Ministerio de Educacion y Ciencia" [SAF2013-48926-P]; AGAUR; European Commission [277899]; EMBO Long-Term Fellowship [ALTF 841-2014]; Ministerio de Economia y Competitividad [BFU2013-41322-P]; Andalusian Government [BIO-396]; University Pablo de Olavide; Instituto de Salud Carlos III (ISCIII) [PT13/0001]; ICREA Funding Source: Custom	Institucio Catalana de Recerca i Estudis Avancats contract(ICREA); European Research Council Consolidator Grant(European Research Council (ERC)); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Ministerio de Economia y Competitividad(Spanish Government); Andalusian Government; University Pablo de Olavide; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); ICREA(ICREA)	We thank Alex de Mendoza, Xavier Grau-Bove, Ignacio Maeso, and Manuel Irimia for comments on the manuscript and figures. This work was supported by an Institucio Catalana de Recerca i Estudis Avancats contract, a European Research Council Consolidator Grant (ERC-2012-Co-616960), and a grant from Ministerio de Economia y Competitividad (MINECO) (BFU-2011-23434) (to I.R.-T.). We also acknowledge financial support from Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (project 2014 SGR 619). The work in L.D.'s laboratory was supported by grants from the Spanish "Ministerio de Educacion y Ciencia" (SAF2013-48926-P), AGAUR, and the European Commission's 7th Framework Program 4DCellFate (277899). A.S.-P. is supported by an EMBO Long-Term Fellowship (ALTF 841-2014). J.L.G.-S. was funded by grants from Ministerio de Economia y Competitividad (BFU2013-41322-P) and the Andalusian Government (BIO-396). J.J.T. has a postdoctoral grant from the University Pablo de Olavide. The CRG/UPF Proteomics Unit is part of the "Plataforma de Recursos Biomoleculares y Bioinformaticos (ProteoRed)'' supported by a grant from Instituto de Salud Carlos III (ISCIII) (PT13/0001). We thank Guadalupe Espadas for her support with the histone derivatization protocol and Nuria Ros and Meritxell Anto for technical support. Finally, we thank the CRG Genomics Unit for helping with ChIP-seq and RNA-seq sequencing.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; de Mendoza A, 2015, ELIFE, V4, DOI 10.7554/eLife.08904; de Mendoza A, 2013, P NATL ACAD SCI USA, V110, pE4858, DOI 10.1073/pnas.1311818110; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Erwin DH, 2009, PHILOS T R SOC B, V364, P2253, DOI 10.1098/rstb.2009.0038; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Gaiti F, 2015, MOL BIOL EVOL, V32, P2367, DOI 10.1093/molbev/msv117; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Irimia M, 2013, TRENDS GENET, V29, P521, DOI 10.1016/j.tig.2013.05.008; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li H, 2010, CURR BIOL, V20, pR746, DOI 10.1016/j.cub.2010.06.056; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marques AC, 2014, CURR OPIN GENET DEV, V27, P48, DOI 10.1016/j.gde.2014.03.009; Marques AC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r131; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reinke AW, 2013, SCIENCE, V340, P730, DOI 10.1126/science.1233465; Schwaiger M, 2014, GENOME RES, V24, P639, DOI 10.1101/gr.162529.113; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Sebe-Pedros A, 2015, ADV MAR GENOMICS, V2, P379, DOI 10.1007/978-94-017-9642-2_18; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Sebe-Pedros A, 2013, P NATL ACAD SCI USA, V110, P16050, DOI 10.1073/pnas.1309748110; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; Simola DF, 2016, SCIENCE, V351, DOI 10.1126/science.aac6633; Sorrells TR, 2015, CELL, V161, P714, DOI 10.1016/j.cell.2015.04.014; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Tanay A, 2013, CURR OPIN GENET DEV, V23, P197, DOI 10.1016/j.gde.2012.12.009; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; van Galen P, 2016, MOL CELL, V61, P170, DOI 10.1016/j.molcel.2015.11.003; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	61	87	90	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1224	1237		10.1016/j.cell.2016.03.034	http://dx.doi.org/10.1016/j.cell.2016.03.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27114036	Green Published, hybrid			2022-12-28	WOS:000376478200021
J	Hammel, P; Huguet, F; van Laethem, JL; Goldstein, D; Glimelius, B; Artru, P; Borbath, I; Bouche, O; Shannon, J; Andre, T; Mineur, L; Chibaudel, B; Bonnetain, F; Louvet, C				Hammel, Pascal; Huguet, Florence; van Laethem, Jean-Luc; Goldstein, David; Glimelius, Bengt; Artru, Pascal; Borbath, Ivan; Bouche, Olivier; Shannon, Jenny; Andre, Thierry; Mineur, Laurent; Chibaudel, Benoist; Bonnetain, Franck; Louvet, Christophe			Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHASE-III TRIAL; RADIATION; ADENOCARCINOMA; THERAPY; 5-FLUOROURACIL; RADIOTHERAPY; CONCURRENT; FOLFIRINOX; CARCINOMA; STOMACH	IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of erlotinib is unknown. OBJECTIVES To assess whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine-based induction chemotherapy and to assess the effect of erlotinib on survival. DESIGN, SETTING, ANDPARTICIPANTS InLAP07, an international, open-label, phase3randomized trial, 449 patientswere enrolled between 2008and 2011. Follow-up ended in February 2013. INTERVENTIONS In the first randomization, 223 patients received 1000mg/m(2) weekly of gemcitabine alone and 219 patients received 1000mg/m(2) of gemcitabine plus 100mg/d of erlotinib. In the second randomization involving patients with progression-free disease after 4 months, 136 patients received 2 months of the same chemotherapy and 133 underwent chemoradiotherapy (54 Gy plus capecitabine). MAIN OUTCOMES AND MEASURES The primary outcomewas overall survival from the date of the first randomization. Secondary outcomeswere the effect of erlotinib and quality assurance of radiotherapy on overall survival, progression-free survival of gemcitabine-erlotinib and erlotinib maintenance with gemcitabine alone at the second randomization, and toxic effects. RESULTS A total of 442 of the 449 patients (232 men; median age, 63.3 years) enrolled underwent the first randomization. Of these, 269 underwent the second randomization. Interim analysis was performed when 221 patients died (109 in the chemoradiotherapy group and 112 in the chemotherapy group), reaching the early stopping boundaries for futility. With a median follow-up of 36.7 months, the median overall survival from the date of the first randomization was not significantly different between chemotherapy at 16.5 months (95% CI, 14.5-18.5 months) and chemoradiotherapy at 15.2 months (95% CI, 13.9-17.3 months; hazard ratio [HR], 1.03; 95% CI, 0.79-1.34; P = .83). Median overall survival from the date of the first randomization for the 223 patients receiving gemcitabine was 13.6 months (95% CI, 12.3-15.3 months) and was 11.9 months (95% CI, 10.4-13.5 months) for the 219 patients receiving gemcitabine plus erlotinib (HR, 1.19; 95% CI, 0.97-1.45; P = .09; 188 deaths vs 191 deaths). Chemoradiotherapy was associated with decreased local progression (32% vs 46%, P = .03) and no increase in grade 3 to 4 toxicity, except for nausea. CONCLUSIONS AND RELEVANCE In this open-label, randomized trial involving patients with locally advanced pancreatic cancer with disease controlled after 4 months of induction chemotherapy, there was no significant difference in overall survival with chemoradiotherapy compared with chemotherapy alone and there was no significant difference in overall survival with gemcitabine compared with gemcitabine plus erlotinib used as maintenance therapy.	[Hammel, Pascal] Hop Beaujon, AP HP, Dept Digest Oncol, F-92110 Clichy, France; [Huguet, Florence] Tenon Hosp, AP HP, Dept Radiotherapy, Paris, France; [van Laethem, Jean-Luc] Erasme Univ Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium; [Goldstein, David] Prince Wales Hosp, Dept Med Oncol, Sydney, NSW, Australia; [Goldstein, David; Shannon, Jenny] Australasian Gastrointestinal Trials Grp AGITG, Camperdown, NSW, Australia; [Goldstein, David; Shannon, Jenny] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Glimelius, Bengt] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Artru, Pascal] Jean Mermoz Hosp, Dept Gastroenterol, Lyon, France; [Borbath, Ivan] Clin Univ St Luc, Dept Gastroenterol, B-1200 Brussels, Belgium; [Bouche, Olivier] Hop Robert Debre, Dept Gastroenterol, Reims, France; [Shannon, Jenny] Nepean Hosp NSW, Dept Med Oncol, Sydney, NSW, Australia; [Andre, Thierry] Hop St Antoine, AP HP, Dept Med Oncol, F-75571 Paris, France; [Mineur, Laurent] St Catherine Inst, Dept Radiotherapy & Med Oncol, Avignon, France; [Chibaudel, Benoist] Franco British Hosp Inst, Dept Med Oncol, Levallois Perret, France; [Chibaudel, Benoist] Oncol Multidisciplinary Res Grp GERCOR, Paris, France; [Bonnetain, Franck] Hosp Minjoz, Dept Methodol & Qual Life Oncol, Besancon, France; [Louvet, Christophe] Inst Mutualiste Montsouris, Dept Med Oncol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Uppsala University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; CHU de Reims; Universite de Reims Champagne-Ardenne; Nepean Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; CHU Besancon; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite	Hammel, P (corresponding author), Hop Beaujon, AP HP, Serv Oncol Digest, 100 Blvd Gen Leclerc, F-92110 Clichy, France.	pascal.hammel@aphp.fr	Pezet, Denis/I-4423-2017; André, Thierry P/N-8830-2017; goldstein, david/J-6711-2012	Pezet, Denis/0000-0001-9416-2876; André, Thierry P/0000-0002-5103-7095; Kneebone, Andrew/0000-0002-7629-504X; Ychou, Marc/0000-0001-7378-9469; Chibaudel, Benoist/0000-0003-1279-2044; Hammel, Pascal/0000-0002-4630-4996; Hruby, George/0000-0003-4193-9682; Borbath, Ivan/0000-0001-7598-214X; LECOMTE, Thierry/0000-0001-5093-0212	Roche; French National Institute of Cancer (INCa)	Roche(Roche Holding); French National Institute of Cancer (INCa)(Institut National du Cancer (INCA) France)	This trial was supported by Roche and French National Institute of Cancer (INCa).	Abrams RA, 2012, INT J RADIAT ONCOL, V82, P809, DOI 10.1016/j.ijrobp.2010.11.039; Ben-Josef E, 2012, INT J RADIAT ONCOL, V84, P1166, DOI 10.1016/j.ijrobp.2012.02.051; Bidard FC, 2013, ANN ONCOL, V24, P2057, DOI 10.1093/annonc/mdt176; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; DOUGLASS HO, 1988, JNCI-J NATL CANCER I, V80, P751; Faris JE, 2013, ONCOLOGIST, V18, P543, DOI 10.1634/theoncologist.2012-0435; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; HAZEL JJ, 1981, J CAN ASSOC RADIOL, V32, P164; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huguet F, 2007, J CLIN ONCOL, V25, P326, DOI 10.1200/JCO.2006.07.5663; Huguet F, 2012, INT J RADIAT ONCOL, V83, P1355, DOI 10.1016/j.ijrobp.2011.11.050; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLAASSEN DJ, 1985, J CLIN ONCOL, V3, P373, DOI 10.1200/JCO.1985.3.3.373; Krishnan S, 2007, CANCER-AM CANCER SOC, V110, P47, DOI 10.1002/cncr.22735; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Melidis C, 2014, INT J RADIAT ONCOL, V90, P1242, DOI 10.1016/j.ijrobp.2014.08.348; MOERTEL CG, 1981, CANCER, V48, P1705, DOI 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mukherjee S, 2013, LANCET ONCOL, V14, P317, DOI 10.1016/S1470-2045(13)70021-4; Pietrasz D, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.e15250; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobin LH, 2002, TNM CLASSIJFICATION; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083, DOI 10.6004/jnccn.2014.0106; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	28	562	579	8	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1844	1853		10.1001/jama.2016.4324	http://dx.doi.org/10.1001/jama.2016.4324			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139057	Bronze			2022-12-28	WOS:000375284400013
J	Lenzer, J				Lenzer, Jeanne			Experts and activists discuss how to get "right care" for patients Jeanne Lenzer reports on a growing movement aiming to overcome the medical and social barriers to appropriate care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Jeanne.lenzer@gmail.com						Ebrahim S, 2016, J CLIN EPIDEMIOL, V70, P155, DOI 10.1016/j.jclinepi.2015.08.021; Fleming PS, 2016, J CLIN EPIDEMIOL, V78, P34, DOI 10.1016/j.jclinepi.2016.03.012; Gawande Atul, 2011, New Yorker, P40; OECD, 2015, HLTH STAT; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Transparency International, GLOB CORR BAR 2013	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2406	10.1136/bmj.i2406	http://dx.doi.org/10.1136/bmj.i2406			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129484				2022-12-28	WOS:000375484100005
J	Nguyen, TT; Koh, MJ; Shen, X; Romiti, F; Schrock, RR; Hoveyda, AH				Nguyen, Thach T.; Koh, Ming Joo; Shen, Xiao; Romiti, Filippo; Schrock, Richard R.; Hoveyda, Amir H.			Kinetically controlled E-selective catalytic olefin metathesis	SCIENCE			English	Article							NATURAL-PRODUCT SYNTHESIS; CROSS-METATHESIS; BORONIC ACIDS; MARINE CYANOBACTERIA; ALKENYL HALIDES; COMPLEXES; VINYL; FLUORINE; MOLYBDENUM; CONVERSION	A major shortcoming in olefin metathesis, a chemical process that is central to research in several branches of chemistry, is the lack of efficient methods that kinetically favor E isomers in the product distribution. Here we show that kinetically E-selective cross-metathesis reactions may be designed to generate thermodynamically disfavored alkenyl chlorides and fluorides in high yield and with exceptional stereoselectivity. With 1.0 to 5.0 mole % of a molybdenum-based catalyst, which may be delivered in the form of air-and moisture-stable paraffin pellets, reactions typically proceed to completion within 4 hours at ambient temperature. Many isomerically pure E-alkenyl chlorides, applicable to catalytic cross-coupling transformations and found in biologically active entities, thus become easily and directly accessible. Similarly, E-alkenyl fluorides can be synthesized from simpler compounds or more complex molecules.	[Nguyen, Thach T.; Koh, Ming Joo; Shen, Xiao; Romiti, Filippo; Hoveyda, Amir H.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Koh, Ming Joo/M-6641-2018; Koh, Ming Joo/GOV-7124-2022; Koh, Ming Joo/O-8549-2019	Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921; Shen, Xiao/0000-0002-8675-1213; Romiti, Filippo/0000-0003-1903-9901	NIH [GM-59426]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was financially supported by the NIH (grant GM-59426). We thank S. Torker for helpful discussions and L. Ondi, J. B. Czirok, and G. M. Nagy for support and helpful advice. We are grateful to XiMo AG for gifts of paraffin tablets.	Barluenga J, 2006, ADV SYNTH CATAL, V348, P347, DOI 10.1002/adsc.200505302; Billingsley KL, 2008, J ORG CHEM, V73, P5589, DOI 10.1021/jo800727s; Campbell MG, 2014, ORG PROCESS RES DEV, V18, P474, DOI 10.1021/op400349g; Chung WJ, 2016, ANGEW CHEM INT EDIT, V55, P4396, DOI 10.1002/anie.201506388; Fujiwara T, 2014, J FLUORINE CHEM, V167, P16, DOI 10.1016/j.jfluchem.2014.06.014; Furuya T, 2009, ORG LETT, V11, P2860, DOI 10.1021/ol901113t; Fustero S, 2015, CHEM REV, V115, P871, DOI 10.1021/cr500182a; Gao F, 2010, J AM CHEM SOC, V132, P10961, DOI 10.1021/ja104896b; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Grubbs R. H., 2014, HDB METATHESIS; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Ibrahem I, 2009, J AM CHEM SOC, V131, P3844, DOI 10.1021/ja900097n; Imaizumi Y, 2002, MOL PHARMACOL, V62, P836, DOI 10.1124/mol.62.4.836; Johns AM, 2016, ORG LETT, V18, P772, DOI 10.1021/acs.orglett.6b00031; Koh MJ, 2016, NATURE, V531, P459, DOI 10.1038/nature17396; Koh MJ, 2015, NATURE, V517, P181, DOI 10.1038/nature14061; LEE SH, 1986, J AM CHEM SOC, V108, P2445, DOI 10.1021/ja00269a052; Marinescu SC, 2009, J AM CHEM SOC, V131, P10840, DOI 10.1021/ja904786y; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; MILLER RB, 1978, J ORG CHEM, V43, P4424, DOI 10.1021/jo00417a006; Molander GA, 2014, ORG LETT, V16, P1904, DOI 10.1021/ol500408a; Molander GA, 2011, J ORG CHEM, V76, P7195, DOI 10.1021/jo201313a; Montaser R, 2013, ORG LETT, V15, P4050, DOI 10.1021/ol401396u; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nunnery JK, 2012, J ORG CHEM, V77, P4198, DOI 10.1021/jo300160e; Petasis NA, 1996, TETRAHEDRON LETT, V37, P567, DOI 10.1016/0040-4039(95)02262-7; Sather AC, 2015, NATURE, V524, P208, DOI 10.1038/nature14654; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; Thakur A, 2012, CHEM COMMUN, V48, P203, DOI 10.1039/c1cc15990a; Torker S, 2016, ORGANOMETALLICS, V35, P543, DOI 10.1021/acs.organomet.5b00970; Wiberg KB, 2009, J CHEM THEORY COMPUT, V5, P1033, DOI 10.1021/ct900059e; Wnuk SF, 2008, BIOORGAN MED CHEM, V16, P5090, DOI 10.1016/j.bmc.2008.03.028; Zhang H, 2011, ORG LETT, V13, P560, DOI 10.1021/ol102645g; Zhu LG, 2010, TETRAHEDRON, V66, P5089, DOI 10.1016/j.tet.2010.04.113	36	78	81	5	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					569	575		10.1126/science.aaf4622	http://dx.doi.org/10.1126/science.aaf4622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126041	Green Accepted, Green Submitted			2022-12-28	WOS:000374998600041
J	Shein-Idelson, M; Ondracek, JM; Liaw, HP; Reiter, S; Laurent, G				Shein-Idelson, Mark; Ondracek, Janie M.; Liaw, Hua-Peng; Reiter, Sam; Laurent, Gilles			Slow waves, sharp waves, ripples, and REM in sleeping dragons	SCIENCE			English	Article							PALLIOPALLIAL CONNECTIVITY; IGUANA-IGUANA; MAMMALS; WAKEFULNESS; HIPPOCAMPUS; EVOLUTION; BIRDS; NEOCORTEX; BRAIN; OSCILLATIONS	Sleep has been described in animals ranging from worms to humans. Yet the electrophysiological characteristics of brain sleep, such as slow-wave (SW) and rapid eye movement (REM) activities, are thought to be restricted to mammals and birds. Recording from the brain of a lizard, the Australian dragon Pogona vitticeps, we identified SW and REM sleep patterns, thus pushing back the probable evolution of these dynamics at least to the emergence of amniotes. The SW and REM sleep patterns that we observed in lizards oscillated continuously for 6 to 10 hours with a period of similar to 80 seconds. The networks controlling SW-REM antagonism in amniotes may thus originate from a common, ancient oscillator circuit. Lizard SW dynamics closely resemble those observed in rodent hippocampal CA1, yet they originate from a brain area, the dorsal ventricular ridge, that has no obvious hodological similarity with the mammalian hippocampus.	[Shein-Idelson, Mark; Ondracek, Janie M.; Liaw, Hua-Peng; Reiter, Sam; Laurent, Gilles] Max Planck Inst Brain Res, Frankfurt, Germany	Max Planck Society	Laurent, G (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.	gilles.laurent@brain.mpg.de	Shein, Mark/M-9170-2018; Ondracek, Janie Michelle/AAA-6135-2021	Shein, Mark/0000-0001-8132-2826; Reiter, Sam/0000-0001-6879-663X; Ondracek, Janie/0000-0002-4570-447X	Max Planck Society; European Research Council; Minerva Foundation; Swiss National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Minerva Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded by the Max Planck Society and the European Research Council (G.L.) and by fellowships from the Minerva Foundation (M.S.-I.) and the Swiss National Science Foundation (J.M.O.). The code for analysis and partial data are available at www.brain.mpg.de/sheinidelsonetal2016, and the full primary data are available from G.L. on request. The authors are grateful to G. Wexel for help in surgery and postoperative care; M. klinkmann, A. Arends, A. M. Pardo, T. Manthey, and C. Thum for technical assistance; F. Baier, T. Maurer, Schmalbach, and A. Umminger for help with mechanical design and fabrication; N. Heller for help with electronics; K. Schroder and C. Schurmann (Gee-he University Medical School, Institute for Cardiovascular Physiology) for help with 9-CT scanning of lizards: the animal caretaker crew for lizard care; and T. Tchumatchenko, H. Ito, M. Kaschube, E. Schuman, A. Siapas and the Laurent laboratory for their suggestions during the course of this no or on the manuscript.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Ayala-Guerrero F, 2008, COMP BIOCHEM PHYS A, V151, P305, DOI 10.1016/j.cbpa.2007.03.027; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; FLANIGAN WF, 1973, BRAIN BEHAV EVOLUT, V8, P401; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Hartse KM, 1994, PRINCIPLES PRACTICE, P95; Hayashi Y, 2015, SCIENCE, V350, P957, DOI 10.1126/science.aad1023; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JOUVET M., 1965, PROGR BRAIN RES, V18, P20; KARTEN HJ, 1991, BRAIN BEHAV EVOLUT, V38, P264, DOI 10.1159/000114393; Libourel P. A., 2015, BIOL REV CAMB PHILOS; Loomis AL, 1937, J EXP PSYCHOL, V21, P127, DOI 10.1037/h0057431; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MONNIER M, 1980, EXPERIENTIA, V36, P16, DOI 10.1007/BF02003944; NORTHCUTT RG, 1981, ANNU REV NEUROSCI, V4, P301, DOI 10.1146/annurev.ne.04.030181.001505; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Rattenborg NC, 2006, BRAIN RES BULL, V69, P20, DOI 10.1016/j.brainresbull.2005.11.002; Rattenborg NC, 2009, NEUROSCI BIOBEHAV R, V33, P253, DOI 10.1016/j.neubiorev.2008.08.010; Rial RV, 2007, BRAIN RES BULL, V72, P183, DOI 10.1016/j.brainresbull.2007.01.003; Rial RV, 2010, NEUROSCI BIOBEHAV R, V34, P1144, DOI 10.1016/j.neubiorev.2010.01.008; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siegel J. M., 2005, PRINCIPLES PRACTICE, P120; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Striedter GF, 2016, J COMP NEUROL, V524, P496, DOI 10.1002/cne.23803; Voigts J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00008; Vorster AP, 2015, NEUROSCI BIOBEHAV R, V50, P103, DOI 10.1016/j.neubiorev.2014.09.020; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zimmerman JE, 2008, TRENDS NEUROSCI, V31, P371, DOI 10.1016/j.tins.2008.05.001	43	102	103	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					590	595		10.1126/science.aaf3621	http://dx.doi.org/10.1126/science.aaf3621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126045				2022-12-28	WOS:000374998600046
J	Biewener, AA; Wilson, A				Biewener, Andrew A.; Wilson, Alan			R. McNeill Alexander (1934-2016) OBITUARY	NATURE			English	Biographical-Item									[Biewener, Andrew A.] Harvard Univ, Biol, Cambridge, MA 02138 USA; [Biewener, Andrew A.] Concord Field Stn, Bedford, MA 01730 USA; [Wilson, Alan] Univ London Royal Vet Coll, Locomotor Biomech, London NW1 0TU, England	Harvard University; University of London; University of London Royal Veterinary College	Biewener, AA (corresponding author), Harvard Univ, Biol, Cambridge, MA 02138 USA.; Biewener, AA (corresponding author), Concord Field Stn, Bedford, MA 01730 USA.; Wilson, A (corresponding author), Univ London Royal Vet Coll, Locomotor Biomech, London NW1 0TU, England.	biewener@fas.harvard.edu; awilson@rvc.ac.uk	Biewener, Andrew/O-2989-2016	Biewener, Andrew/0000-0003-3303-8737; Wilson, Alan/0000-0001-9914-3455				ALEXANDER RD, PUBLICATION LIST	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					442	442		10.1038/532442a	http://dx.doi.org/10.1038/532442a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121834	Bronze			2022-12-28	WOS:000374815900029
J	Welch, HG; Robertson, DJ				Welch, H. Gilbert; Robertson, Douglas J.			Colorectal Cancer on the Decline - Why Screening Can't Explain It All	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Welch, H. Gilbert] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT USA; Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	VA Outcomes Group; Dartmouth College	Welch, HG (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT USA.							GILBERTSEN VA, 1965, SURGERY, V57, P363; Holden Debra J, 2010, Evid Rep Technol Assess (Full Rep), P1; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Smith R, 2008, CA-CANCER J CLIN, V58, P161, DOI 10.3322/CA.2007.0017; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	5	126	130	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1605	1607		10.1056/NEJMp1600448	http://dx.doi.org/10.1056/NEJMp1600448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK3UR	27119236				2022-12-28	WOS:000374843400004
J	Joppa, LN; O'Connor, B; Visconti, P; Smith, C; Geldmann, J; Mann, MH; Watson, JEM; Butchart, SHM; Virah-Sawmy, M; Halpern, BS; Ahmed, SE; Balmford, A; Sutherland, WJ; Harfoot, M; Hilton-Taylor, C; Foden, W; Di Minin, E; Pagad, S; Genovesi, P; Hutton, J; Burgess, ND				Joppa, L. N.; O'Connor, B.; Visconti, P.; Smith, C.; Geldmann, J.; Mann, M. Hof; Watson, J. E. M.; Butchart, S. H. M.; Virah-Sawmy, M.; Halpern, B. S.; Ahmed, S. E.; Balmford, A.; Sutherland, W. J.; Harfoot, M.; Hilton-Taylor, C.; Foden, W.; Di Minin, E.; Pagad, S.; Genovesi, P.; Hutton, J.; Burgess, N. D.			Filling in biodiversity threat gaps	SCIENCE			English	Editorial Material							ET-AL; LAND					lujoppa@microsoft.com	Di Minin, Enrico/J-6904-2013; Sutherland, William/B-1291-2013; Visconti, Piero/A-3253-2009; Genovesi, Piero/Z-1571-2019; Butchart, Stuart HM/Y-2711-2018; Geldmann, Jonas/H-8131-2019; Watson, James Edward Maxwell/D-8779-2013; Hoffmann, Michael/E-6419-2010; Butchart, Stuart/AAJ-1852-2021	Di Minin, Enrico/0000-0002-5562-318X; Visconti, Piero/0000-0001-6823-2826; Geldmann, Jonas/0000-0002-1191-7610; Watson, James Edward Maxwell/0000-0003-4942-1984; Hoffmann, Michael/0000-0003-4785-2254; Butchart, Stuart/0000-0002-1140-4049; Genovesi, Piero/0000-0002-0262-1420; Balmford, Andrew/0000-0002-0144-3589				Addis Ababa Action Agenda, 2015, 3 INT C FIN DEV 13 1; Balmford A, 2009, CONSERV BIOL, V23, P482, DOI 10.1111/j.1523-1739.2009.01196.x; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; De Vos JM, 2015, CONSERV BIOL, V29, P452, DOI 10.1111/cobi.12380; Geldmann J, 2014, CONSERV BIOL, V28, P1604, DOI 10.1111/cobi.12332; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Independent Expert Advisory Group, 2015, WORLD COUNTS MOB DAT; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Salafsky N, 2009, CONSERV BIOL, V23, P488, DOI 10.1111/j.1523-1739.2009.01197.x; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Turner W, 2014, SCIENCE, V346, P301, DOI 10.1126/science.1256014	12	143	146	5	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					416	418		10.1126/science.aaf3565	http://dx.doi.org/10.1126/science.aaf3565			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102469	Green Submitted			2022-12-28	WOS:000374479700028
J	Kealhofer, C; Schneider, W; Ehberger, D; Ryabov, A; Krausz, F; Baum, P				Kealhofer, C.; Schneider, W.; Ehberger, D.; Ryabov, A.; Krausz, F.; Baum, P.			All-optical control and metrology of electron pulses	SCIENCE			English	Article							LASER; ACCELERATION; DIFFRACTION; COMPRESSION; MICROSCOPY; OPERATION	Short electron pulses are central to time-resolved atomic-scale diffraction and electron microscopy, streak cameras, and free-electron lasers. We demonstrate phase-space control and characterization of 5-picometer electron pulses using few-cycle terahertz radiation, extending concepts of microwave electron pulse compression and streaking to terahertz frequencies. Optical-field control of electron pulses provides synchronism to laser pulses and offers a temporal resolution that is ultimately limited by the rise-time of the optical fields applied. We used few-cycle waveforms carried at 0.3 terahertz to compress electron pulses by a factor of 12 with a timing stability of <4 femtoseconds (root mean square) and measure them by means of field-induced beam deflection (streaking). Scaling the concept toward multiterahertz control fields holds promise for approaching the electronic time scale in time-resolved electron diffraction and microscopy.	[Kealhofer, C.; Schneider, W.; Ehberger, D.; Ryabov, A.; Krausz, F.; Baum, P.] Univ Munich, Coulombwall 1, D-85748 Garching, Germany; [Kealhofer, C.; Schneider, W.; Ehberger, D.; Ryabov, A.; Krausz, F.] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany	University of Munich; Max Planck Society	Krausz, F; Baum, P (corresponding author), Univ Munich, Coulombwall 1, D-85748 Garching, Germany.; Krausz, F (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	ferenc.krausz@lmu.de; peter.baum@lmu.de	Baum, Peter/B-7637-2008	Baum, Peter/0000-0002-1521-8729; Ryabov, Andrey/0000-0002-5345-7210	European Research Council; Munich-Centre for Advanced Photonics	European Research Council(European Research Council (ERC)European Commission); Munich-Centre for Advanced Photonics	This work was supported by the European Research Council and the Munich-Centre for Advanced Photonics. We thank D. Frischke for preparing ultrathin aluminum foils. The authors declare no competing financial interests.	Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; Baum P, 2007, P NATL ACAD SCI USA, V104, P18409, DOI 10.1073/pnas.0709019104; Brussaard GJH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823590; de Abajo FJG, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073035; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; England RJ, 2014, REV MOD PHYS, V86, P1337, DOI 10.1103/RevModPhys.86.1337; Esarey E, 2009, REV MOD PHYS, V81, P1229, DOI 10.1103/RevModPhys.81.1229; Fabianska J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05645; Feist A, 2015, NATURE, V521, P200, DOI 10.1038/nature14463; Fill E, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/272; Flannigan DJ, 2012, ACCOUNTS CHEM RES, V45, P1828, DOI 10.1021/ar3001684; Fruhling U, 2009, NAT PHOTONICS, V3, P523, DOI 10.1038/NPHOTON.2009.160; Gliserin A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9723; Greig SR, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904804; Grguras I, 2012, NAT PHOTONICS, V6, P851, DOI [10.1038/NPHOTON.2012.276, 10.1038/nphoton.2012.276]; Hemsing E, 2014, REV MOD PHYS, V86, P897, DOI 10.1103/RevModPhys.86.897; Hoffmann MC, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/8/083001; Hoffrogge J, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867185; Kassier GH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3489118; Kealhofer C, 2015, OPT LETT, V40, P260, DOI 10.1364/OL.40.000260; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kirchner FO, 2014, NAT PHOTONICS, V8, P52, DOI [10.1038/NPHOTON.2013.315, 10.1038/nphoton.2013.315]; Lahme S, 2014, STRUCT DYNAM-US, V1, DOI 10.1063/1.4884937; Nanni EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9486; Plettner T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.134801; Schneider W, 2014, OPT LETT, V39, P6604, DOI 10.1364/OL.39.006604; Schulz S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6938; Sciaini G, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/9/096101; Scoby CM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4776686; Shalaby M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6976; Shao HC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.263201; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; VARTAK SD, 1995, OPT COMMUN, V120, P184, DOI 10.1016/0030-4018(95)00427-A; Walbran M, 2015, PHYS REV APPL, V4, DOI 10.1103/PhysRevApplied.4.044013; Wimmer L, 2014, NAT PHYS, V10, P432, DOI [10.1038/NPHYS2974, 10.1038/nphys2974]; Wong LJ, 2013, OPT EXPRESS, V21, P9792, DOI 10.1364/OE.21.009792; Yakovlev VS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14581; Yoder RB, 2005, PHYS REV SPEC TOP-AC, V8, DOI 10.1103/PhysRevSTAB.8.111301	38	199	201	5	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					429	433		10.1126/science.aae0003	http://dx.doi.org/10.1126/science.aae0003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102476	Green Submitted			2022-12-28	WOS:000374479700039
J	Okabe, Y; Medzhitov, R				Okabe, Yasutaka; Medzhitov, Ruslan			Wormhole Travel for Macrophages	CELL			English	Editorial Material							TISSUE; RECRUITMENT; HOMEOSTASIS; MONOCYTES	Leukocyte recruitment is generally achieved by rapid migration of inflammatory cells out of circulation, through modified blood vessels, and into affected tissues. Now, Wang and Kubes show that macrophages can be rapidly recruited from body cavities to the liver, via a non-vascular route, where they help to coordinate tissue repair.	[Okabe, Yasutaka; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Okabe, Yasutaka/0000-0002-1913-7280				BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Davies LC, 2015, IMMUNOLOGY, V144, P541, DOI 10.1111/imm.12451; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009	10	10	10	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					518	519		10.1016/j.cell.2016.04.005	http://dx.doi.org/10.1016/j.cell.2016.04.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104973	Bronze			2022-12-28	WOS:000374636800010
J	Aveyard, P; Yach, D; Gilmore, AB; Capewell, S				Aveyard, Paul; Yach, Derek; Gilmore, Anna B.; Capewell, Simon			Should we welcome food industry funding of public health research?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCIENCE		[Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Yach, Derek] Vital Inst, New York, NY USA; [Gilmore, Anna B.] Univ Bath, UK Ctr Tobacco & Alcohol Studies, Bath BA2 7AY, Avon, England; [Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England	University of Oxford; University of Bath; University of Liverpool	Aveyard, P (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.; Gilmore, AB (corresponding author), Univ Bath, UK Ctr Tobacco & Alcohol Studies, Bath BA2 7AY, Avon, England.	paul.aveyard@phc.ox.ac.uk; A.gilmore@bath.ac.uk	gilmore, anna B/I-7130-2012	gilmore, anna B/0000-0003-0281-1248; Aveyard, Paul/0000-0002-1802-4217	MRC [G0900847] Funding Source: UKRI; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, G0900847] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bero LA, 2013, 12013 EEA; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Cain DM, 2008, JAMA-J AM MED ASSOC, V299, P2893, DOI 10.1001/jama.299.24.2893; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cohen JE, 2009, TOB CONTROL, V18, P228, DOI 10.1136/tc.2008.027623; Cohen JE, 2001, BMJ-BRIT MED J, V323, P1, DOI 10.1136/bmj.323.7303.1; Department for Business Innovation and Skills, 2010, MAN UK EC AN SECT; Egilman DS, 2005, INT J OCCUP ENV HEAL, V11, P331, DOI 10.1179/oeh.2005.11.4.331; Haddock CK, 2014, BRIT J NUTR, V111, P372, DOI 10.1017/S0007114513002377; Imperial Innovations, 2016, AP THER FUND; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Kearns CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001798; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; Matthews D, 2015, TIMESHIGHEREDUC 1029; Michaels D, 2008, DOUBT IS THEIR PRODU, V1st; Nestle M, 2016, JAMA INTERN MED, V176, P13, DOI 10.1001/jamainternmed.2015.6667; O' Connor A, 2015, NY TIMES; Oreskes N., 2010, MERCHANTS DOUBT; Roberts LM, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-45; Scarborough Peter, 2015, Pilot Feasibility Stud, V1, P21; Union of Concerned Scientists, 2012, HEADS THEY WIN TAILS; White J, 2010, STANFORD LAW POL REV, P21	23	7	7	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2016	353								i2161	10.1136/bmj.i2161	http://dx.doi.org/10.1136/bmj.i2161			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZH	27098491	Green Published			2022-12-28	WOS:000374999300006
J	Guglani, S				Guglani, Sam			Applause	LANCET			English	Editorial Material									[Guglani, Sam] Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1503	1503		10.1016/S0140-6736(16)30132-5	http://dx.doi.org/10.1016/S0140-6736(16)30132-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27115966				2022-12-28	WOS:000373741600016
J	Cheung, KJ; Ewald, AJ				Cheung, Kevin J.; Ewald, Andrew J.			A collective route to metastasis: Seeding by tumor cell clusters	SCIENCE			English	Editorial Material							BREAST-CANCER CELLS; COLONIZATION; MIGRATION; INVASION; PROGRAM	Despite decades of study, there are still many unanswered questions about metastasis, the process by which a localized cancer becomes a systemic disease. One of these questions is the nature of the tumor cells that give rise to metastases. Although conventional models suggest that metastases are seeded by single cells from the primary tumor, there is growing evidence that seeding requires the collective action of tumor cells traveling together in clusters. Here, we review this evidence, which comes from analysis of both experimental models and patient samples. We present a model of metastatic dissemination that highlights the activities of clusters of tumor cells that retain and require their epithelial properties.	[Cheung, Kevin J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, Seattle, WA 98109 USA; [Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 855 North Wolfe St, Baltimore, MD 21205 USA; [Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Oncol, 855 North Wolfe St, Baltimore, MD 21205 USA; [Ewald, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 855 North Wolfe St, Baltimore, MD 21205 USA	Fred Hutchinson Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 855 North Wolfe St, Baltimore, MD 21205 USA.; Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 855 North Wolfe St, Baltimore, MD 21205 USA.; Ewald, AJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 855 North Wolfe St, Baltimore, MD 21205 USA.	andrew.ewald@jhmi.edu			Burroughs Wellcome Fund Career Award for Medical Scientists; American Cancer Society [RSG-12-141-01-CSM]; NIH/National Cancer Institute [P30 CA006973]; Cindy Rosencrans Fund for Triple Negative Breast Cancer Research; Metastatic Breast Cancer Network; Pink Agenda; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cindy Rosencrans Fund for Triple Negative Breast Cancer Research; Metastatic Breast Cancer Network; Pink Agenda; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Marshall and P. Tran for critical comments on the manuscript and B. Moore for the image in Fig. 1B. K.J.C. is supported by a Burroughs Wellcome Fund Career Award for Medical Scientists. A.J.E. is supported by a Research Scholar Grant (RSG-12-141-01-CSM) from the American Cancer Society, funds from the NIH/National Cancer Institute (P30 CA006973), funds from the Cindy Rosencrans Fund for Triple Negative Breast Cancer Research, a Research Leadership Award from the Metastatic Breast Cancer Network, and an award from The Pink Agenda and The Breast Cancer Research Foundation. We apologize to the authors whose work we could not cite because of space constraints. The authors are coinventors on a patent application (U.S. 14/276,099) filed by The Johns Hopkins University that is related to the use of K14 as a biomarker for identifying patients at elevated risk of metastasis.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Bronsert P, 2014, J PATHOL, V234, P410, DOI 10.1002/path.4416; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; LIOTTA LA, 1976, CANCER RES, V36, P889; Maddipati R, 2015, CANCER DISCOV, V5, P1086, DOI 10.1158/2159-8290.CD-15-0120; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; ZEIDMAN I, 1952, CANCER RES, V12, P731	20	302	316	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					167	169		10.1126/science.aaf6546	http://dx.doi.org/10.1126/science.aaf6546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124449	Green Accepted			2022-12-28	WOS:000373681600034
J	Brasil, P; Sequeira, PC; Freitas, AD; Zogbi, HE; Calvet, GA; de Souza, RV; Siqueira, AM; de Mendonca, MCL; Nogueira, RMR; de Filippis, AMB; Solomon, T				Brasil, Patricia; Sequeira, Patricia Carvalho; Freitas, Andrea D'Avila; Zogbi, Heruza Einsfeld; Calvet, Guilherme Amaral; de Souza, Rogerio Valls; Siqueira, Andre Machado; Lima de Mendonca, Marcos Cesar; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria; Solomon, Tom			Guillain-Barre syndrome associated with Zika virus infection	LANCET			English	Editorial Material							DENGUE		[Brasil, Patricia; Freitas, Andrea D'Avila; Zogbi, Heruza Einsfeld; Calvet, Guilherme Amaral; de Souza, Rogerio Valls; Siqueira, Andre Machado] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Sequeira, Patricia Carvalho; Lima de Mendonca, Marcos Cesar; Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Liverpool; University of Liverpool; Walton Centre	Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.	patricia.brasil@ini.fiocruz.br	Sequeira, Patricia/AAK-3739-2021; Calvet, GA/G-6959-2013; Brasil, Patricia/P-3536-2014; Siqueira, Andre M/G-1340-2010	Calvet, GA/0000-0002-3545-5238; Siqueira, Andre M/0000-0003-2208-0294; Solomon, Tom/0000-0001-7266-6547; Brasil, Patricia/0000-0001-9555-7976	MRC [MC_PC_15096] Funding Source: UKRI; Medical Research Council [MC_PC_15096] Funding Source: Medline; Department of Health [IS-HPU-1112-10117, RP-PG-0108-10048] Funding Source: Medline; National Institute for Health Research [RP-PG-0108-10048, IS-HPU-1112-10117, NF-SI-0514-10177] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5	5	221	233	0	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1482	1482		10.1016/S0140-6736(16)30058-7	http://dx.doi.org/10.1016/S0140-6736(16)30058-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	27115821	Bronze			2022-12-28	WOS:000373217500037
J	Fu, QM; Posth, C; Hajdinjak, M; Petr, M; Mallick, S; Fernandes, D; Furtwangler, A; Haak, W; Meyer, M; Mittnik, A; Nickel, B; Peltzer, A; Rohland, N; Slon, V; Talamo, S; Lazaridis, I; Lipson, M; Mathieson, I; Schiffels, S; Skoglund, P; Derevianko, AP; Drozdov, N; Slavinsky, V; Tsybankov, A; Cremonesi, RG; Mallegni, F; Gely, B; Vacca, E; Morales, MRG; Straus, LG; Neugebauer-Maresch, C; Teschler-Nicola, M; Constantin, S; Moldovan, OT; Benazzi, S; Peresani, M; Coppola, D; Lari, M; Ricci, S; Ronchitelli, A; Valentin, F; Thevenet, C; Wehrberger, K; Grigorescu, D; Rougier, H; Crevecoeur, I; Flas, D; Semal, P; Mannino, MA; Cupillard, C; Bocherens, H; Conard, NJ; Harvati, K; Moiseyev, V; Drucker, DG; Svoboda, J; Richards, MP; Caramelli, D; Pinhasi, R; Kelso, J; Patterson, N; Krause, J; Paabo, S; Reich, D				Fu, Qiaomei; Posth, Cosimo; Hajdinjak, Mateja; Petr, Martin; Mallick, Swapan; Fernandes, Daniel; Furtwangler, Anja; Haak, Wolfgang; Meyer, Matthias; Mittnik, Alissa; Nickel, Birgit; Peltzer, Alexander; Rohland, Nadin; Slon, Viviane; Talamo, Sahra; Lazaridis, Iosif; Lipson, Mark; Mathieson, Iain; Schiffels, Stephan; Skoglund, Pontus; Derevianko, Anatoly P.; Drozdov, Nikolai; Slavinsky, Vyacheslav; Tsybankov, Alexander; Cremonesi, Renata Grifoni; Mallegni, Francesco; Gely, Bernard; Vacca, Eligio; Gonzalez Morales, Manuel R.; Straus, Lawrence G.; Neugebauer-Maresch, Christine; Teschler-Nicola, Maria; Constantin, Silviu; Moldovan, Oana Teodora; Benazzi, Stefano; Peresani, Marco; Coppola, Donato; Lari, Martina; Ricci, Stefano; Ronchitelli, Annamaria; Valentin, Frederique; Thevenet, Corinne; Wehrberger, Kurt; Grigorescu, Dan; Rougier, Helene; Crevecoeur, Isabelle; Flas, Damien; Semal, Patrick; Mannino, Marcello A.; Cupillard, Christophe; Bocherens, Herve; Conard, Nicholas J.; Harvati, Katerina; Moiseyev, Vyacheslav; Drucker, Dorothee G.; Svoboda, Jiri; Richards, Michael P.; Caramelli, David; Pinhasi, Ron; Kelso, Janet; Patterson, Nick; Krause, Johannes; Paeaebo, Svante; Reich, David			The genetic history of Ice Age Europe	NATURE			English	Article							GENOME SEQUENCE; RADIOCARBON-DATES; HUNTER-GATHERERS; NEANDERTHAL; MORPHOLOGY; CAVE; DISPERSAL; ADMIXTURE; ANCESTRY; SUGGEST	Modern humans arrived in Europe similar to 45,000 years ago, but little is known about their genetic composition before the start of farming similar to 8,500 years ago. Here we analyse genome-wide data from 51 Eurasians from similar to 45,000-7,000 years ago. Over this time, the proportion of Neanderthal DNA decreased from 3-6% to around 2%, consistent with natural selection against Neanderthal variants in modern humans. Whereas there is no evidence of the earliest modern humans in Europe contributing to the genetic composition of present-day Europeans, all individuals between similar to 37,000 and similar to 14,000 years ago descended from a single founder population which forms part of the ancestry of present-day Europeans. An similar to 35,000-year-old individual from northwest Europe represents an early branch of this founder population which was then displaced across a broad region, before reappearing in southwest Europe at the height of the last Ice Age similar to 19,000 years ago. During the major warming period after similar to 14,000 years ago, a genetic component related to present-day Near Easterners became widespread in Europe. These results document how population turnover and migration have been recurring themes of European prehistory.	[Fu, Qiaomei] Chinese Acad Sci, IVPP, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Fu, Qiaomei; Mallick, Swapan; Rohland, Nadin; Lazaridis, Iosif; Lipson, Mark; Mathieson, Iain; Skoglund, Pontus; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Fu, Qiaomei; Hajdinjak, Mateja; Petr, Martin; Meyer, Matthias; Nickel, Birgit; Slon, Viviane; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Posth, Cosimo; Furtwangler, Anja; Mittnik, Alissa; Peltzer, Alexander; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci Archaeo & Palaeogenet, D-72070 Tubingen, Germany; [Posth, Cosimo; Haak, Wolfgang; Mittnik, Alissa; Schiffels, Stephan; Krause, Johannes] Max Planck Inst Sci Human Hist, Dept Archaeogenet, D-07745 Jena, Germany; [Mallick, Swapan; Patterson, Nick; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Fernandes, Daniel; Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 4, Ireland; [Fernandes, Daniel; Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 4, Ireland; [Fernandes, Daniel] Univ Coimbra, Dept Life Sci, CIAS, P-3000456 Coimbra, Portugal; [Haak, Wolfgang] Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Talamo, Sahra; Benazzi, Stefano; Mannino, Marcello A.; Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Derevianko, Anatoly P.; Drozdov, Nikolai; Slavinsky, Vyacheslav; Tsybankov, Alexander] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, RU-630090 Novosibirsk 17, Russia; [Derevianko, Anatoly P.] Altai State Univ, RU-656049 Barnaul, Russia; [Cremonesi, Renata Grifoni] Univ Pisa, Dipartimento Civilta & Forme Sapere, I-56126 Pisa, Italy; [Mallegni, Francesco] Univ Pisa, Dept Biol, I-56126 Pisa, Italy; [Gely, Bernard] Direct Reg Affaires Culturelles Rhone Alpes, F-69283 Lyon 01, France; [Vacca, Eligio] Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy; [Gonzalez Morales, Manuel R.; Straus, Lawrence G.] Univ Cantabria, Inst Int Invest Prehist, E-39005 Santander, Spain; [Straus, Lawrence G.] Univ New Mexico, Dept Anthropol, MSC01 1040, Albuquerque, NM 87131 USA; [Neugebauer-Maresch, Christine] Austrian Acad Sci, Inst Oriental & European Archaeol, Quaternary Archaeol, A-1010 Vienna, Austria; [Teschler-Nicola, Maria] Nat Hist Museum Vienna, Dept Anthropol, A-1010 Vienna, Austria; [Teschler-Nicola, Maria] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria; [Constantin, Silviu] Emil Racovita Inst Speleol, Bucharest 010986 12, Romania; [Moldovan, Oana Teodora] Emil Racovita Inst Speleol, Cluj Branch, Cluj Napoca 400006, Romania; [Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, I-48121 Ravenna, Italy; [Peresani, Marco] Univ Ferrara, Dipartimento Studi Umanist, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Coppola, Donato] Univ Bari Aldo Moro, I-70125 Bari, Italy; [Coppola, Donato] Museo Civilta Preclassiche Murgia Merid, I-72017 Ostuni, Italy; [Lari, Martina; Caramelli, David] Univ Firenze, Dipartimento Biol, I-50122 Florence, Italy; [Ricci, Stefano; Ronchitelli, Annamaria] Univ Siena, UR Preistoria Antropol, Dipartimento Sci Fis Terra & Ambiente, I-53100 Siena, Italy; [Valentin, Frederique] CNRS UMR 7041 ArScAn, F-92023 Nanterre, France; [Thevenet, Corinne] INRAP UMR 8215, Trajectoires 21, F-92023 Nanterre, France; [Wehrberger, Kurt] Ulmer Museum, D-89073 Ulm, Germany; [Grigorescu, Dan] Univ Bucharest, Fac Geol & Geophys, Dept Geol, Bucharest 01041, Romania; [Rougier, Helene] Calif State Univ Northridge, Dept Anthropol, Northridge, CA 91330 USA; [Crevecoeur, Isabelle] Univ Bordeaux, CNRS, UMR PACEA 5199, F-33615 Pessac, France; [Flas, Damien] Univ Toulouse Jean Jaures, Maison Rech, TRACES UMR 5608, F-31058 Toulouse 9, France; [Semal, Patrick] Royal Belgian Inst Nat Sci, B-1000 Brussels, Belgium; [Mannino, Marcello A.] Aarhus Univ, Sch Culture & Soc, Dept Archaeol, DK-8270 Hojbjerg, Denmark; [Cupillard, Christophe] Serv Reg Archeol Franche Comte, F-25043 Besancon, France; [Cupillard, Christophe] CNRS, UMR 6249, UFR Sci & Tech, Lab Chronoenvironm, F-25030 Besancon, France; [Bocherens, Herve; Drucker, Dorothee G.] Univ Tubingen, Biogeol, Dept Geosci, D-72074 Tubingen, Germany; [Bocherens, Herve; Conard, Nicholas J.; Harvati, Katerina; Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Palaeoenvironm, D-72072 Tubingen, Germany; [Conard, Nicholas J.] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany; [Harvati, Katerina] Univ Tubingen, Inst Archaeol Sci Paleoanthropol, D-72070 Tubingen, Germany; [Moiseyev, Vyacheslav] Museum Anthropol & Ethnog, St Petersburg 34, Russia; [Svoboda, Jiri] Masaryk Univ, Fac Sci, Dept Anthropol, CS-61137 Brno, Czech Republic; [Svoboda, Jiri] Acad Sci Czech Republ, Inst Archaeol Brno, Dolni Vestonice 69129, Czech Republic; [Richards, Michael P.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Harvard University; Harvard Medical School; Max Planck Society; Eberhard Karls University of Tubingen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University College Dublin; University College Dublin; Universidade de Coimbra; University of Adelaide; Max Planck Society; Russian Academy of Sciences; Altai State University; University of Pisa; University of Pisa; Universita degli Studi di Bari Aldo Moro; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC); University of New Mexico; Austrian Academy of Sciences; University of Vienna; Emil Racovita Institute of Speleology; Emil Racovita Institute of Speleology; Romanian Academy of Sciences; University of Bologna; University of Ferrara; Universita degli Studi di Bari Aldo Moro; University of Florence; University of Siena; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); University of Bucharest; California State University System; California State University Northridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Royal Belgian Institute of Natural Sciences; Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Masaryk University Brno; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Brno; Simon Fraser University	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.; Reich, D (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Reich, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu	Harvati, Katerina/A-5197-2008; Drucker, Dorothée G./E-8900-2011; Pinhasi, Ron/AAT-1531-2020; Constantin, Silviu/D-1650-2010; Krause, Johannes/AFP-2642-2022; Haak, Wolfgang/Z-4947-2019; Posth, Cosimo/AAL-6219-2021; Manolescu, Stefan/AAC-9335-2020; Benazzi, Stefano/AAH-3923-2020; Talamo, Sahra/AAD-1774-2022; Schiffels, Stephan/D-5675-2018; Peltzer, Alexander/I-4064-2019; Peresani, Marco/X-1343-2019; Lari, Martina/A-4085-2009; Derevianko, Anatoly P./Q-5975-2016; Svoboda, Jiří/H-4621-2014; Richards, Michael/O-3717-2016; BOCHERENS, Hervé/F-3580-2011; Moldovan, Oana/A-6646-2011; Nikolai, Drozdov/H-9064-2016; Kelso, Janet/N-1812-2019; Moiseyev, Vyacheslav/AAD-2659-2019	Drucker, Dorothée G./0000-0003-0854-4371; Pinhasi, Ron/0000-0003-1629-8131; Constantin, Silviu/0000-0003-3737-2652; Krause, Johannes/0000-0001-9144-3920; Haak, Wolfgang/0000-0003-2475-2007; Talamo, Sahra/0000-0002-2406-3132; Schiffels, Stephan/0000-0002-1017-9150; Peltzer, Alexander/0000-0002-6503-2180; Derevianko, Anatoly P./0000-0003-1156-8331; Svoboda, Jiří/0000-0003-4256-9708; Richards, Michael/0000-0001-5274-8887; BOCHERENS, Hervé/0000-0002-0494-0126; Moldovan, Oana/0000-0002-1262-0675; Kelso, Janet/0000-0002-3618-322X; Vacca, Eligio/0000-0003-4507-5455; Flas, Damien/0000-0002-9159-8030; Changuan, David/0000-0003-1006-9266; Chabra, robbie/0000-0001-6530-1646; Skoglund, Pontus/0000-0002-3021-5913; M Fernandes, Daniel/0000-0002-7434-6552; Calderon, Andres/0000-0001-9186-9729; Aldana Fernandez, Miguel Angel/0000-0002-7194-2172; HUAMAN, EDWIN/0000-0003-0838-5219; Peresani, Marco/0000-0001-6562-6336; Conard, Nicholas/0000-0002-4633-0385; Rougier, Helene/0000-0003-0358-0285; Valentin, Frederique/0000-0002-0575-7681; Hajdinjak, Mateja/0000-0002-4064-0331; Petr, Martin/0000-0003-4879-8421; Semal, Patrick/0000-0002-4048-7728	Wenner-Gren Foundation [7837]; College of Social and Behavioral Sciences of CSUN; CSUN Competition for Research, Scholarship and Creative Activity Awards; RBINS; Gobierno de Cantabria; L.S.B. Leakey Foundation; University of New Mexico; Stone Age Research Fund; town of Ramales de la Victoria; Universidad de Cantabria; MIBACT; Veneto Region; Special Foundation of the President of the Chinese Academy of Sciences; Bureau of International Cooperation of the Chinese Academy of Sciences; Chinese Academy of Sciences [XDA05130202]; National Natural Science Foundation of China [L1524016]; Chinese Academy of Sciences Discipline Development Strategy Project [2015-DX-C-03]; Irish Research Council [GOIPG/2013/36]; Human Frontier Science Program [LT001095/2014-L]; Swedish Research Council [VR 2014-453]; Max Planck Society; FWF [P-17258, P-19347, P-21660, P-23612]; 'Karsthives' Grant [PCCE 31/2010]; Russian Science Foundation [14-50-00036]; European Community [PIEF-GA-2008-219965]; Collective Research Program (PCR); European Research Council [ERC StG 283503]; Deutsche Forschungsgemeinschaft [DFG INST37/706-1FUGG, DFG FOR2237, SFB1052]; European Social Fund; Ministry of Science, Research and Arts of Baden-Wurttemberg; ERC starting grant ADNABIOARC [263441]; DFG [KR 4015/1-1]; Baden Wurttemberg Foundation; Krekeler Foundation; NSF HOMINID [BCS-1032255]; NIH (NIGMS) [GM100233]; Howard Hughes Medical Institute;  [2010EL8TXP_003]; Austrian Science Fund (FWF) [P 23612] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [1032255] Funding Source: National Science Foundation	Wenner-Gren Foundation; College of Social and Behavioral Sciences of CSUN; CSUN Competition for Research, Scholarship and Creative Activity Awards; RBINS; Gobierno de Cantabria; L.S.B. Leakey Foundation; University of New Mexico; Stone Age Research Fund; town of Ramales de la Victoria; Universidad de Cantabria; MIBACT; Veneto Region(Regione Veneto); Special Foundation of the President of the Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of International Cooperation of the Chinese Academy of Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Discipline Development Strategy Project; Irish Research Council(Irish Research Council for Science, Engineering and Technology); Human Frontier Science Program(Human Frontier Science Program); Swedish Research Council(Swedish Research CouncilEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); FWF(Austrian Science Fund (FWF)); 'Karsthives' Grant; Russian Science Foundation(Russian Science Foundation (RSF)); European Community(European Commission); Collective Research Program (PCR); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Social Fund(European Social Fund (ESF)); Ministry of Science, Research and Arts of Baden-Wurttemberg; ERC starting grant ADNABIOARC; DFG(German Research Foundation (DFG)); Baden Wurttemberg Foundation; Krekeler Foundation; NSF HOMINID; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank B. Alex, D. Meltzer, P. Moorjani, I. Olalde, S. Sankararaman and B. Viola for comments, K. Stewardson and E. Harney for sample screening, and F. Hallgren for sharing a radiocarbon date for Motala12. The Fig. 1 map is plotted using data available under the Open Database License (c) OpenStreetMap (http://www.openstreetmap.org/copyright). The Goyet project led by H.R. was funded by the Wenner-Gren Foundation (Gr. 7837), the College of Social and Behavioral Sciences of CSUN, the CSUN Competition for Research, Scholarship and Creative Activity Awards, and the RBINS. The excavation of the El Miron Cave burial, led by L.G.S. and M.R.G.M., was supported by the Gobierno de Cantabria, the L.S.B. Leakey Foundation, the University of New Mexico, the Stone Age Research Fund (J. and R. Auel, principal donors), the town of Ramales de la Victoria and the Universidad de Cantabria. Excavations at Grotta Paglicci were performed by A. Palma di Cesnola in collaboration with the Soprintendenza Archeologia della Puglia (founded by MIUR and local Institutions). Research at Riparo Villabruna was supported by MIBACT and the Veneto Region. Q. F. was funded by the Special Foundation of the President of the Chinese Academy of Sciences (2015-2016), the Bureau of International Cooperation of the Chinese Academy of Sciences, the Chinese Academy of Sciences (XDA05130202), the National Natural Science Foundation of China (L1524016) and the Chinese Academy of Sciences Discipline Development Strategy Project (2015-DX-C-03). D. Fe was supported by an Irish Research Council grant (GOIPG/2013/36). I. M. was supported by a long-term fellowship from the Human Frontier Science Program LT001095/2014-L. P.Sk was supported by the Swedish Research Council (VR 2014-453). S.T., and M.P.R. were funded by the Max Planck Society. C.N.-M. was funded by FWF P-17258, P-19347, P-21660 and P-23612. S.C. and O.T.M. were funded by a 'Karsthives' Grant PCCE 31/2010 (CNCS-UEFISCDI, Romania). A.P.D., N.D., V. Sla and N.D. were funded by the Russian Science Foundation (project No. 14-50-00036). M. A. M. was funded by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (grant number PIEF-GA-2008-219965). M. La and D. C. were funded by grants PRIN 2010-11 and 2010EL8TXP_003. C. C. and the research about the French Jura sites of Rochedane, Rigney and Ranchot was funded by the Collective Research Program (PCR) (2005-2008). K.H. was supported by the European Research Council (ERC StG 283503) and the Deutsche Forschungsgemeinschaft (DFG INST37/706-1FUGG, DFG FOR2237). D.G.D. was funded by the European Social Fund and Ministry of Science, Research and Arts of Baden-Wurttemberg. R. P. was funded by ERC starting grant ADNABIOARC (263441). J. Ke was funded by a grant from the Deutsche Forschungsgemeinschaft (SFB1052, project A02). J. Kr was funded by DFG grant KR 4015/1-1, the Baden Wurttemberg Foundation, and the Max Planck Society. S.P. were funded by the Max Planck Society and the Krekeler Foundation. D. R. was funded by NSF HOMINID grant BCS-1032255, NIH (NIGMS) grant GM100233, and the Howard Hughes Medical Institute.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; AZZI CM, 1974, RADIOCARBON, V16, P10, DOI 10.1017/S0033822200001405; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Coop G., 2015, PREPRINT; Cupillard C, 2015, QUATERN INT, V378, P40, DOI 10.1016/j.quaint.2014.05.032; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Drucker DG, 2011, QUATERN INT, V245, P268, DOI 10.1016/j.quaint.2011.07.019; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Harris K., 2016, GENETICS; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Mallick S., NATURE IN PRESS; Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Montoya C., 2005, MEMOIRE SOC PREHISTO, V40, P123; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Orschiedt J, 1999, THESIS, P13; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Palma di Cesnola A, 2004, AURIGNAZIANO GRAVETT; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; PRICE TD, 1990, ANTIQUITY, V64, P849, DOI 10.1017/S0003598X00078960; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Rougier H, 2007, P NATL ACAD SCI USA, V104, P1165, DOI 10.1073/pnas.0610538104; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Simon U., 1993, BURKHARDTSHOHLE MAGD; Simon U, 2014, QUATERN INT, V351, P5, DOI 10.1016/j.quaint.2013.08.009; Sinitsyn A., 2004, ERAUL, V106, P237; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Soficaru A, 2007, CURR ANTHROPOL, V48, P611, DOI 10.1086/519915; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Straus LG, 2013, J ARCHAEOL METHOD TH, V20, P236, DOI 10.1007/s10816-012-9152-5; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; TeschlerNicola M, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P1, DOI 10.1007/978-3-211-49294-9; Valentin B., 2008, JALONS PALEOHISTOIRE, V1, P325; Valentin F., 2008, REV ARCHEOLOGIQUE IL, V1, P21; Vercellotti G, 2008, J ANTHROPOL SCI, V86, P143; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Wehrberger K., 2000, ARCHAOL KORRESPONDEN, V30, P15	65	467	485	23	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2016	534	7606					200	+		10.1038/nature17993	http://dx.doi.org/10.1038/nature17993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DO0NH	27135931	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000377475100031
J	Selby, JV				Selby, Joseph V.			Complementary Efforts Make for Efficient Research	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR OUTCOMES; MORTALITY		[Selby, Joseph V.] Patient Ctr Outcomes Res Inst, 1828 L St,Suite 900, Washington, DC 20036 USA		Selby, JV (corresponding author), Patient Ctr Outcomes Res Inst, 1828 L St,Suite 900, Washington, DC 20036 USA.	jvselby@pcori.org						Behrman RE, 2011, NEW ENGL J MED, V364, P498, DOI 10.1056/NEJMp1014427; Department of Health and Human Services Food and Drug Administration, 2013, RE ADJ ROS EV CARD O; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Toh S, 2016, ANN INTERN MED, V164, P705, DOI 10.7326/M15-2568; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	10	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					771	772		10.7326/M16-0869	http://dx.doi.org/10.7326/M16-0869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27110867				2022-12-28	WOS:000377510100009
J	Smetana, GW				Smetana, Gerald W.			Update on Novel Drugs for Primary Care Practice: Drugs Approved by the US Food and Drug Administration in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONGESTIVE-HEART-FAILURE; CORONARY-ARTERY-DISEASE; DOUBLE-BLIND; IDARUCIZUMAB; DABIGATRAN; IVABRADINE; REVERSAL; SAFETY; HYPERURICEMIA; TOLERABILITY		Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Smetana, GW (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, YA 102C,330 Brookline Ave, Boston, MA 02215 USA.	gsmetana@bidmc.harvard.edu						[Anonymous], 2015, PRAXB ID INJ INTR US; [Anonymous], 2015, MED LETT DRUGS THER, V57, P75; Ardea Biosciences, 2015, LES COMB XANTH OX IN; Burness CB, 2015, DRUGS, V75, P2155, DOI 10.1007/s40265-015-0508-5; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Dove LS, 2013, GASTROENTEROLOGY, V145, P329, DOI 10.1053/j.gastro.2013.04.006; Dunne Roberts M, 2015, CLIN SAFETY REV; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Glund S, 2015, LANCET, V386, P680, DOI 10.1016/S0140-6736(15)60732-2; Glund S, 2015, THROMB HAEMOSTASIS, V113, P943, DOI 10.1160/TH14-12-1080; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Muldowney L, 2014, NEW DRUG APPL MED RE; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Pereira-Barretto AC, 2015, ADV THER, V32, P906, DOI 10.1007/s12325-015-0257-6; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; U.S. Centers for Disease Control and Prevention, 2015, HIGH CHOL FACTS; U.S. Food and Drug Administration, 2015, ARTHR ADV COMM M LES; US FDA, NOV DRUG APPR 2015; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	25	1	1	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W48	W54		10.7326/M15-3104	http://dx.doi.org/10.7326/M15-3104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136232				2022-12-28	WOS:000375744000011
J	Amer, P				Amer, Pakinam			MAKING THE MOST OF FINANCIAL MIGHT	NATURE			English	Editorial Material																			0	1	1	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S10	S12		10.1038/532S10a	http://dx.doi.org/10.1038/532S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27135099	Bronze			2022-12-28	WOS:000374815900002
J	Vieira, ER; Palmer, RC; Chaves, PHM				Vieira, Edgar R.; Palmer, Richard C.; Chaves, Paulo H. M.			Prevention of falls in older people living in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D SUPPLEMENTATION; HOME-BASED EXERCISE; COGNITIVE IMPAIRMENT; RISK-FACTORS; CALCIUM SUPPLEMENTATION; GAIT SPEED; MULTIFACTORIAL INTERVENTION; ORTHOSTATIC HYPOTENSION; PHYSICAL-ACTIVITY	The number of people living into older age (>= 65 years) is rising rapidly. Older people are more likely to fall and this has adverse consequences for their quality of life and that of their families. Falls also pose a substantial financial burden on healthcare systems. Extensive research from systematic reviews and meta-analyses has established effective approaches for reducing falls among older people, although uncertainties and controversy remain. The evidence suggests that exercise based and tailored interventions are the most effective way to reduce falls and associated healthcare costs among older people in the community. This review integrates current knowledge on assessment and management strategies to prevent falls in older people living in the community. It summarizes known risk factors for falls in this population and presents assessment strategies that can be used to assess the risk of falls. It discusses the management of risks and interventions to reduce falls among older people in the community, as well as future directions and promising approaches.	[Vieira, Edgar R.] Florida Int Univ, Nicole Wertheim Coll Nursing & Hlth Sci, Dept Phys Therapy, Miami, FL 33199 USA; [Vieira, Edgar R.] Florida Int Univ, Dept Neurosci, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Palmer, Richard C.] Florida Int Univ, Dept Hlth Promot & Dis Prevent, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Chaves, Paulo H. M.] Florida Int Univ, Herbert Wertheim Coll Med, Benjamin Leon Ctr Geriatr Res & Educ, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Geriatric Research Education & Clinical Center; State University System of Florida; Florida International University	Vieira, ER (corresponding author), 11200 SW 8st,AHC3-430, Miami, FL 33199 USA.	Edgar.Vieira@fiu.edu	Vieira, Edgar Ramos/I-7609-2013	Vieira, Edgar Ramos/0000-0002-1011-5077	Health Foundation of South Florida; Benjamin Leon Center for Geriatric Research at Florida International University	Health Foundation of South Florida; Benjamin Leon Center for Geriatric Research at Florida International University	ERV was supported by funds from the Health Foundation of South Florida, and PHMC was supported by funds from the Benjamin Leon Center for Geriatric Research at Florida International University. The sponsors had no role in the conception, design, interpretation, or preparation of this review.	Age UK, 2010, FALLS 65S COST NHS 4; Allcock LM, 2000, J GERONTOL A-BIOL, V55, pM458, DOI 10.1093/gerona/55.8.M458; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Amer Geriatrics Soc Workgrp Vitami, 2014, J AM GERIATR SOC, V62, P147, DOI 10.1111/jgs.12631; Anstey KJ, 2006, J AM GERIATR SOC, V54, P1169, DOI 10.1111/j.1532-5415.2006.00813.x; Arnold AC, 2013, CURR HYPERTENS REP, V15, P304, DOI 10.1007/s11906-013-0362-3; Baker DI, 2005, J AM GERIATR SOC, V53, P675, DOI 10.1111/j.1532-5415.2005.53218.x; Batchelor FA, 2012, INT J STROKE, V7, P482, DOI 10.1111/j.1747-4949.2012.00796.x; Bateni H, 2012, PHYSIOTHERAPY, V98, P211, DOI 10.1016/j.physio.2011.02.004; Bauer CM, 2016, Z GERONTOL GERIATR, V49, P232, DOI 10.1007/s00391-015-0885-0; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; BERG K, 1989, Physiotherapy Canada, V41, P304; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bohannon Richard W, 2006, J Geriatr Phys Ther, V29, P64; Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Campbell AJ, 2010, CLIN GERIATR MED, V26, P719, DOI 10.1016/j.cger.2010.06.004; Campbell AJ, 1997, MED J AUSTRALIA, V167, P407, DOI 10.5694/j.1326-5377.1997.tb126644.x; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Carande-Kulis V, 2015, J SAFETY RES, V52, P65, DOI 10.1016/j.jsr.2014.12.007; Carey BJ, 2001, AGE AGEING, V30, P19, DOI 10.1093/ageing/30.suppl_4.19; Carlson JE, 1999, SOUTHERN MED J, V92, P167, DOI 10.1097/00007611-199902000-00002; Center for Disease Control and Prevention, COST FALLS OLD AD; Centers for Disease Control and Prevention, 2014, PREV FALL GUID IMPL; Centers for Disease Control and Prevention: National Center for Health Statistics, 2014, UND CAUS DEATH 1999; Cesari M, 2015, J GERONTOL A-BIOL, V70, P216, DOI 10.1093/gerona/glu099; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Child S, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-91; Chou WC, 2006, J GEN INTERN MED, V21, P117, DOI [10.1007/s11606-006-0244-3, 10.1111/j.1525-1497.2005.00298.x]; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Church J, 2012, AUST NZ J PUBL HEAL, V36, P241, DOI 10.1111/j.1753-6405.2011.00811.x; Clark R, 2009, J GERIATR PHYS THER, V32, P174, DOI 10.1519/00139143-200932040-00006; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Cumming RG, 2000, J GERONTOL A-BIOL, V55, pM299, DOI 10.1093/gerona/55.5.M299; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Davies AJ, 1996, AGE AGEING, V25, P362, DOI 10.1093/ageing/25.5.362; Davies AJ, 2001, AGE AGEING, V30, P289, DOI 10.1093/ageing/30.4.289; Department of Health and Human Services Older Adults Centers for Disease Control and Prevention, 2005, CHECK SAF HOM FALL P; Dhesi JK, 2004, AGE AGEING, V33, P589, DOI 10.1093/ageing/afh209; Duckham RL, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-133; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; Evans WJ, 2008, J GERONTOL A-BIOL, V63, P160; Feder G, 2000, BRIT MED J, V321, P1007, DOI 10.1136/bmj.321.7267.1007; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Fortinsky RH, 2004, J AM GERIATR SOC, V52, P1522, DOI 10.1111/j.1532-5415.2004.52416.x; Freter SH, 2000, CLIN REHABIL, V14, P96, DOI 10.1191/026921500675545616; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Fu AS, 2015, ARCH PHYS MED REHAB, V96, P2096, DOI 10.1016/j.apmr.2015.08.427; Gangavati A, 2011, J AM GERIATR SOC, V59, P383, DOI 10.1111/j.1532-5415.2011.03317.x; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Goodwin VA, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-15; Griffin M, 2012, J AM GERIATR SOC, V60, P385, DOI 10.1111/j.1532-5415.2011.03803.x; Guccione A. A., 2011, GERIATRIC PHYS THERA; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hackney ME, 2014, J GERIATR PHYS THER, V37, P127, DOI 10.1519/JPT.0b013e3182abe784; Hallal CZ, 2013, J ELECTROMYOGR KINES, V23, P1145, DOI 10.1016/j.jelekin.2013.06.006; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hewston P, 2016, CAN J DIABETES, V40, P6, DOI 10.1016/j.jcjd.2015.08.005; Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Joester J, 2010, DRUG AGING, V27, P915, DOI 10.2165/11584480-000000000-00000; Jones TS, 2011, ACCIDENT ANAL PREV, V43, P1605, DOI 10.1016/j.aap.2011.03.013; Jorgensen MG, 2013, J GERONTOL A-BIOL, V68, P845, DOI 10.1093/gerona/gls222; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kenny RA, 2002, AGE AGEING, V31, P272, DOI 10.1093/ageing/31.4.272; Kenny RA, 2009, HAZZARDS GERIATRIC M, P693; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kiel DP., 2014, FALLS PREV COMM DWEL; Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0039-7; Latham NK, 2003, J AM GERIATR SOC, V51, P1219, DOI 10.1046/j.1532-5415.2003.51405.x; Lawlor DA, 2003, BRIT MED J, V327, P712, DOI 10.1136/bmj.327.7417.712; Li FZ, 2016, J AM GERIATR SOC, V64, P425, DOI 10.1111/jgs.13925; Li FZ, 2004, MED SCI SPORT EXER, V36, P2046, DOI 10.1249/01.MSS.0000147590.54632.E7; Liddle J., 1995, CLIN REHABIL, V9, P110, DOI DOI 10.1177/026921559500900204; MaineHealth, WHAT IS MATT BAL; Mansfield A, 2015, PHYSIOTHERAPY, V101, P373, DOI 10.1016/j.physio.2015.01.009; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Moreland J, 2003, GERONTOLOGY, V49, P93, DOI 10.1159/000067948; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; National Institute for Health and Care Excellence, 2013, FALL ASS PREV FALLS; National Safety Council, OLD AD FALL PREV CHE; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Nicholson VP, 2015, J AGING PHYS ACTIV, V23, P153, DOI [10.1123/japa.2013-0148, 10.1123/JAPA.2013-0148]; NSW Ministry of Health, 2011, FALLS PREV FALLS HAR; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Patel KV, 2014, J AM GERIATR SOC, V62, P1844, DOI 10.1111/jgs.13072; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Pit SW, 2007, MED J AUSTRALIA, V187, P23, DOI 10.5694/j.1326-5377.2007.tb01110.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pohl P, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-120; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Quach L, 2011, J AM GERIATR SOC, V59, P1069, DOI 10.1111/j.1532-5415.2011.03408.x; Richardson K, 2015, AGE AGEING, V44, P90, DOI 10.1093/ageing/afu141; Riddle DL, 1999, PHYS THER, V79, P939, DOI 10.1093/ptj/79.10.939; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Ross A, 2011, DIETARY REFERENCE IN; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Sekulic S, 2012, MED HYPOTHESES, V79, P564, DOI 10.1016/j.mehy.2012.07.019; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Shibao C, 2013, J CLIN HYPERTENS, V15, P147, DOI 10.1111/jch.12062; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Siong KH, 2016, GERIATR GERONTOL INT, V16, P259, DOI 10.1111/ggi.12463; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; Stevens J., 2015, CDC COMPENDIUM EFFEC, V3rd; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens J.A., 2015, CDC COMPENDIUM EFFEC; Stevens JA, 2013, HEALTH PROMOT PRACT, V14, P706, DOI 10.1177/1524839912463576; Stubbs B, 2015, PHYS THER, V95, P1095, DOI 10.2522/ptj.20140461; Stubbs B, 2014, ARCH PHYS MED REHAB, V95, P175, DOI 10.1016/j.apmr.2013.08.241; Tan MP, 2006, CLIN INTERV AGING, V1, P57, DOI 10.2147/ciia.2006.1.1.57; The Australian Commission on Safety and Quality in Health Care, 2009, PREV FALLS HARM FALL; Tinetti ME, 2008, J AM GERIATR SOC, V56, P1563, DOI 10.1111/j.1532-5415.2008.01800.x; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Tinetti ME, 2006, GERONTOLOGIST, V46, P717, DOI 10.1093/geront/46.6.717; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; Tinetti ME, 2012, ANN INTERN MED, V157, P213, DOI 10.7326/0003-4819-157-3-201208070-00014; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Turner S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003600.pub3; US Department of Health and Human Services, PREV FALLS HOM; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Vieira ER, 2015, J DIABETES COMPLICAT, V29, P1159, DOI 10.1016/j.jdiacomp.2015.08.005; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Wall JC, 2000, J REHABIL RES DEV, V37, P109; Winter H, 2013, INT PSYCHOGERIATR, V25, P215, DOI 10.1017/S1041610212001573; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; World Health Organization, 2007, WHO GLOB REP FALLP; Yawn BP, 2016, MAYO CLIN PROC, V91, P411, DOI 10.1016/j.mayocp.2016.01.010; Zijlstra A, 2008, GERONTOLOGY, V54, P40, DOI 10.1159/000117808	153	103	108	8	78	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2016	353								i1419	10.1136/bmj.i1419	http://dx.doi.org/10.1136/bmj.i1419			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2RW	27125497				2022-12-28	WOS:000375483900001
J	Gulland, A				Gulland, Anne			Putting health inequalities to music	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2354	10.1136/bmj.i2354	http://dx.doi.org/10.1136/bmj.i2354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27117171				2022-12-28	WOS:000375482500012
J	Bagcchi, S				Bagcchi, Sanjeet			Nearly six in 10 medical colleges in India did not publish any research in past 10 years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ray S, 2016, CURR MED RES PRACT, V6, P49, DOI DOI 10.1016/J.CMRP.2016.04.002	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2352	10.1136/bmj.i2352	http://dx.doi.org/10.1136/bmj.i2352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27112643				2022-12-28	WOS:000375482000008
J	Damianov, A; Ying, Y; Lin, CH; Lee, JA; Tran, D; Vashisht, AA; Bahrami-Samani, E; Xing, Y; Martin, KC; Wohlschlegel, JA; Black, DL				Damianov, Andrey; Ying, Yi; Lin, Chia-Ho; Lee, Ji-Ann; Tran, Diana; Vashisht, Ajay A.; Bahrami-Samani, Emad; Xing, Yi; Martin, Kelsey C.; Wohlschlegel, James A.; Black, Douglas L.			Rbfox Proteins Regulate Splicing as Part of a Large Multiprotein Complex LASR	CELL			English	Article							RNA-BINDING SPECIFICITY; HNRNP PARTICLES; POLYMERASE-II; SR PROTEINS; FOX-1; EXON; GENE; P68; REPRESSION; EXPRESSION	Rbfox proteins control alternative splicing and post-transcriptional regulation in mammalian brain and are implicated in neurological disease. These proteins recognize the RNA sequence (U)GCAUG, but their structures and diverse roles imply a variety of protein-protein interactions. We find that nuclear Rbfox proteins are bound within a large assembly of splicing regulators (LASR), a multimeric complex containing the proteins hnRNP M, hnRNP H, hnRNP C, Matrin3, NF110/NFAR-2, NF45, and DDX5, all approximately equimolar to Rbfox. We show that splicing repression mediated by hnRNP M is stimulated by Rbfox. Virtually all the intron-bound Rbfox is associated with LASR, and hnRNP M motifs are enriched adjacent to Rbfox crosslinking sites in vivo. These findings demonstrate that Rbfox proteins bind RNA with a defined set of cofactors and affect a broader set of exons than previously recognized. The function of this multimeric LASR complex has implications for deciphering the regulatory codes controlling splicing networks.	[Damianov, Andrey; Lin, Chia-Ho; Tran, Diana; Bahrami-Samani, Emad; Xing, Yi; Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ying, Yi] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Lee, Ji-Ann; Vashisht, Ajay A.; Martin, Kelsey C.; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	dougb@microbio.ucla.edu		Lee, Ji-Ann/0000-0002-9069-2113	Howard Hughes Medical Institute; NIH [R21 MH101684, R01 GM088432, R01 GM105431, R01 GM089778]; NARSAD Young Investigator Award; China Scholarship Council; Alfred P. Sloan Fellowship; Broad Center for Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105431, R01GM089778, R01GM049662, R01GM088342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH101684] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); China Scholarship Council(China Scholarship Council); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Broad Center for Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Julian Konig and Jernej Ule for communicating the iCLIP protocol ahead of publication and Celine Vuong and Anthony Linares for critical reading of the manuscript. This work was supported by the Howard Hughes Medical Institute (to D.L.B.); NIH grants R21 MH101684 (to K.C.M.), R01 GM088432 (to Y.X.), R01 GM105431 (to Y.X.), and R01 GM089778 (to J.A.W.); a NARSAD Young Investigator Award (to J.-A.L.); the China Scholarship Council (to Y.Y.); an Alfred P. Sloan Fellowship (to Y.X.); and the Broad Center for Stem Cell Research at UCLA.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bill BR, 2013, INT REV NEUROBIOL, V113, P251, DOI 10.1016/B978-0-12-418700-9.00008-3; Braeutigam C, 2014, ONCOGENE, V33, P1082, DOI 10.1038/onc.2013.50; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chou MY, 1999, MOL CELL BIOL, V19, P69; Close P, 2012, NATURE, V484, P386, DOI 10.1038/nature10925; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Fukumura K, 2007, NUCLEIC ACIDS RES, V35, P5303, DOI 10.1093/nar/gkm569; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Grabowski PJ, 2005, METHODS, V37, P323, DOI 10.1016/j.ymeth.2005.07.014; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang SC, 2012, MOL CELL BIOL, V32, P513, DOI 10.1128/MCB.06423-11; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jangi M, 2014, GENE DEV, V28, P637, DOI 10.1101/gad.235770.113; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kim KK, 2011, NUCLEIC ACIDS RES, V39, P3064, DOI 10.1093/nar/gkq1221; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Kuwasako K, 2014, NAT STRUCT MOL BIOL, V21, P778, DOI 10.1038/nsmb.2870; Lal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073323; Lal D, 2013, EPILEPSIA, V54, P265, DOI 10.1111/epi.12084; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Sharma S, 2014, GENE DEV, V28, P2518, DOI 10.1101/gad.248625.114; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Sun SY, 2012, RNA, V18, P274, DOI 10.1261/rna.030486.111; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; WALKER BW, 1980, NUCLEIC ACIDS RES, V8, P3639, DOI 10.1093/nar/8.16.3639; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Xu YL, 2014, GENE DEV, V28, P1191, DOI 10.1101/gad.241968.114; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhou HL, 2008, MOL CELL BIOL, V28, P5507, DOI 10.1128/MCB.00530-08	68	93	94	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					606	619		10.1016/j.cell.2016.03.040	http://dx.doi.org/10.1016/j.cell.2016.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104978	Bronze, Green Accepted			2022-12-28	WOS:000374636800019
J	Mitchneck, B; Smith, JL; Latimer, M				Mitchneck, Beth; Smith, Jessi L.; Latimer, Melissa			A recipe for change: Creating a more inclusive academy	SCIENCE			English	Editorial Material							SUBTLE GENDER BIASES; SCIENCE; FACULTY; WOMEN		[Mitchneck, Beth] Univ Arizona, Tucson, AZ 85721 USA; [Smith, Jessi L.] Montana State Univ, Bozeman, MT 59717 USA; [Latimer, Melissa] W Virginia Univ, Morgantown, WV 26506 USA	University of Arizona; Montana State University System; Montana State University Bozeman; West Virginia University	Mitchneck, B (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	bethm@email.arizona.edu	; Ayibiowu, Olusola David,/W-4966-2018	Smith, Jessi/0000-0001-6439-1336; Ayibiowu, Olusola David,/0000-0002-6478-8779	Division Of Human Resource Development [1208831] Funding Source: National Science Foundation	Division Of Human Resource Development(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Allport G.W., 1954, NATURE PREJUDICE; Anderson A.D., 2011, ENGAGING RESISTANCE; Boyle P, 2015, NATURE, V525, P181, DOI 10.1038/525181a; Carnes M, 2015, ACAD MED, V90, P221, DOI 10.1097/ACM.0000000000000552; Dovidio JF, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P1, DOI 10.1002/9780470773963; Ely RJ, 2000, ORGANIZATION, V7, P589, DOI 10.1177/135050840074005; Fox MF, 2015, SCI TECHNOL HUM VAL, V40, P487, DOI 10.1177/0162243914564074; Griffin KA, 2011, AM J EDUC, V117, P495, DOI 10.1086/660756; Handley IM, 2015, P NATL ACAD SCI USA, V112, P13201, DOI 10.1073/pnas.1510649112; Latimer M, 2014, ADV GEND RES, V19, P333, DOI 10.1108/S1529-212620140000019015; Marschke R, 2007, J HIGH EDUC-UK, V78, P1, DOI 10.1353/jhe.2007.0003; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Research Council, 2013, SEEK SOL MAX AM TAL; Rhoten D, 2007, RES POLICY, V36, P56, DOI 10.1016/j.respol.2006.08.001; Smith JL, 2015, BIOSCIENCE, V65, P1084, DOI 10.1093/biosci/biv138; Stevens FG, 2008, J APPL BEHAV SCI, V44, P116, DOI 10.1177/0021886308314460; Torres N., 2016, HARVARD BUSINESS REV; Williams J., 1999, UNBENDING GENDER WHY; Wood W, 2000, ANNU REV PSYCHOL, V51, P539, DOI 10.1146/annurev.psych.51.1.539	19	40	40	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					148	149		10.1126/science.aad8493	http://dx.doi.org/10.1126/science.aad8493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI7LM	27124441				2022-12-28	WOS:000373681600024
J	Tan, I; Storelvmo, T; Zelinka, MD				Tan, Ivy; Storelvmo, Trude; Zelinka, Mark D.			Observational constraints on mixed-phase clouds imply higher climate sensitivity	SCIENCE			English	Article							ICE NUCLEATION; MINERAL DUST; MODEL; FEEDBACKS; SATELLITE; ECMWF	Global climate model (GCM) estimates of the equilibrium global mean surface temperature response to a doubling of atmospheric CO2, measured by the equilibrium climate sensitivity (ECS), range from 2.0 degrees to 4.6 degrees C. Clouds are among the leading causes of this uncertainty. Here we show that the ECS can be up to 1.3 degrees C higher in simulations where mixed-phase clouds consisting of ice crystals and supercooled liquid droplets are constrained by global satellite observations. The higher ECS estimates are directly linked to a weakened cloud-phase feedback arising from a decreased cloud glaciation rate in a warmer climate. We point out the need for realistic representations of the supercooled liquid fraction in mixed-phase clouds in GCMs, given the sensitivity of the ECS to the cloud-phase feedback.	[Tan, Ivy; Storelvmo, Trude] Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA; [Zelinka, Mark D.] Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA	Yale University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Tan, I (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	ivy.tan@yale.edu	Zelinka, Mark/C-4627-2011	Zelinka, Mark/0000-0002-6570-5445; Tan, Ivy/0000-0003-4203-4770; Storelvmo, Trude/0000-0002-0068-2430	NASA Headquarters under the NASA Earth and Space Science Fellowship Program [NNX14AL07H]; NSF [1352417]; Regional and Global Climate Modeling Program of the Office of Science at the U.S. Department of Energy (DOE) [DE-SC0012580]; DOE by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	NASA Headquarters under the NASA Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Regional and Global Climate Modeling Program of the Office of Science at the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE by Lawrence Livermore National Laboratory	This work was supported by NASA Headquarters under the NASA Earth and Space Science Fellowship Program, grant NNX14AL07H. We also acknowledge high-performance computing support from Yellowstone provided by National Center for Atmospheric Research's Computational and Information Systems Laboratory, sponsored by NSF under grant 1352417. The effort of M.D.Z. was supported by the Regional and Global Climate Modeling Program of the Office of Science at the U.S. Department of Energy (DOE) under grant DE-SC0012580 and was performed under the auspices of DOE by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. CALIOP data are available online at https://eosweb.larc.nasa.gov/order-data. National Centers for Environmental Prediction-DOE Reanalysis 2 data are also available online at www.esrl.noaa.gov/psd/data/gridded/data.ncep.reanalysis2.pressure.html.	Andrews T, 2012, SURV GEOPHYS, V33, P619, DOI 10.1007/s10712-011-9152-0; Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Cesana G, 2015, J GEOPHYS RES-ATMOS, V120, P7871, DOI 10.1002/2014JD022932; Chylek P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020428; DeMott PJ, 2015, ATMOS CHEM PHYS, V15, P393, DOI 10.5194/acp-15-393-2015; Fan JW, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015375; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Illingworth AJ, 2007, B AM METEOROL SOC, V88, P883, DOI 10.1175/BAMS-88-6-883; Klein SA, 1999, MON WEATHER REV, V127, P2514, DOI 10.1175/1520-0493(1999)127<2514:VASOFC>2.0.CO;2; Komurcu M, 2014, J GEOPHYS RES-ATMOS, V119, P3372, DOI 10.1002/2013JD021119; Korolev AV, 2013, J ATMOS OCEAN TECH, V30, P2527, DOI 10.1175/JTECH-D-13-00115.1; Korolev AV, 2003, Q J ROY METEOR SOC, V129, P39, DOI 10.1256/qj.01.204; LI ZX, 1992, CLIM DYNAM, V7, P133, DOI 10.1007/BF00211155; Lohmann U, 2009, ATMOS CHEM PHYS, V9, P8917, DOI 10.5194/acp-9-8917-2009; Mauritsen T, 2015, NAT GEOSCI, V8, P346, DOI 10.1038/NGEO2414; McCoy DT, 2015, J GEOPHYS RES-ATMOS, V120, P9539, DOI 10.1002/2015JD023603; MITCHELL JFB, 1989, NATURE, V341, P132, DOI 10.1038/341132a0; Morrison H, 2012, NAT GEOSCI, V5, P11, DOI [10.1038/NGEO1332, 10.1038/ngeo1332]; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Neale R. B., 2010, NCARTN486STR; Pruppacher H.R., 2011, MICROPHYSICS CLOUDS; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Shupe MD, 2008, B AM METEOROL SOC, V89, P1549, DOI 10.1175/2008BAMS2378.1; Storelvmo T, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045001; SUN Z, 1994, Q J ROY METEOR SOC, V120, P111, DOI 10.1002/qj.49712051508; Tan I, 2016, J ATMOS SCI, V73, P709, DOI 10.1175/JAS-D-15-0152.1; Tsushima Y, 2006, CLIM DYNAM, V27, P113, DOI 10.1007/s00382-006-0127-7; Webb M, 2001, CLIM DYNAM, V17, P905, DOI 10.1007/s003820100157; Winker DM, 2009, J ATMOS OCEAN TECH, V26, P2310, DOI 10.1175/2009JTECHA1281.1; Zelinka MD, 2012, J CLIMATE, V25, P3736, DOI 10.1175/JCLI-D-11-00249.1	30	267	271	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					224	227		10.1126/science.aad5300	http://dx.doi.org/10.1126/science.aad5300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124459				2022-12-28	WOS:000373681600046
J	Snyder, A				Snyder, Alison			John Kurtzke Obituary	LANCET			English	Biographical-Item																		KURTZKE JF, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1370	1370		10.1016/S0140-6736(16)30088-5	http://dx.doi.org/10.1016/S0140-6736(16)30088-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	27115809	Bronze			2022-12-28	WOS:000373217500020
J	Jazayeri, A; Dore, AS; Lamb, D; Krishnamurthy, H; Southall, SM; Baig, AH; Bortolato, A; Koglin, M; Robertson, NJ; Errey, JC; Andrews, SP; Teobald, I; Brown, AJH; Cooke, RM; Weir, M; Marshall, FH				Jazayeri, Ali; Dore, Andrew S.; Lamb, Daniel; Krishnamurthy, Harini; Southall, Stacey M.; Baig, Asma H.; Bortolato, Andrea; Koglin, Markus; Robertson, Nathan J.; Errey, James C.; Andrews, Stephen P.; Teobald, Iryna; Brown, Alastair J. H.; Cooke, Robert M.; Weir, Malcolm; Marshall, Fiona H.			Extra-helical binding site of a glucagon receptor antagonist	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; THERMOSTABILIZATION; ACTIVATION; DISCOVERY; INSIGHTS; FAMILY	Glucagon is a 29-amino-acid peptide released from the alpha-cells of the islet of Langerhans, which has a key role in glucose homeostasis(1). Glucagon action is transduced by the class B G-protein-coupled glucagon receptor (GCGR), which is located on liver, kidney, intestinal smooth muscle, brain, adipose tissue, heart and pancreas cells, and this receptor has been considered an important drug target in the treatment of diabetes. Administration of recently identified small-molecule GCGR antagonists in patients with type 2 diabetes results in a substantial reduction of fasting and postprandial glucose concentrations(2). Although an X-ray structure of the transmembrane domain of the GCGR(3) has previously been solved, the ligand (NNC0640) was not resolved. Here we report the 2.5 angstrom structure of human GCGR in complex with the antagonist MK-0893 (ref. 4), which is found to bind to an allosteric site outside the seven transmembrane (7TM) helical bundle in a position between TM6 and TM7 extending into the lipid bilayer. Mutagenesis of key residues identified in the X-ray structure confirms their role in the binding of MK-0893 to the receptor. The unexpected position of the binding site for MK-0893, which is structurally similar to other GCGR antagonists, suggests that glucagon activation of the receptor is prevented by restriction of the outward helical movement of TM6 required for G-protein coupling. Structural knowledge of class B receptors is limited, with only one other ligand-binding site defined-for the corticotropin-releasing hormone receptor 1 (CRF1R)-which was located deep within the 7TM bundle(5). We describe a completely novel allosteric binding site for class B receptors, providing an opportunity for structure-based drug design for this receptor class and furthering our understanding of the mechanisms of activation of these receptors.	[Jazayeri, Ali; Dore, Andrew S.; Lamb, Daniel; Krishnamurthy, Harini; Southall, Stacey M.; Baig, Asma H.; Bortolato, Andrea; Koglin, Markus; Robertson, Nathan J.; Errey, James C.; Andrews, Stephen P.; Teobald, Iryna; Brown, Alastair J. H.; Cooke, Robert M.; Weir, Malcolm; Marshall, Fiona H.] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Baig, Asma/0000-0002-3764-1456; Robertson, Nathan/0000-0002-5449-2501; Marshall, Fiona/0000-0002-8681-005X				Ahren B, 2015, PEPTIDES, V67, P74, DOI 10.1016/j.peptides.2015.03.011; Bagger JI, 2011, DIABETES OBES METAB, V13, P965, DOI 10.1111/j.1463-1326.2011.01427.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiong YS, 2012, J MED CHEM, V55, P6137, DOI 10.1021/jm300579z; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287	14	157	161	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					274	+		10.1038/nature17414	http://dx.doi.org/10.1038/nature17414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27111510				2022-12-28	WOS:000376007200056
J	Rakoff-Nahoum, S; Foster, KR; Comstock, LE				Rakoff-Nahoum, Seth; Foster, Kevin R.; Comstock, Laurie E.			The evolution of cooperation within the gut microbiota	NATURE			English	Article							PUBLIC-GOODS DILEMMA; POLYSACCHARIDE UTILIZATION; BACTEROIDES-FRAGILIS; GENERAL-MODEL; COMMUNITIES; PREVALENCE; BACTERIA; YEAST	Cooperative phenotypes are considered central to the functioning of microbial communities in many contexts, including communication via quorum sensing, biofilm formation, antibiotic resistance, and pathogenesis(1-5). The human intestine houses a dense and diverse microbial community critical to health(1,2,4-9), yet we know little about cooperation within this important ecosystem. Here we test experimentally for evolved cooperation within the Bacteroidales, the dominant Gram-negative bacteria of the human intestine. We show that during growth on certain dietary polysaccharides, the model member Bacteroides thetaiotaomicron exhibits only limited cooperation. Although this organism digests these polysaccharides extracellularly, mutants lacking this ability are outcompeted. In contrast, we discovered a dedicated cross-feeding enzyme system in the prominent gut symbiont Bacteroides ovatus, which digests polysaccharide at a cost to itself but at a benefit to another species. Using in vitro systems and gnotobiotic mouse colonization models, we find that extracellular digestion of inulin increases the fitness of B. ovatus owing to reciprocal benefits when it feeds other gut species such as Bacteroides vulgatus. This is a rare example of naturally-evolved cooperation between microbial species. Our study reveals both the complexity and importance of cooperative phenotypes within the mammalian intestinal microbiota.	[Rakoff-Nahoum, Seth] Boston Childrens Hosp, Dept Med, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth] Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth; Comstock, Laurie E.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, 181 Longwood Ave, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth; Comstock, Laurie E.] Harvard Univ, Sch Med, 181 Longwood Ave, Boston, MA 02115 USA; [Foster, Kevin R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Foster, Kevin R.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3PS, England	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oxford; University of Oxford	Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Dept Med, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Harvard Univ, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, 181 Longwood Ave, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Harvard Univ, Sch Med, 181 Longwood Ave, Boston, MA 02115 USA.	seth.rakoff-nahoum@childrens.harvard.edu		Foster, Kevin/0000-0003-4687-6633	HDDC, NIH Grant [P30 DK34845]; PIDS-St Jude Research Hospital Fellowship Program in Basic Research; K12 Child Health Research Center grant through Boston Children's Hospital; Pilot Feasibility Award - HDDC [P30 DK034854]; European Research Council [242670]; Public Health Service grant from the NIH/NIAID [R01AI081843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	HDDC, NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PIDS-St Jude Research Hospital Fellowship Program in Basic Research; K12 Child Health Research Center grant through Boston Children's Hospital; Pilot Feasibility Award - HDDC; European Research Council(European Research Council (ERC)European Commission); Public Health Service grant from the NIH/NIAID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. B. Ogbunugafor, J. Ordovas-Montanes, U. von Andrian and M. Waldor for suggestions. M. Delaney for SCFA analysis, V. Yeliseyev for assistance with gnotobiotics. Inulin and FOS were provided by Beneo-Orafti. Mice were provided by the HDDC, NIH Grant P30 DK34845. S.R.-N. is supported by the PIDS-St Jude Research Hospital Fellowship Program in Basic Research, a K12 Child Health Research Center grant through Boston Children's Hospital and a Pilot Feasibility Award funded by HDDC P30 DK034854. K.R.F. is supported by European Research Council Grant 242670. This work was supported by Public Health Service grant R01AI081843 (to L.E.C.) from the NIH/NIAID.	Cameron EA, 2014, MBIO, V5, DOI 10.1128/mBio.01441-14; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Coyne MJ, 2011, J BACTERIOL, V193, P5252, DOI 10.1128/JB.05337-11; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Estrela S, 2015, TRENDS MICROBIOL, V23, P134, DOI 10.1016/j.tim.2014.11.005; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Frank SA, 2010, J EVOLUTION BIOL, V23, P1245, DOI 10.1111/j.1420-9101.2010.01986.x; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Koschwanez JH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001122; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00960; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Orel R, 2014, WORLD J GASTROENTERO, V20, P11505, DOI 10.3748/wjg.v20.i33.11505; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999; SMITH CJ, 1992, PLASMID, V27, P141, DOI 10.1016/0147-619X(92)90014-2; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; STEVENS AM, 1990, J BACTERIOL, V172, P4271, DOI 10.1128/jb.172.8.4271-4279.1990; Subramanian S, 2015, CELL, V161, P36, DOI 10.1016/j.cell.2015.03.013; Waldor MK, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002050; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10	33	290	299	26	441	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					255	+		10.1038/nature17626	http://dx.doi.org/10.1038/nature17626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27111508	Green Accepted, Green Submitted			2022-12-28	WOS:000376007200052
J	Paquet, D; Kwart, D; Chen, A; Sproul, A; Jacob, S; Teo, S; Olsen, KM; Gregg, A; Noggle, S; Tessier-Lavigne, M				Paquet, Dominik; Kwart, Dylan; Chen, Antonia; Sproul, Andrew; Jacob, Samson; Teo, Shaun; Olsen, Kimberly Moore; Gregg, Andrew; Noggle, Scott; Tessier-Lavigne, Marc			Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9	NATURE			English	Article							PLURIPOTENT STEM-CELLS; FAMILIAL ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; GENE CONVERSION; HIGH-FREQUENCY; GENOME; CRISPR-CAS9; NUCLEASES; GENERATION; MICE	The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells(1,2). CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels)(2). DSBs may also be repaired by homology-directed repair (HDR)(1,2) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations(3). Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient(3-8) and can be corrupted by additional indels(9), preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono-and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Casblocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe))(10) and presenilin 1 (PSEN1M146V)(11) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.	[Paquet, Dominik; Kwart, Dylan; Chen, Antonia; Teo, Shaun; Olsen, Kimberly Moore; Gregg, Andrew; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA; [Sproul, Andrew; Jacob, Samson; Noggle, Scott] New York Stem Cell Fdn Res Inst, New York, NY 10032 USA; [Gregg, Andrew] Rockefeller Univ, Weill Cornell Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA; [Gregg, Andrew] Mem Sloan Kettering Canc Ctr, Triinst MD PhD Program, 1300 York Ave, New York, NY 10065 USA; [Sproul, Andrew] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, 630 West 168th St, New York, NY 10032 USA; [Sproul, Andrew] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, 630 West 168th St, New York, NY 10032 USA	Rockefeller University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Rockefeller University; Memorial Sloan Kettering Cancer Center; Columbia University; Columbia University	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA.	marctl@rockefeller.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Chen, Antonia/K-5284-2019	Noggle, Scott/0000-0002-0374-2240; Paquet, Dominik/0000-0003-2065-1639; Sproul, Andrew/0000-0001-6972-1592	Rockefeller University; New York Stem Cell Foundation; Ellison Foundation; Cure Alzheimer's Fund; Empire State Stem Cell fund through New York State Department of Health [C023046]; CTSA, RUCCTS grant from the National Center for Advancing Translational Sciences (NCATS, NIH) [8 UL1 TR000043]; German Academy of Sciences Leopoldina; National Sciences and Engineering Research Council of Canada; Agency for Science, Technology and Research of Singapore; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health [T32GM007739]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Rockefeller University; New York Stem Cell Foundation; Ellison Foundation(Lawrence Ellison Foundation); Cure Alzheimer's Fund; Empire State Stem Cell fund through New York State Department of Health; CTSA, RUCCTS grant from the National Center for Advancing Translational Sciences (NCATS, NIH); German Academy of Sciences Leopoldina; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by The Rockefeller University, The New York Stem Cell Foundation, The Ellison Foundation, Cure Alzheimer's Fund, the Empire State Stem Cell fund through New York State Department of Health contract number C023046, and CTSA, RUCCTS grant number 8 UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS, NIH). D.P. is a New York Stem Cell Foundation Druckenmiller Fellow and received a fellowship from the German Academy of Sciences Leopoldina. D.K. is a Howard Hughes Medical Institute International Student Research Fellow and received a fellowship from the National Sciences and Engineering Research Council of Canada. S.T. is supported by the Agency for Science, Technology and Research of Singapore. A.G. is supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-institutional MD-PhD program. We thank members of the Tessier-Lavigne laboratory and L. Marraffini for discussions. Our thanks also go to S. Mazel and the team at the Rockefeller Univeristy Flow Cytometry Resource Center, J. Gonzalez and the team at the Rockefeller University Translational Technology Core Laboratory, C. Zhao and the team at the Rockefeller University Genomics Resource Center, and D. Paull and M. Duffield for technical help. Opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the New York State Department of Health, or the State of New York. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews S, FASTQC QUALITY CONTR; [Anonymous], 1995, NATURE GENET, V11, P219; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kahler DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059867; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rivera-Torres N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096483; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Team RC., 2013, R LANG ENV STAT COMP; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	49	485	524	15	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					125	+		10.1038/nature17664	http://dx.doi.org/10.1038/nature17664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120160				2022-12-28	WOS:000375473900052
J	Cook, GM; Poole, RK				Cook, Gregory M.; Poole, Robert K.			A bacterial oxidase like no other?	SCIENCE			English	Editorial Material							CYTOCHROME-C-OXIDASE; ESCHERICHIA-COLI; QUINOL OXIDASE		[Cook, Gregory M.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Cook, Gregory M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1042, New Zealand; [Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Otago; University of Auckland; University of Sheffield	Cook, GM (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand.; Cook, GM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1042, New Zealand.	greg.cook@otago.ac.nz	Cook, Gregory/ABF-4208-2020					Abramson J, 2001, BBA-PROTEIN STRUCT M, V1544, P1, DOI 10.1016/S0167-4838(00)00241-7; Berney M, 2014, MBIO, V5, DOI 10.1128/mBio.01275-14; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Cook GM, 2014, ADV MICROB PHYSIOL, V65, P1, DOI 10.1016/bs.ampbs.2014.08.001; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; Dunn AK, 2010, MOL MICROBIOL, V77, P44, DOI 10.1111/j.1365-2958.2010.07194.x; Hards K, 2015, J ANTIMICROB CHEMOTH, V70, P2028, DOI 10.1093/jac/dkv054; Hoeser J, 2014, FEBS LETT, V588, P1537, DOI 10.1016/j.febslet.2014.03.036; Keilin D., 1966, HIST CELL RESP CYTOC; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Lu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep10333; POOLE RK, 1983, J GEN MICROBIOL, V129, P1335; Safarian S, 2016, SCIENCE, V352, P583, DOI 10.1126/science.aaf2477; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110	15	6	6	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					518	519		10.1126/science.aaf5514	http://dx.doi.org/10.1126/science.aaf5514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126025	Green Accepted			2022-12-28	WOS:000374998600022
J	Snow, R; Gilbert, D				Snow, Rosamund; Gilbert, David			Why some patients are keeping their heads down	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com; davidgilbert43@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2458	10.1136/bmj.i2458	http://dx.doi.org/10.1136/bmj.i2458			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130485	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000375484100013
J	Operskalski, JT; Barbey, AK				Operskalski, Joachim T.; Barbey, Aron K.			Risk literacy in medical decision-making	SCIENCE			English	Editorial Material							FREQUENCY FORMATS; ECOLOGICAL RATIONALITY; JUDGMENT		[Operskalski, Joachim T.; Barbey, Aron K.] Univ Illinois, Beckman Inst, Decis Neurosci Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Barbey, AK (corresponding author), Univ Illinois, Beckman Inst, Decis Neurosci Lab, Urbana, IL 61801 USA.	barbey@illinois.edu	Barbey, Aron/L-7312-2015	Barbey, Aron/0000-0002-6092-0912				Barbey AK, 2007, BEHAV BRAIN SCI, V30, P241, DOI 10.1017/S0140525X07001653; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; Eddy DM, 1982, JUDGMENT UNCERTAINTY, P249; Gigerenzer G, 1996, MED DECIS MAKING, V16, P273, DOI 10.1177/0272989X9601600312; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G., 2010, PSYCHOL SCI PUBL INT, V8, P2; Jorgensen KJ, 2016, JAMA-J AM MED ASSOC, V315, P1402, DOI 10.1001/jama.2015.19126; Neace WP, 2008, JUDGM DECIS MAK, V3, P140; Sloman SA, 2003, ORGAN BEHAV HUM DEC, V91, P296, DOI 10.1016/S0749-5978(03)00021-9; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Todd PM, 2007, CURR DIR PSYCHOL SCI, V16, P167, DOI 10.1111/j.1467-8721.2007.00497.x; US Preventive Services Task Force, 2012, FIN REC STAT PROST C	13	23	24	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					413	414		10.1126/science.aaf7966	http://dx.doi.org/10.1126/science.aaf7966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102467				2022-12-28	WOS:000374479700026
J	Kirtley, S				Kirtley, Shona			Increasing value and reducing waste in biomedical research: librarians are listening and are part of the answer	LANCET			English	Editorial Material									[Kirtley, Shona] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, EQUATOR Network, Oxford OX3 7LD, England	University of Oxford	Kirtley, S (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, EQUATOR Network, Oxford OX3 7LD, England.	shona.kirtley@csm.ox.ac.uk		Kirtley, Shona/0000-0002-7801-5777	Medical Research Council [MR/J00488X/1] Funding Source: Medline; MRC [MR/J00488X/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)		Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jefferson T, 2003, PEER REV HLTH SCI, P297; Kirtley S., 2014, CAN LIB CONTRIBUTE I; Mathisen Mariann, 2013, Tidsskr Nor Laegeforen, V133, P1615, DOI 10.4045/tidsskr.13.0613; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Rethlefsen ML, 2015, J CLIN EPIDEMIOL, V68, P617, DOI 10.1016/j.jclinepi.2014.11.025; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7	10	8	8	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2016	387	10028					1601	1601		10.1016/S0140-6736(16)30241-0	http://dx.doi.org/10.1016/S0140-6736(16)30241-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ3ZL	27116055	Green Submitted			2022-12-28	WOS:000374145100009
J	Pontzer, H; Brown, MH; Raichlen, DA; Dunsworth, H; Hare, B; Walker, K; Luke, A; Dugas, LR; Durazo-Arvizu, R; Schoeller, D; Plange-Rhule, J; Bovet, P; Forrester, TE; Lambert, EV; Thompson, ME; Shumaker, RW; Ross, SR				Pontzer, Herman; Brown, Mary H.; Raichlen, David A.; Dunsworth, Holly; Hare, Brian; Walker, Kara; Luke, Amy; Dugas, Lara R.; Durazo-Arvizu, Ramon; Schoeller, Dale; Plange-Rhule, Jacob; Bovet, Pascal; Forrester, Terrence E.; Lambert, Estelle V.; Thompson, Melissa Emery; Shumaker, Robert W.; Ross, Stephen R.			Metabolic acceleration and the evolution of human brain size and life history	NATURE			English	Article							TOTAL-ENERGY EXPENDITURE; RESPIRATORY METABOLISM; ADAPTATION; ENERGETICS	Humans are distinguished from the other living apes in having larger brains and an unusual life history that combines high reproductive output with slow childhood growth and exceptional longevity(1). This suite of derived traits suggests major changes in energy expenditure and allocation in the human lineage, but direct measures of human and ape metabolism are needed to compare evolved energy strategies among hominoids. Here we used doubly labelled water measurements of total energy expenditure (TEE; kcal day(-1)) in humans, chimpanzees, bonobos, gorillas and orangutans to test the hypothesis that the human lineage has experienced an acceleration in metabolic rate, providing energy for larger brains and faster reproduction without sacrificing maintenance and longevity. In multivariate regressions including body size and physical activity, human TEE exceeded that of chimpanzees and bonobos, gorillas and orangutans by approximately 400, 635 and 820 kcal day(-1), respectively, readily accommodating the cost of humans' greater brain size and reproductive output. Much of the increase in TEE is attributable to humans' greater basal metabolic rate (kcal day(-1)), indicating increased organ metabolic activity. Humans also had the greatest body fat percentage. An increased metabolic rate, along with changes in energy allocation, was crucial in the evolution of human brain size and life history.	[Pontzer, Herman] CUNY Hunter Coll, Dept Anthropol, 695 Pk Ave, New York, NY 10065 USA; [Pontzer, Herman] New York Consortium Evolutionary Primatol, New York, NY 10065 USA; [Brown, Mary H.; Ross, Stephen R.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Raichlen, David A.] Univ Arizona, Sch Anthropol, 1099 E South Campus Dr, Tucson, AZ 85716 USA; [Dunsworth, Holly] Univ Rhode Isl, Dept Sociol & Anthropol, 45 Upper Coll Rd, Kingston, RI 02881 USA; [Hare, Brian; Walker, Kara] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Luke, Amy; Dugas, Lara R.; Durazo-Arvizu, Ramon] Loyola Univ Chicago, Stritch Sch Med, Publ Hlth Sci, 2160 South First Ave, Maywood, IL 60153 USA; [Schoeller, Dale] Univ Wisconsin, Nutr Sci Biotechnol Ctr, 425 Henry Mall, Madison, WI 53705 USA; [Plange-Rhule, Jacob] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Bovet, Pascal] Univ Lausanne Hosp, Inst Social & Prevent Med, Rue Corniche 10, CH-1010 Lausanne, Switzerland; [Bovet, Pascal] Minist Hlth, POB 52, Victoria, Mahe, Seychelles; [Forrester, Terrence E.] Univ W Indies, UWI Solut Developing Countries, 25 West Rd,UWI Mona Campus, Kingston 7, Jamaica; [Lambert, Estelle V.] Univ Cape Town, Res Unit Exercise Sci & Sports Med, POB 115, ZA-7725 Cape Town, South Africa; [Thompson, Melissa Emery] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Shumaker, Robert W.] Indianapolis Zoo, 1200 W Washington St, Indianapolis, IN 46222 USA; [Shumaker, Robert W.] Indiana Univ, Dept Anthropol, 701 E Kirkwood Ave, Bloomington, IN 47405 USA; [Shumaker, Robert W.] Indiana Univ, Ctr Integrated Study Anim Behav, 701 E Kirkwood Ave, Bloomington, IN 47405 USA; [Shumaker, Robert W.] George Mason Univ, Krasnow Inst Adv Study, 4400 Univ Dr, Fairfax, VA 22030 USA	City University of New York (CUNY) System; Hunter College (CUNY); University of Arizona; University of Rhode Island; Duke University; Loyola University Chicago; University of Wisconsin System; University of Wisconsin Madison; Kwame Nkrumah University Science & Technology; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University West Indies Mona Jamaica; University of Cape Town; University of New Mexico; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; George Mason University	Pontzer, H (corresponding author), CUNY Hunter Coll, Dept Anthropol, 695 Pk Ave, New York, NY 10065 USA.	hpontzer@hunter.cuny.edu	Lambert, Estelle/ABF-1268-2020; Bovet, Pascal/F-4477-2011; Thompson, Melissa Emery/ABF-1790-2020	Lambert, Estelle/0000-0003-4315-9153; Bovet, Pascal/0000-0002-0242-4259; Thompson, Melissa Emery/0000-0003-2451-6397; Dugas, Lara/0000-0002-0692-8585; Pontzer, Herman/0000-0003-2397-6543; Brown, Mary H/0000-0003-3974-0172	US National Science Foundation [BCS-1317170]; National Institutes of Health [R01DK080763]; L.S.B. Leakey Foundation; Wenner-Gren Foundation [Gr. 8670]; University of Arizona; Hunter College; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080763] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L.S.B. Leakey Foundation; Wenner-Gren Foundation; University of Arizona; Hunter College; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank participating zoos and staff for their efforts: Houston Zoo, Indianapolis Zoo, Jacksonville Zoo, Lincoln Park Zoo, Milwaukee County Zoo, North Carolina Zoo, Oklahoma City Zoo, Oregon Zoo, Zoo Atlanta, Woodland Park Zoo, Dallas Zoo, Brookfield Zoo and Columbus Zoo. We thank B. Moumbaka for assistance administering doses and collecting samples for analysis. We thank R. Atencia and C. Andre for supporting this project. Work at Tchimpounga and Lola Ya Bonobo was performed under the authority of the Ministry of Research and the Ministry of Environment in the Democratic Republic of Congo (research permit #MIN.RS/SG/004/2009) and the Ministry of Scientific Research and Technical Innovation in the Congo Republic (research permit 09/MRS/DGRST/DMAST), with samples imported under CITES permits 09US223466/9 and 9US207589/9. L. Christopher, K. Stafford and J. Paltan assisted with sample analyses. Funding was provided by the US National Science Foundation (BCS-1317170), National Institutes of Health (R01DK080763), L.S.B. Leakey Foundation, Wenner-Gren Foundation (Gr. 8670), University of Arizona and Hunter College.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Bauernfeind AL, 2015, GENOME BIOL EVOL, V7, P2276, DOI 10.1093/gbe/evv132; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruhn JM, 1936, P AM ACAD ARTS SCI, V71, P259, DOI 10.2307/20023229; Bruhn JM, 1934, AM J PHYSIOL, V110, P477, DOI 10.1152/ajplegacy.1934.110.2.477; Butte NF, 2000, AM J CLIN NUTR, V72, p1246S, DOI 10.1093/ajcn/72.5.1246s; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Charnov EL, 2004, EVOL ECOL RES, V6, P307; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Charnov Eric L., 1993, P1; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Isler K, 2012, CURR ANTHROPOL, V53, pS453, DOI 10.1086/667623; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Nie YG, 2015, SCIENCE, V349, P171, DOI 10.1126/science.aab2413; Pontzer H, 2016, CURR BIOL, V26, P410, DOI 10.1016/j.cub.2015.12.046; Pontzer H, 2015, EXERC SPORT SCI REV, V43, P110, DOI 10.1249/JES.0000000000000048; Pontzer H, 2014, P NATL ACAD SCI USA, V111, P1433, DOI 10.1073/pnas.1316940111; Pontzer H, 2014, J HUM EVOL, V66, P64, DOI 10.1016/j.jhevol.2013.10.002; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Pontzer H, 2010, P NATL ACAD SCI USA, V107, P14048, DOI 10.1073/pnas.1001031107; R Development Core Team, 2009, R LANG ENV STAT COMP; Speakman J.R., 1997, DOUBLY LABELLED WATE; Stearns S.C., 1992, pi; Wang Z, 2011, Int J Body Compos Res, V9, P147; Zihlman AL, 2015, P NATL ACAD SCI USA, V112, P7466, DOI 10.1073/pnas.1505071112	27	139	140	7	206	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					390	+		10.1038/nature17654	http://dx.doi.org/10.1038/nature17654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27144364	Green Accepted			2022-12-28	WOS:000376004300047
J	Laghmani, K; Beck, BB; Yang, SS; Seaayfan, E; Wenzel, A; Reusch, B; Vitzthum, H; Priem, D; Demaretz, S; Bergmann, K; Duin, LK; Gobel, H; Mache, C; Thiele, H; Bartram, MP; Dombret, C; Altmuller, J; Nurnberg, P; Benzing, T; Levtchenko, E; Seyberth, HW; Klaus, G; Yigit, G; Lin, SH; Timmer, A; de Koning, TJ; Scherjon, SA; Schlingmann, KP; Bertrand, MJM; Rinschen, MM; de Backer, O; Konrad, M; Komhoff, M				Laghmani, Kamel; Beck, Bodo B.; Yang, Sung-Sen; Seaayfan, Elie; Wenzel, Andrea; Reusch, Bjorn; Vitzthum, Helga; Priem, Dario; Demaretz, Sylvie; Bergmann, Klasien; Duin, Leonie K.; Goebel, Heike; Mache, Christoph; Thiele, Holger; Bartram, Malte P.; Dombret, Carlos; Altmueller, Janine; Nuernberg, Peter; Benzing, Thomas; Levtchenko, Elena; Seyberth, Hannsjoerg W.; Klaus, Guenter; Yigit, Goekhan; Lin, Shih-Hua; Timmer, Albert; de Koning, Tom J.; Scherjon, Sicco A.; Schlingmann, Karl P.; Bertrand, Mathieu J. M.; Rinschen, Markus M.; de Backer, Olivier; Konrad, Martin; Koemhoff, Martin			Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADENYLATE-CYCLASE; COTRANSPORTER; EXPRESSION; RECURRENT; HYPOXIA; AMNIOCENTESES; DEGRADATION; PREGNANCIES; NEPHRON; DISEASE	BACKGROUND Three' pregnancies with male offspring in one family were complicated by severe polyhydramnios and prematurity. One fetus died; the other two had transient massive salt-wasting and polyuria reminiscent of antenatal Bartter's syndrome. METHODS To uncover the molecular cause of this possibly X-linked disease, we performed whole-exome sequencing of DNA from two members of the index family and targeted gene analysis of other members of this family and of six additional families with affected male fetuses. We also evaluated a series of women with idiopathic polyhydramnios who were pregnant with male fetuses. We performed immunohistochemical analysis, knockdown and overexpression experiments, and protein-protein interaction studies. RESULTS We identified a mutation in MAGED2 in each of the 13 infants in our analysis who had transient antenatal Bartter's syndrome. MAGED2 encodes melanoma-associated antigen D2 (MAGE-D2) and maps to the X chromosome. We also identified two different MAGED2 mutations in two families with idiopathic polyhydramnios. Four patients died perinatally, and 11 survived. The initial presentation was more severe than in known types of antenatal Bartter's syndrome, as reflected by an earlier onset of polyhydramnios and labor. All symptoms disappeared spontaneously during follow-up in the infants who survived. We showed that MAGE-D2 affects the expression and function of the sodium chloride cotransporters NKCC2 and NCC (key components of salt reabsorption in the distal renal tubule), possibly through adenylate cyclase and cyclic AMP signaling and a cytoplasmic heat-shock protein. CONCLUSIONS We found that MAGED2 mutations caused X-linked polyhydramnios with prematurity and a severe but transient form of antenatal Bartter's syndrome. MAGE-D2 is essential for fetal renal salt reabsorption, amniotic fluid homeostasis, and the maintenance of pregnancy.	[Laghmani, Kamel; Seaayfan, Elie; Demaretz, Sylvie] Univ Paris 06, Ctr Natl Rech Sci, Ctr Rech Cordeliers, INSERM,ERL8228,Unite 1138, Paris, France; [Laghmani, Kamel; Seaayfan, Elie; Demaretz, Sylvie] Univ Paris 05, Paris, France; [Beck, Bodo B.; Wenzel, Andrea; Reusch, Bjorn; Altmueller, Janine; Yigit, Goekhan] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Goebel, Heike] Univ Cologne, Dept Pathol, D-50931 Cologne, Germany; [Thiele, Holger; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Thiele, Holger; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Bartram, Malte P.; Benzing, Thomas; Rinschen, Markus M.] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Bartram, Malte P.; Benzing, Thomas; Rinschen, Markus M.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Benzing, Thomas; Rinschen, Markus M.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Vitzthum, Helga] Univ Med Ctr Hamburg, Dept Cellular & Integrat Physiol, Hamburg, Germany; [Seyberth, Hannsjoerg W.] Univ Marburg, Univ Childrens Hosp, Marburg, Germany; [Klaus, Guenter] Pediatr Kidney Ctr, Kuratorium Heimdialyse, Marburg, Germany; [Yigit, Goekhan] Univ Hlth Serv Gottingen, Inst Human Genet, Gottingen, Germany; [Schlingmann, Karl P.; Konrad, Martin] Univ Hosp Munster, Dept Gen Pediat, Munster, Germany; [Yang, Sung-Sen; Lin, Shih-Hua] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Yang, Sung-Sen] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Priem, Dario; Bertrand, Mathieu J. M.] Univ Ghent VIB, Inflammat Res Ctr, Dept Biomed Mol Biol, Ghent, Belgium; [Dombret, Carlos; de Backer, Olivier] Univ Namur, Unite Rech Physiol Mol, Namur, Belgium; [Levtchenko, Elena] Univ Childrens Hosp Leuven, Div Nephrol, Louvain, Belgium; [Bergmann, Klasien] Univ Groningen, Univ Med Ctr Groningen, Div Neonatol, NL-9713 AV Groningen, Netherlands; [Koemhoff, Martin] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, NL-9713 AV Groningen, Netherlands; [Duin, Leonie K.; Scherjon, Sicco A.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9713 AV Groningen, Netherlands; [Duin, Leonie K.; Scherjon, Sicco A.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, NL-9713 AV Groningen, Netherlands; [Timmer, Albert] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [de Koning, Tom J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Mache, Christoph] Med Univ Graz, Univ Childrens Hosp Graz, Graz, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; National Defense Medical Center; Tri-Service General Hospital; Academia Sinica - Taiwan; Flanders Institute for Biotechnology (VIB); Ghent University; University of Namur; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Medical University of Graz	Komhoff, M (corresponding author), Philipps Univ Marburg, Univ Childrens Hosp, Baldinger Str, D-35043 Marburg, Germany.	martinkomhoff@yahoo.com	Rinschen, Markus/N-7283-2019; Bertrand, Mathieu J/P-6465-2016; De Koning, Tom J/AAE-1323-2020; Bertrand, Mathieu JM/AAD-2653-2019; Benzing, Thomas/X-5476-2019; Laghmani, Kamel/AIE-9621-2022; Levtchenko, Elena/AAO-7125-2020; Thiele, Holger/ABE-6792-2020	Rinschen, Markus/0000-0002-9252-1342; Bertrand, Mathieu J/0000-0001-9000-0626; De Koning, Tom J/0000-0001-5609-1309; Bertrand, Mathieu JM/0000-0001-9000-0626; Laghmani, Kamel/0000-0002-2167-5766; Thiele, Holger/0000-0002-0169-998X; Priem, Dario/0000-0002-2527-1101; Komhoff, Martin/0000-0002-6499-5313; Seaayfan, Elie/0000-0003-4839-9834; Altmuller, Janine/0000-0003-4372-1521; Goebel, Heike/0000-0002-0171-7025	University of Groningen	University of Groningen	Funded by the University of Groningen and others.	Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Bertrand M, 2004, DEV DYNAM, V230, P325, DOI 10.1002/dvdy.20026; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brochard K, 2009, NEPHROL DIAL TRANSPL, V24, P1455, DOI 10.1093/ndt/gfn689; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Cantone A, 2008, AM J PHYSIOL-RENAL, V294, pF1366, DOI 10.1152/ajprenal.00608.2007; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; De Jong JC, 2003, J AM SOC NEPHROL, V14, P2428, DOI 10.1097/01.ASN.0000089832.52063.F5; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Dorleijn DMJ, 2009, J MATERN-FETAL NEO M, V22, P315, DOI 10.1080/14767050802531870; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Ecelbarger CA, 1999, AM J PHYSIOL-RENAL, V277, pF235, DOI 10.1152/ajprenal.1999.277.2.F235; Engels A, 1991, ANGEBORENE PASSAGERE, V139, P185; FISELIER T, 1984, EUR J PEDIATR, V143, P18, DOI 10.1007/BF00442742; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; IMBERTTEBOUL M, 1984, AM J PHYSIOL, V247, pF316, DOI 10.1152/ajprenal.1984.247.2.F316; Jeck N, 2005, AM J PHYSIOL-REG I, V288, pR782, DOI 10.1152/ajpregu.00600.2004; Johnston PG, 2012, CLIN PERINATOL, V39, P111, DOI 10.1016/j.clp.2011.12.002; Kanda M, 2016, ANN SURG ONCOL, V23, P214, DOI 10.1245/s10434-015-4457-8; Karar J, 2008, FEBS LETT, V582, P2521, DOI 10.1016/j.febslet.2008.06.019; Magann EF, 2000, AM J OBSTET GYNECOL, V182, P1581, DOI 10.1067/mob.2000.107325; Magann EF, 2007, OBSTET GYNECOL SURV, V62, P795, DOI 10.1097/01.ogx.0000290349.58707.e0; Peters M, 2002, AM J MED, V112, P183, DOI 10.1016/S0002-9343(01)01086-5; PITKIN RM, 1976, OBSTET GYNECOL, V48, pS42; Reinalter S, 1998, PEDIATR NEPHROL, V12, P186, DOI 10.1007/s004670050433; Rode L, 2007, FETAL DIAGN THER, V22, P186, DOI 10.1159/000098714; Ross M G, 2001, J Matern Fetal Med, V10, P2, DOI 10.1080/714904292; RUDOLPH AM, 1971, PEDIATR RES, V5, P452, DOI 10.1203/00006450-197109000-00003; SCHLONDORFF D, 1978, AM J PHYSIOL, V234, pF16, DOI 10.1152/ajprenal.1978.234.1.F16; SCHWEER H, 1994, J CHROMATOGR B, V652, P221, DOI 10.1016/0378-4347(93)E0408-I; SEYBERTH HW, 1985, J PEDIATR-US, V107, P694, DOI 10.1016/S0022-3476(85)80395-4; Tseng HY, 2012, CARCINOGENESIS, V33, P1871, DOI 10.1093/carcin/bgs236; WEISSMAN A, 1987, J REPROD MED, V32, P65; Zaarour N, 2011, J BIOL CHEM, V286, P9489, DOI 10.1074/jbc.M110.166546	36	98	109	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2016	374	19					1853	1863		10.1056/NEJMoa1507629	http://dx.doi.org/10.1056/NEJMoa1507629			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6JS	27120771	Bronze			2022-12-28	WOS:000375746100008
J	Roettenbacher, RM; Monnier, JD; Korhonen, H; Aarnio, AN; Baron, F; Che, X; Harmon, RO; Kovari, Z; Kraus, S; Schaefer, GH; Torres, G; Zhao, M; ten Brummelaar, TA; Sturmann, J; Sturmann, L				Roettenbacher, R. M.; Monnier, J. D.; Korhonen, H.; Aarnio, A. N.; Baron, F.; Che, X.; Harmon, R. O.; Kovari, Zs.; Kraus, S.; Schaefer, G. H.; Torres, G.; Zhao, M.; ten Brummelaar, T. A.; Sturmann, J.; Sturmann, L.			No Sun-like dynamo on the active star zeta Andromedae from starspot asymmetry	NATURE			English	Article							LOW-MASS STARS; BROWN DWARFS; LIGHT-CURVE; CHARA ARRAY; INTERFEROMETRY; SURFACE; SPOTS; CONTROVERSY; EVOLUTION; RADII	Sunspots are cool areas caused by strong surface magnetic fields that inhibit convection(1,2). Moreover, strong magnetic fields can alter the average atmospheric structure(3), degrading our ability to measure stellar masses and ages. Stars that are more active than the Sun have more and stronger dark spots than does the Sun, including on the rotational pole(4). Doppler imaging, which has so far produced the most detailed images of surface structures on other stars, cannot always distinguish the hemisphere in which the starspots are located, especially in the equatorial region and if the data quality is not optimal(5). This leads to problems in investigating the north-south distribution of starspot active latitudes (those latitudes with more starspot activity); this distribution is a crucial constraint of dynamo theory. Polar spots, whose existence is inferred from Doppler tomography, could plausibly be observational artefacts(6). Here we report imaging of the old, magnetically active star zeta Andromedae using long-baseline infrared interferometry. In our data, a dark polar spot is seen in each of two observation epochs, whereas lower-latitude spot structures in both hemispheres do not persist between observations, revealing global starspot asymmetries. The north-south symmetry of active latitudes observed on the Sun(7) is absent on zeta And, which hosts global spot patterns that cannot be produced by solar-type dynamos(8).	[Roettenbacher, R. M.; Monnier, J. D.; Aarnio, A. N.; Baron, F.; Che, X.; Kraus, S.; Zhao, M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Korhonen, H.] Univ Turku, Finnish Ctr Astron ESO FINCA, FI-21500 Piikkio, Finland; [Korhonen, H.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; [Baron, F.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA; [Harmon, R. O.] Ohio Wesleyan Univ, Dept Phys & Astron, Delaware, OH USA; [Kovari, Zs.] Hungarian Acad Sci, Konkoly Observ, Res Ctr Astron & Earth Sci, H-1121 Budapest, Hungary; [Kraus, S.] Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; [Schaefer, G. H.; ten Brummelaar, T. A.; Sturmann, J.; Sturmann, L.] Georgia State Univ, Ctr High Angular Resolut Astron, Mt Wilson, CA 91023 USA; [Torres, G.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Zhao, M.] Penn State Univ, Dept Astron & Astrophys, State Coll, PA 16802 USA	University of Michigan System; University of Michigan; University of Turku; University of Copenhagen; Niels Bohr Institute; University System of Georgia; Georgia State University; Ohio Wesleyan University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; University of Exeter; University System of Georgia; Georgia State University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Roettenbacher, RM (corresponding author), Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA.	rmroett@umich.edu	Korhonen, Heidi/AAZ-5747-2020; Kővári, Zsolt/Y-9953-2019; Kővári, Zsolt/A-9098-2012; Korhonen, Heidi H./E-3065-2016	Korhonen, Heidi/0000-0003-0529-1161; Kővári, Zsolt/0000-0001-5160-307X; Kővári, Zsolt/0000-0001-5160-307X; Korhonen, Heidi H./0000-0003-0529-1161; Roettenbacher, Rachael M/0000-0002-9288-3482; Kraus, Stefan/0000-0001-6017-8773	National Science Foundation [AST-1211929, AST-1411654]; University of Michigan; National Science Foundation (NSF) [AST-1108963]; Hungarian Scientific Research Fund [OTKA K-109276]; Hungarian Academy of Sciences; STFC [ST/J004030/1, ST/K003445/1]; ERC [639889]; Direct For Mathematical & Physical Scien [1411654, 1445935] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1211929] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/K003445/1, ST/J004030/1] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); University of Michigan(University of Michigan System); National Science Foundation (NSF)(National Science Foundation (NSF)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ERC(European Research Council (ERC)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank E. Pedretti for his early efforts in imaging. And. This work is based upon observations obtained with the Georgia State University Center for the High Angular Resolution Astronomy Array at Mount Wilson Observatory. The CHARA Array is supported by the National Science Foundation under grant numbers AST-1211929 and AST-1411654. Institutional support has been provided from the GSU College of Arts and Sciences and the GSU Office of the Vice President for Research and Economic Development. The MIRC instrument at the CHARA Array was funded by the University of Michigan. The 2013 CHARA/MIRC observations were supported by a Rackham Graduate Student Research Grant from the University of Michigan. This imaging work was supported by the National Science Foundation (NSF) grant AST-1108963. The SURFING software was developed in part with funding from the Observatoire de Paris, Meudon. This research made use of the SIMBAD database, operated at CDS, Strasbourg, France and the Jean-Marie Mariotti Center SearchCal and Aspro2 services co-developed by FIZEAU and LAOG/IPAG. This work was supported by the Hungarian Scientific Research Fund (OTKA K-109276), the 'Lendulet-2009' Young Researchers' programme of the Hungarian Academy of Sciences, an STFC Rutherford Fellowship and Grant (ST/J004030/1, ST/K003445/1), and an ERC Starting Grant (grant agreement number 639889).	Baron F, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/46; Berdyugina S.V., 2005, LIVING REV SOL PHYS, V2, P8, DOI [DOI 10.12942/LRSP-2005-8, 10.12942/lrsp-2005-8]; Biermann L., 1941, VIERTELJAHRESSCHR AS, V76, P194; Bonneau D, 2006, ASTRON ASTROPHYS, V456, P789, DOI 10.1051/0004-6361:20054469; BOUVIER J, 1989, ASTRON ASTROPHYS, V211, P99; Bruls JHMJ, 1998, ASTRON ASTROPHYS, V336, P231; Bushby PJ, 2003, MON NOT R ASTRON SOC, V338, P655, DOI 10.1046/j.1365-8711.2003.06080.x; Chabrier G, 2007, ASTRON ASTROPHYS, V472, pL17, DOI 10.1051/0004-6361:20077702; ESA, 1997, ESA; Fekel FC, 1999, ASTRON ASTROPHYS SUP, V137, P369, DOI 10.1051/aas:1999252; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gorski KM, 2005, ASTROPHYS J, V622, P759, DOI 10.1086/427976; Hale GE, 1908, ASTROPHYS J, V28, P315, DOI 10.1086/141602; Harmon RO, 2000, ASTRON J, V120, P3274, DOI 10.1086/316882; Hathaway DH, 2015, LIVING REV SOL PHYS, V12, DOI 10.1007/lrsp-2015-4; KJURKCHIEVA DP, 1989, ASTROPHYS SPACE SCI, V155, P125, DOI 10.1007/BF00645212; Korhonen H, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913736; Kovari Z, 2007, ASTRON ASTROPHYS, V463, P1071, DOI 10.1051/0004-6361:20065982; Kovari Z, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118177; KURUCZ RL, 1979, ASTROPHYS J SUPPL S, V40, P1, DOI 10.1086/190589; Lopez-Morales M, 2007, ASTROPHYS J, V660, P732, DOI 10.1086/513142; MacDonald J, 2009, ASTROPHYS J, V700, P387, DOI 10.1088/0004-637X/700/1/387; Monnier JD, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/1/L3; Monnier JD, 2004, P SOC PHOTO-OPT INS, V5491, P1370, DOI 10.1117/12.550804; Monnier JD, 2007, SCIENCE, V317, P342, DOI 10.1126/science.1143205; Moultaka J, 2004, PUBL ASTRON SOC PAC, V116, P693, DOI 10.1086/422177; Norton AA, 2014, SPACE SCI REV, V186, P251, DOI 10.1007/s11214-014-0100-4; Olah K, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424695; Parks J. R., 2016, ASTROPHYS J UNPUB; Pauls TA, 2005, PUBL ASTRON SOC PAC, V117, P1255, DOI 10.1086/444523; PISKUNOV N, 1994, ASTRON ASTROPHYS, V289, P868; PISKUNOV NE, 1990, ASTRON ASTROPHYS, V230, P363; Reiners A, 2009, ASTROPHYS J, V692, P538, DOI 10.1088/0004-637X/692/1/538; Roettenbacher RM, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/23; Somers G, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/174; SPRUIT HC, 1982, ASTRON ASTROPHYS, V108, P348; Stassun KG, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/47; STRASSMEIER KG, 1991, ASTRON ASTROPHYS, V247, P130; Strassmeier KG, 2009, ASTRON ASTROPHYS REV, V17, P251, DOI 10.1007/s00159-009-0020-6; ten Brummelaar TA, 2005, ASTROPHYS J, V628, P453, DOI 10.1086/430729; Unruh YC, 1997, MON NOT R ASTRON SOC, V290, pL37, DOI 10.1093/mnras/290.3.L37; VOGT SS, 1983, PUBL ASTRON SOC PAC, V95, P565, DOI 10.1086/131208	42	64	64	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					217	+		10.1038/nature17444	http://dx.doi.org/10.1038/nature17444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144357	Green Accepted, Green Submitted			2022-12-28	WOS:000376007200043
J	Ruibal, P; Oestereich, L; Ludtke, A; Becker-Ziaja, B; Wozniak, DM; Kerber, R; Korva, M; Cabeza-Cabrerizo, M; Bore, JA; Koundouno, FR; Duraffour, S; Weller, R; Thorenz, A; Cimini, E; Viola, D; Agrati, C; Repits, J; Afrough, B; Cowley, LA; Ngabo, D; Hinzmann, J; Mertens, M; Vitoriano, I; Logue, CH; Boettcher, JP; Pallasch, E; Sachse, A; Bah, A; Nitzsche, K; Kuisma, E; Michel, J; Holm, T; Zekeng, EG; Garcia-Dorival, I; Wolfel, R; Stoecker, K; Fleischmann, E; Strecker, T; Di Caro, A; Avsic-Zupanc, T; Kurth, A; Meschi, S; Mely, S; Newman, E; Bocquin, A; Kis, Z; Kelterbaum, A; Molkenthin, P; Carletti, F; Portmann, J; Wolff, S; Castilletti, C; Schudt, G; Fizet, A; Ottowell, LJ; Herker, E; Jacobs, T; Kretschmer, B; Severi, E; Ouedraogo, N; Lago, M; Negredo, A; Franco, L; Anda, P; Schmiedel, S; Kreuels, B; Wichmann, D; Addo, MM; Lohse, AW; De Clerck, H; Nanclares, C; Jonckheere, S; Van Herp, M; Sprecher, A; Gao, XJ; Carrington, M; Miranda, O; Castro, CM; Gabriel, M; Drury, P; Formenty, P; Diallo, B; Koivogui, L; Magassouba, N; Carroll, MW; Gunther, S; Munoz-Fontela, C				Ruibal, Paula; Oestereich, Lisa; Luedtke, Anja; Becker-Ziaja, Beate; Wozniak, David M.; Kerber, Romy; Korva, Misa; Cabeza-Cabrerizo, Mar; Bore, Joseph A.; Koundouno, Fara Raymond; Duraffour, Sophie; Weller, Romy; Thorenz, Anja; Cimini, Eleonora; Viola, Domenico; Agrati, Chiara; Repits, Johanna; Afrough, Babak; Cowley, Lauren A.; Ngabo, Didier; Hinzmann, Julia; Mertens, Marc; Vitoriano, Ines; Logue, Christopher H.; Boettcher, Jan Peter; Pallasch, Elisa; Sachse, Andreas; Bah, Amadou; Nitzsche, Katja; Kuisma, Eeva; Michel, Janine; Holm, Tobias; Zekeng, Elsa-Gayle; Garcia-Dorival, Isabel; Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Strecker, Thomas; Di Caro, Antonino; Avsic-Zupanc, Tatjana; Kurth, Andreas; Meschi, Silvia; Mely, Stephane; Newman, Edmund; Bocquin, Anne; Kis, Zoltan; Kelterbaum, Anne; Molkenthin, Peter; Carletti, Fabrizio; Portmann, Jasmine; Wolff, Svenja; Castilletti, Concetta; Schudt, Gordian; Fizet, Alexandra; Ottowell, Lisa J.; Herker, Eva; Jacobs, Thomas; Kretschmer, Birte; Severi, Ettore; Ouedraogo, Nobila; Lago, Mar; Negredo, Anabel; Franco, Leticia; Anda, Pedro; Schmiedel, Stefan; Kreuels, Benno; Wichmann, Dominic; Addo, Marylyn M.; Lohse, Ansgar W.; De Clerck, Hilde; Nanclares, Carolina; Jonckheere, Sylvie; Van Herp, Michel; Sprecher, Armand; Gao Xiaojiang; Carrington, Mary; Miranda, Osvaldo; Castro, Carlos M.; Gabriel, Martin; Drury, Patrick; Formenty, Pierre; Diallo, Boubacar; Koivogui, Lamine; Magassouba, N'Faly; Carroll, Miles W.; Guenther, Stephan; Munoz-Fontela, Cesar			Unique human immune signature of Ebola virus disease in Guinea	NATURE			English	Article							T-CELL RESPONSE; CTLA-4; INFECTION; IDENTIFICATION; PROGRESSION; EXPRESSION; EFFECTOR; INSIGHTS; PATIENT; FEVER	Despite the magnitude of the Ebola virus disease (EVD) outbreak in West Africa, there is still a fundamental lack of knowledge about the pathophysiology of EVD1. In particular, very little is known about human immune responses to Ebola virus(2,3). Here we evaluate the physiology of the human T cell immune response in EVD patients at the time of admission to the Ebola Treatment Center in Guinea, and longitudinally until discharge or death. Through the use of multiparametric flow cytometry established by the European Mobile Laboratory in the field, we identify an immune signature that is unique in EVD fatalities. Fatal EVD was characterized by a high percentage of CD4(+) and CD8(+) T cells expressing the inhibitory molecules CTLA-4 and PD-1, which correlated with elevated inflammatory markers and high virus load. Conversely, surviving individuals showed significantly lower expression of CTLA-4 and PD-1 as well as lower inflammation, despite comparable overall T cell activation. Concomitant with virus clearance, survivors mounted a robust Ebola-virus-specific T cell response. Our findings suggest that dysregulation of the T cell response is a key component of EVD pathophysiology.	[Ruibal, Paula; Luedtke, Anja; Herker, Eva; Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Ruibal, Paula; Oestereich, Lisa; Luedtke, Anja; Becker-Ziaja, Beate; Wozniak, David M.; Kerber, Romy; Cabeza-Cabrerizo, Mar; Duraffour, Sophie; Pallasch, Elisa; Holm, Tobias; Jacobs, Thomas; Kreuels, Benno; Gabriel, Martin; Guenther, Stephan; Munoz-Fontela, Cesar] WHO, Bernhard Nocht Inst Trop Med, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, D-20359 Hamburg, Germany; [Ruibal, Paula; Oestereich, Lisa; Luedtke, Anja; Becker-Ziaja, Beate; Wozniak, David M.; Kerber, Romy; Pallasch, Elisa; Nitzsche, Katja; Holm, Tobias; Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Strecker, Thomas; Kelterbaum, Anne; Molkenthin, Peter; Wolff, Svenja; Schudt, Gordian; Kreuels, Benno; Wichmann, Dominic; Addo, Marylyn M.; Lohse, Ansgar W.; Gabriel, Martin; Guenther, Stephan; Munoz-Fontela, Cesar] German Ctr Infect Res DZIF, Partner Sites Hamburg, Munich, Germany; [Ruibal, Paula; Oestereich, Lisa; Luedtke, Anja; Becker-Ziaja, Beate; Wozniak, David M.; Kerber, Romy; Korva, Misa; Cabeza-Cabrerizo, Mar; Bore, Joseph A.; Koundouno, Fara Raymond; Duraffour, Sophie; Weller, Romy; Thorenz, Anja; Cimini, Eleonora; Viola, Domenico; Agrati, Chiara; Repits, Johanna; Afrough, Babak; Cowley, Lauren A.; Ngabo, Didier; Hinzmann, Julia; Mertens, Marc; Vitoriano, Ines; Logue, Christopher H.; Boettcher, Jan Peter; Pallasch, Elisa; Sachse, Andreas; Bah, Amadou; Nitzsche, Katja; Kuisma, Eeva; Michel, Janine; Holm, Tobias; Zekeng, Elsa-Gayle; Garcia-Dorival, Isabel; Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Strecker, Thomas; Di Caro, Antonino; Avsic-Zupanc, Tatjana; Kurth, Andreas; Meschi, Silvia; Mely, Stephane; Newman, Edmund; Bocquin, Anne; Kis, Zoltan; Kelterbaum, Anne; Molkenthin, Peter; Carletti, Fabrizio; Portmann, Jasmine; Wolff, Svenja; Castilletti, Concetta; Schudt, Gordian; Fizet, Alexandra; Ottowell, Lisa J.; Negredo, Anabel; Lohse, Ansgar W.; Gabriel, Martin; Carroll, Miles W.; Guenther, Stephan; Munoz-Fontela, Cesar] European Mobile Lab Consortium, Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Korva, Misa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana 1000, Slovenia; [Weller, Romy] Twincore, Ctr Expt & Clin Infect Res, Inst Expt Virol, D-30625 Hannover, Germany; [Thorenz, Anja] Hannover Med Sch, D-30625 Hannover, Germany; [Cimini, Eleonora; Viola, Domenico; Agrati, Chiara; Di Caro, Antonino; Meschi, Silvia; Carletti, Fabrizio; Castilletti, Concetta] Natl Inst Infect Dis Lazzaro Spallanzani, I-00149 Rome, Italy; [Afrough, Babak; Ngabo, Didier; Vitoriano, Ines; Logue, Christopher H.; Kuisma, Eeva; Newman, Edmund; Ottowell, Lisa J.; Carroll, Miles W.] Publ Hlth England, Porton Down, Salisbury SP4 0JG, Wilts, England; [Cowley, Lauren A.] Publ Hlth England, Colindale Ave, London NW9 5EQ, England; [Hinzmann, Julia; Boettcher, Jan Peter; Sachse, Andreas; Michel, Janine; Kurth, Andreas; Ouedraogo, Nobila] Robert Koch Inst, D-13353 Berlin, Germany; [Mertens, Marc] Friedrich Loeffler Inst, D-17493 Greifswald, Germany; [Bah, Amadou] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland; [Garcia-Dorival, Isabel] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England; [Woelfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Molkenthin, Peter] Bundeswehr Inst Microbiol, D-80937 Munich, Germany; [Strecker, Thomas; Kelterbaum, Anne; Wolff, Svenja; Schudt, Gordian] Univ Marburg, Inst Virol, D-35043 Marburg, Germany; [Mely, Stephane; Bocquin, Anne] INSERM, Lab P4 Jean Merieux, F-69365 Lyon, France; [Kis, Zoltan] Hungarian Natl Biosafety Lab, Natl Ctr Epidemiol, H-1097 Budapest, Hungary; [Kis, Zoltan; Severi, Ettore] European Ctr Dis Prevent & Control, S-17165 Solna, Sweden; [Portmann, Jasmine] Fed Off Civil Protect, CH-3700 Spiez, Switzerland; [Fizet, Alexandra] Inst Pasteur, Unite Biol Infect Virales Emergentes, F-69365 Lyon, France; [Kretschmer, Birte] European Res & Project Off, Eurice, D-10115 Berlin, Germany; [Lago, Mar] Hosp La Paz, Infect Dis Unit, Internal Med Serv, Madrid 28046, Spain; [Negredo, Anabel; Franco, Leticia; Anda, Pedro] Inst Hlth Carlos III, Natl Ctr Microbiol, Madrid 28220, Spain; [Schmiedel, Stefan; Kreuels, Benno; Wichmann, Dominic; Addo, Marylyn M.; Lohse, Ansgar W.] Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany; [De Clerck, Hilde; Nanclares, Carolina; Jonckheere, Sylvie; Van Herp, Michel; Sprecher, Armand] Med Sans Frontieres, B-1050 Brussels, Belgium; [Gao Xiaojiang; Carrington, Mary] Leidos Biomed Res, Canc & Inflammat Program, Expt Immunol Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Gao Xiaojiang; Carrington, Mary] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Miranda, Osvaldo; Castro, Carlos M.] Hosp Militar Cent Dr Carlos J Finlay, Havana 11400, Cuba; [Drury, Patrick; Formenty, Pierre; Diallo, Boubacar] WHO, CH-1211 Geneva 27, Switzerland; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry 2101, Guinea; [Magassouba, N'Faly] Univ Gamal Abdel Nasser Conakry, CHU Donka, Conakry 2101, Guinea	Heinrich Pette Institute; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization; German Center for Infection Research; Bernhard Nocht Institut fur Tropenmedizin; University of Ljubljana; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; IRCCS Lazzaro Spallanzani; Public Health England; Public Health England; Robert Koch Institute; Friedrich Loeffler Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Liverpool; Bundeswehr Institute of Microbiology (IMB); Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); European Centre for Disease Prevention & Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hospital Universitario La Paz; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Hamburg; University Medical Center Hamburg-Eppendorf; Doctors Without Borders; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; World Health Organization	Munoz-Fontela, C (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany.; Gunther, S; Munoz-Fontela, C (corresponding author), WHO, Bernhard Nocht Inst Trop Med, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, D-20359 Hamburg, Germany.; Gunther, S; Munoz-Fontela, C (corresponding author), German Ctr Infect Res DZIF, Partner Sites Hamburg, Munich, Germany.; Gunther, S; Munoz-Fontela, C (corresponding author), European Mobile Lab Consortium, Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.	guenther@bni.uni-hamburg.de; cesar.munoz-fontela@hpi.uni-hamburg.de	Dorival, Isabel Garcia/AAX-5807-2020; Addo, Marylyn M./GNP-2548-2022; Herker, Eva/AAQ-1944-2021; Ruibal, Paula/Y-2478-2018; Logue, Christopher H/ABH-3469-2020; Strecker, Thomas/AAR-8442-2020; Castilletti, Concetta/AAA-8408-2019; Cimini, Eleonora/K-8878-2016; Di Caro, Antonino/K-6854-2016; Anda, Pedro/V-8436-2019; Wölfel, Roman/AAQ-3977-2021; Negredo, Ana/AAE-6155-2020; Castilletti, Concetta/B-6545-2016; Herker, Eva/B-9699-2014; Agrati, Chiara/K-8806-2016	Dorival, Isabel Garcia/0000-0002-5654-5662; Ruibal, Paula/0000-0003-3217-4497; Castilletti, Concetta/0000-0001-9819-236X; Cimini, Eleonora/0000-0002-2659-0868; Di Caro, Antonino/0000-0001-6027-3009; Anda, Pedro/0000-0001-9081-8188; Wölfel, Roman/0000-0002-8756-7821; Negredo, Ana/0000-0001-7491-1032; Castilletti, Concetta/0000-0001-9819-236X; Herker, Eva/0000-0001-9644-2484; Agrati, Chiara/0000-0002-5252-0927; Cowley, Lauren/0000-0003-0835-7971; Ouedraogo, Nobila/0000-0001-6967-9670; Oestereich, Lisa/0000-0003-0098-7485; Munoz-Fontela, Cesar/0000-0002-7725-2586; Gunther, Stephan/0000-0002-6562-0230; Strecker, Thomas/0000-0002-7857-937X; MELY, Stephane/0000-0002-3278-3455; Cabeza-Cabrerizo, Mar/0000-0001-9061-058X; Addo, Marylyn/0000-0003-2836-9224; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Afrough, Babak/0000-0002-6651-1239; Carroll, Miles/0000-0002-7026-7187; meschi, silvia/0000-0003-0924-993X; Ngabo, Didier/0000-0003-1818-1439; Wozniak, David/0000-0001-6719-6931; Korva, Misa/0000-0003-1501-1004	European Union [666100]; Directorate-General for International Cooperation and Development [IFS/2011/272-372]; German Research Foundation [GU 883/4-1]; Spanish National Plan for Research and Development ISCIII; FEDER [RD12/0018/006]; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research; Leibniz Center of Infection; European Program for Public Health Microbiology Training (EUPHEM); NATIONAL CANCER INSTITUTE [ZIABC010792, ZIABC010791] Funding Source: NIH RePORTER	European Union(European Commission); Directorate-General for International Cooperation and Development; German Research Foundation(German Research Foundation (DFG)); Spanish National Plan for Research and Development ISCIII; FEDER(European Commission); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research; Leibniz Center of Infection; European Program for Public Health Microbiology Training (EUPHEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the African Union, MSF and WHO field teams and the Guinean health authorities in Gueckedou, Coyah and Conakry for their commitment and cooperation. We also thank J. Snyder-Cappione (Boston University) and M. Altfeld (Heinrich Pette Institute) for technical support. The EMLab is a technical partner of the WHO Emerging and Dangerous Pathogens Laboratory Network (EDPLN), and the Global Outbreak Alert and Response Network (GOARN) and the deployments in West Africa have been coordinated and supported by the GOARN Operational Support Team at WHO/HQ. This work was carried out in the context of the project EVIDENT (Ebola virus disease: correlates of protection, determinants of outcome, and clinical management) that received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No. 666100 and in the context of service contract IFS/2011/272-372 funded by Directorate-General for International Cooperation and Development. The project was further supported by grant GU 883/4-1 from the German Research Foundation. This project has been funded in in part with funds from the Spanish National Plan for Research and Development ISCIII and FEDER RD12/0018/006 as well as federal funds from the Frederick National Laboratory for Cancer Research, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, Frederick National Laboratory, Center for Cancer Research. A.L. is a recipient of a pre-doctoral fellowship from the Leibniz Center of Infection. Z.K. is a recipient of a fellowship from the European Program for Public Health Microbiology Training (EUPHEM).	Ayukawa H, 2004, CLIN EXP IMMUNOL, V137, P151, DOI 10.1111/j.1365-2249.2004.02502.x; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; de la Fuente H, 2012, FEBS LETT, V586, P2897, DOI 10.1016/j.febslet.2012.07.032; de La Vega MA, 2015, J CLIN INVEST, V125, P4421, DOI 10.1172/JCI83162; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Hutchinson KL, 2007, J INFECT DIS, V196, pS357, DOI 10.1086/520611; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111; Lindgren T, 2011, J VIROL, V85, P10252, DOI 10.1128/JVI.05548-11; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Marzi A, 2015, EMERG INFECT DIS, V21, P1777, DOI 10.3201/eid2110.150259; McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Modiano D, 2001, TISSUE ANTIGENS, V57, P128, DOI 10.1034/j.1399-0039.2001.057002128.x; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Raue HP, 2007, J LEUKOCYTE BIOL, V81, P1165, DOI 10.1189/jlb.0806535; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Shvets A, 2009, BLOOD, V113, P622, DOI 10.1182/blood-2008-03-139964; Simmons G, 2004, VIROLOGY, V318, P224, DOI 10.1016/j.virol.2003.09.016; Sundar K, 2007, VIROLOGY, V360, P257, DOI 10.1016/j.virol.2006.09.042; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9	30	126	126	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					100	+		10.1038/nature17949	http://dx.doi.org/10.1038/nature17949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27147028	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000375473900047
J	Wise, J				Wise, Jacqui			Dilute apple juice is good alternative to electrolyte fluids for children with gastroenteritis, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Freedman SB, 2016, JAMA-J AM MED ASSOC, V315, P1966, DOI 10.1001/jama.2016.5352	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2479	10.1136/bmj.i2479	http://dx.doi.org/10.1136/bmj.i2479			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27143366				2022-12-28	WOS:000375574000012
J	Johnson, N				Johnson, Nathan			The hidden perks of grad school	SCIENCE			English	Editorial Material								When I was in grad school, I couldn't wait to get out. The learning curve was distressingly steep, everyone seemed to know more than I did, and I was scraping by at just above the poverty line. That's why, after successfully convincing the university that I could graduate without being a total embarrassment, I was thrilled to take a job with a small nongovernmental organization that provides outdoor environmental education and habitat restoration activities to the local community. Just 1 year in the rat race, however, has given me a new perspective. I'm just far enough removed from graduate school to look back fondly on many of the experiences I had and to truly appreciate some of the lessons I learned.				SciCareerEditor@aaas.org							0	0	0	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					622	622		10.1126/science.352.6285.622	http://dx.doi.org/10.1126/science.352.6285.622			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126048				2022-12-28	WOS:000374998600052
J	Amer, P				Amer, Pakinam			OILING THE WHEELS ON A ROAD TO SUCCESS	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S13	S15		10.1038/532S13a	http://dx.doi.org/10.1038/532S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27135100	Bronze			2022-12-28	WOS:000374815900003
J	Calos, MP				Calos, Michele P.			The CRISPR Way to Think about Duchenne's	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MUSCULAR-DYSTROPHY; MUSCLE FUNCTION; MOUSE MODEL		[Calos, Michele P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Calos, MP (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.							Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192	5	8	8	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1684	1686		10.1056/NEJMcibr1601383	http://dx.doi.org/10.1056/NEJMcibr1601383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	27119241				2022-12-28	WOS:000374843400013
J	Agboola, SO; Bates, DW; Kvedar, JC				Agboola, Stephen O.; Bates, David W.; Kvedar, Joseph C.			Digital Health and Patient Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							APPS; CARE		[Agboola, Stephen O.; Bates, David W.; Kvedar, Joseph C.] Partners Healthcare, Boston, MA USA; [Agboola, Stephen O.; Bates, David W.; Kvedar, Joseph C.] Harvard Univ, Sch Med, Boston, MA USA; [Agboola, Stephen O.; Kvedar, Joseph C.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bates, David W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Kvedar, JC (corresponding author), Partners Healthcare, Connected Hlth, 25 New Chardon St,Ste 300, Boston, MA 02114 USA.	jkvedar@partners.org	Bates, David/AAE-7283-2019					Chou EY, 2015, J EXP SOC PSYCHOL, V61, P84, DOI 10.1016/j.jesp.2015.07.010; Dharmar M, 2013, PEDIATRICS, V132, P1090, DOI 10.1542/peds.2013-1374; Ferrero NA, 2013, J AM ACAD DERMATOL, V68, P515, DOI 10.1016/j.jaad.2012.10.045; Huckvale K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0314-7; Institute of Medicine, 2001, CROSSING QUALITY CHA; Katz HP, 2008, J GEN INTERN MED, V23, P517, DOI 10.1007/s11606-007-0491-y; Lilly CM, 2014, CRIT CARE MED, V42, P2429, DOI 10.1097/CCM.0000000000000539; Maeng DD, 2014, POPUL HEALTH MANAG, V17, P340, DOI 10.1089/pop.2013.0107; PwC Health Research Institute. PWC, HLTH WEAR EARL DAYS; Xu WL, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4026	10	30	31	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1697	1698		10.1001/jama.2016.2402	http://dx.doi.org/10.1001/jama.2016.2402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115372				2022-12-28	WOS:000374759300011
J	McCarthy, M				McCarthy, Michael			Patient safety took second place to research needs at NIH hospital, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Clinical Center Working Group of the Advisory Committee to the Director, 2016, RED RISK PROM PAT SA	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2376	10.1136/bmj.i2376	http://dx.doi.org/10.1136/bmj.i2376			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27118733				2022-12-28	WOS:000375482500016
J	Locarnini, S; Chen, DS; Shibuya, K				Locarnini, Stephen; Chen, Ding-Shinn; Shibuya, Kenji			No more excuses: viral hepatitis can be eliminated	LANCET			English	Editorial Material									[Locarnini, Stephen] WHO Collaborating Ctr Viral Hepatitis VIDRL, Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Chen, Ding-Shinn] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Locarnini, Stephen; Chen, Ding-Shinn; Shibuya, Kenji] Coalit Eradicate Viral Hepatitis Asia Pacific, Singapore 058416, Singapore	Victorian Infectious Diseases Reference Laboratory; National Taiwan University; National Taiwan University Hospital; National Taiwan University; University of Tokyo	Locarnini, S (corresponding author), WHO Collaborating Ctr Viral Hepatitis VIDRL, Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	stephen.locarnini@vidrl.org.au	CHEN, DING-SHINN/T-4395-2019	Shibuya, Kenji/0000-0003-2528-7530; CHEN, DING-SHINN/0000-0001-7791-6154				Chen DS, 2015, LANCET INFECT DIS, V15, P626, DOI 10.1016/S1473-3099(15)00026-2; Coalition to Eradicate Viral Hepatitis in Asia Pacifi c, 2013, NEW DAT SHOWS ON PER; Institute for Health Metrics and Evaluation University of Washington, GLOB BURD DIS STUD 2; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Plunket, 2015, AS PEOPL STRAT 2015; UN, 2015, SUSTAINABLE DEV GOAL; United Nations Economic and Social Council, 2016, ECN32016218 UN EC SO; WHO Regional Office for the Americas, 2015, PLAN ACT PREV CONTR; WHO Regional Office for the Western Pacific, 2015, REG ACT PLAB VIR HEP; WHO Regional Office for the Western Pacific, 2014, HEP C TREATM; World Health Organization, 2015, MOD LIST ESS MED 19	11	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1703	1704		10.1016/S0140-6736(16)30295-1	http://dx.doi.org/10.1016/S0140-6736(16)30295-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	27116263				2022-12-28	WOS:000374541900008
J	Gonzalez-Herrero, H; Gomez-Rodriguez, JM; Mallet, P; Moaied, M; Palacios, JJ; Salgado, C; Ugeda, MM; Veuillen, JY; Yndurain, F; Brihuega, I				Gonzalez-Herrero, Hector; Gomez-Rodriguez, Jose M.; Mallet, Pierre; Moaied, Mohamed; Jose Palacios, Juan; Salgado, Carlos; Ugeda, Miguel M.; Veuillen, Jean-Yves; Yndurain, Felix; Brihuega, Ivan			Atomic-scale control of graphene magnetism by using hydrogen atoms	SCIENCE			English	Article							GRAPHITE; DEFECTS; SURFACE; STATES; MODEL; EDGE	Isolated hydrogen atoms absorbed on graphene are predicted to induce magnetic moments. Here we demonstrate that the adsorption of a single hydrogen atom on graphene induces a magnetic moment characterized by a similar to 20-millielectron volt spin-split state at the Fermi energy. Our scanning tunneling microscopy (STM) experiments, complemented by first-principles calculations, show that such a spin-polarized state is essentially localized on the carbon sublattice opposite to the one where the hydrogen atom is chemisorbed. This atomically modulated spin texture, which extends several nanometers away from the hydrogen atom, drives the direct coupling between the magnetic moments at unusually long distances. By using the STM tip to manipulate hydrogen atoms with atomic precision, it is possible to tailor the magnetism of selected graphene regions.	[Gonzalez-Herrero, Hector; Gomez-Rodriguez, Jose M.; Moaied, Mohamed; Jose Palacios, Juan; Salgado, Carlos; Yndurain, Felix; Brihuega, Ivan] Univ Autonoma Madrid, Dept Fis Mat Condensada, Cantoblanco, E-28049 Madrid, Spain; [Gonzalez-Herrero, Hector; Gomez-Rodriguez, Jose M.; Jose Palacios, Juan; Yndurain, Felix; Brihuega, Ivan] Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain; [Gomez-Rodriguez, Jose M.; Jose Palacios, Juan; Yndurain, Felix; Brihuega, Ivan] Univ Autonoma Madrid, Inst Nicolas Cabrera, E-28049 Madrid, Spain; [Mallet, Pierre; Veuillen, Jean-Yves] Univ Grenoble Alpes, Inst NEEL, F-38042 Grenoble, France; [Mallet, Pierre; Veuillen, Jean-Yves] CNRS, Inst NEEL, F-38042 Grenoble, France; [Moaied, Mohamed] Zagazig Univ, Dept Phys, Fac Sci, Zagazig 44519, Egypt; [Ugeda, Miguel M.] CIC NanoGUNE, Donostia San Sebastian 20018, Spain; [Ugeda, Miguel M.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Egyptian Knowledge Bank (EKB); Zagazig University; Basque Foundation for Science	Brihuega, I (corresponding author), Univ Autonoma Madrid, Dept Fis Mat Condensada, Cantoblanco, E-28049 Madrid, Spain.; Brihuega, I (corresponding author), Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain.; Brihuega, I (corresponding author), Univ Autonoma Madrid, Inst Nicolas Cabrera, E-28049 Madrid, Spain.	ivan.brihuega@uam.es	Ugeda, Miguel/N-3006-2016; GOMEZ-RODRIGUEZ, JOSE M./I-3055-2012; González Herrero, Héctor/O-6549-2017; González Herrero, Héctor/AAC-1769-2022; yndurain, felix/J-2794-2014; Palacios, Juan Jose/A-9872-2011; Ugeda, Miguel M./ABG-8106-2020; Brihuega, Ivan/B-8274-2014	GOMEZ-RODRIGUEZ, JOSE M./0000-0002-7621-3331; González Herrero, Héctor/0000-0002-3028-9875; yndurain, felix/0000-0003-0968-4050; Palacios, Juan Jose/0000-0003-2378-0866; Ugeda, Miguel M./0000-0001-7913-1617; Brihuega, Ivan/0000-0001-5032-9304	Spain's Ministerio de Economia y Competitividad [MAT2013-41636-P, CSD2010-00024, PCIN-2015-030, FIS2013-47328, FIS2012-37549-C05-03]; European Union; Comunidad de Madrid MAD2D-CM program [S2013/MIT-3007, P2013/MIT-2850]; Generalitat Valenciana [PROMETEO/2012/011]; CNRS PICS [6182]; European Union [604391]; FLAG-ERA programs	Spain's Ministerio de Economia y Competitividad(Spanish Government); European Union(European Commission); Comunidad de Madrid MAD2D-CM program(Comunidad de Madrid); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CNRS PICS(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); FLAG-ERA programs	We thank V. Cherkez (Institut NEEL, CNRS, and Universite Grenoble Alpes) for his help with the fabrication of samples of graphene grown on SiC, and we thank D. Wong (University of California-Berkeley) for his careful reading of the manuscript. This work was supported by Spain's Ministerio de Economia y Competitividad under grant nos. MAT2013-41636-P, CSD2010-00024, PCIN-2015-030, FIS2013-47328, and FIS2012-37549-C05-03; the European Union structural funds and the Comunidad de Madrid MAD2D-CM program under grant nos. S2013/MIT-3007 and P2013/MIT-2850; the Generalitat Valenciana under grant no. PROMETEO/2012/011; THE CNRS PICS (Projets Internationaux de Cooperation Scientifique) program under grant no. 6182; and the European Union FP7 (7th Framework Programme for Research and Technological Development) Graphene Flagship (grant 604391) and FLAG-ERA programs. The authors acknowledge the computer resources and assistance provided by the Centro de Computacion Cientifica of the Universidad Autonoma de Madrid.	ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Balakrishnan J, 2013, NAT PHYS, V9, P284, DOI 10.1038/nphys2576; Balog R, 2009, J AM CHEM SOC, V131, P8744, DOI 10.1021/ja902714h; Boukhvalov DW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035427; de Laissardiere GT, 2010, NANO LETT, V10, P804, DOI 10.1021/nl902948m; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fernandez-Rossier J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.177204; Fujita M, 1996, J PHYS SOC JPN, V65, P1920, DOI 10.1143/JPSJ.65.1920; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hornekaer L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.186102; Jeloaica L, 1999, CHEM PHYS LETT, V300, P157, DOI 10.1016/S0009-2614(98)01337-2; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Lehtinen PO, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187202; McCreary KM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186604; MIZES HA, 1989, SCIENCE, V244, P559, DOI 10.1126/science.244.4904.559; Nair RR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3010; Nair RR, 2012, NAT PHYS, V8, P199, DOI [10.1038/NPHYS2183, 10.1038/nphys2183]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Palacios JJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195428; Pereira VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036801; Ruffieux P, 2000, PHYS REV LETT, V84, P4910, DOI 10.1103/PhysRevLett.84.4910; Santos EJG, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043022; Sha XW, 2002, SURF SCI, V496, P318, DOI 10.1016/S0039-6028(01)01602-8; SHEN TC, 1995, SCIENCE, V268, P1590, DOI 10.1126/science.268.5217.1590; Sljivancanin Z, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3187941; Soriano D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016602; Sprinkle M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.226803; Tao CG, 2011, NAT PHYS, V7, P616, DOI [10.1038/NPHYS1991, 10.1038/nphys1991]; Uchoa B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026805; Ugeda MM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.096804; Varchon F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165415; Yazyev OV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125408; Yazyev OV, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/5/056501	35	431	433	25	643	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					437	441		10.1126/science.aad8038	http://dx.doi.org/10.1126/science.aad8038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102478	Green Submitted			2022-12-28	WOS:000374479700041
J	Oliver, D				Oliver, David			David Oliver: Progress on dementia in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Alzheimer's Society, 2009, COUNT COST CAR PEOPL; Alzheimers Society, DEM ACT ALL; Department of Health, 2012, PRIM MIN CHALL DEM; Department of Health, 2010, QUAL OUTC PEOPL DEM; Department of Health, 2009, LIVING WELL DEMENTIA; Johns Campaign, JOHNS CAMP RIGHT STA; Kings Fund, 2012, CAR FRAIL OLD PEOPL; Kings Fund, ENV CAR PEOPL DEM; NHS Confederation, 2010, AC AW IMPR HOSP CAR; NHS England, 2019, NHS INT PEOPL PLAN; Oliver D, 2016, GUARDIAN HEALTH 0316; Royal College of Nursing, 2010, IMPR QUAL CAR PEOPL; Royal College of Psychiatrists, NAT AUD CAR PEOPL DE; Royal College of Psychiatrists, 2005, WHO CAR WINS IMPR OU; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2204	10.1136/bmj.i2204	http://dx.doi.org/10.1136/bmj.i2204			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106668	Green Published, Bronze			2022-12-28	WOS:000374999700004
J	Athuluri-Divakar, SK; Vasquez-Del Carpio, R; Dutta, K; Baker, SJ; Cosenza, SC; Basu, I; Gupta, YK; Reddy, MVR; Ueno, L; Hart, JR; Vogt, PK; Mulholland, D; Guha, C; Aggarwal, AK; Reddy, EP				Athuluri-Divakar, Sai Krishna; Vasquez-Del Carpio, Rodrigo; Dutta, Kaushik; Baker, Stacey J.; Cosenza, Stephen C.; Basu, Indranil; Gupta, Yogesh K.; Reddy, M. V. Ramana; Ueno, Lynn; Hart, Jonathan R.; Vogt, Peter K.; Mulholland, David; Guha, Chandan; Aggarwal, Aneel K.; Reddy, E. Premkumar			A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling	CELL			English	Article							BLADDER-CARCINOMA ONCOGENE; IN-VIVO; TRANSFORMING PROPERTIES; SELECTIVE INHIBITOR; POINT MUTATIONS; ACTIVATION; BINDING; KINASE; PHOSPHORYLATION; MUTANT	Oncogenic activation of RAS genes via point mutations occurs in 20%-30% of human cancers. The development of effective RAS inhibitors has been challenging, necessitating new approaches to inhibit this oncogenic protein. Functional studies have shown that the switch region of RAS interacts with a large number of effector proteins containing a common RAS-binding domain (RBD). Because RBD-mediated interactions are essential for RAS signaling, blocking RBD association with small molecules constitutes an attractive therapeutic approach. Here, we present evidence that rigosertib, a styryl-benzyl sulfone, acts as a RAS-mimetic and interacts with the RBDs of RAF kinases, resulting in their inability to bind to RAS, disruption of RAF activation, and inhibition of the RAS-RAF-MEK pathway. We also find that ribosertib binds to the RBDs of Ral-GDS and PI3Ks. These results suggest that targeting of RBDs across multiple signaling pathways by rigosertib may represent an effective strategy for inactivation of RAS signaling.	[Athuluri-Divakar, Sai Krishna; Vasquez-Del Carpio, Rodrigo; Baker, Stacey J.; Cosenza, Stephen C.; Gupta, Yogesh K.; Reddy, M. V. Ramana; Mulholland, David; Aggarwal, Aneel K.; Reddy, E. Premkumar] Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA; [Athuluri-Divakar, Sai Krishna; Vasquez-Del Carpio, Rodrigo; Baker, Stacey J.; Cosenza, Stephen C.; Gupta, Yogesh K.; Reddy, M. V. Ramana; Mulholland, David; Aggarwal, Aneel K.; Reddy, E. Premkumar] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, 1425 Madison Ave, New York, NY 10029 USA; [Dutta, Kaushik] New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA; [Ueno, Lynn; Hart, Jonathan R.; Vogt, Peter K.] Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Basu, Indranil; Guha, Chandan] Yeshiva Univ Albert Einstein Coll Med, Dept Radiat Oncol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Scripps Research Institute; Yeshiva University; Albert Einstein College of Medicine	Reddy, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.; Reddy, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, 1425 Madison Ave, New York, NY 10029 USA.	ep.reddy@mssm.edu	Vogt, Peter K./R-7547-2019; Gupta, Yogesh K/B-6949-2009; Reddy, E. Premkumar/F-6233-2011; Gupta, Yogesh/AFH-5204-2022	Vogt, Peter K./0000-0002-4519-7500; Gupta, Yogesh K/0000-0001-6372-5007; Gupta, Yogesh/0000-0001-6372-5007; Ueno, Lynn/0000-0001-8993-5168; Hart, Jonathan/0000-0002-3905-225X; A. DIVAKAR, SAI KRISHNA/0000-0003-0232-4052	Onconova Therapeutics (OTI); NIH [CA158209, CA78230, CA151574, CA153124, CO6RR015495, P41GM066354]; NYSTAR; Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA153124, R01CA197910, R01CA151574, R01CA078230, R01CA158209] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER	Onconova Therapeutics (OTI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTAR; Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Deborah Morrison (NCI) for material and intellectual help with the design and execution of some of these studies. E.P.R. was supported by grants from Onconova Therapeutics (OTI) and NIH CA158209. Data collection at New York Structural Biology Center (NYSBC) was supported by grants from NYSTAR, NIH CO6RR015495, NIH P41GM066354, and the Keck Foundation. P.K.V. was supported by NIH grants CA78230, CA151574, and CA153124. E.P.R. is a founder, paid consultant, and board member of OTI. R.V.-D.C., S.J.B., S.C.C., M.V.R., and A.K.A. are consultants for OTI.	Agoni L, 2014, INT J RADIAT ONCOL, V88, P1180, DOI 10.1016/j.ijrobp.2013.12.051; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Fernandez TD, 1998, LEUKEMIA RES, V22, P125, DOI 10.1016/S0145-2126(97)00112-4; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Garcia-Manero G., 2016, LANCET ONCOL; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Ito Y, 2014, P NATL ACAD SCI USA, V111, P16826, DOI 10.1073/pnas.1420281111; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; REDDY EP, 1983, SCIENCE, V220, P1061, DOI 10.1126/science.6844927; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reddy MVR, 2011, J MED CHEM, V54, P6254, DOI 10.1021/jm200570p; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Satyamoorthy K, 2003, CANCER RES, V63, P756; SHIMIZU K, 1983, NATURE, V304, P497, DOI 10.1038/304497a0; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; STEPHENSON J, 1995, LEUKEMIA RES, V19, P741, DOI 10.1016/0145-2126(95)00056-T; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Terada T, 1999, J MOL BIOL, V286, P219, DOI 10.1006/jmbi.1998.2472; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0	43	177	182	1	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					643	655		10.1016/j.cell.2016.03.045	http://dx.doi.org/10.1016/j.cell.2016.03.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104980	Bronze, Green Accepted			2022-12-28	WOS:000374636800022
J	Coyne, MJ; Comstock, LE				Coyne, Michael J.; Comstock, Laurie E.			A New Pillar in Pilus Assembly	CELL			English	Editorial Material								Pilus assembly in bacteria typically occurs by one of four pathways. In the study by Xu et al., the structures of 20 pilin subunits of human oral and gut Bacteroidales are elucidated, revealing a new pilin superfamily, assembled into pili by a distinct fifth pathway.	[Coyne, Michael J.; Comstock, Laurie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis, 181 Longwood Ave, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis, 181 Longwood Ave, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu			NIAID NIH HHS [R01 AI093771, R01 AI120633] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093771, R01AI120633] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Coyne MJ, 2003, P NATL ACAD SCI USA, V100, P10446, DOI 10.1073/pnas.1832655100; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Nakayama-Imaohji H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148887; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Roche-Hakansson H, 2007, J BACTERIOL, V189, P2119, DOI 10.1128/JB.01362-06; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; VANDOORN J, 1987, MICROB PATHOGENESIS, V3, P87, DOI 10.1016/0882-4010(87)90067-2; VANDOORN J, 1992, MICROB PATHOGENESIS, V13, P75, DOI 10.1016/0882-4010(92)90033-K; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Xu QP, 2016, CELL, V165, P690, DOI 10.1016/j.cell.2016.03.016	10	2	2	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					520	521		10.1016/j.cell.2016.04.024	http://dx.doi.org/10.1016/j.cell.2016.04.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104974	Bronze			2022-12-28	WOS:000374636800011
J	Perez-Cornejo, P				Perez-Cornejo, Patricia			A researcher discovers teaching	SCIENCE			English	Editorial Material									[Perez-Cornejo, Patricia] Autonomous Univ San Luis Potosi, San Luis Potosi, Mexico	Universidad Autonoma de San Luis Potosi	Perez-Cornejo, P (corresponding author), Autonomous Univ San Luis Potosi, San Luis Potosi, Mexico.		Perez-Cornejo, Patricia/B-5500-2016	Perez-Cornejo, Patricia/0000-0002-9985-7543					0	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					262	262		10.1126/science.352.6282.262	http://dx.doi.org/10.1126/science.352.6282.262			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI7LM	27124462				2022-12-28	WOS:000373681600053
J	Brasure, M; Fuchs, E; MacDonald, R; Nelson, VA; Koffel, E; Olson, CM; Khawaja, IS; Diem, S; Carlyle, M; Wilt, TJ; Ouellette, J; Butler, M; Kane, RL				Brasure, Michelle; Fuchs, Erika; MacDonald, Roderick; Nelson, Victoria A.; Koffel, Erin; Olson, Carin M.; Khawaja, Imran S.; Diem, Susan; Carlyle, Maureen; Wilt, Timothy J.; Ouellette, Jeannine; Butler, Mary; Kane, Robert L.			Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; SELF-HELP TREATMENT; LATE-LIFE INSOMNIA; SLEEP-ONSET INSOMNIA; COGNITIVE-BEHAVIOR; OLDER-ADULTS; PRIMARY-CARE; COMPARATIVE EFFICACY; PERSISTENT INSOMNIA; COMORBID INSOMNIA	Background: Psychological and behavioral interventions are frequently used for insomnia disorder. Purpose: To assess benefits and harms of psychological and behavioral interventions for insomnia disorder in adults. Data Sources: Ovid MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and PsycINFO through September 2015, supplemented with hand-searching. Study Selection: Randomized, controlled trials of psychological or behavioral interventions that were published in English and enrolled adults with insomnia disorder lasting 4 or more weeks. Data Extraction: Data extraction by single investigator confirmed by a second reviewer; dual investigator assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Sixty trials with low to moderate risk of bias compared psychological and behavioral interventions with inactive controls or other psychological and behavioral interventions. Cognitive behavioral therapy for insomnia (CBT-I) improved posttreatment global and most sleep outcomes, often compared with information or waitlist controls (moderate-strength evidence). Use of CBT-I improved several sleep outcomes in older adults (low-to moderate-strength evidence). Multicomponent behavioral therapy improved several sleep outcomes in older adults (low-to moderate-strength evidence). Stimulus control improved 1 or 2 sleep outcomes (low-strength evidence). Evidence for other comparisons and for harms was insufficient to permit conclusions. Limitations: A wide variety of comparisons limited the ability to pool data. Trials did not always report global outcomes and infrequently conducted remitter or responder analysis. Comparisons were often information or waitlist groups, and publication bias was possible. Conclusion: Use of CBT-I improves most outcomes compared with inactive controls. Multicomponent behavioral therapy and stimulus control may improve some sleep outcomes. Evidence on other outcomes, comparisons, and long-term efficacy were limited.	Univ Minnesota, Minnesota Reg Sleep Disorders Ctr, Minneapolis Vet Affairs Hlth Care Syst, Sch Publ Hlth, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Optum, Eden Prairie, MN USA; Univ Texas Med Branch, Galveston, TX 77555 USA; [Brasure, Michelle; Nelson, Victoria A.; Ouellette, Jeannine; Butler, Mary; Kane, Robert L.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, MMC 197,Mayo Mem Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA; [Fuchs, Erika] Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, 301 Univ Blvd, Galveston, TX 77555 USA; [MacDonald, Roderick; Koffel, Erin; Olson, Carin M.; Wilt, Timothy J.] Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA; [Khawaja, Imran S.] Minnesota Reg Sleep Disorders Ctr, 701 Pk Ave,G8-220, Minneapolis, MN 55415 USA; [Diem, Susan] Univ Minnesota, Sch Med, Dept Med, 1100 Washington Ave S, Minneapolis, MN 55415 USA; [Carlyle, Maureen] Optum Hlth Econ & Outcomes Res, 11000 Optum Circle, Eden Prairie, MN 55344 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Optum; University of Texas System; University of Texas Medical Branch Galveston; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Medical Branch Galveston; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Optum	Brasure, M (corresponding author), Sch Publ Hlth, Div Hlth Policy & Management, MMC 197,Mayo Mem Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA.	brasu001@umn.edu			Agency for Healthcare Research and Quality [PROSPERO: CRD42014009908]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42014009908)	Altena E, 2008, SLEEP, V31, P1271; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Arnedt JT, 2013, SLEEP, V36, P353, DOI 10.5665/sleep.2448; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; Berkman N, 2011, AHRQ PUBLICATION, V11-E006; Bjorvatn B, 2011, SCAND J PSYCHOL, V52, P580, DOI 10.1111/j.1467-9450.2011.00902.x; Blom K, 2015, BEHAV RES THER, V70, P47, DOI 10.1016/j.brat.2015.05.002; Bothelius K, 2013, J SLEEP RES, V22, P688, DOI 10.1111/jsr.12067; Brasure M, 2015, AHRQ PUBLICATION NO; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Cortoos A, 2010, APPL PSYCHOPHYS BIOF, V35, P125, DOI 10.1007/s10484-009-9116-z; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; Edinger JD, 2009, SLEEP, V32, P499, DOI 10.1093/sleep/32.4.499; Edinger JD, 2003, SLEEP, V26, P177, DOI 10.1093/sleep/26.2.177; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Epstein DR, 2012, SLEEP, V35, P797, DOI 10.5665/sleep.1878; ESPIE CA, 1989, BEHAV RES THER, V27, P79, DOI 10.1016/0005-7967(89)90123-X; Espie CA, 2001, BEHAV RES THER, V39, P45, DOI 10.1016/S0005-7967(99)00157-6; Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2014, SLEEP MED, V15, P913, DOI 10.1016/j.sleep.2014.03.001; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Falloon K, 2015, BRIT J GEN PRACT, V65, pE508, DOI 10.3399/bjgp15X686137; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Fernando A, 2013, J PRIM HEALTH CARE, V5, P5, DOI 10.1071/HC13005; Friedman L, 2009, J AM GERIATR SOC, V57, P441, DOI 10.1111/j.1532-5415.2008.02164.x; Hammer BU, 2011, APPL PSYCHOPHYS BIOF, V36, P251, DOI 10.1007/s10484-011-9165-y; Harris J, 2012, SLEEP, V35, P49, DOI 10.5665/sleep.1584; Harvey AG, 2014, J CONSULT CLIN PSYCH, V82, P670, DOI 10.1037/a0036606; Ho FYY, 2015, SLEEP MED REV, V19, P17, DOI 10.1016/j.smrv.2014.06.010; Ho FYY, 2014, BEHAV RES THER, V63, P147, DOI 10.1016/j.brat.2014.10.002; Holmqvist M, 2014, SLEEP MED, V15, P187, DOI 10.1016/j.sleep.2013.10.013; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Irwin MR, 2014, SLEEP, V37, P1543, DOI 10.5665/sleep.4008; JACOBS GD, 1993, BEHAV MODIF, V17, P498, DOI 10.1177/01454455930174005; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jansson M, 2005, J OCCUP REHABIL, V15, P177, DOI 10.1007/s10926-005-1217-9; Jansson-Frojmark M, 2012, BRIT J CLIN PSYCHOL, V51, P142, DOI 10.1111/j.2044-8260.2011.02018.x; Jansson-Frojmark M, 2012, J CLIN PSYCHOL MED S, V19, P224, DOI 10.1007/s10880-011-9275-y; Jernelov S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-5; Johnston Bradley C, 2013, Health Qual Life Outcomes, V11, P211, DOI 10.1186/1477-7525-11-211; Jungquist Carla R, 2012, Sleep Disord, V2012, P679648, DOI 10.1155/2012/679648; Jungquist CR, 2010, SLEEP MED, V11, P302, DOI 10.1016/j.sleep.2009.05.018; Kaldo V, 2015, BEHAV RES THER, V71, P90, DOI 10.1016/j.brat.2015.06.001; Kirisoglu C, 2004, J PSYCHOSOM RES, V56, P537, DOI 10.1016/j.jpsychores.2004.02.005; Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001; Lancee J, 2014, BEHAV THER, V45, P507, DOI 10.1016/j.beth.2014.02.012; Lancee J, 2013, BEHAV RES THER, V51, P797, DOI 10.1016/j.brat.2013.09.004; Lichstein KL, 2001, J CONSULT CLIN PSYCH, V69, P227, DOI 10.1037/0022-006X.69.2.227; Lovato N, 2014, SLEEP, V37, P117, DOI 10.5665/sleep.3320; McCrae CS, 2007, AM J GERIAT PSYCHIAT, V15, P979, DOI 10.1097/JGP.0b013e31813547e6; McCurry SM, 2014, SLEEP, V37, P299, DOI 10.5665/sleep.3402; Mimeault V, 1999, J CONSULT CLIN PSYCH, V67, P511, DOI 10.1037/0022-006X.67.4.511; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003161, 10.1002/14651858.CD003161]; Morgan K, 2003, BRIT J GEN PRACT, V53, P923; Morgan K, 2012, J AM GERIATR SOC, V60, P1803, DOI 10.1111/j.1532-5415.2012.04175.x; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; MORIN CM, 1987, J CONSULT CLIN PSYCH, V55, P260, DOI 10.1037/0022-006X.55.2.260; MORIN CM, 1993, J CONSULT CLIN PSYCH, V61, P137, DOI 10.1037/0022-006X.61.1.137; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Ong JC, 2014, SLEEP, V37, P1553, DOI 10.5665/sleep.4010; Pallesen S, 2003, BEHAV RES THER, V41, P31, DOI 10.1016/S0005-7967(01)00122-X; Passos GS, 2011, SLEEP MED, V12, P1018, DOI 10.1016/j.sleep.2011.02.007; Pech M, 2013, SLEEP, V36, P739, DOI 10.5665/sleep.2640; Pigeon WR, 2012, BEHAV RES THER, V50, P685, DOI 10.1016/j.brat.2012.07.005; Riley WT, 2010, BEHAV SLEEP MED, V8, P2, DOI 10.1080/15402000903425314; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Rybarczyk B, 2005, J CONSULT CLIN PSYCH, V73, P1164, DOI 10.1037/0022-006X.73.6.1164; Rybarczyk B, 2013, CLIN GERONTOLOGIST, V36, P70, DOI 10.1080/07317115.2012.731478; Rybarczyk B, 2011, REHABIL PSYCHOL, V56, P257, DOI 10.1037/a0025577; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Smith MT, 2015, ARTHRITIS RHEUMATOL, V67, P1221, DOI 10.1002/art.39048; Soeffing JP, 2008, SLEEP MED, V9, P165, DOI 10.1016/j.sleep.2007.02.009; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; Tang NKY, 2012, BEHAV RES THER, V50, P814, DOI 10.1016/j.brat.2012.08.006; Taylor DJ, 2014, BEHAV THER, V45, P376, DOI 10.1016/j.beth.2013.12.010; Tegeler CH, 2012, BRAIN BEHAV, V2, P814, DOI 10.1002/brb3.101; Thorndike FP, 2013, J CLIN PSYCHOL, V69, P1078, DOI 10.1002/jclp.22032; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; van Straten A, 2014, PSYCHOL MED, V44, P1521, DOI 10.1017/S0033291713002249; van Straten A, 2009, PATIENT EDUC COUNS, V74, P29, DOI 10.1016/j.pec.2008.07.050; Vincent N, 2009, SLEEP, V32, P807, DOI 10.1093/sleep/32.6.807; Viswanathan M, 2012, ASSESSING RISK BIAS; Vitiello MV, 2013, J AM GERIATR SOC, V61, P947, DOI 10.1111/jgs.12275; Vitiello MV, 2009, J CLIN SLEEP MED, V5, P355; Wilt TJ, 2016, ANN INTERN MED, V165, P103, DOI 10.7326/M15-1781; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892; Xu M, 2011, SLEEP MED, V12, P65, DOI 10.1016/j.sleep.2010.09.003; Yang M, 2009, CURR MED RES OPIN, V25, P2487, DOI 10.1185/03007990903167415; Zhang JX, 2015, EXPLORE-NY, V11, P180, DOI 10.1016/j.explore.2015.02.005	93	68	75	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					113	+		10.7326/M15-1782	http://dx.doi.org/10.7326/M15-1782			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2GY	27136619				2022-12-28	WOS:000380583100018
J	Dunn, AG				Dunn, Adam G.			Set up a public registry of competing interests	NATURE			English	Editorial Material									[Dunn, Adam G.] Macquarie Univ, Ctr Hlth Informat, Sydney, NSW 2109, Australia	Macquarie University	Dunn, AG (corresponding author), Macquarie Univ, Ctr Hlth Informat, Sydney, NSW 2109, Australia.	adam.dunn@mq.edu.au	Dunn, Adam/H-4425-2019	Dunn, Adam/0000-0002-1720-8209					0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					9	9		10.1038/533009a	http://dx.doi.org/10.1038/533009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27146998				2022-12-28	WOS:000375473900013
J	Pendse, M; Hooper, LV				Pendse, Mihir; Hooper, Lora V.			IMMUNOLOGY Mum's microbes boost baby's immunity	NATURE			English	Editorial Material									[Pendse, Mihir; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu			NIAID NIH HHS [T32 AI005284] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Killig M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00142; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791	7	6	6	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					42	43		10.1038/nature17895	http://dx.doi.org/10.1038/nature17895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120165				2022-12-28	WOS:000375473900033
J	Qadri, F; Wierzba, TF; Ali, M; Chowdhury, F; Khan, AI; Saha, A; Khan, IA; Asaduzzaman, M; Akter, A; Khan, A; Begum, YA; Bhuiyan, TR; Khanam, F; Chowdhury, MI; Islam, T; Chowdhury, AI; Rahman, A; Siddique, SA; Chowdhury, AI; Rahman, A; Siddique, SA; You, YA; Kim, DR; Siddik, AU; Saha, NC; Kabir, A; Cravioto, A; Desai, SN; Singh, AP; Clemens, JD				Qadri, Firdausi; Wierzba, Thomas F.; Ali, Mohammad; Chowdhury, Fahima; Khan, Ashraful I.; Saha, Amit; Khan, Iqbal A.; Asaduzzaman, Muhammad; Akter, Afroza; Khan, Arifuzzaman; Begum, Yasmin A.; Bhuiyan, Taufiqur R.; Khanam, Farhana; Chowdhury, Mohiul I.; Islam, Taufiqul; Chowdhury, Atique I.; Rahman, Anisur; Siddique, Shah A.; Chowdhury, Atique I.; Rahman, Anisur; Siddique, Shah A.; You, Young A.; Kim, Deok R.; Siddik, Ashraf U.; Saha, Nirod C.; Kabir, Alamgir; Cravioto, Alejandro; Desai, Sachin N.; Singh, Ajit P.; Clemens, John D.			Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							O1; TRIAL; DHAKA	BACKGROUND A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. We conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic. METHODS Nonpregnant residents of Dhaka, Bangladesh, who were 1 year of age or older were randomly assigned to receive a single dose of oral cholera vaccine or oral placebo. The primary outcome was vaccine protective efficacy against culture-confirmed cholera occurring 7 to 180 days after dosing. Prespecified secondary outcomes included protective efficacy against severely dehydrating culture-confirmed cholera during the same interval, against cholera and severe cholera occurring 7 to 90 versus 91 to 180 days after dosing, and against cholera and severe cholera according to age at baseline. RESULTS A total of 101 episodes of cholera, 37 associated with severe dehydration, were detected among the 204,700 persons who received one dose of vaccine or placebo. The vaccine protective efficacy was 40% (95% confidence interval [CI], 11 to 60%; 0.37 cases per 1000 vaccine recipients vs. 0.62 cases per 1000 placebo recipients) against all cholera episodes, 63% (95% CI, 24 to 82%; 0.10 vs. 0.26 cases per 1000 recipients) against severely dehydrating cholera episodes, and 63% (95% CI, -39 to 90%), 56% (95% CI, 16 to 77%), and 16% (95% CI, -49% to 53%) against all cholera episodes among persons vaccinated at the age of 5 to 14 years, 15 or more years, and 1 to 4 years, respectively, although the differences according to age were not significant (P = 0.25). Adverse events occurred at similar frequencies in the two groups. CONCLUSIONS A single dose of the oral cholera vaccine was efficacious in older children (= 5 years of age) and in adults in a setting with a high level of cholera endemicity.	[Qadri, Firdausi; Chowdhury, Fahima; Khan, Ashraful I.; Saha, Amit; Asaduzzaman, Muhammad; Akter, Afroza; Khan, Arifuzzaman; Begum, Yasmin A.; Bhuiyan, Taufiqur R.; Khanam, Farhana; Chowdhury, Mohiul I.; Islam, Taufiqul; Chowdhury, Atique I.; Rahman, Anisur; Siddique, Shah A.; Siddik, Ashraf U.; Saha, Nirod C.; Kabir, Alamgir; Clemens, John D.] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh; [Khan, Iqbal A.] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Wierzba, Thomas F.; Ali, Mohammad; You, Young A.; Kim, Deok R.; Cravioto, Alejandro; Desai, Sachin N.; Singh, Ajit P.] Int Vaccine Inst, Seoul, South Korea; [Ali, Mohammad] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Clemens, John D.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Vaccine Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles	Qadri, F (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.; Qadri, F (corresponding author), Icddr B, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh.	fqadri@icddrb.org	Qadri, Firdausi/AAF-4583-2019; Khan, Arifuzzaman/C-1117-2019; Ali, Mohammad/E-2365-2017; Asaduzzaman, Muhammad/O-5081-2017; Kabir, Alamgir/H-3430-2019; Al, Mamun M./AAF-5850-2019	Khan, Arifuzzaman/0000-0003-4770-8308; Ali, Mohammad/0000-0003-1410-388X; Asaduzzaman, Muhammad/0000-0001-9048-7980; , Mohiul/0000-0001-5534-2161; Kabir, Alamgir/0000-0002-3762-8307	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funded by the Bill and Melinda Gates Foundation and others	Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Amarasinghe A., 2016, GLOB MAN SURV ADV EV; [Anonymous], PROGR DRINK WAT SAN; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Chowdhury F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000999; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Clemens JNA, 2010, NEW GENERATION VACCI; Kanungo S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003574; Kanungo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096499; Kanungo S, 2009, VACCINE, V27, P6887, DOI 10.1016/j.vaccine.2009.09.008; Khan IA, 2013, VACCINE, V31, P6058, DOI 10.1016/j.vaccine.2013.10.021; Maruo K, 2014, STAT MED, V33, P2288, DOI 10.1002/sim.6147; MONSUR K. A., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P440, DOI 10.1016/0035-9203(61)90090-6; MOSLEY WH, 1968, B WORLD HEALTH ORGAN, V38, P777; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Qadri F, 1997, CLIN DIAGN LAB IMMUN, V4, P429, DOI 10.1128/CDLI.4.4.429-434.1997; QADRI F, 1994, CLIN DIAGN LAB IMMUN, V1, P51, DOI 10.1128/CDLI.1.1.51-54.1994; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; World Health Organization, 2012, VERB AUT STAND 2012; World Health Organization, 2005, TREATM DIARRH MAN PH	25	108	110	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1723	1732		10.1056/NEJMoa1510330	http://dx.doi.org/10.1056/NEJMoa1510330			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144848	Bronze, Green Published			2022-12-28	WOS:000375341500005
J	Ram, J; Gupta, R				Ram, Jagat; Gupta, Rohit			Petaloid Cataract	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ram, Jagat; Gupta, Rohit] Postgrad Inst Med Educ & Res, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ram, J (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh 160012, India.	drjagatram@gmail.com							0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					E22	E22		10.1056/NEJMicm1507349	http://dx.doi.org/10.1056/NEJMicm1507349			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144871				2022-12-28	WOS:000375341500011
J	Brummel, NE; Ely, EW				Brummel, Nathan E.; Ely, E. Wesley			Update in Critical Care Medicine: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNATIONAL CONSENSUS DEFINITIONS; MORTALITY PREDICTION MODEL; SEPSIS		[Brummel, Nathan E.] Vanderbilt Univ, Sch Med, Suite 350,2525 West End Ave, Nashville, TN 37203 USA; Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Nashville, TN USA; Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Ely, E. Wesley] VA Tennesse Valley Healthcare Syst Geriatr Res Ed, Nashville, TN 37232 USA; [Ely, E. Wesley] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Brummel, NE (corresponding author), Vanderbilt Univ, Sch Med, Suite 350,2525 West End Ave, Nashville, TN 37203 USA.	nathan.brummel@vanderbilt.edu	Brummel, Nathan/AAB-5466-2020; Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172				[Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; Aslakson RA, 2014, CRIT CARE MED, V42, P2418, DOI 10.1097/CCM.0000000000000573; Carson SS, 2012, CRIT CARE MED, V40, P1171, DOI 10.1097/CCM.0b013e3182387d43; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Hough CL, 2015, CRIT CARE MED, V43, P2339, DOI 10.1097/CCM.0000000000001205; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kahn JM, 2010, JAMA-J AM MED ASSOC, V303, P2253, DOI 10.1001/jama.2010.761; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007	14	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W15	W20		10.7326/M16-0572	http://dx.doi.org/10.7326/M16-0572			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136226				2022-12-28	WOS:000375744000005
J	Cole, TB				Cole, Thomas B.			Market in San Miguel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1818	1819		10.1001/jama.2015.14242	http://dx.doi.org/10.1001/jama.2015.14242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139043				2022-12-28	WOS:000375284400001
J	Howard, C; Guntupalli, K				Howard, Christopher; Guntupalli, Kalpalatha			Update in Pulmonary Medicine: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; VENTILATION; TIOTROPIUM; ASTHMA		[Howard, Christopher; Guntupalli, Kalpalatha] Baylor Coll Med, 6620 Main St, Houston, TX 77030 USA	Baylor College of Medicine	Guntupalli, K (corresponding author), Baylor Coll Med, 6620 Main St, Houston, TX 77030 USA.	kkg@bcm.edu						ADRENAL, ADJUNCTIVE CORT TREA; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Checkley W, 2008, AM J RESP CRIT CARE, V177, P1215, DOI 10.1164/rccm.200709-1424OC; Criner GJ, 2015, CHEST, V147, P894, DOI 10.1378/chest.14-1676; ESCAPe, EXT STER CAP E CLIN; Fiore MC, 2008, TREATING TOBACCO USE; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; McMillan A, 2014, LANCET RESP MED, V2, P804, DOI 10.1016/S2213-2600(14)70172-9; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Sforza Emilia, 2012, Front Neurol, V3, P87, DOI 10.3389/fneur.2012.00087; Singh Sonal, 2010, Int J Chron Obstruct Pulmon Dis, V5, P189; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Wewers ME, 2003, PREV MED, V36, P710, DOI 10.1016/S0091-7435(03)00044-6	16	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W55	W60		10.7326/M16-0225	http://dx.doi.org/10.7326/M16-0225			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136233				2022-12-28	WOS:000375744000012
J	Maiti, A; Das, A				Maiti, Abhishek; Das, Avash			A man with altered mental status and metabolic acidosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Maiti, Abhishek] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Das, Avash] Beth Israel Deaconess Med Ctr, Dept Cardiol, Boston, MA 02215 USA	University of Texas System; University of Texas Health Science Center Houston; Harvard University; Beth Israel Deaconess Medical Center	Maiti, A (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	abhishek.maiti@uth.tmc.edu							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2016	353								i2338	10.1136/bmj.i2338	http://dx.doi.org/10.1136/bmj.i2338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RW	27126444				2022-12-28	WOS:000375483900003
J	Park, CH; Lee, SY; Hwang, DS; Shin, DW; Cho, DH; Lee, KH; Kim, TW; Kim, TW; Lee, M; Kim, DS; Doherty, CM; Thornton, AW; Hill, AJ; Guiver, MD; Lee, YM				Park, Chi Hoon; Lee, So Young; Hwang, Doo Sung; Shin, Dong Won; Cho, Doo Hee; Lee, Kang Hyuck; Kim, Tae-Woo; Kim, Tae-Wuk; Lee, Mokwon; Kim, Deok-Soo; Doherty, Cara M.; Thornton, Aaron W.; Hill, Anita J.; Guiver, Michael D.; Lee, Young Moo			Nanocrack-regulated self-humidifying membranes	NATURE			English	Article							PROTON-EXCHANGE MEMBRANE; MEDIUM-TEMPERATURE; FUEL-CELLS; WATER; TRANSPORT; NANOCHANNELS; CHEMISTRY; NAFION; STATE	The regulation of water content in polymeric membranes is important in a number of applications, such as reverse electrodialysis and proton-exchange fuel-cell membranes. External thermal and water management systems add both mass and size to systems, and so intrinsic mechanisms of retaining water and maintaining ionic transport(1-3) in such membranes are particularly important for applications where small system size is important. For example, in proton-exchange membrane fuel cells, where water retention in the membrane is crucial for efficient transport of hydrated ions(1,4-7), by operating the cells at higher temperatures without external humidification, the membrane is self-humidified with water generated by electrochemical reactions(5,8). Here we report an alternative solution that does not rely on external regulation of water supply or high temperatures. Water content in hydrocarbon polymer membranes is regulated through nanometre-scale cracks ('nanocracks') in a hydrophobic surface coating. These cracks work as nanoscale valves to retard water desorption and to maintain ion conductivity in the membrane on dehumidification. Hydrocarbon fuel-cell membranes with surface nanocrack coatings operated at intermediate temperatures show improved electrochemical performance, and coated reverse-electrodialysis membranes show enhanced ionic selectivity with low bulk resistance.	[Park, Chi Hoon; Lee, So Young; Hwang, Doo Sung; Shin, Dong Won; Cho, Doo Hee; Lee, Kang Hyuck; Lee, Young Moo] Hanyang Univ, Coll Engn, Dept Energy Engn, Seoul 133791, South Korea; [Kim, Tae-Woo; Kim, Tae-Wuk] Hanyang Univ, Dept Life Sci, Coll Nat Sci, Seoul 133791, South Korea; [Lee, Mokwon; Kim, Deok-Soo] Hanyang Univ, Sch Mech Engn, Coll Engn, Seoul 133791, South Korea; [Doherty, Cara M.; Thornton, Aaron W.; Hill, Anita J.] CSIRO, Mfg Flagship, Clayton, Vic 3168, Australia; [Guiver, Michael D.] Tianjin Univ, State Key Lab Engines, Tianjin 300072, Peoples R China; [Guiver, Michael D.] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Park, Chi Hoon] Gyeongnam Natl Univ Sci & Technol, Dept Energy Engn, Jinju 660758, South Korea; [Lee, So Young] Korea Inst Sci & Technol, Fuel Cell Res Ctr, 39-1 Hawolgok Dong, Seoul 136791, South Korea; [Hwang, Doo Sung] Univ Illinois, Dept Chem Engn, Chicago, IL 60607 USA; [Shin, Dong Won] Korea Inst Energy Res, Fuel Cell Lab, Daejeon 34129, South Korea	Hanyang University; Hanyang University; Hanyang University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tianjin University; Gyeongnam National University of Science and Technology; Korea Institute of Science & Technology (KIST); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Korea Institute of Energy Research (KIER)	Lee, YM (corresponding author), Hanyang Univ, Coll Engn, Dept Energy Engn, Seoul 133791, South Korea.; Guiver, MD (corresponding author), Tianjin Univ, State Key Lab Engines, Tianjin 300072, Peoples R China.; Guiver, MD (corresponding author), Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.	guiver@tju.edu.cn; ymlee@hanyang.ac.kr	Hill, Anita J/B-9231-2011; Thornton, Aaron/A-6675-2011; Doherty, Cara M/B-8081-2014; Kim, Deok-Soo/K-8661-2015; Lee, Young Moo/G-5920-2015; Doherty, Cara/AAY-1334-2020; Guiver, Michael/I-3248-2016	Hill, Anita J/0000-0003-1574-243X; Doherty, Cara M/0000-0003-3407-2873; Lee, Young Moo/0000-0002-5047-3143; Doherty, Cara/0000-0003-3407-2873; Guiver, Michael/0000-0003-2619-6809; Thornton, Aaron/0000-0002-7959-1397	Nano-Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M3A7B4049745]; Australian Research Council [DE40101359]; CSIRO Julius Career award; CSIRO Office of the Chief Executive Science Leader Scheme; Australia-Korea Foundation Early Career Researchers Program	Nano-Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Australian Research Council(Australian Research Council); CSIRO Julius Career award; CSIRO Office of the Chief Executive Science Leader Scheme; Australia-Korea Foundation Early Career Researchers Program	This research was supported by the Nano-Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012M3A7B4049745). C.M.D. is supported by the Australian Research Council (DE40101359). C.M.D., A.W.T. and A.J.H. acknowledge the CSIRO Julius Career award, the CSIRO Office of the Chief Executive Science Leader Scheme and the Australia-Korea Foundation Early Career Researchers Program. M.D.G. is a BK21-Plus visiting professor at Hanyang University.	Appleby AJ, 1989, FUEL CELL HDB; Bonnar MP, 1999, CHEM VAPOR DEPOS, V5, P117, DOI 10.1002/(SICI)1521-3862(199906)5:3<117::AID-CVDE117>3.0.CO;2-4; Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l; Chen YB, 2010, NAT CHEM, V2, P503, DOI [10.1038/NCHEM.629, 10.1038/nchem.629]; Denes FS, 2004, PROG POLYM SCI, V29, P815, DOI 10.1016/j.progpolymsci.2004.05.001; Fan YF, 2013, J MEMBRANE SCI, V430, P106, DOI 10.1016/j.memsci.2012.11.069; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Huang YH, 2012, J MEMBRANE SCI, V417, P201, DOI 10.1016/j.memsci.2012.06.036; Hwang DS, 2011, INT J HYDROGEN ENERG, V36, P9876, DOI 10.1016/j.ijhydene.2011.05.073; Kansy J, 1996, NUCL INSTRUM METH A, V374, P235, DOI 10.1016/0168-9002(96)00075-7; Kim JK, 2014, J COMPUT DES ENG, V1, P79, DOI 10.7315/JCDE.2014.008; Kim YS, 2003, MACROMOLECULES, V36, P6281, DOI 10.1021/ma0301451; Kreuer KD, 2004, CHEM REV, V104, P4637, DOI 10.1021/cr020715f; Kreuer KD, 2013, ADV FUNCT MATER, V23, P5390, DOI 10.1002/adfm.201300376; Lee SY, 2013, ELECTROCHEM COMMUN, V31, P120, DOI 10.1016/j.elecom.2013.03.018; Lee SY, 2012, ENERG ENVIRON SCI, V5, P9795, DOI 10.1039/c2ee21992a; Li QF, 2009, PROG POLYM SCI, V34, P449, DOI 10.1016/j.progpolymsci.2008.12.003; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Moghaddam S, 2010, NAT NANOTECHNOL, V5, P230, DOI [10.1038/nnano.2010.13, 10.1038/NNANO.2010.13]; Park CH, 2011, PROG POLYM SCI, V36, P1443, DOI 10.1016/j.progpolymsci.2011.06.001; Park CH, 2010, J PHYS CHEM B, V114, P12036, DOI 10.1021/jp105708m; Schmidt-Rohr K, 2008, NAT MATER, V7, P75, DOI 10.1038/nmat2074; Service RF, 2004, SCIENCE, V303, P29, DOI 10.1126/science.303.5654.29; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003; Zhang SS, 2009, J POWER SOURCES, V194, P588, DOI 10.1016/j.jpowsour.2009.06.073	26	285	290	38	650	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					480	+		10.1038/nature17634	http://dx.doi.org/10.1038/nature17634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121841				2022-12-28	WOS:000374815900042
J	Gulland, A				Gulland, Anne			Quentin Young Doctor and activist OBITUARIES	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												annecgulland@yahoo.co.uk						YOUNG QD, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i2393	10.1136/bmj.i2393	http://dx.doi.org/10.1136/bmj.i2393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27121211				2022-12-28	WOS:000375483300009
J	Kiberstis, PA				Kiberstis, Paula A.			METASTASIS AN EVOLVING STORY	SCIENCE			English	Editorial Material																			0	15	18	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					163	163		10.1126/science.352.6282.162	http://dx.doi.org/10.1126/science.352.6282.162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124447				2022-12-28	WOS:000373681600032
J	Paluck, EL				Paluck, Elizabeth Levy			How to overcome prejudice	SCIENCE			English	Editorial Material									[Paluck, Elizabeth Levy] Princeton Univ, Dept Psychol & Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Paluck, EL (corresponding author), Princeton Univ, Dept Psychol & Publ & Int Affairs, Princeton, NJ 08544 USA.	epaluck@princeton.edu						BLANCHARD FA, 1991, PSYCHOL SCI, V2, P101, DOI 10.1111/j.1467-9280.1991.tb00108.x; Broockman D, 2016, SCIENCE, V352, P220, DOI 10.1126/science.aad9713; Gerber AS, 2011, AM POLIT SCI REV, V105, P135, DOI 10.1017/S000305541000047X; Green DP, 1998, AM J SOCIOL, V104, P372, DOI 10.1086/210042; Johnson, 1989, COOPERATION COMPETIT; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Small ML, 2013, SOC NETWORKS, V35, P470, DOI 10.1016/j.socnet.2013.05.004; Wilson TD, 2006, SCIENCE, V313, P1251, DOI 10.1126/science.1133017	10	27	27	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					147	147		10.1126/science.aaf5207	http://dx.doi.org/10.1126/science.aaf5207			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI7LM	27124440				2022-12-28	WOS:000373681600023
J	Cao, N; Huang, Y; Zheng, JS; Spencer, CI; Zhang, Y; Fu, JD; Nie, BM; Xie, M; Zhang, ML; Wang, HX; Ma, TH; Xu, T; Shi, GL; Srivastava, D; Ding, S				Cao, Nan; Huang, Yu; Zheng, Jiashun; Spencer, C. Ian; Zhang, Yu; Fu, Ji-Dong; Nie, Baoming; Xie, Min; Zhang, Mingliang; Wang, Haixia; Ma, Tianhua; Xu, Tao; Shi, Guilai; Srivastava, Deepak; Ding, Sheng			Conversion of human fibroblasts into functional cardiomyocytes by small molecules	SCIENCE			English	Article							PLURIPOTENT STEM-CELLS; CARDIAC DIFFERENTIATION; MOUSE FIBROBLASTS; DEFINED FACTORS; INDUCTION; MYOCYTES; LINES	Reprogramming somatic fibroblasts into alternative lineages would provide a promising source of cells for regenerative therapy. However, transdifferentiating human cells into specific homogeneous, functional cell types is challenging. Here we show that cardiomyocyte-like cells can be generated by treating human fibroblasts with a combination of nine compounds that we term 9C. The chemically induced cardiomyocyte-like cells uniformly contracted and resembled human cardiomyocytes in their transcriptome, epigenetic, and electrophysiological properties. 9C treatment of human fibroblasts resulted in a more open-chromatin conformation at key heart developmental genes, enabling their promoters and enhancers to bind effectors of major cardiogenic signals. When transplanted into infarcted mouse hearts, 9C-treated fibroblasts were efficiently converted to chemically induced cardiomyocyte-like cells. This pharmacological approach to lineage-specific reprogramming may have many important therapeutic implications after further optimization to generate mature cardiac cells.	[Cao, Nan; Huang, Yu; Spencer, C. Ian; Zhang, Yu; Nie, Baoming; Xie, Min; Zhang, Mingliang; Wang, Haixia; Ma, Tianhua; Xu, Tao; Shi, Guilai; Srivastava, Deepak; Ding, Sheng] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Cao, Nan; Zhang, Yu; Nie, Baoming; Xie, Min; Zhang, Mingliang; Wang, Haixia; Ma, Tianhua; Xu, Tao; Shi, Guilai; Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Zheng, Jiashun; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zheng, Jiashun] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Fu, Ji-Dong] Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University	Ding, S (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.; Ding, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu	Xu, Tao/I-1561-2014; Zhang, Yu/F-6583-2016; Nie, Baoming/H-4316-2012	Xu, Tao/0000-0002-3436-3024; Nie, Baoming/0000-0002-8343-0262; Fu, Jidong/0000-0003-2797-5193; Xu, Tao/0000-0002-4085-6191; Zhang, Yu/0000-0001-5512-9272	California Institute for Regenerative Medicine (CIRM); American Heart Association; CIRM; National Heart, Lung, and Blood Institute; National Institutes of Health; Roddenberry Foundation; Younger Family Foundation; Whittier Foundation	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); American Heart Association(American Heart Association); CIRM(California Institute for Regenerative Medicine); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roddenberry Foundation; Younger Family Foundation; Whittier Foundation	N.C. is supported by the California Institute for Regenerative Medicine (CIRM). J.-D.F. is supported by the American Heart Association. S.D. and D.S. are supported by the CIRM, the National Heart, Lung, and Blood Institute, the National Institutes of Health, and the Roddenberry Foundation. D.S. is supported by the Younger Family Foundation and the Whittier Foundation. Data associated with this manuscript are available in the Gene Expression Omnibus (accession numbers GSE55820 and GSE78096). N.C. and S.D. are inventors on patent applications filed by the Gladstone Institute of Cardiovascular Disease that are related to the chemical reprogramming method reported in this paper.	Azad GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059003; Birket MJ, 2015, NAT BIOTECHNOL, V33, P970, DOI 10.1038/nbt.3271; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Jayawardena TM, 2015, CIRC RES, V116, P418, DOI 10.1161/CIRCRESAHA.116.304510; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Pogribny IP, 2013, INT J ONCOL, V42, P1822, DOI 10.3892/ijo.2013.1855; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2015, CURR OPIN GENET DEV, V34, P77, DOI 10.1016/j.gde.2015.09.004; Synnergren J, 2012, PHYSIOL GENOMICS, V44, P245, DOI 10.1152/physiolgenomics.00118.2011; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	24	230	249	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1216	1220		10.1126/science.aaf1502	http://dx.doi.org/10.1126/science.aaf1502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27127239				2022-12-28	WOS:000377045700042
J	Dovrat, D; Aharoni, A				Dovrat, Daniel; Aharoni, Amir			BIOENGINEERING Evolved to overcome Bt-toxin resistance	NATURE			English	Editorial Material							EVOLUTION		[Dovrat, Daniel; Aharoni, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Dovrat, Daniel; Aharoni, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Aharoni, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.; Aharoni, A (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	aaharoni@bgu.ac.il		Aharoni, Amir/0000-0003-2701-6996; Dovrat, Daniel/0000-0002-0613-7679				Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2016, TRENDS BIOTECHNOL, V34, P291, DOI 10.1016/j.tibtech.2015.12.011; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597	9	1	2	1	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					39	40		10.1038/nature17893	http://dx.doi.org/10.1038/nature17893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120166				2022-12-28	WOS:000375473900031
J	Aune, D; Sen, A; Prasad, M; Norat, T; Janszky, I; Tonstad, S; Romundstad, P; Vatten, LJ				Aune, Dagfinn; Sen, Abhijit; Prasad, Manya; Norat, Teresa; Janszky, Imre; Tonstad, Serena; Romundstad, Pal; Vatten, Lars J.			BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BODY-MASS INDEX; CORONARY-HEART-DISEASE; LONG-TERM MORTALITY; CROSS-SECTIONAL SURVEYS; BEHAVIORAL RISK-FACTORS; SELF-REPORTED HEIGHT; MIDDLE-AGED MEN; WAIST-HIP RATIO; FOLLOW-UP; CARDIOVASCULAR-DISEASE	OBJECTIVE To conduct a systematic review and meta-analysis of cohort studies of body mass index (BMI) and the risk of all cause mortality, and to clarify the shape and the nadir of the dose-response curve, and the influence on the results of confounding from smoking, weight loss associated with disease, and preclinical disease. DATA SOURCES PubMed and Embase databases searched up to 23 September 2015. STUDY SELECTION Cohort studies that reported adjusted risk estimates for at least three categories of BMI in relation to all cause mortality. DATA SYNTHESIS Summary relative risks were calculated with random effects models. Non-linear associations were explored with fractional polynomial models. RESULTS 230 cohort studies (207 publications) were included. The analysis of never smokers included 53 cohort studies (44 risk estimates) with >738 144 deaths and >9 976 077 participants. The analysis of all participants included 228 cohort studies (198 risk estimates) with >3 744 722 deaths among 30 233 329 participants. The summary relative risk for a 5 unit increment in BMI was 1.18 (95% confidence interval 1.15 to 1.21; I-2=95%, n=44) among never smokers, 1.21 (1.18 to 1.25; I-2=93%, n=25) among healthy never smokers, 1.27 (1.21 to 1.33; I-2=89%, n=11) among healthy never smokers with exclusion of early follow-up, and 1.05 (1.04 to 1.07; I-2=97%, n=198) among all participants. There was a J shaped dose-response relation in never smokers (Pnon-linearity < 0.001), and the lowest risk was observed at BMI 23-24 in never smokers, 22-23 in healthy never smokers, and 20-22 in studies of never smokers with >= 20 years' follow-up. In contrast there was a U shaped association between BMI and mortality in analyses with a greater potential for bias including all participants, current, former, or ever smokers, and in studies with a short duration of follow-up (<5 years or <10 years), or with moderate study quality scores. CONCLUSION Overweight and obesity is associated with increased risk of all cause mortality and the nadir of the curve was observed at BMI 23-24 among never smokers, 22-23 among healthy never smokers, and 20-22 with longer durations of follow-up. The increased risk of mortality observed in underweight people could at least partly be caused by residual confounding from prediagnostic disease. Lack of exclusion of ever smokers, people with prevalent and preclinical disease, and early follow-up could bias the results towards a more U shaped association.	[Aune, Dagfinn; Sen, Abhijit; Janszky, Imre; Romundstad, Pal; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Fac Med, N-7034 Trondheim, Norway; [Aune, Dagfinn; Norat, Teresa] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Prasad, Manya; Tonstad, Serena] Postgrad Inst Med Sci, Dept Community Med, Rohtak, Haryana, India; Univ Oslo, Ulleval Hosp, Sect Prevent Cardiol, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway	Norwegian University of Science & Technology (NTNU); Imperial College London; University of Oslo	Aune, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England.	d.aune@imperial.ac.uk	Prasad, Manya/AAQ-6436-2021; Sen, Abhijit/AAD-6009-2022; Vatten, Lars/AFK-2073-2022; Vatten, Lars/AAF-9380-2022	Sen, Abhijit/0000-0001-9560-4226; Aune, Dagfinn/0000-0002-4533-1722	liaison committee; Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)	liaison committee; Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)	This project was funded by the liaison committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), and Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre (BRC). The funders had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Atlantis E, 2010, AGE AGEING, V39, P643, DOI 10.1093/ageing/afq073; Aune D, 2015, ANN ONCOL, V26, P1635, DOI 10.1093/annonc/mdv142; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Aune D, 2015, EUR J EPIDEMIOL, V30, P1009, DOI 10.1007/s10654-015-0081-y; Aune D, 2015, INT J CANCER, V136, P1888, DOI 10.1002/ijc.29207; Aune D, 2014, EUR J NUTR, V53, P1591, DOI 10.1007/s00394-014-0766-0; Bagnardi V, 2004, AM J EPIDEMIOL, V159, P1077, DOI 10.1093/aje/kwh142; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Baldinger Beatrice, 2006, J Insur Med, V38, P44; Barbagallo CM, 2001, INT J OBESITY, V25, P185, DOI 10.1038/sj.ijo.0801321; BarrettConnor E, 1996, J AM GERIATR SOC, V44, P1147, DOI 10.1111/j.1532-5415.1996.tb01362.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behrens G, 2014, CAN MED ASSOC J, V186, pE457, DOI 10.1503/cmaj.140025; Beleigoli AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052111; Bellocco R, 2010, EUR J EPIDEMIOL, V25, P777, DOI 10.1007/s10654-010-9497-6; Berraho M, 2010, J AGING HEALTH, V22, P68, DOI 10.1177/0898264309349422; Bes-Rastrollo M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-213; Bessonova L, 2011, INT J CANCER, V129, P2492, DOI 10.1002/ijc.25905; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Burman M, 2015, J NUTR HEALTH AGING, V19, P461, DOI 10.1007/s12603-015-0443-x; Buys DR, 2014, J GERONTOL A-BIOL, V69, P1146, DOI 10.1093/gerona/glu024; Byers T, 2006, NEW ENGL J MED, V355, P758, DOI 10.1056/NEJMp068156; Byun W, 2010, MED SCI SPORT EXER, V42, P1632, DOI 10.1249/MSS.0b013e3181d43f29; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2007, BRIT MED J, V335, P1107, DOI 10.1136/bmj.39384.472072.80; Campbell PT, 2012, DIABETES CARE, V35, P1835, DOI 10.2337/dc12-0002; Campbell PT, 2012, J CLIN ONCOL, V30, P42, DOI 10.1200/JCO.2011.38.0287; Cao BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129946; Carlsson S, 2011, EPIDEMIOLOGY, V22, P98, DOI 10.1097/EDE.0b013e3181fce2a2; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Chang-Claude J, 2005, CANCER EPIDEM BIOMAR, V14, P963, DOI 10.1158/1055-9965.EPI-04-0696; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; Chen ZM, 2012, INT J EPIDEMIOL, V41, P472, DOI 10.1093/ije/dyr208; Choi KM, 2013, CLIN ENDOCRINOL, V79, P364, DOI 10.1111/cen.12154; Chung WS, 2015, PUBLIC HEALTH NUTR, V18, P1839, DOI 10.1017/S136898001400281X; Chyou PH, 1997, ANN EPIDEMIOL, V7, P311, DOI 10.1016/S1047-2797(97)00019-7; Claessen H, 2012, EUR J EPIDEMIOL, V27, P215, DOI 10.1007/s10654-012-9669-7; Clark DO, 2014, J GERONTOL A-BIOL, V69, P1162, DOI 10.1093/gerona/glu035; Cohen SS, 2012, AM J EPIDEMIOL, V176, P431, DOI 10.1093/aje/kws032; Cohen-Mansfield Jiska, 2011, J Aging Res, V2011, P765071, DOI 10.4061/2011/765071; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Dahl AK, 2013, J AM GERIATR SOC, V61, P512, DOI 10.1111/jgs.12158; Dankner R, 2015, DIABETES-METAB RES, V31, P530, DOI 10.1002/dmrr.2642; Davey Smith George, 2009, BMJ, V339, pb5043, DOI 10.1136/bmj.b5043; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Hollander EL, 2012, J NUTR HEALTH AGING, V16, P100, DOI 10.1007/s12603-011-0077-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; Dobson A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-669; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engeland A, 2003, EPIDEMIOLOGY, V14, P293, DOI 10.1097/00001648-200305000-00008; Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58; Ferrie JE, 2009, HEART, V95, P1250, DOI 10.1136/hrt.2008.164251; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Fontaine KR, 2012, INT J OBESITY, V36, P1121, DOI 10.1038/ijo.2011.194; Ford Dara W., 2014, Journal of Nutrition in Gerontology and Geriatrics, V33, P23, DOI 10.1080/21551197.2014.875819; Fortes C, 2000, EPIDEMIOLOGY, V11, P440, DOI 10.1097/00001648-200007000-00013; Freedman DM, 2006, AM J PREV MED, V31, P355, DOI 10.1016/j.amepre.2006.07.022; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Fujino Y, 2007, ASIAN PAC J CANCER P, V8, P105; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Gao SJ, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-9; Gaudet MM, 2015, INT J EPIDEMIOL, V44, P673, DOI 10.1093/ije/dyv059; Gelber RP, 2007, INT J OBESITY, V31, P1240, DOI 10.1038/sj.ijo.0803564; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Graf CE, 2015, AM J CLIN NUTR, V101, P760, DOI 10.3945/ajcn.114.102566; Greenberg JA, 2007, INT J OBESITY, V31, P1449, DOI 10.1038/sj.ijo.0803615; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Guallar-Castillon P, 2009, OBESITY, V17, P2232, DOI 10.1038/oby.2009.115; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Gulsvik AK, 2009, EUR J EPIDEMIOL, V24, P683, DOI 10.1007/s10654-009-9390-3; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; Hara M, 2000, Environ Health Prev Med, V5, P90, DOI 10.1265/ehpm.2000.90; Hart CL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3785; Hayashi R, 2005, J EPIDEMIOL, V15, P70, DOI 10.2188/jea.15.70; He Y, 2014, DIABETES CARE, V37, P2540, DOI 10.2337/dc14-0243; Heir T, 2011, PREV MED, V52, P223, DOI 10.1016/j.ypmed.2011.01.010; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Hirani V, 2014, AGE, V36, DOI 10.1007/s11357-014-9732-2; Hjartaker A, 2005, EUR J EPIDEMIOL, V20, P747, DOI 10.1007/s10654-005-2145-x; HO SC, 1991, AM J EPIDEMIOL, V133, P907, DOI 10.1093/oxfordjournals.aje.a115970; Hodge AM, 1996, AM J EPIDEMIOL, V143, P442, DOI 10.1093/oxfordjournals.aje.a008764; Hong ES, 2015, OBESITY, V23, P220, DOI 10.1002/oby.20914; Hong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117731; Hosegood V, 2003, AM J CLIN NUTR, V77, P341, DOI 10.1093/ajcn/77.2.341; Hotchkiss JW, 2013, INT J OBESITY, V37, P732, DOI 10.1038/ijo.2012.102; Hotchkiss JW, 2011, INT J OBESITY, V35, P838, DOI 10.1038/ijo.2010.207; Hozawa A, 2008, OBESITY, V16, P1714, DOI 10.1038/oby.2008.237; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; Hwang LC, 2011, J FORMOS MED ASSOC, V110, P290, DOI 10.1016/S0929-6646(11)60044-2; Iribarren C, 2005, SOC SCI MED, V60, P471, DOI 10.1016/j.socscimed.2004.06.007; Iversen L, 2010, BRIT J GEN PRACT, V60, P563, DOI 10.3399/bjgp10X515052; Jain MG, 2005, INT J OBESITY, V29, P792, DOI 10.1038/sj.ijo.0802952; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jerant A, 2012, J AM BOARD FAM MED, V25, P422, DOI 10.3122/jabfm.2012.04.110289; JOHANSEN H, 1987, CAN MED ASSOC J, V136, P823; Joshy G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088641; Kamat P, 2009, ANN THORAC SURG, V87, P655, DOI 10.1016/j.athoracsur.2008.08.003; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147, DOI 10.1007/BF03404221; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; KJELSBERG MO, 1986, PREV MED, V15, P254; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Kokkinos P, 2014, MAYO CLIN PROC, V89, P754, DOI 10.1016/j.mayocp.2014.01.029; Korkeila M, 2009, OBESITY FACTS, V2, P344, DOI 10.1159/000261416; KORNITZER M, 1993, CARDIOLOGY, V82, P153, DOI 10.1159/000175865; Kulminski AM, 2008, J AM GERIATR SOC, V56, P105, DOI 10.1111/j.1532-5415.2007.01494.x; Kumar A, 2015, SALUD PUBLICA MEXICO, V57, pS31; Kuriyama S, 2004, J EPIDEMIOL, V14, pS33, DOI 10.2188/jea.14.S33; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Lee DH, 2011, J EPIDEMIOL, V21, P30, DOI 10.2188/jea.JE20100058; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Lee Y, 2014, GERONTOLOGY, V60, P475, DOI 10.1159/000362330; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Lindsted KD, 1997, AM J EPIDEMIOL, V146, P1, DOI 10.1093/oxfordjournals.aje.a009185; Lindsted KD, 1998, INT J OBESITY, V22, P544, DOI 10.1038/sj.ijo.0800623; Lisko I, 2011, J GERONTOL A-BIOL, V66, P1244, DOI 10.1093/gerona/glr147; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Locher JL, 2007, J GERONTOL A-BIOL, V62, P1389, DOI 10.1093/gerona/62.12.1389; Long G, 2015, EUR J EPIDEMIOL, V30, P71, DOI 10.1007/s10654-014-9965-5; Lu JL, 2015, LANCET DIABETES ENDO, V3, P704, DOI 10.1016/S2213-8587(15)00128-X; Lubin F, 2003, J NUTR, V133, P1180, DOI 10.1093/jn/133.4.1180; Luchsinger JA, 2008, J NUTR HEALTH AGING, V12, P127, DOI 10.1007/BF02982565; Ma JM, 2013, PREV MED, V56, P178, DOI 10.1016/j.ypmed.2012.12.012; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Maralani HG, 2014, DIABETES RES CLIN PR, V103, P42, DOI 10.1016/j.diabres.2013.11.025; Maru S, 2004, AM J CLIN NUTR, V80, P231; Maskarinec G, 1998, EPIDEMIOLOGY, V9, P654, DOI 10.1097/00001648-199811000-00016; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; Matsuo T, 2008, OBESITY, V16, P2348, DOI 10.1038/oby.2008.342; Mazza A, 2007, GERONTOLOGY, V53, P36, DOI 10.1159/000095783; McTigue KM, 2014, OBESITY, V22, P801, DOI 10.1002/oby.20224; Mehta NK, 2014, EPIDEMIOLOGY, V25, P707, DOI 10.1097/EDE.0000000000000147; Mehta NK, 2011, POPUL DEV REV, V37, P435, DOI 10.1111/j.1728-4457.2011.00429.x; Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x; Mirbolouk M, 2015, GERIATR GERONTOL INT, V15, P449, DOI 10.1111/ggi.12295; Miyazaki Motonobu, 2002, J Epidemiol, V12, P40; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; Nakade M, 2015, PREV MED, V77, P112, DOI 10.1016/j.ypmed.2015.05.015; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niedhammer I, 2011, EUR J EPIDEMIOL, V26, P1, DOI 10.1007/s10654-010-9506-9; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Niverthi M, 2001, J Insur Med, V33, P321; NORRISH A, 1995, INT J EPIDEMIOL, V24, P908, DOI 10.1093/ije/24.5.908; Nyholm M, 2005, SCAND J PUBLIC HEALT, V33, P478, DOI 10.1080/14034940510006102; Odegaard AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014000; Okabayashi K, 2012, AM J GASTROENTEROL, V107, P1175, DOI 10.1038/ajg.2012.180; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Orsini N, 2008, J INTERN MED, V264, P442, DOI 10.1111/j.1365-2796.2008.01985.x; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Ostbye T, 1999, J AM GERIATR SOC, V47, P1249, DOI 10.1111/j.1532-5415.1999.tb05207.x; Pajak A, 2005, KARDIOL POL, V62, P106; Pajak Andrzej, 2005, Kardiol Pol, V62, P95; Pan WH, 2012, ASIA PAC J CLIN NUTR, V21, P577; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Park Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050091; Patel AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109153; Patterson RE, 2004, AM J PREV MED, V27, P385, DOI 10.1016/j.amepre.2004.08.001; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Pednekar MS, 2008, AM J EPIDEMIOL, V167, P330, DOI 10.1093/aje/kwm293; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ponce-Garcia Isabel, 2015, PLoS One, V10, pe0127369, DOI 10.1371/journal.pone.0127369; Price GM, 2006, AM J CLIN NUTR, V84, P449; Puddu PE, 2011, EUR J EPIDEMIOL, V26, P595, DOI 10.1007/s10654-011-9600-7; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reeves GK, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-45; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reuser M, 2009, OBESITY, V17, P783, DOI 10.1038/oby.2008.640; Rhee Chul Woo, 2012, J Prev Med Public Health, V45, P14, DOI 10.3961/jpmph.2012.45.1.14; RISSANEN A, 1989, J CLIN EPIDEMIOL, V42, P781, DOI 10.1016/0895-4356(89)90076-0; RISSANEN A, 1991, J CLIN EPIDEMIOL, V44, P787, DOI 10.1016/0895-4356(91)90131-R; Roh L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-371; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Rumpel C, 1993, Ann Epidemiol, V3, P343, DOI 10.1016/1047-2797(93)90060-H; Sai XY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-290; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Schmidt M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002698; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Seccareccia F, 1998, J EPIDEMIOL COMMUN H, V52, P20, DOI 10.1136/jech.52.1.20; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Singh PN, 1999, AM J EPIDEMIOL, V150, P1152, DOI 10.1093/oxfordjournals.aje.a009942; Singh PN, 2014, J GERONTOL A-BIOL, V69, P63, DOI 10.1093/gerona/glt049; Smith TC, 2007, J CLIN EPIDEMIOL, V60, P309, DOI 10.1016/j.jclinepi.2006.06.013; Somes GW, 2002, AM J EPIDEMIOL, V156, P132, DOI 10.1093/aje/kwf019; SORKIN JD, 1994, INT J OBESITY, V18, P752; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stenholm S, 2014, INT J OBESITY, V38, P1126, DOI 10.1038/ijo.2013.214; Stessman J, 2009, J AM GERIATR SOC, V57, P2232, DOI 10.1111/j.1532-5415.2009.02567.x; Stevens J, 2004, INT J OBESITY, V28, P1463, DOI 10.1038/sj.ijo.0802770; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Stevens J, 2001, AM J EPIDEMIOL, V153, P946, DOI 10.1093/aje/153.10.946; Stevens J, 2000, J AM DIET ASSOC, V100, P825, DOI 10.1016/S0002-8223(00)00238-8; Strand BH, 2012, J EPIDEMIOL COMMUN H, V66, P225, DOI 10.1136/jech.2010.110155; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suemoto CK, 2015, J GERONTOL A-BIOL, V70, P503, DOI 10.1093/gerona/glu165; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Sundquist K, 2004, AM J PREV MED, V27, P22, DOI 10.1016/j.amepre.2004.03.011; Takata Y, 2013, ARCH GERONTOL GERIAT, V57, P46, DOI 10.1016/j.archger.2013.02.006; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; Tice JA, 2006, ARCH INTERN MED, V166, P2469, DOI 10.1001/archinte.166.22.2469; Tognon G, 2011, AGE, V33, P439, DOI 10.1007/s11357-010-9193-1; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V55, P217, DOI 10.1016/j.archger.2011.08.006; Tsai SP, 2008, DIABETES RES CLIN PR, V82, P148, DOI 10.1016/j.diabres.2008.07.016; Tsai SP, 2006, J OCCUP ENVIRON MED, V48, P22, DOI 10.1097/01.jom.0000184866.49000.e5; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Vapattanawong P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-604; Vessey M, 2010, CONTRACEPTION, V82, P221, DOI 10.1016/j.contraception.2010.04.006; Zunzunegui MV, 2012, J AGING HEALTH, V24, P29, DOI 10.1177/0898264311408419; Visscher TLS, 2000, AM J EPIDEMIOL, V151, P660, DOI 10.1093/oxfordjournals.aje.a010260; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Wandell PE, 2009, INT J OBESITY, V33, P577, DOI 10.1038/ijo.2009.36; Wang ZQ, 2002, AUST NZ J PUBL HEAL, V26, P305, DOI 10.1111/j.1467-842X.2002.tb00176.x; Wannamethee SG, 2001, INT J EPIDEMIOL, V30, P777, DOI 10.1093/ije/30.4.777; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003; Weitoft GR, 2008, SCAND J PUBLIC HEALT, V36, P169, DOI 10.1177/1403494807085080; Wells G.A., 2009, NEWCASTLE OTTAWA SCA; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett K, 2006, OBESITY, V14, P480, DOI 10.1038/oby.2006.63; Willett WC, 2013, JAMA-J AM MED ASSOC, V309, P1681, DOI 10.1001/jama.2013.3075; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Winslow UC, 2015, INT J EPIDEMIOL, V44, P540, DOI 10.1093/ije/dyu276; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]; Xiao Q, 2014, OBESITY, V22, P260, DOI 10.1002/oby.20412; Yang L, 2010, INT J EPIDEMIOL, V39, P1027, DOI 10.1093/ije/dyq051; Yano Y, 2013, DIABETES CARE, V36, P1186, DOI 10.2337/dc12-1736; Yi SW, 2015, INT J EPIDEMIOL, V44, P1696, DOI 10.1093/ije/dyv138; Yiengprugsawan V, 2014, J OBES, V2014, DOI 10.1155/2014/708606; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	268	381	393	3	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353								i2156	10.1136/bmj.i2156	http://dx.doi.org/10.1136/bmj.i2156			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL4AR	27146380	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000375575500001
J	Song, MY; Hu, FB; Wu, KN; Must, A; Chan, AT; Willett, WC; Giovannucci, EL				Song, Mingyang; Hu, Frank B.; Wu, Kana; Must, Aviva; Chan, Andrew T.; Willett, Walter C.; Giovannucci, Edward L.			Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOMETABOLIC RISK-FACTORS; MASS INDEX; FOLLOW-UP; WEIGHT-GAIN; DIABETES-MELLITUS; COLORECTAL-CANCER; CHILDHOOD OBESITY; YOUNG ADULTHOOD; PREMATURE DEATH; NURSES HEALTH	OBJECTIVE To assess body shape trajectories in early and middle life in relation to risk of mortality. DESIGN Prospective cohort study. SETTING Nurses' Health Study and Health Professionals Follow-up Study. POPULATION 80 266 women and 36 622 men who recalled their body shape at ages 5, 10, 20, 30, and 40 years and provided body mass index at age 50, followed from age 60 over a median of 15-16 years for death. MAIN OUTCOME MEASURES All cause and cause specific mortality. RESULTS Using a group based modeling approach, five distinct trajectories of body shape from age 5 to 50 were identified: lean-stable, lean-moderate increase, lean-marked increase, medium-stable/increase, and heavy-stable/increase. The lean-stable group was used as the reference. Among never smokers, the multivariable adjusted hazard ratio for death from any cause was 1.08 (95% confidence interval 1.02 to 1.14) for women and 0.95 (0.88 to 1.03) for men in the lean-moderate increase group, 1.43 (1.33 to 1.54) for women and 1.11 (1.02 to 1.20) for men in the lean-marked increase group, 1.04 (0.97 to 1.12) for women and 1.01 (0.94 to 1.09) for men in the medium-stable/increase group, and 1.64 (1.49 to 1.81) for women and 1.19 (1.08 to 1.32) for men in the heavy-stable/increase group. For cause specific mortality, participants in the heavy-stable/increase group had the highest risk, with a hazard ratio among never smokers of 2.30 (1.88 to 2.81) in women and 1.45 (1.23 to 1.72) in men for cardiovascular disease, 1.37 (1.14 to 1.65) in women and 1.07 (0.89 to 1.30) in men for cancer, and 1.59 (1.38 to 1.82) in women and 1.10 (0.95 to 1.29) in men for other causes. The trajectory-mortality association was generally weaker among ever smokers than among never smokers (for all cause mortality: P for interaction <0.001 in women and 0.06 in men). When participants were classified jointly according to trajectories and history of type 2 diabetes, the increased risk of death associated with heavier body shape trajectories was more pronounced among participants with type 2 diabetes than those without diabetes, and those in the heavy-stable/increase trajectory and with a history of diabetes had the highest risk of death. CONCLUSIONS Using the trajectory approach, we found that heavy body shape from age 5 up to 50, especially the increase in middle life, was associated with higher mortality. In contrast, people who maintained a stably lean body shape had the lowest mortality. These results indicate the importance of weight management across the lifespan.	[Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Song, Mingyang; Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Song, Mingyang; Hu, Frank B.; Wu, Kana; Willett, Walter C.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Song, Mingyang; Hu, Frank B.; Wu, Kana; Willett, Walter C.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.; Chan, Andrew T.; Willett, Walter C.; Giovannucci, Edward L.] Harvard Univ, Sch Med, Channing Div Network Med, Dept Med, Boston, MA 02115 USA; [Must, Aviva] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts Department of Public Health; Tufts University	Song, MY (corresponding author), Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA.; Song, MY (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Song, MY (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	msong2@mgh.harvard.edu			National Institutes of Health [UM1 CA186107, P01 CA87969, UM1 CA167552, 1U54CA155626, K24 DK098311]; Boston Obesity Nutrition Research Center [DK46200]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Obesity Nutrition Research Center	This work was supported by the National Institutes of Health (UM1 CA186107, P01 CA87969, UM1 CA167552, 1U54CA155626, and K24 DK098311) and Boston Obesity Nutrition Research Center (DK46200). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; or the decision to submit the manuscript for publication.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bouchonville M, 2014, INT J OBESITY, V38, P423, DOI 10.1038/ijo.2013.122; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Mutsert R, 2014, AM J EPIDEMIOL, V179, P1353, DOI 10.1093/aje/kwu052; Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fryar CD., 2014, PREVALENCE OVERWEIGH; GARRISON RJ, 1983, JAMA-J AM MED ASSOC, V249, P2199, DOI 10.1001/jama.249.16.2199; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Hirko KA, 2015, AM J EPIDEMIOL, V182, P441, DOI 10.1093/aje/kwv084; Hsiao Chun-Ju, 2014, Natl Health Stat Report, P1; Hu F., 2008, OBESITY EPIDEMIOLOGY, DOI [10.1093/acprof:oso/9780195312911.001.0001, DOI 10.1093/ACPROF:OSO/9780195312911.001.0001]; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Keum N, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/dju428, 10.1093/jnci/djv088]; Kodama S, 2014, OBES REV, V15, P202, DOI 10.1111/obr.12129; Kritchevsky SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121993; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Ma JM, 2011, AM J EPIDEMIOL, V174, P934, DOI 10.1093/aje/kwr169; Murayama H, 2015, AM J EPIDEMIOL, V182, P597, DOI 10.1093/aje/kwv107; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; Nagin D. S, 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Ogden CL, 2010, PREVALENCE OVERWEIGH; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Song MY, 2016, INT J CANCER, V138, P2383, DOI 10.1002/ijc.29981; Song MY, 2015, CANCER PREV RES, V8, P620, DOI 10.1158/1940-6207.CAPR-15-0061; Stenholm S, 2015, EPIDEMIOLOGY, V26, P165, DOI 10.1097/EDE.0000000000000228; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Tian J, 2015, OBES REV, V16, P883, DOI 10.1111/obr.12304; Tobias DK, 2013, OBESITY, V21, P1746, DOI 10.1002/oby.20602; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	53	80	81	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353								i2195	10.1136/bmj.i2195	http://dx.doi.org/10.1136/bmj.i2195			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27146280	hybrid, Green Published			2022-12-28	WOS:000375575500002
J	Mayor, S				Mayor, Susan			Short term increase in neuropsychiatric events is seen with H pylori treatment containing clarithromycin	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Wong AYS, 2016, JAMA INTERN MED, V176, P828, DOI 10.1001/jamainternmed.2016.1586	1	0	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2481	10.1136/bmj.i2481	http://dx.doi.org/10.1136/bmj.i2481			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27143325				2022-12-28	WOS:000375574000013
J	Ding, FF; O'Donnell, J; Xu, QW; Kang, N; Goldman, N; Nedergaard, M				Ding, Fengfei; O'Donnell, John; Xu, Qiwu; Kang, Ning; Goldman, Nanna; Nedergaard, Maiken			Changes in the composition of brain interstitial ions control the sleep-wake cycle	SCIENCE			English	Article							GLIAL-CELLS; MAGNESIUM; HOMEOSTASIS; WAKEFULNESS; NEURONS; CORTEX; MEMORY; MICE	Wakefulness is driven by the widespread release of neuromodulators by the ascending arousal system. Yet, it is unclear how these substances orchestrate state-dependent, global changes in neuronal activity. Here, we show that neuromodulators induce increases in the extracellular K+ concentration ([K+](e)) in cortical slices electrically silenced by tetrodotoxin. In vivo, arousal was linked to AMPA receptor-independent elevations of [K+](e) concomitant with decreases in [Ca2+](e), [Mg2+](e), [H+](e), and the extracellular volume. Opposite, natural sleep and anesthesia reduced [K+](e) while increasing [Ca2+](e), [Mg2+](e), and [H+](e) as well as the extracellular volume. Local cortical activity of sleeping mice could be readily converted to the stereotypical electroencephalography pattern of wakefulness by simply imposing a change in the extracellular ion composition. Thus, extracellular ions control the state-dependent patterns of neural activity.	[Ding, Fengfei; O'Donnell, John; Xu, Qiwu; Kang, Ning; Goldman, Nanna; Nedergaard, Maiken] Univ Rochester, Ctr Translat Neuromed, 601 Elmwood Ave, Rochester, NY 14642 USA; [Ding, Fengfei] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Nedergaard, Maiken] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark	University of Rochester; Huazhong University of Science & Technology; University of Copenhagen	Nedergaard, M (corresponding author), Univ Rochester, Ctr Translat Neuromed, 601 Elmwood Ave, Rochester, NY 14642 USA.; Nedergaard, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark.	nedergaard@urmc.rochester.edu		O'Donnell, John/0000-0002-0774-9028	NIH [NS078167, NS078304]; Office of Naval Research/Department of the Navy; Novo Nordisk Fonden [NNF13OC0004258] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078304, R01NS078167, R01NS075177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research/Department of the Navy; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH (NS078167 and NS078304) and the Office of Naval Research/Department of the Navy. We thank W. Song. R. Rasmussen, E. Nicholas, and W. Peng for expert technical assistance and C. Cirelli, G. Tononi, W. Wang, and C. Nicholson, for comments on the manuscript. All authors contributed to data collection technical design and writing.	Abbasi B, 2012, J RES MED SCI, V17, P1161; Anderova M, 2001, GLIA, V35, P189, DOI 10.1002/glia.1084; ANDERSON WW, 1986, BRAIN RES, V398, P215, DOI 10.1016/0006-8993(86)91274-6; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Seigneur J, 2006, CEREB CORTEX, V16, P655, DOI 10.1093/cercor/bhj011; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Somjen G. G., 2004, IONS BRAIN NORMAL FU; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun LY, 2009, MAGNESIUM RES, V22, P266, DOI 10.1684/mrh.2009.0186; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Torres A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002160; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	24	176	179	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					550	555		10.1126/science.aad4821	http://dx.doi.org/10.1126/science.aad4821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126038	Green Accepted			2022-12-28	WOS:000374998600037
J	Edwards, N				Edwards, Nigel			The NHS's sustainability and transformation plans: doing so much with so little There are no easy fixes for the gap in the NHS's finances	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edwards, Nigel] Nuffield Trust, London, England		Edwards, N (corresponding author), Nuffield Trust, London, England.	nigel.edwards@nuffieldtrust.org.uk						Centers for Medicare and Medicaid Services, 2015, MED ACOS PROV IMPR C; Gainsbury S., 2015, HSJ              NOV; NHS England, 2013, SUPP STRAT OP PLANN; NHS England, 2014, 5 YEAR FORW VIEW; Nuffield Trust, 2013, EV INT COMM BAS CAR	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2380	10.1136/bmj.i2380	http://dx.doi.org/10.1136/bmj.i2380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129603				2022-12-28	WOS:000375484100003
J	Pamer, EG				Pamer, Eric G.			Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens	SCIENCE			English	Review							CLOSTRIDIUM-DIFFICILE; COLONIZATION RESISTANCE; GUT MICROBIOTA; DONOR FECES; INFECTION; MICE; BACTERIOTHERAPY; SUSCEPTIBILITY; ERADICATION; SPECIFICITY	The intestinal microbiota, which is composed of diverse populations of commensal bacterial species, provides resistance against colonization and invasion by pathogens. Antibiotic treatment can damage the intestinal microbiota and, paradoxically, increase susceptibility to infections. Reestablishing microbiota-mediated colonization resistance after antibiotic treatment could markedly reduce infections, particularly those caused by antibiotic-resistant bacteria. Ongoing studies are identifying commensal bacterial species that can be developed into next-generation probiotics to reestablish or enhance colonization resistance. These live medicines are at various stages of discovery, testing, and production and are being subjected to existing regulatory gauntlets for eventual introduction into clinical practice. The development of next-generation probiotics to reestablish colonization resistance and eliminate potential pathogens from the gut is warranted and will reduce health care-associated infections caused by highly antibiotic-resistant bacteria.	[Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med, Serv Immunol, New York, NY 10035 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Lucille Castor Ctr Microbes Inflammat & Canc, New York, NY 10035 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med, Serv Immunol, New York, NY 10035 USA.; Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Lucille Castor Ctr Microbes Inflammat & Canc, New York, NY 10035 USA.	pamere@mskcc.org			NIH [R01 AI095706, AI042135, U01 AI124275, P01 CA023766]; Leonard Tow Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI124275, R01AI042135, R01AI095706] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leonard Tow Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH grants R01 AI095706, AI042135, U01 AI124275, and P01 CA023766 and by the Leonard Tow Foundation. E.G.P. is an inventor on patent application WPO2015179437A1, entitled "Methods and compositions for reducing Clostridium difficile infection."	BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brown Amy C, 2004, Nutr Clin Care, V7, P56; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caballero S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005132; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Coyne MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2377-z; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; FRETER R, 1955, J INFECT DIS, V97, P57, DOI 10.1093/infdis/97.1.57; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garber K, 2002, J NATL CANCER I, V94, P324; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; HENTGES DJ, 1962, J INFECT DIS, V110, P30, DOI 10.1093/infdis/110.1.30; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Khanna S., 2016, J INFECT DIS, Vjiv766; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Podolsky SH, 2016, NEW ENGL J MED, V374, P201, DOI 10.1056/NEJMp1513393; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Sherkow JS, 2015, ANNU REV GENET, V49, P161, DOI 10.1146/annurev-genet-112414-054731; Singh R, 2014, CLIN MICROBIOL INFEC, V20, pO977, DOI 10.1111/1469-0691.12683; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Stripling J, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv078; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; TVEDE M, 1989, LANCET, V1, P1156; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; VOLLAARD EJ, 1987, J ANTIMICROB CHEMOTH, V20, P131, DOI 10.1093/jac/20.suppl_B.131; VOLLAARD EJ, 1990, J ANTIMICROB CHEMOTH, V25, P861, DOI 10.1093/jac/25.5.861	42	236	251	10	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					535	538		10.1126/science.aad9382	http://dx.doi.org/10.1126/science.aad9382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126035	Green Accepted			2022-12-28	WOS:000374998600033
J	Thiele, CM; Ulrich, AS				Thiele, Christina M.; Ulrich, Anne S.			Light flips a membrane-embedded helix	SCIENCE			English	Editorial Material							HANDEDNESS PREFERENCE; AMINO-ACIDS; SENSE		[Thiele, Christina M.] Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany; [Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76021 Karlsruhe, Germany	Technical University of Darmstadt; Helmholtz Association; Karlsruhe Institute of Technology	Thiele, CM (corresponding author), Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany.	cthiele@thielelab.de	Thiele, Christina M./Y-2299-2019; Ulrich, Anne S./H-5519-2013	Thiele, Christina M./0000-0001-7876-536X; Ulrich, Anne S./0000-0001-5571-9483				Babii O., 2016, ANGEW CHEM, V128, P5583, DOI DOI 10.1002/ANGE.201600506; Babii O, 2014, ANGEW CHEM INT EDIT, V53, P3392, DOI 10.1002/anie.201310019; Crisma M, 2015, J PEPT SCI, V21, P148, DOI 10.1002/psc.2743; De Poli M, 2016, SCIENCE, V352, P575, DOI 10.1126/science.aad8352; De Zotti M, 2014, J PEPT SCI, V20, P307, DOI 10.1002/psc.2638; GREEN MM, 1989, J AM CHEM SOC, V111, P6452, DOI 10.1021/ja00198a084; Le Bailly BAF, 2016, CHEM COMMUN, V52, P4852, DOI 10.1039/c6cc00788k; Pijper D, 2007, ANGEW CHEM INT EDIT, V46, P3693, DOI 10.1002/anie.200604941; Sola J, 2011, J AM CHEM SOC, V133, P3712, DOI 10.1021/ja1097034; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q	10	2	2	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					520	520		10.1126/science.aaf6191	http://dx.doi.org/10.1126/science.aaf6191			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126026				2022-12-28	WOS:000374998600023
J	El-Awady, N				El-Awady, Nadia			MAKING THE MOST OF LOCAL EXPERTISE	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S19	S21		10.1038/532S19a	http://dx.doi.org/10.1038/532S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27135102	Bronze			2022-12-28	WOS:000374815900005
J	Phillips, JP				Phillips, James P.			Workplace Violence against Health Care Workers in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OF-THE-LITERATURE; EMERGENCY-DEPARTMENT; RISK-FACTORS; HOSPITAL WORKERS; METAL DETECTORS; ASSAULT RATES; SAFETY; INJURIES; PROGRAMS; PATIENT		[Phillips, James P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Phillips, James P.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, 1 Deaconess Rd, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Phillips, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, 1 Deaconess Rd, Boston, MA 02215 USA.	jpphilli@bidmc.harvard.edu						[Anonymous], 2014, ED Manag, V26, P97; [Anonymous], 2010, Sentinel Event Alert, P1; [Anonymous], STAT ISS; Arnetz JE, 2014, AM J IND MED, V57, P1276, DOI 10.1002/ajim.22371; Behnam M, 2011, J EMERG MED, V40, P565, DOI 10.1016/j.jemermed.2009.11.007; Blair J. Pete, 2014, STUDY ACTIVE SHOOTER; Blando J, 2015, ONLINE J ISSUES NURS, V20; Blando JD, 2012, J EMERG MED, V42, P329, DOI 10.1016/j.jemermed.2008.06.026; Bureau of Labor Statistics, 2014, CENS FAT OCC INJ CFO; Callaway DW, 2015, CITTONES DISASTER ME, P424; Campbell JC, 2011, J OCCUP ENVIRON MED, V53, P82, DOI 10.1097/JOM.0b013e3182028d55; Canton Allison N, 2009, Home Healthc Nurse, V27, P364, DOI 10.1097/01.NHH.0000356828.27090.bd; Casteel C, 2009, ANN EPIDEMIOL, V19, P125, DOI 10.1016/j.annepidem.2008.10.009; Deery S, 2011, WORK EMPLOY SOC, V25, P742, DOI 10.1177/0950017011419707; DUHART DT, 2001, VIOLENCE WORKPLACE 1; Duncan S, 2000, Alta RN, V56, P13; Findorff Mary J, 2005, AAOHN J, V53, P399; Findorff MJ, 2004, INJURY PREV, V10, P296, DOI 10.1136/ip.2003.004747; Furin M, 2015, WEST J EMERG MED, V16, P459, DOI 10.5811/westjem.2015.2.24124; Gacki-Smith J, 2009, J NURS ADMIN, V39, P340, DOI 10.1097/NNA.0b013e3181ae97db; Gates Donna, 2002, J Am Med Dir Assoc, V3, P366, DOI 10.1016/S1525-8610(04)70528-9; Gates D, 2011, ADV EMERG NURS J, V33, P303, DOI 10.1097/TME.0b013e3182330530; Gates DM, 2006, J EMERG MED, V31, P331, DOI 10.1016/j.jemermed.2005.12.028; Gerberich SG, 2005, EPIDEMIOLOGY, V16, P704, DOI 10.1097/01.ede.0000164556.14509.a3; Gerberich SG, 2004, OCCUP ENVIRON MED, V61, P495, DOI 10.1136/oem.2003.007294; Grange Jeff T, 2002, Prehosp Emerg Care, V6, P186, DOI 10.1080/10903120290938526; Green M., 1999, APPROPRIATE EFFECTIV; Gross Nathan, 2013, Online J Issues Nurs, V18, P1; Hahn S, 2008, AGGRESS VIOLENT BEH, V13, P431, DOI 10.1016/j.avb.2008.07.001; Hanson GC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1340-7; Harnum Justin, 2014, J Healthc Prot Manage, V30, P36; Harrell E., 2011, WORKPLACE VIOLENCE 1; Hartley D, 2012, WORK, V42, P125, DOI 10.3233/WOR-2012-1328; Heckemann B, 2015, NURS EDUC TODAY, V35, P212, DOI 10.1016/j.nedt.2014.08.003; Henson B, 2010, VIOLENCE VICTIMS, V25, P553, DOI 10.1891/0886-6708.25.4.553; Hesketh KL, 2003, HEALTH POLICY, V63, P311, DOI 10.1016/S0168-8510(02)00142-2; Hoskins A.B., 2006, OCCUPATIONAL INJURIE; Howard J, 1996, OCCUP MED, V11, P293; Judy K, 2009, OCCUP MED-OXFORD, V59, P472, DOI 10.1093/occmed/kqp068; Kansagra SM, 2008, ACAD EMERG MED, V15, P1268, DOI 10.1111/j.1553-2712.2008.00282.x; Kelen GD, 2012, ANN EMERG MED, V60, P790, DOI 10.1016/j.annemergmed.2012.08.012; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Kelly EL, 2015, J ADV NURS, V71, P1110, DOI 10.1111/jan.12609; Kowalenko T, 2005, ANN EMERG MED, V46, P142, DOI 10.1016/j.annemergmed.2004.10.010; Kowalenko T, 2012, WEST J EMERG MED, V13, P429, DOI 10.5811/westjem.2011.12.6795; Kowalenko T, 2013, AM J EMERG MED, V31, P197, DOI 10.1016/j.ajem.2012.07.010; Kowalenko T, 2012, J EMERG MED, V43, P523, DOI 10.1016/j.jemermed.2012.02.056; Lanza Marilyn L, 2006, AAOHN J, V54, P397; Lau Jacqui Bc, 2006, Accid Emerg Nurs, V14, P111, DOI 10.1016/j.aaen.2006.02.003; Lehmann LS, 1999, PSYCHIATR SERV, V50, P384, DOI 10.1176/ps.50.3.384; Longton J, 2015, MON LABOR REV; Mattox EA, 2000, PEDIATR EMERG CARE, V16, P163, DOI 10.1097/00006565-200006000-00006; May Deborah D, 2002, J Emerg Nurs, V28, P11, DOI 10.1067/men.2002.121835; McGovern P, 2000, HEALTH SERV RES, V35, P663; McNamara R, 1997, AM J EMERG MED, V15, P40, DOI 10.1016/S0735-6757(97)90045-0; McPhaul Kathleen M, 2004, Online J Issues Nurs, V9, P7; Meyer T, 1997, ANN EMERG MED, V29, P621, DOI 10.1016/S0196-0644(97)70250-6; Mohr DC, 2011, J OCCUP ENVIRON MED, V53, P511, DOI 10.1097/JOM.0b013e31820d101e; Nachreiner NM, 2007, IND HEALTH, V45, P672, DOI 10.2486/indhealth.45.672; National Institute for Occupational Safety and Health, 2002, VIOL OCC HAZ HOSP; Occupational Safety and Health Administration, 2015, 314804R OSHA; Peek-Asa C, 2007, J OCCUP ENVIRON MED, V49, P756, DOI 10.1097/JOM.0b013e318076b7eb; PeekAsa C, 1997, J OCCUP ENVIRON MED, V39, P44, DOI 10.1097/00043764-199701000-00009; Perkins C., 2003, WEAPON USE VIOLENT C; Pompeii L, 2013, J SAFETY RES, V44, P57, DOI 10.1016/j.jsr.2012.09.004; Pompeii LA, 2015, AM J IND MED, V58, P1194, DOI 10.1002/ajim.22489; Privitera M, 2005, OCCUP MED-OXFORD, V55, P480, DOI 10.1093/occmed/kqi110; Rankins RG, 1999, ANN EMERG MED, V33, P676, DOI 10.1016/S0196-0644(99)70197-6; Rosenman KD, 2006, J OCCUP ENVIRON MED, V48, P357, DOI 10.1097/01.jom.0000205864.81970.63; Rugala E., 2003, WORKPLACE VIOLENCE I; Runyan CW, 2000, AM J PREV MED, V18, P116, DOI 10.1016/S0749-3797(00)00147-1; Ruser JW, 2008, MON LABOR REV, V131, P20; Simon HK, 2003, PEDIATR EMERG CARE, V19, P248, DOI 10.1097/01.pec.0000086236.54586.db; Statistics BoL, 2011, NONF OCC INJ ILLN RE; Tak S, 2010, AM J PUBLIC HEALTH, V100, P1938, DOI 10.2105/AJPH.2009.185421; Taylor JL, 2011, J CLIN NURS, V20, P1072, DOI 10.1111/j.1365-2702.2010.03342.x; Thompson M, 2015, TIME            0109; Vellani Karim H, 2014, J Healthc Prot Manage, V30, P28; Wuellner SE, 2014, AM J IND MED, V57, P1133, DOI 10.1002/ajim.22350	79	316	330	5	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1661	1669		10.1056/NEJMra1501998	http://dx.doi.org/10.1056/NEJMra1501998			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK3UR	27119238				2022-12-28	WOS:000374843400009
J	McCarthy, M				McCarthy, Michael			Suicide rates rise sharply in the US, figures show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2355	10.1136/bmj.i2355	http://dx.doi.org/10.1136/bmj.i2355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27112501				2022-12-28	WOS:000375482000009
J	Macdonald, D				Macdonald, Donald			Donald Macdonald OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2305	10.1136/bmj.i2305	http://dx.doi.org/10.1136/bmj.i2305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106861				2022-12-28	WOS:000374999700009
J	Ebell, MH; Call, M; Shinholser, J; Gardner, J				Ebell, Mark H.; Call, Marlene; Shinholser, JoAnna; Gardner, Jack			Does This Patient Have Infectious Mononucleosis? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							EPSTEIN-BARR-VIRUS; YOUNG-ADULTS; SORE THROAT; CHILDREN; SPECIFICITY; SENSITIVITY; HETEROPHILE; ANTIBODY; PHARYNGITIS; FREQUENCY	IMPORTANCE Early, accurate diagnosis of infectious mononucleosis can help clinicians target treatment, avoid antibiotics, and provide an accurate prognosis. OBJECTIVE To systematically review the literature regarding the value of the clinical examination and white blood cell count for the diagnosis of mononucleosis. DATA SOURCES The databases of PubMed (from 1966-2016) and EMBASE (from 1947-2015) were searched and a total of 670 articles and abstracts were reviewed for eligibility. STUDY SELECTION Eleven studies were included that reported data sufficient to calculate sensitivity, specificity, or both for clinical examination findings and white blood cell count parameters compared with a valid reference standard. DATA EXTRACTION AND SYNTHESIS Data were abstracted from each article by at least 2 reviewers, with discrepancies reconciled by consensus. Clinical findings evaluated in only 1 study are reported with sensitivity, specificity, likelihood ratio (LR), and 95% confidence interval, which were calculated from the available data. Findings evaluated in only 2 studies were summarized with their range, findings evaluated in 3 studies were summarized with a univariate random-effects summary, and findings evaluated in 4 or more studies were summarized with a bivariate random-effects meta-analysis. MAIN OUTCOMES AND MEASURES Sensitivity, specificity, and LRs for the diagnosis of mononucleosis. RESULTS Mononucleosis is most commonly present among patients aged 5 to 25 years (especially those aged 16-20 years, among whom approximately 1 in 13 patients presenting with sore throat has mononucleosis). The likelihood of mononucleosis is reduced with the absence of any lymphadenopathy (summary sensitivity, 0.91; positive LR range, 0.23-0.44), whereas the likelihood increases with the presence of posterior cervical adenopathy (summary specificity, 0.87; positive LR, 3.1 [95% CI, 1.6-5.9]), inguinal or axillary adenopathy (specificity range, 0.82-0.91; positive LR range, 3.0-3.1), palatine petechiae (specificity, 0.95; positive LR, 5.3 [95% CI, 2.1-13]), and splenomegaly (specificity range, 0.71-0.99; positive LR range, 1.9-6.6). Symptoms are of limited value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive (range, 0.81-0.83) but nonspecific. The presence of atypical lymphocytosis significantly increases the likelihood of mononucleosis (summary LR, 11.4 [95% CI, 2.7-35] for atypical lymphocytes >= 10%, 26 [95% CI, 9.6-68] for those with 20%, and 50 [95% CI, 38-64] for those with 40%). The combination of a patient having greater than 50% lymphocytes and greater than 10% atypical lymphocytes also is useful (specificity, 0.99; positive LR, 54 [95% CI, 8.4-189]). CONCLUSIONS AND RELEVANCE In adolescent and adult patients presenting with sore throat, the presence of posterior cervical, inguinal or axillary adenopathy, palatine petechiae, splenomegaly, or atypical lymphocytosis is associated with an increased likelihood of mononucleosis.	[Ebell, Mark H.; Call, Marlene; Shinholser, JoAnna; Gardner, Jack] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Atlanta, GA USA; [Call, Marlene] Georgia Hlth Sci Univ, Augusta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Ebell, MH (corresponding author), 233 Miller Hall,UGA Hlth Sci Campus, Athens, GA 30602 USA.	ebell@uga.edu						ARONSON MD, 1982, ANN INTERN MED, V96, P505, DOI 10.7326/0003-4819-96-4-505; Biggs TC, 2013, LARYNGOSCOPE, V123, P2401, DOI 10.1002/lary.24030; Brigden ML, 1999, ARCH PATHOL LAB MED, V123, P875; Candy B, 2002, BRIT J GEN PRACT, V52, P844; Chovel-Sella A, 2013, PEDIATRICS, V131, pE1424, DOI 10.1542/peds.2012-1575; Del Mar C, 1995, Aust Fam Physician, V24, P625; Del Mar C, 1995, AUST FAM PHYSICIAN, V24, P632; Donner-Banzhoff N, 2002, FAM PRACT, V19, P466, DOI 10.1093/fampra/19.5.466; EVANS AS, 1975, J INFECT DIS, V132, P546, DOI 10.1093/infdis/132.5.546; FLEISHER G, 1979, J INFECT DIS, V139, P553, DOI 10.1093/infdis/139.5.553; FLEISHER GR, 1983, J CLIN MICROBIOL, V17, P619, DOI 10.1128/JCM.17.4.619-624.1983; Fleming DM, 2003, BRIT J GEN PRACT, V53, P778; Grotto I, 2003, EPIDEMIOL INFECT, V131, P683, DOI 10.1017/S0950268803008550; GROVER SA, 1993, JAMA-J AM MED ASSOC, V270, P2218, DOI 10.1001/jama.270.18.2218; HENKE CE, 1973, AM J EPIDEMIOL, V98, P483, DOI 10.1093/oxfordjournals.aje.a121577; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoagland R J, 1975, Prim Care, V2, P295; HOAGLAND RJ, 1960, AM J MED SCI, V240, P21, DOI 10.1097/00000441-196007000-00003; Hocqueloux L, 2013, CLIN INFECT DIS, V57, P1661, DOI 10.1093/cid/cit553; Jensen DM, 2005, PEDIATR EMERG CARE, V21, P238, DOI 10.1097/01.pec.0000161467.35089.f4; Klutts JS, 2008, DIAGN MICR INFEC DIS, V61, P351, DOI 10.1016/j.diagmicrobio.2008.02.016; Lennon P, 2013, J LARYNGOL OTOL, V127, P187, DOI 10.1017/S0022215112002976; Levine H, 2012, EUR J CLIN MICROBIOL, V31, P757, DOI 10.1007/s10096-011-1371-2; LOFSNESS KG, 1987, AM J CLIN PATHOL, V87, P485, DOI 10.1093/ajcp/87.4.485; NAYLOR CD, 1994, JAMA-J AM MED ASSOC, V271, P1859, DOI 10.1001/jama.271.23.1859; Rea T D, 2001, J Am Board Fam Pract, V14, P234; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Simel DL, 2009, RATIONAL CLIN EXAMIN; Sprunt TP, 1920, B JOHNS HOPKINS HOSP, V31, P410; SUMAYA CV, 1985, PEDIATRICS, V75, P1003; VANCAUWENBERGE PB, 1991, PEDIATR INFECT DIS J, V10, pS39, DOI 10.1097/00006454-199110001-00009; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9	33	35	42	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1502	1509		10.1001/jama.2016.2111	http://dx.doi.org/10.1001/jama.2016.2111			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115266				2022-12-28	WOS:000373873800016
J	Smit, JG; Kasius, JC; Eijkemans, MJC; Koks, CAM; van Golde, R; Nap, AW; Scheffer, GJ; Manger, PAP; Hoek, A; Schoot, BC; van Heusden, AM; Kuchenbecker, WKH; Perquin, DAM; Fleischer, K; Kaaijk, EM; Sluijmer, A; Friederich, J; Dykgraaf, RHM; van Hooff, M; Louwe, LA; Kwee, J; de Koning, CH; Janssen, ICAH; Mol, F; Mol, BWJ; Broekmans, FJM; Torrance, HL				Smit, Janine G.; Kasius, Jenneke C.; Eijkemans, Marinus J. C.; Koks, Carolien A. M.; van Golde, Ronald; Nap, Annemiek W.; Scheffer, Gabrielle J.; Manger, Petra A. P.; Hoek, Annemieke; Schoot, Benedictus C.; van Heusden, Arne M.; Kuchenbecker, Walter K. H.; Perquin, Denise A. M.; Fleischer, Kathrin; Kaaijk, Eugenie M.; Sluijmer, Alexander; Friederich, Jaap; Dykgraaf, Ramon H. M.; van Hooff, Marcel; Louwe, Leonie A.; Kwee, Janet; de Koning, Corry H.; Janssen, Ineke C. A. H.; Mol, Femke; Mol, Ben W. J.; Broekmans, Frank J. M.; Torrance, Helen L.			Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial	LANCET			English	Article							DIAGNOSTIC-ACCURACY; UTERINE CAVITY; TRANSVAGINAL SONOGRAPHY; ASSISTED REPRODUCTION; OFFICE HYSTEROSCOPY; PREGNANCY RATES; SONOHYSTEROGRAPHY; IMPLANTATION; INJURY	Background Hysteroscopy is often done in infertile women starting in-vitro fertilisation (IVF) to improve their chance of having a baby. However, no data are available from randomised controlled trials to support this practice. We aimed to assess whether routine hysteroscopy before the first IVF treatment cycle increases the rate of livebirths. Methods We did a pragmatic, multicentre, randomised controlled trial in seven university hospitals and 15 large general hospitals in the Netherlands. Women with a normal transvaginal ultrasound of the uterine cavity and no previous hysteroscopy who were scheduled for their first IVF treatment were randomly assigned (1: 1) to either hysteroscopy with treatment of detected intracavitary abnormalities before starting IVF (hysteroscopy group) or immediate start of the IVF treatment (immediate IVF group). Randomisation was done with web-based concealed allocation and was stratified by centre with variable block sizes. Participants, doctors, and outcome assessors were not masked to the assigned group. The primary outcome was ongoing pregnancy (detection of a fetal heartbeat at >12 weeks of gestation) within 18 months of randomisation and resulting in livebirth. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01242852. Findings Between May 25, 2011, and Aug 27, 2013, we randomly assigned 750 women to receive either hysteroscopy (n=373) or immediate IVF (n=377). 209 (57%) of 369 women eligible for assessment in the hysteroscopy group and 200 (54%) of 373 in the immediate IVF group had a livebirth from a pregnancy during the trial period (relative risk 1.06, 95% CI 0.93-1.20; p=0.41). One (<1%) woman in the hysteroscopy group developed endometritis after hysteroscopy. Interpretation Routine hysteroscopy does not improve livebirth rates in infertile women with a normal transvaginal ultrasound of the uterine cavity scheduled for a first IVF treatment. Women with a normal transvaginal ultrasound should not be offered routine hysteroscopy.	[Smit, Janine G.; Kasius, Jenneke C.; Broekmans, Frank J. M.; Torrance, Helen L.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, NL-3508 GA Utrecht, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Koks, Carolien A. M.] Maxima Med Ctr, Veldhoven, Netherlands; [van Golde, Ronald] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Nap, Annemiek W.] Rijnstate Hosp, Arnhem, Netherlands; [Scheffer, Gabrielle J.] Gelre Hosp, Apeldoorn, Netherlands; [Manger, Petra A. P.] Diakonessen Hosp Utrecht, Utrecht, Netherlands; [Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Schoot, Benedictus C.] Catharina Hosp, Eindhoven, Netherlands; [van Heusden, Arne M.] St Antonius Hosp, Nieuwegein, Netherlands; [Kuchenbecker, Walter K. H.] Isala, Zwolle, Netherlands; [Perquin, Denise A. M.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Fleischer, Kathrin] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Kaaijk, Eugenie M.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Kwee, Janet] Sint Lucas Andreas Hosp, Amsterdam, Netherlands; [Mol, Femke] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Sluijmer, Alexander] Wilhelmina Gasthuis, Assen, Netherlands; [Friederich, Jaap] Gemini Hosp, Den Helder, Netherlands; [Dykgraaf, Ramon H. M.] Erasmus MC, Rotterdam, Netherlands; [van Hooff, Marcel] St Franciscus Gasthuis, Rotterdam, Netherlands; [Louwe, Leonie A.] Leiden Univ, Leids Univ Med Ctr, Leiden, Netherlands; [de Koning, Corry H.] Tergooi Hosp, Blaricum, Netherlands; [Janssen, Ineke C. A. H.] Groene Hart Hosp, Gouda, Netherlands; [Mol, Ben W. J.] Robinson Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Mol, Ben W. J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maxima Medical Center; Maastricht University; Rijnstate Hospital; Gelre Hospitals; Diakonessenhuis; University of Groningen; Catharina Hospital; St. Antonius Hospital Utrecht; Medical Center Leeuwarden; Radboud University Nijmegen; Onze Lieve Vrouwe Gasthuis Hospital; Sint Lucas Andreas Hospital; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC; Franciscus Gasthuis; Leiden University; Leiden University - Excl LUMC; Tergooi Blaricum; Robinson Research Institute; South Australian Health & Medical Research Institute (SAHMRI)	Smit, JG (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynaecol, NL-3508 GA Utrecht, Netherlands.	jsmit9@umcutrecht.nl	NAP, Annemiek/ABE-1897-2021; Fleischer, Kathrin/ABG-2648-2020	Fleischer, Kathrin/0000-0002-2785-5573; Mol, Femke/0000-0002-6892-5574				Bettocchi S, 2004, OBSTET GYN CLIN N AM, V31, P641, DOI 10.1016/j.ogc.2004.05.007; Bingol B, 2011, J OBSTET GYNAECOL, V31, P54, DOI 10.3109/01443615.2010.532246; Bosteels J, 2010, HUM REPROD UPDATE, V16, P1, DOI 10.1093/humupd/dmp033; Ceci O, 2002, FERTIL STERIL, V78, P628, DOI 10.1016/S0015-0282(02)03246-6; Demirol A, 2004, REPROD BIOMED ONLINE, V8, P590, DOI 10.1016/S1472-6483(10)61108-X; El-Sherbiny W, 2011, J MINIM INVAS GYN, V18, P54, DOI 10.1016/j.jmig.2010.08.697; El-Toukhy T, 2016, LANCET; Elsetohy KAAA, 2015, ARCH GYNECOL OBSTET, V291, P193, DOI 10.1007/s00404-014-3397-z; Fatemi HM, 2013, REPROD BIOMED ONLINE, V27, P530, DOI 10.1016/j.rbmo.2013.05.018; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Gnainsky Y, 2010, FERTIL STERIL, V94, P2030, DOI 10.1016/j.fertnstert.2010.02.022; Kamphuis EI, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g252; Kasius JC, 2011, HUM REPROD, V26, P801, DOI 10.1093/humrep/der003; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Perez-Medina T, 2005, HUM REPROD, V20, P1632, DOI 10.1093/humrep/deh822; Potdar N, 2012, REPROD BIOMED ONLINE, V25, P561, DOI 10.1016/j.rbmo.2012.08.005; Pundir J, 2014, REPROD BIOMED ONLINE, V28, P151, DOI 10.1016/j.rbmo.2013.09.025; Raju G. A. Rama, 2006, Archives of Gynecology and Obstetrics, V274, P160, DOI 10.1007/s00404-006-0174-7; Simon C, 2000, BEST PRACT RES CL OB, V14, P815, DOI 10.1053/beog.2000.0121; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Smit JG, 2013, FERTIL STERIL, V99, P2108, DOI 10.1016/j.fertnstert.2013.02.027; Smit JG, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-22; Smit JG, 2015, 31 ESHRE ANN M LIBS, pO; Soares SR, 2000, FERTIL STERIL, V73, P406, DOI 10.1016/S0015-0282(99)00532-4; Taylor E, 2008, FERTIL STERIL, V89, P1, DOI 10.1016/j.fertnstert.2007.09.069	25	52	55	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2622	2629		10.1016/S0140-6736(16)00231-2	http://dx.doi.org/10.1016/S0140-6736(16)00231-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27132052				2022-12-28	WOS:000378390500030
J	Hollande, F				Hollande, Francois			Towards a global agenda on health security	LANCET			English	Editorial Material									[Hollande, Francois] 55 Rue Faubourg St Honore, F-75008 Paris, France		Hollande, F (corresponding author), 55 Rue Faubourg St Honore, F-75008 Paris, France.	scp.courrier@elysee.fr							0	8	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2173	2174		10.1016/S0140-6736(16)30393-2	http://dx.doi.org/10.1016/S0140-6736(16)30393-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145711				2022-12-28	WOS:000376820800010
J	Ludwig, JR; Zimmerman, PM; Gianino, JB; Schindler, CS				Ludwig, Jacob R.; Zimmerman, Paul M.; Gianino, Joseph B.; Schindler, Corinna S.			Iron(III)-catalysed carbonyl-olefin metathesis	NATURE			English	Article							MECHANISM; ALCOHOLS	The olefin metathesis reaction of two unsaturated substrates is one of the most powerful carbon-carbon-bond-forming reactions in organic chemistry. Specifically, the catalytic olefin metathesis reaction has led to profound developments in the synthesis of molecules relevant to the petroleum, materials, agricultural and pharmaceutical industries(1). These reactions are characterized by their use of discrete metal alkylidene catalysts that operate via a well-established mechanism(2). While the corresponding carbonyl-olefin metathesis reaction can also be used to construct carbon-carbon bonds, currently available methods are scarce and severely hampered by either harsh reaction conditions or the required use of stoichiometric transition metals as reagents. To date, no general protocol for catalytic carbonyl-olefin metathesis has been reported. Here we demonstrate a catalytic carbonyl-olefin ring-closing metathesis reaction that uses iron, an Earth-abundant and environmentally benign transition metal, as a catalyst. This transformation accommodates a variety of substrates and is distinguished by its operational simplicity, mild reaction conditions, high functional-group tolerance, and amenability to gram-scale synthesis. We anticipate that these characteristics, coupled with the efficiency of this reaction, will allow for further advances in areas that have historically been enhanced by olefin metathesis.	[Ludwig, Jacob R.; Zimmerman, Paul M.; Gianino, Joseph B.; Schindler, Corinna S.] Univ Michigan, Dept Chem, Willard Henry Dow Lab, 930 North Univ Ave, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schindler, CS (corresponding author), Univ Michigan, Dept Chem, Willard Henry Dow Lab, 930 North Univ Ave, Ann Arbor, MI 48109 USA.	corinnas@umich.edu			Petroleum Research Fund (PRF) [54688-DNI1, 54267-DNI6]; University of Michigan; National Science Foundation; Office of Naval Research [N00014-14-1-0551]	Petroleum Research Fund (PRF)(American Chemical Society); University of Michigan(University of Michigan System); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	This work was supported by the Petroleum Research Fund (PRF#54688-DNI1) and start-up funds provided by the University of Michigan. J.R.L. thanks the National Science Foundation for a predoctoral fellowship. P.M.Z. thanks the Office of Naval Research for support under grant N00014-14-1-0551 and the Petroleum Research Fund (PRF#54267-DNI6). We are grateful to A. Speelman, A. McQuarters and N. Lehnert at the University of Michigan for helpful discussions.	CARLESS HAJ, 1979, J CHEM SOC CHEM COMM, P382, DOI 10.1039/c39790000382; Chauvin Y, 2006, ANGEW CHEM INT EDIT, V45, P3740, DOI 10.1002/anie.200601234; Clarke ML, 2008, TETRAHEDRON, V64, P9003, DOI 10.1016/j.tet.2008.06.075; DEMOLE E, 1971, HELV CHIM ACTA, V54, P1845, DOI 10.1002/hlca.19710540712; FU GC, 1993, J AM CHEM SOC, V115, P3800, DOI 10.1021/ja00062a066; Furstner A, 2000, ANGEW CHEM INT EDIT, V39, P3012; Griffith AK, 2012, J AM CHEM SOC, V134, P18581, DOI 10.1021/ja309650u; Grubbs R. H., 2015, HDB METATHESIS, V3; Grubbs R. H., 2015, HDB METATHESIS, V1-3; GRUBBS RH, 1976, J AM CHEM SOC, V98, P3478, DOI 10.1021/ja00428a015; Heller ST, 2013, ANGEW CHEM INT EDIT, V52, P11129, DOI 10.1002/anie.201304687; Hong BK, 2015, ANGEW CHEM INT EDIT, V54, P1011, DOI 10.1002/anie.201409503; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Iyer K, 2007, J AM CHEM SOC, V129, P12604, DOI 10.1021/ja073880r; JACKSON AC, 1984, J ORG CHEM, V49, P3988, DOI 10.1021/jo00195a022; JONES G, 1975, J CHEM SOC CHEM COMM, P206, DOI 10.1039/c39750000206; Jossifov C, 2008, CHIM OGGI, V26, P85; KATZ TJ, 1975, J AM CHEM SOC, V97, P1592, DOI 10.1021/ja00839a063; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; Miles RB, 2006, J ORG CHEM, V71, P1493, DOI 10.1021/jo052142n; Naidu VR, 2015, EUR J ORG CHEM, V2015, P1834, DOI 10.1002/ejoc.201403651; Perez-Ruiz R, 2006, PHOTOCH PHOTOBIO SCI, V5, P51, DOI 10.1039/b513875b; PETASIS NA, 1990, J AM CHEM SOC, V112, P6392, DOI 10.1021/ja00173a035; REETZ MT, 1982, ANGEW CHEM INT EDIT, V21, P96, DOI 10.1002/anie.198200961; Soicke A, 2011, SYNLETT, P2487, DOI 10.1055/s-0030-1260320; STILLE JR, 1990, J ORG CHEM, V55, P843, DOI 10.1021/jo00290a013; Takeda T., 2003, MODERN CARBONYL OLEF, P151; Valiulin RA, 2009, ORG LETT, V11, P3886, DOI 10.1021/ol901456m; VANSCHAIK HP, 1994, ANGEW CHEM INT EDIT, V33, P1611, DOI 10.1002/anie.199416111; Zimmerman PM, 2013, J CHEM THEORY COMPUT, V9, P3043, DOI 10.1021/ct400319w; Zimmerman PM, 2013, J COMPUT CHEM, V34, P1385, DOI 10.1002/jcc.23271	31	131	131	4	155	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					374	379		10.1038/nature17432	http://dx.doi.org/10.1038/nature17432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27120158				2022-12-28	WOS:000376004300044
J	Binns, WR; Israel, MH; Christian, ER; Cummings, AC; de Nolfo, GA; Lave, KA; Leske, RA; Mewaldt, RA; Stone, EC; von Rosenvinge, TT; Wiedenbeck, ME				Binns, W. R.; Israel, M. H.; Christian, E. R.; Cummings, A. C.; de Nolfo, G. A.; Lave, K. A.; Leske, R. A.; Mewaldt, R. A.; Stone, E. C.; von Rosenvinge, T. T.; Wiedenbeck, M. E.			Observation of the Fe-60 nucleosynthesis-clock isotope in galactic cosmic rays	SCIENCE			English	Article							SOLAR METALLICITY; OB ASSOCIATIONS; EARTH; STARS	Iron-60 (Fe-60) is a radioactive isotope in cosmic rays that serves as a clock to infer an upper limit on the time between nucleosynthesis and acceleration. We have used the ACE-CRIS instrument to collect 3.55 x 10(5) iron nuclei, with energies similar to 195 to similar to 500mega-electron volts per nucleon, of which we identify 15 Fe-60 nuclei. The Fe-60/Fe-56 source ratio is (7.5 +/- 2.9) x 10(-5). The detection of supernova-produced Fe-60 in cosmic rays implies that the time required for acceleration and transport to Earth does not greatly exceed the Fe-60 half-life of 2.6 million years and that the Fe-60 source distance does not greatly exceed the distance cosmic rays can diffuse over this time, (less than or similar to) under bar1 kiloparsec. A natural place for Fe-60 origin is in nearby clusters of massive stars.	[Binns, W. R.; Israel, M. H.; Lave, K. A.] Washington Univ, St Louis, MO 63130 USA; [Christian, E. R.; de Nolfo, G. A.; von Rosenvinge, T. T.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Cummings, A. C.; Leske, R. A.; Mewaldt, R. A.; Stone, E. C.] CALTECH, Pasadena, CA 91125 USA; [Wiedenbeck, M. E.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA	Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Binns, WR; Israel, MH (corresponding author), Washington Univ, St Louis, MO 63130 USA.	wrb@wustl.edu; mhi@wustl.edu			NASA [NNX08Al11G, NNX13AH66G]; Jet Propulsion Laboratory; Washington University in St. Louis	NASA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA)); Washington University in St. Louis	This work was supported by NASA grants NNX08Al11G and NNX13AH66G for work performed at the California Institute of Technology, the Jet Propulsion Laboratory, and Washington University in St. Louis. Work done at Goddard Space Flight Center was funded by NASA through the ACE Project. We thank S. Woosley and J. Brown at the University of California Santa Cruz for providing modeling calculation data and for discussions about uncertainties in their calculations. We thank A. Chieffi at the Institute for Space Astrophysics and Planetology, Rome, Italy, for discussions on the uncertainties in the C&L calculations. Accelerator testing of the CRIS detectors was made possible by N. Anantaraman, R. Ronningen, and the staff at the National Superconducting Cyclotron Laboratory at Michigan State University, while H. Specht, D. Schardt, and the staff of the GSI heavy-ion accelerator in Darmstadt, Germany made possible the heavy-ion calibrations of the completed CRIS instrument. The data used are archived at NASA's Space Physics Data Facility (http://spdf.gsfc.nasa.gov) as data set ac_h2_cris and can be retrieved from this site by direct download or through the SPDF's CDAWeb data service.	Binns WR, 2011, SCIENCE, V334, P1071, DOI 10.1126/science.1213490; Chieffi A, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/21; de Zeeuw PT, 1999, ASTRON J, V117, P354, DOI 10.1086/300682; Fimiani L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.151104; Fimiani L., 2014, 45 LUN PLAN SCI C, P1778; Fimiani L., 2012, 43 LUN PLAN SCI C, P1279; Fitoussi C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.121101; Fry BJ, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/71; Higdon JC, 2005, ASTROPHYS J, V628, P738, DOI 10.1086/430814; Higdon JC, 2003, ASTROPHYS J, V590, P822, DOI 10.1086/375192; Knie K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171103; Knie K, 1999, PHYS REV LETT, V83, P18, DOI 10.1103/PhysRevLett.83.18; Lave KA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/117; Rugel G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.072502; Stone EC, 1998, SPACE SCI REV, V86, P285, DOI 10.1023/A:1005075813033; Voss R, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/201014408; Wallner A, 2016, NATURE, V532, P69, DOI 10.1038/nature17196; Wang W, 2007, ASTRON ASTROPHYS, V469, P1005, DOI 10.1051/0004-6361:20066982; Wiedenbeck ME, 1999, ASTROPHYS J, V523, pL61, DOI 10.1086/312242; Woosley SE, 2007, PHYS REP, V442, P269, DOI 10.1016/j.physrep.2007.02.009; Yanasak NE, 2001, ASTROPHYS J, V563, P768, DOI 10.1086/323842	21	75	76	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					677	680		10.1126/science.aad6004	http://dx.doi.org/10.1126/science.aad6004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL1UC	27103666	Bronze			2022-12-28	WOS:000375417100030
J	Buntrock, C; Ebert, DD; Lehr, D; Smit, F; Riper, H; Berking, M; Cuijpers, P				Buntrock, Claudia; Ebert, David Daniel; Lehr, Dirk; Smit, Filip; Riper, Heleen; Berking, Matthias; Cuijpers, Pim			Effect of a Web-Based Guided Self-help Intervention for Prevention of Major Depression in Adults With Subthreshold Depression A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-BEHAVIOR THERAPY; PRIMARY-CARE; DSM-IV; DISORDER; VALIDATION; INTERVIEW; DISEASE; ANXIETY; BURDEN; ONSET	IMPORTANCE Evidence-based treatments for major depressive disorder (MDD) are not very successful in improving functional and health outcomes. Attention has increasingly been focused on the prevention of MDD. OBJECTIVE To evaluate the effectiveness of a web-based guided self-help intervention for the prevention of MDD. DESIGN, SETTING, AND PARTICIPANTS Two-group randomized clinical trial conducted between March 1, 2013, and March 4, 2015. Participants were recruited in Germany from the general population via a large statutory health insurance company (ie, insurance funded by joint employer-employee contributions). Participants included 406 self-selected adults with subthreshold depression (Centre for Epidemiologic Studies Depression Scale score >= 16, no current MDD according to Diagnostic and Statistical Manual of Mental Disorders [Fourth Edition, Text Revision] criteria). INTERVENTIONS All participants had unrestricted access to usual care (visits to the primary care clinician) and were randomized to either a web-based guided self-help intervention (cognitive-behavioral and problem-solving therapy supported by an online trainer; n = 202) or a web-based psychoeducation program (n = 204). MAIN OUTCOMES AND MEASURES The primary outcomewas time to onset of MDD in the intervention group relative to the control group over a 12-month follow-up period as assessed by blinded diagnostic raters using the telephone-administered Structured Clinical Interview for DSM-IV Axis Disorders at 6-and 12-month follow-up, covering the period to the previous assessment. RESULTS Among 406 randomized patients (mean age, 45 years; 73.9% women), 335 (82%) completed the telephone follow-up at 12 months. Fifty-five participants (27%) in the intervention group experienced MDD compared with 84 participants (41%) in the control group. Cox regression analyses controlling for baseline depressive symptom severity revealed a hazard ratio of 0.59 (95% CI, 0.42-0.82; P =.002) at 12-month follow-up. The number needed to treat to avoid 1 new case of MDD was 5.9 (95% CI, 3.9-14.6). CONCLUSIONS AND RELEVANCE Among patients with subthreshold depression, the use of a web-based guided self-help intervention compared with enhanced usual care reduced the incidence of MDD over 12 months. Further research is needed to understand whether the effects are generalizable to both first onset of depression and depression recurrence as well as efficacy without the use of an online trainer.	[Buntrock, Claudia; Ebert, David Daniel; Lehr, Dirk; Riper, Heleen; Berking, Matthias; Cuijpers, Pim] Leuphana Univ, Div Online Hlth Training, Innovat Incubator, Luneburg, Germany; [Buntrock, Claudia; Smit, Filip; Riper, Heleen; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Clin Psychol, Amsterdam, Netherlands; [Ebert, David Daniel; Berking, Matthias] Univ Erlangen Nurnberg, Dept Clin Psychol & Psychotherapy, D-91054 Erlangen, Germany; [Smit, Filip] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Dept Publ Mental Hlth, Utrecht, Netherlands; [Smit, Filip] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Riper, Heleen] Univ Southern Denmark, Inst Telepsychiat, Odense, Denmark	Leuphana University Luneburg; Vrije Universiteit Amsterdam; University of Erlangen Nuremberg; Trimbos Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Southern Denmark	Buntrock, C (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	buntrockclaudia@gmail.com	Lehr, Dirk/AAN-2010-2020; Cuijpers, Pim/G-1703-2013	Lehr, Dirk/0000-0002-5560-3605; Ebert, David Daniel/0000-0001-6820-0146	European Union (project EFRE) [CCI 2007DE161PR001]; BARMER GEK (German statutory health insurance company)	European Union (project EFRE); BARMER GEK (German statutory health insurance company)	The associated project of all authors was funded by the European Union (project EFRE: CCI 2OO7DE161PROO1) and the BARMER GEK (German statutory health insurance company).	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berle D, 2011, CLIN PSYCHOL PSYCHOT, V18, P339, DOI 10.1002/cpp.724; [Bundesarztekammer Bundesarztekammer. Bundesvereinigung K Fachgesellschaften AdWM], 2011, GERM S3 GUID NAT DIS; Buntrock C, 2015, PSYCHOTHER PSYCHOSOM, V84, P348, DOI 10.1159/000438673; Cookson J, 2006, INT CLIN PSYCHOPHARM, V21, P267, DOI 10.1097/00004850-200609000-00004; Crippa JAS, 2008, PERSPECT PSYCHIATR C, V44, P241, DOI 10.1111/j.1744-6163.2008.00183.x; Cuijpers P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-181; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; Dam EAV, 2007, J AFFECT DISORDERS, V97, P219, DOI 10.1016/j.jad.2006.06.020; de Jonge P, 2009, PSYCHOSOMATICS, V50, P227, DOI 10.1176/appi.psy.50.3.227; Ebert DD, 2015, J AFFECT DISORDERS, V176, P9, DOI 10.1016/j.jad.2015.01.056; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gilbody S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5627; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hagan R, 2004, BJOG-INT J OBSTET GY, V111, P641, DOI 10.1111/j.1471-0528.2004.00165.x; Hakkaart-van Roijen L, 2002, MANUAL TRIMBOS IMTA; Kessler RC, 2015, EPIDEMIOL PSYCH SCI, V24, P210, DOI 10.1017/S2045796015000189; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; KUPFER DJ, 1991, J CLIN PSYCHIAT, V52, P28; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Lohse MJ, 2008, ARZNEIVERORDNUNGSREP, P775; LYKETSOS CG, 1994, INT J METHOD PSYCH, V4, P143; Mack S, 2014, INT J METH PSYCH RES, V23, P289, DOI 10.1002/mpr.1438; Manos RC, 2011, BEHAV THER, V42, P726, DOI 10.1016/j.beth.2011.04.004; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Newcombe RG, 1999, STAT MED, V18, P1293, DOI 10.1002/(SICI)1097-0258(19990530)18:10<1293::AID-SIM175>3.0.CO;2-7; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Otero P, 2015, PSYCHOL MED, V45, P1401, DOI 10.1017/S0033291714002505; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; StataCorp, 2013, STAT STAT SOFTW REL; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Willemse GRWM, 2004, BRIT J PSYCHIAT, V185, P416, DOI 10.1192/bjp.185.5.416; Zhang DX, 2014, J AFFECT DISORDERS, V169, P212, DOI 10.1016/j.jad.2014.08.015; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	42	147	149	1	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1854	1863		10.1001/jama.2016.4326	http://dx.doi.org/10.1001/jama.2016.4326			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK9XF	27139058	Bronze, Green Published			2022-12-28	WOS:000375284400014
J	Crane, LA; Dellavalle, RP				Crane, Lori A.; Dellavalle, Robert P.			Recognizing Sun Safety as an Employee Health Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MELANOMA; US; COLORADO; EXPOSURE	IMPORTANCE Skin cancer prevention remains a national priority. Reducing chronic UV radiation exposure for outdoor workers through sun-safety practices is an important step to help reduce the incidence of skin cancer. OBJECTIVE To determine the presence of occupational sun-safety policies at local government organizations in a single state. DESIGN, SETTING, AND PARTICIPANTS Of 571 potentially eligible local government organizations of Colorado cities, counties, and special tax districts, we enrolled 98 in a randomized pretest-posttest controlled experiment starting August 15, 2010, that evaluated an intervention to promote the adoption of sun-safety policies. We used a policy-coding protocol to evaluate personal sun-protection practices, environmental and administrative controls, and policy directives for sun safety starting February 10, 2011. We report the baseline assessment of the occupational sun-protection policies of these organizations. MAIN OUTCOMES AND MEASURES The presence of an occupational sun-safety policy. RESULTS Overall, 85 local government organizations (87%) had policies that required personal sun-protection practices, including the use of eyewear, hats, and protective clothing. However, of the 98 responding organizations, only 8 hat policies (8%), 10 eyewear policies (10%), and 7 clothing policies (7%) mentioned sun protection as the intent of the policy. Only cosmopoliteness, operationalized as proximity to an urban area, was associated with the presence of a sun-safety policy (odds ratio, 0.99 [95% CI, 0.98-1.00]; P = .02). CONCLUSIONS AND RELEVANCE Outdoorworkers are at increased risk for skin cancer because of long-term exposure to solar UV radiation. Although organizational policies have the potential to increase sun protection in occupational settings, occupational sun-safety policies were uncommon among local governments. Opportunities exist for dermatologists and other physicians to influence occupational sun-safety practices and policies, which are consistent with other safety procedures and could easily be integrated into existing workplace practices.	[Crane, Lori A.] Univ Colorado, Colorado Sch Publ Hlth, Dept Community & Behav Hlth, Anschutz Med Campus,13001 17th Pl,Box B119, Aurora, CO 80045 USA; [Dellavalle, Robert P.] Univ Colorado, Dept Dermatol, Aurora, CO USA; [Dellavalle, Robert P.] US Dept Vet Affairs, Dermatol Serv, Eastern Colorado Hlth Care Syst, Denver, CO USA; [Dellavalle, Robert P.] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Crane, LA (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Dept Community & Behav Hlth, Anschutz Med Campus,13001 17th Pl,Box B119, Aurora, CO 80045 USA.	lori.crane@ucdenver.edu						[Anonymous], SKIN CANC CAUS SUN E; Autier P, 2011, J CLIN ONCOL, V29, pE425, DOI 10.1200/JCO.2010.34.4275; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Godar DE, 2003, PHOTOCHEM PHOTOBIOL, V77, P453, DOI 10.1562/0031-8655(2003)077<0453:UDOYA>2.0.CO;2; Guy GP, 2015, AM J PREV MED, V48, P183, DOI 10.1016/j.amepre.2014.08.036; Juhl AL, 2009, MELANOMA RES, V19, P252, DOI 10.1097/CMR.0b013e32832e0b81; Mayer JA, 2007, AM J PUBLIC HEALTH, V97, P559, DOI 10.2105/AJPH.2005.083907; US Department of Health and Human Services, SURG GEN CALL ACT PR; Walkosz BJ, 2015, JAMA DERMATOL, V151, P991, DOI 10.1001/jamadermatol.2015.0575	10	1	1	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1894	1895		10.1001/jama.2016.1008	http://dx.doi.org/10.1001/jama.2016.1008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK9XF	27139062				2022-12-28	WOS:000375284400018
J	Maiti, A; Bhattacharya, S				Maiti, Abhishek; Bhattacharya, Sreyasi			A patient with cancer and nail pigmentation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Maiti, Abhishek] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Bhattacharya, Sreyasi] Pacific Cardiol Associates, Dept Cardiol, Fremont, CA USA	University of Texas System; University of Texas Health Science Center Houston	Maiti, A (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	abhishek.maiti@uth.tmc.edu						Braun RP, 2007, J AM ACAD DERMATOL, V56, P835, DOI 10.1016/j.jaad.2006.12.021; Gilbar Peter, 2009, J Oncol Pharm Pract, V15, P143, DOI 10.1177/1078155208100450; Lateur N, 2002, DERMATOL THER, V15, P131; Quinlan KE, 2005, J AM ACAD DERMATOL, V53, pS112, DOI 10.1016/j.jaad.2004.11.020	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2346	10.1136/bmj.i2346	http://dx.doi.org/10.1136/bmj.i2346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27142474				2022-12-28	WOS:000375574000003
J	Falony, G; Joossens, M; Vieira-Silva, S; Wang, J; Darzi, Y; Faust, K; Kurilshikov, A; Bonder, MJ; Valles-Colomer, M; Vandeputte, D; Tito, RY; Chaffron, S; Rymenans, L; Verspecht, C; De Sutter, L; Lima-Mendez, G; D'hoe, K; Jonckheere, K; Homola, D; Garcia, R; Tigchelaar, EF; Eeckhaudt, L; Fu, JY; Henckaerts, L; Zhernakova, A; Wijmenga, C; Raes, J				Falony, Gwen; Joossens, Marie; Vieira-Silva, Sara; Wang, Jun; Darzi, Youssef; Faust, Karoline; Kurilshikov, Alexander; Bonder, Marc Jan; Valles-Colomer, Mireia; Vandeputte, Doris; Tito, Raul Y.; Chaffron, Samuel; Rymenans, Leen; Verspecht, Chlo; De Sutter, Lise; Lima-Mendez, Gipsi; D'hoe, Kevin; Jonckheere, Karl; Homola, Daniel; Garcia, Roberto; Tigchelaar, Ettje F.; Eeckhaudt, Linda; Fu, Jingyuan; Henckaerts, Liesbet; Zhernakova, Alexandra; Wijmenga, Cisca; Raes, Jeroen			Population-level analysis of gut microbiome variation	SCIENCE			English	Article							FAECALIBACTERIUM-PRAUSNITZII; INTESTINAL MICROBIOTA; ENTEROTYPES; ACQUISITION; METAGENOME; DIVERSITY; RICHNESS; HEALTH; IMPACT; RISK	Fecal microbiome variation in the average, healthy population has remained under-investigated. Here, we analyzed two independent, extensively phenotyped cohorts: the Belgian Flemish Gut Flora Project (FGFP; discovery cohort; N = 1106) and the Dutch LifeLines-DEEP study (LLDeep; replication; N = 1135). Integration with global data sets (N combined = 3948) revealed a 14-genera core microbiota, but the 664 identified genera still underexplore total gut diversity. Sixty-nine clinical and questionnaire-based covariates were found associated to microbiota compositional variation with a 92% replication rate. Stool consistency showed the largest effect size, whereas medication explained largest total variance and interacted with other covariate-microbiota associations. Early-life events such as birth mode were not reflected in adult microbiota composition. Finally, we found that proposed disease marker genera associated to host covariates, urging inclusion of the latter in study design.	[Falony, Gwen; Joossens, Marie; Vieira-Silva, Sara; Wang, Jun; Darzi, Youssef; Faust, Karoline; Valles-Colomer, Mireia; Vandeputte, Doris; Tito, Raul Y.; Chaffron, Samuel; Rymenans, Leen; Verspecht, Chlo; De Sutter, Lise; Lima-Mendez, Gipsi; D'hoe, Kevin; Henckaerts, Liesbet; Raes, Jeroen] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium; [Falony, Gwen; Joossens, Marie; Vieira-Silva, Sara; Wang, Jun; Darzi, Youssef; Faust, Karoline; Valles-Colomer, Mireia; Vandeputte, Doris; Tito, Raul Y.; Chaffron, Samuel; Rymenans, Leen; Verspecht, Chlo; De Sutter, Lise; Lima-Mendez, Gipsi; D'hoe, Kevin; Jonckheere, Karl; Homola, Daniel; Garcia, Roberto; Eeckhaudt, Linda; Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Joossens, Marie; Darzi, Youssef; Faust, Karoline; Vandeputte, Doris; Tito, Raul Y.; Chaffron, Samuel; Rymenans, Leen; De Sutter, Lise; D'hoe, Kevin; Jonckheere, Karl; Homola, Daniel; Garcia, Roberto; Eeckhaudt, Linda; Raes, Jeroen] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Microbiol Unit, Brussels, Belgium; [Kurilshikov, Alexander] Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia; [Kurilshikov, Alexander] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Bonder, Marc Jan; Tigchelaar, Ettje F.; Fu, Jingyuan; Zhernakova, Alexandra; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Tigchelaar, Ettje F.; Zhernakova, Alexandra] Top Inst Food & Nutr, Wageningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9700 RB Groningen, Netherlands; [Henckaerts, Liesbet] Univ Hosp Leuven, Dept Gen Internal Med, KU Leuven, Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; University of Groningen; Top Institute Food & Nutrition; University of Groningen; KU Leuven; University Hospital Leuven	Raes, J (corresponding author), Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium.; Raes, J (corresponding author), VIB, Ctr Biol Dis, Leuven, Belgium.; Raes, J (corresponding author), Vrije Univ Brussel, Fac Sci & Bioengn Sci, Microbiol Unit, Brussels, Belgium.	jeroen.raes@kuleuven.be	Kurilshikov, Alexander/GWC-1519-2022; Lima-Mendez, Gipsi/AAX-6291-2021; Fu, JY/GRR-6179-2022; raes, jeroen/D-7835-2018; Fu, Jingyuan/ABE-6868-2020; Chaffron, Samuel/B-2300-2012; Wijmenga, Cisca/AAE-7719-2019; Vieira-Silva, Sara/ABE-1247-2021; Chaffron, Samuel/K-1104-2019; Darzi, Youssef/I-8920-2019; Zhernakova, Alexandra/ABA-9372-2020; Vandeputte, Doris/G-7231-2015; Wijmenga, Cisca/D-2173-2009; Fu, Jingyuan/E-8980-2012; Faust, Karoline/P-7578-2017; Lima-Mendez, Gipsi/AAV-4158-2021; Joossens, Marie/U-7551-2017; Tito, Raul/CAG-3546-2022; Henckaerts, Liesbet/AAB-5706-2021; Falony, Gwen/AAN-5011-2020	Kurilshikov, Alexander/0000-0003-2541-5627; Lima-Mendez, Gipsi/0000-0002-5309-1845; raes, jeroen/0000-0002-1337-041X; Fu, Jingyuan/0000-0001-5578-1236; Chaffron, Samuel/0000-0001-5903-617X; Wijmenga, Cisca/0000-0002-5635-1614; Vieira-Silva, Sara/0000-0002-4616-7602; Chaffron, Samuel/0000-0001-5903-617X; Darzi, Youssef/0000-0001-7655-5764; Vandeputte, Doris/0000-0003-3019-5585; Faust, Karoline/0000-0001-7129-2803; Lima-Mendez, Gipsi/0000-0002-5309-1845; Joossens, Marie/0000-0001-8410-5528; Falony, Gwen/0000-0003-2450-0782; Valles-Colomer, Mireia/0000-0002-1988-6054; Bonder, Marc Jan/0000-0002-8431-3180; Henckaerts, Liesbet/0000-0003-2880-1400; Tito Tadeo, Raul Yhossef/0000-0001-9660-7621	Flemish government [531130359]; Research Fund Flanders (FWO) [G.0924.09]; King Baudouin Foundation [2012-J80000-004]; VIB; Rega institute for Medical Research; KU Leuven; Agency for Innovation by Science and Technology (IWT); Marie Curie Actions FP7 People COFUND [267139]; FWO; Top institiute Food and Nutrition [HEN GH001]; CardioVasculair Onderzoek Nederland [CVON 2012-03]; Netherlands Organization for Scientific Research [NWO-VIDI 864.13.013]; FP7 ERC Advanced Grant [2012-322698];  [FP7 METACARDIS HEALTH-F4-2012-305312]	Flemish government(European Commission); Research Fund Flanders (FWO)(FWO); King Baudouin Foundation; VIB; Rega institute for Medical Research(KU Leuven); KU Leuven(KU Leuven); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Marie Curie Actions FP7 People COFUND; FWO(FWO); Top institiute Food and Nutrition; CardioVasculair Onderzoek Nederland; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); FP7 ERC Advanced Grant; 	FGFP procedures were approved by the medical ethics committee of the University of Brussels Brussels University Hospital (approval 143201215505, 5/12/2012). A declaration concerning the FGFP privacy policy was submitted to the Belgian Commission for the Protection, of Privacy. Written informed consent was obtained from all participants. The FGFP was funded with support of the Flemish government (531130359), the Research Fund Flanders (FWO) Odysseus program (G.0924.09), the King Baudouin Foundation (2012-J80000-004), FP7 METACARDIS HEALTH-F4-2012-305312, VIB, the Rega institute for Medical Research, and KU Leuven. D.V. is funded by the Agency for Innovation by Science and Technology (IWT). S.V.S. is supported by Marie Curie Actions FP7 People COFUND-Proposal 267139 (acronym OMICS@VIB). M.J., S.V.S., G.L.M S.C.. K.F., J.W., and M.V., K.D. are supported by postdoctoral (six) and predoctoral (two) fellowships, respectively, from the FWO. The LifeLines-DEEP study was funded by the Top institiute Food and Nutrition (HEN GH001), CardioVasculair Onderzoek Nederland (CVON 2012-03) the Netherlands Organization for Scientific Research (NWO-VIDI 864.13.013), and FP7 ERC Advanced Grant to C.W. (Agreement no. 2012-322698). We thank P. Cornelis and all members of the Rays lab for lively discussions and feedback. We acknowledge the contribution of Flemish GPs and pharmacists to data. and sample collection. Finally, we thank all FGFP volunteers for participating in the project. Data are available at the European Genotyping Agency (https://www.ebi.ac.uk/ega/)-study no. EGAS00001001689.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Devriese S., 2006, IPH EPI REPORTS; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eloe-Fadrosh EA, 2013, ANNU REV MED, V64, P145, DOI 10.1146/annurev-med-010312-133513; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Holmes I., 2012, PLOS ONE, V7; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132; Mairbaurl H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00332; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rajilic-Stojanovic M, 2015, AM J GASTROENTEROL, V110, P278, DOI 10.1038/ajg.2014.427; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Stock J, 2013, ATHEROSCLEROSIS, V229, P440, DOI 10.1016/j.atherosclerosis.2013.05.019; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	36	1136	1175	22	441	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					560	564		10.1126/science.aad3503	http://dx.doi.org/10.1126/science.aad3503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126039				2022-12-28	WOS:000374998600039
J	Wise, J				Wise, Jacqui			NICE approves innovative treatment for moderate to severe heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; National Institute for Health and Care Excellence, 2016, SAC VALS TREAT SYMPT	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i2402	10.1136/bmj.i2402	http://dx.doi.org/10.1136/bmj.i2402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27121700				2022-12-28	WOS:000375483300010
J	Rafferty, EA; Durand, MA; Conant, EF; Copit, DS; Friedewald, SM; Plecha, DM; Miller, DP				Rafferty, Elizabeth A.; Durand, Melissa A.; Conant, Emily F.; Copit, Debra Somers; Friedewald, Sarah M.; Plecha, Donna M.; Miller, Dave P.			Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TUMOR CHARACTERISTICS; RISK		[Rafferty, Elizabeth A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Rafferty, Elizabeth A.] L&M Radiol, POB 615, West Acton, MA 01720 USA; [Durand, Melissa A.] Yale Univ, Sch Med, New Haven, CT USA; [Conant, Emily F.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Copit, Debra Somers] Albert Einstein Healthcare Network, Philadelphia, PA USA; [Friedewald, Sarah M.] Advocate Lutheran Gen Hosp, Caldwell Breast Ctr, Park Ridge, IL USA; [Friedewald, Sarah M.] Northwestern Univ, Lynn Sage Comprehens Breast Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Plecha, Donna M.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Miller, Dave P.] Genom Hlth, Redwood City, CA USA	Harvard University; Massachusetts General Hospital; Yale University; University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; Northwestern University; Feinberg School of Medicine; Case Western Reserve University; Case Western Reserve University Hospital; Genomic Health	Rafferty, EA (corresponding author), L&M Radiol, POB 615, West Acton, MA 01720 USA.	erafferty@lmradiology.com		Miller, Dave/0000-0003-2947-152X; Plecha, Donna/0000-0003-1714-4337				Bertrand KA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3570; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Slanetz PJ, 2015, NEW ENGL J MED, V372, P593, DOI 10.1056/NEJMp1413728; Yaghjyan L, 2011, J NATL CANCER I, V103, P1179, DOI 10.1093/jnci/djr225	5	137	141	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1784	1786		10.1001/jama.2016.1708	http://dx.doi.org/10.1001/jama.2016.1708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115381	Bronze			2022-12-28	WOS:000374759300026
J	Allain, JP; Owusu-Ofori, AK; Assennato, SM; Marschner, S; Goodrich, RP; Owusu-Ofori, S				Allain, Jean-Pierre; Owusu-Ofori, Alex K.; Assennato, Sonny Michael; Marschner, Susanne; Goodrich, Raymond P.; Owusu-Ofori, Shirley			Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial	LANCET			English	Article							MEROZOITE SURFACE PROTEIN-2; FALCIPARUM; REDUCTION; RIBOFLAVIN; CHILDREN	Background Transfusion-transmitted malaria is a frequent but neglected adverse event in Ghana. We did a randomised controlled clinical trial to assess the efficacy and safety of a whole blood pathogen reduction technology at preventing transfusion transmission of Plasmodium spp parasites. Methods For this randomised, double-blind, parallel-group clinical trial, eligible adult patients (aged >= 18 years) with blood group O+, who required up to two whole blood unit transfusions within 3 days of randomisation and were anticipated to remain in hospital for at least 3 consecutive days after initial transfusion, were enrolled from Komfo Anokye Teaching Hospital in Kumasi, Ghana. The main exclusion criteria were symptoms of clinical malaria, antimalaria treatment within 7 days before randomisation, fever, and haemorrhage expected to require transfusion with up to two units of whole blood during the 3 days following study entry. Eligible patients were randomly assigned 1: 1 by computer-generated permuted block randomisation (block size four) list to receive transfusion with either pathogen-reduced whole blood (treated) or whole blood prepared and transfused by standard local practice (untreated). Patients, health-care providers, and data collectors were masked to treatment allocation. Patients in both groups received up to two whole blood unit transfusions that were retrospectively tested for parasitaemia. Pre-transfusion and post-transfusion blood samples (taken on days 0, 1, 3, 7, and 28) were tested for presence and amount of parasite genome, and assessed for haematological and biochemical parameters. The primary endpoint was the incidence of transfusion-transmitted malaria in non-parasitaemic recipients exposed to parasitaemic whole blood, defined as two consecutive parasitaemic post-transfusion samples with parasite allelic matching, assessed at 1-7 days after transfusion. Secondary endpoints included haematological parameters and a safety analysis of adverse events in patients. This study is registered with ClinicalTrials.gov, number NCT02118428, and with the Pan African Clinical Trials Registry, number PACTR201406000777310. Findings Between March 12, 2014, and Nov 7, 2014, 227 patients were enrolled into the study, one of whom was subsequently excluded because she did not meet the inclusion criteria. Of the 226 randomised patients, 113 were allocated to receive treated whole blood and 113 to receive standard untreated whole blood. 223 patients (111 treated and 112 untreated) received study-related transfusions, whereas three patients (two treated and one untreated) did not. 214 patients (107 treated and 107 untreated) completed the protocol as planned and comprised the per-protocol population. Overall, 65 non-parasitaemic patients (28 treated and 37 untreated) were exposed to parasitaemic blood. The incidence of transfusion-transmitted malaria was significantly lower for the pathogen-reduced (treated) patients (1 [4%] of 28 patients) than the untreated group (8 [22%] of 37 patients) in this population (p=0.039). Overall, 92 (41%) of 223 patients reported 145 treatment-related emergent adverse events during the conduct of the study, with a similar incidence of adverse events between groups receiving untreated or treated whole blood. No transfusion-related deaths occurred in the trial. Interpretation Treatment of whole blood with the Mirasol pathogen reduction system for whole blood reduced the incidence of transfusion-transmitted malaria. The primary endpoint of the study was achieved in the population of non-parasitaemic patients receiving parasitaemic whole blood. The safety profile and clinical outcomes were similar across the two treatment groups.	[Allain, Jean-Pierre; Assennato, Sonny Michael] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Owusu-Ofori, Alex K.] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana; [Marschner, Susanne; Goodrich, Raymond P.] Terumo BCT, Lakewood, CO USA; [Owusu-Ofori, Shirley] Komfo Anokye Teaching Hosp, Transfus Med Unit, Kumasi, Ghana	University of Cambridge; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Allain, JP (corresponding author), Univ Cambridge, Cambridge Blood Ctr, Dept Haematol, Long Rd, Cambridge CB2 0PT, England.	jpa1000@cam.ac.uk	Goodrich, Raymond P./D-7014-2019; Owusu-Ofori, Alex/AAU-9071-2020	Goodrich, Raymond P./0000-0002-5945-4571; Owusu-Ofori, Alex Kwame/0000-0002-2172-8645	Terumo BCT Inc.	Terumo BCT Inc.	Terumo BCT Inc.	Candotti D, 2001, BRIT J HAEMATOL, V113, P37, DOI 10.1046/j.1365-2141.2001.02679.x; Dechavanne C, 2013, INFECT GENET EVOL, V20, P16, DOI 10.1016/j.meegid.2013.07.026; Eisen D, 1998, INFECT IMMUN, V66, P239, DOI 10.1128/IAI.66.1.239-246.1998; El Chaar M, 2013, TRANSFUSION, V53, P3174, DOI 10.1111/trf.12235; Fast LD, 2013, TRANSFUSION, V53, P373, DOI 10.1111/j.1537-2995.2012.03715.x; Freimanis G, 2013, TRANSFUSION, V53, P1429, DOI 10.1111/j.1537-2995.2012.03943.x; Goodrich RP, 2010, BIOLOGICALS, V38, P20, DOI 10.1016/j.biologicals.2009.10.016; Keil SD, 2012, VOX SANG, V103, P144; Ogouyemi-Hounto A, 2013, PARASITE, V20, DOI 10.1051/parasite/2013039; Okoye OT, 2015, TRANSFUSION, V55, P532, DOI 10.1111/trf.12894; Owusu-Ofori S, 2005, TRANSFUSION, V45, P1542, DOI 10.1111/j.1537-2995.2005.00567.x; Owusu-Ofori S, 2015, SHOCK, V44, P33, DOI 10.1097/SHK.0000000000000280; Pidcoke HF, 2013, TRANSFUSION, V53, p137S, DOI 10.1111/trf.12048; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930	14	83	86	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1753	1761		10.1016/S0140-6736(16)00581-X	http://dx.doi.org/10.1016/S0140-6736(16)00581-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	27116282				2022-12-28	WOS:000374541900028
J	Hollen, SM; Gupta, JA				Hollen, S. M.; Gupta, J. A.			Painting magnetism on a canvas of graphene	SCIENCE			English	Editorial Material									[Hollen, S. M.] Univ New Hampshire, Dept Phys, Durham, NH 03824 USA; [Gupta, J. A.] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA	University System Of New Hampshire; University of New Hampshire; Ohio State University	Gupta, JA (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.	jgupta@physics.osu.edu	Gupta, Jay/AGK-0162-2022	Gupta, Jay/0000-0002-3908-7719; Hollen, Shawna/0000-0002-9158-7876				Esquinazi P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.227201; Ferrari AC, 2015, NANOSCALE, V7, P4598, DOI 10.1039/c4nr01600a; Gonzalez-Herrero H, 2016, SCIENCE, V352, P437, DOI 10.1126/science.aad8038; Makarova TL, 2006, NATURE, V440, P707, DOI 10.1038/nature04622; Makarova TL, 2001, NATURE, V413, P716, DOI 10.1038/35099527; McCreary KM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186604; Nair RR, 2012, NAT PHYS, V8, P199, DOI [10.1038/NPHYS2183, 10.1038/nphys2183]; Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401; Yazyev OV, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/5/056501; Zhou J, 2009, NANO LETT, V9, P3867, DOI 10.1021/nl9020733	10	17	17	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					415	416		10.1126/science.aaf4521	http://dx.doi.org/10.1126/science.aaf4521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102468				2022-12-28	WOS:000374479700027
J	Kermode-Scott, B				Kermode-Scott, Barbara			Terry-Nan Tannenbaum OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												kermodeb@gmail.com						GRAHAM B, 2016, CANADIAN LUNG ASS BL; SCHWARTZ S, 2014, MONTREAL GAZETTE; TANNENBAUM T, PUBLICATION LIST	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2016	353								i2227	10.1136/bmj.i2227	http://dx.doi.org/10.1136/bmj.i2227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZJ	27102115				2022-12-28	WOS:000374999500003
J	Titov, DV; Cracan, V; Goodman, RP; Peng, J; Grabarek, Z; Mootha, VK				Titov, Denis V.; Cracan, Valentin; Goodman, Russell P.; Peng, Jun; Grabarek, Zenon; Mootha, Vamsi K.			Complementation of mitochondrial electron transport chain by manipulation of the NAD(+)/NADH ratio	SCIENCE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; SUPPORTING ASPARTATE BIOSYNTHESIS; NADH-OXIDASE; SACCHAROMYCES-CEREVISIAE; LACTOBACILLUS-BREVIS; OVERFLOW METABOLISM; CELL-PROLIFERATION; REDOX STATE; PYRUVATE; CHLORAMPHENICOL	A decline in electron transport chain (ETC) activity is associated with many human diseases. Although diminished mitochondrial adenosine triphosphate production is recognized as a source of pathology, the contribution of the associated reduction in the ratio of the amount of oxidized nicotinamide adenine dinucleotide (NAD(+)) to that of its reduced form (NADH) is less clear. We used a water-forming NADH oxidase from Lactobacillus brevis (LbNOX) as a genetic tool for inducing a compartment-specific increase of the NAD(+)/NADH ratio in human cells. We used LbNOX to demonstrate the dependence of key metabolic fluxes, gluconeogenesis, and signaling on the cytosolic or mitochondrial NAD(+)/NADH ratios. Expression of LbNOX in the cytosol or mitochondria ameliorated proliferative and metabolic defects caused by an impaired ETC. The results underscore the role of reductive stress in mitochondrial pathogenesis and demonstrate the utility of targeted LbNOX for direct, compartment-specific manipulation of redox state.	[Titov, Denis V.; Cracan, Valentin; Goodman, Russell P.; Peng, Jun; Grabarek, Zenon; Mootha, Vamsi K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Titov, Denis V.; Cracan, Valentin; Goodman, Russell P.; Peng, Jun; Grabarek, Zenon; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Titov, Denis V.; Cracan, Valentin; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Titov, Denis V.; Cracan, Valentin; Grabarek, Zenon; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Goodman, Russell P.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Mootha, VK (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.; Mootha, VK (corresponding author), Broad Inst, Cambridge, MA USA.	vamsi@hms.harvard.edu	Titov, Denis/L-5943-2015; Titov, Denis/AAI-1600-2021	Titov, Denis/0000-0001-5677-0651; Titov, Denis/0000-0001-5677-0651; Cracan, Valentin/0000-0002-3280-0593; Grabarek, Zenon/0000-0002-3636-5701	NIH [T-R01 R01GM099683, T32DK007191]; Tosteson; Fund for Medical Discovery Postdoctoral Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, T32DK007191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099683] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tosteson; Fund for Medical Discovery Postdoctoral Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Vitvitsky for technical support with HPLC. We thank members of the Mootha lab for valuable discussions and feedback. This work was supported by a T-R01 R01GM099683 grant from NIH. D.V.T. was supported by a Tosteson and Fund for Medical Discovery Postdoctoral Fellowship Award. R.P.G. was supported by a T32DK007191 grant from NIH. V.K.M. is an investigator of the Howard Hughes Medical Institute. The Massachusetts General Hospital has filed a patent application on the technology described in this paper. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession number 5ER0.	Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; de Felipe FL, 2001, INT DAIRY J, V11, P37, DOI 10.1016/S0958-6946(01)00031-0; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; HARRIS M, 1980, SOMAT CELL GENET, V6, P699, DOI 10.1007/BF01538969; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; HIGUCHI M, 1993, J GEN MICROBIOL, V139, P2343, DOI 10.1099/00221287-139-10-2343; Higuchi M, 2000, J BIOSCI BIOENG, V90, P484, DOI 10.1016/S1389-1723(01)80028-1; Hummel W, 2003, BIOTECHNOL LETT, V25, P51, DOI 10.1023/A:1021730131633; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KREBS HA, 1969, BIOCHEM J, V112, P117, DOI 10.1042/bj1120117; Kuzu M, 2005, ACTA CRYSTALLOGR F, V61, P528, DOI 10.1107/S174430910501153X; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; MCKEEHAN WL, 1979, J CELL PHYSIOL, V101, P9, DOI 10.1002/jcp.1041010103; MORAIS R, 1980, BIOCHEM BIOPH RES CO, V94, P71, DOI 10.1016/S0006-291X(80)80189-6; Murray J. F., 2010, MURRAY NADELS TXB RE; PETTIT FH, 1975, BIOCHEM BIOPH RES CO, V65, P575, DOI 10.1016/S0006-291X(75)80185-9; Sies H, 1982, METABOLIC COMPARTMEN; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; STANTON TB, 1993, J BACTERIOL, V175, P2980, DOI 10.1128/JB.175.10.2980-2987.1993; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallen JR, 2015, BIOCHEMISTRY-US, V54, P6815, DOI 10.1021/acs.biochem.5b00676; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	34	189	193	8	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					231	235		10.1126/science.aad4017	http://dx.doi.org/10.1126/science.aad4017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124460	Green Accepted			2022-12-28	WOS:000373681600048
J	Louder, RK; He, Y; Lopez-Blanco, JR; Fang, J; Chacon, P; Nogales, E				Louder, Robert K.; He, Yuan; Lopez-Blanco, Jose Ramon; Fang, Jie; Chacon, Pablo; Nogales, Eva			Structure of promoter-bound TFIID and model of human pre-initiation complex assembly (vol 531, pg 604, 2016)	NATURE			English	Correction									[Chacon, Pablo] CSIC, Rocasolano Phys Chem Inst, Dept Biol Phys Chem, Serrano 119, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)			Chacon, Pablo/B-4211-2014	Chacon, Pablo/0000-0002-3168-4826				Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394	1	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614								10.1038/nature17984	http://dx.doi.org/10.1038/nature17984			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UF	27096372	Bronze			2022-12-28	WOS:000452218600002
J	Butkus, R; Lane, S; Steinmann, AF; Caverzagie, KJ; Tape, TG; Hingle, ST; Moyer, DV				Butkus, Renee; Lane, Susan; Steinmann, Alwin F.; Caverzagie, Kelly J.; Tape, Thomas G.; Hingle, Susan T.; Moyer, Darilyn V.		Alliance Acad Internal Med; Amer Coll Phys Grad Med Educ; Amer Coll Phys	Financing US Graduate Medical Education: A Policy Position Paper of the Alliance for Academic Internal Medicine and the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							PRIMARY-CARE; UNITED-STATES; COST IMPLICATIONS; WORKFORCE; SHORTAGE; NEED; STUDENTS; COULD	In this position paper, the Alliance for Academic Internal Medicine and the American College of Physicians examine the state of graduate medical education (GME) financing in the United States and recent proposals to reform GME funding. They make a series of recommendations to reform the current funding system to better align GME with the needs of the nation's health care workforce. These recommendations include using Medicare GME funds to meet policy goals and to ensure an adequate supply of physicians, a proper specialty mix, and appropriate training sites; spreading the costs of financing GME across the health care system; evaluating the true cost of training a resident and establishing a single per-resident amount; increasing transparency and innovation; and ensuring that primary care residents receive training in well-functioning ambulatory settings that are financially supported for their training roles.	[Butkus, Renee] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Steinmann, Alwin F.] St Joseph Hosp, 1960 North Ogden St,Suite 300, Denver, CO 80218 USA; Univ Nebraska Med Ctr, Omaha, NE USA; [Hingle, Susan T.] Southern Illinois Univ, Sch Med, 801 North Rutledge St,Mail Code 9628, Springfield, IL 62794 USA; Univ Penn, Temple Univ, Philadelphia, PA 19104 USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Cristiana Care Hlth Syst, Newark, DE USA; Michigan State Univ, Lansing, MO USA; Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; St Francis Med Ctr, Trenton, NJ USA; Univ N Carolina, Chapel Hill, NC USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Bassett Healthcare Network, Cooperstown, NY USA; Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA; Univ Vermont, Med Ctr, Burlington, VT USA; Northwell Hlth, Great Neck, NY USA; [Lane, Susan] Stony Brook Med, 101 Nicolls Rd, Stony Brook, NY 11794 USA; [Caverzagie, Kelly J.; Tape, Thomas G.] Univ Nebraska Med Ctr, Dept Internal Med, 42nd St & Emile St, Omaha, NE 68198 USA; [Moyer, Darilyn V.] Temple Univ, Dept Med, 3401 North Broad St,8 Parkinson Pavilion, Philadelphia, PA 19140 USA	American College of Physicians; University of Nebraska System; University of Nebraska Medical Center; Southern Illinois University System; Southern Illinois University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Jefferson University; Michigan State University; Yale University; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham; University of Vermont; University of Vermont Medical Center; Northwell Health; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	RButkus@acponline.org						Accreditation Council for Graduate Medical Education, 2015, ACGME DAT RES BOOK 2; Accreditation Council for Graduate Medical Education, 2014, ACGME DAT RES BOOK 2; Alfero C, 2015, STATE BASED STRATEGY; Alliance for Academic Internal Medicine, 2010, PRINC MED GME REF; Altschuler J, 2012, ANN FAM MED, V10, P396, DOI 10.1370/afm.1400; American Academy of Family Physicians, 2014, ALIGNING RESOURCES I; American College of Emergency Physicians, 2015, AM EM CAR ENV STAT B; American College of Physicians, 2008, IS SHORT PRIM CAR PH; [American Medical Association AmericanEHR], 2015, PHYS US EHR SYST 201; [Anonymous], 2015, 2015 ANN REP BOARDS; [Anonymous], 2012, HLTH POL BRIEFS GRAD; Association of American Medical Colleges, 2010, MED DIR GRAD MED ED; Association of American Medical Colleges, 2013, MED SCH GRAD QUEST 2; Association of American Medical Colleges, 2015, 2015 STAT PHYS WORKF; Association of American Medical Colleges, DO TEACH HOSP SERV A; Association of American Medical Colleges, 2013, MED GRAD MED ED PAYM; Association of American Medical Colleges, 2015, MED SCH ENR APPR 30; Association of American Medical Colleges, 2014, MED STUD ED DEBT COS; Auerbach DI, 2013, HEALTH AFFAIR, V32, P1933, DOI 10.1377/hlthaff.2013.0596; Ben-Ari R, 2014, AM J MED, V127, P1017, DOI 10.1016/j.amjmed.2014.06.040; Bodenheimer TS, 2013, HEALTH AFFAIR, V32, P1881, DOI 10.1377/hlthaff.2013.0234; Brass LF, 2010, ACAD MED, V85, P692, DOI 10.1097/ACM.0b013e3181d3ca17; Butkus R, 2011, ALIGNING GME POLICY; Center for Health Workforce Studies, 2006, FOR ALL IMM PHYS SUP; Centers for Medicare & Medicaid Services, 2014, CMS COST REP FORM 25; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Conn Joseph, 2015, MODERN HEALTHCARE; Council on Graduate Medical Education, 1998, PHYS DISTR HLTH CAR; Council on Graduate Medical Education, 2014, 22 HLTH RES SERV ADM; Deal CL, 2007, ARTHRITIS RHEUM, V56, P722, DOI 10.1002/art.22437; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Duke EM, 2006, REPORT C CRITICAL CA; Eden J., 2014, GRADUATE MED ED MEET; Erikson C, 2007, J ONCOL PRACT, V3, P79, DOI 10.1200/JOP.0723601; Fye WB, 2004, HLTH AFF MILLWOO SWE; Gorey TM, 2004, ANN FAM MED, V2, pS3, DOI 10.1370/afm.130; Government Accountability Office, 2008, GAO08472T; Green LV, 2013, HEALTH AFFAIR, V32, P11, DOI 10.1377/hlthaff.2012.1086; Health Resources and Services Administration, TEACH HLTH CTR GRAD; Health Resources and Services Administration, SHORT DES HLTH PROF; Henderson T., 2015, WASHINGTON POST; [IHS Association of American Medical Colleges], 2015, COMPL PHYS SUPPL DEM; Kane GC, 2009, AM J MED, V122, P1156, DOI 10.1016/j.amjmed.2009.07.010; Kim WJ, 2003, ACAD PSYCHIATR, V27, P277, DOI 10.1176/appi.ap.27.4.277; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Lynge DC, 2008, ARCH SURG-CHICAGO, V143, P345, DOI 10.1001/archsurg.143.4.345; Mullan F, 2013, HEALTH AFFAIR, V32, P1914, DOI 10.1377/hlthaff.2013.0545; National Resident Matching Program, 2015, RES DAT SPEC MATCH S; Nuckols TK, 2012, J GEN INTERN MED, V27, P241, DOI 10.1007/s11606-011-1775-9; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; Petterson SM, 2013, UNEQUAL DISTRIBUTION, DOI [13/0601/od1.pdf, DOI 13/0601/OD1.PDF]; Petterson SM, 2013, AM FAM PHYSICIAN, V88, P230; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Phillips RL, 2009, SPECIALTY GEOGRAPHIC; Pittman D., 2013, MEDPAGE TODAY; [Reynolds Foundation and the John A Hartford Foundation The Donald W], 2009, GRANT FIN PROGR REP; Rieselbach Richard E, 2014, J Grad Med Educ, V6, P395, DOI 10.4300/JGME-D-14-00119.1; Rizza Robert A, 2003, Endocr Pract, V9, P210; Schubert A, 2003, ANESTH ANALG, V96, P207, DOI 10.1097/00000539-200301000-00043; Schwartz MD, 2011, ARCH INTERN MED, V171, P744, DOI 10.1001/archinternmed.2011.139; Scully JH, 2003, ACAD PSYCHIATR, V27, P247, DOI 10.1176/appi.ap.27.4.247; SEIFER SD, 1995, JAMA-J AM MED ASSOC, V274, P685, DOI 10.1001/jama.274.9.685; Steinmann AF, 2011, ANN INTERN MED, V155, P461, DOI 10.7326/0003-4819-155-7-201110040-00008; US Department of Health and Human Services, 2013, PROJ SUPPL DEM PRIM; Weida NA, 2010, ARCH INTERN MED, V170, P389, DOI 10.1001/archinternmed.2009.529; Wynn B, 2006, ALTERNATIVE WAYS FIN; Zhang XY, 2008, AM FAM PHYSICIAN, V77, P1378	67	18	19	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					134	+		10.7326/M15-2917	http://dx.doi.org/10.7326/M15-2917			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2GY	27135592	Green Published			2022-12-28	WOS:000380583100020
J	Fujimitsu, K; Grimaldi, M; Yamano, H				Fujimitsu, Kazuyuki; Grimaldi, Margaret; Yamano, Hiroyuki			Cyclin-dependent kinase 1-dependent activation of APC/C ubiquitin ligase	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC EXIT; ANTIMITOTIC DRUGS; CANCER-CELLS; PHOSPHORYLATION; MITOSIS; PROTEIN; CDK1; CDC20; EXPRESSION	Error-free genome duplication and segregation are ensured through the timely activation of ubiquitylation enzymes. The anaphase-promoting complex or cyclosome (APC/C), a multisubunit E3 ubiquitin ligase, is regulated by phosphorylation. However, the mechanism remains elusive. Using systematic reconstitution and analysis of vertebrate APC/Cs under physiological conditions, we show how cyclin-dependent kinase 1 (CDK1) activates the APC/C through coordinated phosphorylation between Apc3 and Apc1. Phosphorylation of the loop domains by CDK1 in complex with p9/Cks2 (a CDK regulatory subunit) controlled loading of coactivator Cdc20 onto APC/C. A phosphomimetic mutation introduced into Apc1 allowed Cdc20 to increase APC/C activity in interphase. These results define a previously unrecognized subunit-subunit communication over a distance and the functional consequences of CDK phosphorylation. Cdc20 is a potential therapeutic target, and our findings may facilitate the development of specific inhibitors.	[Fujimitsu, Kazuyuki; Grimaldi, Margaret; Yamano, Hiroyuki] UCL, UCL Canc Inst, Cell Cycle Control Grp, London WC1E 6DD, England	University of London; University College London	Yamano, H (corresponding author), UCL, UCL Canc Inst, Cell Cycle Control Grp, London WC1E 6DD, England.	h.yamano@ucl.ac.uk			Marie Curie Cancer Care; Cancer Research UK [C8320/A13586]; Medical Research Council [MR/M010899/1]; MRC [MR/M010899/1] Funding Source: UKRI; Cancer Research UK [13586] Funding Source: researchfish	Marie Curie Cancer Care; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank J. Gannon for monoclonal Apc3-, Cdc20-, and pPlx1-specific antibodies; C. Ellenrieder for p9-specific antibodies; K. Ohsumi for securin-specific antibodies; J. Endicott for purified CDK1-cyclin B; F. Esashi for helpful advice on affinity purification of antibodies; Z. Zhang and D. Barford for providing the methodology and MultiBac-USER expression vectors; members of the Yamano laboratory for helpful discussion; and I. Hagan and F. Uhlmann for critical reading of the manuscript. This work was supported by Marie Curie Cancer Care, Cancer Research UK (C8320/A13586), and Medical Research Council (MR/M010899/1).	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Huang JY, 2007, J CELL SCI, V120, P1990, DOI 10.1242/jcs.006833; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Koivomagi M, 2013, NAT STRUCT MOL BIOL, V20, P1415, DOI 10.1038/nsmb.2706; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Labit H, 2012, EMBO J, V31, P3351, DOI 10.1038/emboj.2012.168; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; McGrath DA, 2013, NAT STRUCT MOL BIOL, V20, P1407, DOI 10.1038/nsmb.2707; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V257, P12, DOI 10.1006/bbrc.1999.0409; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374	30	69	71	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2016	352	6289					1121	1124		10.1126/science.aad3925	http://dx.doi.org/10.1126/science.aad3925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6RT	27103671	Green Submitted			2022-12-28	WOS:000376480800044
J	Lee, JY; Kinch, LN; Borek, DM; Wang, J; Wang, JM; Urbatsch, IL; Xie, XS; Grishin, NV; Cohen, JC; Otwinowski, Z; Hobbs, HH; Rosenbaum, DM				Lee, Jyh-Yeuan; Kinch, Lisa N.; Borek, Dominika M.; Wang, Jin; Wang, Junmei; Urbatsch, Ina L.; Xie, Xiao-Song; Grishin, Nikolai V.; Cohen, Jonathan C.; Otwinowski, Zbyszek; Hobbs, Helen H.; Rosenbaum, Daniel M.			Crystal structure of the human sterol transporter ABCG5/ABCG8	NATURE			English	Article							PROTEIN-SEQUENCE ALIGNMENT; ABC TRANSPORTER; DROSOPHILA-MELANOGASTER; DIFFRACTION INTENSITIES; DENSITY MODIFICATION; DIETARY-CHOLESTEROL; MALTOSE TRANSPORTER; MEMBRANE-PROTEINS; BINDING-PROTEIN; FORCE-FIELD	ATP binding cassette (ABC) transporters play critical roles in maintaining sterol balance in higher eukaryotes. The ABCG5/ABCG8 heterodimer (G5G8) mediates excretion of neutral sterols in liver and intestines(1-5). Mutations disrupting G5G8 cause sitosterolaemia, a disorder characterized by sterol accumulation and premature atherosclerosis. Here we use crystallization in lipid bilayers to determine the X-ray structure of human G5G8 in a nucleotide-free state at 3.9 angstrom resolution, generating the first atomic model of an ABC sterol transporter. The structure reveals a new transmembrane fold that is present in a large and functionally diverse superfamily of ABC transporters. The transmembrane domains are coupled to the nucleotide-binding sites by networks of interactions that differ between the active and inactive ATPases, reflecting the catalytic asymmetry of the transporter. The G5G8 structure provides a mechanistic framework for understanding sterol transport and the disruptive effects of mutations causing sitosterolaemia.	[Lee, Jyh-Yeuan; Wang, Jin; Xie, Xiao-Song; Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kinch, Lisa N.; Borek, Dominika M.; Grishin, Nikolai V.; Otwinowski, Zbyszek; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Kinch, Lisa N.; Borek, Dominika M.; Grishin, Nikolai V.; Otwinowski, Zbyszek; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nikolai V.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Wang, Junmei] Univ Texas SW Med Ctr Dallas, Cecil & Ida Green Ctr Mol Computat & Syst Biol, Dallas, TX 75390 USA; [Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.; Rosenbaum, DM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Rosenbaum, DM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Helen.Hobbs@UTSouthwestern.edu; Dan.Rosenbaum@UTSouthwestern.edu	Lee, Jyh-Yeuan/ACA-2717-2022; Wang, Junmei/C-8636-2014; Borek, Dominika M/D-2943-2011; Wang, Junmei/ACQ-2446-2022	Lee, Jyh-Yeuan/0000-0003-1799-2416; Wang, Junmei/0000-0002-9607-8229; Borek, Dominika M/0000-0002-4321-6253; Wang, Junmei/0000-0002-9607-8229; Kinch, Lisa/0000-0003-3041-2615; Otwinowski, Zbyszek/0000-0003-3640-8545	American Heart Association South Central Affiliate- [0825285F]; American Heart Association Texas Affiliate [0463130Y]; Welch Foundation [I-1770]; Packard Foundation; Howard Hughes Medical Institute; National Institutes of Health [HL72304, P01-HL20948, GM094575, GM053163, GM117080, GM113050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R37HL072304, R01HL072304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117080, R01GM113050, R01GM094575, R01GM053163] Funding Source: NIH RePORTER	American Heart Association South Central Affiliate-(American Heart Association); American Heart Association Texas Affiliate(American Heart Association); Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Texas Southwestern Structural Biology Laboratory and the staff of the Advanced Photon Source (beamlines 19ID and 23ID) for support during data collection. We thank C. Zelasko, L. Donnelly, F. Xu, L. Nie, Z. Wang, Y. Ma, and C. Zhao for technical assistance. We also thank S. Wilkens for comments, and L. Rice, Y. Jiang, and R. Hibbs for providing reagents and equipment. This project was supported by grants from the American Heart Association South Central Affiliate- (0825285F; J.-Y.L.), the American Heart Association Texas Affiliate Beginning Grant-in-Aid (0463130Y; I.L.U.), the Welch Foundation (I-1770; D.M.R.), the Packard Foundation (D.M.R.), the Howard Hughes Medical Institute (H.H.H., N.V.G.), and the National Institutes of Health (HL72304 and P01-HL20948 (H.H.H., J.C.C., X.-S.X.), GM094575 (N.V.G.), GM053163 and GM117080 (Z.O.), and GM113050 (D.M.R.)). The Advanced Photon Source is a US Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory (DE-AC02-06CH11357).	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Borek D, 2013, J SYNCHROTRON RADIAT, V20, P37, DOI 10.1107/S0909049512048807; Borek D, 2007, J SYNCHROTRON RADIAT, V14, P24, DOI 10.1107/S0909049506046589; Borek D, 2010, ACTA CRYSTALLOGR D, V66, P426, DOI 10.1107/S0907444909040177; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS IJ, 1986, GENE, V43, P95, DOI 10.1016/0378-1119(86)90012-0; EWART GD, 1994, J BIOL CHEM, V269, P10370; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lin DYW, 2015, NATURE, V523, P425, DOI 10.1038/nature14623; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Ryckaert J. P., 1977, J COMPUT PHYS, V23, P321; Sagui C, 2004, J CHEM PHYS, V120, P73, DOI 10.1063/1.1630791; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STONE DK, 1984, J BIOL CHEM, V259, P2701; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang FQ, 2013, BIOCHEMISTRY-US, V52, P9497, DOI 10.1021/bi401285j; Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544; Wang J, 2011, J BIOL CHEM, V286, P7308, DOI 10.1074/jbc.M110.210880; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	73	182	186	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					561	+		10.1038/nature17666	http://dx.doi.org/10.1038/nature17666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27144356	Green Accepted			2022-12-28	WOS:000376443100047
J	Katsnelson, A; Ashour, M				Katsnelson, Alla; Ashour, Mohamed			CASHING IN ON SCIENCE	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S6	S7		10.1038/533S6a	http://dx.doi.org/10.1038/533S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UB	27144612	Bronze			2022-12-28	WOS:000452214400001
J	Wapner, J				Wapner, Jessica			TECHNOLOGY TRANSFER The leap to industry	NATURE			English	Editorial Material																			0	8	8	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S13	S15		10.1038/533S13a	http://dx.doi.org/10.1038/533S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144603	Bronze			2022-12-28	WOS:000375473900002
J	Fleming-Dutra, KE; Hersh, AL; Shapiro, DJ; Bartoces, M; Enns, EA; File, TM; Finkelstein, JA; Gerber, JS; Hyun, DY; Linder, JA; Lynfield, R; Margolis, DJ; May, LS; Merenstein, D; Metlay, JP; Newland, JG; Piccirillo, JF; Roberts, RM; Sanchez, GV; Suda, KJ; Thomas, A; Woo, TM; Zetts, RM; Hicks, LA				Fleming-Dutra, Katherine E.; Hersh, Adam L.; Shapiro, Daniel J.; Bartoces, Monina; Enns, Eva A.; File, Thomas M., Jr.; Finkelstein, Jonathan A.; Gerber, Jeffrey S.; Hyun, David Y.; Linder, Jeffrey A.; Lynfield, Ruth; Margolis, David J.; May, Larissa S.; Merenstein, Daniel; Metlay, Joshua P.; Newland, Jason G.; Piccirillo, Jay F.; Roberts, Rebecca M.; Sanchez, Guillermo V.; Suda, Katie J.; Thomas, Ann; Woo, Teri Moser; Zetts, Rachel M.; Hicks, Lauri A.			Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINE; RESPIRATORY-TRACT INFECTIONS; MANAGEMENT; DIAGNOSIS; TRENDS; PRINCIPLES; CHILDREN; UPDATE	IMPORTANCE The National Action Plan for Combating Antibiotic-Resistant Bacteria set a goal of reducing inappropriate outpatient antibiotic use by 50% by 2020, but the extent of inappropriate outpatient antibiotic use is unknown. OBJECTIVE To estimate the rates of outpatient oral antibiotic prescribing by age and diagnosis, and the estimated portions of antibiotic use that may be inappropriate in adults and children in the United States. DESIGN, SETTING, AND PARTICIPANTS Using the 2010-2011 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, annual numbers and population-adjusted rates with 95% confidence intervals of ambulatory visits with oral antibiotic prescriptions by age, region, and diagnosis in the United States were estimated. EXPOSURES Ambulatory care visits. MAIN OUTCOMES AND MEASURES Based on national guidelines and regional variation in prescribing, diagnosis-specific prevalence and rates of total and appropriate antibiotic prescriptions were determined. These rates were combined to calculate an estimate of the appropriate annual rate of antibiotic prescriptions per 1000 population. RESULTS Of the 184 032 sampled visits, 12.6% of visits (95% CI, 12.0%-13.3%) resulted in antibiotic prescriptions. Sinusitis was the single diagnosis associated with the most antibiotic prescriptions per 1000 population (56 antibiotic prescriptions [95% CI, 48-64]), followed by suppurative otitis media (47 antibiotic prescriptions [95% CI, 41-54]), and pharyngitis (43 antibiotic prescriptions [95% CI, 38-49]). Collectively, acute respiratory conditions per 1000 population led to 221 antibiotic prescriptions (95% CI, 198-245) annually, but only 111 antibiotic prescriptions were estimated to be appropriate for these conditions. Per 1000 population, among all conditions and ages combined in 2010-2011, an estimated 506 antibiotic prescriptions (95% CI, 458-554) were written annually, and, of these, 353 antibiotic prescriptions were estimated to be appropriate antibiotic prescriptions. CONCLUSIONS AND RELEVANCE In the United States in 2010-2011, there was an estimated annual antibiotic prescription rate per 1000 population of 506, but only an estimated 353 antibiotic prescriptions were likely appropriate, supporting the need for establishing a goal for outpatient antibiotic stewardship.	[Fleming-Dutra, Katherine E.; Bartoces, Monina; Roberts, Rebecca M.; Sanchez, Guillermo V.; Hicks, Lauri A.] Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A-31, Atlanta, GA 30329 USA; [Hersh, Adam L.] Univ Utah, Pediat Infect Dis, Salt Lake City, UT USA; [Shapiro, Daniel J.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Enns, Eva A.] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN USA; [File, Thomas M., Jr.] Summa Hlth Syst, Akron, OH USA; [File, Thomas M., Jr.] Northeast Ohio Med Univ, Akron, OH USA; [Finkelstein, Jonathan A.] Boston Childrens Hosp, Boston, MA USA; [Finkelstein, Jonathan A.; Linder, Jeffrey A.] Harvard Univ, Sch Med, Boston, MA USA; [Gerber, Jeffrey S.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Gerber, Jeffrey S.; Margolis, David J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hyun, David Y.; Zetts, Rachel M.] Pew Charitable Trusts, Washington, DC USA; [Linder, Jeffrey A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [May, Larissa S.] Univ Calif Davis, Dept Emergency Med, Sacramento, CA 95817 USA; [Merenstein, Daniel] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Newland, Jason G.] Washington Univ, Sch Med, Div Pediat Infect Dis, St Louis, MO USA; [Piccirillo, Jay F.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA; [Suda, Katie J.] Univ Illinois, Dept Vet Affairs, Chicago, IL USA; [Thomas, Ann] Oregon Publ Hlth Div, Portland, OR USA; [Woo, Teri Moser] Pacific Lutheran Univ, Tacoma, WA 98447 USA	Centers for Disease Control & Prevention - USA; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; Summa Health System; Northeast Ohio Medical University (NEOMED); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Minnesota Department of Health (MHD); University of California System; University of California Davis; Georgetown University; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pacific Lutheran University	Fleming-Dutra, KE (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A-31, Atlanta, GA 30329 USA.	ftu2@cdc.gov	Linder, Jeffrey/AAF-3424-2021; Gerber, Jeffrey/GYD-3567-2022	Linder, Jeffrey/0000-0003-2217-184X; Gerber, Jeffrey/0000-0002-3076-3186	Pew Charitable Trusts	Pew Charitable Trusts	This project was made possible through a partnership with the Centers for Disease Control and Prevention (CDC) Foundation. Support for this project was provided by Pew Charitable Trusts.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Centers for Disease Control and Prevention, AMB HLTH CAR DAT; Centers for Disease Control and Prevention, GET SMART KNOW ANT W; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Drekonja DM, 2015, INFECT CONT HOSP EP, V36, P142, DOI 10.1017/ice.2014.41; European Centre for Disease Prevention and Control, ANN EP REP 2014 ANT; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gerber JS, 2013, PEDIATRICS, V131, P677, DOI 10.1542/peds.2012-2500; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Groth A, 2011, INT J PEDIATR OTORHI, V75, P1496, DOI 10.1016/j.ijporl.2011.08.015; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Healthy People, 2020, IMM INF DIS; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Hing E, NONRESPONSE BIAS EST; Irwin RS, 2006, CHEST, V129, p1S, DOI 10.1378/chest.129.1_suppl.1S; Kronman MP, 2014, PEDIATRICS, V134, pE956, DOI 10.1542/peds.2014-0605; Levri K, 2011, EIS C APR 28 ATL GA; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Linder JA, 2008, CLIN INFECT DIS, V47, P744, DOI 10.1086/591149; Metlay JP, 2015, CLIN INFECT DIS, V60, P1317, DOI 10.1093/cid/civ081; National Asthma Education and Prevention Program NH Lung and Blood Institute National Institutes of Health US Department of Health and Human Services., 2007, 3 US DEP HLTH HUM SE; NCQA. HEDIS, 2016, HEDIS 2016; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; Suda KJ, 2014, ANTIMICROB AGENTS CH, V58, P2763, DOI 10.1128/AAC.02239-13; Swedres-Svarm Reports, 2014, SWEDR SVARM REP; The White House, NAT ACT PLAN COMB AN; US Census Bureau Population Division Vintage, 2010, VINT 2010 SPEC TAB V; Vaz LE, 2014, PEDIATRICS, V133, P375, DOI 10.1542/peds.2013-2903; Wald ER, 2013, PEDIATRICS, V132, pE262, DOI 10.1542/peds.2013-1071	39	944	955	7	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1864	1873		10.1001/jama.2016.4151	http://dx.doi.org/10.1001/jama.2016.4151			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139059	Bronze			2022-12-28	WOS:000375284400015
J	Messler, J; Bulger, JB				Messler, Jordan; Bulger, John B.			Update in Hospital Medicine: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA; NONINVASIVE VENTILATION; METAANALYSIS; MORTALITY; DELIRIUM; THERAPY; ADULTS		[Messler, Jordan] Morton Plant Hospitalists, 300 Pinellas St,47, Clearwater, FL 33756 USA; [Bulger, John B.] Geisinger Hlth Syst, 100 North Acad Ave, Danville, PA 17822 USA	Geisinger Health System	Messler, J (corresponding author), Morton Plant Hospitalists, 300 Pinellas St,47, Clearwater, FL 33756 USA.	jordan.messler@baycare.org	Bulger, John/AHD-0594-2022					BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Clark NP, 2015, JAMA INTERN MED, V175, P1163, DOI 10.1001/jamainternmed.2015.1843; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodrigo C, 2015, J INFECT DIS, V212, P183, DOI 10.1093/infdis/jiu645; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Wilson RS, 2012, NEUROLOGY, V78, P950, DOI 10.1212/WNL.0b013e31824d5894	12	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W37	W41		10.7326/M16-0224	http://dx.doi.org/10.7326/M16-0224			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136230				2022-12-28	WOS:000375744000009
J	Moran, I; James, M; Cook, W; Perry, M				Moran, Isabelle; James, Martin; Cook, William; Perry, Michael			10-MINUTE CONSULTATION Tooth avulsion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DENTAL TRAUMATOLOGY GUIDELINES; INTERNATIONAL ASSOCIATION; MANAGEMENT; INJURIES		[Moran, Isabelle; James, Martin; Perry, Michael] Northwick Pk Hosp & Clin Res Ctr, Oral & Maxillofacial Surg, London HA1 3UJ, England; [Cook, William] Northwick Pk Hosp & Clin Res Ctr, Emergency Med, London HA1 3UJ, England	Imperial College London; Imperial College London	Moran, I (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Oral & Maxillofacial Surg, London HA1 3UJ, England.	isabellemoran@nhs.net						Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; Day PF, 2020, DENT TRAUMATOL, V36, P343, DOI 10.1111/edt.12576; Dental Trauma Guide, 2010, DENT TRAUMA GUIDE; Leith R, 2008, DENT TRAUMATOL, V24, pE24, DOI 10.1111/j.1600-9657.2008.00593.x; TROPE M, 1992, ENDOD DENT TRAUMATOL, V8, P183	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i1394	10.1136/bmj.i1394	http://dx.doi.org/10.1136/bmj.i1394			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27114481				2022-12-28	WOS:000375482000001
J	Iacobucci, G				Iacobucci, Gareth			Smokers and overweight patients are denied surgery, royal college finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1993; Royal College of Surgeons, 2016, SMOK OV PAT SOFT TAR	2	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2335	10.1136/bmj.i2335	http://dx.doi.org/10.1136/bmj.i2335			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106805				2022-12-28	WOS:000374999700014
J	Jacobs, C				Jacobs, Colin			Leonard Jacobs OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2304	10.1136/bmj.i2304	http://dx.doi.org/10.1136/bmj.i2304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106603				2022-12-28	WOS:000374999700008
J	McKenzie, NR; Horton, BK; Loomis, SE; Stockli, DF; Planavsky, NJ; Lee, CTA				McKenzie, N. Ryan; Horton, Brian K.; Loomis, Shannon E.; Stockli, Daniel F.; Planavsky, Noah J.; Lee, Cin-Ty A.			Continental arc volcanism as the principal driver of icehouse-greenhouse variability	SCIENCE			English	Article							ATMOSPHERIC CO2; BREAK-UP; CLIMATE; CARBON; HISTORY; TRENDS; RECORD; EARTH; MODEL	Variations in continental volcanic arc emissions have the potential to control atmospheric carbon dioxide (CO2) levels and climate change on multimillion-year time scales. Here we present a compilation of similar to 120,000 detrital zircon uranium-lead (U-Pb) ages from global sedimentary deposits as a proxy to track the spatial distribution of continental magmatic arc systems from the Cryogenian period to the present. These data demonstrate a direct relationship between global arc activity and major climate shifts: Widespread continental arcs correspond with prominent early Paleozoic and Mesozoic greenhouse climates, whereas reduced continental arc activity corresponds with icehouse climates of the Cryogenian, Late Ordovician, late Paleozoic, and Cenozoic. This persistent coupled behavior provides evidence that continental volcanic outgassing drove long-term shifts in atmospheric CO2 levels over the past similar to 720 million years.	[McKenzie, N. Ryan; Planavsky, Noah J.] Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA; [McKenzie, N. Ryan; Horton, Brian K.; Loomis, Shannon E.; Stockli, Daniel F.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA; [McKenzie, N. Ryan] Univ Hong Kong, Dept Earth Sci, Pokfulam, Hong Kong, Peoples R China; [Horton, Brian K.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, 8701 Mopac Blvd, Austin, TX 78712 USA; [Lee, Cin-Ty A.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA	Yale University; University of Texas System; University of Texas Austin; University of Hong Kong; University of Texas System; University of Texas Austin; Rice University	McKenzie, NR (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.; McKenzie, NR (corresponding author), Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX 78712 USA.; McKenzie, NR (corresponding author), Univ Hong Kong, Dept Earth Sci, Pokfulam, Hong Kong, Peoples R China.	ryan.mckenzie@yale.edu	Lee, Cin-Ty/AAV-8155-2021; Horton, Brian K/A-1804-2009	Lee, Cin-Ty/0000-0002-3586-0110; Horton, Brian K/0000-0002-1402-3524; McKenzie, Ryan/0000-0003-4489-1004	NSF-Tectonics [EAR-1348031]; NSF [OCE-1338842]; Directorate For Geosciences [1348031] Funding Source: National Science Foundation	NSF-Tectonics(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	N.R.M and B.K.H. acknowledge funding from NSF-Tectonics grant EAR-1348031. N.R.M. and S.E.L. acknowledge the Jackson School of Geosciences Distinguished Postdoctoral Program, University of Texas at Austin. N.R.M. acknowledges the Flint Postdoctoral Program, Yale University. C.-T.A.L. acknowledges funding from NSF award OCE-1338842. We thank C. Reinhard, M. Brandon, D. Evans, A. Smye, and O. Anfinson for helpful discussions. This is University of Texas Institute for Geophysics contribution no. 2955. Literature sources and data tables for new U-Pb ages used in the compilation are provided in the supplementary materials.	Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bradley DC, 2011, EARTH-SCI REV, V108, P16, DOI 10.1016/j.earscirev.2011.05.003; Burton MR, 2013, REV MINERAL GEOCHEM, V75, P323, DOI 10.2138/rmg.2013.75.11; Cawood PA, 2012, GEOLOGY, V40, P875, DOI 10.1130/G32945.1; Condie KC, 2009, EARTH PLANET SC LETT, V282, P294, DOI 10.1016/j.epsl.2009.03.033; Conrad CP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002991; Dasgupta R, 2013, REV MINERAL GEOCHEM, V75, P183, DOI 10.2138/rmg.2013.75.7; Donnadieu Y, 2004, NATURE, V428, P303, DOI 10.1038/nature02408; Ernst RE, 2005, LITHOS, V79, P271, DOI 10.1016/j.lithos.2004.09.004; Evans DAD, 2013, GEOL SOC AM BULL, V125, P1735, DOI 10.1130/B30950.1; Finnegan S, 2011, SCIENCE, V331, P903, DOI 10.1126/science.1200803; Gehrels G, 2014, ANNU REV EARTH PL SC, V42, P127, DOI 10.1146/annurev-earth-050212-124012; Godderis Y, 2014, EARTH-SCI REV, V128, P122, DOI 10.1016/j.earscirev.2013.11.004; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Kerrick DM, 1998, CHEM GEOL, V145, P213, DOI 10.1016/S0009-2541(97)00144-7; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; Lee CTA, 2015, ELEMENTS, V11, P125, DOI 10.2113/gselements.11.2.125; Lee CTA, 2014, EARTH PLANET SC LETT, V393, P266, DOI 10.1016/j.epsl.2014.02.044; Lee CTA, 2013, GEOSPHERE, V9, P21, DOI 10.1130/GES00822.1; Lenardic A, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003663; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; McKenzie NR, 2014, GEOLOGY, V42, P127, DOI 10.1130/G34962.1; Montanez IP, 2013, ANNU REV EARTH PL SC, V41, P629, DOI 10.1146/annurev.earth.031208.100118; Paterson SR, 2015, ELEMENTS, V11, P91, DOI 10.2113/gselements.11.2.91; Pierrehumbert RT, 2011, ANNU REV EARTH PL SC, V39, P417, DOI 10.1146/annurev-earth-040809-152447; Planavsky N. J., 2015, EARTH LIFE TRANSITIO, V21, P47; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Schrag DP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000219; Scotese C. R., 2001, PLATE TECTONIC MAPS; Silver PG, 2008, SCIENCE, V319, P85, DOI 10.1126/science.1148397; Van der Meer DG, 2014, P NATL ACAD SCI USA, V111, P4380, DOI 10.1073/pnas.1315657111; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	38	186	201	7	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					444	447		10.1126/science.aad5787	http://dx.doi.org/10.1126/science.aad5787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102480				2022-12-28	WOS:000374479700043
J	Hong, J; Ball, PA				Hong, Jennifer; Ball, Perry A.			Resolution of Lumbar Disk Herniation without Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hong, Jennifer; Ball, Perry A.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Dartmouth College	Hong, J (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA.	jennifer.hong@hitchcock.org							0	15	19	6	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1564	1564		10.1056/NEJMicm1511194	http://dx.doi.org/10.1056/NEJMicm1511194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	27096582				2022-12-28	WOS:000374383900010
J	Wilt, TJ; MacDonald, R; Brasure, M; Olson, CM; Carlyle, M; Fuchs, E; Khawaja, IS; Diem, S; Koffel, E; Ouellette, J; Butler, M; Kane, RL				Wilt, Timothy J.; MacDonald, Roderick; Brasure, Michelle; Olson, Carin M.; Carlyle, Maureen; Fuchs, Erika; Khawaja, Imran S.; Diem, Susan; Koffel, Erin; Ouellette, Jeannine; Butler, Mary; Kane, Robert L.			Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							LONG-TERM USE; DOUBLE-BLIND; OLDER-ADULTS; COGNITIVE-BEHAVIOR; BENZODIAZEPINE USE; OUTPATIENT TRIAL; SLEEP LATENCY; ZOLPIDEM; EFFICACY; SAFETY	Background: Pharmacologic interventions are often prescribed for insomnia disorder. Purpose: To assess the benefits, harms, and comparative effectiveness of pharmacologic treatments for adults with insomnia disorder. Data Sources: Several electronic databases (2004-September 2015), reference lists, and U.S. Food and Drug Administration (FDA) documents. Study Selection: 35 randomized, controlled trials of at least 4 weeks' duration that evaluated pharmacotherapies available in the United States and that reported global or sleep outcomes; 11 long-term observational studies that reported harm information; FDA review data for nonbenzodiazepine hypnotics and orexin receptor antagonists; and product labels for all agents. Data Extraction: Data extraction by single investigator confirmed by a second reviewer; dual-investigator assessment of risk of bias; consensus determination of strength of evidence. Data Synthesis: Eszopiclone, zolpidem, and suvorexant improved short-term global and sleep outcomes compared with placebo, although absolute effect sizes were small (low-to moderate-strength evidence). Evidence for benzodiazepine hypnotics, melatonin agonists, and antidepressants, and for most pharmacologic interventions in older adults, was insufficient or low strength. Evidence was also insufficient to compare efficacy within or across pharmacotherapy classes or versus behavioral therapy. Harms evidence reported in trials was judged insufficient or low strength; observational studies suggested that use of hypnotics for insomnia was associated with increased risk for dementia, fractures, and major injury. The FDA documents reported that most pharmacotherapies had risks for cognitive and behavioral changes, including driving impairment, and other adverse effects, and they advised dose reduction in women and in older adults. Limitations: Most trials were small and short term and enrolled individuals meeting stringent criteria. Minimum important differences in outcomes were often not established or reported. Data were scant for many treatments. Conclusion: Eszopiclone, zolpidem, and suvorexant may improve short-term global and sleep outcomes for adults with insomnia disorder, but the comparative effectiveness and longterm efficacy of pharmacotherapies for insomnia are not known. Pharmacotherapies for insomnia may cause cognitive and behavioral changes and may be associated with infrequent but serious harms.	Univ Minnesota, Sch Publ Hlth,Evidence Based Practice Ctr, Minneapolis Vet Affairs Hlth Care Syst,Sch Med,Mi, Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN 55455 USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Wilt, Timothy J.; MacDonald, Roderick; Olson, Carin M.; Koffel, Erin] Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA; [Brasure, Michelle; Ouellette, Jeannine; Butler, Mary; Kane, Robert L.] Sch Publ Hlth, Div Hlth Policy & Management, MMC 197,Mayo Mem Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA; [Fuchs, Erika] Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, 301 Univ Blvd, Galveston, TX 77555 USA; [Khawaja, Imran S.] Minnesota Reg Sleep Disorders Ctr, 701 Pk Ave,G8-220, Minneapolis, MN 55415 USA; [Diem, Susan] Univ Minnesota, Dept Med, Sch Med, 1100 Washington Ave S, Minneapolis, MN 55415 USA; [Carlyle, Maureen] Optum Hlth Econ & Outcomes Res, 11000 Optum Circle, Eden Prairie, MN 55344 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Hennepin County Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Texas System; University of Texas Medical Branch Galveston; University of Minnesota System; University of Minnesota Twin Cities; Optum	Wilt, TJ (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA.	tim.wilt@va.gov			Agency for Healthcare Research and Quality [PROSPERO: CRD42014009908]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42014009908)	Allain H, 2001, CLIN DRUG INVEST, V21, P391, DOI 10.2165/00044011-200121060-00001; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ancoli-Israel S, 2005, SLEEP MED, V6, P107, DOI 10.1016/j.sleep.2004.10.015; Ancoli-Israel S, 2010, SLEEP, V33, P225, DOI 10.1093/sleep/33.2.225; Berkman N, 2011, AHRQ PUBLICATION, V11-E006; Brasure M, 2015, COMP EFFECTIVENESS R, V159; Brasure M, 2016, ANN INTERN MED, V165, P113, DOI 10.7326/M15-1782; Carson S, 2008, DRUG CLASS REV NEWER; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; Elie R, 1999, J CLIN PSYCHIAT, V60, P536, DOI 10.4088/JCP.v60n0806; Fry J, 2000, INT CLIN PSYCHOPHARM, V15, P141, DOI 10.1097/00004850-200015030-00003; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Guideline Development Group for the Management of Patients in Primary Care, 2009, CLIN PRACT GUID MAN; Hajak G, 2001, J CLIN PSYCHIAT, V62, P453, DOI 10.4088/JCP.v62n0609; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jaussent I, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-212; Joya FL, 2009, J CLIN SLEEP MED, V5, P377; Kang Dong-Yoon, 2012, J Prev Med Public Health, V45, P219, DOI 10.3961/jpmph.2012.45.4.219; Kripke DF, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-42; Kripke DF, 2008, J SLEEP RES, V17, P245, DOI 10.1111/j.1365-2869.2008.00685.x; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Krystal AD, 2003, SLEEP, V26, P793, DOI 10.1093/sleep/26.7.793; Krystal AD, 2008, SLEEP, V31, P79, DOI 10.1093/sleep/31.1.79; Krystal AD, 2011, SLEEP, V34, P1433, DOI 10.5665/SLEEP.1294; Krystal AD, 2010, SLEEP, V33, P1553, DOI 10.1093/sleep/33.11.1553; Kuriyama A, 2014, SLEEP MED, V15, P385, DOI 10.1016/j.sleep.2013.11.788; Kyle SD, 2010, SLEEP MED REV, V14, P69, DOI 10.1016/j.smrv.2009.07.004; Lahmeyer H, 1997, CLIN DRUG INVEST, V13, P134, DOI 10.2165/00044011-199713030-00003; Lai MM, 2014, MAYO CLIN PROC, V89, P589, DOI 10.1016/j.mayocp.2014.01.021; Lankford A, 2012, SLEEP MED, V13, P133, DOI 10.1016/j.sleep.2011.09.006; Leppik IE, 1997, DRUG DEVELOP RES, V40, P230, DOI 10.1002/(SICI)1098-2299(199703)40:3<230::AID-DDR3>3.3.CO;2-Y; Mayer G, 2009, SLEEP, V32, P351, DOI 10.1093/sleep/32.3.351; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003161, 10.1002/14651858.CD003161]; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; National Institutes of Health, 2005, Sleep, V28, P1049; Perlis ML, 2004, J CLIN PSYCHIAT, V65, P1128; Randall S, 2012, SLEEP, V35, P1551, DOI 10.5665/sleep.2208; Richardson GS, 2009, J CLIN PSYCHIAT, V70, P467, DOI 10.4088/JCP.07m03834; Roth T, 2005, SLEEP MED, V6, P487, DOI 10.1016/j.sleep.2005.06.004; Roth T, 2006, SLEEP MED, V7, P312, DOI 10.1016/j.sleep.2006.01.003; Roth T, 2013, SLEEP, V36, P189, DOI 10.5665/sleep.2370; Rybarczyk B, 2013, CLIN GERONTOLOGIST, V36, P70, DOI 10.1080/07317115.2012.731478; SCHARF MB, 1994, J CLIN PSYCHIAT, V55, P192; SCHLICH D, 1991, J INT MED RES, V19, P271, DOI 10.1177/030006059101900313; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Thomas RE, 1998, CAN FAM PHYSICIAN, V44, P799; Uchimura N, 2011, EXPERT REV NEUROTHER, V11, P215, DOI [10.1586/ern.10.197, 10.1586/ERN.10.197]; Uchiyama M, 2011, SLEEP MED, V12, P127, DOI 10.1016/j.sleep.2010.10.006; Viswanathan M, 2012, ASSESSING RISK BIAS; Voshaar RCO, 2004, EUR NEUROPSYCHOPHARM, V14, P301, DOI 10.1016/S0924-977X(03)00192-5; Wade AG, 2011, CURR MED RES OPIN, V27, P87, DOI 10.1185/03007995.2010.537317; Wade AG, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-51; Walsh JK, 2007, SLEEP, V30, P959, DOI 10.1093/sleep/30.8.959; Walsh JK, 2002, SLEEP MED REV, V6, pS7, DOI 10.1016/S1087-0792(02)80002-8; Walsh JK, 2002, SLEEP MED REV SUPPL, V6, pS31; Walsh JK, 2002, SLEEP MED REV SUPPL, V6, pS10; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892; Xu M, 2011, SLEEP MED, V12, P65, DOI 10.1016/j.sleep.2010.09.003; Zammit G, 2007, J CLIN SLEEP MED, V3, P495; Zammit GK, 2004, CURR MED RES OPIN, V20, P1979, DOI 10.1185/174234304X15174	68	117	125	1	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					103	+		10.7326/M15-1781	http://dx.doi.org/10.7326/M15-1781			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2GY	27136278				2022-12-28	WOS:000380583100017
J	Anderson, I; Robson, B; Connolly, M; Al-Yaman, F; Bjertness, E; King, A; Tynan, M; Madden, R; Bang, A; Coimbra, CEA; Pesantes, MA; Amigo, H; Andronov, S; Armien, B; Obando, DA; Axelsson, P; Bhatti, ZS; Bhutta, ZQA; Bjerregaard, P; Bjertness, MB; Briceno-Leon, R; Broderstad, AR; Bustos, P; Chongsuvivatwong, V; Chu, J; Deji; Gouda, J; Harikumar, R; Htay, TT; Htet, AS; Izugbara, C; Kamaka, M; King, M; Kodavanti, MR; Lara, M; Laxmaiah, A; Lema, C; Taborda, AML; Liabsuetrakul, T; Lobanov, A; Melhus, M; Meshram, I; Miranda, JJ; Mu, TT; Nagalla, B; Nimmathota, A; Popov, AI; Poveda, AMP; Ram, F; Reich, H; Santos, RV; Sein, AA; Shekhar, C; Sherpa, LY; Skold, P; Tano, SA; Tanywe, A; Ugwu, C; Ugwu, F; Vapattanawong, P; Wan, X; Welch, JR; Yang, GH; Yang, ZQ; Yap, L				Anderson, Ian; Robson, Bridget; Connolly, Michele; Al-Yaman, Fadwa; Bjertness, Espen; King, Alexandra; Tynan, Michael; Madden, Richard; Bang, Abhay; Coimbra, Carlos E. A., Jr.; Pesantes, Maria Amalia; Amigo, Hugo; Andronov, Sergei; Armien, Blas; Obando, Daniel Ayala; Axelsson, Per; Bhatti, Zaid Shakoor; Bhutta, Zulfi Qar Ahmed; Bjerregaard, Peter; Bjertness, Marius B.; Briceno-Leon, Roberto; Broderstad, Ann Ragnhild; Bustos, Patricia; Chongsuvivatwong, Virasakdi; Chu, Jiayou; Deji; Gouda, Jitendra; Harikumar, Rachakulla; Htay, Thein Thein; Htet, Aung Soe; Izugbara, Chimaraoke; Kamaka, Martina; King, Malcolm; Kodavanti, Mallikharjuna Rao; Lara, Macarena; Laxmaiah, Avula; Lema, Claudia; Taborda, Ana Maria Leon; Liabsuetrakul, Tippawan; Lobanov, Andrey; Melhus, Marita; Meshram, Indrapal; Miranda, J. Jaime; Mu, Thet Thet; Nagalla, Balkrishna; Nimmathota, Arlappa; Popov, Andrey Ivanovich; Poveda, Ana Maria Penuela; Ram, Faujdar; Reich, Hannah; Santos, Ricardo V.; Sein, Aye Aye; Shekhar, Chander; Sherpa, Lhamo Y.; Skold, Peter; Tano, Sofi A.; Tanywe, Asahngwa; Ugwu, Chidi; Ugwu, Fabian; Vapattanawong, Patama; Wan, Xia; Welch, James R.; Yang, Gonghuan; Yang, Zhaoqing; Yap, Leslie			Indigenous and tribal peoples' health (The Lancet-Lowitja Institute Global Collaboration): a population study	LANCET			English	Article							NEW-ZEALAND; ABORIGINAL MORTALITY; LATIN-AMERICA; CANADA; SAMI; AUSTRALIA; CANCER; INUIT; OBESITY; DETERMINANTS	Background International studies of the health of Indigenous and tribal peoples provide important public health insights. Reliable data are required for the development of policy and health services. Previous studies document poorer outcomes for Indigenous peoples compared with benchmark populations, but have been restricted in their coverage of countries or the range of health indicators. Our objective is to describe the health and social status of Indigenous and tribal peoples relative to benchmark populations from a sample of countries. Methods Collaborators with expertise in Indigenous health data systems were identified for each country. Data were obtained for population, life expectancy at birth, infant mortality, low and high birthweight, maternal mortality, nutritional status, educational attainment, and economic status. Data sources consisted of governmental data, data from non-governmental organisations such as UNICEF, and other research. Absolute and relative differences were calculated. Findings Our data (23 countries, 28 populations) provide evidence of poorer health and social outcomes for Indigenous peoples than for non-Indigenous populations. However, this is not uniformly the case, and the size of the rate difference varies. We document poorer outcomes for Indigenous populations for: life expectancy at birth for 16 of 18 populations with a difference greater than 1 year in 15 populations; infant mortality rate for 18 of 19 populations with a rate difference greater than one per 1000 livebirths in 16 populations; maternal mortality in ten populations; low birthweight with the rate difference greater than 2% in three populations; high birthweight with the rate difference greater than 2% in one population; child malnutrition for ten of 16 populations with a difference greater than 10% in five populations; child obesity for eight of 12 populations with a difference greater than 5% in four populations; adult obesity for seven of 13 populations with a difference greater than 10% in four populations; educational attainment for 26 of 27 populations with a difference greater than 1% in 24 populations; and economic status for 15 of 18 populations with a difference greater than 1% in 14 populations. Interpretation We systematically collated data across a broader sample of countries and indicators than done in previous studies. Taking into account the UN Sustainable Development Goals, we recommend that national governments develop targeted policy responses to Indigenous health, improving access to health services, and Indigenous data within national surveillance systems.	[Anderson, Ian; Reich, Hannah] Univ Melbourne, Melbourne, Vic, Australia; [Robson, Bridget] Univ Otago, Ropu Rangahau Hauora & Eru Pomare, Dunedin, New Zealand; [Connolly, Michele] Int Grp Indigenous Hlth Measurement, Baltimore, MD USA; [Al-Yaman, Fadwa] Australian Inst Hlth & Welf, Indigenous & Childrens Grp, Canberra, ACT, Australia; [Bjertness, Espen; Bjertness, Marius B.; Htet, Aung Soe; Sherpa, Lhamo Y.] Univ Oslo, Inst Hlth & Soc, Dept Community Med, Oslo, Norway; [King, Alexandra] Simon Fraser Univ, Burnaby, BC, Canada; [Tynan, Michael] Lowitja Inst, Melbourne, Vic, Australia; [Madden, Richard] Univ Sydney, Sydney, NSW, Australia; [Bang, Abhay] Soc Educ Act & Res Community Hlth, Gadchiroli, Maharashtra, India; [Coimbra, Carlos E. A., Jr.; Santos, Ricardo V.; Welch, James R.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Pesantes, Maria Amalia; Lema, Claudia] Salud Sin Limites Peru, Lima, Peru; [Pesantes, Maria Amalia; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Ctr Excellence Chron Dis, Lima, Peru; [Amigo, Hugo; Bustos, Patricia; Lara, Macarena] Univ Chile, Santiago, Chile; [Andronov, Sergei; Lobanov, Andrey; Popov, Andrey Ivanovich] Sci Res Ctr Arct, Salekhard, Russia; [Armien, Blas] Univ Interamericana Panama, Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Obando, Daniel Ayala] Dept Adm Nacl Estadist, Bogota, Colombia; [Axelsson, Per] Umea Univ, Ctr Sami Res, Umea, Sweden; [Bhatti, Zaid Shakoor] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfi Qar Ahmed] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfi Qar Ahmed] SickKids Ctr Global Child Hlth, Toronto, ON, Canada; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Briceno-Leon, Roberto] Cent Univ Venezuela, LACSO, Social Sci Lab, Caracas, Venezuela; [Broderstad, Ann Ragnhild; Melhus, Marita] Arctic Univ Norway, Ctr Sami Hlth Res, Fac Hlth, UiT, Tromso, Norway; [Chongsuvivatwong, Virasakdi; Liabsuetrakul, Tippawan] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand; [Chu, Jiayou; Yang, Zhaoqing] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Deji] Tibet Univ, Coll Med, Dept Prevent Med, Lhasa, Tibet, Peoples R China; [Bang, Abhay; Gouda, Jitendra; Ram, Faujdar; Shekhar, Chander] Deemed Univ, Int Inst Populat Sci, Bombay, Maharashtra, India; [Harikumar, Rachakulla; Kodavanti, Mallikharjuna Rao; Laxmaiah, Avula; Meshram, Indrapal; Nagalla, Balkrishna; Nimmathota, Arlappa] Indian Council Med Res, Natl Inst Nutr, Hyderabad, Andhra Pradesh, India; [Htay, Thein Thein; Htet, Aung Soe; Mu, Thet Thet; Sein, Aye Aye] Minist Hlth, Nay Pyi Taw, Myanmar; [Izugbara, Chimaraoke] African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Program, Nairobi, Kenya; [Kamaka, Martina] Univ Hawaii, Dept Native Hawaiian Hlth, Honolulu, HI USA; [Yap, Leslie] Univ Hawaii, Native Hawaiian Ctr Excellence, John A Burns Sch Med, Honolulu, HI USA; [King, Malcolm] Simon Fraser Univ, CIHR Inst Aboriginal Peoples Hlth, Burnaby, BC, Canada; [Taborda, Ana Maria Leon; Poveda, Ana Maria Penuela] Minist Salud Protecc Social, Bogota, Colombia; [Skold, Peter] Umea Univ, Arctic Res Ctr, Umea, Sweden; [Tano, Sofi A.] Umea Univ, Sch Business & Econ, Umea, Sweden; [Tanywe, Asahngwa] Cameroon Ctr Evidence Based Hlth Care, Yaounde, Cameroon; [Ugwu, Chidi] Univ Nigeria, Dept Sociol Anthropol, Nsukka, Nigeria; [Ugwu, Fabian] Fed Univ, Dept Psychol, Ndufu Alike, Nigeria; [Vapattanawong, Patama] Mahidol Univ Salaya, Inst Populat & Social Res, Phuttamonton, Nakhon Pathom, Thailand; [Wan, Xia; Yang, Gonghuan] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing, Peoples R China; [Wan, Xia; Yang, Gonghuan] Peking Union Med Coll, Beijing, Peoples R China	University of Melbourne; University of Otago; University of Oslo; Simon Fraser University; University of Sydney; Fundacao Oswaldo Cruz; Universidad Peruana Cayetano Heredia; Universidad de Chile; Instituto Conmemorativo Gorgas de Estudios de la Salud; Umea University; Aga Khan University; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Southern Denmark; University of Central Venezuela; UiT The Arctic University of Tromso; Prince of Songkla University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Tibet University; International Institute for Population Sciences; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); African Population & Health Research Centre; University of Hawaii System; University of Hawaii System; Simon Fraser University; Umea University; Umea University; University of Nigeria; Mahidol University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Anderson, I (corresponding author), Univ Melbourne, Level 4,Raymond Priestley Bldg, Parkville, Vic 3010, Australia.	i.anderson@unimelb.edu.au	Welch, James R/B-5042-2013; Meshram, Indrapal/AGD-7915-2022; Andronov, Sergei/G-4977-2016; Ugwu, Chidi/AAA-3805-2019; Lobanov, Andrey/AAI-3489-2020; Briceno-Leon, Roberto/HGC-2836-2022; Bjerregaard, Peter/ABD-8894-2020; Ugwu, Fabian/Y-4354-2019; Lobanov, Andrei/AAC-8310-2019; Pesantes, Maria Amalia/L-6547-2019; Nagalla, Balakrishna/GRR-4393-2022; Bhutta, Zulfiqar/L-7822-2015	Welch, James R/0000-0002-9094-5491; Andronov, Sergei/0000-0002-5616-5897; Bjerregaard, Peter/0000-0001-7153-8447; Pesantes, Maria Amalia/0000-0002-0649-3649; Briceno-Leon, Roberto/0000-0002-8882-7787; Ugwu, Chidi/0000-0002-6540-7763; Shekhar, Chander/0000-0002-6090-8470; Nagalla, Balakrishna/0000-0002-5613-0942; Axelsson, Per/0000-0002-3880-2135; Lobanov, Andrey/0000-0002-6615-733X; Ugwu, Fabian/0000-0001-9889-7132; Coimbra Jr., Carlos E. A./0000-0003-4085-1080; Liabsuetrakul, Tippawan/0000-0001-7687-5629; Bhutta, Zulfiqar/0000-0003-0637-599X	Lowitja Institute; Lowitja Institute, Australia's national institute for Aboriginal and Torres Strait Islander health research; Norwegian Ministry of Health and Care Services; Norwegian Directorate of Health, Northern Norway Regional Health Authority; Regional Research Council of Northern Norway; Sami Parliament, Sami National Centre for Mental Health Karasjok; Troms County Council; Finnmark County Council; Nordland County Council; Knut and Alice Wallenberg Foundation: Wallenberg Academy Fellows; Swedish Research Council [2012-5490]; Peruvian National Council of Science and Technology; Brazilian Association of Public Health; Brazilian National Council for Scientific and Technological Development; ICER [1128040] Funding Source: National Science Foundation	Lowitja Institute; Lowitja Institute, Australia's national institute for Aboriginal and Torres Strait Islander health research; Norwegian Ministry of Health and Care Services; Norwegian Directorate of Health, Northern Norway Regional Health Authority; Regional Research Council of Northern Norway; Sami Parliament, Sami National Centre for Mental Health Karasjok; Troms County Council; Finnmark County Council; Nordland County Council; Knut and Alice Wallenberg Foundation: Wallenberg Academy Fellows; Swedish Research Council(Swedish Research CouncilEuropean Commission); Peruvian National Council of Science and Technology; Brazilian Association of Public Health; Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Lowitja Institute.; We thank the countless individuals who have contributed to reviewing this study in various capacities. Funding for the study was provided by The Lowitja Institute, Australia's national institute for Aboriginal and Torres Strait Islander health research. Funding provided by the Lowitja Intitute supported the meetings of contributors in New York and London in 2014. BR would like to thank Gordon Purdie (biostatistician), Department of Public Health, University of Otago, Wellington, New Zealand (for calculating low birthweight and high birthweight from unit record data). FA-Y would like to acknowledge the assistance of Tracy Dixon, Helen Johnstone, and Indrani Pieris-Caldwell from the Indigenous and Children's Group at the Australian Institute of Health and Welfare. EB, GY, XW, and Deji would like to thank Network for University Co-operation Tibet-Norway, University of Oslo, Oslo, Norway for providing support to data collections among adults and children in Tibet. They would also like to thank the China Medical Board Fund, Centre of Disease Prevention and Control of Tibet Autonomous Region (TAR), Centre of Disease Prevention and Control of China, Statistic Bureau of TAR, Health Bureau of TAR, and the Institute of Basic Medical Science at China Academy of Medical Science for providing census, communicable disease, and disease of surveillance points system data in Tibet and mainland China. AB wishes to thank the Office of the Registrar General and Census Commissioner, Government of India (for the national census data including those for tribal people); The International Institute of Population Sciences, Mumbai (for the segregated data on tribal people in India); The National Nutrition Monitoring Bureau, Indian Council of Medical Research, Hyderabad, India (for the data on the nutritional status of tribal people); and the National Sample Survey Office, Ministry of Statistics and Program Implementation, Government of India (for the economic and educational status of tribal people). LYS would like to thank the Himalayan Health and Environmental Services Solukhumbu for providing the maternal and child health data and Prof Om Gurung (Head of the Central Department of Sociology/Anthropology, Tribhuwan University, Nepal). TTH, AAS, MBB, ASH, TTM, and EB acknowledge the Norwegian Programme for Capacity Development in Higher Education and Research for Development and the project MY-NORTH for providing support to data collections among adults in Myanmar. The SAMINOR study (ARB, MM) was funded by the Norwegian Ministry of Health and Care Services, the Norwegian Directorate of Health, Northern Norway Regional Health Authority, the Regional Research Council of Northern Norway, the Sami Parliament, Sami National Centre for Mental Health Karasjok, and the Troms, Finnmark, and Nordland County Councils. The Knut and Alice Wallenberg Foundation: Wallenberg Academy Fellows and the Swedish Research Council Grant Dnr 2012-5490 fund the work of PA and ST. AT acknowledges the Centre for Behavioural and Social Research, Cameroon and the Cameroon Centre for Evidence Based Healthcare for granting access to information on Pygmy health in Cameroon. Core support for the Chief Investigator was provided by the African Population and Health Research Centre by Sida and the Hewlett Foundation. MAP has a postdoctoral fellowship funded by the Peruvian National Council of Science and Technology. AMLT thanks Lia Marcela Guiza for assistance with health indicators. MC, MKa, and LY wish to thank Sam Notzon for his contributions to the sections on data sources and data issues.; CEAC, RVS, and JRW acknowledge the support of the Brazilian Association of Public Health and the Brazilian National Council for Scientific and Technological Development.	Agyepong I, 2015, LANCET, V385, P1377, DOI 10.1016/S0140-6736(15)60024-1; Ahlm K, 2010, INT J CIRCUMPOL HEAL, V69, P129, DOI 10.3402/ijch.v69i2.17432; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Anderson IP, 2008, AUST HEALTH REV, V32, P626, DOI 10.1071/AH080626; Australian Bureau of Statistics, 2013, 2077 0 CENS POP HOUS; Australian Institute of Health and Welfare, 2011, COMP LIF EXP IND PEO; Australian Institute of Health and Welfare, 2009, INT GROUP IND HLTH M; Bastien Joseph W., 1992, DRUM STETHOSCOPE INT; Bjerregaard P, 2003, SCAND J PUBLIC HEALT, V31, P92, DOI 10.1080/14034940210133924; Bramley D, 2005, AM J PUBLIC HEALTH, V95, P844, DOI 10.2105/AJPH.2004.040907; Bramley Dale, 2004, N Z Med J, V117, pU1215; Brustad M, 2014, INT J CIRCUMPOL HEAL, V73, DOI 10.3402/ijch.v73.23147; Carson B., 2007, SOCIAL DETERMINANTS; CLAYTON D, 1993, STAT METHODS EPIDEMI; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Commonwealth of Australia, 2013, NAT AB TORR STRAIT I; Cooke M, 2007, BMC INT HLTH HUM RIG, V7; Cunningham J., 1998, AUSTRALASIAN EPIDEMI, V5, P6; Dachs GU, 2008, LANCET ONCOL, V9, P473, DOI 10.1016/S1470-2045(08)70127-X; Departamento Administrativo Nacional de Estadistica, 2012, DIR CENS DEM DCD NOT; District Health Office, 2009, ANN REPORT; Ferreira L. O., 2013, MED INDIGENAS POLITI; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Freemantle J, 2015, AM J PUBLIC HEALTH, V105, P644, DOI 10.2105/AJPH.2014.301994; Galloway T, 2012, SCAND J PUBLIC HEALT, V40, P712, DOI 10.1177/1403494812462495; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Hales S, 1999, LANCET, V354, P2047, DOI 10.1016/S0140-6736(99)03763-0; Hall G, 2006, INDIGENOUS PEOPLES P; Hall GH, 2012, INDIGENOUS PEOPLES, POVERTY, AND DEVELOPMENT, P1, DOI 10.1017/CBO9781139105729; Hamrick Kari J, 2004, Int J Circumpolar Health, VSuppl 1, P43; Haozous EA, 2014, J ENV PUBLIC HLTH, V2014; Hill K, 2007, INT J EPIDEMIOL, V36, P580, DOI 10.1093/ije/dym011; HOGG RS, 1992, SOC SCI MED, V35, P335, DOI 10.1016/0277-9536(92)90030-T; Hotez PJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000606; Humphrey MD, 2015, AUSTR I HLTH WELFARE, V5; Hunter Ernest, 2002, Emerg Med (Fremantle), V14, P14, DOI 10.1046/j.1442-2026.2002.00281.x; Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933; Kaiser N, 2012, SUICIDOL ONLINE-SOL, V3, P102; Kaiser N, 2010, INT J CIRCUMPOL HEAL, V69, P383, DOI 10.3402/ijch.v69i4.17674; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kukutai T., 2015, STAT J IAOS, V31, P317, DOI [10.3233/sji-150896, DOI 10.3233/SJI-150896, 10.1080/14486563.2020.1786861, DOI 10.1080/14486563.2020.1786861]; KUNITZ SJ, 1990, POPUL DEV REV, V16, P647, DOI 10.2307/1972961; Lacaze DD, 2002, EXPERIENCIAS MED TRA; Larrea Carlos, 2002, Rev Panam Salud Publica, V11, P356, DOI 10.1590/S1020-49892002000500010; Loppie Reading C, 2009, HEATH INEQUALITIES S; Lund E, 2007, INT J CIRCUMPOL HEAL, V66, P113, DOI 10.3402/ijch.v66i2.18241; Maple-Brown LJ, 2013, DIABETES RES CLIN PR, V100, P133, DOI 10.1016/j.diabres.2012.12.017; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Mejia GC, 2010, INT DENT J, V60, P212, DOI 10.1922/IDJ_2565Jamieson04; Mendoza OM, 1983, COMPARISON ALTERNATI; Mitrou F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-201; Moewaka Barnes H, 2013, HAP OR WELLB EARL ST; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Moore SP, 2015, LANCET ONCOL, V16, P1483, DOI 10.1016/S1470-2045(15)00232-6; Moore SP, 2014, CANCER MED-US, V3, P70, DOI 10.1002/cam4.134; Mowbrary M, 2007, SOCIAL DETERMINANTS, P40; Murray CJL, 2015, GPE DISCUSSION PAPER, V8; National Bureau of Statistics of China, 2011, 6 NAT POP CENS 2010; Noahsen P, 2013, ETHNIC DIS, V23, P77; Office of the Registrar General & Census Commissioner India, CENS 2011 FERT TABL; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; Omma L, 2015, ACTA PAEDIATR, V104, P75, DOI 10.1111/apa.12786; Omma L, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.19862; Omma L, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18381; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Paradies Y, 2002, AUST NZ J PUBL HEAL, V26, P11, DOI 10.1111/j.1467-842X.2002.tb00264.x; Paradies Y, 2006, CRIT PUBLIC HEALTH, V16, P143, DOI [10.1080/09581590600828881, DOI 10.1080/09581590600828881]; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Peters EJ, 2011, ABORIG POLICY STUD, V1, P68, DOI 10.5663/aps.v1i2.11685; Ring IT, 1998, MED J AUSTRALIA, V169, P528, DOI 10.5694/j.1326-5377.1998.tb123400.x; Ring IT, 1998, MED J AUSTRALIA, V169, P532; Ruben Alan R, 2009, Pediatr Clin North Am, V56, P1285, DOI 10.1016/j.pcl.2009.09.008; Sarkin J, 2010, J TRANSNATIONAL LAW, V20, P1; Schell LM, 2012, AM J HUM BIOL, V24, P302, DOI 10.1002/ajhb.22257; Schnabel SK, 2009, DEMOGR RES, V21, P109, DOI 10.4054/DemRes.2009.21.5; SHAH CP, 1992, CAN FAM PHYSICIAN, V38, P1205; Shah PS, 2011, WOMEN HEALTH ISS, V21, P28, DOI 10.1016/j.whi.2010.08.005; Simon P, 2012, ETHNIC RACIAL STUD, V35, P1366, DOI 10.1080/01419870.2011.607507; Smylie J, 2006, CAN MED ASSOC J, V175, P602, DOI 10.1503/cmaj.060940; Smylie Janet, 2015, Stat J IAOS, V31, P67; Smylie Janet, 2010, Open Womens Health J, P7; Statbank Greenland, POP POP GROWTH 1901; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Tauli Corpuz V, 2005, UN EC SOC COUNC PERM; The High-Level Committee (or the Xaxa Committee), 2013, REP HIGH LEV COMM SO; Trovato F, 2001, J BIOSOC SCI, V33, P67, DOI 10.1017/S0021932001000670; U.S. National Center for Health Statistics, 2000, GROWTH CHARTS; UN, 2015, STAT WORLD IND PEOPL; UN, 2009, STESA328 UN DEP EC S; UN, 1983, MAN 10 IND TECHN DEM; UN, 2013, MORTPAK WIND VERS 4; UN Department of Economic and Social Affairs, 2004, CONC IND PEOPL; UN General Assembly, 2015, A RES 70 1 TRANSF OU; United Nations Permanent Forum on Indigenous Issues, WHO AR IND PEOPL; Valery PC, 2014, LANCET ONCOL, V15, pE90, DOI 10.1016/S1470-2045(13)70553-9; Walter M, 2014, INDIGENOUS STAT QUAN; Weil EJ, 2006, ETHN DIS S2, V16, pS2; WHO, 2011, NONC DIS RISK FACT S; World Health Organization, 2006, WHO CHILD GROWTH STA; Young TK, 2007, AM J PUBLIC HEALTH, V97, P691, DOI 10.2105/AJPH.2005.080614; YOUNG TK, 1992, INT J EPIDEMIOL, V21, P730, DOI 10.1093/ije/21.4.730; Zhai ZW., 1989, MODERN POPULATION AN	105	480	492	16	285	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					131	157		10.1016/S0140-6736(16)00345-7	http://dx.doi.org/10.1016/S0140-6736(16)00345-7			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5TZ	27108232				2022-12-28	WOS:000379269200030
J	Kirmayer, LJ; Brass, G				Kirmayer, Laurence J.; Brass, Gregory			Addressing global health disparities among Indigenous peoples	LANCET			English	Editorial Material									[Kirmayer, Laurence J.] McGill Univ, Div Social & Transcultural Psychiat, Montreal, PQ H3T 1E4, Canada; Jewish Gen Hosp, Inst Community & Family Psychiat, Culture & Mental Hlth Res Unit, Montreal, PQ H3T 1E4, Canada	McGill University; McGill University	Kirmayer, LJ (corresponding author), McGill Univ, Div Social & Transcultural Psychiat, Montreal, PQ H3T 1E4, Canada.	laurence.kirmayer@mcgill.ca	Kirmayer, Laurence J/F-8022-2019	Kirmayer, Laurence J/0000-0002-6228-1739				Anderson I, 2016, LANCET; Anderson T, 2016, ASSESSING SOCIAL DET; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kirmayer LJ, 2014, TRANSCULT PSYCHIATRY, V51, P759, DOI 10.1177/1363461514557202; Kirmayer LJ, 2009, INT J INDIG HEALTH, V5, P62; Marmot M, 2015, HLTH GAP CHALLENGE U; Mitrou F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-201; Paradies Y, 2016, J POPUL RES, V33, P83, DOI 10.1007/s12546-016-9159-y; Truth and Reconciliation Commission of Canada, HON TRUTH REC FUT; UN Department of Economic and Social Affairs, 2015, STAT WORLDS IND PEOP; Valeggia CR, 2015, ANNU REV ANTHROPOL, V44, P117, DOI 10.1146/annurev-anthro-102214-013831; Whitehead M, 2016, HEALTH PLACE, V39, P51, DOI 10.1016/j.healthplace.2016.02.002	12	42	42	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					105	106		10.1016/S0140-6736(16)30194-5	http://dx.doi.org/10.1016/S0140-6736(16)30194-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ5TZ	27108233				2022-12-28	WOS:000379269200008
J	Kim, TH; Puggioni, D; Yuan, Y; Xie, L; Zhou, H; Campbell, N; Ryan, PJ; Choi, Y; Kim, JW; Patzner, JR; Ryu, S; Podkaminer, JP; Irwin, J; Ma, Y; Fennie, CJ; Rzchowski, MS; Pan, XQ; Gopalan, V; Rondinelli, JM; Eom, CB				Kim, T. H.; Puggioni, D.; Yuan, Y.; Xie, L.; Zhou, H.; Campbell, N.; Ryan, P. J.; Choi, Y.; Kim, J-W; Patzner, J. R.; Ryu, S.; Podkaminer, J. P.; Irwin, J.; Ma, Y.; Fennie, C. J.; Rzchowski, M. S.; Pan, X. Q.; Gopalan, V.; Rondinelli, J. M.; Eom, C. B.			Polar metals by geometric design	NATURE			English	Article							IMPROPER FERROELECTRICITY; PEROVSKITE; TRANSITION; ROUTE; FILMS	Gauss's law dictates that the net electric field inside a conductor in electrostatic equilibrium is zero by effective charge screening; free carriers within a metal eliminate internal dipoles that may arise owing to asymmetric charge distributions(1). Quantum physics supports this view(2), demonstrating that delocalized electrons make a static macroscopic polarization, an ill-defined quantity in metals(3)-it is exceedingly unusual to find a polar metal that exhibits long-range ordered dipoles owing to cooperative atomic displacements aligned from dipolar interactions as in insulating phases(4). Here we describe the quantum mechanical design and experimental realization of room-temperature polar metals in thin-film ANiO(3) perovskite nickelates using a strategy based on atomic-scale control of inversion-preserving (centric) displacements(5). We predict with ab initio calculations that cooperative polar A cation displacements are geometrically stabilized with a non-equilibrium amplitude and tilt pattern of the corner-connected NiO6 octahedra-the structural signatures of perovskites-owing to geometric constraints imposed by the underlying substrate. Heteroepitaxial thin-films grown on LaAlO3 (111) substrates fulfil the design principles. We achieve both a conducting polar monoclinic oxide that is inaccessible in compositionally identical films grown on (001) substrates, and observe a hidden, previously unreported(6-10), non-equilibrium structure in thin-film geometries. We expect that the geometric stabilization approach will provide novel avenues for realizing new multifunctional materials with unusual coexisting properties.	[Kim, T. H.; Patzner, J. R.; Ryu, S.; Podkaminer, J. P.; Ma, Y.; Eom, C. B.] Univ Wisconsin, Dept Mat Sci & Engn, 1509 Univ Ave, Madison, WI 53706 USA; [Puggioni, D.; Rondinelli, J. M.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Yuan, Y.; Gopalan, V.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Yuan, Y.; Gopalan, V.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Xie, L.; Pan, X. Q.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92697 USA; [Xie, L.; Pan, X. Q.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Xie, L.] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Xie, L.] Nanjing Univ, Coll Engn & Appl Sci, Nanjing 210093, Jiangsu, Peoples R China; [Zhou, H.; Ryan, P. J.; Choi, Y.; Kim, J-W] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Campbell, N.; Irwin, J.; Rzchowski, M. S.] Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA; [Fennie, C. J.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Irvine; University of California System; University of California Irvine; Nanjing University; Nanjing University; United States Department of Energy (DOE); Argonne National Laboratory; University of Wisconsin System; University of Wisconsin Madison; Cornell University	Eom, CB (corresponding author), Univ Wisconsin, Dept Mat Sci & Engn, 1509 Univ Ave, Madison, WI 53706 USA.	ceom@wisc.edu	Puggioni, Danilo/ABD-2198-2020; Zhou, Hua/V-1827-2017; Zhou, Hai/B-7331-2009; Pan, Xiaoqing/ABF-4088-2020; Patzner, Jacob/P-7064-2017; Puggioni, Danilo/AAA-6632-2020; Rondinelli, James M/A-2071-2009; Rzchowski, Mark S/X-3600-2019; Eom, Chang-Beom/I-5567-2014	Zhou, Hua/0000-0001-9642-8674; Pan, Xiaoqing/0000-0002-0965-8568; Patzner, Jacob/0000-0001-5338-5256; Puggioni, Danilo/0000-0002-2128-4191; Rondinelli, James M/0000-0003-0508-2175; Choi, Yongseong/0000-0001-5790-3129; Kim, Jong-Woo/0000-0001-9641-2947; Yuan, Yakun/0000-0001-7384-9767; Irwin, Julian/0000-0002-4845-7558	National Science Foundation (NSF) under Designing Materials to Revolutionize and Engineer our Future grant [DMR-1234096]; US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES) [DE-FG02-06ER46327]; DOE-BES [DE-SC0012375, DE-AC-02-06CH11357]; Army Research Office [W911NF-15-1-0017]; NSF XSEDE [ACI-1053575];  [DMR-1056441]; Direct For Mathematical & Physical Scien [1056441] Funding Source: National Science Foundation; Division Of Materials Research [1234096] Funding Source: National Science Foundation	National Science Foundation (NSF) under Designing Materials to Revolutionize and Engineer our Future grant(National Science Foundation (NSF)); US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE-BES(United States Department of Energy (DOE)); Army Research Office; NSF XSEDE(National Science Foundation (NSF)); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation (NSF) under Designing Materials to Revolutionize and Engineer our Future grant number DMR-1234096. Transport measurement at the University of Wisconsin-Madison was supported by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), under award number DE-FG02-06ER46327. The work at Pennsylvania State University was supported by the DOE-BES, under award number DE-SC0012375 (Y.Y., V.G.). The work at Northwestern University was supported by the Army Research Office under award numbers W911NF-15-1-0017 (J.M.R.) and DOE-BES DE-SC0012375 (D.P.). The work at the Argonne National Laboratory is supported by the DOE-BES under contract number DE-AC-02-06CH11357 (H.Z., P.J.R., Y.C., J.W.K.). The computational work made use of the Haise and Kilrain clusters at the Navy DoD Supercomputing Resource Center under the High Performance Computing Modernization Program initiative of the US Department of Defense and NSF XSEDE (ACI-1053575). The work at Cornell University was funded by DMR-1056441 (C.J.F.).	ANDERSON PW, 1965, PHYS REV LETT, V14, P217, DOI 10.1103/PhysRevLett.14.217; Benedek NA, 2013, J PHYS CHEM C, V117, P13339, DOI 10.1021/jp402046t; Bilc DI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.147602; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Breckenfeld E, 2014, ACS APPL MATER INTER, V6, P22436, DOI 10.1021/am506436s; Catalan G, 2008, PHASE TRANSIT, V81, P729, DOI 10.1080/01411590801992463; Catalano S, 2015, APL MATER, V3, DOI 10.1063/1.4919803; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Cohen-Tannoudji C., 1989, PHOTONS ATOMS INTRO; Gibert M, 2012, NAT MATER, V11, P195, DOI [10.1038/nmat3224, 10.1038/NMAT3224]; Halilov SV, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.174107; Hepting M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.227206; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; King PDC, 2014, NAT NANOTECHNOL, V9, P443, DOI [10.1038/nnano.2014.59, 10.1038/NNANO.2014.59]; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kumah DP, 2014, ADV MATER, V26, P1935, DOI 10.1002/adma.201304256; Liu JA, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3451462; Middey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06819; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Nelson-Cheeseman BB, 2014, ADV FUNCT MATER, V24, P6884, DOI 10.1002/adfm.201401077; Oh YS, 2015, NAT MATER, V14, P407, DOI [10.1038/NMAT4168, 10.1038/nmat4168]; Okamoto S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195121; Orobengoa D, 2009, J APPL CRYSTALLOGR, V42, P820, DOI 10.1107/S0021889809028064; Park H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.245133; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Perez-Mato JM, 2010, ACTA CRYSTALLOGR A, V66, P558, DOI 10.1107/S0108767310016247; Pitcher MJ, 2015, SCIENCE, V347, P420, DOI 10.1126/science.1262118; Puggioni D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4432; Resta R, 2002, J PHYS-CONDENS MAT, V14, pR625, DOI 10.1088/0953-8984/14/20/201; Rondinelli JM, 2012, MRS BULL, V37, P261, DOI 10.1557/mrs.2012.49; Rondinelli JM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113402; Ruegg A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.201103; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Shi YG, 2013, NAT MATER, V12, P1024, DOI [10.1038/nmat3754, 10.1038/NMAT3754]; VAUGHEY JT, 1991, CHEM MATER, V3, P935, DOI 10.1021/cm00017a032; Zhou H, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/19/195302; Zhou H, 2010, P NATL ACAD SCI USA, V107, P8103, DOI 10.1073/pnas.0914702107	40	214	217	10	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					68	+		10.1038/nature17628	http://dx.doi.org/10.1038/nature17628			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27096369				2022-12-28	WOS:000375473900040
J	Sohn, E				Sohn, Emily			COLLABORATION The geography of discovery	NATURE			English	Editorial Material																		Agrawal A., 2014, CHANGING FRONTIER RE, P75; Agrawal A, 2008, AM ECON REV, V98, P1578, DOI 10.1257/aer.98.4.1578; [Anonymous], 2012, RATE DIRECTION INVEN; Bernstein S., 2015, J FINANCE; Catalini C., 2015, 2126890 ROT SCH MAN, DOI 10.2139/ssrn.2126890.; Delgado M., 2015, CLUSTERS GREAT RECES; Fitjar R. D., 2016, DP11067 CEPR; Giroud X. Q., 2012, J ECON, V128, P861; Guzman J, 2015, SCIENCE, V347, P606, DOI 10.1126/science.aaa0201; Lee K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014279; Moretti E., 2012, NEW GEOGRAPHY JOBS; Waber B., 2010, P 30 INT SUNB SOC NE; [No title captured]	13	6	6	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S40	S42		10.1038/533S40a	http://dx.doi.org/10.1038/533S40a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144608	Bronze			2022-12-28	WOS:000375473900007
J	Bartner, S				Bartner, Simon			Antony Pascal Barter	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353								i2535	10.1136/bmj.i2535	http://dx.doi.org/10.1136/bmj.i2535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27147105				2022-12-28	WOS:000375575500015
J	[Anonymous]				[Anonymous]			Cooperation in Social Insurance Investigation (Reprinted from JAMA, vol 66, pg 1469, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1916, JAMA, V66, P1469	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1909	1909		10.1001/jama.2015.17084	http://dx.doi.org/10.1001/jama.2015.17084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139075				2022-12-28	WOS:000375284400030
J	Dyer, C				Dyer, Clare			Clause in junior contract that allows terms to vary is "a form of slavery," says barrister	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2473	10.1136/bmj.i2473	http://dx.doi.org/10.1136/bmj.i2473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129596				2022-12-28	WOS:000375484100018
J	Maiti, A; Lodato, RF				Maiti, Abhishek; Lodato, Robert F.			An abnormal post-procedure chest radiograph	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Maiti, Abhishek] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Lodato, Robert F.] Univ Texas Hlth Sci Ctr Houston, Dept Pulm Crit Care & Sleep Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Maiti, A (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	abhishek.maiti@uth.tmc.edu							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2359	10.1136/bmj.i2359	http://dx.doi.org/10.1136/bmj.i2359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130350				2022-12-28	WOS:000375484100001
J	Csiszar, A				Csiszar, Alex			Troubled from the start	NATURE			English	Editorial Material									[Csiszar, Alex] Harvard Univ, Hist Sci, Cambridge, MA 02138 USA	Harvard University	Csiszar, A (corresponding author), Harvard Univ, Hist Sci, Cambridge, MA 02138 USA.	acsiszar@fas.harvard.edu						[Anonymous], 1845, WADES LONDON REV, V1, P351; [Anonymous], 1894, NATURE, V49, P563; [Anonymous], 1832, P R SOC LOND, V3, P140; [Anonymous], 1832, COMMUNICATION; [Anonymous], 1833, NEW MONTHLY MAGAZINE, V39, P2; [Anonymous], 1831, COMMUNICATION; Baldwin M, 2015, MAKING NATURE HIST S; Kaiser D, 2014, NATURE, V505, P153, DOI 10.1038/505153a; Ziman J. M., 1968, PUBLIC KNOWLEDGE ESS	9	72	74	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					306	308		10.1038/532306a	http://dx.doi.org/10.1038/532306a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7WU	27111616	Bronze			2022-12-28	WOS:000374424700014
J	Pasakarnis, L; Dreher, D; Brunner, D				Pasakarnis, Laurynas; Dreher, David; Brunner, Damian			SnapShot: Mechanical Forces in Development I	CELL			English	Editorial Material							MORPHOGENESIS; ZEBRAFISH		[Pasakarnis, Laurynas; Dreher, David; Brunner, Damian] Univ Zurich, Dept Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Pasakarnis, L (corresponding author), Univ Zurich, Dept Mol Life Sci, CH-8057 Zurich, Switzerland.		Brunner, Damian/F-2024-2011	Brunner, Damian/0000-0001-5250-492X				Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bruce AEE, 2016, DEV DYNAM, V245, P244, DOI 10.1002/dvdy.24353; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Ernst S, 2012, DEVELOPMENT, V139, P4571, DOI 10.1242/dev.083253; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; Monier B, 2015, NATURE, V518, P245, DOI 10.1038/nature14152; Roper Katja, 2013, Bioarchitecture, V3, P45, DOI 10.4161/bioa.25339; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723	10	10	10	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					754	+	754.e1	10.1016/j.cell.2016.03.044	http://dx.doi.org/10.1016/j.cell.2016.03.044			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104981	Bronze			2022-12-28	WOS:000374636800031
J	Kotecha, D; Manzano, L; Krum, H; Rosano, G; Holmes, J; Altman, DG; Collins, PD; Packer, M; Wikstrand, J; Coats, AJS; Cleland, JGF; Kirchhof, P; von Lueder, TG; Rigby, AS; Andersson, B; Lip, GYH; van Veldhuisen, DJ; Shibata, MC; Wedel, H; Bohm, M; Flather, MD				Kotecha, Dipak; Manzano, Luis; Krum, Henry; Rosano, Giuseppe; Holmes, Jane; Altman, Douglas G.; Collins, Peter D.; Packer, Milton; Wikstrand, John; Coats, Andrew J. S.; Cleland, John G. F.; Kirchhof, Paulus; von Lueder, Thomas G.; Rigby, Alan S.; Andersson, Bert; Lip, Gregory Y. H.; van Veldhuisen, Dirk J.; Shibata, Marcelo C.; Wedel, Hans; Boehm, Michael; Flather, Marcus D.		Beta-Blockers Heart Failure Collab	Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED INTERVENTION TRIAL; LEFT-VENTRICULAR DYSFUNCTION; ATRIAL-FIBRILLATION; METOPROLOL CR/XL; ELDERLY-PATIENTS; GENDER; CARVEDILOL; MORTALITY; ASSOCIATION; BLOCKADE	OBJECTIVES To determine the efficacy and tolerability of beta blockers in a broad age range of women and men with heart failure with reduced ejection fraction (HFrEF) by pooling individual patient data from placebo controlled randomised trials. DESIGN Prospectively designed meta-analysis of individual patient data from patients aged 40-85 in sinus rhythm at baseline, with left ventricular ejection fraction < 0.45. PARTICIPANTS 13 833 patients from 11 trials; median age 64; 24% women. MAIN OUTCOME MEASURES The primary outcome was all cause mortality; the major secondary outcome was admission to hospital for heart failure. Analysis was by intention to treat with an adjusted one stage Cox proportional hazards model. RESULTS Compared with placebo, beta blockers were effective in reducing mortality across all ages: hazard ratios were 0.66 (95% confidence interval 0.53 to 0.83) for the first quarter of age distribution (median age 50); 0.71 (0.58 to 0.87) for the second quarter (median age 60); 0.65 (0.53 to 0.78) for the third quarter (median age 68); and 0.77 (0.64 to 0.92) for the fourth quarter (median age 75). There was no significant interaction when age was modelled continuously (P=0.1), and the absolute reduction in mortality was 4.3% over a median follow-up of 1.3 years (number needed to treat 23). Admission to hospital for heart failure was significantly reduced by beta blockers, although this effect was attenuated at older ages (interaction P=0.05). There was no evidence of an interaction between treatment effect and sex in any age group. Drug discontinuation was similar regardless of treatment allocation, age, or sex (14.4% in those give beta blockers, 15.6% in those receiving placebo). CONCLUSION Irrespective of age or sex, patients with HFrEF in sinus rhythm should receive beta blockers to reduce the risk of death and admission to hospital.	[Kotecha, Dipak; Kirchhof, Paulus; Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Kotecha, Dipak; Krum, Henry] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Manzano, Luis] Univ Alcala de Henares, Hosp Univ Ramon & Cajal, Dept Internal Med, Madrid, Spain; [Rosano, Giuseppe] IRCCS San Raffaele Pisana, Dept Med Sci, Rome, Italy; [Rosano, Giuseppe] St Georges Univ London, Cardiovasc & Cell Sci Inst, London, England; [Holmes, Jane; Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Collins, Peter D.; Cleland, John G. F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Packer, Milton] Baylor Univ, Med Ctr, Dallas, TX USA; [Wikstrand, John; Andersson, Bert] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden; [Coats, Andrew J. S.] Monash Univ, Monash Warwick Alliance, Melbourne, Vic 3004, Australia; [Coats, Andrew J. S.] Univ Warwick, Monash Warwick Alliance, Warwick, England; [von Lueder, Thomas G.] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Rigby, Alan S.] Castle Hill Hosp, Acad Cardiol, Kingston Upon Hull, Yorks, England; [van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Shibata, Marcelo C.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Boehm, Michael] Univ Saarlandes Kliniken, Homburg, Germany; [Flather, Marcus D.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; Monash University; Hospital Universitario Ramon y Cajal; Universidad de Alcala; IRCCS San Raffaele Pisana; St Georges University London; University of Oxford; Imperial College London; Baylor University; Baylor University Medical Center; University of Gothenburg; Monash University; University of Warwick; University of Oslo; University of Hull; University of Groningen; University of Alberta; Universitatsklinikum des Saarlandes; University of East Anglia	Kotecha, D (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Sch Med, Birmingham B15 2TT, W Midlands, England.	d.kotecha@bham.ac.uk	Kotecha, Dipak/Q-2827-2016; Kirchhof, Paulus/AAT-7074-2021; Rigby, Alan/AFM-1194-2022; Rosano, Giuseppe M. C./K-8718-2018; Shibata, Marcelo/AAS-9521-2021; Espinosa, Luis Manzano/AAB-1702-2020; Cleland, John G./AAZ-4185-2020	Kotecha, Dipak/0000-0002-2570-9812; Kirchhof, Paulus/0000-0002-1881-0197; Rigby, Alan/0000-0001-8331-3907; Rosano, Giuseppe M. C./0000-0003-4023-2263; Espinosa, Luis Manzano/0000-0002-0472-1820; Cleland, John G./0000-0002-1471-7016	Menarini Farmaceutica Internazionale; National Institute for Health Research (NIHR) Career Development Fellowship; British Heart Foundation [FS/13/43/30324] Funding Source: researchfish; National Institute for Health Research [CDF-2015-08-074, NF-SI-0611-10227] Funding Source: researchfish	Menarini Farmaceutica Internazionale(Menarini Group); National Institute for Health Research (NIHR) Career Development Fellowship(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	BB-meta-HF was investigator initiated. Menarini Farmaceutica Internazionale also provided an unrestricted research grant for administrative costs and GlaxoSmithKline provided data extraction support. None of the pharmaceutical groups had any role in data analysis or manuscript preparation. DK is funded by a National Institute for Health Research (NIHR) Career Development Fellowship, although this work is not a direct output of the fellowship. The opinions expressed are those of the authors and do not represent the NIHR or the UK Department of Health.	Alehagen U, 2015, CIRC-HEART FAIL, V8, P252, DOI 10.1161/CIRCHEARTFAILURE.114.001730; Barron AJ, 2013, INT J CARDIOL, V168, P3572, DOI 10.1016/j.ijcard.2013.05.068; Baumhakel M, 2009, EUR J HEART FAIL, V11, P299, DOI 10.1093/eurjhf/hfn041; Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Deedwania PC, 2004, EUR HEART J, V25, P1300, DOI 10.1016/j.ehj.2004.05.022; Dobre D, 2007, DRUG AGING, V24, P1031, DOI 10.2165/00002512-200724120-00006; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Follath F, 2006, EUR HEART J SUPPL, V8, pC28, DOI 10.1093/eurheartj/sul011; Ghali JK, 2003, J AM COLL CARDIOL, V42, P2128, DOI 10.1016/j.jacc.2003.05.012; Ghali JK, 2002, CIRCULATION, V105, P1585, DOI 10.1161/01.CIR.0000012546.20194.33; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066; Ko DT, 2004, ARCH INTERN MED, V164, P1389, DOI 10.1001/archinte.164.13.1389; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Komajda M, 2009, EUR HEART J, V30, P478, DOI 10.1093/eurheartj/ehn539; Koopman L, 2008, INT J TECHNOL ASSESS, V24, P358, DOI 10.1017/S0266462308080471; Kotecha D, 2014, PROSPERO REGISTER; Kotecha D, 2016, INT J CARDIOL, V203, P660, DOI 10.1016/j.ijcard.2015.10.220; Kotecha D, 2015, EUR HEART J, V36, P3250, DOI 10.1093/eurheartj/ehv513; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; Kotecha D, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-7; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768; MacMahon S, 1997, LANCET, V349, P375; Martinez-Selles M, 2012, EUR J HEART FAIL, V14, P473, DOI 10.1093/eurjhf/hfs026; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehta PA, 2006, HEART, V92, P14, DOI 10.1136/hrt.2005.070342; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Raza JA, 2002, INT J CARDIOL, V85, P203; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shah SM, 2008, BRIT J GEN PRACT, V58, P862, DOI 10.3399/bjgp08X376195; Sheppard R, 2005, AM J CARDIOL, V95, P955, DOI 10.1016/j.amjcard.2004.12.033; Sinha S, 2006, J GEN INTERN MED, V21, P1306, DOI 10.1111/j.1525-1497.2006.00601.x; Smith CT, 2007, CLIN TRIALS, V4, P621, DOI 10.1177/1740774507085276; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063; Voigt Andrew, 2010, Clin Cardiol, V33, pE1, DOI 10.1002/clc.20500; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Yancy CW., 2013, J AM COLL CARDIOL, V62, DOI [DOI 10.1016/J.JACC.2013.05.019, 10.1161/CIR.0b013e31829e8807]	53	58	62	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2016	353								i1855	10.1136/bmj.i1855	http://dx.doi.org/10.1136/bmj.i1855			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZH	27098105	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000374999300003
J	Malhi, GS				Malhi, Gin S.			Bipolar disorders: key clinical considerations	LANCET			English	Editorial Material							PREDICTORS; DIAGNOSIS; CHILD		[Malhi, Gin S.] Kolling Inst, Acad Dept Psychiat, St Leonards, NSW, Australia; [Malhi, Gin S.] Univ Sydney, Sydney Med Sch Northern, Sydney, NSW 2006, Australia; [Malhi, Gin S.] Northern Sydney Local Hlth Dist, Royal N Shore Hosp, CADE Clin, Dept Psychiat, St Leonards, NSW 2065, Australia	University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital	Malhi, GS (corresponding author), Kolling Inst, Acad Dept Psychiat, St Leonards, NSW, Australia.; Malhi, GS (corresponding author), Univ Sydney, Sydney Med Sch Northern, Sydney, NSW 2006, Australia.; Malhi, GS (corresponding author), Northern Sydney Local Hlth Dist, Royal N Shore Hosp, CADE Clin, Dept Psychiat, St Leonards, NSW 2065, Australia.	gin.malhi@sydney.edu.au	Malhi, Gin/Z-2418-2019	Malhi, Gin/0000-0002-4524-9091				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Biederman J, 2000, BIOL PSYCHIAT, V48, P458, DOI 10.1016/S0006-3223(00)00911-2; Blader JC, 2007, BIOL PSYCHIAT, V62, P107, DOI 10.1016/j.biopsych.2006.11.006; Dougherty LR, 2014, PSYCHOL MED, V44, P2339, DOI 10.1017/S0033291713003115; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Geller B, 2008, ARCH GEN PSYCHIAT, V65, P1125, DOI 10.1001/archpsyc.65.10.1125; Grande I, 2016, LANCET, V387, P1561, DOI 10.1016/S0140-6736(15)00241-X; Malhi GS, 2014, AUST NZ J PSYCHIAT, V48, P697, DOI 10.1177/0004867414544037; Malhi GS, 2014, AUST NZ J PSYCHIAT, V48, P500, DOI 10.1177/0004867414536670; Malhi GS, 2013, LANCET, V381, P1599, DOI 10.1016/S0140-6736(13)60893-4; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moreno C, 2007, ARCH GEN PSYCHIAT, V64, P1032, DOI 10.1001/archpsyc.64.9.1032; Ruggero CJ, 2010, BIPOLAR DISORD, V12, P21, DOI 10.1111/j.1399-5618.2009.00777.x; Smith DJ, 2011, BRIT J PSYCHIAT, V199, P49, DOI 10.1192/bjp.bp.110.083840; Towbin K, 2013, J AM ACAD CHILD PSY, V52, P466, DOI 10.1016/j.jaac.2013.02.006; Wozniak J, 1997, J Assoc Acad Minor Phys, V8, P78	16	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1492	1494		10.1016/S0140-6736(15)01045-4	http://dx.doi.org/10.1016/S0140-6736(15)01045-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27115960				2022-12-28	WOS:000373741600008
J	Choi, JH; Wang, H; Oh, SJ; Paik, T; Jo, PS; Sung, J; Ye, XC; Zhao, TS; Diroll, BT; Murray, CB; Kagan, CR				Choi, Ji-Hyuk; Wang, Han; Oh, Soong Ju; Paik, Taejong; Jo, Pil Sung; Sung, Jinwoo; Ye, Xingchen; Zhao, Tianshuo; Diroll, Benjamin T.; Murray, Christopher B.; Kagan, Cherie R.			Exploiting the colloidal nanocrystal library to construct electronic devices	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; QUANTUM-DOT SOLIDS; SURFACE-CHEMISTRY; CHARGE-TRANSPORT; SOLAR-CELLS; CIRCUITS; ROUTE; FILMS; SIZE	Synthetic methods produce libraries of colloidal nanocrystals with tunable physical properties by tailoring the nanocrystal size, shape, and composition. Here, we exploit colloidal nanocrystal diversity and design the materials, interfaces, and processes to construct all-nanocrystal electronic devices using solution-based processes. Metallic silver and semiconducting cadmium selenide nanocrystals are deposited to form high-conductivity and high-mobility thin-film electrodes and channel layers of field-effect transistors. Insulating aluminum oxide nanocrystals are assembled layer by layer with polyelectrolytes to form high-dielectric constant gate insulator layers for low-voltage device operation. Metallic indium nanocrystals are codispersed with silver nanocrystals to integrate an indium supply in the deposited electrodes that serves to passivate and dope the cadmiumselenide nanocrystal channel layer. We fabricate all-nanocrystal field-effect transistors on flexible plastics with electron mobilities of 21.7 square centimeters per volt-second.	[Choi, Ji-Hyuk; Oh, Soong Ju; Paik, Taejong; Jo, Pil Sung; Zhao, Tianshuo; Murray, Christopher B.; Kagan, Cherie R.] Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA; [Choi, Ji-Hyuk; Jo, Pil Sung] CNRS, SOLVAY, PENN, UMI 3254, Complex Assemblies Soft Matter, Bristol, PA 19007 USA; [Choi, Ji-Hyuk] Korea Inst Geosci & Mineral Resources, Rare Met Res Ctr, 124 Gwahang No, Daejeon 305350, South Korea; [Wang, Han; Kagan, Cherie R.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Oh, Soong Ju] Korea Univ, Dept Mat Sci & Engn, Seoul 136713, South Korea; [Sung, Jinwoo] Yonsei Univ, Dept Mat Sci & Engn, Seoul 120747, South Korea; [Ye, Xingchen; Diroll, Benjamin T.; Murray, Christopher B.; Kagan, Cherie R.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Solvay SA; Korea Institute of Geoscience & Mineral Resources (KIGAM); University of Pennsylvania; Korea University; Yonsei University; University of Pennsylvania	Kagan, CR (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.; Kagan, CR (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.; Kagan, CR (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	kagan@seas.upenn.edu	Oh, Soong Ju/C-8842-2015; Ye, Xingchen/D-3202-2017; Ye, Xingchen/AAN-4494-2020; Zhao, Tianshuo/G-5083-2018	Oh, Soong Ju/0000-0003-1434-8844; Ye, Xingchen/0000-0001-6851-2721; Ye, Xingchen/0000-0001-6851-2721; Zhao, Tianshuo/0000-0003-3952-7603	NSF Materials Research Science and Engineering Centers [DMR-1120901]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-SC0002158]; Office of Naval Research Multidisciplinary University Research Initiative [ONR-N00014-10-1-0942]; Korea Institute of Geoscience and Mineral Resources (KIGAM) - Ministry of Science, ICT and Future Planning of Korea	NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); Korea Institute of Geoscience and Mineral Resources (KIGAM) - Ministry of Science, ICT and Future Planning of Korea	We thank J. Chen for assistance with indium NC synthesis and H. D. Jang for discussions of ToF-SIMS. We are grateful for primary support of this work from the NSF Materials Research Science and Engineering Centers under award no. DMR-1120901 for NC layer deposition, ligand exchange, NC device fabrication, atomic force microscopy, Fourier transform infrared spectroscopy, energy-dispersive x-ray spectroscopy, conductivity, and transistor measurements. Indium and CdSe NC synthesis was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering, under award no. DE-SC0002158. Ag NC synthesis and TEM imaging were supported by the Office of Naval Research Multidisciplinary University Research Initiative Award no. ONR-N00014-10-1-0942. Cyclic voltammetry measurements were supported by the NSF CBET-1236406. ToF-SIMS measurements were supported by the Basic Research Project of the Korea Institute of Geoscience and Mineral Resources (KIGAM) funded by the Ministry of Science, ICT and Future Planning of Korea. The authors declare no competing financial interests.	Caruge JM, 2008, NAT PHOTONICS, V2, P247, DOI 10.1038/nphoton.2008.34; Choi JH, 2013, ACS NANO, V7, P8275, DOI 10.1021/nn403752d; Choi JH, 2012, NANO LETT, V12, P2631, DOI 10.1021/nl301104z; Fafarman AT, 2014, ACS NANO, V8, P2746, DOI 10.1021/nn406461p; Fafarman AT, 2011, J AM CHEM SOC, V133, P15753, DOI 10.1021/ja206303g; Goodwin ED, 2014, J PHYS CHEM C, V118, P27097, DOI 10.1021/jp5076912; Groner MD, 2004, CHEM MATER, V16, P639, DOI 10.1021/cm0304546; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Jana NR, 2003, J AM CHEM SOC, V125, P14280, DOI 10.1021/ja038219b; Keuleyan S, 2011, NAT PHOTONICS, V5, P489, DOI [10.1038/NPHOTON.2011.142, 10.1038/nphoton.2011.142]; Kim DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2218; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lee J, 2003, APPL PHYS LETT, V83, P2689, DOI 10.1063/1.1613997; Lee JS, 2011, NAT NANOTECHNOL, V6, P348, DOI [10.1038/nnano.2011.46, 10.1038/NNANO.2011.46]; Li YN, 2005, J AM CHEM SOC, V127, P3266, DOI 10.1021/ja043425k; Majewski LA, 2004, J PHYS D APPL PHYS, V37, P21, DOI 10.1088/0022-3727/37/1/005; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Ning ZJ, 2014, NAT MATER, V13, P822, DOI [10.1038/NMAT4007, 10.1038/nmat4007]; Oh SJ, 2014, NANO LETT, V14, P6210, DOI [10.1021/1502491d, 10.1021/nl502491d]; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Pileni MP, 2003, NAT MATER, V2, P145, DOI 10.1038/nmat817; Ridley BA, 1999, SCIENCE, V286, P746, DOI 10.1126/science.286.5440.746; Sargent EH, 2012, NAT PHOTONICS, V6, P133, DOI 10.1038/nphoton.2012.33; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; Stoeva S, 2002, J AM CHEM SOC, V124, P2305, DOI 10.1021/ja012076g; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Tedeschi C, 2001, J AM CHEM SOC, V123, P954, DOI 10.1021/ja0031974	29	199	201	4	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					205	208		10.1126/science.aad0371	http://dx.doi.org/10.1126/science.aad0371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124455				2022-12-28	WOS:000373681600041
J	Di Cesare, M; Bentham, J; Stevens, GA; Zhou, B; Danaei, G; Lu, Y; Bixby, H; Cowan, MJ; Riley, LM; Hajifathalian, K; Fortunato, L; Taddei, C; Bennett, JE; Ikeda, N; Khang, YH; Kyobutungi, C; Laxmaiah, A; Li, YP; Lin, HH; Miranda, JJ; Mostafa, A; Turley, ML; Paciorek, CJ; Gunter, M; Ezzati, M; Abdeen, ZA; Hamid, ZA; Abu-Rmeileh, NM; Acosta-Cazares, B; Adams, R; Aekplakorn, W; Aguilar-Salinas, CA; Ahmadvand, A; Ahrens, W; Ali, MM; Alkerwi, A; Alvarez-Pedrerol, M; Aly, E; Amouyel, P; Amuzu, A; Andersen, LB; Anderssen, SA; Andrade, DS; Anjana, RM; Aounallah-Skhiri, H; Ariansen, I; Aris, T; Arlappa, N; Arveiler, D; Assah, FK; Avdicova, M; Azizi, F; Babu, BV; Balakrishna, N; Bandosz, P; Banegas, JR; Barbagallo, CM; Barcelo, A; Barkat, A; Barros, MV; Bata, I; Batieha, AM; Batista, RL; Baur, LA; Beaglehole, R; Ben Romdhane, H; Benet, M; Bernabe-Ortiz, A; Bernotiene, G; Bettiol, H; Bhagyalaxmi, A; Bharadwaj, S; Bhargava, SK; Bhatti, Z; Bhutta, ZA; Bi, HS; Bi, YF; Bjerregaard, P; Bjertness, E; Bjertness, MB; Bjorkelund, C; Blake, M; Blokstra, A; Bo, S; Bobak, M; Boddy, LM; Boehm, BO; Boeing, H; Boissonnet, CP; Bongard, V; Bovet, P; Braeckman, L; Bragt, MCE; Brajkovich, I; Branca, F; Breckenkamp, J; Brenner, H; Brewster, LM; Brian, GR; Bruno, G; Bueno-de-Mesquita, HB; Bugge, A; Burns, C; de Leon, AC; Cacciottolo, J; Cama, T; Cameron, C; Camolas, J; Can, G; Candido, APC; Capuano, V; Cardoso, VC; Carvalho, MJ; Casanueva, FF; Casas, JP; Caserta, CA; Castetbon, K; Chamukuttan, S; Chan, AW; Chan, Q; Chaturvedi, HK; Chaturvedi, N; Chen, CJ; Chen, FF; Chen, HS; Chen, SH; Chen, ZM; Cheng, CY; Chetrit, A; Chiolero, A; Chiou, ST; Chirita-Emandi, A; Cho, Y; Christensen, K; Chudek, J; Cifkova, R; Claessens, F; Clays, E; Concin, H; Cooper, C; Cooper, R; Coppinger, TC; Costanzo, S; Cottel, D; Cowell, C; Craig, CL; Crujeiras, AB; D'Arrigo, G; d'Orsi, E; Dallongeville, J; Damasceno, A; Damsgaard, CT; Danaei, G; Dankner, R; Dauchet, L; De Backer, G; De Bacquer, D; de Gaetano, G; De Henauw, S; De Smedt, D; Deepa, M; Deev, AD; Dehghan, A; Delisle, H; Delpeuch, F; Dhana, K; Di Castelnuovo, AF; Dias-da-Costa, JS; Diaz, A; Djalalinia, S; Do, HTP; Dobson, AJ; Donfrancesco, C; Doring, A; Doua, K; Drygas, W; Egbagbe, EE; Eggertsen, R; Ekelund, U; El Ati, J; Elliott, P; Engle-Stone, R; Erasmus, RT; Erem, C; Eriksen, L; Escobedo-de la Pena, J; Evans, A; Faeh, D; Fall, CH; Farzadfar, F; Felix-Redondo, FJ; Ferguson, TS; Fernandez-Berges, D; Ferrante, D; Ferrari, M; Ferreccio, C; Ferrieres, J; Finn, JD; Fischer, K; Flores, EM; Foger, B; Foo, LH; Forslund, AS; Fortmann, SP; Fouad, HM; Francis, DK; Franco, MD; Franco, OH; Frontera, G; Fuchs, FD; Fuchs, SC; Fujita, Y; Furusawa, T; Gaciong, Z; Gafencu, M; Gareta, D; Garnett, SP; Gaspoz, JM; Gasull, M; Gates, L; Geleijnse, JM; Ghasemian, A; Giampaoli, S; Gianfagna, F; Giovannelli, J; Giwercman, A; Goldsmith, RA; Gross, MG; Rivas, JPG; Gorbea, MB; Gottrand, F; -Iversen, SG; Grafnetter, D; Grajda, A; Grammatikopoulou, MG; Gregor, RD; Grodzicki, T; Grontved, A; Gruden, G; Grujic, V; Gu, DF; Guan, OP; Gudnason, V; Guerrero, R; Guessous, I; Guimaraes, AL; Gulliford, MC; Gunnlaugsdottir, J; Gunter, M; Guo, XH; Guo, Y; Gupta, PC; Gureje, O; Gurzkowska, B; Gutierrez, L; Gutzwiller, F; Halkjaer, J; Hardy, R; Kumar, RH; Hayes, AJ; He, J; Hendriks, ME; Cadena, LH; Heshmat, R; Hihtaniemi, IT; Ho, SY; Ho, SC; Hobbs, M; Hofman, A; Hormiga, CM; Horta, BL; Houti, L; Htay, TT; Htet, AS; Htike, MMT; Hu, YH; Hussieni, AS; Huu, CN; Huybrechts, I; Hwalla, N; Iacoviello, L; Iannone, AG; Ibrahim, MM; Ikeda, N; Ikram, MA; Irazola, VE; Islam, M; Iwasaki, M; Jackson, RT; Jacobs, JM; Jafar, T; Jamil, KM; Jamrozik, K; Jasienska, G; Jiang, CQ; Joffres, M; Johansson, M; Jonas, JB; Jorgensen, T; Joshi, P; Juolevi, A; Jurak, G; Juresa, V; Kaaks, R; Kafatos, A; Kalter-Leibovici, O; Kapantais, E; Kasaeian, A; Katz, J; Kaur, P; Kavousi, M; Keil, U; Boker, LK; Kelishadi, R; Kemper, HHCG; Kengne, AP; Kersting, M; Key, T; Khader, YS; Khalili, D; Khang, YH; Khaw, KTH; Khouw, IMSL; Kiechl, S; Killewo, J; Kim, J; Kiyohara, Y; Klimont, J; Kolle, E; Kolsteren, P; Korrovits, P; Koskinen, S; Kouda, K; Koziel, S; Kratzer, W; Krokstad, S; Kromhout, D; Kruger, HS; Kula, K; Kulaga, Z; Kumar, RK; Kusuma, YS; Kuulasmaa, K; Kyobutungi, C; Laamiri, FZ; Laatikainen, T; Lachat, C; Laid, Y; Lam, TH; Landrove, O; Lanska, V; Lappas, G; Laugsand, LE; Laxmaiah, A; Bao, KLN; Le, TD; Leclercq, C; Lee, J; Lee, J; Lehtimaki, T; Lekhraj, R; Leon-Munoz, LM; Li, YP; Lim, WY; Lima-Costa, MF; Lin, HH; Lin, X; Linneberg, A; Lissner, L; Litwin, M; Liu, J; Lorbeer, R; Lotufo, PA; Lozano, JE; Luksiene, D; Lundqvist, A; Lunet, N; Lytsy, P; Ma, GS; Machi, S; Maggi, S; Magliano, DJ; Makdisse, M; Malekzadeh, R; Malhotra, R; Rao, KM; Manios, Y; Mann, JI; Manzato, E; Margozzini, P; Markey, O; Marques-Vidal, P; Marrugat, J; Martin-Prevel, Y; Martorell, R; Masoodi, SR; Matsha, TE; Mazur, A; Mbanya, JCN; McFarlane, SR; McGarvey, ST; McKee, M; McLachlan, S; McLean, RM; McNulty, BA; Yusof, SM; Mediene-Benchekor, S; Meirhaeghe, A; Meisinger, C; Mendes, LL; Menezes, AMB; Mensink, GBM; Meshram, II; Metspalu, A; Mi, J; Michaelsen, KF; Mikkel, K; Miller, JC; Miquel, JF; Miranda, JJ; Misigoj-Durakovic, M; Mohamed, MK; Mohammad, K; Mohammadifard, N; Mohan, V; Yusoff, MFM; Molbo, D; Moller, NC; Molnar, D; Mondo, CK; Monterrubio, EA; Monyeki, KDK; Moreira, LB; Morejon, A; Moreno, LA; Morgan, K; Mortensen, EL; Moschonis, G; Mossakowska, M; Mostafa, A; Mota, J; Motlagh, ME; Motta, J; Mu, TT; Muiesan, ML; Muller-Nurasyid, M; Murphy, N; Mursu, J; Murtagh, EM; Musa, KI; Musil, V; Nagel, G; Nakamura, H; Namesna, J; Nang, EEK; Nangia, VB; Nankap, M; Narake, S; Navarrete-Munoz, EM; Nenko, I; Neovius, M; Nervi, F; Neuhauser, HK; Nguyen, ND; Nguyen, QN; Nieto-Martinez, RE; Ning, G; Ninomiya, T; Nishtar, S; Noale, M; Norat, T; Noto, D; Al Nsour, M; O'Reilly, D; Ochoa-Aviles, AM; Oh, K; Olayan, IH; Olinto, MTA; Oltarzewski, M; Omar, MA; Onat, A; Ordunez, P; Ortiz, AP; Osler, M; Osmond, C; Ostojic, SM; Otero, JA; Overvad, K; Paccaud, FM; Padez, C; Pajak, A; Palli, D; Palloni, A; Palmieri, L; Panda-Jonas, S; Panza, F; Parnell, WR; Parsaeian, M; Pednekar, MS; Peeters, PH; Peixoto, SV; Pereira, AC; Perez, CM; Peters, A; Peykari, N; Pham, ST; Pigeot, I; Pikhart, H; Pilav, A; Pilotto, L; Pistelli, F; Pitakaka, F; Piwonska, A; Piwonski, J; Plans-Rubio, P; Poh, BK; Porta, M; Portegies, MLP; Poulimeneas, D; Pradeepa, R; Prashant, M; Price, JF; Puiu, M; Punab, M; Qasrawi, RF; Qorbani, M; Bao, TQ; Radic, I; Radisauskas, R; Rahman, M; Raitakari, O; Raj, M; Rao, SR; Ramachandran, A; Ramke, J; Ramos, R; Rampal, S; Rasmussen, F; Redon, J; Reganit, PFM; Ribeiro, R; Riboli, E; Rigo, F; de Wit, TFR; Ritti-Dias, RM; Rivera, JA; Robinson, SM; Robitaille, C; Rodriguez-Artalejo, F; Rodriguez-Perez, MD; Rodriguez-Villamizar, LA; Rojas-Martinez, R; Rojroongwasinkul, N; Romaguera, D; Ronkainen, K; Rosengren, A; Rouse, I; Rubinstein, A; Ruhli, FJ; Rui, O; Ruiz-Betancourt, BS; Horimoto, ARVR; Rutkowski, M; Sabanayagam, C; Sachdev, HS; Saidi, O; Salanave, B; Martinez, ES; Salomaa, V; Salonen, JT; Salvetti, M; Sanchez-Abanto, J; Sandjaja; Sans, S; Santos, DA; Santos, O; dos Santos, RN; Santos, R; Sardinha, LB; Sarrafzadegan, N; Saum, KU; Savva, SC; Scazufca, M; Rosario, AS; Schargrodsky, H; Schienkiewitz, A; Schmidt, IM; Schneider, IJ; Schultsz, C; Schutte, AE; Sein, AA; Senbanjo, IO; Sepanlou, SG; Shalnova, SA; Shaw, JE; Shibuya, K; Shin, YC; Shiri, R; Siantar, R; Sibai, AM; Silva, AM; Silva, DAS; Simon, M; Simons, J; Simons, LA; Sjostrom, M; Slowikowska-Hilczer, J; Slusarczyk, P; Smeeth, L; Smith, MC; Snijder, MB; So, HK; Sobngwi, E; Soderberg, S; Soekatri, MYE; Solfrizzi, V; Sonestedt, E; Sorensen, TIA; Soric, M; Jerome, CS; Soumare, A; Staessen, JA; Starc, G; Stathopoulou, MG; Staub, K; Stavreski, B; Steene-Johannessen, J; Stehle, P; Stein, AD; Stergiou, GS; Stessman, J; Stieber, J; Stockl, D; Stocks, T; Stokwiszewski, J; Stratton, G; Strufaldi, MW; Sun, CA; Sundstrom, J; Sung, YT; Sunyer, J; Suriyawongpaisal, P; Swinburn, BA; Sy, RG; Szponar, L; Tai, ES; Tammesoo, ML; Tamosiunas, A; Tang, L; Tang, X; Tanser, F; Tao, Y; Tarp, J; Tarqui-Mamani, CB; Taylor, A; Tchibindat, F; Thijs, L; Thuesen, BH; Tjonneland, A; Tolonen, HK; Tolstrup, JS; Topbas, M; Topor-Madry, R; Torrent, M; Traissac, P; Trichopoulou, A; Trichopoulos, D; Trinh, OTH; Trivedi, A; Tshepo, L; Tulloch-Reid, MK; Tuomainen, TP; Tuomilehto, J; Turley, ML; Tynelius, P; Tzotzas, T; Tzourio, C; Ueda, P; Ukoli, FAM; Ulmer, H; Unal, B; Valdivia, G; Vale, S; Valvi, D; van der Schouw, YT; Van Herck, K; Minh, HV; van Valkengoed, IGM; Vanderschueren, D; Vanuzzo, D; Vatten, L; Vega, T; Velasquez-Melendez, G; Veronesi, G; Verschuren, WMM; Viegi, G; Viet, L; Viikari-Juntura, E; Vineis, P; Vioque, J; Virtanen, JK; Visvikis-Siest, S; Viswanathan, B; Vollenweider, P; Voutilainen, S; Vrijheid, M; Wade, AN; Wagner, A; Walton, J; Mohamud, WNW; Wang, MD; Wang, Q; Wang, YX; Wannamethee, SG; Wareham, N; Weerasekera, D; Whincup, PH; Widhalm, K; Widyahening, IS; Wiecek, A; Wilks, RJ; Willeit, J; Wojtyniak, B; Wong, JE; Wong, TY; Woo, J; Woodward, M; Wu, FC; Wu, JF; Wu, SL; Xu, HQ; Xu, L; Yamborisut, U; Yan, WL; Yang, XG; Yardim, N; Ye, XW; Yiallouros, PK; Yoshihara, A; You, QS; Younger-Coleman, NO; Yusoff, AF; Zainuddin, AA; Zambon, S; Zdrojewski, T; Zeng, Y; Zhao, D; Zhao, WH; Zheng, YF; Zhou, MG; Zhu, D; Zimmermann, E; Cisneros, JZ				Di Cesare, Mariachiara; Bentham, James; Stevens, Gretchen A.; Zhou, Bin; Danaei, Goodarz; Lu, Yuan; Bixby, Honor; Cowan, Melanie J.; Riley, Leanne M.; Hajifathalian, Kaveh; Fortunato, Lea; Taddei, Cristina; Bennett, James E.; Ikeda, Nayu; Khang, Young-Ho; Kyobutungi, Catherine; Laxmaiah, Avula; Li, Yanping; Lin, Hsien-Ho; Miranda, J. Jaime; Mostafa, Aya; Turley, Maria L.; Paciorek, Christopher J.; Gunter, Marc; Ezzati, Majid; Abdeen, Ziad A.; Hamid, Zargar Abdul; Abu-Rmeileh, Niveen M.; Acosta-Cazares, Benjamin; Adams, Robert; Aekplakorn, Wichai; Aguilar-Salinas, Carlos A.; Ahmadvand, Alireza; Ahrens, Wolfgang; Ali, Mohamed M.; Alkerwi, Ala'a; Alvarez-Pedrerol, Mar; Aly, Eman; Amouyel, Philippe; Amuzu, Antoinette; Andersen, Lars Bo; Anderssen, Sigmund A.; Andrade, Dolores S.; Anjana, Ranjit Mohan; Aounallah-Skhiri, Hajer; Ariansen, Inger; Aris, Tahir; Arlappa, Nimmathota; Arveiler, Dominique; Assah, Felix K.; Avdicova, Maria; Azizi, Fereidoun; Babu, Bontha V.; Balakrishna, Nagalla; Bandosz, Piotr; Banegas, Jose R.; Barbagallo, Carlo M.; Barcelo, Alberto; Barkat, Amina; Barros, Mauro V.; Bata, Iqbal; Batieha, Anwar M.; Batista, Rosangela L.; Baur, Louise A.; Beaglehole, Robert; Ben Romdhane, Habiba; Benet, Mikhail; Bernabe-Ortiz, Antonio; Bernotiene, Gailute; Bettiol, Heloisa; Bhagyalaxmi, Aroor; Bharadwaj, Sumit; Bhargava, Santosh K.; Bhatti, Zaid; Bhutta, Zulfiqar A.; Bi, HongSheng; Bi, Yufang; Bjerregaard, Peter; Bjertness, Espen; Bjertness, Marius B.; Bjorkelund, Cecilia; Blake, Margaret; Blokstra, Anneke; Bo, Simona; Bobak, Martin; Boddy, Lynne M.; Boehm, Bernhard O.; Boeing, Heiner; Boissonnet, Carlos P.; Bongard, Vanina; Bovet, Pascal; Braeckman, Lutgart; Bragt, Marjolijn C. E.; Brajkovich, Imperia; Branca, Francesco; Breckenkamp, Juergen; Brenner, Hermann; Brewster, Lizzy M.; Brian, Garry R.; Bruno, Graziella; Bueno-de-Mesquita, H. B(as); Bugge, Anna; Burns, Con; Cabrera de Leon, Antonio; Cacciottolo, Joseph; Cama, Tilema; Cameron, Christine; Camolas, Jose; Can, Gunay; Candido, Ana Paula C.; Capuano, Vincenzo; Cardoso, Viviane C.; Carvalho, Maria J.; Casanueva, Felipe F.; Casas, Juan-Pablo; Caserta, Carmelo A.; Castetbon, Katia; Chamukuttan, Snehalatha; Chan, Angelique W.; Chan, Queenie; Chaturvedi, Himanshu K.; Chaturvedi, Nishi; Chen, Chien-Jen; Chen, Fangfang; Chen, Huashuai; Chen, Shuohua; Chen, Zhengming; Cheng, Ching-Yu; Chetrit, Angela; Chiolero, Arnaud; Chiou, Shu-Ti; Chirita-Emandi, Adela; Cho, Yumi; Christensen, Kaare; Chudek, Jerzy; Cifkova, Renata; Claessens, Frank; Clays, Els; Concin, Hans; Cooper, Cyrus; Cooper, Rachel; Coppinger, Tara C.; Costanzo, Simona; Cottel, Dominique; Cowell, Chris; Craig, Cora L.; Crujeiras, Ana B.; D'Arrigo, Graziella; d'Orsi, Eleonora; Dallongeville, Jean; Damasceno, Albertino; Damsgaard, Camilla T.; Danaei, Goodarz; Dankner, Rachel; Dauchet, Luc; De Backer, Guy; De Bacquer, Dirk; de Gaetano, Giovanni; De Henauw, Stefaan; De Smedt, Delphine; Deepa, Mohan; Deev, Alexander D.; Dehghan, Abbas; Delisle, Helene; Delpeuch, Francis; Dhana, Klodian; Di Castelnuovo, Augusto F.; Dias-da-Costa, Juvenal Soares; Diaz, Alejandro; Djalalinia, Shirin; Do, Ha T. P.; Dobson, Annette J.; Donfrancesco, Chiara; Doering, Angela; Doua, Kouamelan; Drygas, Wojciech; Egbagbe, Eruke E.; Eggertsen, Robert; Ekelund, Ulf; El Ati, Jalila; Elliott, Paul; Engle-Stone, Reina; Erasmus, Rajiv T.; Erem, Cihangir; Eriksen, Louise; Escobedo-de la Pena, Jorge; Evans, Alun; Faeh, David; Fall, Caroline H.; Farzadfar, Farshad; Felix-Redondo, Francisco J.; Ferguson, Trevor S.; Fernandez-Berges, Daniel; Ferrante, Daniel; Ferrari, Marika; Ferreccio, Catterina; Ferrieres, Jean; Finn, Joseph D.; Fischer, Krista; Monterubio Flores, Eric; Foeger, Bernhard; Foo, Leng Huat; Forslund, Ann-Sofie; Fortmann, Stephen P.; Fouad, Heba M.; Francis, Damian K.; Franco, Maria do Carmo; Franco, Oscar H.; Frontera, Guillermo; Fuchs, Flavio D.; Fuchs, Sandra C.; Fujita, Yuki; Furusawa, Takuro; Gaciong, Zbigniew; Gafencu, Mihai; Gareta, Dickman; Garnett, Sarah P.; Gaspoz, Jean-Michel; Gasull, Magda; Gates, Louise; Geleijnse, Johanna M.; Ghasemian, Anoosheh; Giampaoli, Simona; Gianfagna, Francesco; Giovannelli, Jonathan; Giwercman, Aleksander; Goldsmith, Rebecca A.; Gonzalez Gross, Marcela; Gonzalez Rivas, Juan P.; Bonet Gorbea, Mariano; Gottrand, Frederic; -Iversen, Sidsel Graff; Grafnetter, Dusan; Grajda, Aneta; Grammatikopoulou, Maria G.; Gregor, Ronald D.; Grodzicki, Tomasz; Grontved, Anders; Gruden, Grabriella; Grujic, Vera; Gu, Dongfeng; Guan, Ong Peng; Gudnason, Vilmundur; Guerrero, Ramiro; Guessous, Idris; Guimaraes, Andre L.; Gulliford, Martin C.; Gunnlaugsdottir, Johanna; Gunter, Marc; Guo, Xiu H.; Guo, Yin; Gupta, Prakash C.; Gureje, Oye; Gurzkowska, Beata; Gutierrez, Laura; Gutzwiller, Felix; Halkjaer, Jytte; Hardy, Rebecca; Kumar, Rachakulla Hari; Hayes, Alison J.; He, Jiang; Hendriks, Marleen Elisabeth; Hernandez Cadena, Leticia; Heshmat, Ramin; Hihtaniemi, Ilpo Tapani; Ho, Sai Yin; Ho, Suzanne C.; Hobbs, Michael; Hofman, Albert; Hormiga, Claudia M.; Horta, Bernardo L.; Houti, Leila; Htay, Thein Thein; Htet, Aung Soe; Htike, Maung Maung Than; Hu, Yonghua; Hussieni, Abdullatif S.; Chinh Nguyen Huu; Huybrechts, Inge; Hwalla, Nahla; Iacoviello, Licia; Iannone, Anna G.; Ibrahim, M. Mohsen; Ikeda, Nayu; Ikram, M. Arfan; Irazola, Vilma E.; Islam, Muhammad; Iwasaki, Masanori; Jackson, Rod T.; Jacobs, Jeremy M.; Jafar, Tazeen; Jamil, Kazi M.; Jamrozik, Konrad; Jasienska, Grazyna; Jiang, Chao Qiang; Joffres, Michel; Johansson, Mattias; Jonas, Jost B.; Jorgensen, Torben; Joshi, Pradeep; Juolevi, Anne; Jurak, Gregor; Juresa, Vesna; Kaaks, Rudolf; Kafatos, Anthony; Kalter-Leibovici, Ofra; Kapantais, Efthymios; Kasaeian, Amir; Katz, Joanne; Kaur, Prabhdeep; Kavousi, Maryam; Keil, Ulrich; Boker, Lital Keinan; Kelishadi, Roya; Kemper, Han H. C. G.; Kengne, Andre P.; Kersting, Mathilde; Key, Timothy; Khader, Yousef Saleh; Khalili, Davood; Khang, Young-Ho; Khaw, Kay-Tee H.; Khouw, Ilse M. S. L.; Kiechl, Stefan; Killewo, Japhet; Kim, Jeongseon; Kiyohara, Yutaka; Klimont, Jeannette; Kolle, Elin; Kolsteren, Patrick; Korrovits, Paul; Koskinen, Seppo; Kouda, Katsuyasu; Koziel, Slawomir; Kratzer, Wolfgang; Krokstad, Steinar; Kromhout, Daan; Kruger, Herculina S.; Kula, Krzysztof; Kulaga, Zbigniew; Kumar, R. Krishna; Kusuma, Yadlapalli S.; Kuulasmaa, Kari; Kyobutungi, Catherine; Laamiri, Fatima Zahra; Laatikainen, Tiina; Lachat, Carl; Laid, Youcef; Lam, Tai Hing; Landrove, Orlando; Lanska, Vera; Lappas, Georg; Laugsand, Lars E.; Laxmaiah, Avula; Khanh Le Nguyen Bao; Le, Tuyen D.; Leclercq, Catherine; Lee, Jeannette; Lee, Jeonghee; Lehtimaki, Terho; Lekhraj, Rampal; Leon-Munoz, Luz M.; Li, Yanping; Lim, Wei-Yen; Fernanda Lima-Costa, M.; Lin, Hsien-Ho; Lin, Xu; Linneberg, Allan; Lissner, Lauren; Litwin, Mieczyslaw; Liu, Jing; Lorbeer, Roberto; Lotufo, Paulo A.; Eugenio Lozano, Jose; Luksiene, Dalia; Lundqvist, Annamari; Lunet, Nuno; Lytsy, Per; Ma, Guansheng; Machi, Suka; Maggi, Stefania; Magliano, Dianna J.; Makdisse, Marcia; Malekzadeh, Reza; Malhotra, Rahul; Rao, Kodavanti Mallikharjuna; Manios, Yannis; Mann, Jim I.; Manzato, Enzo; Margozzini, Paula; Markey, Oonagh; Marques-Vidal, Pedro; Marrugat, Jaume; Martin-Prevel, Yves; Martorell, Reynaldo; Masoodi, Shariq R.; Matsha, Tandi E.; Mazur, Artur; Mbanya, Jean Claude N.; McFarlane, Shelly R.; McGarvey, Stephen T.; McKee, Martin; McLachlan, Stela; McLean, Rachael M.; McNulty, Breige A.; Yusof, Safiah Md; Mediene-Benchekor, Sounnia; Meirhaeghe, Aline; Meisinger, Christa; Mendes, Larissa L.; Menezes, Ana Maria B.; Mensink, Gert B. M.; Meshram, Indrapal I.; Metspalu, Andres; Mi, Jie; Michaelsen, Kim F.; Mikkel, Kairit; Miller, Jody C.; Francisco Miquel, Juan; Jaime Miranda, J.; Misigoj-Durakovic, Marjeta; Mohamed, Mostafa K.; Mohammad, Kazem; Mohammadifard, Noushin; Mohan, Viswanathan; Yusoff, Muhammad Fadhli Mohd; Molbo, Drude; Moller, Niels C.; Molnar, Denes; Mondo, Charles K.; Monterrubio, Eric A.; Monyeki, Kotsedi Daniel K.; Moreira, Leila B.; Morejon, Alain; Moreno, Luis A.; Morgan, Karen; Mortensen, Erik Lykke; Moschonis, George; Mossakowska, Malgorzata; Mostafa, Aya; Mota, Jorge; Motlagh, Mohammad Esmaeel; Motta, Jorge; Mu, Thet Thet; Muiesan, Maria Lorenza; Mueller-Nurasyid, Martina; Murphy, Neil; Mursu, Jaakko; Murtagh, Elaine M.; Musa, Kamarul Imran; Musil, Vera; Nagel, Gabriele; Nakamura, Harunobu; Namesna, Jana; Nang, Ei Ei K.; Nangia, Vinay B.; Nankap, Martin; Narake, Sameer; Maria Navarrete-Munoz, Eva; Nenko, Ilona; Neovius, Martin; Nervi, Flavio; Neuhauser, Hannelore K.; Nguyen, Nguyen D.; Quang Ngoc Nguyen; Nieto-Martinez, Ramfis E.; Ning, Guang; Ninomiya, Toshiharu; Nishtar, Sania; Noale, Marianna; Norat, Teresa; Noto, Davide; Al Nsour, Mohannad; O'Reilly, Dermot; Ochoa-Aviles, Angelica M.; Oh, Kyungwon; Olayan, Iman H.; Anselmo Olinto, Maria Teresa; Oltarzewski, Maciej; Omar, Mohd A.; Onat, Altan; Ordunez, Pedro; Ortiz, Ana P.; Osler, Merete; Osmond, Clive; Ostojic, Sergej M.; Otero, Johanna A.; Overvad, Kim; Paccaud, Fred Michel; Padez, Cristina; Pajak, Andrzej; Palli, Domenico; Palloni, Alberto; Palmieri, Luigi; Panda-Jonas, Songhomitra; Panza, Francesco; Parnell, Winsome R.; Parsaeian, Mahboubeh; Pednekar, Mangesh S.; Peeters, Petra H.; Peixoto, Sergio Viana; Pereira, Alexandre C.; Perez, Cynthia M.; Peters, Annette; Peykari, Niloofar; Son Thai Pham; Pigeot, Iris; Pikhart, Hynek; Pilav, Aida; Pilotto, Lorenza; Pistelli, Francesco; Pitakaka, Freda; Piwonska, Aleksandra; Piwonski, Jerzy; Plans-Rubio, Pedro; Poh, Bee Koon; Porta, Miquel; Portegies, Marileen L. P.; Poulimeneas, Dimitrios; Pradeepa, Rajendra; Prashant, Mathur; Price, Jacqueline F.; Puiu, Maria; Punab, Margus; Qasrawi, Radwan F.; Qorbani, Mostafa; Tran Quoc Bao; Radic, Ivana; Radisauskas, Ricardas; Rahman, Mahmudur; Raitakari, Olli; Raj, Manu; Rao, Sudha Ramachandra; Ramachandran, Ambady; Ramke, Jacqueline; Ramos, Rafel; Rampal, Sanjay; Rasmussen, Finn; Redon, Josep; Reganit, Paul Ferdinand M.; Ribeiro, Robespierre; Riboli, Elio; Rigo, Fernando; de Wit, Tobias Floris Rinke; Ritti-Dias, Raphael M.; Rivera, Juan A.; Robinson, Sian M.; Robitaille, Cynthia; Rodriguez-Artalejo, Fernando; del Cristo Rodriguez-Perez, Maria; Rodriguez-Villamizar, Laura A.; Rojas-Martinez, Rosalba; Rojroongwasinkul, Nipa; Romaguera, Dora; Ronkainen, Kimmo; Rosengren, Annika; Rouse, Ian; Rubinstein, Adolfo; Ruehli, Frank J.; Rui, Ornelas; Sandra Ruiz-Betancourt, Blanca; Russo Horimoto, Andrea R. V.; Rutkowski, Marcin; Sabanayagam, Charumathi; Sachdev, Harshpal S.; Saidi, Olfa; Salanave, Benoit; Salazar Martinez, Eduardo; Salomaa, Veikko; Salonen, Jukka T.; Salvetti, Massimo; Sanchez-Abanto, Jose; Sandjaja; Sans, Susana; Santos, Diana A.; Santos, Osvaldo; dos Santos, Renata Nunes; Santos, Rute; Sardinha, Luis B.; Sarrafzadegan, Nizal; Saum, Kai-Uwe; Savva, Savvas C.; Scazufca, Marcia; Rosario, Angelika Schaffrath; Schargrodsky, Herman; Schienkiewitz, Anja; Schmidt, Ida Maria; Schneider, Ione J.; Schultsz, Constance; Schutte, Aletta E.; Sein, Aye Aye; Senbanjo, Idowu O.; Sepanlou, Sadaf G.; Shalnova, Svetlana A.; Shaw, Jonathan E.; Shibuya, Kenji; Shin, Youchan; Shiri, Rahman; Siantar, Rosalynn; Sibai, Abla M.; Silva, Antonio M.; Santos Silva, Diego Augusto; Simon, Mary; Simons, Judith; Simons, Leon A.; Sjostrom, Michael; Slowikowska-Hilczer, Jolanta; Slusarczyk, Przemyslaw; Smeeth, Liam; Smith, Margaret C.; Snijder, Marieke B.; So, Hung-Kwan; Sobngwi, Eugene; Soderberg, Stefan; Soekatri, Moesijanti Y. E.; Solfrizzi, Vincenzo; Sonestedt, Emily; Sorensen, Thorkild I. A.; Soric, Maroje; Jerome, Charles Sossa; Soumare, Aicha; Staessen, Jan A.; Starc, Gregor; Stathopoulou, Maria G.; Staub, Kaspar; Stavreski, Bill; Steene-Johannessen, Jostein; Stehle, Peter; Stein, Aryeh D.; Stergiou, George S.; Stessman, Jochanan; Stieber, Jutta; Stoeckl, Doris; Stocks, Tanja; Stokwiszewski, Jakub; Stratton, Gareth; Strufaldi, Maria Wany; Sun, Chien-An; Sundstrom, Johan; Sung, Yn-Tz; Sunyer, Jordi; Suriyawongpaisal, Paibul; Swinburn, Boyd A.; Sy, Rody G.; Szponar, Lucjan; Tai, E. Shyong; Tammesoo, Mari-Liis; Tamosiunas, Abdonas; Tang, Line; Tang, Xun; Tanser, Frank; Tao, Yong; Tarp, Jakob; Tarqui-Mamani, Carolina B.; Taylor, Anne; Tchibindat, Felicite; Thijs, Lutgarde; Thuesen, Betina H.; Tjonneland, Anne; Tolonen, Hanna K.; Tolstrup, Janne S.; Topbas, Murat; Topor-Madry, Roman; Torrent, Maties; Traissac, Pierre; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Trinh, Oanh T. H.; Trivedi, Atul; Tshepo, Lechaba; Tulloch-Reid, Marshall K.; Tuomainen, Tomi-Pekka; Tuomilehto, Jaakko; Turley, Maria L.; Tynelius, Per; Tzotzas, Themistoklis; Tzourio, Christophe; Ueda, Peter; Ukoli, Flora A. M.; Ulmer, Hanno; Unal, Belgin; Valdivia, Gonzalo; Vale, Susana; Valvi, Damaskini; van der Schouw, Yvonne T.; Van Herck, Koen; Hoang Van Minh; van Valkengoed, Irene G. M.; Vanderschueren, Dirk; Vanuzzo, Diego; Vatten, Lars; Vega, Tomas; Velasquez-Melendez, Gustavo; Veronesi, Giovanni; Verschuren, W. M. Monique; Viegi, Giovanni; Viet, Lucie; Viikari-Juntura, Eira; Vineis, Paolo; Vioque, Jesus; Virtanen, Jyrki K.; Visvikis-Siest, Sophie; Viswanathan, Bharathi; Vollenweider, Peter; Voutilainen, Sari; Vrijheid, Martine; Wade, Alisha N.; Wagner, Aline; Walton, Janette; Mohamud, Wan Nazaimoon Wan; Wang, Ming-Dong; Wang, Qian; Wang, Ya Xing; Wannamethee, S. Goya; Wareham, Nicholas; Weerasekera, Deepa; Whincup, Peter H.; Widhalm, Kurt; Widyahening, Indah S.; Wiecek, Andrzej; Wilks, Rainford J.; Willeit, Johann; Wojtyniak, Bogdan; Wong, Jyh Eiin; Wong, Tien Yin; Woo, Jean; Woodward, Mark; Wu, Frederick C.; Wu, JianFeng; Wu, Shou Ling; Xu, Haiquan; Xu, Liang; Yamborisut, Uruwan; Yan, Weili; Yang, Xiaoguang; Yardim, Nazan; Ye, Xingwang; Yiallouros, Panayiotis K.; Yoshihara, Akihiro; You, Qi Sheng; Younger-Coleman, Novie O.; Yusoff, Ahmad F.; Zainuddin, Ahmad A.; Zambon, Sabina; Zdrojewski, Tomasz; Zeng, Yi; Zhao, Dong; Zhao, Wenhua; Zheng, Yingfeng; Zhou, Maigeng; Zhu, Dan; Zimmermann, Esther; Zuniga Cisneros, Julio		NCD Risk Factor Collaboration NCD	Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants	LANCET			English	Article							RISK-FACTORS; OBESITY; MORTALITY; OVERWEIGHT; ASSOCIATION; EPIDEMIC; CHILDREN; INCOME; BIAS	Background Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries. Methods We analysed, with use of a consistent protocol, population-based studies that had measured height and weight in adults aged 18 years and older. We applied a Bayesian hierarchical model to these data to estimate trends from 1975 to 2014 in mean BMI and in the prevalences of BMI categories (<18.5 kg/m(2) [underweight], 18.5 kg/m(2) to <20 kg/m(2), 20 kg/m(2) to <25 kg/m(2), 25 kg/m(2) to <30 kg/m(2), 30 kg/m(2) to <35 kg/m(2), 35 kg/m(2) to <40 kg/m(2), = 40 kg/m(2) [morbid obesity]), by sex in 200 countries and territories, organised in 21 regions. We calculated the posterior probability of meeting the target of halting by 2025 the rise in obesity at its 2010 levels, if post-2000 trends continue. Findings We used 1698 population-based data sources, with more than 19.2 million adult participants (9.9 million men and 9.3 million women) in 186 of 200 countries for which estimates were made. Global age-standardised mean BMI increased from 21.7 kg/m(2) (95% credible interval 21.3-22.1) in 1975 to 24.2 kg/m(2) (24.0-24.4) in 2014 in men, and from 22.1 kg/m(2) (21.7-22.5) in 1975 to 24.4 kg/m(2) (24.2-24.6) in 2014 in women. Regional mean BMIs in 2014 for men ranged from 21.4 kg/m(2) in central Africa and south Asia to 29.2 kg/m(2) (28.6-29.8) in Polynesia and Micronesia; for women the range was from 21.8 kg/m(2) (21.4-22.3) in south Asia to 32.2 kg/m(2) (31.5-32.8) in Polynesia and Micronesia. Over these four decades, age-standardised global prevalence of underweight decreased from 13.8% (10.5-17.4) to 8.8% (7.4-10.3) in men and from 14.6% (11.6-17.9) to 9.7% (8.3-11.1) in women. South Asia had the highest prevalence of underweight in 2014, 23.4% (17.8-29.2) in men and 24.0% (18.9-29.3) in women. Age-standardised prevalence of obesity increased from 3.2% (2.4-4.1) in 1975 to 10.8% (9.7-12.0) in 2014 in men, and from 6.4% (5.1-7.8) to 14.9% (13.6-16.1) in women. 2.3% (2.0-2.7) of the world's men and 5.0% (4.4-5.6) of women were severely obese (ie, have BMI = 35 kg/m(2)). Globally, prevalence of morbid obesity was 0.64% (0.46-0.86) in men and 1.6% (1.3-1.9) in women. Interpretation If post-2000 trends continue, the probability of meeting the global obesity target is virtually zero. Rather, if these trends continue, by 2025, global obesity prevalence will reach 18% in men and surpass 21% in women; severe obesity will surpass 6% in men and 9% in women. Nonetheless, underweight remains prevalent in the world's poorest regions, especially in south Asia. Copyright (C) NCD Risk Factor Collaboration. Open Access article distributed under the terms of CC BY.	[Di Cesare, Mariachiara; Bentham, James; Zhou, Bin; Bixby, Honor; Fortunato, Lea; Bennett, James E.; Gunter, Marc; Ezzati, Majid; Chan, Queenie; Elliott, Paul; Hihtaniemi, Ilpo Tapani; Murphy, Neil; Norat, Teresa; Riboli, Elio; Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, London, England; [Di Cesare, Mariachiara] Middlesex Univ, London N17 8HR, England; [Stevens, Gretchen A.; Cowan, Melanie J.; Riley, Leanne M.; Branca, Francesco] WHO, CH-1211 Geneva, Switzerland; [Danaei, Goodarz; Lu, Yuan; Hajifathalian, Kaveh; Li, Yanping; Trichopoulos, Dimitrios; Ueda, Peter; Valvi, Damaskini] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Taddei, Cristina] Univ Florence, Florence, Italy; [Ikeda, Nayu] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Khang, Young-Ho] Seoul Natl Univ, Seoul, South Korea; [Kyobutungi, Catherine] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Laxmaiah, Avula; Arlappa, Nimmathota; Babu, Bontha V.; Balakrishna, Nagalla; Kumar, Rachakulla Hari; Rao, Kodavanti Mallikharjuna; Meshram, Indrapal I.; Prashant, Mathur] Indian Council Med Res, New Delhi, India; [Lin, Hsien-Ho] Natl Taiwan Univ, Taipei 10764, Taiwan; [Miranda, J. Jaime; Bernabe-Ortiz, Antonio; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Lima, Peru; [Mostafa, Aya; Mohamed, Mostafa K.] Ain Shams Univ, Cairo, Egypt; [Turley, Maria L.] Minist Hlth, Wellington, New Zealand; [Paciorek, Christopher J.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Abdeen, Ziad A.; Qasrawi, Radwan F.] Al Quds Univ, Jerusalem, Israel; [Hamid, Zargar Abdul] Ctr Diabet & Endocrine Care, Bengaluru, India; [Abu-Rmeileh, Niveen M.; Hussieni, Abdullatif S.] Birzeit Univ, Bir Zayt, Palestine; [Acosta-Cazares, Benjamin; Escobedo-de la Pena, Jorge; Sandra Ruiz-Betancourt, Blanca] Inst Mexicano Seguro Social, Rio Grande, Mexico; [Adams, Robert; Jamrozik, Konrad; Taylor, Anne] Univ Adelaide, Adelaide, SA 5005, Australia; [Aekplakorn, Wichai; Rojroongwasinkul, Nipa; Suriyawongpaisal, Paibul; Yamborisut, Uruwan] Mahidol Univ, Bangkok 10700, Thailand; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Rio Grande, Mexico; [Ahmadvand, Alireza; Djalalinia, Shirin; Ghasemian, Anoosheh; Kasaeian, Amir; Parsaeian, Mahboubeh; Peykari, Niloofar] Noncommunicable Dis Res Ctr, Tehran, Iran; [Ahrens, Wolfgang; Pigeot, Iris] Leibniz Inst Prevent Res & Epidemiol BIPS, Leibniz, Germany; [Ali, Mohamed M.; Aly, Eman] World Hlth Org Reg Off Eastern Mediterranean, Giza, Egypt; [Alkerwi, Ala'a] Luxembourg Inst Hlth, Luxembourg, Luxembourg; [Alvarez-Pedrerol, Mar; Sunyer, Jordi; Vrijheid, Martine] Ctr Res Environm Epidemiol, Madrid, Spain; [Amouyel, Philippe] Lille Univ & Hosp, Lille, France; [Amuzu, Antoinette; McKee, Martin; Smeeth, Liam] London Sch Hyg & Trop Med, London, England; [Andersen, Lars Bo; Bjerregaard, Peter; Bugge, Anna; Christensen, Kaare; Eriksen, Louise; Grontved, Anders; Moller, Niels C.; Tarp, Jakob; Tolstrup, Janne S.] Univ Southern Denmark, Lyngby, Denmark; [Anderssen, Sigmund A.; Ekelund, Ulf; Kolle, Elin; Steene-Johannessen, Jostein] Norwegian Sch Sport Sci, Oslo, Norway; [Andrade, Dolores S.; Ochoa-Aviles, Angelica M.] Univ Cuenca, Cuenca, Ecuador; [Anjana, Ranjit Mohan; Deepa, Mohan; Mohan, Viswanathan; Pradeepa, Rajendra] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Aounallah-Skhiri, Hajer] Natl Inst Publ Hlth, Tunis, Tunisia; [Ariansen, Inger; -Iversen, Sidsel Graff] Norwegian Inst Publ Hlth, Oslo, Norway; [Aris, Tahir; Yusoff, Muhammad Fadhli Mohd; Omar, Mohd A.; Yusoff, Ahmad F.] Minist Hlth, Kuala Lumpur, Malaysia; [Arveiler, Dominique] Strasbourg Univ & Hosp, Strasbourg, France; [Assah, Felix K.; Mbanya, Jean Claude N.; Sobngwi, Eugene] Univ Yaounde I, Yaounde, Cameroon; [Avdicova, Maria; Namesna, Jana] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Azizi, Fereidoun; Khalili, Davood] Shahid Beheshti Univ Med Sci, Tehran, Iran; [Bandosz, Piotr; Rutkowski, Marcin; Zdrojewski, Tomasz] Med Univ Gdansk, Gdansk, Poland; [Banegas, Jose R.; Leon-Munoz, Luz M.; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Barbagallo, Carlo M.; Noto, Davide] Univ Palermo, I-90133 Palermo, Italy; [Barcelo, Alberto; Ordunez, Pedro] Pan Amer Hlth Org, El Paso, TX USA; [Barkat, Amina; Laamiri, Fatima Zahra] Univ Mohammed V Rabat, Rabat, Morocco; [Barros, Mauro V.] Univ Pernambuco, Petrolina, PE, Brazil; [Bata, Iqbal; Gregor, Ronald D.] Dalhousie Univ, Halifax, NS B3H 3J5, Canada; [Batieha, Anwar M.; Khader, Yousef Saleh] Jordan Univ Sci & Technol, Amman, Jordan; [Batista, Rosangela L.; Silva, Antonio M.] Univ Fed Maranhao, Sao Luis, Brazil; [Baur, Louise A.; Garnett, Sarah P.; Hayes, Alison J.; Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Beaglehole, Robert; Jackson, Rod T.; Swinburn, Boyd A.] Univ Auckland, Auckland 1, New Zealand; [Ben Romdhane, Habiba] Univ Tunis El Manar, Tunis, Tunisia; [Benet, Mikhail; Morejon, Alain] Univ Med Sci, Havana, Cuba; [Bernotiene, Gailute; Luksiene, Dalia; Radisauskas, Ricardas; Tamosiunas, Abdonas] Lithuanian Univ Hlth Sci, Kaunas, Lithuania; [Bettiol, Heloisa; Cardoso, Viviane C.; Lotufo, Paulo A.; dos Santos, Renata Nunes; Scazufca, Marcia] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil; [Bhagyalaxmi, Aroor] BJ Med Coll, New Delhi, India; [Bharadwaj, Sumit] Chirayu Med Coll, Bhopal, India; [Bhargava, Santosh K.] Sunder Lal Jain Hosp, New Delhi, India; [Bhatti, Zaid; Bhutta, Zulfiqar A.; Islam, Muhammad] Aga Khan Univ, Lahore, Pakistan; [Bi, HongSheng; Wu, JianFeng] Shandong Univ Tradit Chinese Med, Jinan, Peoples R China; [Bi, Yufang; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Bjertness, Espen; Bjertness, Marius B.; Htet, Aung Soe] Univ Oslo, N-0316 Oslo, Norway; [Bjorkelund, Cecilia; Eggertsen, Robert; Lissner, Lauren; Rosengren, Annika] Gothenburg Univ, S-41124 Gothenburg, Sweden; [Blake, Margaret] NatCen Social Res, London, England; [Blokstra, Anneke; Bueno-de-Mesquita, H. B(as); Verschuren, W. M. Monique; Viet, Lucie] Natl Inst Publ Hlth & Environm, Amsterdam, Netherlands; [Bo, Simona; Bruno, Graziella; Gruden, Grabriella] Univ Turin, I-10124 Turin, Italy; [Bobak, Martin; Casas, Juan-Pablo; Chaturvedi, Nishi; Cooper, Rachel; Hardy, Rebecca; Pikhart, Hynek; Wannamethee, S. Goya] UCL, London WC1E 6BT, England; [Boddy, Lynne M.] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England; [Boehm, Bernhard O.] Nanyang Technol Univ, Singapore 639798, Singapore; [Boeing, Heiner] German Inst Human Nutr, Berlin, Germany; [Boissonnet, Carlos P.] CEMIC, Buenos Aires, DF, Argentina; [Bongard, Vanina; Ferrieres, Jean] Toulouse Univ, Sch Med, Toulouse, France; [Bovet, Pascal; Viswanathan, Bharathi] Minist Hlth, Victoria, Seychelles; [Bovet, Pascal] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Braeckman, Lutgart; Clays, Els; De Backer, Guy; De Bacquer, Dirk; De Henauw, Stefaan; De Smedt, Delphine; Lachat, Carl; Van Herck, Koen] Univ Ghent, B-9000 Ghent, Belgium; [Bragt, Marjolijn C. E.; Khouw, Ilse M. S. L.] FrieslandCampina, Singapore, Singapore; [Brajkovich, Imperia] Cent Univ Venezuela, Caracas, Venezuela; [Breckenkamp, Juergen] Univ Bielefeld, Bielefeld, Germany; [Brenner, Hermann; Kaaks, Rudolf; Saum, Kai-Uwe] German Canc Res Ctr, Berlin, Germany; [Brewster, Lizzy M.] Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; [Brian, Garry R.] Fred Hollows Fdn New Zealand, Auckland, New Zealand; [Burns, Con; Coppinger, Tara C.] Cork Inst Technol, Cork, Ireland; [Cabrera de Leon, Antonio] Univ La Laguna, E-38207 San Cristobal la Laguna, Spain; [Cacciottolo, Joseph] Univ Malta, Msida, Malta; [Cama, Tilema] Minist Hlth, Nukualofa, Tonga; [Cameron, Christine; Craig, Cora L.] Canadian Fitness & Lifestyle Res Inst, Toronto, ON, Canada; [Camolas, Jose] Hosp Santa Maria, CHLN, Lisbon, Portugal; [Can, Gunay; Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Candido, Ana Paula C.; Mendes, Larissa L.] Univ Fed Juiz de Fora, Juiz De Fora, Brazil; [Capuano, Vincenzo; Iannone, Anna G.] Cardiol Mercato S Severino, Mercato San Severino, Italy; [Carvalho, Maria J.; Santos, Rute; Vale, Susana] Univ Porto, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Casanueva, Felipe F.] Univ Santiago de Compostela, Santiago De Compostela, Spain; [Caserta, Carmelo A.] Assoc Calabrese Epatol, Rome, Italy; [Castetbon, Katia; Salanave, Benoit] French Inst Hlth Surveillance, Lyon, France; [Chamukuttan, Snehalatha; Ramachandran, Ambady; Simon, Mary] India Diabet Res Fdn, New Delhi, India; [Chan, Angelique W.; Cheng, Ching-Yu; Jafar, Tazeen; Malhotra, Rahul; Wong, Tien Yin] Duke NUS Grad Med Sch, Singapore, Singapore; [Chaturvedi, Himanshu K.] Natl Inst Med Stat, New Delhi, India; [Chen, Chien-Jen] Acad Sinica, Taipei, Taiwan; [Chen, Fangfang; Mi, Jie] Capital Inst Pediat, Beijing, Peoples R China; [Chen, Huashuai; Zeng, Yi] Duke Univ, Durham, NC 27706 USA; [Chen, Shuohua; Wu, Shou Ling] Kailuan Gen Hosp, Beijing, Peoples R China; [Chen, Zhengming; Key, Timothy; Smith, Margaret C.; Woodward, Mark] Univ Oxford, Oxford OX1 2JD, England; [Chetrit, Angela; Dankner, Rachel; Kalter-Leibovici, Ofra] Gertner Inst Epidemiol & Hlth Policy Res, Tel Aviv, Israel; [Chiolero, Arnaud; Marques-Vidal, Pedro; Vollenweider, Peter] Univ Lausanne Hosp, Lausanne, Switzerland; [Chiou, Shu-Ti] Minist Hlth & Welf, Taipei, Taiwan; [Chirita-Emandi, Adela; Gafencu, Mihai; Puiu, Maria] Victor Babes Univ Med & Pharm, Timisoara, Romania; [Cho, Yumi; Oh, Kyungwon] Korea Ctr Dis Control & Prevent, Seoul, South Korea; [Chudek, Jerzy; Wiecek, Andrzej] Med Univ Silesia, Katowice, Poland; [Cifkova, Renata] Charles Univ Prague, Prague, Czech Republic; [Claessens, Frank; Vanderschueren, Dirk] Katholieke Univ Leuven, Louvain, Belgium; [Concin, Hans; Foeger, Bernhard] Agcy Prevent & Social Med, Vienna, Austria; [Cooper, Cyrus; Fall, Caroline H.; Robinson, Sian M.] Univ Southampton, Southampton SO9 5NH, Hants, England; [Costanzo, Simona; de Gaetano, Giovanni; Di Castelnuovo, Augusto F.; Iacoviello, Licia] IRCCS Ist Neurol Mediterraneo Neuromed, Rome, Italy; [Cottel, Dominique; Dallongeville, Jean] Inst Pasteur, Lille, France; [Cowell, Chris] Westmead Univ Sydney, Sydney, NSW, Australia; [Crujeiras, Ana B.; Romaguera, Dora] CIBEROBN, Madrid, Spain; [D'Arrigo, Graziella] CNR, Rome, Italy; [d'Orsi, Eleonora; Schneider, Ione J.; Silva, Antonio M.] Univ Fed Santa Catarina, BR-88040900 Florianopolis, SC, Brazil; [Damasceno, Albertino] Eduardo Mondlane Univ, Maputo, Mozambique; [Damsgaard, Camilla T.; Michaelsen, Kim F.; Molbo, Drude; Mortensen, Erik Lykke; Sorensen, Thorkild I. A.] Univ Copenhagen, DK-1168 Copenhagen, Denmark; [Dauchet, Luc; Giovannelli, Jonathan] Lille Univ Hosp, Lille, France; [Deev, Alexander D.; Shalnova, Svetlana A.] Natl Res Ctr Prevent Med, Moscow, Russia; [Dehghan, Abbas; Dhana, Klodian; Franco, Oscar H.; Hofman, Albert; Ikram, M. Arfan; Kavousi, Maryam; Portegies, Marileen L. P.] Erasmus MC, Rotterdam, Netherlands; [Delisle, Helene] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Delpeuch, Francis; Martin-Prevel, Yves; Traissac, Pierre] Inst Rech Dev, Montpellier, France; [Dias-da-Costa, Juvenal Soares; Anselmo Olinto, Maria Teresa] Univ Vale Rio dos Sinos, Sao Leopoldo, RS, Brazil; [Diaz, Alejandro] Natl Council Sci & Tech Res, Buenos Aires, DF, Argentina; [Do, Ha T. P.] Natl Inst Nutr, Hanoi, Vietnam; [Dobson, Annette J.] Univ Queensland, Brisbane, Qld 4072, Australia; [Donfrancesco, Chiara; Giampaoli, Simona; Palmieri, Luigi] Ist Super Sanita, Rome, Italy; [Doering, Angela; Meisinger, Christa; Mueller-Nurasyid, Martina; Peters, Annette; Stieber, Jutta; Stoeckl, Doris] Helmholtz Zentrum mUNCHEN, Munich, Germany; [Doua, Kouamelan] Minist Sante & Lutte Sida, Yamoussoukro, Cote Ivoire; [Drygas, Wojciech] Cardinal Wyszynski Inst Cardiol, Warsaw, Poland; [Egbagbe, Eruke E.] Univ Benin, Coll Med Sci, Benin, Nigeria; [El Ati, Jalila] Natl Inst Nutr & Food Technol, Tunis, Tunisia; [Engle-Stone, Reina] Univ Calif Davis, Davis, CA USA; [Erasmus, Rajiv T.] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Erem, Cihangir] Karadeniz Tech Univ, Trabzon, Turkey; [Evans, Alun] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [Faeh, David] Univ Zurich, CH-8006 Zurich, Switzerland; [Fall, Caroline H.] Univ Tehran Med Sci, Tehran, Iran; [Ferguson, Trevor S.] Univ W Indies, Kingston, Jamaica; [Ferrante, Daniel] Minist Hlth, Buenos Aires, DF, Argentina; [Ferrari, Marika] Council Agr Res & Econ, Rome, Italy; [Finn, Joseph D.] Univ Manchester, Manchester M13 9PL, Lancs, England; [Fischer, Krista] Univ Tartu, Tartu, Estonia; [Monterubio Flores, Eric] Inst Nacl Salud Publ, Mexico City, DF, Mexico; [Foo, Leng Huat] Univ Sains Malaysia, Shah Alam, Malaysia; [Forslund, Ann-Sofie] Univ Lulea, S-97187 Lulea, Sweden; [Fortmann, Stephen P.] Stanford Univ, Stanford, CA 94305 USA; [Franco, Oscar H.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Fuchs, Sandra C.] Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil; [Fujita, Yuki] Kinki Univ, Fac Med, Higashiosaka, Osaka 577, Japan; [Furusawa, Takuro] Kyoto Univ, Kyoto 6068501, Japan; [Gaciong, Zbigniew] Med Univ Warsaw, Warsaw, Poland; [Gaspoz, Jean-Michel] Univ Hosp Geneva, Geneva, Switzerland; [Geleijnse, Johanna M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Gianfagna, Francesco] Univ Insubria, Varese, Italy; [Giwercman, Aleksander] Lund Univ, S-22100 Lund, Sweden; [Gonzalez Gross, Marcela] Univ Politecn Madrid, E-28040 Madrid, Spain; [Gonzalez Rivas, Juan P.] Andes Clin Cardiometab Studies, Caracas, Venezuela; [Bonet Gorbea, Mariano] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Gottrand, Frederic] Univ Lille 2, F-59800 Lille, France; [Grafnetter, Dusan] Inst Clin & Expt Med, Prague, Czech Republic; [Grajda, Aneta] Childrens Mem Hlth Inst, Warsaw, Poland; [Grammatikopoulou, Maria G.] Alexander Technol Educ Inst, Athens, Greece; [Grodzicki, Tomasz] Jagiellonian Univ, Coll Med, PL-31007 Krakow, Poland; [Grujic, Vera] Inst Publ Hlth Vojvodina, Belgrade, Serbia; [Gu, Dongfeng] Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Guan, Ong Peng] Singapore Eye Res Inst, Singapore, Singapore; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Guerrero, Ramiro] Univ Icesi, Cali, Colombia; [Guessous, Idris] Univ Hosp Geneva, Geneva, Switzerland; [Gulliford, Martin C.] Kings Coll London, London WC2R 2LS, England; [Guo, Xiu H.; Guo, Yin] Capital Med Univ, Beijing, Peoples R China; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, New Delhi, India; [Gureje, Oye] Univ Ibadan, Ibadan, Nigeria; [Gurzkowska, Beata] Childrens Mem Hlth Inst, Warsaw, Poland; [Gutierrez, Laura] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Gutzwiller, Felix] Univ Zurich, CH-8006 Zurich, Switzerland; [Halkjaer, Jytte] Danish Canc Soc Res Ctr, Lyngby, Denmark; [Hayes, Alison J.] Tulane Univ, New Orleans, LA 70118 USA; [Dehghan, Abbas; Hendriks, Marleen Elisabeth] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Hernandez Cadena, Leticia] Natl Inst Publ Hlth, Mexicali, Baja California, Mexico; [Ho, Sai Yin] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Hobbs, Michael] Univ Western Australia, Nedlands, WA 6009, Australia; [Horta, Bernardo L.] Univ Fed Pelotas, Pelotas, Brazil; [Houti, Leila] Univ Oran 1, Oran, Algeria; [Htike, Maung Maung Than] Minist Hlth, Naypyidaw, Myanmar; [Hu, Yonghua] Peking Univ, Hlth Sci Ctr, Beijing, Peoples R China; [Huybrechts, Inge] Int Agcy Res Canc, Lyon, France; [Hwalla, Nahla] Amer Univ Beirut, Beirut, Lebanon; [Ibrahim, M. Mohsen] Cairo Univ, Cairo, Egypt; [Iwasaki, Masanori] Niigata Univ, Niigata 95021, Japan; [Jacobs, Jeremy M.] Hadassah Univ, Med Ctr, Tel Aviv, Israel; [Jamil, Kazi M.] Kuwait Inst Scientifi c Res, Kuwait, Kuwait; [Jiang, Chao Qiang] Guangzhou 12th Hosp, Guangzhou, Guangdong, Peoples R China; [Joffres, Michel] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Jonas, Jost B.] Heidelberg Univ, Heidelberg, Germany; [Joshi, Pradeep] World Hlth Org Country Off, New Delhi, India; [Juolevi, Anne] Natl Inst Hlth & Welf, Espoo, Finland; [Jurak, Gregor] Univ Ljubljana, Ljubljana 61000, Slovenia; [Juresa, Vesna] Univ Zagreb, Zagreb 41000, Croatia; [Kafatos, Anthony] Univ Crete, Iraklion, Greece; [Kapantais, Efthymios] Hellen Med Assoc Obes, Iraklion, Greece; [Katz, Joanne] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kaur, Prabhdeep] Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Keil, Ulrich] Univ Munster, Munster, Germany; [Boker, Lital Keinan] Univ Haifa, IL-31999 Haifa, Israel; [Kemper, Han H. C. G.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Kengne, Andre P.] South African Med Res Council, Johannesburg, South Africa; [Kersting, Mathilde] Res Inst Child Nutr FKE, Munich, Germany; [Khaw, Kay-Tee H.] Univ Cambridge, Cambridge CB2 1TN, England; [Kiechl, Stefan] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Killewo, Japhet] Univ Hlth & Allied Sci, Tanza, Tanzania; [Kim, Jeongseon] Natl Canc Ctr, Seoul, South Korea; [Kiyohara, Yutaka] Kyushu Univ, Fukuoka 812, Japan; [Klimont, Jeannette] Stat Austria, Vienna, Austria; [Kolsteren, Patrick] Inst Trop Med, Brussels, Belgium; [Korrovits, Paul] Tartu Univ Clin, Tartu, Estonia; [Kouda, Katsuyasu] Kinki Univ, Fac Med, Higashiosaka, Osaka 577, Japan; [Koziel, Slawomir] Polish Acad Sci, Anthropol Unit, Wroclaw, Poland; [Kratzer, Wolfgang] Univ Hosp Ulm, Ulm, Germany; [Krokstad, Steinar; Laugsand, Lars E.] Norwegian Univ Sci & Technol, Oslo, Norway; [Kromhout, Daan] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Kruger, Herculina S.] North West Univ, Johannesburg, South Africa; [Kula, Krzysztof] Med Univ Lodz, Lodz, Poland; [Kulaga, Zbigniew] Childrens Mem Hlth Inst, Warsaw, Poland; [Kumar, R. Krishna] Amrita Inst Med Sci, Kochi, India; [Kusuma, Yadlapalli S.] All India Inst Med Sci, New Delhi 110029, India; [Lappas, Georg] Sahlgrens Acad, Stockholm, Sweden; [Khanh Le Nguyen Bao; Le, Tuyen D.] Natl Inst Nutr, Hanoi, Vietnam; [Leclercq, Catherine] Food & Agr Org, Rome, Italy; [Lee, Jeannette] Natl Univ Singapore, Singapore 117548, Singapore; [Lee, Jeonghee] Natl Canc Ctr, Seoul, South Korea; [Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Lekhraj, Rampal] Univ Putra Malaysia, Serdang 43400, Malaysia; [Lim, Wei-Yen] Natl Univ Singapore, Singapore 117548, Singapore; [Fernanda Lima-Costa, M.] Fundacao Oswaldo Cruz, Rene Rachou Res Inst, Rio De Janeiro, Brazil; [Lin, Xu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Linneberg, Allan] Res Ctr Prevent & Hlth, Aalborg, Denmark; [Litwin, Mieczyslaw] Childrens Mem Hlth Inst, Lodz, Poland; [Liu, Jing] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Lorbeer, Roberto] Univ Med Greifswald, Greifswald, Germany; [Eugenio Lozano, Jose] Consejeria Sanidad Junta Castilla & Leon, Leon, Spain; [Lundqvist, Annamari] Natl Inst Hlth & Welf, Tampere, Finland; [Lunet, Nuno] Univ Porto, Sch Med, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Lytsy, Per] Uppsala Univ, S-75105 Uppsala, Sweden; [Ma, Guansheng] Peking Univ, Beijing 100871, Peoples R China; [Machi, Suka] Jikei Univ, Sch Med, Tokyo, Japan; [Maggi, Stefania] CNR, Pisa, Italy; [Magliano, Dianna J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Makdisse, Marcia] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Malekzadeh, Reza] Univ Tehran Med Sci, Tehran, Iran; [Manios, Yannis] Harokopio Univ Athens, Athens, Greece; [Mann, Jim I.] Univ Otago, Otaru, Hokkaido, Japan; [Manzato, Enzo] Univ Padua, I-35100 Padua, Italy; [Margozzini, Paula] Pontificia Univ Catolica Chile, Santiago, Chile; [Markey, Oonagh] Univ Reading, Reading RG6 2AH, Berks, England; [Martorell, Reynaldo] Emory Univ, Atlanta, GA 30322 USA; [Masoodi, Shariq R.] Sherikashmir Inst Med Sci, Jammu, India; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Cape Town, South Africa; [Mazur, Artur] Univ Rzeszow, Rzeszow, Poland; [McGarvey, Stephen T.] Brown Univ, Providence, RI 02912 USA; [McLachlan, Stela] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [McNulty, Breige A.] Univ Coll Dublin, Dublin, Ireland; [Yusof, Safiah Md] Univ Teknol MARA, Serdang, Malaysia; [Mensink, Gert B. M.] Robert Koch Inst, Berlin, Germany; [Metspalu, Andres; Mikkel, Kairit] Univ Tartu, Ulikooli 18, EE-50090 Tartu, Estonia; [Misigoj-Durakovic, Marjeta] Univ Zagreb, Zagreb 41000, Croatia; [Mohammad, Kazem] Univ Tehran Med Sci, Tehran, Iran; [Mohammadifard, Noushin] Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Molnar, Denes] Univ Pecs, Pecs, Hungary; [Mondo, Charles K.] Mulago Hosp, Kampala, Uganda; [Monyeki, Kotsedi Daniel K.] Univ Limpopo, Limpopo, South Africa; [Moreno, Luis A.] Univ Zaragoza, E-50009 Zaragoza, Spain; [Morgan, Karen] RCSI Dublin, Dublin, Ireland; [Moschonis, George] Harokopio Univ Athens, Athens, Greece; [Mota, Jorge] Univ Porto, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Motlagh, Mohammad Esmaeel] Ahvaz Jundishapur Univ Med Sci, Tehran, Iran; [Motta, Jorge] Gorgas Mem Inst Publ Hlth, Panama City, Panama; [Muiesan, Maria Lorenza] Univ Brescia, I-25121 Brescia, Italy; [Mursu, Jaakko] Univ Eastern Finland, Joensuu, Finland; [Murtagh, Elaine M.] Mary Immaculate Coll, Limerick, Ireland; [Musa, Kamarul Imran] Univ Sains Malaysia, Kota Baharu, Malaysia; [Musil, Vera] Univ Zagreb, Zagreb 41000, Croatia; [Nagel, Gabriele] Univ Ulm, D-89069 Ulm, Germany; [Nangia, Vinay B.] Suraj Eye Inst, Nagpur, Maharashtra, India; [Nankap, Martin] Helen Keller Int, Yaounde, Cameroon; [Neovius, Martin] Karolinska Inst, S-10401 Stockholm, Sweden; [Nguyen, Nguyen D.] Univ Pharm & Med Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Quang Ngoc Nguyen] Hanoi Med Univ, Hanoi 100803, Vietnam; [Nishtar, Sania] Heartfile, Karachi, Pakistan; [Al Nsour, Mohannad] Eastern Mediterranean Publ Hlth Network, Amman, Jordan; [Olayan, Iman H.] Kuwait Inst Sci Res, Kuwait, Kuwait; [Ortiz, Ana P.] Univ Puerto Rico, San Juan, PR USA; [Osmond, Clive] MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Ostojic, Sergej M.] Univ Novi Sad, Novi Sad 21000, Serbia; [Overvad, Kim] Aarhus Univ, DK-8000 Aarhus C, Denmark; [Padez, Cristina] Univ Coimbra, P-3000 Coimbra, Portugal; [Palloni, Alberto] Univ Madison Wisconsin, Madison, WI USA; [Panza, Francesco] Univ Bari, I-70121 Bari, Italy; [Peeters, Petra H.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Pereira, Alexandre C.] Heart Inst InCor, Sao Paulo, Brazil; [Son Thai Pham] Vietnam Natl Heart Inst, Hanoi, Vietnam; [Pilav, Aida] Fed Minist Hlth, Sarajevo, Bosnia & Herceg; [Pistelli, Francesco] Univ Hosp Pisa, Pisa, Italy; [Pitakaka, Freda] Univ New S Wales, Sydney, NSW 2052, Australia; [Piwonska, Aleksandra] Cardinal Wyszynski Inst Cardiol, Warsaw, Poland; [Poh, Bee Koon] Publ Hlth Agcy Catalonia, Catalonia, Spain; [Trichopoulos, Dimitrios] Alexander Technol Educ Inst, Athens, Greece; [Price, Jacqueline F.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Punab, Margus] Tartu Univ Clin, Tartu, Estonia; [Qorbani, Mostafa] Alborz Univ Med Sci, Golestan, Iran; [Radic, Ivana] Inst Publ Hlth Vojvodina, Vojvodina, Serbia; [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Raitakari, Olli] Turku Univ Hosp, FIN-20520 Turku, Finland; [Ramke, Jacqueline] Univ New S Wales, Sydney, NSW 2052, Australia; [Rampal, Sanjay] Univ Malaya, Serdang, Malaysia; [Redon, Josep] Univ Valencia, E-46003 Valencia, Spain; [Reganit, Paul Ferdinand M.] Univ Philippines, Quezon City 1101, Philippines; [Rigo, Fernando] Hlth Ctr San Agustin, Madrid, Spain; [de Wit, Tobias Floris Rinke] PharmAccess Fdn, Groningen, Netherlands; [Robitaille, Cynthia] Publ Hlth Agcy Canada, Montreal, PQ, Canada; [del Cristo Rodriguez-Perez, Maria] Canarian Hlth Serv, Madrid, Spain; [Rodriguez-Villamizar, Laura A.] Univ Ind Santander, Santander, Colombia; [Rouse, Ian] Fiji Natl Univ, Nasinu, Fiji; [Rubinstein, Adolfo] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Ruehli, Frank J.] Univ Zurich, CH-8006 Zurich, Switzerland; [Rui, Ornelas] Univ Madeira, Funchal, Portugal; [Sabanayagam, Charumathi] Singapore Eye Res Inst, Singapore, Singapore; [Sachdev, Harshpal S.] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Saidi, Olfa] Fac Med Tunis, Tunis, Tunisia; [Salonen, Jukka T.] Univ Helsinki, FIN-00014 Helsinki, Finland; [Salvetti, Massimo] Univ Brescia, I-25121 Brescia, Italy; [Sanchez-Abanto, Jose] Natl Inst Hlth, Lima, Peru; [Sandjaja] Minist Hlth, Bandung, Indonesia; [Sans, Susana] Catalan Dept Hlth, Madrid, Spain; [Santos, Diana A.; Sardinha, Luis B.] Univ Lisbon, P-1699 Lisbon, Portugal; [Savva, Savvas C.] Res & Educ Inst Child Hlth, Nicosia, Cyprus; [Schargrodsky, Herman] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Schmidt, Ida Maria] Rigshosp, Copenhagen, Denmark; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Schutte, Aletta E.] MRC North West Univ, Johannesburg, South Africa; [Sein, Aye Aye] Minist Hlth, Bangkok, Thailand; [Senbanjo, Idowu O.] Lagos State Univ, Coll Med, Lagos, Nigeria; [Sepanlou, Sadaf G.] Digest Dis Res Inst, Tehran, Iran; [Shibuya, Kenji] Univ Tokyo, Tokyo 1138654, Japan; [Shiri, Rahman] Finnish Inst Occupat Hlth, Espoo, Finland; [Simons, Judith] St Vincents Hosp, Melbourne, Vic, Australia; [Slowikowska-Hilczer, Jolanta] Med Univ Lodz, Lodz, Poland; [So, Hung-Kwan] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Soderberg, Stefan] Umea Univ, S-90187 Umea, Sweden; [Soekatri, Moesijanti Y. E.] Hlth Polytech Inst, Bandung, Indonesia; [Solfrizzi, Vincenzo] Univ Bari, I-70121 Bari, Italy; [Sonestedt, Emily] Lund Univ, S-22100 Lund, Sweden; [Soric, Maroje] Univ Zagreb, Zagreb 41000, Croatia; [Soumare, Aicha] Univ Bordeaux, Bordeaux, France; [Staessen, Jan A.] Univ Leuven, Leuven, Belgium; [Stathopoulou, Maria G.] INSERM, F-75654 Paris 13, France; [Staub, Kaspar] Univ Zurich, CH-8006 Zurich, Switzerland; [Stavreski, Bill] Heart Fdn, Sydney, NSW, Australia; [Stehle, Peter] Univ Bonn, Bonn, Germany; [Stein, Aryeh D.] Emory Univ, Atlanta, GA 30322 USA; [Stergiou, George S.] Sotiria Hosp, Athina, Greece; [Stokwiszewski, Jakub] Natl Inst Hyg, Natl Inst Publ Hlth, Warsaw, Poland; [Stratton, Gareth] Swansea Univ, Swansea, W Glam, Wales; [Sun, Chien-An] Fu Jen Catholic Univ, Taipei, Taiwan; [Sundstrom, Johan] Uppsala Univ, Uppsala, Sweden; [Sung, Yn-Tz] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Sy, Rody G.] Univ Philippines, Quezon City 1101, Philippines; [Szponar, Lucjan] Natl Food & Nutr Inst, Warsaw, Poland; [Tai, E. Shyong] Natl Univ Singapore, Singapore 117548, Singapore; [Tammesoo, Mari-Liis] Univ Tartu, Ulikooli 18, EE-50090 Tartu, Estonia; [Tang, Line] Res Ctr Prevent & Hlth, Odense, Denmark; [Tang, Xun] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Tanser, Frank] Univ KwaZulu Natal, Durban, South Africa; [Tao, Yong] Peking Univ, Beijing 100871, Peoples R China; [Tarqui-Mamani, Carolina B.] Natl Inst Hlth, Lima, Peru; [Tchibindat, Felicite] UNICEF, Yaounde, Cameroon; [Tjonneland, Anne] Danish Canc Soc Res Ctr, Odense, Denmark; [Topbas, Murat] Karadeniz Tech Univ, Ankara, Turkey; [Jasienska, Grazyna; Nenko, Ilona; Pajak, Andrzej; Topor-Madry, Roman] Jagiellonian Univ, Coll Med, PL-31007 Krakow, Poland; [Trivedi, Atul] Govt Med Coll, New Delhi, India; [Tshepo, Lechaba] Sefako Makgatho Hlth Sci Univ, Johannesburg, South Africa; [Tuomilehto, Jaakko] Dasman Diabet Inst, Kuwait, Kuwait; Minist Hlth, Hamilton, New Zealand; [Tynelius, Per] Karolinska Inst, S-10401 Stockholm, Sweden; [Tzotzas, Themistoklis] Hellen Med Assoc Obes, Athens, Greece; [Tzourio, Christophe] Univ Bordeaux, Bordeaux, France; [Ukoli, Flora A. M.] Meharry Med Coll, Nashville, TN USA; [Ulmer, Hanno] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Unal, Belgin] Dokuz Eylul Univ, TR-35210 Alsancak, Turkey; [van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Hoang Van Minh] Hanoi Med Univ, Hanoi 100803, Vietnam; [van Valkengoed, Irene G. M.] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Vanuzzo, Diego] Ctr Prevenz Cardiovasc Udine, Udine, Italy; [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Veronesi, Giovanni] Univ Insubria, Varese, Italy; [Viikari-Juntura, Eira] Finnish Inst Occupat Hlth, Helsinki, Finland; [Vioque, Jesus] Univ Miguel Hernandez, Madrid, Spain; [Visvikis-Siest, Sophie] INSERM, F-75654 Paris 13, France; [Wade, Alisha N.] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa; [Wagner, Aline] Univ Strasbourg, Strasbourg, France; [Walton, Janette] Univ Coll Cork, Cork, Ireland; [Mohamud, Wan Nazaimoon Wan] Inst Med Res, Serdang, Malaysia; [Wang, Qian] Xinjiang Med Univ, Xinjiang, Peoples R China; [Wang, Ya Xing] Beijing Tongren Hosp, Beijing, Peoples R China; [Wareham, Nicholas] Univ Cambridge, Cambridge CB2 1TN, England; [Weerasekera, Deepa] Minist Hlth, Hamilton, New Zealand; [Whincup, Peter H.] Univ London, London WC1E 7HU, England; [Widhalm, Kurt] Med Univ Vienna, Vienna, Austria; [Widyahening, Indah S.] Univ Indonesia, Bandung, Indonesia; [Willeit, Johann] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Wong, Jyh Eiin] Univ Kebangsaan Malaysia, Bangi 43600, Malaysia; [Woo, Jean] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Wu, Frederick C.] Univ Manchester, Manchester M13 9PL, Lancs, England; [Xu, Haiquan] Minist Agr, Inst Food & Nutr Dev, Beijing, Peoples R China; [Xu, Liang] Capital Med Univ, Beijing, Peoples R China; [Yan, Weili] Fudan Univ, Shanghai, Peoples R China; [Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yardim, Nazan] Minist Hlth, Ankara, Turkey; [Ye, Xingwang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yiallouros, Panayiotis K.] Cyprus Univ Technol, Limassol, Cyprus; [Yoshihara, Akihiro] Niigata Univ, Niigata 95021, Japan; [Zainuddin, Ahmad A.] Univ Teknol MARA, Serdang, Malaysia; [Zambon, Sabina] Univ Padua, I-35100 Padua, Italy; [Zeng, Yi] Peking Univ, Beijing 100871, Peoples R China; [Zhao, Dong] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Zhao, Wenhua; Zhou, Maigeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zheng, Yingfeng] Singapore Eye Res Inst, Singapore, Singapore; [Zhu, Dan] Inner Mongolia Med Univ, Inner Mongolia, Peoples R China; [Zimmermann, Esther] Bispebjerg Hosp, Copenhagen, Denmark; [Zimmermann, Esther] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Zuniga Cisneros, Julio] Gorgas Mem Inst Publ Hlth, Panama City, Panama	Imperial College London; Middlesex University; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; University of Florence; National Institute of Health & Nutrition - Japan; Seoul National University (SNU); African Population & Health Research Centre; Indian Council of Medical Research (ICMR); National Taiwan University; Universidad Peruana Cayetano Heredia; Egyptian Knowledge Bank (EKB); Ain Shams University; University of California System; University of California Berkeley; Birzeit University; Instituto Mexicano del Seguro Social; University of Adelaide; Mahidol University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Leibniz Institute for Prevention Research & Epidemiology (BIPS); World Health Organization; Luxembourg Institute of Health; Universite de Lille - ISITE; CHU Lille; University of London; London School of Hygiene & Tropical Medicine; University of Southern Denmark; Norwegian School of Sport Sciences; Universidad de Cuenca; Madras Diabetes Research Foundation; Norwegian Institute of Public Health (NIPH); Kementerian Kesihatan Malaysia; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Yaounde I; Regional Authority of Public Health Banska Bystrica; Shahid Beheshti University Medical Sciences; Fahrenheit Universities; Medical University Gdansk; Autonomous University of Madrid; University of Palermo; Pan American Health Organization; Mohammed V University in Rabat; Universidade de Pernambuco (UPE); Dalhousie University; Jordan University of Science & Technology; Universidade Federal do Maranhao; University of Sydney; University of Auckland; Universite de Tunis-El-Manar; Lithuanian University of Health Sciences; Universidade de Sao Paulo; Shandong University of Traditional Chinese Medicine; Shanghai Jiao Tong University; University of Oslo; University of Gothenburg; Netherlands National Institute for Public Health & the Environment; University of Turin; University of London; University College London; Liverpool John Moores University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Lausanne; Ghent University; University of Central Venezuela; University of Bielefeld; Helmholtz Association; German Cancer Research Center (DKFZ); University of Amsterdam; Cork Institute of Technology; Universidad de la Laguna; University of Malta; Canadian Fitness & Lifestyle Research Institute; Universidade de Lisboa; Hospital Santa Maria; Istanbul University; Universidade Federal de Juiz de Fora; Universidade do Porto; Universidade de Santiago de Compostela; National University of Singapore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Medical Statistics (NIMS); Academia Sinica - Taiwan; Capital Institute of Pediatrics (CIP); Duke University; University of Oxford; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Victor Babes University of Medicine & Pharmacy, Timisoara; Korea Centers for Disease Control & Prevention (KCDC); Medical University Silesia; Charles University Prague; KU Leuven; University of Southampton; IRCCS Neuromed; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Sydney; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consiglio Nazionale delle Ricerche (CNR); Universidade Federal de Santa Catarina (UFSC); Eduardo Mondlane University; University of Copenhagen; Universite de Lille - ISITE; CHU Lille; National Medical Research Center for Therapy & Preventive Medicine; Erasmus University Rotterdam; Erasmus MC; Universite de Montreal; Institut de Recherche pour le Developpement (IRD); Universidade do Vale do Rio dos Sinos (Unisinos); University of Queensland; Istituto Superiore di Sanita (ISS); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institute of Cardiology - Poland; University of Benin; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire; University of California System; University of California Davis; Stellenbosch University; Karadeniz Technical University; Queens University Belfast; University of Zurich; Tehran University of Medical Sciences; University West Indies Mona Jamaica; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Manchester; University of Tartu; Instituto Nacional de Salud Publica; Universiti Sains Malaysia; Lulea University of Technology; Stanford University; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Sul; Kindai University (Kinki University); Kyoto University; Medical University of Warsaw; University of Geneva; Wageningen University & Research; University of Insubria; Lund University; Universidad Politecnica de Madrid; Universite de Lille - ISITE; Universite de Lille; Institute for Clinical & Experimental Medicine (IKEM); Children's Memorial Health Institute; Jagiellonian University; Collegium Medicum Jagiellonian University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; National University of Singapore; Singapore National Eye Center; Icelandic Heart Association; Universidad ICESI; University of Geneva; University of London; King's College London; Capital Medical University; University of Ibadan; Children's Memorial Health Institute; University of Zurich; Danish Cancer Society; Tulane University; University of Amsterdam; Academic Medical Center Amsterdam; Instituto Nacional de Salud Publica; University of Hong Kong; Chinese University of Hong Kong; University of Western Australia; Universidade Federal de Pelotas; Peking University; World Health Organization; International Agency for Research on Cancer (IARC); American University of Beirut; Egyptian Knowledge Bank (EKB); Cairo University; Niigata University; Simon Fraser University; Ruprecht Karls University Heidelberg; World Health Organization; Finland National Institute for Health & Welfare; University of Ljubljana; University of Zagreb; University of Crete; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); University of Munster; University of Haifa; Vrije Universiteit Amsterdam; South African Medical Research Council; University of Cambridge; Medical University of Innsbruck; National Cancer Center - Korea (NCC); Kyushu University; Institute of Tropical Medicine (ITM); University of Tartu; Kindai University (Kinki University); Polish Academy of Sciences; Ulm University; Norwegian University of Science & Technology (NTNU); Wageningen University & Research; North West University - South Africa; Medical University Lodz; Children's Memorial Health Institute; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; All India Institute of Medical Sciences (AIIMS) New Delhi; Food & Agriculture Organization of the United Nations (FAO); National University of Singapore; National Cancer Center - Korea (NCC); Tampere University; Tampere University Hospital; Universiti Putra Malaysia; National University of Singapore; Fundacao Oswaldo Cruz; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Children's Memorial Health Institute; Capital Medical University; Greifswald Medical School; Finland National Institute for Health & Welfare; Universidade do Porto; Uppsala University; Peking University; Jikei University; Consiglio Nazionale delle Ricerche (CNR); Baker Heart and Diabetes Institute; Hospital Israelita Albert Einstein; Tehran University of Medical Sciences; Harokopio University Athens; University of Padua; Pontificia Universidad Catolica de Chile; University of Reading; Emory University; Sher-i-Kashmir Institute of Medical Sciences; Cape Peninsula University of Technology; University of Rzeszow; Brown University; University of Edinburgh; University College Dublin; Universiti Teknologi MARA; Robert Koch Institute; University of Tartu; University of Zagreb; Tehran University of Medical Sciences; University of Pecs; Mulago National Referral Hospital; University of Limpopo; University of Zaragoza; Royal College of Surgeons - Ireland; Harokopio University Athens; Universidade do Porto; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Instituto Conmemorativo Gorgas de Estudios de la Salud; University of Brescia; University of Eastern Finland; University of Limerick; Mary Immaculate College - University Limerick; Universiti Sains Malaysia; University of Zagreb; Ulm University; Suraj Eye Institute; Karolinska Institutet; Hanoi Medical University; Kuwait Institute for Scientific Research; University of Puerto Rico; University of Novi Sad; Aarhus University; Universidade de Coimbra; Universita degli Studi di Bari Aldo Moro; Utrecht University; Utrecht University Medical Center; Universidade de Sao Paulo; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of New South Wales Sydney; Institute of Cardiology - Poland; University of Edinburgh; University of Tartu; University of Turku; University of New South Wales Sydney; Universiti Malaya; University of Valencia; University of the Philippines System; University of the Philippines Diliman; Public Health Agency of Canada; Universidad Industrial de Santander; Fiji National University (FNU); University of Zurich; Universidade da Madeira; National University of Singapore; Singapore National Eye Center; Sitaram Bhartia Institute of Science & Research; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); University of Helsinki; University of Brescia; Instituto Nacional de Salud - Peru; Universidade de Lisboa; Hospital Italiano de Buenos Aires; University of Buenos Aires; Rigshospitalet; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Ministry of Public Health - Thailand; Lagos State University; University of Tokyo; Finnish Institute of Occupational Health; St Vincent's Hospital Melbourne; Medical University Lodz; Chinese University of Hong Kong; Umea University; Universita degli Studi di Bari Aldo Moro; Lund University; University of Zagreb; UDICE-French Research Universities; Universite de Bordeaux; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Zurich; University of Bonn; Emory University; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Swansea University; Fu Jen Catholic University; Uppsala University; Chinese University of Hong Kong; University of the Philippines System; University of the Philippines Diliman; National University of Singapore; University of Tartu; Peking University; University of Kwazulu Natal; Peking University; Instituto Nacional de Salud - Peru; Danish Cancer Society; Karadeniz Technical University; Jagiellonian University; Collegium Medicum Jagiellonian University; Sefako Makgatho Health Sciences University; Karolinska Institutet; UDICE-French Research Universities; Universite de Bordeaux; Meharry Medical College; Medical University of Innsbruck; Dokuz Eylul University; Utrecht University; Utrecht University Medical Center; Hanoi Medical University; University of Amsterdam; Academic Medical Center Amsterdam; Universidade Federal de Minas Gerais; University of Insubria; Finnish Institute of Occupational Health; Universidad Miguel Hernandez de Elche; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Witwatersrand; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University College Cork; Xinjiang Medical University; Capital Medical University; University of Cambridge; University of London; Medical University of Vienna; University of Indonesia; Medical University of Innsbruck; Universiti Kebangsaan Malaysia; Chinese University of Hong Kong; University of Manchester; Ministry of Agriculture & Rural Affairs; Capital Medical University; Fudan University; Chinese Center for Disease Control & Prevention; Ministry of Health - Turkey; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Cyprus University of Technology; Niigata University; Universiti Teknologi MARA; University of Padua; Peking University; Capital Medical University; Chinese Center for Disease Control & Prevention; National University of Singapore; Singapore National Eye Center; Inner Mongolia Medical University; University of Copenhagen; Bispebjerg Hospital; Instituto Conmemorativo Gorgas de Estudios de la Salud	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Can, Günay/AAB-1669-2020; Pikhart, Hynek/E-3074-2010; Fischer, Kathelijn/M-2395-2017; Iwasaki, Masanori/H-8434-2019; Danaei, Goodarz/B-6085-2008; lachat, carl/AAH-9764-2020; Markey, Oonagh/E-5490-2017; Castetbon, Katia/F-2686-2017; Abdeen, Ziad/AAC-7889-2019; Noto, Davide/AAA-9208-2019; Plans-Rubió, Pedro/AAB-1778-2022; McLean, Rachael/AAF-7596-2019; Di Castelnuovo, Augusto Filippo/AAC-2436-2022; Viegi, Giovanni/K-2746-2016; Gudnason, Vilmundur/AAE-7126-2019; vhmpp, aks/F-9756-2012; Kavousi, Maryam/F-1174-2018; Valvi, Dania/ABE-6650-2020; Santos, Osvaldo/E-7995-2010; Morejon, Alain/AAS-4280-2020; Shiri, Rahman/ABB-1780-2021; Ritti-Dias, Raphael/G-4200-2013; Schneider, Ione J.C./J-8762-2013; Ramos, Rafel/D-9627-2016; Damsgaard, Camilla T/B-4866-2015; Widyahening, Indah/ABB-9058-2021; Topbas, Murat/AAT-1095-2020; Ikeda, Nayu/J-9890-2019; Meirhaeghe, Aline/E-4663-2015; mota, jorge/B-2980-2013; Muiesan, M.L./AAC-2060-2022; Bettiol, Heloisa/B-4190-2013; Silva, Diego Augusto Santos/AAB-9249-2020; Bjerregaard, Peter/ABD-8894-2020; Murtagh, Elaine M/AAF-4146-2022; Shalnova, Svetlana/D-3824-2016; Misigoj-Durakovic, Marjeta/GRJ-4802-2022; Chirita-Emandi, Adela/G-5574-2016; Visvikis-Siest, Sophie/H-2324-2014; León-Muñoz, Luz M/H-8275-2017; li, yong/HDN-3885-2022; Rodriguez, Laura/GWC-8446-2022; Tzourio, christophe/L-6344-2019; MOREIRA, LEILA LEILA B/AAC-2240-2019; McFarlane, Shelly/AFU-7579-2022; Panza, Francesco/M-6804-2017; Vrijheid, Martine/H-2702-2014; Pistelli, Francesco/Y-8270-2019; Qasrawi, Radwan/AAA-6245-2019; Osler, Merete/AAF-7885-2019; Mohammadifard, Noushin/M-2244-2018; Christensen, Kaare/C-2360-2009; Wong, Tien Yin/AAC-9724-2020; Zhou, Bin/E-4102-2017; Peixoto, SÃ©rgio/AAK-7335-2021; Benet, Marta/H-4168-2017; Gureje, Oye/J-1183-2014; REDON, JOSEP/E-1719-2019; Iwasaki, Masanori/GQH-9944-2022; do Carmo P Franco, Maria/F-7771-2015; Azizi, Fereidoun/ABD-4136-2021; TANG, Xun/L-8375-2013; Sepanlou, Sadaf G/H-9343-2016; Sundström, Johan/A-6286-2009; Peykari, Niloofar/L-4521-2016; Bovet, Pascal/F-4477-2011; Sardinha, Luís B./ABG-5389-2020; Zheng, Yingfeng/AAE-2983-2022; paccaud, fred/M-7516-2019; Kengne, Andre Pascal/ABB-3696-2020; Mensink, Gert B/B-2447-2009; Brewster, Lizzy M/K-7675-2019; Olinto, Maria Teresa Anselmo/AAH-5897-2021; Cheng, Ching-Yu/Y-2229-2019; Chan, Queenie/C-5017-2011; del Cristo Rodriguez Perez, Maria/AAD-4214-2020; deev, alexander/M-7754-2014; Murtagh, Elaine M/AEU-2463-2022; Nakamura, Harunobu/R-9237-2019; Mostafa, Aya/X-6686-2019; Khader, Yousef/AAE-9620-2019; Hardy, Rebecca/AFR-1989-2022; Ferguson, Trevor/Q-7209-2019; Sabanayagam, Charumathi/C-1294-2011; Guimarães, André Luiz Sena/D-8122-2011; Salvetti, Massimo/E-9929-2010; Manios, Yannis/AAM-8953-2021; Wong, Jyh Eiin/AAK-4382-2020; Li, Yuan/GXV-1310-2022; Mathur, Prashant/AAY-9373-2020; Sorić, Maroje/AAR-6770-2021; Gonzalez-Gross, Marcela/W-8000-2018; Navarrete-Muñoz, Eva Maria/F-1666-2011; Benet, Mikhail/AAS-2086-2020; Woodward, Mark/D-8492-2015; Litwin, Mieczyslaw/L-4648-2017; solfrizzi, vincenzo/AAL-3222-2020; Virtanen, Jyrki/G-5149-2013; Molnár, Dénes/AAB-6820-2022; Tzourio, christophe/B-4015-2009; Woodward, Mark/L-6817-2017; Louzada Strufaldi, Maria Wany/GVU-7692-2022; Costanzo, Simona/K-5076-2016; Stathopoulou, Maria/H-7324-2016; Sunyer, Jordi/G-6909-2014; Gulliford, Martin C/I-8606-2018; Van Hoang, Minh/AET-0962-2022; van Valkengoed, Irene/ABA-1551-2021; Van Herck, Koen/L-2549-2019; SOUMARE, AICHA/T-4739-2019; Claessens, Frank/M-8565-2016; Ueda, Peter/AAB-8961-2020; Bugge, Anna/P-5100-2016; Scazufca, Marcia/K-7418-2012; Ueda, Peter/AGH-9915-2022; Sarrafzadegan, Nizal/V-5826-2017; morgan, karen/C-3846-2012; De Bacquer, Dirk/HGU-3191-2022; Gunter, Marc/AAP-8621-2020; Strufaldi, Maria Wany L/C-6663-2016; Porta, Miquel/AAD-5371-2020; Musa, Kamarul Imran/N-3198-2015; mohamed, mostafa/AFE-7371-2022; Tanser, Frank/ABE-8326-2021; Van Herck, Koen/G-5223-2013; Colaus, PsyColaus/K-6607-2013; Vatten, Lars/AAF-9380-2022; Zdrojewski, Tomasz/AAA-8875-2020; Bandosz, Piotr/E-4964-2017; Jørgensen, Torben/Z-1335-2018; Meshram, Indrapal/AGD-7915-2022; Schutte, Aletta E/E-5126-2018; Radišauskas, Ričardas/AAT-8920-2021; Dauchet, Luc/S-3228-2016; li, yan/GTI-4638-2022; Horta, Bernardo/A-7604-2008; Santos, Diana A/H-9086-2013; Heshmat, Ramin/S-7435-2017; Zhao, D/AAX-5040-2021; van der Schouw, Yvonne T./F-8327-2014; Müller-Nurasyid, Martina/I-8735-2018; Motta, Jorge Alejandro/ABI-6006-2020; Batista, Rosangela Fernandes Lucena/G-6808-2016; Bo, Simona/AAC-1110-2019; Widyahening, Indah/GNP-8450-2022; Rampal, Sanjay/B-9691-2010; Unal, Belgin/E-7064-2017; Hajifathalian, Kaveh/AAX-6179-2021; Pereira, Alexandre/HHN-1038-2022; Grøntved, Anders/AAA-8025-2022; Raj, Manu/U-7187-2019; Bentham, James/ABF-5746-2020; Cooper, Rachel/ABE-3768-2021; Geleijnse, Johanna Marianna M/B-5749-2012; Malhotra, Rahul/I-7818-2019; McNulty, Breige/GSI-4486-2022; van Valkengoed, Irene G.M./B-2974-2013; Aekplakorn, Wichai/AAK-6867-2021; Jasienska, Grazyna/E-4901-2011; Johansson, Mattias/ABF-3365-2020; Siani, Alfonso/B-7925-2015; Iacoviello, Licia/AGX-7071-2022; Murphy, Neil/E-1189-2017; stratton, Gareth/Z-5471-2019; BABU, BONTHA VEERRAJU/X-2096-2019; Masoodi, Shariq/AAV-7265-2020; Khalili, Davood/T-2913-2017; Yan, Weili/AAS-9448-2021; McKee, Marc D/E-2187-2011; vioque, jesus/A-1066-2008; Virtanen, Jyrki/AAC-8945-2020; Grodzicki, Tomasz/K-4451-2012; Gafencu, Mihai/G-1251-2017; Staessen, Jan A/A-1065-2011; Litwin, Mieczyslaw/ABH-4315-2020; Escobedo, Jorge/AAH-3917-2020; Crujeiras, Ana/ABA-8866-2021; Zheng, Yingfeng/CAE-9225-2022; Mckee, Martin/E-6673-2018; Sans, Susana/ABD-5378-2021; Martorell, Reynaldo/I-2539-2012; Porta, Miquel/B-5787-2008; Martinez, Ramfis Nieto/I-7205-2019; Schienkiewitz, Anja/A-8463-2019; Kelishadi, Roya/E-6154-2012; Drygas, Wojciech/GLR-9863-2022; Ulmer, Hanno/S-6615-2019; Romaguera, Dora/AAB-2852-2020; Li, Yang/GWM-7879-2022; Raitakari, Olli/AAQ-7389-2021; Adams, Robert/Z-3197-2019; Kasaeian, Amir/C-8290-2017; Chaturvedi, Himanshu K./AAD-7705-2020; d'Orsi, Eleonora/D-1905-2015; Vale, Susana/L-8367-2013; Stergiou, George/J-3083-2019; Soekatri, Moesijanti Y.E./AAM-8754-2021; Brenner, Hermann/ABE-6383-2020; Benoit, Salanave/F-3062-2017; de Barros, Mauro Virgilio Gomes/B-8983-2014; KIM, JEONGSEON/AAA-4643-2022; Vatten, Lars/AFK-2073-2022; Soric, Maroje/AAE-8272-2021; Ramos, Rafel/P-2083-2019; Dehghan, Abbas/ABE-7377-2020; Gianfagna, Francesco/K-4561-2016; Veronesi, Giovanni/E-3859-2010; Makdisse, Marcia/AAY-9814-2020; Sardinha, Luís Bettencourt/F-2641-2013; Malekzadeh, Reza/U-1382-2017; Lotufo, Paulo/A-9843-2008; Brenner, Hermann/B-4627-2017; Yiallouros, Panayiotis/AAF-6026-2019; Menezes, Ana MB/G-7266-2012; Tamosiunas, Abdonas/AAD-4274-2021; Cardoso, Viviane/D-6254-2012; ATI, Jalila EL/Y-5467-2018; TRIVEDI, ATUL/AAK-1984-2021; Fuchs, Flávio D/L-5078-2016; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Murtagh, Elaine M/AEO-8704-2022; Zhou, Maigeng/HCH-7703-2022; Ikram, M. Arfan/AAM-5225-2021; Nagel, Gabriele/C-3635-2012; Nguyen, Nguyen/GVT-4511-2022; Silva, Diego/GRF-5446-2022; Salinas, Carlos A Aguilar/AAL-4491-2020; Khaw, Kay-Tee/AAZ-3209-2021; Moreno, Luis/S-1780-2019; wang, YA XING/K-9671-2016; Lehtimäki, Terho/AAD-1094-2022; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Nguyen, Ngoc/HHZ-0886-2022; Moschonis, George/AAM-9616-2021; Qorbani, Mostafa/M-8171-2017; De Backer, Guy/AAI-4607-2021; Iacoviello, Licia/K-4676-2016; Pigeot, Iris/A-2722-2012; He, Jiang/AAF-5303-2020; Sundstrom, Johan/R-2139-2019; Laatikainen, Tiina/ABD-6622-2021; Padez, Cristina/AAN-1156-2020; Kemper, Han CG/N-9746-2019; Franco, Óscar H/ABE-2305-2020; Santos, Vanessa/AAP-4130-2020; Fuchs, Sandra C/T-2670-2019; You, Qisheng/AAG-7153-2020; Boehm, Bernhard Otto/F-8750-2015; Topor-Madry, Roman/ABF-5449-2020; Ekelund, Ulf/AAE-8471-2019; Cífková, Renata/O-5731-2017; Fernandez-Berges, Daniel/R-5998-2019; Panza, Francesco/Y-2539-2019; Kruger, Salome/R-2476-2019; Pilav, Aida/GLR-8893-2022; Meisinger, Christine/B-5358-2014; Ramke, Jacqueline/I-8844-2019; Peters, Annette/A-6117-2011; Chen, Chien-Jen/N-4723-2019; Romaguera, Dora/ABE-7004-2020; Redon, Josep/L-5997-2019; Woo, Jean/K-2625-2014; /AAZ-4039-2021; Silva, Antonio A M/B-5410-2009; Foo, Leng Huat/I-1127-2012; Stehle, Peter/G-2015-2012; Nagalla, Balakrishna/GRR-4393-2022; Dehghan, Abbas/B-9896-2008; Ahmadvand, Alireza/J-8932-2015; gottrand, frederic/G-7370-2015; Garnett, Sarah/D-8067-2012; Khaing, Nang Ei Ei/C-2219-2011; Peixoto, Sergio/K-3230-2016; Ferrieres, Jean/S-7993-2016; Santos, Rute/A-6401-2012; Li, Yanping/H-6437-2011; Marques-Vidal, Pedro/C-9449-2009; Lu, Yuan/D-4941-2015; Dankner, Rachel/Q-5245-2019; donfrancesco, chiara/K-1460-2016; Smeeth, Liam/X-5862-2018; Sonestedt, Emily/I-3814-2016; Mbanya, Jean Claude N/T-5147-2018; Taylor, Anne/F-5708-2010; giovannelli, jonathan/I-5307-2018; Ahrens, Wolfgang/A-2740-2012; Lam, Tai Hing/C-4317-2009; Mendes, Larissa/Q-4817-2017; Carlos Candido, Ana Paula/L-9217-2013; Palmieri, Luigi/O-1845-2017; Ho, Daniel Sai Yin/C-4307-2009	Pikhart, Hynek/0000-0001-5277-4049; Iwasaki, Masanori/0000-0002-5739-2936; lachat, carl/0000-0002-1389-8855; Markey, Oonagh/0000-0001-5293-7354; Plans-Rubió, Pedro/0000-0002-4424-2971; McLean, Rachael/0000-0002-0005-328X; Di Castelnuovo, Augusto Filippo/0000-0001-9767-7998; Viegi, Giovanni/0000-0002-1855-4410; Gudnason, Vilmundur/0000-0001-5696-0084; Kavousi, Maryam/0000-0001-5976-6519; Santos, Osvaldo/0000-0002-0836-4314; Morejon, Alain/0000-0002-4652-1771; Shiri, Rahman/0000-0002-9312-3100; Ritti-Dias, Raphael/0000-0001-7883-6746; Schneider, Ione J.C./0000-0001-6339-7832; Ramos, Rafel/0000-0001-7970-5537; Widyahening, Indah/0000-0002-7952-2893; Ikeda, Nayu/0000-0002-3424-1991; Meirhaeghe, Aline/0000-0001-6983-2364; mota, jorge/0000-0001-7571-9181; Muiesan, M.L./0000-0002-4007-9441; Bettiol, Heloisa/0000-0001-8744-4373; Silva, Diego Augusto Santos/0000-0002-0489-7906; Bjerregaard, Peter/0000-0001-7153-8447; Murtagh, Elaine M/0000-0003-4232-1403; Chirita-Emandi, Adela/0000-0001-7554-4625; Visvikis-Siest, Sophie/0000-0001-8104-8425; Tzourio, christophe/0000-0002-6517-2984; MOREIRA, LEILA LEILA B/0000-0002-4730-7988; Panza, Francesco/0000-0002-7220-0656; Vrijheid, Martine/0000-0002-7090-1758; Pistelli, Francesco/0000-0001-5612-6364; Mohammadifard, Noushin/0000-0003-1776-1060; Christensen, Kaare/0000-0002-5429-5292; Wong, Tien Yin/0000-0002-8448-1264; Zhou, Bin/0000-0002-1741-8628; Gureje, Oye/0000-0003-0094-5947; Azizi, Fereidoun/0000-0002-6470-2517; TANG, Xun/0000-0002-6990-0168; Sepanlou, Sadaf G/0000-0002-3669-5129; Sundström, Johan/0000-0003-2247-8454; Peykari, Niloofar/0000-0003-3219-3751; Bovet, Pascal/0000-0002-0242-4259; Sardinha, Luís B./0000-0002-6230-6027; Mensink, Gert B/0000-0001-6268-5998; Olinto, Maria Teresa Anselmo/0000-0002-3950-4594; Cheng, Ching-Yu/0000-0003-0655-885X; Chan, Queenie/0000-0001-9278-230X; Mostafa, Aya/0000-0002-2803-2608; Khader, Yousef/0000-0002-7830-6857; Ferguson, Trevor/0000-0002-2393-1452; Sabanayagam, Charumathi/0000-0002-4042-4719; Guimarães, André Luiz Sena/0000-0002-3162-3206; Salvetti, Massimo/0000-0001-8101-1374; Manios, Yannis/0000-0001-6486-114X; Wong, Jyh Eiin/0000-0002-9206-3257; Mathur, Prashant/0000-0002-9271-1373; Sorić, Maroje/0000-0001-6835-1438; Litwin, Mieczyslaw/0000-0002-5241-2483; solfrizzi, vincenzo/0000-0002-8524-0315; Virtanen, Jyrki/0000-0002-0648-999X; Tzourio, christophe/0000-0002-6517-2984; Costanzo, Simona/0000-0003-4569-1186; Stathopoulou, Maria/0000-0003-4376-2083; Sunyer, Jordi/0000-0002-2602-4110; Gulliford, Martin C/0000-0003-1898-9075; van Valkengoed, Irene/0000-0002-9306-7831; Van Herck, Koen/0000-0003-0717-2406; SOUMARE, AICHA/0000-0002-0178-6506; Claessens, Frank/0000-0002-8676-7709; Ueda, Peter/0000-0002-3275-8743; Bugge, Anna/0000-0002-8345-1434; Ueda, Peter/0000-0002-3275-8743; Sarrafzadegan, Nizal/0000-0002-8352-0540; morgan, karen/0000-0001-6193-1747; Strufaldi, Maria Wany L/0000-0003-0335-5344; Porta, Miquel/0000-0003-1684-7428; Musa, Kamarul Imran/0000-0002-3708-0628; mohamed, mostafa/0000-0002-1421-2667; Van Herck, Koen/0000-0003-0717-2406; Zdrojewski, Tomasz/0000-0001-6015-8561; Schutte, Aletta E/0000-0001-9217-4937; Radišauskas, Ričardas/0000-0002-1227-2674; Dauchet, Luc/0000-0002-2398-0596; Horta, Bernardo/0000-0001-9843-412X; Santos, Diana A/0000-0003-0429-3093; van der Schouw, Yvonne T./0000-0002-4605-435X; Müller-Nurasyid, Martina/0000-0003-3793-5910; Batista, Rosangela Fernandes Lucena/0000-0002-1529-0165; Rampal, Sanjay/0000-0002-0105-6407; Unal, Belgin/0000-0002-4354-8266; Hajifathalian, Kaveh/0000-0002-3931-2576; Raj, Manu/0000-0001-7130-3437; Cooper, Rachel/0000-0003-3370-5720; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Malhotra, Rahul/0000-0002-9978-4276; McNulty, Breige/0000-0003-0841-063X; van Valkengoed, Irene G.M./0000-0002-9306-7831; Jasienska, Grazyna/0000-0001-8716-6342; Iacoviello, Licia/0000-0003-0514-5885; Murphy, Neil/0000-0003-3347-8249; stratton, Gareth/0000-0001-5618-0803; BABU, BONTHA VEERRAJU/0000-0001-5096-2222; Masoodi, Shariq/0000-0002-8664-9614; Khalili, Davood/0000-0003-4956-1039; Yan, Weili/0000-0002-7633-7449; McKee, Marc D/0000-0001-8349-965X; vioque, jesus/0000-0002-2284-148X; Virtanen, Jyrki/0000-0002-0648-999X; Grodzicki, Tomasz/0000-0003-0159-4915; Gafencu, Mihai/0000-0002-9029-5919; Staessen, Jan A/0000-0002-3026-1637; Litwin, Mieczyslaw/0000-0002-5241-2483; Escobedo, Jorge/0000-0003-1942-7402; Crujeiras, Ana/0000-0003-4392-0301; Zheng, Yingfeng/0000-0002-0914-7864; Mckee, Martin/0000-0002-0121-9683; Sans, Susana/0000-0002-0400-5197; Porta, Miquel/0000-0003-1684-7428; Martinez, Ramfis Nieto/0000-0002-0575-7534; Schienkiewitz, Anja/0000-0003-3821-9772; Kelishadi, Roya/0000-0001-7455-1495; Ulmer, Hanno/0000-0001-5911-1002; Kasaeian, Amir/0000-0003-2018-9368; Stergiou, George/0000-0002-6132-0038; Brenner, Hermann/0000-0002-6129-1572; Benoit, Salanave/0000-0002-4573-3166; de Barros, Mauro Virgilio Gomes/0000-0003-3165-0965; Ramos, Rafel/0000-0001-7970-5537; Gianfagna, Francesco/0000-0003-4615-0816; Veronesi, Giovanni/0000-0002-4119-6615; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Malekzadeh, Reza/0000-0002-9820-6335; Lotufo, Paulo/0000-0002-4856-8450; Brenner, Hermann/0000-0002-6129-1572; Menezes, Ana MB/0000-0002-2996-9427; Cardoso, Viviane/0000-0002-2677-5600; TRIVEDI, ATUL/0000-0001-7921-7971; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Murtagh, Elaine M/0000-0003-4232-1403; Nagel, Gabriele/0000-0001-6185-8535; Moreno, Luis/0000-0003-0454-653X; wang, YA XING/0000-0003-2749-7793; Lehtimäki, Terho/0000-0002-2555-4427; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Iacoviello, Licia/0000-0003-0514-5885; Pigeot, Iris/0000-0001-7483-0726; He, Jiang/0000-0002-8286-9652; Sundstrom, Johan/0000-0003-2247-8454; Laatikainen, Tiina/0000-0002-6614-4782; Padez, Cristina/0000-0002-1967-3497; Franco, Óscar H/0000-0002-4606-4929; You, Qisheng/0000-0003-0743-7320; Ekelund, Ulf/0000-0003-2115-9267; Cífková, Renata/0000-0003-2765-3821; Fernandez-Berges, Daniel/0000-0002-9561-2901; Panza, Francesco/0000-0002-7220-0656; Pilav, Aida/0000-0002-6765-0812; Ramke, Jacqueline/0000-0002-5764-1306; Peters, Annette/0000-0001-6645-0985; Romaguera, Dora/0000-0002-5762-8558; Redon, Josep/0000-0001-8777-6773; Woo, Jean/0000-0001-7593-3081; Silva, Antonio A M/0000-0003-4968-5138; Sibai, Abla/0000-0002-1851-5606; Nagalla, Balakrishna/0000-0002-5613-0942; Dehghan, Abbas/0000-0001-6403-016X; LIN, HSIEN-HO/0000-0002-7481-6016; Tanser, Frank/0000-0001-9797-0000; Ahmadvand, Alireza/0000-0001-5568-8787; Y.E. SOEKATRI, Moesijanti/0000-0001-9289-2197; TOPBAS, MURAT/0000-0003-4047-4027; Neovius, Martin/0000-0003-2300-3055; CASTETBON, Katia/0000-0002-1207-6729; Poulimeneas, Dimitrios/0000-0003-4868-9620; Valvi, Dania/0000-0003-4633-229X; Robinson, Sian/0000-0003-1766-7269; Shibuya, Kenji/0000-0003-2528-7530; Baur, Louise/0000-0002-4521-9482; gottrand, frederic/0000-0002-5290-0436; Garnett, Sarah/0000-0001-7552-0789; Sachdev, Harshpal Singh/0000-0002-4956-9391; PALLI, Domenico/0000-0002-5558-2437; Lunet, Nuno/0000-0003-1870-1430; Rojas, Rosalba/0000-0003-4474-7926; Scazufca, Marcia/0000-0002-4545-006X; Linneberg, Allan/0000-0002-0994-0184; Stokwiszewski, Jakub/0000-0002-9328-4924; Valdivia, Gonzalo/0000-0001-5368-6745; Dhana, Klodian/0000-0002-6397-7009; EL ATI, Jalila/0000-0002-8715-455X; Tarp, Jakob/0000-0002-9186-7077; Sen, Abhijit/0000-0001-9560-4226; Otero, Johanna/0000-0002-2044-2071; Jackson, Rod/0000-0001-5914-6934; Bernabe-Ortiz, Antonio/0000-0002-6834-1376; Khaing, Nang Ei Ei/0000-0002-5361-0481; Damsgaard, Camilla T/0000-0002-5013-0562; Peixoto, Sergio/0000-0001-9431-2280; Ferrieres, Jean/0000-0001-6144-1297; Bobak, Martin/0000-0002-2633-6851; Santos, Rute/0000-0002-7604-5753; fuchs, flavio/0000-0002-1191-0523; ZAINUDDIN, AHMAD ANWAR/0000-0001-6822-0075; Staub, Kaspar/0000-0002-3951-1807; Matsha, Tandi/0000-0001-5251-030X; Li, Yanping/0000-0002-0412-2748; MAKDISSE, MARCIA/0000-0001-7522-9430; Bentham, James/0000-0001-5733-9417; Ben Romdhane, Habiba/0000-0003-4311-5038; BRUNO, Graziella/0000-0002-3011-8304; Wojtyniak, Bogdan/0000-0002-2135-8226; Fall, Caroline/0000-0003-4402-5552; Osmond, Clive/0000-0002-9054-4655; Mollehave, Line Tang/0000-0001-7116-9346; Lozano Alonso, Jose Eugenio/0000-0003-2589-0671; Kulaga, Zbigniew/0000-0003-0509-1004; Hernandez Cadena, Leticia/0000-0003-3807-2758; Hardy, Rebecca/0000-0001-9949-0799; Jurak, Gregor/0000-0003-4269-0970; Overvad, Kim/0000-0001-6429-7921; Marques-Vidal, Pedro/0000-0002-4548-8500; Di Cesare, Mariachiara/0000-0002-3934-3364; Gasull, Magda/0000-0003-4546-3650; Kaur, Prabhdeep/0000-0002-2605-3739; Khang, Young-Ho/0000-0002-9585-8266; Koziel, Slawomir/0000-0002-0584-4427; Husseini, Abdullatif/0000-0001-8767-5956; Camolas, Jose/0000-0002-1366-6755; Qorbani, Mostafa/0000-0001-9465-7588; Navarrete-Munoz, Eva Maria/0000-0002-1494-5676; Stein, Aryeh/0000-0003-1138-6458; BARCELO, ALBERTO/0000-0002-5258-6299; Bo, Simona/0000-0001-6862-8628; Wade, Alisha/0000-0002-1158-2523; Thijs, Lutgarde/0000-0002-8108-2356; Clays, Els/0000-0002-1092-945X; Johansson, Mattias/0000-0002-3116-5081; Batieha, Anwar/0000-0001-8639-2807; Kumar, Raman Krishna/0000-0003-4343-0951; Jacobs, Jeremy Michael/0000-0002-7001-7815; Vale, Susana/0000-0002-1703-9361; Tolonen, Hanna/0000-0003-3121-4303; Lu, Yuan/0000-0001-5264-2169; Riboli, Elio/0000-0001-6795-6080; Kotowska, Aneta/0000-0003-3289-2878; Yiallouros, Panayiotis/0000-0002-8339-9285; De Bacquer, Dirk/0000-0002-3202-7238; Dankner, Rachel/0000-0001-6454-6000; Bongard, Vanina/0000-0001-5789-0815; Michaelsen, Kim F/0000-0003-0449-0839; ferreccio, catterina/0000-0001-6331-5534; donfrancesco, chiara/0000-0002-8040-5571; Acosta-Cazares, Benjamin/0000-0001-9697-6160; Lucjan, szponar/0000-0003-4225-8299; Kruger, Herculina Salome/0000-0002-5365-1777; Punab, Margus/0000-0001-9601-6311; motlagh, mohammad esmaiel/0000-0002-2971-8660; Smeeth, Liam/0000-0002-9168-6022; Pradeepa, Rajendra/0000-0002-4909-3733; Tai, E Shyong/0000-0003-2929-8966; Meisinger, Christa/0000-0002-9026-6544; Ochoa-Aviles, Angelica/0000-0001-7926-3644; Sonestedt, Emily/0000-0002-0747-4562; Leclercq, Catherine/0000-0002-9416-7738; Tolstrup, Janne/0000-0002-9796-3967; Katz, Joanne/0000-0002-5997-7823; Moller, Niels Christian/0000-0001-5842-5595; Kuulasmaa, Kari/0000-0003-2165-1411; Alkerwi, Ala'a/0000-0002-7448-3936; vanderschueren, dirk/0000-0003-1395-0104; Noale, Marianna/0000-0001-7115-139X; Moschonis, George/0000-0003-3009-6675; Mbanya, Jean Claude N/0000-0001-9651-8653; Yardim, Nazan/0000-0002-1186-7094; Taylor, Anne/0000-0002-4422-7974; giovannelli, jonathan/0000-0002-7516-4670; Farzadfar, Farshad/0000-0001-8288-4046; Ahrens, Wolfgang/0000-0003-3777-570X; Lam, Tai Hing/0000-0002-2033-9971; Bennett, James Elston/0000-0002-9616-6878; Reis, AlessanRSS/0000-0001-8486-7469; Ostojic, Sergej/0000-0002-7270-2541; Molbo, Drude/0000-0003-3372-8711; Magliano, Dianna/0000-0002-9507-6096; Rodriguez-Villamizar, Laura Andrea/0000-0002-5551-2586; Cooper, Cyrus/0000-0003-3510-0709; Mendes, Larissa/0000-0003-0776-6845; Dias da Costa, Juvenal Soares/0000-0003-3160-6075; Jorgensen, Torben/0000-0001-9453-2830; Tjonneland, Anne/0000-0003-4385-2097; Carlos Candido, Ana Paula/0000-0002-1481-5927; Palmieri, Luigi/0000-0002-4298-2642; Nakamura, Harunobu/0000-0003-0512-2253; Brewster, Lizzy M/0000-0002-7434-0038; Chudek, Jerzy/0000-0002-6367-7794; Neuhauser, Hannelore K./0000-0002-6605-6221; Mazur, Artur/0000-0001-5393-3515; Mediene Benchekor, Sounnia/0000-0003-2163-7679; Gurzkowska, Beata/0000-0003-2681-3221; Walton, Janette/0000-0003-4758-5328; Grontved, Anders/0000-0003-1584-679X; Ho, Daniel Sai Yin/0000-0001-9485-0273	Wellcome Trust; Grand Challenges Canada; MRC [MR/N003284/1, MR/L01341X/1, MC_UU_12011/4, G0400519, MC_UU_12019/1, MC_UU_12011/3, MC_UP_A620_1016, G0400491, MC_UU_12011/2, MC_U147585819, MC_UP_A620_1015, MC_U147585827] Funding Source: UKRI; British Heart Foundation [PG/13/66/30442] Funding Source: researchfish; Medical Research Council [MC_UU_12011/1, U1475000003, MC_UP_A620_1016, G0400491, MR/L01341X/1, U1475000001, MC_U147585824, MC_UP_A620_1015, MC_U147585827, MC_UP_A620_1014, G0400519, MR/N003284/1, MC_UU_12011/2, MC_UU_12019/1, MC_UU_12011/4, MR/K006584/1, U1475000002, MC_UU_12011/3, G0401527, MC_U147585819] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085, NF-SI-0512-10114, NF-SI-0510-10090] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15H05123] Funding Source: KAKEN	Wellcome Trust(Wellcome TrustEuropean Commission); Grand Challenges Canada(CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Wellcome Trust, Grand Challenges Canada.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Beaglehole R, 2014, LANCET, V384, P105, DOI 10.1016/S0140-6736(14)61091-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Finucane MM, 2014, STAT SCI, V29, P18, DOI 10.1214/13-STS427; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hayes AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-53; Hilton S, 2012, OBESITY, V20, P1688, DOI 10.1038/oby.2012.27; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Kitahara CM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001673; Kleinert S, 2015, LANCET, V385, P2326, DOI 10.1016/S0140-6736(15)60163-5; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mamun AA, 2015, OBES RES CLIN PRACT, V9, P75, DOI 10.1016/j.orcp.2014.03.001; MCGARVEY ST, 1991, AM J CLIN NUTR, V53, pS1586, DOI 10.1093/ajcn/53.6.1586S; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Popkin BM, 2006, OBESITY, V14, P1846, DOI 10.1038/oby.2006.213; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; STAMLER J, 1993, ARCH INTERN MED, V153, P1040, DOI 10.1001/archinte.153.9.1040; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; ZIMMET P, 1978, AUST NZ J MED, V8, P141, DOI 10.1111/j.1445-5994.1978.tb04500.x	43	2680	2810	59	514	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1377	1396		10.1016/s0140-6736(16)30054-x	http://dx.doi.org/10.1016/s0140-6736(16)30054-x			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	27115820	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000373217500031
J	Maguid, E; Yulevich, I; Veksler, D; Kleiner, V; Brongersma, ML; Hasman, E				Maguid, Elhanan; Yulevich, Igor; Veksler, Dekel; Kleiner, Vladimir; Brongersma, Mark L.; Hasman, Erez			Photonic spin-controlled multifunctional shared-aperture antenna array	SCIENCE			English	Article							PANCHARATNAM-BERRY PHASE; OPTICAL-ELEMENTS; LIGHT; METASURFACES; MANIPULATION; GRATINGS	The shared-aperture phased antenna array developed in the field of radar applications is a promising approach for increased functionality in photonics. The alliance between the shared-aperture concepts and the geometric phase phenomenon arising from spin-orbit interaction provides a route to implement photonic spin-control multifunctional metasurfaces. We adopted a thinning technique within the shared-aperture synthesis and investigated interleaved sparse nanoantenna matrices and the spin-enabled asymmetric harmonic response to achieve helicity-controlled multiple structured wavefronts such as vortex beams carrying orbital angular momentum. We used multiplexed geometric phase profiles to simultaneously measure spectrum characteristics and the polarization state of light, enabling integrated on-chip spectropolarimetric analysis. The shared-aperture metasurface platform opens a pathway to novel types of nanophotonic functionality.	[Maguid, Elhanan; Yulevich, Igor; Veksler, Dekel; Kleiner, Vladimir; Hasman, Erez] Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-32000 Haifa, Israel; [Maguid, Elhanan; Yulevich, Igor; Veksler, Dekel; Kleiner, Vladimir; Hasman, Erez] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Brongersma, Mark L.] Stanford Univ, Geballe Lab Adv Mat, 476 Lomita Mall, Stanford, CA 94305 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Stanford University	Hasman, E (corresponding author), Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-32000 Haifa, Israel.; Hasman, E (corresponding author), Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.	mehasman@technion.ac.il			United States-Israel Binational Science Foundation; Israel Science Foundation; Israel Nanotechnology Focal Technology Area on Nanophotonics for Detection; KLA-Tencor	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Israel Nanotechnology Focal Technology Area on Nanophotonics for Detection; KLA-Tencor	This research was supported by the United States-Israel Binational Science Foundation, the Israel Science Foundation, the Israel Nanotechnology Focal Technology Area on Nanophotonics for Detection, and KLA-Tencor.	Albero J, 2013, APPL OPTICS, V52, P3637, DOI 10.1364/AO.52.003637; Biener G, 2002, OPT LETT, V27, P1875, DOI 10.1364/OL.27.001875; Bliokh KY, 2015, NAT PHOTONICS, V9, P796, DOI 10.1038/nphoton.2015.201; Bomzon Z, 2002, OPT LETT, V27, P1141, DOI 10.1364/OL.27.001141; Bomzon Z, 2001, OPT LETT, V26, P1424, DOI 10.1364/OL.26.001424; Chong KE, 2015, NANO LETT, V15, P5369, DOI 10.1021/acs.nanolett.5b01752; Dahan N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136402; Dammann H., 1971, Optics Communications, V3, P312, DOI 10.1016/0030-4018(71)90095-2; Davidson N, 1999, OPT LETT, V24, P1835, DOI 10.1364/OL.24.001835; Dregely D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5354; Ee HS, 2015, NANO LETT, V15, P1759, DOI 10.1021/nl504442v; Gori F, 1998, OPT COMMUN, V157, P13, DOI 10.1016/S0030-4018(98)00518-5; Gorodetski Y, 2005, OPT LETT, V30, P2245, DOI 10.1364/OL.30.002245; Haupt RL, 2005, IEEE T ANTENN PROPAG, V53, P2858, DOI 10.1109/TAP.2005.854522; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Lager IE, 2009, IEEE T ANTENN PROPAG, V57, P2486, DOI 10.1109/TAP.2009.2024573; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Nielsen MG, 2011, OPT EXPRESS, V19, P19310, DOI 10.1364/OE.19.019310; Niv A, 2006, OPT EXPRESS, V14, P4208, DOI 10.1364/OE.14.004208; Papakostas A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.107404; Penzkofer A., 2013, J ANAL SCI METHODS I, V3, P234; Pors A, 2015, OPTICA, V2, P716, DOI 10.1364/OPTICA.2.000716; Pors A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02155; Pors A, 2013, OPT LETT, V38, P513, DOI 10.1364/OL.38.000513; Pozar DM, 2001, IEEE T ANTENN PROPAG, V49, P150, DOI 10.1109/8.914255; Sayeed AM, 2007, IEEE J-STSP, V1, P156, DOI 10.1109/JSTSP.2007.897057; Shaltout A, 2015, OPTICA, V2, P860, DOI 10.1364/OPTICA.2.000860; Sun JB, 2014, NANO LETT, V14, P2726, DOI 10.1021/nl500658n; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]	30	329	341	31	542	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2016	352	6290					1202	1206		10.1126/science.aaf3417	http://dx.doi.org/10.1126/science.aaf3417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN4NY	27103668				2022-12-28	WOS:000377045700038
J	Erikson, GA; Bodian, DL; Rueda, M; Molparia, B; Scott, ER; Scott-Van Zeeland, AA; Topol, SE; Wineinger, NE; Niederhuber, JE; Topol, EJ; Torkamani, A				Erikson, Galina A.; Bodian, Dale L.; Rueda, Manuel; Molparia, Bhuvan; Scott, Erick R.; Scott-Van Zeeland, Ashley A.; Topol, Sarah E.; Wineinger, Nathan E.; Niederhuber, John E.; Topol, Eric J.; Torkamani, Ali			Whole-Genome Sequencing of a Healthy Aging Cohort	CELL			English	Article							COMMON GENETIC-VARIATION; WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CLAC BINDS; VARIANTS; METAANALYSIS; LONGEVITY; MORTALITY; ANCESTRY; PROTEIN	Studies of long-lived individuals have revealed few genetic mechanisms for protection against age-associated disease. Therefore, we pursued genome sequencing of a related phenotype-healthy aging-to understand the genetics of disease-free aging without medical intervention. In contrast with studies of exceptional longevity, usually focused on centenarians, healthy aging is not associated with known longevity variants, but is associated with reduced genetic susceptibility to Alzheimer and coronary artery disease. Additionally, healthy aging is not associated with a decreased rate of rare pathogenic variants, potentially indicating the presence of disease-resistance factors. In keeping with this possibility, we identify suggestive common and rare variant genetic associations implying that protection against cognitive decline is a genetic component of healthy aging. These findings, based on a relatively small cohort, require independent replication. Overall, our results suggest healthy aging is an overlapping but distinct phenotype from exceptional longevity that may be enriched with disease-protective genetic factors.	[Erikson, Galina A.; Rueda, Manuel; Molparia, Bhuvan; Scott, Erick R.; Topol, Sarah E.; Wineinger, Nathan E.; Topol, Eric J.; Torkamani, Ali] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Erikson, Galina A.; Rueda, Manuel; Molparia, Bhuvan; Scott, Erick R.; Topol, Sarah E.; Wineinger, Nathan E.; Topol, Eric J.; Torkamani, Ali] Scripps Res Inst, La Jolla, CA 92037 USA; [Bodian, Dale L.; Niederhuber, John E.] Inova Hlth Syst, Inova Translat Med Inst, Falls Church, VA 22042 USA; [Niederhuber, John E.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Scott-Van Zeeland, Ashley A.; Torkamani, Ali] Cypher Genom Inc, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Inova Health System; Johns Hopkins University	Topol, EJ; Torkamani, A (corresponding author), Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Topol, EJ; Torkamani, A (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Cypher Genom Inc, San Diego, CA 92121 USA.	etopol@scripps.edu; atorkama@scripps.edu		Rueda, Manuel/0000-0001-9280-058X; Torkamani, Ali/0000-0003-0232-8053	Scripps Genomic Medicine; NIH-NCATS Clinical and Translational Science Award (CTSA) [5 UL1 RR025774]; Inova Health System; Gary and Mary West Foundation; Lavin Family Foundation; NIH [NIH-U01 HG006476, U54GM114833]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833] Funding Source: NIH RePORTER	Scripps Genomic Medicine; NIH-NCATS Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Inova Health System; Gary and Mary West Foundation; Lavin Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Complete Genomics produced and provided all Wellderly WGS data. We would like to thank Wayne Pfeiffer (San Diego Supercomputer Center) for his helpful comments on the manuscript and Chunlei Wu, Jiwen Xin, Jackie Atkins, and Quang Tran for IT support. This work was supported by Scripps Genomic Medicine, an NIH-NCATS Clinical and Translational Science Award (CTSA; 5 UL1 RR025774) (to STSI), the Inova Health System, and a generous gift from the Odeen family to ITMI. Further support was from the Gary and Mary West Foundation, Lavin Family Foundation, and the NIH (NIH-U01 HG006476 and U54GM114833) (to A.T.).	Al-Tassan NA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10442; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bell F. C., 2005, 120 SOC SEC ACT; Bi R, 2014, NEUROBIOL AGING, V35, DOI [10.1016/j.neurobiolaging.2013.08.013, 10.1016/j.neurobiolaging.2013.12.021]; Bodian DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094554; Bojesen SE, 2008, CELL CYCLE, V7, P158, DOI 10.4161/cc.7.2.5249; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kakuyama H, 2005, BIOCHEMISTRY-US, V44, P15602, DOI 10.1021/bi051263e; Kilarski LL, 2014, NEUROLOGY, V83, P678, DOI 10.1212/WNL.0000000000000707; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Libiger Ondrej, 2013, Frontiers in Genetics, V3, P322, DOI 10.3389/fgene.2012.00322; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ma JM, 2015, JAMA-J AM MED ASSOC, V314, P1731, DOI 10.1001/jama.2015.12319; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Pham PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116815; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Sanders AE, 2010, JAMA-J AM MED ASSOC, V303, P150, DOI 10.1001/jama.2009.1988; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Soderberg L, 2005, J BIOL CHEM, V280, P1007, DOI 10.1074/jbc.M403628200; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	56	125	126	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					1002	1011		10.1016/j.cell.2016.03.022	http://dx.doi.org/10.1016/j.cell.2016.03.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27114037	Green Accepted, Bronze			2022-12-28	WOS:000375800300025
J	Safronova, M				Safronova, Marianna			NUCLEAR PHYSICS Elusive transition spotted in thorium	NATURE			English	Editorial Material							ATOMIC CLOCKS		[Safronova, Marianna] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA	University of Delaware	Safronova, M (corresponding author), Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA.	msafrono@udel.edu						Beck BR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.142501; Beck B. R., 2009, P 12 INT C NUCL REAC; Berengut JC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.210801; Bondarescu M, 2015, EPJ WEB CONF, V95, DOI 10.1051/epjconf/20159504009; Campbell CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120802; Derevianko A, 2014, NAT PHYS, V10, P933, DOI 10.1038/NPHYS3137; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Nicholson TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7896; Peik E, 2015, CR PHYS, V16, P516, DOI 10.1016/j.crhy.2015.02.007; Tkalya EV, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054324; Uzan JP, 2011, LIVING REV RELATIV, V14, DOI 10.12942/lrr-2011-2; von der Wense L, 2016, NATURE, V533, P47, DOI 10.1038/nature17669; Webb JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191101	13	6	6	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					44	45		10.1038/533044a	http://dx.doi.org/10.1038/533044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27147025				2022-12-28	WOS:000375473900035
J	Birch, R				Birch, Robert			Norman Henry Birch OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353									10.1136/bmj.i2536	http://dx.doi.org/10.1136/bmj.i2536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27147473				2022-12-28	WOS:000375575500016
J	McCarthy, M				McCarthy, Michael			US gets lower return on its cancer drug spending, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Salas-Vega S, 2016, HEALTH AFFAIR, V35, P813, DOI 10.1377/hlthaff.2015.1453	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2016	353								i2494	10.1136/bmj.i2494	http://dx.doi.org/10.1136/bmj.i2494			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AE	27142646				2022-12-28	WOS:000375574000015
J	Singh, M; Jaiswal, N				Singh, Meenu; Jaiswal, Nishant			Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia	ANNALS OF INTERNAL MEDICINE			English	Letter							METAANALYSIS		[Singh, Meenu; Jaiswal, Nishant] Postgrad Inst Med Educ & Res, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Singh, M (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh 160012, India.		Jaiswal, Nishant/GPW-5502-2022	Jaiswal, Nishant/0000-0001-5511-4572				DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715	3	1	1	2	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					636	636		10.7326/L15-0582	http://dx.doi.org/10.7326/L15-0582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136219				2022-12-28	WOS:000375744000033
J	Goodrich, JK; Davenport, ER; Waters, JL; Clark, AG; Ley, RE				Goodrich, Julia K.; Davenport, Emily R.; Waters, Jillian L.; Clark, Andrew G.; Ley, Ruth E.			Cross-species comparisons of host genetic associations with the microbiome	SCIENCE			English	Review							GUT MICROBIOME; GENOME; DIET; DIVERSITY; NUTRITION; SHAPE	Recent studies in human populations and mouse models reveal notable congruences in gut microbial taxa whose abundances are partly regulated by host genotype. Host genes associating with these taxa are related to diet sensing, metabolism, and immunity. These broad patterns are further validated in similar studies of nonmammalian microbiomes. The next generation of genome-wide association studies will expand the size of the data sets and refine the microbial phenotypes to fully capture these intriguing signatures of host-microbiome coevolution.	[Goodrich, Julia K.; Davenport, Emily R.; Waters, Jillian L.; Clark, Andrew G.; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [Waters, Jillian L.; Ley, Ruth E.] Max Planck Inst Dev Biol, Dept Microbiome Sci, Tubingen, Germany	Cornell University; Cornell University; Max Planck Society	Ley, RE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA.; Ley, RE (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY USA.; Ley, RE (corresponding author), Max Planck Inst Dev Biol, Dept Microbiome Sci, Tubingen, Germany.	rel222@cornell.edu	Goodrich, Julia/ABD-8368-2021; Ley, Ruth E/M-8542-2014; wang, edwin/G-5372-2010; Waters, Jillian L./Q-5368-2019	Ley, Ruth E/0000-0002-9087-1672; Waters, Jillian L./0000-0002-4460-1591; Davenport, Emily R./0000-0002-6938-4933; Clark, Andrew/0000-0001-7159-8511	NIH [R01 DK093595]; David and Lucile Packard Foundation; Cornell Center for Comparative Population Genomics; National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK109595, R01DK093595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Cornell Center for Comparative Population Genomics; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Spector, J. Bell, and C. Ober. This work was funded by NIH R01 DK093595, a David and Lucile Packard Foundation Fellowship (R.E.L.), The Cornell Center for Comparative Population Genomics (R.E.L. and J.K.G.), and a National Science Foundation Graduate Fellowship (J.K.G.)	Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bodenhausen N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004283; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Chaston JM, 2016, APPL ENVIRON MICROB, V82, P671, DOI 10.1128/AEM.03301-15; Davenport ER, 2016, GUT MICROBES, V7, P178, DOI 10.1080/19490976.2016.1155022; Davenport ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140301; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dobson AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7312; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; GARIBOLDI M, 1993, CANCER RES, V53, P209; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Horton MW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6320; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Joshi PK, 2015, NATURE, V523, P459, DOI 10.1038/nature14618; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Ma J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-257; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; O'Connor A, 2014, MAMM GENOME, V25, P583, DOI 10.1007/s00335-014-9540-0; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Roehe R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005846; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sommer F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0614-4; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VANDEMERWE JP, 1983, A VAN LEEUW J MICROB, V49, P119, DOI 10.1007/BF00393669; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	39	163	174	10	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					532	535		10.1126/science.aad9379	http://dx.doi.org/10.1126/science.aad9379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126034	Green Accepted			2022-12-28	WOS:000374998600032
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on ... placing GPs in hospital emergency departments	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ashwood JS, 2016, HEALTH AFFAIR, V35, P449, DOI 10.1377/hlthaff.2015.0995; Mann C., 2015, BMJ BLOGS; Ramlakhan S, 2016, EMERG MED J, V33, P495, DOI 10.1136/emermed-2015-204900	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2315	10.1136/bmj.i2315	http://dx.doi.org/10.1136/bmj.i2315			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27117269				2022-12-28	WOS:000375482500008
J	Bate, J				Bate, Jonathan			The art of medicine "The infirmity of his age": Shakespeare's 400th anniversary	LANCET			English	Editorial Material									[Bate, Jonathan] Univ Oxford Worcester Coll, Oxford OX1 2HB, England	University of Oxford	Bate, J (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.	provost@worc.ox.ac.uk	Bate, Jonathan/E-5181-2019	Bate, Jonathan/0000-0002-3894-8580					0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1715	1716		10.1016/S0140-6736(16)30269-0	http://dx.doi.org/10.1016/S0140-6736(16)30269-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	27116271				2022-12-28	WOS:000374541900015
J	Brown, KA; Harris, DF; Wilker, MB; Rasmussen, A; Khadka, N; Hamby, H; Keable, S; Dukovic, G; Peters, JW; Seefeldt, LC; King, PW				Brown, Katherine A.; Harris, Derek F.; Wilker, Molly B.; Rasmussen, Andrew; Khadka, Nimesh; Hamby, Hayden; Keable, Stephen; Dukovic, Gordana; Peters, John W.; Seefeldt, Lance C.; King, Paul W.			Light-driven dinitrogen reduction catalyzed by a CdS:nitrogenase MoFe protein biohybrid	SCIENCE			English	Article							SEMICONDUCTOR CLUSTERS; NITROGENASE; INTERMEDIATE; ACETYLENE; OXIDATION; AMMONIA; WATER; CDS	The splitting of dinitrogen (N-2) and reduction to ammonia (NH3) is a kinetically complex and energetically challenging multistep reaction. In the Haber-Bosch process, N-2 reduction is accomplished at high temperature and pressure, whereas N-2 fixation by the enzyme nitrogenase occurs under ambient conditions using chemical energy from adenosine 5'-triphosphate (ATP) hydrolysis. We show that cadmium sulfide (CdS) nanocrystals can be used to photosensitize the nitrogenase molybdenum-iron (MoFe) protein, where light harvesting replaces ATP hydrolysis to drive the enzymatic reduction of N-2 into NH3. The turnover rate was 75 per minute, 63% of the ATP-coupled reaction rate for the nitrogenase complex under optimal conditions. Inhibitors of nitrogenase (i.e., acetylene, carbon monoxide, and dihydrogen) suppressed N-2 reduction. The CdS: MoFe protein biohybrids provide a photochemical model for achieving light-driven N-2 reduction to NH3.	[Brown, Katherine A.; King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Harris, Derek F.; Rasmussen, Andrew; Khadka, Nimesh; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Wilker, Molly B.; Hamby, Hayden; Dukovic, Gordana] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Keable, Stephen; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Wilker, Molly B.] Luther Coll, Dept Chem, Decorah, IA 52101 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Utah System of Higher Education; Utah State University; University of Colorado System; University of Colorado Boulder; Montana State University System; Montana State University Bozeman	King, PW (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	paul.king@nrel.gov	King, Paul W./D-9979-2011	King, Paul W./0000-0001-5039-654X; Seefeldt, Lance/0000-0002-6457-9504; Brown, Katherine/0000-0001-6060-8294; Peters, John/0000-0001-9117-9568; Hamby, Hayden/0000-0002-3823-0931; DUKOVIC, GORDANA/0000-0001-5102-0958	Laboratory Directed Research and Development Program seed project; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences; U.S. Department of Energy [DE-AC36-08-GO28308]; National Renewable Energy Laboratory; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0010334]; U.S. Department of Energy, Office of Science [DE-SC0012518]	Laboratory Directed Research and Development Program seed project; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE))	K.A.B. and P.W.K. were supported by a Laboratory Directed Research and Development Program seed project at the National Renewable Energy Laboratory for CdS:MoFe protein photochemical H<INF>2</INF> production experiments, and by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences; and the U.S. Department of Energy under Contract no. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory for CdS:MoFe protein biohybrid N<INF>2</INF> reduction experiments. M.B.W., H.H., and G.D. conducted nanocrystal synthesis and ligand exchange under support by U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-SC0010334. D.F.H., A.R., N.K., S.K., L.C.S., and J.W.P. were supported for nitrogenase purification and product quantification as part of the Biological and Electron Transfer and Catalysis (BETCy) EFRC, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science (DE-SC0012518). The authors thank W. Tumas and R. Greene for thoughtful advice and many helpful discussions, and B. Hoffman for helpful discussions and constructive reading of the manuscript. Data are available in the supplementary materials. K.A.B. preformed photochemical experiments, including colorimetric NH<INF>3</INF> measurements; N.K., A.R., D.F.H., and S.K. preformed nitrogenase and MoFe protein purifications, physiological nitrogenase assays, and fluorometric NH<INF>3</INF> measurements; M.B.W. and H.H. performed CdS nanocrystal synthesis, ligand exchange, and transmission electron microscopy imaging; K.A.B, L.C.S., G.D., J.W.P., and P.W.K. conceived and designed the study. All authors contributed to the writing of the manuscript.	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Brown KA, 2012, J AM CHEM SOC, V134, P5627, DOI 10.1021/ja2116348; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; BRUS L, 1986, J PHYS CHEM-US, V90, P2555, DOI 10.1021/j100403a003; Danyal K, 2015, BIOCHEMISTRY-US, V54, P2456, DOI 10.1021/acs.biochem.5b00140; Danyal K, 2010, J AM CHEM SOC, V132, P13197, DOI 10.1021/ja1067178; DILWORTH MJ, 1966, BIOCHIM BIOPHYS ACTA, V127, P285, DOI 10.1016/0304-4165(66)90383-7; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Kim D, 2015, ANGEW CHEM INT EDIT, V54, P3259, DOI 10.1002/anie.201409116; Lan R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01145; Lanzilotta WN, 1997, BIOCHEMISTRY-US, V36, P12976, DOI 10.1021/bi9715371; Lukoyanov D, 2015, J AM CHEM SOC, V137, P3610, DOI 10.1021/jacs.5b00103; Lukoyanov D, 2010, J AM CHEM SOC, V132, P2526, DOI 10.1021/ja910613m; Roth LE, 2012, J AM CHEM SOC, V134, P8416, DOI 10.1021/ja303265m; Roth LE, 2010, J AM CHEM SOC, V132, P13672, DOI 10.1021/ja1071866; SCHOLLHORN R, 1967, P NATL ACAD SCI USA, V58, P213, DOI 10.1073/pnas.58.1.213; Tseng HW, 2013, J AM CHEM SOC, V135, P3383, DOI 10.1021/ja400178g; WINTER HC, 1976, ANNU REV BIOCHEM, V45, P409, DOI 10.1146/annurev.bi.45.070176.002205; Zhao GH, 2006, ANAL BIOCHEM, V349, P262, DOI 10.1016/j.ab.2005.10.005	21	529	544	44	800	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					448	450		10.1126/science.aaf2091	http://dx.doi.org/10.1126/science.aaf2091			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102481				2022-12-28	WOS:000374479700044
J	McCarthy, M				McCarthy, Michael			US hepatitis C virus testing recommendations may miss 25% of cases, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hsieh YH, 2016, CLIN INFECT DIS, V62, P1059, DOI 10.1093/cid/ciw074	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2337	10.1136/bmj.i2337	http://dx.doi.org/10.1136/bmj.i2337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106899				2022-12-28	WOS:000374999700015
J	Hazlewood, GS; Barnabe, C; Tomlinson, G; Marshall, D; Devoe, D; Bombardier, C				Hazlewood, Glen S.; Barnabe, Cheryl; Tomlinson, George; Marshall, Deborah; Devoe, Dan; Bombardier, Claire			Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EULAR RECOMMENDATIONS; AMERICAN-COLLEGE; EFFICACY; PLACEBO; GLUCOCORTICOIDS; CLASSIFICATION; HETEROGENEITY; DISTRIBUTIONS; TOFACITINIB; ADALIMUMAB	OBJECTIVE To compare methotrexate based disease modifying antirheumatic drug (DMARD) treatments for rheumatoid arthritis in patients naive to or with an inadequate response to methotrexate. DESIGN Systematic review and Bayesian random effects network meta-analysis of trials assessing methotrexate used alone or in combination with other conventional synthetic DMARDs, biologic drugs, or tofacitinib in adult patients with rheumatoid arthritis. DATA SOURCES Trials were identified from Medline, Embase, and Central databases from inception to 19 January 2016; abstracts from two major rheumatology meetings from 2009 to 2015; two trial registers; and hand searches of Cochrane reviews. STUDY SELECTION CRITERIA Randomized or quasi-randomized trials that compared methotrexate with any other DMARD or combination of DMARDs and contributed to the network of evidence between the treatments of interest. MAIN OUTCOMES American College of Rheumatology (ACR) 50 response (major clinical improvement), radiographic progression, and withdrawals due to adverse events. A comparison between two treatments was considered statistically significant if its credible interval excluded the null effect, indicating >97.5% probability that one treatment was superior. RESULTS 158 trials were included, with between 10 and 53 trials available for each outcome. In methotrexate naive patients, several treatments were statistically superior to oral methotrexate for ACR50 response: sulfasalazine and hydroxychloroquine ("triple therapy"), several biologics (abatacept, adalimumab, etanercept, infliximab, rituximab, tocilizumab), and tofacitinib. The estimated probability of ACR50 response was similar between these treatments (range 56-67%), compared with 41% with methotrexate. Methotrexate combined with adalimumab, etanercept, certolizumab, or infliximab was statistically superior to oral methotrexate for inhibiting radiographic progression, but the estimated mean change over one year with all treatments was less than the minimal clinically important difference of 5 units on the Sharp-van der Heijde scale. Triple therapy had statistically fewer withdrawals due to adverse events than methotrexate plus infliximab. After an inadequate response to methotrexate, several treatments were statistically superior to oral methotrexate for ACR50 response: triple therapy, methotrexate plus hydroxychloroquine, methotrexate plus leflunomide, methotrexate plus intramuscular gold, methotrexate plus most biologics, and methotrexate plus tofacitinib. The probability of response was 61% with triple therapy and ranged widely (27-70%) with other treatments. No treatment was statistically superior to oral methotrexate for inhibiting radiographic progression. Methotrexate plus abatacept had a statistically lower rate of withdrawals due to adverse events than several treatments. CONCLUSIONS Triple therapy (methotrexate plus sulfasalazine plus hydroxychloroquine) and most regimens combining biologic DMARDs with methotrexate were effective in controlling disease activity, and all were generally well tolerated in both methotrexate naive and methotrexate exposed patients.	[Hazlewood, Glen S.; Barnabe, Cheryl] Univ Calgary, Dept Med, Calgary, AB T2N 4Z6, Canada; [Hazlewood, Glen S.; Barnabe, Cheryl; Marshall, Deborah] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 4Z6, Canada; [Hazlewood, Glen S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Hazlewood, Glen S.; Barnabe, Cheryl; Marshall, Deborah; Devoe, Dan] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada; [Tomlinson, George; Bombardier, Claire] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Tomlinson, George; Bombardier, Claire] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 2C4, Canada; [Bombardier, Claire] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M6J 3S3, Canada; [Bombardier, Claire] Mt Sinai Hosp, Div Rheumatol, Toronto, ON M5T 3L9, Canada	University of Calgary; University of Calgary; University of Toronto; University of Calgary; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Hazlewood, GS (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 1N1, Canada.	glenhazlewood@gmail.com	Tomlinson, George A/L-5432-2016; Hazlewood, Glen S/N-2233-2019; Barnabe, Cheryl/C-3577-2011; Marshall, Deborah/J-7248-2015	Tomlinson, George A/0000-0002-9328-6399; Hazlewood, Glen S/0000-0001-7709-3741; Marshall, Deborah/0000-0002-8467-8008; Bombardier, Claire/0000-0001-5083-2137	Arthur J E Child chair in rheumatology outcomes research	Arthur J E Child chair in rheumatology outcomes research	Partial funding was provided by the Arthur J E Child chair in rheumatology outcomes research.	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; Choy EHS, 2005, RHEUMATOLOGY, V44, P1414, DOI 10.1093/rheumatology/kei031; Cuomo G, 2006, REUMATISMO, V58, P22, DOI 10.4081/reumatismo.2006.22; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Gaujoux-Viala C, 2014, ANN RHEUM DIS, V73, P510, DOI 10.1136/annrheumdis-2013-204588; Graudal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106408; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hawkins N, 2009, MED DECIS MAKING, V29, P273, DOI 10.1177/0272989X08330120; Hazlewood G, 2013, COCHRANE DB SYST REV, V1; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jonas DE, 2013, FINDINGS OF BAYESIAN; Joo K, 2012, INT J RHEUM DIS, V15, P53; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Katchamart W, 2010, COCHRANE DB SYST REV, V4; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Ory PA, 2003, ANN RHEUM DIS, V62, P597, DOI 10.1136/ard.62.7.597; Plummer M, 2014, RJAGS BAYESIAN GRAPH; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rhodes KM, 2015, J CLIN EPIDEMIOL, V68, P52, DOI 10.1016/j.jclinepi.2014.08.012; ROPES M W, 1958, Bull Rheum Dis, V9, P175; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Thorlund K, 2013, ANN RHEUM DIS, V72, P1524, DOI 10.1136/annrheumdis-2012-201574; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; van Vollenhoven RF, 2012, LANCET, V379, P1712, DOI 10.1016/S0140-6736(12)60027-0	38	125	138	2	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2016	353								i1777	10.1136/bmj.i1777	http://dx.doi.org/10.1136/bmj.i1777			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZJ	27102806	Green Published, hybrid			2022-12-28	WOS:000374999500002
J	Van Brabandt, H; Desomer, A; Gerkens, S; Neyt, M				Van Brabandt, Hans; Desomer, Anja; Gerkens, Sophie; Neyt, Mattias			Harms and benefits of screening young people to prevent sudden cardiac death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; CORONARY-ARTERY ANOMALIES; HYPERTROPHIC CARDIOMYOPATHY; SCIENTIFIC STATEMENT; CONSENSUS STATEMENT; EUROPEAN-SOCIETY; TASK-FORCE; PARTICIPATION; RISK; CARDIOLOGY		[Van Brabandt, Hans; Desomer, Anja; Gerkens, Sophie; Neyt, Mattias] Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium		Van Brabandt, H (corresponding author), Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium.	hans.vanbrabandt@kce.fgov.be						Angelini P, 2007, CIRCULATION, V115, P1296, DOI 10.1161/CIRCULATIONAHA.106.618082; Bahr R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4914; Brosnan M, 2014, BRIT J SPORT MED, V48, P1144, DOI 10.1136/bjsports-2013-092420; Carroll AE, 2015, JAMA-J AM MED ASSOC, V313, P1304, DOI 10.1001/jama.2015.1496; Cohen MI, 2012, HEART RHYTHM, V9, P1006, DOI 10.1016/j.hrthm.2012.03.050; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Corrado D, 2013, EUR HEART J, V34, P3606, DOI 10.1093/eurheartj/eht458; Corrado D, 2012, CURR OPIN CARDIOL, V27, P41, DOI 10.1097/HCO.0b013e32834dc4cb; Corrado D, 2011, EUR HEART J, V32, P934, DOI 10.1093/eurheartj/ehq482; Corrado D, 2008, J AM COLL CARDIOL, V52, P1981, DOI 10.1016/j.jacc.2008.06.053; Desomer A, 2015, CARDIOVASCULAR PREPA; Drezner JA, 2013, BRIT J SPORT MED, V47, P122, DOI 10.1136/bjsports-2012-092067; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Elston J., 2008, POPULATION SCREENING; Elston J, 2011, BRIT J SPORT MED, V45, P576, DOI 10.1136/bjsm.2009.061184; Engelfriet P, 2009, PREPARTICIPATIESCREE; Fudge J, 2014, BRIT J SPORT MED, V48, P1172, DOI 10.1136/bjsports-2014-093840; Gersh BJ, 2011, J THORAC CARDIOV SUR, V142, pE153, DOI 10.1016/j.jtcvs.2011.10.020; Gotzsche PC, 2015, INT J EPIDEMIOL, V44, P278, DOI 10.1093/ije/dyu267; Harmon KG, 2014, HEART, V100, P1185, DOI 10.1136/heartjnl-2014-093872.rep; Health and Social Care Information Centre, 2012, NAT AUD SUDD ARRH DE; Kaltman JR, 2011, CIRCULATION, V123, P1911, DOI 10.1161/CIRCULATIONAHA.110.017228; La Gerche A, 2013, JACC-CARDIOVASC IMAG, V6, P993, DOI 10.1016/j.jcmg.2013.06.003; Magalski A, 2011, AM J MED, V124, P511, DOI 10.1016/j.amjmed.2011.01.009; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2014, CIRCULATION, V130, P1303, DOI 10.1161/CIR.0000000000000025; Maron BJ, 2009, AM J CARDIOL, V104, P276, DOI 10.1016/j.amjcard.2009.03.037; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Nishimura RA, 2003, CIRCULATION, V108, pE133, DOI 10.1161/01.CIR.0000097621.97566.96; Obeyesekere M, 2012, CIRCULATION, V125, P659, DOI 10.1161/CIRCULATIONAHA.111.085159; Obeyesekere MN, 2012, CIRCULATION, V125, P2308, DOI 10.1161/CIRCULATIONAHA.111.055350; Papadakis M, 2009, EUROPACE, V11, P1353, DOI 10.1093/europace/eup229; Pelliccia A, 2001, J AM COLL CARDIOL, V37, P598, DOI 10.1016/S0735-1097(00)01122-0; Pelliccia A, 2007, EUR HEART J, V28, P2006, DOI 10.1093/eurheartj/ehm219; Pelliccia A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4923; Rodday AM, 2012, PEDIATRICS, V129, pE999, DOI 10.1542/peds.2011-0643; Sackett DL, 2002, CAN MED ASSOC J, V167, P363; Semsarian C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1218; Sharma S, 2015, JAMA INTERN MED, V175, P125, DOI 10.1001/jamainternmed.2014.6023; Sharma Sanjay, 2013, N Engl J Med, V369, P2049; Steinvil A, 2011, J AM COLL CARDIOL, V57, P1291, DOI 10.1016/j.jacc.2010.10.037; UK National Screening Committee, 2015, WHAT IS IMP SCREEN R; UK National Screening Committee, 2015, UK NSC REC SCREEN PR; Wren C, 2009, HEART, V95, P2040, DOI 10.1136/hrt.2009.172858; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108	48	27	30	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2016	353								i1156	10.1136/bmj.i1156	http://dx.doi.org/10.1136/bmj.i1156			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZH	27097983				2022-12-28	WOS:000374999300001
J	Tirosh, I; Izar, B; Prakadan, SM; Wadsworth, MH; Treacy, D; Trombetta, JJ; Rotem, A; Rodman, C; Lian, C; Murphy, G; Fallahi-Sichani, M; Dutton-Regester, K; Lin, JR; Cohen, O; Shah, P; Lu, D; Genshaft, AS; Hughes, TK; Ziegler, CGK; Kazer, SW; Gaillard, A; Kolb, KE; Villani, AC; Johannessen, CM; Andreev, AY; Van Allen, EM; Bertagnolli, M; Sorger, PK; Sullivan, RJ; Flaherty, KT; Frederick, DT; Jane-Valbuena, J; Yoon, CH; Rozenblatt-Rosen, O; Shalek, AK; Regev, A; Garraway, LA				Tirosh, Itay; Izar, Benjamin; Prakadan, Sanjay M.; Wadsworth, Marc H., II; Treacy, Daniel; Trombetta, John J.; Rotem, Asaf; Rodman, Christopher; Lian, Christine; Murphy, George; Fallahi-Sichani, Mohammad; Dutton-Regester, Ken; Lin, Jia-Ren; Cohen, Ofir; Shah, Parin; Lu, Diana; Genshaft, Alex S.; Hughes, Travis K.; Ziegler, Carly G. K.; Kazer, Samuel W.; Gaillard, Aleth; Kolb, Kellie E.; Villani, Alexandra-Chloe; Johannessen, Cory M.; Andreev, Aleksandr Y.; Van Allen, Eliezer M.; Bertagnolli, Monica; Sorger, Peter K.; Sullivan, Ryan J.; Flaherty, Keith T.; Frederick, Dennie T.; Jane-Valbuena, Judit; Yoon, Charles H.; Rozenblatt-Rosen, Orit; Shalek, Alex K.; Regev, Aviv; Garraway, Levi A.			Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq	SCIENCE			English	Article							CTLA-4 BLOCKADE; AXL KINASE; T-CELLS; SAFETY; RESISTANCE; NIVOLUMAB; CANCER; EXHAUSTION; EXPRESSION; HETEROGENEITY	To explore the distinct genotypic and phenotypic states of melanoma tumors, we applied single-cell RNA sequencing (RNA-seq) to 4645 single cells isolated from 19 patients, profiling malignant, immune, stromal, and endothelial cells. Malignant cells within the same tumor displayed transcriptional heterogeneity associated with the cell cycle, spatial context, and a drug-resistance program. In particular, all tumors harbored malignant cells from two distinct transcriptional cell states, such that tumors characterized by high levels of the MITF transcription factor also contained cells with low MITF and elevated levels of the AXL kinase. Single-cell analyses suggested distinct tumor microenvironmental patterns, including cell-to-cell interactions. Analysis of tumor-infiltrating T cells revealed exhaustion programs, their connection to T cell activation and clonal expansion, and their variability across patients. Overall, we begin to unravel the cellular ecosystem of tumors and how single-cell genomics offers insights with implications for both targeted and immune therapies.	[Tirosh, Itay; Izar, Benjamin; Prakadan, Sanjay M.; Wadsworth, Marc H., II; Treacy, Daniel; Trombetta, John J.; Rotem, Asaf; Rodman, Christopher; Dutton-Regester, Ken; Cohen, Ofir; Lu, Diana; Genshaft, Alex S.; Hughes, Travis K.; Ziegler, Carly G. K.; Kazer, Samuel W.; Gaillard, Aleth; Kolb, Kellie E.; Villani, Alexandra-Chloe; Johannessen, Cory M.; Andreev, Aleksandr Y.; Van Allen, Eliezer M.; Jane-Valbuena, Judit; Rozenblatt-Rosen, Orit; Shalek, Alex K.; Regev, Aviv; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Izar, Benjamin; Rotem, Asaf; Dutton-Regester, Ken; Shah, Parin; Van Allen, Eliezer M.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Izar, Benjamin; Rotem, Asaf; Van Allen, Eliezer M.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA; [Prakadan, Sanjay M.; Wadsworth, Marc H., II; Genshaft, Alex S.; Hughes, Travis K.; Ziegler, Carly G. K.; Kazer, Samuel W.; Gaillard, Aleth; Kolb, Kellie E.; Shalek, Alex K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Prakadan, Sanjay M.; Wadsworth, Marc H., II; Genshaft, Alex S.; Kazer, Samuel W.; Gaillard, Aleth; Kolb, Kellie E.; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02142 USA; [Prakadan, Sanjay M.; Wadsworth, Marc H., II; Genshaft, Alex S.; Hughes, Travis K.; Ziegler, Carly G. K.; Kazer, Samuel W.; Gaillard, Aleth; Kolb, Kellie E.; Shalek, Alex K.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Prakadan, Sanjay M.; Wadsworth, Marc H., II; Genshaft, Alex S.; Hughes, Travis K.; Ziegler, Carly G. K.; Kazer, Samuel W.; Gaillard, Aleth; Kolb, Kellie E.; Shalek, Alex K.] Harvard Univ, Cambridge, MA 02139 USA; [Lian, Christine; Murphy, George] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fallahi-Sichani, Mohammad; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Program Therapeut Sci, Boston, MA 02115 USA; [Dutton-Regester, Ken] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Lin, Jia-Ren; Sorger, Peter K.] Harvard Univ, Sch Med, HMS LINCS Ctr & Lab Syst Pharmacol, Boston, MA 02115 USA; [Hughes, Travis K.; Ziegler, Carly G. K.; Shalek, Alex K.] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Bertagnolli, Monica; Yoon, Charles H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Surg Oncol, Boston, MA 02215 USA; [Bertagnolli, Monica; Yoon, Charles H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg Oncol, Boston, MA 02215 USA; [Sorger, Peter K.; Garraway, Levi A.] Harvard Univ, Ludwig Ctr, Boston, MA 02215 USA; [Sullivan, Ryan J.; Flaherty, Keith T.; Frederick, Dennie T.] Massachusetts Gen Hosp, Ctr Canc, Div Med Oncol, Boston, MA 02114 USA; [Shalek, Alex K.] Massachusetts Gen Hosp, Dept Immunol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Boston, MA 02142 USA; [Regev, Aviv] MIT, Koch Inst, Boston, MA 02142 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; QIMR Berghofer Medical Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Izar, B; Regev, A; Garraway, LA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Izar, B; Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Izar, B; Garraway, LA (corresponding author), Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA.; Garraway, LA (corresponding author), Harvard Univ, Ludwig Ctr, Boston, MA 02215 USA.; Regev, A (corresponding author), MIT, Dept Biol, Boston, MA 02142 USA.; Regev, A (corresponding author), MIT, Koch Inst, Boston, MA 02142 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	bizar@partners.org; aregev@broadinstitute.org; levi_garraway@dfci.harvard.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022; Shah, Parin/J-6018-2019; Shalek, Alex/Y-2434-2019; wang, edwin/G-5372-2010	Shah, Parin/0000-0003-4648-7830; Shalek, Alex/0000-0001-5670-8778; Sorger, Peter/0000-0002-3364-1838; Kazer, Samuel/0000-0002-7380-9594; Ziegler, Carly/0000-0002-8279-7150; Dutton-Regester, Ken/0000-0002-8884-6355	National Cancer Institute (NCI) [P01CA163222, R35CA197737]; Dr. Miriam and Sheldon Adelson Medical Research Foundation; Melanoma Research Alliance; Ludwig Center at Harvard Medical School; Howard Hughes Medicine Institute; Klarman Cell Observatory; STARR Cancer Consortium; NCI [1U24CA180922, K99CA194163]; Koch Institute from NCI [P30-CA14051]; Broad Institute; Searle Scholars Program; Beckman Young Investigator Program; NIH [DP2 OD020839, P50GM107618]; Wong Family Award for Translational Oncology of the Dana-Farber Cancer Institute; Human Frontier Science Program long-term fellowship, a Rothschild fellowship; Integrative Cancer Biology Program grant [U54CA112962]; Next Generation Fund at the Broad Institute of MIT and Harvard; NSF Graduate Research Fellowships Program; Ludwig Center at Harvard; NATIONAL CANCER INSTITUTE [K99CA194163, U54CA112962, R33CA202820, P30CA014051, P01CA163222, U24CA180922, R35CA197737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI118672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618, DP2GM119419, T32GM008313, T32GM007753] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dr. Miriam and Sheldon Adelson Medical Research Foundation; Melanoma Research Alliance; Ludwig Center at Harvard Medical School; Howard Hughes Medicine Institute; Klarman Cell Observatory; STARR Cancer Consortium; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Koch Institute from NCI; Broad Institute; Searle Scholars Program; Beckman Young Investigator Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wong Family Award for Translational Oncology of the Dana-Farber Cancer Institute; Human Frontier Science Program long-term fellowship, a Rothschild fellowship; Integrative Cancer Biology Program grant; Next Generation Fund at the Broad Institute of MIT and Harvard; NSF Graduate Research Fellowships Program(National Science Foundation (NSF)); Ludwig Center at Harvard; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Singer, A. Anderson, V. K. Kuchroo, and A. Aguirre for fruitful discussions; S. Barthel and T. Schatton for providing the Tim-3 antibody; Q. Zhan for preparing IF staining; and J. Thurman for guidance on complement biology. L.A.G., B.I., S.M.P., A. Re., O.R.-R., A. K. S., I. T., M.H.W.II, The Broad Institute, Brigham and Women's Hospital, Dana-Farber Cancer Institute, MIT, and the president and fellows of Harvard College have filed a patent application (BI-2015/077) that relates to tumor and microenvironment gene expression, compositions of matter, and methods of use thereof. L.A.G., B.I., A.Ro., and the Dana-Farber Cancer Institute have filed a patent application (DFCI 2105.001) that relates to cancer-patient-derived tumor dissociation for biological analysis. L.A.G was supported by National Cancer Institute (NCI) grants P01CA163222 and R35CA197737, the Dr. Miriam and Sheldon Adelson Medical Research Foundation, the Melanoma Research Alliance, and the Ludwig Center at Harvard Medical School. L.A.G. is a member of the scientific advisory board for Warp Drive; a consultant for Novartis, Bayer Oncology, and Foundation Medicine, and an equity holder in Foundation Medicine. A. Re. was supported by funds from the Howard Hughes Medicine Institute, the Klarman Cell Observatory, STARR Cancer Consortium, NCI grant 1U24CA180922, Koch Institute support (core) grant P30-CA14051 from NCI, and the Broad Institute. A. Re. is a scientific advisory board member for ThermoFisher Scientific and Syros Pharmaceuticals and a consultant for Driver Group. E.M.V.A. is a consultant for Roche Ventana, Takeda, and Third Rock Ventures. A. K. S. was supported by the Searle Scholars Program, the Beckman Young Investigator Program, and the NIH New Innovator Award (DP2 OD020839). B.I. was supported by the Wong Family Award for Translational Oncology of the Dana-Farber Cancer Institute. I. T. was supported by a Human Frontier Science Program long-term fellowship, a Rothschild fellowship, STARR Cancer Consortium, and an Integrative Cancer Biology Program grant (U54CA112962). I. T., A. K. S., and O.R.-R. were supported by the Broad Institute. O. R.-R. was supported by a grant from the Next Generation Fund at the Broad Institute of MIT and Harvard. S.W.K. was supported by a fellowship from the NSF Graduate Research Fellowships Program. M.F.-S. was supported by the NCI (grant K99CA194163), and P.K.S. was supported by the NIH (grant P50GM107618) and the Ludwig Center at Harvard. Processed single-cell and bulk RNA-seq data are available through the Gene Expression Omnibus (accession numbers GSE72056 and GSE77940). Raw RNA-seq and WES data will be available through dbGAP (the database of Genotypes and Phenotypes).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Ester M., 1996, DENSITY BASED ALGORI, V96, P226; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahoney KM, 2014, ONCOLOGY-NY, V28, P39; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro G., 2013, 2013 AM SOC CLIN ONC; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	49	1932	1982	20	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					189	196		10.1126/science.aad0501	http://dx.doi.org/10.1126/science.aad0501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124452	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000373681600038
J	Qaseem, A; Kansagara, D; Forciea, MA; Cooke, M; Denberg, TD				Qaseem, Amir; Kansagara, Devan; Forciea, Mary Ann; Cooke, Molly; Denberg, Thomas D.		Clinical Guidelines Comm Amer	Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; SELF-HELP TREATMENT; LATE-LIFE INSOMNIA; DOUBLE-BLIND; LONG-TERM; OLDER-ADULTS; PSYCHOLOGICAL TREATMENT; OUTPATIENT TRIAL; SLEEP LATENCY	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. Methods: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Recommendation 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence) Recommendation 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Forciea, Mary Ann] Penn Hlth Syst, 3615 Chestnut St, Philadelphia, PA 19104 USA; [Kansagara, Devan] Portland VA Med Ctr, 3805 NE 34th Ave, Portland, OR 97212 USA; [Cooke, Molly] Univ Calif San Francisco, 550 16th St, San Francisco, CA 94158 USA; [Qaseem, Amir; Denberg, Thomas D.] Caril Clin, POB 13727, Roanoke, VA 24036 USA	American College of Physicians; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of California System; University of California San Francisco	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Schunemann, Holger/0000-0003-3211-8479				Allain H, 2001, CLIN DRUG INVEST, V21, P391, DOI 10.2165/00044011-200121060-00001; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DISO; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ancoli-Israel S, 2010, SLEEP, V33, P225, DOI 10.1093/sleep/33.2.225; Arnedt JT, 2013, SLEEP, V36, P353, DOI 10.5665/sleep.2448; Bjorvatn B, 2011, SCAND J PSYCHOL, V52, P580, DOI 10.1111/j.1467-9450.2011.00902.x; Bothelius K, 2013, J SLEEP RES, V22, P688, DOI 10.1111/jsr.12067; Brasure M, 2015, AHRQ PUBLICATION; Brasure M, 2016, ANN INTERN MED, V165, P113, DOI 10.7326/M15-1782; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; Edinger JD, 2009, SLEEP, V32, P499, DOI 10.1093/sleep/32.4.499; Edinger JD, 2003, SLEEP, V26, P177, DOI 10.1093/sleep/26.2.177; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Elie R, 1999, J CLIN PSYCHIAT, V60, P536, DOI 10.4088/JCP.v60n0806; Epstein DR, 2012, SLEEP, V35, P797, DOI 10.5665/sleep.1878; ESPIE CA, 1989, BEHAV RES THER, V27, P79, DOI 10.1016/0005-7967(89)90123-X; Espie CA, 2001, BEHAV RES THER, V39, P45, DOI 10.1016/S0005-7967(99)00157-6; Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Fry J, 2000, INT CLIN PSYCHOPHARM, V15, P141, DOI 10.1097/00004850-200015030-00003; Germain A, 2006, J CLIN SLEEP MED, V2, P403; Harris J, 2012, SLEEP, V35, P49, DOI 10.5665/sleep.1584; Herring WJ, 2016, BIOL PSYCHIAT, V79, P136, DOI 10.1016/j.biopsych.2014.10.003; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Irwin MR, 2014, SLEEP, V37, P1543, DOI 10.5665/sleep.4008; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jansson M, 2005, J OCCUP REHABIL, V15, P177, DOI 10.1007/s10926-005-1217-9; Jansson-Frojmark M, 2012, J CLIN PSYCHOL MED S, V19, P224, DOI 10.1007/s10880-011-9275-y; Jernelov S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-5; Kaldo V, 2015, BEHAV RES THER, V71, P90, DOI 10.1016/j.brat.2015.06.001; Kang Dong-Yoon, 2012, J Prev Med Public Health, V45, P219, DOI 10.3961/jpmph.2012.45.4.219; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Kraus SS, 2012, J AFFECT DISORDERS, V138, P192, DOI 10.1016/j.jad.2011.05.014; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Krystal AD, 2003, SLEEP, V26, P793, DOI 10.1093/sleep/26.7.793; Krystal AD, 2008, SLEEP, V31, P79, DOI 10.1093/sleep/31.1.79; Krystal AD, 2011, SLEEP, V34, P1433, DOI 10.5665/SLEEP.1294; Krystal AD, 2010, SLEEP, V33, P1553, DOI 10.1093/sleep/33.11.1553; Lahmeyer H, 1997, CLIN DRUG INVEST, V13, P134, DOI 10.2165/00044011-199713030-00003; Lai MM, 2014, MAYO CLIN PROC, V89, P589, DOI 10.1016/j.mayocp.2014.01.021; Lankford A, 2012, SLEEP MED, V13, P133, DOI 10.1016/j.sleep.2011.09.006; Leppik IE, 1997, DRUG DEVELOP RES, V40, P230, DOI 10.1002/(SICI)1098-2299(199703)40:3<230::AID-DDR3>3.3.CO;2-Y; Lovato N, 2014, SLEEP, V37, P117, DOI 10.5665/sleep.3320; McCrae CS, 2007, AM J GERIAT PSYCHIAT, V15, P979, DOI 10.1097/JGP.0b013e31813547e6; Mimeault V, 1999, J CONSULT CLIN PSYCH, V67, P511, DOI 10.1037/0022-006X.67.4.511; Morgan K, 2003, BRIT J GEN PRACT, V53, P923; Morgan K, 2012, J AM GERIATR SOC, V60, P1803, DOI 10.1111/j.1532-5415.2012.04175.x; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2005, SLEEP, V28, P1319, DOI 10.1093/sleep/28.10.1319; MORIN CM, 1988, J CONSULT CLIN PSYCH, V56, P748, DOI 10.1037/0022-006X.56.5.748; MORIN CM, 1993, J CONSULT CLIN PSYCH, V61, P137, DOI 10.1037/0022-006X.61.1.137; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Perlis ML, 2004, J CLIN PSYCHIAT, V65, P1128; Pigeon WR, 2012, BEHAV RES THER, V50, P685, DOI 10.1016/j.brat.2012.07.005; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Randall S, 2012, SLEEP, V35, P1551, DOI 10.5665/sleep.2208; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Roth T, 2006, SLEEP MED, V7, P312, DOI 10.1016/j.sleep.2006.01.003; Roth T, 2013, SLEEP, V36, P189, DOI 10.5665/sleep.2370; Rybarczyk B, 2005, J CONSULT CLIN PSYCH, V73, P1164, DOI 10.1037/0022-006X.73.6.1164; Rybarczyk B, 2013, CLIN GERONTOLOGIST, V36, P70, DOI 10.1080/07317115.2012.731478; SCHARF MB, 1994, J CLIN PSYCHIAT, V55, P192; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Soeffing JP, 2008, SLEEP MED, V9, P165, DOI 10.1016/j.sleep.2007.02.009; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; van Straten A, 2014, PSYCHOL MED, V44, P1521, DOI 10.1017/S0033291713002249; van Straten A, 2009, PATIENT EDUC COUNS, V74, P29, DOI 10.1016/j.pec.2008.07.050; Vincent N, 2009, SLEEP, V32, P807, DOI 10.1093/sleep/32.6.807; Viswanathan M, 2008, AHRQ PUBLICATION; Walsh JK, 2007, SLEEP, V30, P959, DOI 10.1093/sleep/30.8.959; Walsh JK, 2002, SLEEP MED REV, V6, pS7, DOI 10.1016/S1087-0792(02)80002-8; White CM, 2009, METHODS GUIDE COMP E; Wilt TJ, 2016, ANN INTERN MED, V165, P103, DOI 10.7326/M15-1781; Xu M, 2011, SLEEP MED, V12, P65, DOI 10.1016/j.sleep.2010.09.003; Zammit GK, 2004, CURR MED RES OPIN, V20, P1979, DOI 10.1185/174234304X15174	78	782	811	12	123	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2016	165	2					125	+		10.7326/M15-2175	http://dx.doi.org/10.7326/M15-2175			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2GY	27136449				2022-12-28	WOS:000380583100019
J	Sapp, JL; Wells, GA; Parkash, R; Stevenson, WG; Blier, L; Sarrazin, JF; Thibault, B; Rivard, L; Gula, L; Leong-Sit, P; Essebag, V; Nery, PB; Tung, SK; Raymond, JM; Sterns, LD; Veenhuyzen, GD; Healey, JS; Redfearn, D; Roux, JF; Tang, ASL				Sapp, John L.; Wells, George A.; Parkash, Ratika; Stevenson, William G.; Blier, Louis; Sarrazin, Jean-Francois; Thibault, Bernard; Rivard, Lena; Gula, Lorne; Leong-Sit, Peter; Essebag, Vidal; Nery, Pablo B.; Tung, Stanley K.; Raymond, Jean-Marc; Sterns, Laurence D.; Veenhuyzen, George D.; Healey, Jeff S.; Redfearn, Damian; Roux, Jean-Francois; Tang, Anthony S. L.			Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CATHETER ABLATION; EXPERT CONSENSUS; HEART-DISEASE; FOLLOW-UP; PREVENTION; AMIODARONE; SHOCKS; TRIAL	BACKGROUND Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter-defibrillator (ICD) is frequent despite antiarrhythmic drug therapy. The most effective approach to management of this problem is uncertain. METHODS We conducted a multicenter, randomized, controlled trial involving patients with ischemic cardiomyopathy and an ICD who had ventricular tachycardia despite the use of antiarrhythmic drugs. Patients were randomly assigned to receive either catheter ablation (ablation group) with continuation of baseline antiarrhythmic medications or escalated antiarrhythmic drug therapy (escalated-therapy group). In the escalated-therapy group, amiodarone was initiated if another agent had been used previously. The dose of amiodarone was increased if it had been less than 300 mg per day or mexiletine was added if the dose was already at least 300 mg per day. The primary outcome was a composite of death, three or more documented episodes of ventricular tachycardia within 24 hours (ventricular tachycardia storm), or appropriate ICD shock. RESULTS Of the 259 patients who were enrolled, 132 were assigned to the ablation group and 127 to the escalated-therapy group. During a mean (+/- SD) of 27.9 +/- 17.1 months of follow-up, the primary outcome occurred in 59.1% of patients in the ablation group and 68.5% of those in the escalated-therapy group (hazard ratio in the ablation group, 0.72; 95% confidence interval, 0.53 to 0.98; P = 0.04). There was no significant between-group difference in mortality. There were two cardiac perforations and three cases of major bleeding in the ablation group and two deaths from pulmonary toxic effects and one from hepatic dysfunction in the escalated-therapy group. CONCLUSIONS In patients with ischemic cardiomyopathy and an ICD who had ventricular tachycardia despite antiarrhythmic drug therapy, there was a significantly lower rate of the composite primary outcome of death, ventricular tachycardia storm, or appropriate ICD shock among patients undergoing catheter ablation than among those receiving an escalation in antiarrhythmic drug therapy.	[Sapp, John L.; Parkash, Ratika] QEII Hlth Sci Ctr, Dept Med, Halifax, NS, Canada; [Sapp, John L.; Parkash, Ratika] Dalhousie Univ, Halifax, NS, Canada; [Wells, George A.; Nery, Pablo B.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Blier, Louis; Sarrazin, Jean-Francois] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Thibault, Bernard; Rivard, Lena] Inst Cardiol Montreal, Montreal, PQ, Canada; [Essebag, Vidal] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Essebag, Vidal] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Raymond, Jean-Marc] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Gula, Lorne; Leong-Sit, Peter; Tang, Anthony S. L.] Western Univ, London, ON, Canada; [Tung, Stanley K.] Royal Columbian Hosp, Div Cardiol, New Westminster, BC, Canada; [Sterns, Laurence D.] Royal Jubilee Hosp, Victoria, BC, Canada; [Veenhuyzen, George D.] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Healey, Jeff S.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Redfearn, Damian] Kingston Gen Hosp, Kingston, ON, Canada; [Roux, Jean-Francois] CHU Sherbrooke, Sherbrooke, PQ, Canada; [Stevenson, William G.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA	Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Ottawa; University of Ottawa Heart Institute; Universite de Montreal; Institut de Cardiologie de Montreal; McGill University; Universite de Montreal; Universite de Montreal; Western University (University of Western Ontario); Libin Cardiovascular Institute Of Alberta; Population Health Research Institute; Queens University - Canada; University of Sherbrooke; Harvard University; Brigham & Women's Hospital	Sapp, JL (corresponding author), Halifax Infirm, Rm 2501F,1796 Summer St, Halifax, NS, Canada.	john.sapp@nshealth.ca	Gula, Lorne/G-3298-2011; Wells, George A/M-4549-2017; Leong-Sit, Peter/G-3319-2011	Wells, George A/0000-0002-2289-9139; rivard, lena/0000-0002-1340-0850; Essebag, Vidal/0000-0003-0107-5197; Sarrazin, Jean-Francois/0000-0002-1114-0661	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research and others; VANISH ClinicalTrials.gov number, NCT00905853.	Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030; Bokhari F, 2004, CIRCULATION, V110, P112, DOI 10.1161/01.CIR.0000134957.51747.6E; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Dev S, 2014, AM J CARDIOL, V113, P314, DOI 10.1016/j.amjcard.2013.09.023; Dunbar SB, 2012, CIRCULATION, V126, P2146, DOI 10.1161/CIR.0b013e31825d59fd; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; GREENE HL, 1993, AM J CARDIOL, V72, P280; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Pacifico A, 1999, NEW ENGL J MED, V340, P1855, DOI 10.1056/NEJM199906173402402; Pedersen CT, 2014, HEART RHYTHM, V11, pE166, DOI 10.1016/j.hrthm.2014.07.024; Piccini JP, 2009, EUR HEART J, V30, P1245, DOI 10.1093/eurheartj/ehp100; Pollak PT, 2000, CLIN PHARMACOL THER, V67, P642, DOI 10.1067/mcp.2000.107047; Raitt MH, 2003, AM J CARDIOL, V91, P812, DOI 10.1016/S0002-9149(03)00015-8; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Saxon LA, 2010, CIRCULATION, V122, P2359, DOI 10.1161/CIRCULATIONAHA.110.960633; Tung R, 2015, HEART RHYTHM, V12, P1997, DOI 10.1016/j.hrthm.2015.05.036; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Wilkoff BL, 2006, J AM COLL CARDIOL, V48, P330, DOI 10.1016/j.jacc.2006.03.037	20	376	382	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2016	375	2					111	121		10.1056/NEJMoa1513614	http://dx.doi.org/10.1056/NEJMoa1513614			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ9KY	27149033	Bronze			2022-12-28	WOS:000379530000004
J	Tarantino, MD; Bussel, JB; Blanchette, VS; Despotovic, J; Bennett, C; Raj, A; Williams, B; Beam, D; Morales, J; Rose, MJ; Carpenter, N; Nie, K; Eisen, M				Tarantino, Michael D.; Bussel, James B.; Blanchette, Victor S.; Despotovic, Jenny; Bennett, Carolyn; Raj, Ashok; Williams, Bronwyn; Beam, Donald; Morales, Jaime; Rose, Melissa J.; Carpenter, Nancy; Nie, Kun; Eisen, Melissa			Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study	LANCET			English	Article							STUDY-GROUP ICIS; INTRACRANIAL HEMORRHAGE; PURPURA; ITP; ADULTS; PERSISTENT; ELTROMBOPAG; MULTICENTER; MANAGEMENT; CHILDHOOD	Background The thrombopoietin receptor agonist romiplostim could be an effective treatment in symptomatic children with persistent or chronic immune thrombocytopenia. We aimed to assess whether romiplostim is safe and effective in children with immune thrombocytopenia of more than 6 months' duration. Methods In this phase 3 double-blind study, eligible participants were children with immune thrombocytopenia aged 1 year to 17 years and mean platelet counts 30 x 10(9)/L or less (mean of two measurements during the screening period) with no single count greater than 35 x 10(9)/L, and were recruited from 27 sites in the USA, Canada, and Australia. Participants were randomly assigned (2: 1) through the interactive voice response system to receive weekly romiplostim or placebo for 24 weeks stratified by age (1 year to <6 years, 6 years to <12 years, 12 years to <18 years), adjusting the dose weekly from 1 mu g/kg to 10 mu g/kg to target platelet counts of 50-200 x 10(9)/L. Patients and investigators were blinded to the treatment assignment. The primary analysis included all randomised patients and the safety analysis included all randomised patients who received at least one dose of investigational product. The primary endpoint, durable platelet response, was defined as achievement of weekly platelet responses (platelet counts >= 50 x 10(9)/L without rescue drug use in the preceding 4 weeks) in 6 or more of the final 8 weeks (weeks 18-25). This study is registered with ClinicalTrials.gov, NCT 01444417. Findings Between Jan 24, 2012, and Sept 3, 2014, 62 patients were randomly assigned; 42 to romiplostim and 20 to placebo. Durable platelet response was seen in 22 (52%) patients in the romiplostim group and two (10%) in the placebo group (p=0.002, odds ratio 9.1 [95% CI 1.9-43.2]). Durable platelet response rates with romiplostim by age were 38% (3/8) for 1 year to younger than 6 years, 56% (10/18) for 6 years to younger than 12 years, and 56% (9/16) for 12 years to younger than 18 years. One (5%) of 19 patients in the placebo group had serious adverse events compared with 10 (24%) of 42 patients in the romiplostim group. Of these serious adverse events, headache and thrombocytosis, in one (2%) of 42 patients in the romiplostim group, were considered treatment related. No patients withdrew due to adverse events. Interpretation In children with chronic immune thrombocytopenia, romiplostim induced a high rate of platelet response with no new safety signals. Ongoing romiplostim studies will provide further information as to long-term efficacy, safety, and remission in children with immune thrombocytopenia.	[Tarantino, Michael D.] Univ Illinois, Coll Med Peoria, Bleeding & Clotting Disorders Inst, Peoria, IL 61615 USA; [Bussel, James B.] Weill Cornell Med, Div Hematol, Dept Pediat, New York, NY USA; [Blanchette, Victor S.] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Despotovic, Jenny] Texas Childrens Hematol Ctr, Houston, TX USA; [Bennett, Carolyn] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Atlanta, GA USA; [Bennett, Carolyn] Aflac Canc & Blood Disorder Serv, Atlanta, GA USA; [Raj, Ashok] Pediat Blood & Canc Disorders Clin, Louisville, KY USA; [Williams, Bronwyn] Lady Cilento Childrens Hosp, South Brisbane, Qld, Australia; [Beam, Donald] Cook Childrens Med Ctr, Ft Worth, TX USA; [Morales, Jaime] Childrens Hosp New Orleans, New Orleans, LA USA; [Morales, Jaime] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Rose, Melissa J.] Nationwide Childrens Hosp, Columbus, OH USA; [Rose, Melissa J.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Carpenter, Nancy] Amgen Ltd, Uxbridge, Middx, England; [Nie, Kun; Eisen, Melissa] Amgen Inc, Thousand Oaks, CA 91320 USA	University of Illinois System; University of Illinois Peoria; Cornell University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Healthcare of Atlanta (CHOA); Emory University; Cook Children's Medical Center; Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Amgen; Amgen Limited; Amgen	Tarantino, MD (corresponding author), Univ Illinois, Coll Med Peoria, Bleeding & Clotting Disorders Inst, Peoria, IL 61615 USA.	mtarantino@ilbcdi.org			Amgen Inc. Susanna Mac (Amgen Inc, Thousand Oaks, CA, USA); Meghan Johnson (Complete Healthcare Communications Inc (Chadds Ford, PA, USA); Amgen Inc.	Amgen Inc. Susanna Mac (Amgen Inc, Thousand Oaks, CA, USA); Meghan Johnson (Complete Healthcare Communications Inc (Chadds Ford, PA, USA); Amgen Inc.(Amgen)	This study was sponsored by Amgen Inc. Susanna Mac (Amgen Inc, Thousand Oaks, CA, USA) and Meghan Johnson (Complete Healthcare Communications Inc (Chadds Ford, PA, USA) provided medical writing support paid for by Amgen Inc. The authors wish to thank the other investigators recruiting patients for this study including (in alphabetical order): Sharon Abish of Montreal Children's Hospital, Chris Barnes of Royal Children's Hospital, Vicky Breakey of Hamilton Health Sciences McMaster University Medical Centre and Children's Hospital, Michael Callaghan of Children's Hospital in Michigan, Richard Drachtman of Rutgers-Robert Wood Johnson Medical School, Ayman El-Sheikh of University of Iowa Hospitals and Clinics, Heather Escoto of Peyton Manning Children's Hospital at St Vincent, Amy Geddis of University of California at San Diego, Rady Children's Hospital San Diego, Michael F Guerrera of Children's National Medical Center, Richard Ho of Vanderbilt University Medical Center, Alan Ikeda of Children's Specialty Center of Nevada, Ram Kalpatthi of Children's Mercy Hospital, Lakshmanan Krishnamurti of Emory University, Yves Pastore of Centre Hospitalier Universitaire Sainte-Justine, Charles T Quinn of Cincinnati Children's Hospital Medical Center, Arthur Ritchey of Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Susan Russell of Sydney Children's Hospital, and Alexis Thompson of Ann and Robert H Lurie Children's Hospital of Chicago. The authors would also like to thank Greg Brandt of Southern Illinois University for referring patients.	Bennett CM, 2006, BLOOD, V107, P2639, DOI 10.1182/blood-2005-08-3518; Broudy VC, 2004, CYTOKINE, V25, P52, DOI 10.1016/j.cyto.2003.05.001; Buchanan GR, 2002, J PEDIATR-US, V141, P683, DOI 10.1067/mpd.2002.128547; Bussel JB, 2015, LANCET HAEMATOL, V2, pE315, DOI 10.1016/S2352-3026(15)00114-3; Bussel JB, 2015, PEDIATR BLOOD CANCER, V62, P208, DOI 10.1002/pbc.25136; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Butros LJ, 2003, J PEDIAT HEMATOL ONC, V25, P660, DOI 10.1097/00043426-200308000-00017; Cancer Therapy Evaluation Program, COMM TERM CRIT ADV E; Chalmers S, 2015, J BLOOD MED, V6, P37, DOI 10.2147/JBM.S47240; Elalfy MS, 2011, ANN HEMATOL, V90, P1341, DOI 10.1007/s00277-011-1172-9; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Grainger JD, 2015, LANCET, V386, P1649, DOI 10.1016/S0140-6736(15)61107-2; Imbach P, 2006, PEDIATR BLOOD CANCER, V46, P351, DOI 10.1002/pbc.20453; Klaassen RJ, 2007, J PEDIATR-US, V150, P510, DOI 10.1016/j.jpeds.2007.01.037; Kuhne T, 2011, HAEMATOL-HEMATOL J, V96, P1831, DOI 10.3324/haematol.2011.050799; LILLEYMAN JS, 1994, ARCH DIS CHILD, V71, P251, DOI 10.1136/adc.71.3.251; Mathias SD, PEDIAT BLOO IN PRESS; Medeiros D, 1998, J PEDIATR-US, V133, P334, DOI 10.1016/S0022-3476(98)70265-3; Neunert C, 2015, J THROMB HAEMOST, V13, P457, DOI 10.1111/jth.12813; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Neunert CE, 2008, BLOOD, V112, P4003, DOI 10.1182/blood-2008-03-138487; Neunert CE, 2013, BLOOD, V121, P4457, DOI 10.1182/blood-2012-12-466375; Parodi E, 2009, BRIT J HAEMATOL, V144, P552, DOI 10.1111/j.1365-2141.2008.07487.x; Pasquet M, 2014, BRIT J HAEMATOL, V164, P266, DOI 10.1111/bjh.12609; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Psaila B, 2009, BLOOD, V114, P4777, DOI 10.1182/blood-2009-04-215525; Ramaswamy K, 2014, J PEDIATR-US, V165, P600, DOI 10.1016/j.jpeds.2014.03.060; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Terrell DR, 2010, AM J HEMATOL, V85, P174, DOI 10.1002/ajh.21616; Wang B, 2004, CLIN PHARMACOL THER, V76, P628, DOI 10.1016/j.clpt.2004.08.010	30	79	81	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					45	54		10.1016/S0140-6736(16)00279-8	http://dx.doi.org/10.1016/S0140-6736(16)00279-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27103127				2022-12-28	WOS:000378828400027
J	Zanos, P; Moaddel, R; Morris, PJ; Georgiou, P; Fischell, J; Elmer, GI; Alkondon, M; Yuan, PX; Pribut, HJ; Singh, NS; Dossou, KSS; Fang, YH; Huang, XP; Mayo, CL; Wainer, IW; Albuquerque, EX; Thompson, SM; Thomas, CJ; Zarate, CA; Gould, TD				Zanos, Panos; Moaddel, Ruin; Morris, Patrick J.; Georgiou, Polymnia; Fischell, Jonathan; Elmer, Greg I.; Alkondon, Manickavasagom; Yuan, Peixiong; Pribut, Heather J.; Singh, Nagendra S.; Dossou, Katina S. S.; Fang, Yuhong; Huang, Xi-Ping; Mayo, Cheryl L.; Wainer, Irving W.; Albuquerque, Edson X.; Thompson, Scott M.; Thomas, Craig J.; Zarate, Carlos A., Jr.; Gould, Todd D.			NMDAR inhibition-independent antidepressant actions of ketamine metabolites	NATURE			English	Article							D-ASPARTATE ANTAGONIST; STAR-ASTERISK-D; SUSTAINED ANTIDEPRESSANT; RECEPTOR ANTAGONIST; SEX-DIFFERENCES; AMPA RECEPTOR; DEPRESSION; STRESS; CORTEX; RAT	Major depressive disorder affects around 16 per cent of the world population at some point in their lives. Despite the availability of numerous monoaminergic-based antidepressants, most patients require several weeks, if not months, to respond to these treatments, and many patients never attain sustained remission of their symptoms. The non-competitive, glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist(R,S)-ketamine exerts rapid and sustained antidepressant effects after a single dose in patients with depression, but its use is associated with undesirable side effects. Here we show that the metabolism of (R,S)-ketamine to (2S,6S;2R,6R)-hydroxynorketamine (HNK) is essential for its antidepressant effects, and that the (2R,6R)-HNK enantiomer exerts behavioural, electroencephalographic, electrophysiological and cellular antidepressant-related actions in mice. These antidepressant actions are independent of NMDAR inhibition but involve early and sustained activation of AMPARs (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors). We also establish that (2R,6R)-HNK lacks ketamine-related side effects. Our data implicate a novel mechanism underlying the antidepressant properties of (R,S)-ketamine and have relevance for the development of next-generation, rapid-acting antidepressants.	[Zanos, Panos; Georgiou, Polymnia; Elmer, Greg I.; Pribut, Heather J.; Thompson, Scott M.; Gould, Todd D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Moaddel, Ruin; Singh, Nagendra S.; Dossou, Katina S. S.; Wainer, Irving W.] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Morris, Patrick J.; Fang, Yuhong; Thomas, Craig J.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Fischell, Jonathan; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Elmer, Greg I.; Albuquerque, Edson X.; Gould, Todd D.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Elmer, Greg I.; Mayo, Cheryl L.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA; [Alkondon, Manickavasagom; Albuquerque, Edson X.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Translat Toxicol, Baltimore, MD 21201 USA; [Yuan, Peixiong; Zarate, Carlos A., Jr.] NIMH, Expt Therapeut & Pathophysiol Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Huang, Xi-Ping] Univ N Carolina, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27516 USA; [Huang, Xi-Ping] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27516 USA; [Albuquerque, Edson X.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Gould, Todd D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Wainer, Irving W.] Mitchell Woods Pharmaceut, Shelton, CT 06484 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gould, TD (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA.; Gould, TD (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.; Gould, TD (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	gouldlab@me.com	Zanos, Panos/ABD-8906-2021; Moaddel, Ruin/AAE-3378-2020; Zarate, Carlos/ABD-6843-2021; ZANOS, PANOS/AAX-4568-2020; Thompson, Scott M/K-8921-2015	Zanos, Panos/0000-0002-1968-8648; Morris, Patrick/0000-0003-2380-4178; Moaddel, Ruin/0000-0002-6812-0127; Elmer, Greg/0000-0002-1483-3690; Georgiou, Polymnia/0000-0003-3171-9993; Zarate Jr., Carlos A./0000-0003-4442-7412; Thomas, Craig/0000-0001-9386-9001	NIMH [MH099345, MH107615, MH086828, HHSN-271-2008-025C]; NIA, NIH; NIMH, NIH; NCATS, NIH; NIA [HHSN271201000008I]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099345, R01MH107615, R01MH086828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000297] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCATS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Keller for his assistance with the qEEG experiments, M. K. Lobo for assistance with the social defeat experiments, B. Alkondon for the rat hippocampal slice preparation and biocytin processing, V. Meadows and S. Krimmel for assistance with behavioural experiments and manuscript review, E. Pereira for critical comments on the manuscript and figures, D. Luckenbaugh for assistance with statistical analysis, and C. Moore for the small molecule X-ray crystallography. Research was supported by NIMH grants MH099345 and MH107615 to T.D.G. and MH086828 to S.M.T., and the NIA (R.M., I.W.W.), NIMH (C.A.Z.), and NCATS (C.J.T.) NIH intramural research programs. Receptor binding profiles and K<INF>i</INF> determinations were supported by the NIMH Psychoactive Drug Screening Program, Contract HHSN-271-2008-025C, to B. L. Roth in conjunction with J. Driscoll. Initial synthesis of the ketamine metabolites used in this study was supported by NIA Contract HHSN271201000008I to I.W.W.	ADAMS JD, 1981, BIOMED MASS SPECTROM, V8, P527, DOI 10.1002/bms.1200081103; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Carrier N, 2013, NEUROPHARMACOLOGY, V70, P27, DOI 10.1016/j.neuropharm.2012.12.009; Chiu J, 1999, ALCOHOL, V17, P215, DOI 10.1016/S0741-8329(98)00050-0; Cunningham MO, 2003, J NEUROSCI, V23, P9761; De Vry J, 2003, BEHAV PHARMACOL, V14, P229, DOI 10.1097/00008877-200305000-00007; Desta Z, 2012, XENOBIOTICA, V42, P1076, DOI 10.3109/00498254.2012.685777; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Donahue RJ, 2014, BIOL PSYCHIAT, V76, P550, DOI 10.1016/j.biopsych.2013.12.014; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Ebert B, 1997, EUR J PHARMACOL, V333, P99, DOI 10.1016/S0014-2999(97)01116-3; Franceschelli A, 2015, NEUROSCIENCE, V290, P49, DOI 10.1016/j.neuroscience.2015.01.008; Gant TG, 2014, J MED CHEM, V57, P3595, DOI 10.1021/jm4007998; IRIFUNE M, 1995, PHARMACOL BIOCHEM BE, V51, P291, DOI 10.1016/0091-3057(94)00379-W; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Koike H, 2014, BEHAV BRAIN RES, V271, P111, DOI 10.1016/j.bbr.2014.05.065; Koike H, 2011, BEHAV BRAIN RES, V224, P107, DOI 10.1016/j.bbr.2011.05.035; Lally N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.105; Lepack AE, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu033; LEUNG LY, 1986, J MED CHEM, V29, P2396, DOI 10.1021/jm00161a043; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; Moaddel R, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.157; Moaddel R, 2013, EUR J PHARMACOL, V698, P228, DOI 10.1016/j.ejphar.2012.11.023; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Murrough JW, 2013, AM J PSYCHIAT, V170, P1134, DOI 10.1176/appi.ajp.2013.13030392; Muthukumaraswamy SD, 2015, J NEUROSCI, V35, P11694, DOI 10.1523/JNEUROSCI.0903-15.2015; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Raver SM, 2013, NEUROPSYCHOPHARMACOL, V38, P2338, DOI 10.1038/npp.2013.164; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Yang C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.136; Zanos P, 2015, J PHARMACOL EXP THER, V355, P76, DOI 10.1124/jpet.115.225664; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate CA, 2012, BIOL PSYCHIAT, V72, P331, DOI 10.1016/j.biopsych.2012.03.004	39	868	913	11	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					481	+		10.1038/nature17998	http://dx.doi.org/10.1038/nature17998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27144355	Green Accepted, Green Submitted			2022-12-28	WOS:000376443100030
J	Torres, M				Torres, Miguel			REGENERATION Limb regrowth takes two	NATURE			English	Editorial Material							VERTEBRATE LIMB; FEEDBACK LOOP		[Torres, Miguel] Ctr Nacl Invest Cardiovasc, Cardiovasc Dev Program, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Torres, M (corresponding author), Ctr Nacl Invest Cardiovasc, Cardiovasc Dev Program, Madrid 28029, Spain.	mtorres@cnic.es	Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013	Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767				BRYANT SV, 1976, NATURE, V263, P676, DOI 10.1038/263676a0; Dinsmore CE, 1996, INT J DEV BIOL, V40, P621; LHEUREUX E, 1977, J EMBRYOL EXP MORPH, V38, P151; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P115; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Sugiura T, 2016, NATURE, V531, P237, DOI 10.1038/nature16974; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	10	1	1	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					328	330		10.1038/nature17889	http://dx.doi.org/10.1038/nature17889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27120168				2022-12-28	WOS:000376004300034
J	Alam, MZ; De Leon, I; Boyd, RW				Alam, M. Zahirul; De Leon, Israel; Boyd, Robert W.			Large optical nonlinearity of indium tin oxide in its epsilon-near-zero region	SCIENCE			English	Article							GOLD; METAMATERIALS; FILMS	Nonlinear optical phenomena are crucial for a broad range of applications, such as microscopy, all-optical data processing, and quantum information. However, materials usually exhibit a weak optical nonlinearity even under intense coherent illumination. We report that indium tin oxide can acquire an ultrafast and large intensity-dependent refractive index in the region of the spectrum where the real part of its permittivity vanishes. We observe a change in the real part of the refractive index of 0.72 +/- 0.025, corresponding to 170% of the linear refractive index. This change in refractive index is reversible with a recovery time of about 360 femtoseconds. Our results offer the possibility of designing material structures with large ultrafast nonlinearity for applications in nanophotonics.	[Alam, M. Zahirul; De Leon, Israel; Boyd, Robert W.] Univ Ottawa, Dept Phys, 25 Templeton St, Ottawa, ON K1N 6N5, Canada; [Alam, M. Zahirul; De Leon, Israel; Boyd, Robert W.] Univ Ottawa, Max Planck Ctr Extreme & Quantum Photon, 25 Templeton St, Ottawa, ON K1N 6N5, Canada; [Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Boyd, Robert W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [De Leon, Israel] Tecnol Monterrey, Sch Engn & Sci, Monterrey 64849, Nuevo Leon, Mexico	University of Ottawa; University of Ottawa; University of Rochester; University of Rochester; Tecnologico de Monterrey	De Leon, I (corresponding author), Univ Ottawa, Dept Phys, 25 Templeton St, Ottawa, ON K1N 6N5, Canada.; De Leon, I (corresponding author), Univ Ottawa, Max Planck Ctr Extreme & Quantum Photon, 25 Templeton St, Ottawa, ON K1N 6N5, Canada.; De Leon, I (corresponding author), Tecnol Monterrey, Sch Engn & Sci, Monterrey 64849, Nuevo Leon, Mexico.	ideleon@itesm.mx	De Leon, Israel/AAG-7478-2020	De Leon, Israel/0000-0002-5745-0139	Canada Excellence Research Chairs Program	Canada Excellence Research Chairs Program(Canada Research Chairs)	The authors gratefully acknowledge the support of the Canada Excellence Research Chairs Program. R.W.B. is the cofounder and Chief Technology Officer of KBN Optics, Pittsford, NY.	Abb M, 2011, NANO LETT, V11, P2457, DOI 10.1021/nl200901w; Alu A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155410; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; BRORSON SD, 1987, PHYS REV LETT, V59, P1962, DOI 10.1103/PhysRevLett.59.1962; Capretti A, 2015, OPT LETT, V40, P1500, DOI 10.1364/OL.40.001500; Carpene E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024301; Davoyan AR, 2013, OPT EXPRESS, V21, P3279, DOI 10.1364/OE.21.003279; de Ceglia D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155140; Elim HI, 2006, APPL PHYS B-LASERS O, V82, P439, DOI 10.1007/s00340-005-2079-8; Feigenbaum E, 2010, NANO LETT, V10, P2111, DOI 10.1021/nl1006307; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/NPHOTON.2012.244, 10.1038/nphoton.2012.244]; Kinsey N, 2015, OPTICA, V2, P616, DOI 10.1364/OPTICA.2.000616; Luk TS, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4917457; Naik GV, 2013, ADV MATER, V25, P3264, DOI 10.1002/adma.201205076; Neira AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8757; Rethfeld B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.214303; Rhee BK, 1996, J OPT SOC AM B, V13, P2720, DOI 10.1364/JOSAB.13.002720; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Silveirinha M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.157403; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; SUN CK, 1993, PHYS REV B, V48, P12365, DOI 10.1103/PhysRevB.48.12365	21	583	589	33	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2016	352	6287					795	797		10.1126/science.aae0330	http://dx.doi.org/10.1126/science.aae0330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5FP	27127238				2022-12-28	WOS:000375663000032
J	Currie, J; Schwandt, H				Currie, J.; Schwandt, H.			Inequality in mortality decreased among the young while increasing for older adults, 1990-2010	SCIENCE			English	Article							US LIFE EXPECTANCY; UNITED-STATES; TRENDS; DISPARITIES; GRADIENTS; EDUCATION; HEALTH	Many recent studies point to increasing inequality in mortality in the United States over the past 20 years. These studies often use mortality rates in middle and old age. We used poverty level rankings of groups of U.S. counties as a basis for analyzing inequality in mortality for all age groups in 1990, 2000, and 2010. Consistent with previous studies, we found increasing inequality in mortality at older ages. For children and young adults below age 20, however, we found strong mortality improvements that were most pronounced in poorer counties, implying a strong decrease in mortality inequality. These younger cohorts will form the future adult U.S. population, so this research suggests that inequality in old-age mortality is likely to decline.	[Currie, J.] Princeton Univ, Ctr Hlth & Wellbeing, Princeton, NJ 08542 USA; [Currie, J.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Currie, J.; Schwandt, H.] Inst Study Labor IZA, D-53072 Bonn, Germany; [Schwandt, H.] Univ Zurich, Dept Econ, CH-8031 Zurich, Switzerland; [Schwandt, H.] London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England	Princeton University; National Bureau of Economic Research; IZA Institute Labor Economics; University of Zurich; University of London; London School Economics & Political Science	Currie, J (corresponding author), Princeton Univ, Ctr Hlth & Wellbeing, Princeton, NJ 08542 USA.; Currie, J (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Currie, J (corresponding author), Inst Study Labor IZA, D-53072 Bonn, Germany.	jcurrie@princeton.edu			Princeton Center for Translational Research on Aging [2P30AG024928]; ESRC [ES/M010341/1] Funding Source: UKRI; Economic and Social Research Council [ES/M010341/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024928] Funding Source: NIH RePORTER	Princeton Center for Translational Research on Aging; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Barbieri, A. Case, A. Deaton, J. Goldstein, I. Kuziemko, R. Lee, and K. Wachter, as well as seminar participants at Berkeley, the Chicago Federal Reserve, Fundacao Getulio Vargas Sao Paulo, Bonn University, University of Munich, Princeton University, ETH Zurich, and the University of Zurich for comments. Supported by Princeton Center for Translational Research on Aging grant 2P30AG024928. Data and code are available at http://dx.doi.org/10.7910/DVN/C2VYNM.	Aizer A, 2014, SCIENCE, V344, P856, DOI 10.1126/science.1251872; Bosworth B., 2015, 201513 CTR RET RES B; Bosworth Barry P., 2014, DIFFERENTIAL MORTALI; Bound J., 2014, 2014314 U MICH RET R; Brown D.W., 2015, 20835 NAT BUR EC RES; Cahodes S., 2014, 20178 NAT BUR EC RES; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cutler DM, 2011, J HEALTH ECON, V30, P1174, DOI 10.1016/j.jhealeco.2011.06.009; de Walque D, 2010, J HUM RESOUR, V45, P682, DOI 10.1353/jhr.2010.0009; Dowd JB, 2014, INT J EPIDEMIOL, V43, P983, DOI 10.1093/ije/dyu120; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Fenelon A, 2012, DEMOGRAPHY, V49, P797, DOI 10.1007/s13524-012-0108-x; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Goldring T., 2015, 20993 NAT BUR EC RES; Hendi AS, 2015, INT J EPIDEMIOL, V44, P946, DOI 10.1093/ije/dyv062; Hoynes H., 2012, 18535 NAT BUR EC RES; Isen Adam, 2014, 19858 NAT BUR EC RES; Ludwig J, 2007, Q J ECON, V122, P159, DOI 10.1162/qjec.122.1.159; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Meyer Bruce D., 2015, 20929 NAT BUR EC RES; Miller S., 2015, 2466691 SOC SCI RES; Montez JK, 2014, AM J PUBLIC HEALTH, V104, pE82, DOI 10.2105/AJPH.2013.301526; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; National Research Council, 2015, GROW GAP LIF EXP INC; Olshansky J. S., 2011, HLTH AFF, V31, P1803; Pijoan-Mas J, 2014, DEMOGRAPHY, V51, P2075, DOI 10.1007/s13524-014-0346-1; Reidpath DD, 2003, J EPIDEMIOL COMMUN H, V57, P344, DOI 10.1136/jech.57.5.344; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Waldron Hilary, 2013, Soc Secur Bull, V73, P1; Waldron Hilary, 2007, Soc Secur Bull, V67, P1; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Wherry L. R., 2013, 18309 NAT BUR EC RES; Wilmoth J., 2011, INT DIFFERENCES MORT, P337	34	56	56	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286					708	712		10.1126/science.aaf1437	http://dx.doi.org/10.1126/science.aaf1437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	27103667	Green Accepted			2022-12-28	WOS:000375417100038
J	Mechanic, RE				Mechanic, Robert E.			When New Medicare Payment Systems Collide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BUNDLED PAYMENTS		[Mechanic, Robert E.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA	Brandeis University	Mechanic, RE (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA.							Dupree JM, 2014, HEALTH AFFAIR, V33, P972, DOI 10.1377/hlthaff.2013.1300; Mechanic R, 2012, NEW ENGL J MED, V367, P1873, DOI 10.1056/NEJMp1210823; Medicare Payment Advisory Commission, 2014, COMMUNICATION; Press MJ, 2016, JAMA-J AM MED ASSOC, V315, P131, DOI 10.1001/jama.2015.18161; Rajkumar R, 2015, NEW ENGL J MED, V372, P1981, DOI 10.1056/NEJMp1501951	5	21	21	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1706	1709		10.1056/NEJMp1601464	http://dx.doi.org/10.1056/NEJMp1601464			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL0RY	27144847				2022-12-28	WOS:000375341500003
J	Maus, TP; Duszynski, BS				Maus, Timothy P.; Duszynski, Belinda S.		Multisoc Pain Workgrp	Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis	ANNALS OF INTERNAL MEDICINE			English	Letter							LOW-BACK-PAIN		[Maus, Timothy P.] Mayo Clin, Rochester, MN USA; [Duszynski, Belinda S.] Spine Intervent Soc, Hinsdale, IL USA	Mayo Clinic	Maus, TP (corresponding author), Mayo Clin, Rochester, MN USA.							Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; DePalma MJ, 2015, PAIN MED, V16, P1453, DOI 10.1111/pme.12850; Deyo RA, 2014, PAIN MED, V15, P1249, DOI 10.1111/pme.12538; MacVicar J, 2013, PAIN MED, V14, P14, DOI 10.1111/j.1526-4637.2012.01508.x	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					633	634		10.7326/L15-0564	http://dx.doi.org/10.7326/L15-0564			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136214				2022-12-28	WOS:000375744000029
J	Dyer, O				Dyer, Owen			US drug regulator warns manufacturers that it will not accept data from Indian research center	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Food and Drug Administration, 2015, FDA INSP REP SEML RE; Food and Drug Administration, 2016, FDA NOT PHARM CO CLI	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2476	10.1136/bmj.i2476	http://dx.doi.org/10.1136/bmj.i2476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130404				2022-12-28	WOS:000375484100020
J	Zhernakova, A; Kurilshikov, A; Bonder, MJ; Tigchelaar, EF; Schirmer, M; Vatanen, T; Mujagic, Z; Vila, AV; Falony, G; Vieira-Silva, S; Wang, J; Imhann, F; Brandsma, E; Jankipersadsing, SA; Joossens, M; Cenit, MC; Deelen, P; Swertz, MA; Weersma, RK; Feskens, EJM; Netea, MG; Gevers, D; Jonkers, D; Franke, L; Aulchenko, YS; Huttenhower, C; Raes, J; Hofker, MH; Xavier, RJ; Wijmenga, C; Fu, JY				Zhernakova, Alexandra; Kurilshikov, Alexander; Bonder, Marc Jan; Tigchelaar, Ettje F.; Schirmer, Melanie; Vatanen, Tommi; Mujagic, Zlatan; Vila, Arnau Vich; Falony, Gwen; Vieira-Silva, Sara; Wang, Jun; Imhann, Floris; Brandsma, Eelke; Jankipersadsing, Soesma A.; Joossens, Marie; Cenit, Maria Carmen; Deelen, Patrick; Swertz, Morris A.; Weersma, Rinse K.; Feskens, Edith J. M.; Netea, Mihai G.; Gevers, Dirk; Jonkers, Daisy; Franke, Lude; Aulchenko, Yurii S.; Huttenhower, Curtis; Raes, Jeroen; Hofker, Marten H.; Xavier, Ramnik J.; Wijmenga, Cisca; Fu, Jingyuan		LifeLines Cohort Study	Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity	SCIENCE			English	Article							CHROMOGRANIN-A; ENTEROTYPES; POLYPHENOLS; METABOLISM; CHILDREN	Deep sequencing of the gut microbiomes of 1135 participants from a Dutch population-based cohort shows relations between the microbiome and 126 exogenous and intrinsic host factors, including 31 intrinsic factors, 12 diseases, 19 drug groups, 4 smoking categories, and 60 dietary factors. These factors collectively explain 18.7% of the variation seen in the interindividual distance of microbial composition. We could associate 110 factors to 125 species and observed that fecal chromogranin A (CgA), a protein secreted by enteroendocrine cells, was exclusively associated with 61 microbial species whose abundance collectively accounted for 53% of microbial composition. Low CgA concentrations were seen in individuals with a more diverse microbiome. These results are an important step toward a better understanding of environment-diet-microbe-host interactions.	[Zhernakova, Alexandra; Bonder, Marc Jan; Tigchelaar, Ettje F.; Jankipersadsing, Soesma A.; Cenit, Maria Carmen; Deelen, Patrick; Swertz, Morris A.; Franke, Lude; Wijmenga, Cisca; Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Zhernakova, Alexandra; Tigchelaar, Ettje F.; Mujagic, Zlatan; Feskens, Edith J. M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Kurilshikov, Alexander] Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia; [Kurilshikov, Alexander; Aulchenko, Yurii S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Schirmer, Melanie; Vatanen, Tommi; Gevers, Dirk; Huttenhower, Curtis; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Schirmer, Melanie; Huttenhower, Curtis] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vatanen, Tommi] Aalto Univ, Sch Sci, Dept Comp Sci, Espoo, Finland; [Mujagic, Zlatan; Jonkers, Daisy] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Div Gastroenterol Hepatol,Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [Vila, Arnau Vich; Imhann, Floris; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Falony, Gwen; Vieira-Silva, Sara; Wang, Jun; Joossens, Marie; Raes, Jeroen] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Mol Bacteriol, Leuven, Belgium; [Falony, Gwen; Vieira-Silva, Sara; Wang, Jun; Joossens, Marie; Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Brandsma, Eelke; Hofker, Marten H.; Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Joossens, Marie; Raes, Jeroen] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Microbiol Unit, Brussels, Belgium; [Cenit, Maria Carmen] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Grp, Valencia, Spain; [Cenit, Maria Carmen] Dr Peset Univ Hosp, Dept Pediat, Valencia, Spain; [Deelen, Patrick; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Aulchenko, Yurii S.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland; [Aulchenko, Yurii S.] PolyOmica, Groningen, Netherlands; [Aulchenko, Yurii S.] Inst Cytol & Genet SB RAS, Novosibirsk, Russia; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Groningen; Top Institute Food & Nutrition; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Aalto University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Groningen; Vrije Universiteit Brussel; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Groningen; Wageningen University & Research; Radboud University Nijmegen; Radboud University Nijmegen; University of Edinburgh; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Zhernakova, A; Wijmenga, C; Fu, JY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; Zhernakova, A (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Fu, JY (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.	a.zhernakova@umcg.nl; wijmenga@umcg.nl; j.fu@umcg.nl	Fu, Jingyuan/E-8980-2012; Vieira-Silva, Sara/ABE-1247-2021; Weersma, Rinse/ABE-3807-2021; Fu, Jingyuan/ABE-6868-2020; Gevers, Dirk/C-1451-2009; Falony, Gwen/AAN-5011-2020; Kurilshikov, Alexander/GWC-1519-2022; Fu, JY/GRR-6179-2022; Wijmenga, Cisca/AAE-7719-2019; Feskens, Edith/ABI-1446-2020; raes, jeroen/D-7835-2018; Franke, Lude/P-7036-2016; Schirmer, Melanie/HDN-5528-2022; Netea, Mihai/N-5155-2014; Aulchenko, Yurii/M-8270-2013; Vatanen, Tommi/J-5458-2018; Joossens, Marie/U-7551-2017; Wijmenga, Cisca/D-2173-2009; Zhernakova, Alexandra/ABA-9372-2020; Cenit, Maria Carmen MC/E-9538-2017; Deelen, Patrick/B-3566-2013	Vieira-Silva, Sara/0000-0002-4616-7602; Fu, Jingyuan/0000-0001-5578-1236; Falony, Gwen/0000-0003-2450-0782; Kurilshikov, Alexander/0000-0003-2541-5627; Wijmenga, Cisca/0000-0002-5635-1614; Feskens, Edith/0000-0001-5819-2488; raes, jeroen/0000-0002-1337-041X; Franke, Lude/0000-0002-5159-8802; Aulchenko, Yurii/0000-0002-7899-1575; Vatanen, Tommi/0000-0003-0949-1291; Joossens, Marie/0000-0001-8410-5528; Cenit, Maria Carmen MC/0000-0001-8667-5313; Deelen, Patrick/0000-0002-5654-3966; Schirmer, Melanie/0000-0001-6456-3679; Jankipersadsing, Soesma/0000-0001-9225-9236; Bonder, Marc Jan/0000-0002-8431-3180; Vich Vila, Arnau/0000-0003-4691-5583	Top Institute Food and Nutrition, Wageningen [TiFN GH001]; Netherlands Organization for Scientific Research [NWO-VIDI 864.13.013, ZonMW-VIDI 917.14.374, ZonMW-VIDI 016.136308]; CardioVasculair Onderzoek Nederland [CVON 2012-03]; University of Groningen; Fundacion Alfonso Martin Escudero; European Research Council (ERC) under the European Union [2012-322698]; ERC [310312, 637640]; VIB; FWO; IWT (Agency for Innovation by Science and Technology); Rega institute for Medical Research; KU Leuven; NIH; JDRF; CCFA; EU [305564, 305479];  [259867];  [FP7 METACARDIS HEALTH-F4-2012-305312]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Top Institute Food and Nutrition, Wageningen; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); CardioVasculair Onderzoek Nederland; University of Groningen; Fundacion Alfonso Martin Escudero; European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); VIB; FWO(FWO); IWT (Agency for Innovation by Science and Technology); Rega institute for Medical Research(KU Leuven); KU Leuven(KU Leuven); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); CCFA; EU(European Commission); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the LifeLines-DEEP participants and the Groningen LifeLines staff for their collaboration. We thank J. Dekens, (A. Platteel, and A. Maatman for management and technical support. We thank J. Senior and K. McIntyre for editing the manuscript. This project was funded by grants from the Top Institute Food and Nutrition, Wageningen, to C.W. (TiFN GH001); the Netherlands Organization for Scientific Research to J.F. (NWO-VIDI 864.13.013), L.F. (ZonMW-VIDI 917.14.374), and R.K.W. (ZonMW-VIDI 016.136308) and CardioVasculair Onderzoek Nederland to M.H.H. and A.Z. (CVON 2012-03). A.Z. holds a Rosalind Franklin Fellowship (University of Groningen), and M.C.C. holds a postdoctoral fellowship from the Fundacion Alfonso Martin Escudero. This research received funding from the European Research Council (ERC) under the European Union's Seventh Framework Program: C.W. is supported by FP7/2007-2013)/ERC advanced Grant Agreement no. 2012-322698. M.G.N. is supported by an ERC Consolidator Grant (no. 310312). L.F. is supported by FP7/2007-2013, grant agreement 259867, and by an ERC Starting Grant, grant agreement 637640 (ImmRisk). J.R. and G.F. are supported by FP7 METACARDIS HEALTH-F4-2012-305312, VIB, FWO, IWT (Agency for Innovation by Science and Technology), the Rega institute for Medical Research, and KU Leuven. S.V.-S. and M.J. are supported by postdoctoral fellowships from FWO. T.V. M.S. and R.J.X. are supported by NIH, JDRF, and CCFA. A.Z. C.W. and J.F. designed the study. A.Z., E.F.T., L.F. and C.W. initiated the cohort and collected cohort data. A.Z., E.F.T., Z.M., S.A.J., M.C.C., and D.G. generated data. A.Z., A.K., M.J.B., E.F.T., M.S., T.V., A.V.V., G.F., S.V.-S., J.W., F.I., P.D., M.A.S., C.H., R.J.X., and J.F. analyzed data. G.F, S.V.-S., J.W., E.B., M.J. R.K.W., E.J.M.F. M.G.N., D.G., D.J., L.F., Y.S.A., C.H., J.R., R.J.X. and M.H.H. participated in integral discussions. A.Z., A.K., M.J.B., R.J.X., C.W., and J.F. wrote the manuscript. The authors have no conflicts of interest to report. The raw sequence data for both MGS and 163 rRNA gene sequencing data sets, and age and gender integration per sample are available from the European genome-phenome archive (https://www.ebi.ac.uk/ega/) at aocession, number EGAS00001001704. Other phenotypic data can be requested from the LifeLines cohort study (https://lifelines.nl/lifelines-research/access-to-lifelines) following the standard protocol for data access. The study was approved by the institutional review board of UMCG, ref.M12. 113965. D.J. has additional funding from EU FP7/ no. 305564 and EU FP/ no. 305479. C.H. is on the Scientific Advisory Board for Seres Therapeutics. Y.S.A. is a director and co-owner of PolyOmica, which provides services in statistical (gen)omics.	Aslam R, 2012, CURR MED CHEM, V19, P4115, DOI 10.2174/092986712802430063; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Burton Jeffrey H, 2015, J Diabetes Sci Technol, V9, P808, DOI 10.1177/1932296815577425; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Duda-Chodak A, 2015, EUR J NUTR, V54, P325, DOI 10.1007/s00394-015-0852-y; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hedin C, 2016, GUT, V65, P944, DOI 10.1136/gutjnl-2014-308896; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee T, 2006, ACTA PAEDIATR, V95, P935, DOI 10.1080/08035250500538940; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948; Ohman L, 2012, AM J GASTROENTEROL, V107, P440, DOI 10.1038/ajg.2011.458; Poullis A, 2003, EUR J GASTROEN HEPAT, V15, P573, DOI 10.1097/01.meg.0000059108.41030.23; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Sciolo V, 2009, INFLAMM BOWEL DIS, V15, P867, DOI 10.1002/ibd.20851; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Wagner M, 2013, INFLAMMATION, V36, P855, DOI 10.1007/s10753-013-9612-4; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	29	937	981	22	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					565	569		10.1126/science.aad3369	http://dx.doi.org/10.1126/science.aad3369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126040	Green Accepted			2022-12-28	WOS:000374998600040
J	Mayor, S				Mayor, Susan			Supplements such as fish oils improve antidepressant effectiveness, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sarris J, 2016, AM J PSYCHIAT, V173, P575, DOI 10.1176/appi.ajp.2016.15091228	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2016	353								i2418	10.1136/bmj.i2418	http://dx.doi.org/10.1136/bmj.i2418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RW	27127304				2022-12-28	WOS:000375483900011
J	Sinnott, JD; Howlett, DC				Sinnott, Joseph Dalby; Howlett, David C.			SPOT DIAGNOSIS A man with severe abdominal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, England; [Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England		Sinnott, JD (corresponding author), East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, England.	j.d.sinnott@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i2379	10.1136/bmj.i2379	http://dx.doi.org/10.1136/bmj.i2379			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27122019				2022-12-28	WOS:000375483300008
J	Smith, JM				Smith, Jeanette M.			Truncated View of the Broekzijder Mill on the Gein, Wings Facing West	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1686	1687		10.1001/jama.2015.14229	http://dx.doi.org/10.1001/jama.2015.14229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115363				2022-12-28	WOS:000374759300001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: How to misspend 2.4bn pound	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Central London Clinical Commissioning Group, 2014, IMPL SKYP CONS GEN P; Greenhalgh T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009388; Royal College of General Practitioners NHS England, 2016, NHS ENGL GEN PRACT F; Salisbury C, 2013, BRIT J GEN PRACT, V63, pE751, DOI 10.3399/bjgp13X674431	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2366	10.1136/bmj.i2366	http://dx.doi.org/10.1136/bmj.i2366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27114479	Bronze, Green Published			2022-12-28	WOS:000375482000011
J	Kruger, RP				Kruger, Robert P.			Zika Research Shifts into High Gear	CELL			English	Editorial Material																		Bayer A., 2016, CELL HOST MICROBE; Faria NR, 2016, SCIENCE; Kruger RP, 2016, CELL, V164, P585; Lazear HM, 2016, CELL HOST MICROBE; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063; Rossi SL, 2016, AM J TROP MED HYG; Sirohi D., 2016, SCIENCE; Tang H., 2016, CELL STEM CELL	9	0	1	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					503	505						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104968	Bronze			2022-12-28	WOS:000374636800001
J	Rodriguez, B				Rodriguez, Barbra			ECOLOGY Change is in the air	NATURE			English	Editorial Material																		Bailey LD, 2016, J ANIM ECOL, V85, P85, DOI 10.1111/1365-2656.12451; California Department of Fish and Wildlife, 2015, RAP ASS VULN SENS WI; IPCC, 2012, MAN RISKS EXTR EV DI; Lawson C. R., 2013, STATUS CONSERVATION; McKinney AM, 2012, ECOLOGY, V93, P1987, DOI 10.1890/12-0255.1; Roth T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082490; Taylor SA, 2014, CURR BIOL, V24, P671, DOI 10.1016/j.cub.2014.01.069; Windsor M. L., 2012, CNL12 NASCO	8	2	2	0	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					403	404		10.1038/nj7599-403a	http://dx.doi.org/10.1038/nj7599-403a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27127819				2022-12-28	WOS:000374424700041
J	Watts, G				Watts, Geoff			Majid Ezzati: a positive enthusiasm for global health	LANCET			English	Biographical-Item																		EZZATI M, PUBLICATION LIST	1	0	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1505	1505		10.1016/S0140-6736(16)30134-9	http://dx.doi.org/10.1016/S0140-6736(16)30134-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27115968				2022-12-28	WOS:000373741600017
J	Meinert, C; Myrgorodska, I; de Marcellus, P; Buhse, T; Nahon, L; Hoffmann, SV; d'Hendecourt, LL; Meierhenrich, UJ				Meinert, Cornelia; Myrgorodska, Iuliia; de Marcellus, Pierre; Buhse, Thomas; Nahon, Laurent; Hoffmann, Soren V.; d'Hendecourt, Louis Le Sergeant; Meierhenrich, Uwe J.			Ribose and related sugars from ultraviolet irradiation of interstellar ice analogs	SCIENCE			English	Article							GLYCOLALDEHYDE; EVOLUTION; GRAINS	Ribose is the central molecular subunit in RNA, but the prebiotic origin of ribose remains unknown. We observed the formation of substantial quantities of ribose and a diversity of structurally related sugar molecules such as arabinose, xylose, and lyxose in the room-temperature organic residues of photo-processed interstellar ice analogs initially composed of H2O, CH3OH, and NH3. Our results suggest that the generation of numerous sugar molecules, including the aldopentose ribose, may be possible from photochemical and thermal treatment of cosmic ices in the late stages of the solar nebula. Our detection of ribose provides plausible insights into the chemical processes that could lead to formation of biologically relevant molecules in suitable planetary environments.	[Meinert, Cornelia; Myrgorodska, Iuliia; Meierhenrich, Uwe J.] Univ Nice Sophia Antipolis, Inst Chim Nice, UMR CNRS 7272, 28 Ave Valrose, F-06108 Nice, France; [Myrgorodska, Iuliia; Nahon, Laurent] Synchrotron SOLEIL, St Aubin BP48, F-91192 Gif Sur Yvette, France; [de Marcellus, Pierre; d'Hendecourt, Louis Le Sergeant] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Astrophys Spatiale, Bat 121, F-91405 Orsay, France; [Buhse, Thomas] Univ Autonoma Estado Morelos, Ctr Invest Quim, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico; [Hoffmann, Soren V.] Aarhus Univ, Dept Phys & Astron, Ny Munkegade 120, DK-8000 Aarhus, Denmark	UDICE-French Research Universities; Universite Cote d'Azur; SOLEIL Synchrotron; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Universidad Autonoma del Estado de Morelos; Aarhus University	Meinert, C; Meierhenrich, UJ (corresponding author), Univ Nice Sophia Antipolis, Inst Chim Nice, UMR CNRS 7272, 28 Ave Valrose, F-06108 Nice, France.	cornelia.meinert@unice.fr; uwe.meierhenrich@unice.fr	Meinert, Cornelia/A-9293-2010; Buhse, Thomas/H-9156-2019	Meinert, Cornelia/0000-0002-7256-2112; Hoffmann, Soren Vronning/0000-0002-8018-5433; Buhse, Thomas/0000-0001-5082-0873	Agence Nationale de la Recherche [ANR-12-IS07-0006]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [C001-CONACYT-ANR-188689]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by the Agence Nationale de la Recherche grant ANR-12-IS07-0006 and Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant C001-CONACYT-ANR-188689. L.L.S.d'H. thanks the Centre National d'Etudes Spatiales for the continuous support of the MICMOC (Matiere Interstellaire et Cometaire: Molecules Organiques Compexes) experiment. The data obtained in this study are available through the open archive HAL (hal-01278288, https://hal.archives-ouvertes.fr).	AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; Biver N, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500863; BRESLOW R, 1959, TETRAHEDRON LETT, P22; Butlerow M. A., 1861, CR HEBD ACAD SCI, V53, P145; Butlerow M. A., 1861, LIEBIGS ANN CHEM, V120, P295; Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; Cooper G, 2001, NATURE, V414, P879, DOI 10.1038/414879a; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; de Marcellus P, 2015, P NATL ACAD SCI USA, V112, P965, DOI 10.1073/pnas.1418602112; Gesteland R. F., 2005, RNA WORLD; Goesmann F, 2015, SCIENCE, V349, DOI 10.1126/science.aab0689; GREENBERG JM, 1993, NATO ADV SCI INST SE, V416, P195; Hollis JM, 2000, ASTROPHYS J, V540, pL107, DOI 10.1086/312881; Hudson RL, 2005, ADV SPACE RES, V36, P184, DOI 10.1016/j.asr.2005.01.017; Jorgensen JK, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/1/L4; Meierhenrich U, 2015, COMETS AND THEIR ORIGIN: THE TOOL TO DECIPHER A COMET, P1; Meinert C, 2012, ANGEW CHEM INT EDIT, V51, P10460, DOI 10.1002/anie.201200842; Meinert C, 2012, CHEMPLUSCHEM, V77, P186, DOI 10.1002/cplu.201100048; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Ritson DJ, 2013, ANGEW CHEM INT EDIT, V52, P5845, DOI 10.1002/anie.201300321; SHIGEMASA Y, 1977, B CHEM SOC JPN, V50, P222, DOI 10.1246/bcsj.50.222; Tsai CH, 2007, P NATL ACAD SCI USA, V104, P14598, DOI 10.1073/pnas.0704211104; Woese C, 1967, GENETIC CODE, P179; Wright IP, 2015, SCIENCE, V349, DOI 10.1126/science.aab0673; Yu HY, 2012, NAT CHEM, V4, P183, DOI [10.1038/NCHEM.1241, 10.1038/nchem.1241]; Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z; Zweckmair T, 2014, J CHROMATOGR SCI, V52, P169, DOI 10.1093/chromsci/bmt004	28	168	169	6	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					208	212		10.1126/science.aad8137	http://dx.doi.org/10.1126/science.aad8137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124456	Green Submitted			2022-12-28	WOS:000373681600042
J	Sommer, MOA; Suess, B				Sommer, Morten O. A.; Suess, Beatrix			(Meta-)genome mining for new ribo-regulators	SCIENCE			English	Editorial Material									[Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Suess, Beatrix] Tech Univ Darmstadt, Petersenstr 30, D-64287 Darmstadt, Germany	Technical University of Denmark; Technical University of Darmstadt	Sommer, MOA (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark.	msom@bio.dtu.dk		Sommer, Morten Otto Alexander/0000-0003-4005-5674	Lundbeck Foundation [R140-2013-13496, R77-2010-6772] Funding Source: researchfish; Novo Nordisk Fonden [NNF13SA0006019, NNF14OC0011335, NNF13SA0009311, NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Synthetic Biology] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability		Berens C, 2015, CURR OPIN BIOTECH, V31, P10, DOI 10.1016/j.copbio.2014.07.014; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Couzin J, 2002, SCIENCE, V298, P2296, DOI 10.1126/science.298.5602.2296; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024	5	3	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					144	145		10.1126/science.aaf6189	http://dx.doi.org/10.1126/science.aaf6189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124438				2022-12-28	WOS:000373681600021
J	Tavor, I; Jones, OP; Mars, RB; Smith, SM; Behrens, TE; Jbabdi, S				Tavor, I.; Jones, O. Parker; Mars, R. B.; Smith, S. M.; Behrens, T. E.; Jbabdi, S.			Task-free MRI predicts individual differences in brain activity during task performance	SCIENCE			English	Article							CORTEX; CONNECTIVITY; ARCHITECTURE; PATTERNS; BEHAVIOR; MEMORY; FMRI; REST	When asked to perform the same task, different individuals exhibit markedly different patterns of brain activity. This variability is often attributed to volatile factors, such as task strategy or compliance. We propose that individual differences in brain responses are, to a large degree, inherent to the brain and can be predicted from task-independent measurements collected at rest. Using a large set of task conditions, spanning several behavioral domains, we train a simple model that relates task-independent measurements to task activity and evaluate the model by predicting task activation maps for unseen subjects using magnetic resonance imaging. Our model can accurately predict individual differences in brain activity and highlights a coupling between brain connectivity and function that can be captured at the level of individual subjects.	[Tavor, I.; Jones, O. Parker; Mars, R. B.; Smith, S. M.; Behrens, T. E.; Jbabdi, S.] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England; [Tavor, I.] Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; [Mars, R. B.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EZ Nijmegen, Netherlands; [Behrens, T. E.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	University of Oxford; Chaim Sheba Medical Center; Radboud University Nijmegen; University of London; University College London	Jbabdi, S (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England.	saad@fmrib.ox.ac.uk	Tavor, Ido/AAB-1345-2019; Mars, Rogier/GWZ-9665-2022; Mars, Rogier/G-2312-2018; Parker Jones, Oiwi/I-6681-2013	Tavor, Ido/0000-0002-9117-4449; Mars, Rogier/0000-0001-6302-8631; Behrens, Timothy/0000-0003-0048-1177; Smith, Stephen/0000-0001-8166-069X; Jbabdi, Saad/0000-0003-3234-5639; Parker Jones, Oiwi/0000-0003-0307-9837	McDonnell Center for Systems Neuroscience at Washington University in St. Louis; U.K. Medical Research Council [MR/L009013/1]; U.K. Engineering and Physical Sciences Research Council [EP/L023067/1]; James S. McDonnell Foundation [JSMF220020372]; Wellcome Trust [WT104765MA, 098369/Z/12/Z]; Netherlands Organization for Scientific Research (NWO) [452-13-015];  [1U54MH091657]; EPSRC [EP/L023067/1] Funding Source: UKRI; MRC [MR/L009013/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L023067/1] Funding Source: researchfish; Medical Research Council [MR/L009013/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	McDonnell Center for Systems Neuroscience at Washington University in St. Louis; U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); James S. McDonnell Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: D. Van Essen and K. Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University in St. Louis. The data are available for download at www.humanconnectome.org. Data from the Q3 release (September 2013) were used in this paper. All code available upon request from the corresponding author. Funding was provided by the U.K. Medical Research Council (MR/L009013/1 to S.J.), U.K. Engineering and Physical Sciences Research Council (EP/L023067/1 to S.J. and T.E.B.), James S. McDonnell Foundation (JSMF220020372 to T.E.B.), the Wellcome Trust (WT104765MA to T.E.B. and 098369/Z/12/Z to S.M.S.), and the Netherlands Organization for Scientific Research (NWO) (452-13-015 to R.B.M.). Author contributions were as follows: S.J. and I. T. built the model and performed the analyses. S.J., I. T., R.B.M., O.P.J., S.M.S., and T.E.B. wrote the paper.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Behrens TEJ, 2005, PHILOS T R SOC B, V360, P903, DOI 10.1098/rstb.2005.1640; Besle J, 2013, J NEUROPHYSIOL, V109, P2293, DOI 10.1152/jn.00499.2012; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wig GS, 2008, P NATL ACAD SCI USA, V105, P18555, DOI 10.1073/pnas.0804546105; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	24	423	431	10	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					216	220		10.1126/science.aad8127	http://dx.doi.org/10.1126/science.aad8127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124457	Green Accepted, Green Submitted			2022-12-28	WOS:000373681600044
J	Edmunds, LD; Ovseiko, PV; Shepperd, S; Greenhalgh, T; Frith, P; Roberts, NW; Pololi, LH; Buchan, AM				Edmunds, Laurel D.; Ovseiko, Pavel V.; Shepperd, Sasha; Greenhalgh, Trisha; Frith, Peggy; Roberts, Nia W.; Pololi, Linda H.; Buchan, Alastair M.			Why do women choose or reject careers in academic medicine? A narrative review of empirical evidence	LANCET			English	Review							GENDER-DIFFERENCES; PERCEIVED BARRIERS; NATIONAL COHORT; PHYSICIANS; STUDENTS; SCHOOL; RESIDENTS; OBSTETRICS; UNIVERSITY; INSTITUTE	Women are under-represented in academic medicine. We reviewed the empirical evidence focusing on the reasons for women's choice or rejection of careers in academic medicine. Using a systematic search, we identified 52 studies published between 1985, and 2015. More than half had methodological limitations and most were from North America. Eight main themes were explored in these studies. There was consistent evidence for four of these themes: women are interested in teaching more than in research; participation in research can encourage women into academic medicine; women lack adequate mentors and role models; and women experience gender discrimination and bias. The evidence was conflicting on four themes: women are less interested in research than men; women lose commitment to research as their education and training progress; women are deterred from academic careers by financial considerations; and women are deterred by concerns about work-life balance. Inconsistency of findings across studies suggests significant opportunities to overcome barriers by providing a more enabling environment. We identified substantial gaps in the scientific literature that could form the focus of future research, including shifting the focus from individuals' career choices to the societal and organisational contexts and cultures within which those choices are made; extending the evidence base to include a wider range of countries and settings; and testing the efficacy of interventions.	[Edmunds, Laurel D.; Ovseiko, Pavel V.; Buchan, Alastair M.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Div Med Sci, Oxford, England; [Shepperd, Sasha] Univ Oxford, Nuffield Dept Populat Hlth, Div Med Sci, Oxford, England; [Greenhalgh, Trisha] Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Frith, Peggy] Univ Oxford, Sch Med, John Radcliffe Hosp, Oxford, England; [Frith, Peggy; Buchan, Alastair M.] John Radcliffe Hosp, Oxford Univ Hosp NHS Trust, Oxford, England; [Roberts, Nia W.] Univ Oxford, Bodleian Hlth Care Lib, Oxford, England; [Pololi, Linda H.] Brandeis Univ, Natl Initiat Gender Culture & Leadership Med Chan, Womens Studies Res Ctr, Waltham, MA USA	University of Oxford; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Brandeis University	Buchan, AM (corresponding author), Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford OX3 9DU, England.	alastair.buchan@medsci.ox.ac.uk	Ovseiko, Pavel/E-1824-2013; Buchan, Alastair M/B-9095-2009; Roberts, Nia W/F-9842-2010; Greenhalgh, Trisha/B-1825-2015	Ovseiko, Pavel/0000-0002-3504-2177; Buchan, Alastair M/0000-0002-2918-5200; Roberts, Nia W/0000-0002-1142-6440; Greenhalgh, Trisha/0000-0003-2369-8088; Edmunds, Laurel/0000-0001-9677-3742; Shepperd, Sasha/0000-0001-6384-8322	John Fell Fund, University of Oxford; Vice Chancellor's Diversity Fund, University of Oxford; NIHR Oxford Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10031, NF-SI-0515-10002] Funding Source: researchfish	John Fell Fund, University of Oxford; Vice Chancellor's Diversity Fund, University of Oxford; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the John Fell Fund and the Vice Chancellor's Diversity Fund, University of Oxford, and the NIHR Oxford Biomedical Research Centre. We thank the following individuals from the University of Oxford Medical School for providing most helpful comments and suggestions: Tim Lancaster (director of studies), Lois Brand (associate director of studies), Catherine Swales (associate director of studies), Brid Cronin (Athena SWAN advisor and facilitator), and Hasneen Karbalai (medical student). We also thank Stephen Goss (pro-vice chancellor for personnel and equality) for hosting the workshop Accelerating women's advancement and leadership in academic medicine at Wadham College, Oxford on Feb 19, 2014, where early ideas for this study were presented, and all the participants at the workshop for their feedback. Finally, we acknowledge the senior executive editor and the five anonymous reviewers whose valuable and insightful comments helped improve the report substantially.	Abu-Zaid A, 2014, MED TEACH, V36, pS3, DOI 10.3109/0142159X.2014.886006; Academy of Medical Sciences, 2015, SUSTAIN; Academy of Medical Sciences, 2015, AB INSPIRE IN; Andriole DA, 2008, JAMA-J AM MED ASSOC, V300, P1165, DOI 10.1001/jama.300.10.1165; Andriole DA, 2012, ACAD MED, V87, P1722, DOI 10.1097/ACM.0b013e318271e57b; Andriole DA, 2010, ACAD MED, V85, P1250, DOI 10.1097/ACM.0b013e3181e10159; [Anonymous], COUNTR LEND GROUPS 2; Association of American Medical Colleges Group on Women in Medicine and Science, 2014, TABL 1 MED STUD SEL; Beddoes K, 2013, ASEE ANN C EXP ATL G; Bell E. Moberly, 1953, STORMING CITADEL RIS; BENSON MC, 1985, MED CARE, V23, P1256, DOI 10.1097/00005650-198511000-00004; BICKEL J, 1995, ACAD MED, V70, P552, DOI 10.1097/00001888-199506000-00021; Borges NJ, 2013, PERSPECT MED EDUC, V2, P156, DOI 10.1007/s40037-013-0055-2; Borges NJ, 2012, ACAD MED, V87, P105, DOI 10.1097/ACM.0b013e31823ab4a8; Borges NJ, 2010, ACAD MED, V85, P680, DOI 10.1097/ACM.0b013e3181d29cb9; Brass LF, 2010, ACAD MED, V85, P692, DOI 10.1097/ACM.0b013e3181d3ca17; Bright CM, 1998, J NATL MED ASSOC, V90, P681; British Medical Association, 2008, WOM AC MED DEV EQ GO; Buddeberg-Fischer B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-120; Burgess DJ, 2012, ACAD MED, V87, P506, DOI 10.1097/ACM.0b013e318248f718; Burgoyne LN, 2010, MED EDUC ONLINE, V15, DOI 10.3402/meo.v15i0.5212; Cain JM, 2001, ACAD MED, V76, P628, DOI 10.1097/00001888-200106000-00015; Caniano DA, 2004, J PEDIATR SURG, V39, P984, DOI 10.1016/j.jpedsurg.2004.02.039; Carnes M, 2008, J WOMENS HEALTH, V17, P1453, DOI 10.1089/jwh.2007.0688; Centre for Workforce Intelligence, 2012, SHAP MED WORKF START; Cochran A, 2013, AM J SURG, V206, P263, DOI 10.1016/j.amjsurg.2012.07.044; Coleman VH, 2005, J CONTIN EDUC HEALTH, V25, P268, DOI 10.1002/chp.40; Corrigan MA, 2007, WORLD J SURG, V31, P1921, DOI 10.1007/s00268-007-9175-3; Craig L, 2011, AM SOCIOL REV, V76, P834, DOI 10.1177/0003122411427673; Danczyk RC, 2012, J VASC SURG, V55; Donovan A, 2010, AM J ROENTGENOL, V194, P704, DOI 10.2214/AJR.09.3403; Dorsey ER, 2006, NEUROLOGY, V67, P1335, DOI 10.1212/01.wnl.0000240058.26740.22; Elston MA, 2009, WOMEN MED FUTURE; Equality Challenge Unit, 2015, ATH SWAN CHART; Fang D, 2003, ACAD MED, V78, P1271, DOI 10.1097/00001888-200312000-00017; Freiman A, 2005, ARCH DERMATOL, V141, P1100, DOI 10.1001/archderm.141.9.1100; Galletly C, 2009, AUSTRALAS PSYCHIATRY, V17, P502, DOI 10.1080/10398560903284935; Gerson LB, 2007, GASTROENTEROLOGY, V132, P1598, DOI 10.1053/j.gastro.2007.02.045; Golub JS, 2011, LARYNGOSCOPE, V121, P882, DOI 10.1002/lary.21445; Gordon MB, 2009, PEDIATRICS, V124, pE355, DOI 10.1542/peds.2008-3626; Guelich JM, 2002, J INVEST MED, V50, P412, DOI 10.1136/jim-50-06-01; Haviland MG, 2011, TEACH LEARN MED, V23, P231, DOI 10.1080/10401334.2011.586914; Heathcote J, 1997, GASTROENTEROLOGY, V113, P669, DOI 10.1053/gast.1997.v113.pm9247490; Jagsi R, 2007, ARCH INTERN MED, V167, P343, DOI 10.1001/archinte.167.4.343; Jeffe DB, 2008, J NATL MED ASSOC, V100, P1026, DOI 10.1016/S0027-9684(15)31439-5; Jeffe DB, 2014, ACAD MED, V89, P1398, DOI 10.1097/ACM.0000000000000400; Jeffe DB, 2014, ACAD MED, V89, P84, DOI 10.1097/ACM.0000000000000071; Jeffe DB, 2011, ACAD MED, V86, P953, DOI 10.1097/ACM.0b013e31822225c5; KOMAROMY M, 1993, NEW ENGL J MED, V328, P322, DOI 10.1056/NEJM199302043280507; Kong X, 2014, TRAJECTORY MED STUDE; Krupat E, 2013, ACAD MED, V88, P1252, DOI 10.1097/ACM.0b013e31829e84e0; Lanzon J, 2012, J ORAL MAXIL SURG, V70, P1751, DOI 10.1016/j.joms.2012.02.008; Larsson C, 2003, MED EDUC, V37, P39, DOI 10.1046/j.1365-2923.2003.01404.x; Lautenberger DM, 2014, STATE WOMEN ACAD MED; Leonard JC, 1996, ACAD MED, V71, P502, DOI 10.1097/00001888-199605000-00023; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; McDonald A, 2012, AUST NZ J OBSTET GYN, V52, P476, DOI 10.1111/j.1479-828X.2012.01468.x; McGinty K L, 1994, Acad Psychiatry, V18, P95, DOI 10.1007/BF03341527; Medical Schools Council, 2013, SURV STAFF LEV MED C; Medical Schools Council, 2015, SURV STAFF LEV MED C; Medical Schools Council, 2007, WOM CLIN AC ATTR DEV; Mendick H, 2014, FORUM QUALITATIVE SO; National Initiative on Gender CaLiMC-C, 2015, AB C CHANG; National Institutes of Health, 2015, PROM INN DIV; National Science Foundation, 2015, ADVANCE INCR PART AD; Nikkar-Esfahani A, 2012, MED TEACH, V34, pE317, DOI 10.3109/0142159X.2012.670324; Nomura K, 2010, ACAD MED, V85, P647, DOI 10.1097/ACM.0b013e3181d2a796; OSBORN EHS, 1992, ACAD MED, V67, P59, DOI 10.1097/00001888-199201000-00012; Ovseiko PV, 2012, ACAD MED, V87, P709, DOI 10.1097/ACM.0b013e3182537983; Penny M, 2014, J ROY SOC MED, V107, P259, DOI 10.1177/0141076814528893; PINCUS S, 1994, ARCH DERMATOL, V130, P1131, DOI 10.1001/archderm.130.9.1131; Pololi LH, 2013, J GEN INTERN MED, V28, P201, DOI 10.1007/s11606-012-2207-1; Primack BA, 2010, CTS-CLIN TRANSL SCI, V3, P186, DOI 10.1111/j.1752-8062.2010.00202.x; Salgueira A, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-95; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Schroen AT, 2004, ACAD MED, V79, P310, DOI 10.1097/00001888-200404000-00006; Shah DN, 2010, OPHTHAL EPIDEMIOL, V17, P1, DOI 10.3109/09286580903324892; Silberman EK, 2012, ACAD PSYCHIATR, V36, P85, DOI 10.1176/appi.ap.10010010; Smith F, 2014, POSTGRAD MED J, V90, P557, DOI 10.1136/postgradmedj-2014-132681; Smith WH, 2009, PEDIATR RES, V65, P474, DOI 10.1203/PDR.0b013e3181975f85; Straus SE, 2006, J GEN INTERN MED, V21, P1222, DOI 10.1111/j.1525-1497.2006.00599.x; Tacconelli E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001993; Tugwell P, 2004, LANCET, V363, P836, DOI 10.1016/S0140-6736(04)15772-3; Watt CD, 2005, ACAD MED, V80, P193, DOI 10.1097/00001888-200502000-00019; Yamazaki Y, 2012, TOHOKU J EXP MED, V228, P75, DOI 10.1620/tjem.228.75; Yang G, 2012, J UROLOGY, V188, P1286, DOI 10.1016/j.juro.2012.06.022	86	169	171	3	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2948	2958		10.1016/S0140-6736(15)01091-0	http://dx.doi.org/10.1016/S0140-6736(15)01091-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27105721	Green Submitted			2022-12-28	WOS:000389631700039
J	Persad, GC; Emanuel, EJ				Persad, Govind C.; Emanuel, Ezekiel J.			The ethics of expanding access to cheaper, less effective treatments	LANCET			English	Editorial Material							STAVUDINE; HEALTH		[Persad, Govind C.] Georgetown Univ, McDonough Sch Business, Dept Strategy Econ Eth & Publ Policy, Washington, DC USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Hlth Care Management, Off Provost,Dept Med Eths & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	Georgetown University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Hlth Care Management, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.	MEHPchair@upenn.edu	Persad, Govind/K-2593-2019	Persad, Govind/0000-0002-9436-9209				Andrieux-Meyer I, 2012, S AFR J HIV MED, P17; Farmer P, 2002, J LAW MED ETHICS, V30, P655, DOI 10.1111/j.1748-720X.2002.tb00433.x; Garrett L., 2015, FOREIGN AFFAIRS; [Global Network of People Living with HIV WHO], 2009, PLHIV INP REV WHO AR; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P225, DOI 10.1001/jama.298.2.225; UNAIDS, 2015, AIDS CHANG EV FACTSH; UNITAID, 2013, UNITAID PROV USD 77; Venter WDF, 2012, S AFR J HIV MED, P20; WHO, 1997, M 18 20 JUN GEN SWIT; *WHO, WORLD HLTH REP 1999; WHO, NUMB PEOPL EL ANT TH; WHO, 2004, EP WHO AFR REG BRIDG, P15; WOOD R, 2006, S AFR J HIV MED  JUN, P5; World Health Organization, 2015, CONS GUID US ANT DRU; World Health Organization, 2003, MED DEV REG GLOB OV	15	15	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					932	934		10.1016/S0140-6736(15)01025-9	http://dx.doi.org/10.1016/S0140-6736(15)01025-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU0RI	27108231	Green Published			2022-12-28	WOS:000381911800032
J	Yttri, EA; Dudman, JT				Yttri, Eric A.; Dudman, Joshua T.			Opponent and bidirectional control of movement velocity in the basal ganglia	NATURE			English	Article							STRIATAL NEURONS; CRE-RECOMBINASE; DOPAMINE; REPRESENTATION; ORGANIZATION; STIMULATION; ACTIVATION; SELECTION; CIRCUIT; LIGHT	For goal-directed behaviour it is critical that we can both select the appropriate action and learn to modify the underlying movements (for example, the pitch of a note or velocity of a reach) to improve outcomes. The basal ganglia are a critical nexus where circuits necessary for the production of behaviour, such as the neocortex and thalamus, are integrated with reward signalling(1) to reinforce successful, purposive actions(2). The dorsal striatum, a major input structure of basal ganglia, is composed of two opponent pathways, direct and indirect, thought to select actions that elicit positive outcomes and suppress actions that do not, respectively(3,4). Activity-dependent plasticity modulated by reward is thought to be sufficient for selecting actions in the striatum(5,6). Although perturbations of basal ganglia function produce profound changes in movement(7), it remains unknown whether activity-dependent plasticity is sufficient to produce learned changes in movement kinematics, such as velocity. Here we use cell-type-specific stimulation in mice delivered in closed loop during movement to demonstrate that activity in either the direct or indirect pathway is sufficient to produce specific and sustained increases or decreases in velocity, without affecting action selection or motivation. These behavioural changes were a form of learning that accumulated over trials, persisted after the cessation of stimulation, and were abolished in the presence of dopamine antagonists. Our results reveal that the direct and indirect pathways can each bidirectionally control movement velocity, demonstrating unprecedented specificity and flexibility in the control of volition by the basal ganglia.	[Yttri, Eric A.; Dudman, Joshua T.] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Dudman, JT (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	dudmanj@janelia.hhmi.org		Yttri, Eric/0000-0002-7214-1481; Dudman, Joshua/0000-0002-4436-1057	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by funding from the Howard Hughes Medical Institute. J.T.D. is a Group Leader at Janelia Research Campus. We thank A. Lee, A. Karpova, N. Spruston, and members of our laboratory for critical reading and feedback on the manuscript. We also thank M. Frank for helpful discussions of the OpAL model.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Brown J, 2014, ELIFE, V3, DOI 10.7554/eLife.02397; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Cooper LN, 2012, NAT REV NEUROSCI, V13, P798, DOI 10.1038/nrn3353; Deacon RM, 2013, J VIS EXP; Desmurget M, 2010, J NEUROSCI, V30, P7685, DOI 10.1523/JNEUROSCI.0163-10.2010; Dudman J. T., 2015, RAT NERVOUS SYSTEM, V4; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gurney KN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002034; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Osborne JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089007; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Panigrahi B, 2015, CELL, V162, P1418, DOI 10.1016/j.cell.2015.08.014; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PHILLIPS AG, 1978, CAN J PSYCHOL, V32, P58, DOI 10.1037/h0081676; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	40	128	129	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2016	533	7603					402	+		10.1038/nature17639	http://dx.doi.org/10.1038/nature17639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0AH	27135927	Green Accepted			2022-12-28	WOS:000376004300050
J	Badran, AH; Guzov, VM; Huai, Q; Kemp, MM; Vishwanath, P; Kain, W; Nance, AM; Evdokimov, A; Moshiri, F; Turner, KH; Wang, P; Malvar, T; Liu, DR				Badran, Ahmed H.; Guzov, Victor M.; Huai, Qing; Kemp, Melissa M.; Vishwanath, Prashanth; Kain, Wendy; Nance, Autumn M.; Evdokimov, Artem; Moshiri, Farhad; Turner, Keith H.; Wang, Ping; Malvar, Thomas; Liu, David R.			Continuous evolution of Bacillus thuringiensis toxins overcomes insect resistance	NATURE			English	Article							CONTINUOUS DIRECTED EVOLUTION; PROTEIN EVOLUTION; CRYSTAL PROTEIN; CABBAGE-LOOPER; BT CROPS; IN-VIVO; CADHERIN; BINDING; CRY1AC; POPULATION	The Bacillus thuringiensis d-endotoxins (Bt toxins) are widely used insecticidal proteins in engineered crops that provide agricultural, economic, and environmental benefits. The development of insect resistance to Bt toxins endangers their long-term effectiveness. Here we have developed a phage-assisted continuous evolution selection that rapidly evolves high-affinity protein-protein interactions, and applied this system to evolve variants of the Bt toxin Cry1Ac that bind a cadherin-like receptor from the insect pest Trichoplusia ni (TnCAD) that is not natively bound by wild-type Cry1Ac. The resulting evolved Cry1Ac variants bind TnCAD with high affinity (dissociation constant K-d = 11-41 nM), kill TnCAD-expressing insect cells that are not susceptible to wild-type Cry1Ac, and kill Cry1Ac-resistant T. ni insects up to 335-fold more potently than wild-type Cry1Ac. Our findings establish that the evolution of Bt toxins with novel insect cell receptor affinity can overcome insect Bt toxin resistance and confer lethality approaching that of the wild-type Bt toxin against non-resistant insects.	[Badran, Ahmed H.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Badran, Ahmed H.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Guzov, Victor M.; Huai, Qing; Kemp, Melissa M.; Vishwanath, Prashanth] Monsanto Co, 245 First St,Suite 200, Cambridge, MA 02142 USA; [Kain, Wendy; Wang, Ping] Cornell Univ, Dept Entomol, Geneva, NY 14456 USA; [Nance, Autumn M.; Evdokimov, Artem; Moshiri, Farhad; Turner, Keith H.; Malvar, Thomas] Monsanto Co, 700 Chesterfield Pkwy West, Chesterfield, MO 63017 USA; [Evdokimov, Artem] HarkerBIO, 700 Ellicott St, Buffalo, NY 14023 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Monsanto; Cornell University; Monsanto	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Turner, Keith/AAJ-6890-2021; Liu, David R./HCH-3132-2022	Turner, Keith/0000-0002-3993-3831; 	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [R01EB022376]; DARPA [HR0011-11-2-0003, N66001-12-C-4207]; Howard Hughes Medical Institute; US Department of Agriculture National Institute of Food and Agriculture and Agricultural Research Service Biotechnology Risk Assessment [2012-33522-19791]; Harvard Chemical Biology Program; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022376] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US Department of Agriculture National Institute of Food and Agriculture and Agricultural Research Service Biotechnology Risk Assessment; Harvard Chemical Biology Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering R01EB022376, DARPA HR0011-11-2-0003, DARPA N66001-12-C-4207, the Howard Hughes Medical Institute, and the US Department of Agriculture National Institute of Food and Agriculture and Agricultural Research Service Biotechnology Risk Assessment Grant Program 2012-33522-19791. A.H.B. was supported by the Harvard Chemical Biology Program and a National Science Foundation Graduate Research Fellowship. We are grateful to J. Carlson, J. Nageotte, D. Rappoli, J.-L. Kouadio, M. Zheng, J. Milligan, M. Huang, Z. Du, X. Zhou, E. Kraft, and J. Wang for their assistance.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Badran AH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9425; Baum JA, 2012, J ECON ENTOMOL, V105, P616, DOI 10.1603/EC11207; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chougule NP, 2013, P NATL ACAD SCI USA, V110, P8465, DOI 10.1073/pnas.1222144110; Dickinson BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6352; Dickinson BC, 2013, P NATL ACAD SCI USA, V110, P9007, DOI 10.1073/pnas.1220670110; DONOVAN WP, 1988, J BIOL CHEM, V263, P561; Dove SL, 1998, GENE DEV, V12, P745, DOI 10.1101/gad.12.5.745; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Fu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115318; Fujii Y, 2013, MOL BIOTECHNOL, V54, P888, DOI 10.1007/s12033-012-9638-0; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Hubbard BP, 2015, NAT METHODS, V12, P939, DOI [10.1038/NMETH.3515, 10.1038/nmeth.3515]; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leconte AM, 2013, BIOCHEMISTRY-US, V52, P1490, DOI 10.1021/bi3016185; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lund AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096693; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Peng DH, 2010, APPL MICROBIOL BIOT, V85, P1033, DOI 10.1007/s00253-009-2142-1; Prado JR, 2014, ANNU REV PLANT BIOL, V65, P769, DOI 10.1146/annurev-arplant-050213-040039; Song XZ, 2015, APPL ENVIRON MICROB, V81, P5184, DOI 10.1128/AEM.00593-15; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Tan YP, 2000, J BIOTECHNOL, V84, P67, DOI 10.1016/S0168-1656(00)00328-X; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Zhang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029084, 10.1371/journal.pone.0031868]	42	122	140	14	190	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					58	+		10.1038/nature17938	http://dx.doi.org/10.1038/nature17938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120167	Green Submitted, Green Accepted			2022-12-28	WOS:000375473900038
J	Gulland, A				Gulland, Anne			Main paediatric centre in Aleppo is destroyed by airstrike	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Physicians for Human Rights, 2015, AL AB CAS STUD HEALT	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2471	10.1136/bmj.i2471	http://dx.doi.org/10.1136/bmj.i2471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129355				2022-12-28	WOS:000375484100016
J	Fung, R; Hanna, AM; Vendrell, O; Ramakrishna, S; Seideman, T; Santra, R; Ourmazd, A				Fung, R.; Hanna, A. M.; Vendrell, O.; Ramakrishna, S.; Seideman, T.; Santra, R.; Ourmazd, A.			Dynamics from noisy data with extreme timing uncertainty	NATURE			English	Article							TIME; MOLECULES; EMISSION; NITROGEN; IONS	Imperfect knowledge of the times at which ' snapshots' of a system are recorded degrades our ability to recover dynamical information, and can scramble the sequence of events. In X-ray free-electron lasers, for example, the uncertainty-the so-called timing jitter-between the arrival of an optical trigger ('pump') pulse and a probing X-ray pulse can exceed the length of the X-ray pulse by up to two orders of magnitude(1), marring the otherwise precise time-resolution capabilities of this class of instruments. The widespread notion that little dynamical information is available on timescales shorter than the timing uncertainty has led to various hardware schemes to reduce timing uncertainty(2-4). These schemes are expensive, tend to be specific to one experimental approach and cannot be used when the record was created under ill-defined or uncontrolled conditions such as during geological events. Here we present a data-analytical approach, based on singular-value decomposition and nonlinear Laplacian spectral analysis(5-7), that can recover the history and dynamics of a system from a dense collection of noisy snapshots spanning a sufficiently large multiple of the timing uncertainty. The power of the algorithm is demonstrated by extracting the underlying dynamics on the few-femtosecond timescale from noisy experimental X-ray free-electron laser data recorded with 300-femtosecond timing uncertainty(1). Using a noisy dataset from a pump-probe experiment on the Coulomb explosion of nitrogen molecules, our analysis reveals vibrational wave-packets consisting of components with periods as short as 15 femtoseconds, as well as more rapid changes, which have yet to be fully explored. Our approach can potentially be applied whenever dynamical or historical information is tainted by timing uncertainty.	[Fung, R.; Ourmazd, A.] Univ Wisconsin, Dept Phys, 3135 North Maryland Ave, Milwaukee, WI 53211 USA; [Hanna, A. M.; Vendrell, O.; Santra, R.] DESY, Ctr Free Electron Laser Sci, Notkestr 85, D-22607 Hamburg, Germany; [Hanna, A. M.; Vendrell, O.; Santra, R.] Hamburg Ctr Ultrafast Imaging, Luruper Chausee 149, D-22761 Hamburg, Germany; [Hanna, A. M.; Santra, R.] Univ Hamburg, Dept Chem, Grindelallee 117, D-20146 Hamburg, Germany; [Ramakrishna, S.; Seideman, T.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Santra, R.] Univ Hamburg, Dept Phys, Jungiusstr 9, D-20355 Hamburg, Germany	University of Wisconsin System; University of Wisconsin Milwaukee; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; University of Hamburg; Northwestern University; University of Hamburg	Ourmazd, A (corresponding author), Univ Wisconsin, Dept Phys, 3135 North Maryland Ave, Milwaukee, WI 53211 USA.	Ourmazd@uwm.edu	Vendrell, Oriol/B-5576-2008; Santra, Robin/E-8332-2014; Hanna, Athiya/G-2025-2017	Vendrell, Oriol/0000-0003-4629-414X; Santra, Robin/0000-0002-1442-9815; Hanna, Athiya/0000-0001-7578-1946; Ramakrishna, Sai/0000-0001-9190-2453	US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0002164, DE-FG02-04ER15612]; US National Science Foundation [STC 1231306, 1551489]	US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF))	We thank P. Bucksbaum, J. M. Glownia and A. Natan for experimental data and comments on an earlier version of the manuscript, and acknowledge discussions with A. Dashti, D. Giannakis, A. Hosseinizadeh, A. Rudenko, M. Schmidt and P. Schwander. The research conducted by A.O. and R.F. was supported by the US Department of Energy, Office of Science, Basic Energy Sciences under award DE-SC0002164 (algorithm design and development, and data analysis), and by the US National Science Foundation under awards STC 1231306 (numerical trial models) and 1551489 (underlying analytical models). The research conducted by T.S. and S.R. was supported by the US Department of Energy, Office of Science, Basic Energy Sciences under award DE-FG02-04ER15612. T.S. thanks the Hamburg Centre for Ultrafast Imaging for a Mildred Dresselhaus Visiting Professorship.	AUBRY N, 1991, J STAT PHYS, V64, P683, DOI 10.1007/BF01048312; Berry T, 2013, SIAM J APPL DYN SYST, V12, P618, DOI 10.1137/12088183X; Bocharova IA, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.013417; Coifman RR, 2008, IEEE T IMAGE PROCESS, V17, P1891, DOI 10.1109/TIP.2008.2002305; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Dashti A, 2014, P NATL ACAD SCI USA, V111, P17492, DOI 10.1073/pnas.1419276111; DAWBER G, 1994, J PHYS B-AT MOL OPT, V27, P2191, DOI 10.1088/0953-4075/27/11/014; De S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043410; EBERHARDT W, 1983, PHYS REV LETT, V51, P2370, DOI 10.1103/PhysRevLett.51.2370; Gahl C, 2008, NAT PHOTONICS, V2, P165, DOI 10.1038/nphoton.2007.298; Giannakis D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051575; Giannakis D, 2012, P NATL ACAD SCI USA, V109, P2222, DOI 10.1073/pnas.1118984109; Glownia JM, 2010, OPT EXPRESS, V18, P17620, DOI 10.1364/OE.18.017620; Guo W, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.033415; Harmand M, 2013, NAT PHOTONICS, V7, P215, DOI [10.1038/nphoton.2013.11, 10.1038/NPHOTON.2013.11]; JERRI AJ, 1977, P IEEE, V65, P1565, DOI 10.1109/PROC.1977.10771; Lohl F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.144801; Meyer K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.098302; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Pavicic D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243001; Pellegrini C, 2003, NUCL INSTRUM METH A, V500, P33, DOI 10.1016/S0168-9002(03)00739-3; Rudenko A, 2006, CHEM PHYS, V329, P193, DOI 10.1016/j.chemphys.2006.06.038; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Schmidt M, 1999, PHYS REV A, V60, P4706, DOI 10.1103/PhysRevA.60.4706; Stapelfeldt H, 2003, REV MOD PHYS, V75, P543, DOI 10.1103/RevModPhys.75.543; Stark J, 2003, J NONLINEAR SCI, V13, P519, DOI 10.1007/s00332-003-0534-4; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; Timmers H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.113003; Voss S, 2004, J PHYS B-AT MOL OPT, V37, P4239, DOI 10.1088/0953-4075/37/21/002	29	33	33	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					471	475		10.1038/nature17627	http://dx.doi.org/10.1038/nature17627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121840				2022-12-28	WOS:000374815900040
J	Gopal, S				Gopal, Satish			Moonshot to Malawi	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Gopal, Satish] Malawi Canc Consortium, Lilongwe, Malawi; [Gopal, Satish] Univ North Carolina Project Malawi, Lilongwe, Malawi; [Gopal, Satish] Univ Malawi, Coll Med, Blantyre, Malawi; [Gopal, Satish] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA; [Gopal, Satish] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of Malawi; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gopal, S (corresponding author), Malawi Canc Consortium, Lilongwe, Malawi.; Gopal, S (corresponding author), Univ North Carolina Project Malawi, Lilongwe, Malawi.; Gopal, S (corresponding author), Univ Malawi, Coll Med, Blantyre, Malawi.; Gopal, S (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA.; Gopal, S (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.				FOGARTY INTERNATIONAL CENTER [K01TW009488] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA058223, U54CA190152, R21CA180815] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW009488] Funding Source: Medline; NCI NIH HHS [P50 CA058223, U54 CA190152] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Gopal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070361; Kohler RE, 2015, MALAWI MED J, V27, P10, DOI 10.4314/mmj.v27i1.3; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; UNAIDS, 2015, MAL AIDS RESP PROGR	5	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1604	1605		10.1056/NEJMp1601982	http://dx.doi.org/10.1056/NEJMp1601982			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK3UR	27119235	Green Accepted			2022-12-28	WOS:000374843400003
J	Haley, CAL				Haley, Charlotte A. L.			Glitches in time	NATURE			English	Editorial Material									[Haley, Charlotte A. L.] Argonne Natl Lab, Math & Comp Sci Div, Lemont, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Haley, CAL (corresponding author), Argonne Natl Lab, Math & Comp Sci Div, Lemont, IL 60439 USA.	haley@anl.gov		Haley, Charlotte/0000-0003-3996-773X				Fuentes M, 2007, J AM STAT ASSOC, V102, P321, DOI 10.1198/016214506000000852; Fung R, 2016, NATURE, V532, P471, DOI 10.1038/nature17627; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Glownia JM, 2010, OPT EXPRESS, V18, P17620, DOI 10.1364/OE.18.017620; Kondrashov D, 2006, NONLINEAR PROC GEOPH, V13, P151, DOI 10.5194/npg-13-151-2006; KUHN JR, 1982, ASTRON J, V87, P196, DOI 10.1086/113096; Pellegrini C, 2003, NUCL INSTRUM METH A, V500, P33, DOI 10.1016/S0168-9002(03)00739-3; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Wittman DM, 2000, NATURE, V405, P143, DOI 10.1038/35012001	10	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					450	451		10.1038/532450a	http://dx.doi.org/10.1038/532450a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121837	Green Submitted			2022-12-28	WOS:000374815900035
J	Sanchez, E; Vannier, E; Wormser, GP; Hu, LT				Sanchez, Edgar; Vannier, Edouard; Wormser, Gary P.; Hu, Linden T.			Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POLYMERASE-CHAIN-REACTION; SPIROCHETE BORRELIA-MIYAMOTOI; LINKED-IMMUNOSORBENT-ASSAY; SOLITARY ERYTHEMA MIGRANS; POSITIVE PREDICTIVE-VALUE; IXODES-DAMMINI ACARI; DEER TICK VIRUS; TIME PCR ASSAY; ORAL DOXYCYCLINE; UNITED-STATES	IMPORTANCE Lyme disease, human granulocytic anaplasmosis (HGA), and babesiosis are emerging tick-borne infections. OBJECTIVE To provide an update on diagnosis, treatment, and prevention of tick-borne infections. EVIDENCE REVIEW Search of PubMed and Scopus for articles on diagnosis, treatment, and prevention of tick-borne infections published in English from January 2005 through December 2015. FINDINGS The search yielded 3550 articles for diagnosis and treatment and 752 articles for prevention. Of these articles, 361 were reviewed in depth. Evidence supports the use of US Food and Drug Administration-approved serologic tests, such as an enzyme immunoassay (EIA), followed by Western blot testing, to diagnose extracutaneous manifestations of Lyme disease. Microscopy and polymerase chain reaction assay of blood specimens are used to diagnose active HGA and babesiosis. The efficacy of oral doxycycline, amoxicillin, and cefuroxime axetil for treating Lyme disease has been established in multiple trials. Ceftriaxone is recommended when parenteral antibiotic therapy is recommended. Multiple trials have shown efficacy for a 10-day course of oral doxycycline for treatment of erythema migrans and for a 14-day course for treatment of early neurologic Lyme disease in ambulatory patients. Evidence indicates that a 10-day course of oral doxycycline is effective for HGA and that a 7- to 10-day course of azithromycin plus atovaquone is effective for mild babesiosis. Based on multiple case reports, a 7-to 10-day course of clindamycin plus quinine is often used to treat severe babesiosis. A recent study supports a minimum of 6 weeks of antibiotics for highly immunocompromised patients with babesiosis, with no parasites detected on blood smear for at least the final 2 weeks of treatment. CONCLUSIONS AND RELEVANCE Evidence is evolving regarding the diagnosis, treatment, and prevention of Lyme disease, HGA, and babesiosis. Recent evidence supports treating patients with erythema migrans for no longer than 10 days when doxycycline is used and prescription of a 14-day course of oral doxycycline for early neurologic Lyme disease in ambulatory patients. The duration of antimicrobial therapy for babesiosis in severely immunocompromised patients should be extended to 6 weeks or longer.	[Sanchez, Edgar; Vannier, Edouard] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Wormser, Gary P.] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA; [Hu, Linden T.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, 136 Harrison Ave, Boston, MA 02111 USA	Tufts Medical Center; New York Medical College; Tufts University	Hu, LT (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	linden.hu@tufts.edu	Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558	Gordon and Llura Gund Foundation; Dorothy Egan Harrison Foundation; Immunetics Inc; Institute for Systems Biology; Rarecyte Inc; bioMerieux SA; Massbiologics at the University of Massachusetts Medical School; National Institutes of Health [U01AI109656, R21AI111317, R21AI103905, R42AI078631]; Steven and Alexandra Cohen Foundation;  [T32AI055412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R42AI078631, U01AI109656, T32AI055412, R21AI103905, R21AI111317] Funding Source: NIH RePORTER	Gordon and Llura Gund Foundation; Dorothy Egan Harrison Foundation; Immunetics Inc; Institute for Systems Biology; Rarecyte Inc; bioMerieux SA; Massbiologics at the University of Massachusetts Medical School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steven and Alexandra Cohen Foundation; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sanchez reported being supported by grant T32AI055412. Dr Vannier reported owning stock in Eli Lilly, Pfizer, and GlaxoSmithKline and receiving grant support from The Gordon and Llura Gund Foundation and the Dorothy Egan Harrison Foundation. Dr Wormser reported receiving research grants from Immunetics Inc, Institute for Systems Biology, Rarecyte Inc, and bioMerieux SA; owning equity in Abbott; serving as an expert witness in malpractice cases involving Lyme disease and babesiosis; serving as an unpaid board member of the American Lyme Disease Foundation; and serving as a consultant to Baxter for Lyme disease vaccine development. Dr Hu reported receiving research funding from Massbiologics at the University of Massachusetts Medical School; working as a consultant for Abzyme; and being supported by National Institutes of Health grants U01AI109656, R21AI111317, R21AI103905, and R42AI078631 and by the Steven and Alexandra Cohen Foundation.	Aguero-Rosenfeld ME, 2002, VECTOR-BORNE ZOONOT, V2, P233, DOI 10.1089/153036602321653815; Aguero-Rosenfeld ME, 2008, INFECT DIS CLIN N AM, V22, P301, DOI 10.1016/j.idc.2007.12.005; [Anonymous], PREV TICK BIT; Arnez M, 2002, WIEN KLIN WOCHENSCHR, V114, P498; Arnez M, 2015, PEDIATR INFECT DIS J, V34, P1045, DOI 10.1097/INF.0000000000000804; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; Aucott J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-79; Avery RA, 2005, PEDIATR INFECT DIS J, V24, P705, DOI 10.1097/01.inf.0000172903.14077.4c; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Bakken JS, 2008, INFECT DIS CLIN N AM, V22, P433, DOI 10.1016/j.idc.2008.03.011; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bakken JS, 2001, CLIN INFECT DIS, V32, P862, DOI 10.1086/319350; Barclay SS, 2012, CLIN VACCINE IMMUNOL, V19, P1806, DOI 10.1128/CVI.00383-12; Belongia EA, 1999, CLIN INFECT DIS, V29, P1472, DOI 10.1086/313532; Blanton L, 2008, SOUTH MED J, V101, P759, DOI 10.1097/SMJ.0b013e31817a8b3f; Bloch EM, 2013, TRANSFUSION, V53, P2299, DOI 10.1111/trf.12098; Borg R, 2005, SCAND J INFECT DIS, V37, P449, DOI 10.1080/00365540510027228; Branda JA, 2013, CLIN INFECT DIS, V57, P333, DOI 10.1093/cid/cit235; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Branda JA, 2010, CLIN INFECT DIS, V50, P20, DOI 10.1086/648674; Bremell D, 2014, EUR J NEUROL, V21, P1162, DOI 10.1111/ene.12420; Buitrago MI, 1998, CLIN INFECT DIS, V27, P213, DOI 10.1086/517678; Carroll JF, 2003, J MED ENTOMOL, V40, P732, DOI 10.1603/0022-2585-40.5.732; Centers for Disease Control and Prevention (CDC), 2016, MMWR-MORBID MORTAL W, p[64, ND]; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; Cornett JK, 2012, INFECT DIS CLIN PRAC, V20, P408; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; DEBLINGER RD, 1991, J MED ENTOMOL, V28, P708, DOI 10.1093/jmedent/28.5.708; Dotevall L, 1999, CLIN INFECT DIS, V28, P569, DOI 10.1086/515145; El Khoury MY, 2013, EMERG INFECT DIS, V19, P1926, DOI 10.3201/eid1912.130903; El Khoury MY, 2011, TICKS TICK-BORNE DIS, V2, P235, DOI 10.1016/j.ttbdis.2011.08.001; Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703; Farber FR, 2015, TICKS TICK-BORNE DIS, V6, P649, DOI 10.1016/j.ttbdis.2015.05.010; Feder HM, 2011, CLIN INFECT DIS, V53, pE142, DOI 10.1093/cid/cir553; Forrester JD, 2014, MMWR-MORBID MORTAL W, V63, P982; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grear JS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-292; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Haselbarth K, 2007, INT J MED MICROBIOL, V297, P197, DOI 10.1016/j.ijmm.2007.01.002; Halperin JJ, 2015, CLIN LAB MED, V35, P779, DOI 10.1016/j.cll.2015.07.002; Halperin JJ, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0445-6; Hamburg BJ, 2008, MEDICINE, V87, P53, DOI 10.1097/MD.0b013e318168da1d; Herman-Giddens ME, 2012, CLIN INFECT DIS, V54, P887, DOI 10.1093/cid/cir1009; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; HERWALDT BL, 1995, AM J TROP MED HYG, V53, P146, DOI 10.4269/ajtmh.1995.53.146; Hinckley AF, 2016, J INFECT DIS, V214, P182, DOI 10.1093/infdis/jiv775; Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022; Horowitz HW, 2013, CLIN INFECT DIS, V56, P93, DOI 10.1093/cid/cis852; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Hunfeld KP, 2008, INT J PARASITOL, V38, P1219, DOI 10.1016/j.ijpara.2008.03.001; Hytonen J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-103; Jin Chenggang, 2013, Cells, V2, P607, DOI 10.3390/cells2030607; Johnson BJB, 2014, J CLIN MICROBIOL, V52, P721, DOI 10.1128/JCM.01674-13; Johnson BJB, 2011, ADV M C M, P73, DOI 10.1079/9781845938048.0073; Joseph JT, 2012, EMERG INFECT DIS, V18, P1318, DOI 10.3201/eid1808.110988; KARLSSON M, 1994, NEUROLOGY, V44, P1203, DOI 10.1212/WNL.44.7.1203; Kirkland KB, 1997, ARCH INTERN MED, V157, P2635, DOI 10.1001/archinte.157.22.2635; Klempner MS, 2001, AM J MED, V110, P217, DOI 10.1016/S0002-9343(00)00701-4; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; KRAUSE PJ, 1994, J INFECT DIS, V169, P923, DOI 10.1093/infdis/169.4.923; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2003, PEDIATRICS, V112, pE252, DOI 10.1542/peds.112.3.e252; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Lantos PM, 2015, CLIN INFECT DIS, V61, P1374, DOI 10.1093/cid/civ584; Levin AE, 2014, TRANSFUSION, V54, P2237, DOI 10.1111/trf.12763; Lipsett SC, 2015, PEDIATR INFECT DIS J, V34, P1260, DOI 10.1097/INF.0000000000000858; Ljostad U, 2008, LANCET NEUROL, V7, P690, DOI 10.1016/S1474-4422(08)70119-4; Ljostad U, 2008, J NEUROL, V255, P732, DOI 10.1007/s00415-008-0785-y; Lubina AS, 2011, LEUKEMIA RES, V35, pE77, DOI 10.1016/j.leukres.2010.11.029; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; LUGER SW, 1995, ANTIMICROB AGENTS CH, V39, P661, DOI 10.1128/AAC.39.3.661; Marques A, 2009, CLIN VACCINE IMMUNOL, V16, P1249, DOI 10.1128/CVI.00167-09; MASSAROTTI EM, 1992, AM J MED, V92, P396, DOI 10.1016/0002-9343(92)90270-L; Mathiesen MJ, 1998, J CLIN MICROBIOL, V36, P3474, DOI 10.1128/JCM.36.12.3474-3479.1998; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273; Nizic T, 2012, WIEN KLIN WOCHENSCHR, V124, P427, DOI 10.1007/s00508-012-0194-1; NOCTON JJ, 1994, NEW ENGL J MED, V330, P229, DOI 10.1056/NEJM199401273300401; PERSING DH, 1995, NEW ENGL J MED, V332, P298, DOI 10.1056/NEJM199502023320504; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; Priest JW, 2012, CLIN VACCINE IMMUNOL, V19, P1539, DOI 10.1128/CVI.00313-12; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Rollend L, 2013, VECTOR-BORNE ZOONOT, V13, P784, DOI 10.1089/vbz.2011.0935; Sapi E, 2013, INT J MED SCI, V10, P362, DOI 10.7150/ijms.5698; Schriefer ME, 2015, CLIN LAB MED, V35, P797, DOI 10.1016/j.cll.2015.08.001; Semel ME, 2009, SURG INFECT, V10, P553, DOI 10.1089/sur.2008.001; Seriburi V, 2012, CLIN MICROBIOL INFEC, V18, P1236, DOI 10.1111/j.1469-0691.2011.03749.x; Shapiro ED, 2014, NEW ENGL J MED, V370, P1724, DOI [10.1056/NEJMcp1314325, 10.1056/NEJMc1407264]; Shatzel JJ, 2015, TRANSFUSION, V55, P661, DOI 10.1111/trf.12901; Sillanpaa H, 2013, SCAND J INFECT DIS, V45, P526, DOI 10.3109/00365548.2013.776700; Solberg VB, 2003, J VECTOR ECOL, V28, P117; Spaete J, 2009, J CLIN APHERESIS, V24, P97, DOI 10.1002/jca.20197; STAFFORD KC, 1991, J MED ENTOMOL, V28, P611, DOI 10.1093/jmedent/28.5.611; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; Stowell CP, 2007, NEW ENGL J MED, V356, P2313, DOI 10.1056/NEJMcpc079011; Stricker RB, 2009, CLIN VACCINE IMMUNOL, V16, P1704, DOI 10.1128/CVI.00260-09; Strle F, 1996, INFECTION, V24, P64, DOI 10.1007/BF01780661; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Teal AE, 2012, J CLIN MICROBIOL, V50, P903, DOI 10.1128/JCM.05848-11; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; Tjernberg I, 2011, J INFECTION, V62, P149, DOI 10.1016/j.jinf.2010.11.005; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Vyas JM, 2007, CLIN INFECT DIS, V45, P1588, DOI 10.1086/523731; Wang GQ, 2015, DIAGN MICR INFEC DIS, V82, P109, DOI 10.1016/j.diagmicrobio.2015.03.010; Wang GQ, 2015, TICKS TICK-BORNE DIS, V6, P376, DOI 10.1016/j.ttbdis.2015.03.001; Weil AA, 2012, MAYO CLIN PROC, V87, P233, DOI 10.1016/j.mayocp.2011.09.008; Weiss LM, 2001, NEW ENGL J MED, V344, P773; Wittner M, 1996, AM J TROP MED HYG, V55, P219, DOI 10.4269/ajtmh.1996.55.219; Wormser GP, 2008, CLIN VACCINE IMMUNOL, V15, P1519, DOI 10.1128/CVI.00109-08; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2015, INFECT DIS CLIN N AM, V29, P371, DOI 10.1016/j.idc.2015.02.009; Wormser GP, 2014, MED MICROBIOL IMMUN, V203, P65, DOI 10.1007/s00430-013-0315-0; Wormser GP, 2013, J CLIN MICROBIOL, V51, P4045, DOI 10.1128/JCM.01853-13; Wormser GP, 2013, J CLIN MICROBIOL, V51, P954, DOI 10.1128/JCM.02929-12; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003; Wormser GP, 2011, AM SURGEON, V77, P345; Wormser GP, 2010, CLIN INFECT DIS, V50, P381, DOI 10.1086/649859; Wormser GP, 2005, CLIN INFECT DIS, V40, P423, DOI 10.1086/427289; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Wormser JP, 1997, JAMA-J AM MED ASSOC, V336, P1107; Wroblewski HA, 2012, ANTIMICROB AGENTS CH, V56, P4495, DOI 10.1128/AAC.06396-11	136	165	169	0	86	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1767	1777		10.1001/jama.2016.2884	http://dx.doi.org/10.1001/jama.2016.2884			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115378	Green Accepted			2022-12-28	WOS:000374759300023
J	Neupane, K; Foster, DAN; Dee, DR; Yu, H; Wang, F; Woodside, MT				Neupane, Krishna; Foster, Daniel A. N.; Dee, Derek R.; Yu, Hao; Wang, Feng; Woodside, Michael T.			Direct observation of transition paths during the folding of proteins and nucleic acids	SCIENCE			English	Article							MOLECULE FORCE SPECTROSCOPY; ENERGY-LANDSCAPE; REACTION-COORDINATE; SLOW DIFFUSION; SINGLE; DYNAMICS; TRAJECTORIES; COEFFICIENTS; PROBABILITY; RATES	Transition paths, the fleeting trajectories through the transition states that dominate the dynamics of biomolecular folding reactions, encapsulate the critical information about how structure forms. Owing to their brief duration, however, they have not previously been observed directly. We measured transition paths for both nucleic acid and protein folding, using optical tweezers to observe the microscopic diffusive motion of single molecules traversing energy barriers. The average transit times and the shapes of the transit-time distributions agreed well with theoretical expectations for motion over the one-dimensional energy landscapes reconstructed for the samemolecules, validating the physical theory of folding reactions. These measurements provide a first look at the critical microscopic events that occur during folding, opening exciting new avenues for investigating folding phenomena.	[Neupane, Krishna; Foster, Daniel A. N.; Dee, Derek R.; Yu, Hao; Woodside, Michael T.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Wang, Feng; Woodside, Michael T.] CNR, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; National Research Council Canada	Woodside, MT (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada.; Woodside, MT (corresponding author), CNR, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada.	michael.woodside@ualberta.ca	Dee, Derek/AAK-5892-2020	YU, HAO/0000-0003-1589-7781	Alberta Prion Research Institute; Alberta Innovates (AI) Technology Futures; AI Health Solutions; Natural Sciences and Engineering Research Council; National Research Council Canada	Alberta Prion Research Institute; Alberta Innovates (AI) Technology Futures; AI Health Solutions; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada	We thank D. Makarov and A. Szabo for helpful discussions. This work was supported by the Alberta Prion Research Institute, Alberta Innovates (AI) Technology Futures, AI Health Solutions, the Natural Sciences and Engineering Research Council, and National Research Council Canada. M.T.W., K.N., and D.R.D. designed the research; F.W. provided new reagents; K.N., D.A.N.F., and H.Y. performed measurements; K.N., D.R.D., and M.T.W. analyzed the data; and M.T.W., K.N., D.R.D., D.A.N.F., and H.Y. wrote the paper.	Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Borgia A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2204; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Buchner J, 2005, PROTEIN FOLDING HANDBOOK, P1, DOI 10.1002/9783527619498; Chaudhury S, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3459058; Chung HS, 2015, SCIENCE, V349, P1504, DOI 10.1126/science.aab1369; Chung HS, 2013, NATURE, V502, P685, DOI 10.1038/nature12649; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Cossio P, 2015, P NATL ACAD SCI USA, V112, P14248, DOI 10.1073/pnas.1519633112; Engel MC, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238104; Gupta AN, 2011, NAT PHYS, V7, P631, DOI [10.1038/nphys2022, 10.1038/NPHYS2022]; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hinczewski M, 2010, P NATL ACAD SCI USA, V107, P21493, DOI 10.1073/pnas.1010476107; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Manuel AP, 2015, P NATL ACAD SCI USA, V112, P7183, DOI 10.1073/pnas.1419490112; Nam GM, 2016, PROTEIN SCI, V25, P123, DOI 10.1002/pro.2727; Neupane K, 2015, J PHYS CHEM LETT, V6, P1005, DOI 10.1021/acs.jpclett.5b00176; Neupane K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.068102; Ritchie DB, 2015, CURR OPIN STRUC BIOL, V34, P43, DOI 10.1016/j.sbi.2015.06.006; Truex K, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.018101; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Woodside MT, 2014, BIOPHYS J, V107, P1647, DOI 10.1016/j.bpj.2014.08.007; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103; Yu H, 2015, P NATL ACAD SCI USA, V112, P8308, DOI 10.1073/pnas.1419197112; Yu H, 2012, P NATL ACAD SCI USA, V109, P14452, DOI 10.1073/pnas.1206190109; Zheng WW, 2015, J PHYS CHEM B, V119, P15247, DOI 10.1021/acs.jpcb.5b09741	29	170	171	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					239	242		10.1126/science.aad0637	http://dx.doi.org/10.1126/science.aad0637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124461				2022-12-28	WOS:000373681600050
J	Horton, R; Ceschia, A				Horton, Richard; Ceschia, Audrey			France: a philosophy for health	LANCET			English	Editorial Material									[Horton, Richard; Ceschia, Audrey] The Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Atlani-Duault L, 2016, LANCET; Baron E., 2016, LANCET; Brechot C., 2016, LANCET; Delfraissy J-F, 2016, LANCET; Nay O, 2016, LANCET; Sidibe M., 2016, LANCET	6	5	5	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2174	2176		10.1016/S0140-6736(16)30243-4	http://dx.doi.org/10.1016/S0140-6736(16)30243-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN1IZ	27145705				2022-12-28	WOS:000376820800011
J	Browne, HP; Forster, SC; Anonye, BO; Kumar, N; Neville, BA; Stares, MD; Goulding, D; Lawley, TD				Browne, Hilary P.; Forster, Samuel C.; Anonye, Blessing O.; Kumar, Nitin; Neville, B. Anne; Stares, Mark D.; Goulding, David; Lawley, Trevor D.			Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation	NATURE			English	Article							HUMAN GUT MICROBIOTA; CLOSTRIDIUM-DIFFICILE; REFERENCE GENOMES; SEQUENCE DATA; GEN. NOV.; IDENTIFICATION; BACTERIA; ALIGNMENTS; CATALOG; TREES	Our intestinal microbiota harbours a diverse bacterial community required for our health, sustenance and wellbeing(1,2). Intestinal colonization begins at birth and climaxes with the acquisition of two dominant groups of strict anaerobic bacteria belonging to the Firmicutes and Bacteroidetes phyla(2). Culture-independent, genomic approaches have transformed our understanding of the role of the human microbiome in health and many diseases(1). However, owing to the prevailing perception that our indigenous bacteria are largely recalcitrant to culture, many of their functions and phenotypes remain unknown(3). Here we describe a novel workflow based on targeted phenotypic culturing linked to large-scale whole-genome sequencing, phylogenetic analysis and computational modelling that demonstrates that a substantial proportion of the intestinal bacteria are culturable. Applying this approach to healthy individuals, we isolated 137 bacterial species from characterized and candidate novel families, genera and species that were archived as pure cultures. Whole-genome and metagenomic sequencing, combined with computational and phenotypic analysis, suggests that at least 50-60% of the bacterial genera from the intestinal microbiota of a healthy individual produce resilient spores, specialized for host-to-host transmission. Our approach unlocks the human intestinal microbiota for phenotypic analysis and reveals how a marked proportion of oxygen-sensitive intestinal bacteria can be transmitted between individuals, affecting microbiota heritability.	[Browne, Hilary P.; Forster, Samuel C.; Anonye, Blessing O.; Kumar, Nitin; Neville, B. Anne; Stares, Mark D.; Lawley, Trevor D.] Wellcome Trust Sanger Inst, Host Microbiota Interact Lab, Hinxton CB10 1SA, England; [Forster, Samuel C.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Forster, Samuel C.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3800, Australia; [Goulding, David] Wellcome Trust Sanger Inst, Microbial Pathogenesis Lab, Hinxton CB10 1SA, England	Wellcome Trust Sanger Institute; Hudson Institute of Medical Research; Monash University; Wellcome Trust Sanger Institute	Lawley, TD (corresponding author), Wellcome Trust Sanger Inst, Host Microbiota Interact Lab, Hinxton CB10 1SA, England.	tl2@sanger.ac.uk	Forster, Samuel C/F-4206-2014; Anonye, Blessing/AAE-8762-2020	Forster, Samuel C/0000-0003-4144-2537; Anonye, Blessing/0000-0003-1619-5554; Browne, Hilary/0000-0002-1305-2470	Wellcome Trust [098051]; United Kingdom Medical Research Council [PF451]; Australian National Health and Medical Research Council [1091097]; Victorian Government; Wellcome Trust Sanger Institute Technology Translation team; Medical Research Council [G1000214, MR/K000551/1] Funding Source: researchfish; MRC [G1000214, MR/K000551/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Wellcome Trust Sanger Institute Technology Translation team; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (098051); the United Kingdom Medical Research Council (PF451 to T.D.L.); the Australian National Health and Medical Research Council (1091097 to S.C.F.) and the Victorian Government's Operational Infrastructure Support Program (S.C.F.). We are grateful to G. Dougan and A. Walker for their input. We would also like to acknowledge funding from the Wellcome Trust Sanger Institute Technology Translation team, and sequencing and bioinformatics support from the Pathogen Informatics team.	Abecasis AB, 2013, J BACTERIOL, V195, P2101, DOI 10.1128/JB.02110-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forster SC, 2016, NUCLEIC ACIDS RES, V44, pD604, DOI 10.1093/nar/gkv1216; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lino T, 2007, INT J SYST EVOL MICR, V57, P1840, DOI 10.1099/ijs.0.64717-0; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; RILEY TV, 1987, EPIDEMIOL INFECT, V99, P355, DOI 10.1017/S0950268800067832; Schloss PD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-25; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Walker AW, 2014, TRENDS MICROBIOL, V22, P267, DOI 10.1016/j.tim.2014.03.001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	40	621	669	7	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					543	+		10.1038/nature17645	http://dx.doi.org/10.1038/nature17645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27144353	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000376443100043
J	Gillon, M; Jehin, E; Lederer, SM; Delrez, L; de Wit, J; Burdanov, A; Van Grootel, V; Burgasser, AJ; Triaud, AHMJ; Opitom, C; Demory, BO; Sahu, DK; Gagliuffi, DB; Magain, P; Queloz, D				Gillon, Michael; Jehin, Emmanuel; Lederer, Susan M.; Delrez, Laetitia; de Wit, Julien; Burdanov, Artem; Van Grootel, Valerie; Burgasser, Adam J.; Triaud, Amaury H. M. J.; Opitom, Cyrielle; Demory, Brice-Olivier; Sahu, Devendra K.; Gagliuffi, Daniella Bardalez; Magain, Pierre; Queloz, Didier			Temperate Earth-sized planets transiting a nearby ultracool dwarf star	NATURE			English	Article							ADAPTIVE OPTICS SURVEY; VOLUME-LIMITED SAMPLE; SOLAR NEIGHBORHOOD; MAIN-SEQUENCE; HABITABLE ZONES; SUPER-EARTHS; MASS; II.; MULTIPLICITY; STELLAR	Star-like objects with effective temperatures of less than 2,700 kelvin are referred to as 'ultracool dwarfs'(1). This heterogeneous group includes stars of extremely low mass as well as brown dwarfs (substellar objects not massive enough to sustain hydrogen fusion), and represents about 15 per cent of the population of astronomical objects near the Sun(2). Core-accretion theory predicts that, given the small masses of these ultracool dwarfs, and the small sizes of their protoplanetary disks(3,4), there should be a large but hitherto undetected population of terrestrial planets orbiting them(5)-ranging from metal-rich Mercury-sized planets(6) to more hospitable volatile-rich Earth-sized planets(7). Here we report observations of three short-period Earth-sized planets transiting an ultracool dwarf star only 12 parsecs away. The inner two planets receive four times and two times the irradiation of Earth, respectively, placing them close to the inner edge of the habitable zone of the star(8). Our data suggest that 11 orbits remain possible for the third planet, the most likely resulting in irradiation significantly less than that received by Earth. The infrared brightness of the host star, combined with its Jupiter-like size, offers the possibility of thoroughly characterizing the components of this nearby planetary system.	[Gillon, Michael; Jehin, Emmanuel; Delrez, Laetitia; Burdanov, Artem; Van Grootel, Valerie; Opitom, Cyrielle; Magain, Pierre] Univ Liege, Inst Astrophys & Geophys, Allee 6 Aout 19C, B-4000 Liege, Belgium; [Lederer, Susan M.] NASA Johnson Space Ctr, 2101 NASA Pkwy, Houston, TX 77058 USA; [de Wit, Julien] MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Burgasser, Adam J.; Gagliuffi, Daniella Bardalez] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Triaud, Amaury H. M. J.] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Demory, Brice-Olivier; Queloz, Didier] Univ Cambridge, Cavendish Lab, Astrophys Grp, 19 JJ Thomson Ave, Cambridge CB3 0HE, England; [Sahu, Devendra K.] Indian Inst Astrophys, Bangalore 560034, Karnataka, India	University of Liege; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; University of Cambridge; University of Cambridge; Department of Science & Technology (India); Indian Institute of Astrophysics (IIA)	Gillon, M (corresponding author), Univ Liege, Inst Astrophys & Geophys, Allee 6 Aout 19C, B-4000 Liege, Belgium.	michael.gillon@ulg.ac.be	Demory, Brice-Olivier/ABG-1063-2020; Triaud, Amaury/AAT-5603-2021	Demory, Brice-Olivier/0000-0002-9355-5165; Triaud, Amaury/0000-0002-5510-8751; Sahu, Devendra Kumar/0000-0002-6688-0800; Bardalez Gagliuffi, Daniella/0000-0001-8170-7072; Queloz, Didier/0000-0002-3012-0316; Opitom, Cyrielle/0000-0002-9298-7484; Burgasser, Adam J./0000-0002-6523-9536; Gillon, Michael/0000-0003-1462-7739	Belgian Fund for Scientific Research (FRS-FNRS) [FRFC 2.5.594.09.F]; Swiss Fund for Scientific Research; European Research Council (ERC) [336480]; Action de Recherche Concertee (ARC) grant - Wallonia-Brussels Federation; NASA [NNX15AI75G]	Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Swiss Fund for Scientific Research; European Research Council (ERC)(European Research Council (ERC)); Action de Recherche Concertee (ARC) grant - Wallonia-Brussels Federation; NASA(National Aeronautics & Space Administration (NASA))	TRAPPIST is funded by the Belgian Fund for Scientific Research (FRS-FNRS) under grant FRFC 2.5.594.09.F, with the participation of the Swiss Fund for Scientific Research. The research leading to our results was funded in part by the European Research Council (ERC) under the FP/2007-2013 ERC grant 336480, and through an Action de Recherche Concertee (ARC) grant financed by the Wallonia-Brussels Federation. Our work was also supported in part by NASA under contract NNX15AI75G. UKIRT is supported by NASA and operated under an agreement among the University of Hawaii, the University of Arizona, and Lockheed Martin Advanced Technology Center; operations are enabled through the cooperation of the East Asian Observatory. The facilities at the Indian Astronomical Observatory (IAO) and the Consortium for Research Excellence, Support and Training (CREST) are operated by the Indian Institute of Astrophysics, Bangalore. M.G., E.J. and V.V.G. are FRS-FNRS research associates. L.D. and C.O. are FRS-FNRS PhD students. We thank V. Megevand, the ASTELCO telescope team, S. Sohy, V. Chantry, and A. Fumel for their contributions to the TRAPPIST project; the Infrared Telescope Facility (IRTF) operators B. Cabreira and D. Griep for assistance with the SpeX observations; UKIRT staff scientists W. Varricatt & T. Kerr, telescope operators S. Benigni, E. Moore and T. Carroll, and Cambridge Astronomy Survey Unit (CASU) scientists G. Madsen and M. Irwin for assistance with UKIRT observations; the European Southern Observatory (ESO) astronomers A. Smette and G. Hau for providing us with the best possible VLT data; and the staff of IAO (in Hanle) and CREST (in Hosakote) for making observations with the HCT possible. Ad.B. and D. B. G. are visiting astronomers at the IRTF, which is operated by the University of Hawaii under Cooperative Agreement NNX-08AE38A with NASA's Science Mission Directorate, Planetary Astronomy Program.	Abell, 1963, BASIC ASTRONOMICAL D, P481; Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Andrews SM, 2010, ASTROPHYS J, V723, P1241, DOI 10.1088/0004-637X/723/2/1241; Baraffe I, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425481; Barnes JR, 2014, MON NOT R ASTRON SOC, V439, P3094, DOI 10.1093/mnras/stu172; Bartlett Jennifer Lynn, 2007, Publications of the Astronomical Society of the Pacific, V119, P828, DOI 10.1086/520554; Berta ZK, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/35; Bouy H, 2003, ASTRON J, V126, P1526, DOI 10.1086/377343; Burgasser AJ, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/3/104; Cantrell JR, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/4/99; Casali M, 2001, ASTR SOC P, V232, P357; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Claret A, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116451; Costa E, 2006, ASTRON J, V132, P1234, DOI 10.1086/505706; Cruz KL, 2007, ASTRON J, V133, P439, DOI 10.1086/510132; Cushing MC, 2004, PUBL ASTRON SOC PAC, V116, P362, DOI 10.1086/382907; Cutri R. M., 2012, VIZIER ONLINE DATA C; Davenport JRA, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/122; de Wit J, 2013, SCIENCE, V342, P1473, DOI 10.1126/science.1245450; Driscoll PE, 2015, ASTROBIOLOGY, V15, P739, DOI 10.1089/ast.2015.1325; Filippazzo JC, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/2/158; France K, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/149; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillon M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201218817; Gizis JE, 2000, ASTRON J, V120, P1085, DOI 10.1086/301456; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Han EK, 2014, PUBL ASTRON SOC PAC, V126, P827, DOI 10.1086/678447; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Hosey AD, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/1/6; Izmailov IS, 2010, ASTRON LETT+, V36, P349, DOI 10.1134/S1063773710050051; Janson M, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/44; Jehin E., 2011, MESSENGER, V145, P2; KIRKPATRICK JD, 1995, ASTRON J, V109, P797, DOI 10.1086/117323; Kreidberg L, 2014, NATURE, V505, P69, DOI 10.1038/nature12888; Leconte J, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321042; Lee KG, 2010, ASTROPHYS J, V708, P1482, DOI 10.1088/0004-637X/708/2/1482; Liebert J, 2006, PUBL ASTRON SOC PAC, V118, P659, DOI 10.1086/503333; Limbach MA, 2015, P NATL ACAD SCI USA, V112, P20, DOI 10.1073/pnas.1406545111; Lopez ED, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/59; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mann AW, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/160; Menou K, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/51; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; Montgomery R, 2009, ICARUS, V202, P1, DOI 10.1016/j.icarus.2009.02.035; Murray C.D., 2001, SOLAR SYSTEM DYNAMIC; Payne MJ, 2007, MON NOT R ASTRON SOC, V381, P1597, DOI 10.1111/j.1365-2966.2007.12362.x; Pirard JF, 2004, P SOC PHOTO-OPT INS, V5492, P1763, DOI 10.1117/12.578293; Raymond SN, 2007, ASTROPHYS J, V669, P606, DOI 10.1086/521587; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Reiners A, 2010, ASTROPHYS J, V710, P924, DOI 10.1088/0004-637X/710/2/924; Reiners A, 2009, ASTROPHYS J, V705, P1416, DOI 10.1088/0004-637X/705/2/1416; Rodler F, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/54; Rogers LA, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/41; Rojas-Ayala B, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/93; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schmidt SJ, 2007, ASTRON J, V133, P2258, DOI 10.1086/512158; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Siegler N, 2005, ASTROPHYS J, V621, P1023, DOI 10.1086/427743; Siegler N, 2003, ASTROPHYS J, V598, P1265, DOI 10.1086/378935; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Stelzer B, 2013, MON NOT R ASTRON SOC, V431, P2063, DOI 10.1093/mnras/stt225; Tanner A, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/10; Tian F, 2015, NAT GEOSCI, V8, P177, DOI 10.1038/NGEO2372; Vacca WD, 2003, PUBL ASTRON SOC PAC, V115, P389, DOI 10.1086/346193; Wolfgang A, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/183; Yu L, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/48; Zacharias N, 2004, ASTRON J, V127, P3043, DOI 10.1086/386353	78	374	376	9	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					221	+		10.1038/nature17448	http://dx.doi.org/10.1038/nature17448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27135924	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000376007200044
J	Kremkow, J; Jin, JZ; Wang, YS; Alonso, JM				Kremkow, Jens; Jin, Jianzhong; Wang, Yushi; Alonso, Jose M.			Principles underlying sensory map topography in primary visual cortex	NATURE			English	Article							CELL ORIENTATION SELECTIVITY; MONKEY STRIATE CORTEX; RECEPTIVE-FIELDS; DIRECTIONAL SELECTIVITY; ORDERED ARRANGEMENT; RESPONSE PROPERTIES; LINEAR MECHANISMS; OCULAR DOMINANCE; SINGLE NEURONS; ON-CENTER	The primary visual cortex contains a detailed map of the visual scene, which is represented according to multiple stimulus dimensions including spatial location, ocular dominance and stimulus orientation. The maps for spatial location and ocular dominance arise from the spatial arrangement of thalamic afferent axons in the cortex. However, the origins of the other maps remain unclear. Here we show that the cortical maps for orientation, direction and retinal disparity in the cat (Felis catus) are all strongly related to the organization of the map for spatial location of light (ON) and dark (OFF) stimuli, an organization that we show is OFF-dominated, OFF-centric and runs orthogonal to ocular dominance columns. Because this ON-OFF organization originates from the clustering of ON and OFF thalamic afferents in the visual cortex, we conclude that all main features of visual cortical topography, including orientation, direction and retinal disparity, follow a common organizing principle that arranges thalamic axons with similar retinotopy and ON-OFF polarity in neighbouring cortical regions.	[Kremkow, Jens; Jin, Jianzhong; Wang, Yushi; Alonso, Jose M.] SUNY Coll Optometry, Grad Ctr Vis Res, 33 West 42nd St, New York, NY 10036 USA; [Kremkow, Jens] Humboldt Univ, Inst Theoret Biol, Dept Biol, Philippstr 13, D-10115 Berlin, Germany	State University of New York (SUNY) System; SUNY Optometry; Humboldt University of Berlin	Alonso, JM (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, 33 West 42nd St, New York, NY 10036 USA.	jalonso@sunyopt.edu		Kremkow, Jens/0000-0001-7077-4528	US National Institutes of Health [EY005253]; DFG [KR 4062/1-1]; Humboldt-Universitat zu Berlin in the framework of the Excellence Initiative of the BMBF; Humboldt-Universitat zu Berlin in the framework of the Excellence Initiative of DFG; NATIONAL EYE INSTITUTE [R37EY005253, R01EY020679, R01EY005253] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Humboldt-Universitat zu Berlin in the framework of the Excellence Initiative of the BMBF(Federal Ministry of Education & Research (BMBF)); Humboldt-Universitat zu Berlin in the framework of the Excellence Initiative of DFG; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank R. Lashgari, S. Komban, M. Jansen, C. Pons and E. Koch for helping collect data in some experiments; H. Swadlow, Q. Zaidi and R. Mazade for comments on the manuscript; and A. Movshon for lending some experimental equipment. This work was supported by the US National Institutes of Health (EY005253, J.M.A.), a DFG Research Fellowship (KR 4062/1-1, J.K.) and Humboldt-Universitat zu Berlin in the framework of the Excellence Initiative of the BMBF and DFG (J.K.).	ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chapman B, 2000, J NEUROSCI, V20, P1922; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Friedman RM, 2004, P NATL ACAD SCI USA, V101, P12724, DOI 10.1073/pnas.0404884101; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kaschube M, 2003, EUR J NEUROSCI, V18, P3251, DOI 10.1111/j.1460-9568.2003.02979.x; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kremkow J., 2013, SOC NEUROSCI; Lashgari R, 2012, J NEUROSCI, V32, P11396, DOI 10.1523/JNEUROSCI.0429-12.2012; Lee K.-S., 2015, SOC NEUROSCI; Levy M, 2014, J NEUROSCI, V34, P3231, DOI 10.1523/JNEUROSCI.4985-13.2014; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Nauhaus I, 2014, CURR OPIN NEUROBIOL, V24, P1, DOI 10.1016/j.conb.2013.08.007; NORTON TT, 1985, BRAIN RES, V327, P319, DOI 10.1016/0006-8993(85)91527-6; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; REID RC, 1987, P NATL ACAD SCI USA, V84, P8740, DOI 10.1073/pnas.84.23.8740; Sarnaik R, 2014, CEREB CORTEX, V24, P1658, DOI 10.1093/cercor/bht027; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Smith GB, 2015, NEURON, V88, P805, DOI 10.1016/j.neuron.2015.10.019; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TOLHURST DJ, 1991, VISUAL NEUROSCI, V6, P421, DOI 10.1017/S0952523800001280; Wang YS, 2015, NAT NEUROSCI, V18, P97, DOI 10.1038/nn.3878; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	45	75	76	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					52	+		10.1038/nature17936	http://dx.doi.org/10.1038/nature17936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27120164	Green Accepted			2022-12-28	WOS:000375473900037
J	Chou, R; Hashimoto, R; Friedly, J				Chou, Roger; Hashimoto, Robin; Friedly, Janna			Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis Response	ANNALS OF INTERNAL MEDICINE			English	Letter							TRANSFORAMINAL INJECTION; STEROIDS		[Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Hashimoto, Robin] Spectrum Res, Tacoma, WA USA; [Friedly, Janna] Univ Washington, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Chou, Roger/0000-0001-9889-8610				Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V10; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; MacVicar J, 2013, PAIN MED, V14, P14, DOI 10.1111/j.1526-4637.2012.01508.x; Manchikanti Laxmaiah, 2015, Anesth Pain Med, V5, pe23139, DOI 10.5812/aapm.23139	4	4	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					635	636		10.7326/L15-0563	http://dx.doi.org/10.7326/L15-0563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136217				2022-12-28	WOS:000375744000032
J	Gandhi, TK; Berwick, DM; Shojania, KG				Gandhi, Tejal K.; Berwick, Donald M.; Shojania, Kaveh G.			Patient Safety at the Crossroads	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gandhi, Tejal K.] Natl Patient Safety Fdn, 268 Summer St, Boston, MA 02210 USA; [Berwick, Donald M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Inst Healthcare Improvement, Boston, MA USA; [Shojania, Kaveh G.] Univ Toronto, Ctr Qual Improvement & Patient Safety, Toronto, ON, Canada	Harvard University; Harvard Medical School; Institute for Healthcare Improvement; University of Toronto; Centre for Quality Improvement & Patient Safety	Gandhi, TK (corresponding author), Natl Patient Safety Fdn, 268 Summer St, Boston, MA 02210 USA.	tgandhi@npsf.org						Agency for Healthcare Research and Quality, EFF IMPR PAT SAF RES; Department of Health and Human Services Office of Inspector General, ADV EV HOSP; National Patient Safety Foundation, 2015, FREE HARM ACC PAT SA; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P628, DOI 10.1377/hlthaff.2011.0047; Runciman W, 2009, INT J QUAL HEALTH C, V21, P18, DOI 10.1093/intqhc/mzn057; Schutz Will, 1982, PROFOUND SIMPLICITY	6	36	36	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1829	1830		10.1001/jama.2016.1759	http://dx.doi.org/10.1001/jama.2016.1759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK9XF	27139052				2022-12-28	WOS:000375284400006
J	Battle, C; Broedersz, CP; Fakhri, N; Geyer, VF; Howard, J; Schmidt, CF; MacKintosh, FC				Battle, Christopher; Broedersz, Chase P.; Fakhri, Nikta; Geyer, Veikko F.; Howard, Jonathon; Schmidt, Christoph F.; MacKintosh, Fred C.			Broken detailed balance at mesoscopic scales in active biological systems	SCIENCE			English	Article							BASAL BODIES; NONEQUILIBRIUM; CELLS	Systems in thermodynamic equilibrium are not only characterized by time-independent macroscopic properties, but also satisfy the principle of detailed balance in the transitions between microscopic configurations. Living systems function out of equilibrium and are characterized by directed fluxes through chemical states, which violate detailed balance at the molecular scale. Here we introduce a method to probe for broken detailed balance and demonstrate how such nonequilibrium dynamics are manifest at the mesosopic scale. The periodic beating of an isolated flagellum from Chlamydomonas reinhardtii exhibits probability flux in the phase space of shapes. With a model, we show how the breaking of detailed balance can also be quantified in stationary, nonequilibrium stochastic systems in the absence of periodic motion. We further demonstrate such broken detailed balance in the nonperiodic fluctuations of primary cilia of epithelial cells. Our analysis provides a general tool to identify nonequilibrium dynamics in cells and tissues.	[Battle, Christopher; Fakhri, Nikta; Schmidt, Christoph F.] Univ Gottingen, Drittes Phys Inst, D-37077 Gottingen, Germany; [Battle, Christopher; Broedersz, Chase P.; Fakhri, Nikta; Schmidt, Christoph F.; MacKintosh, Fred C.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Broedersz, Chase P.] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Theresienstr 37, D-80333 Munich, Germany; [Broedersz, Chase P.] Univ Munich, Ctr NanoSci, Theresienstr 37, D-80333 Munich, Germany; [Broedersz, Chase P.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Broedersz, Chase P.] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Fakhri, Nikta] MIT, Dept Phys, Cambridge, MA 02139 USA; [Geyer, Veikko F.; Howard, Jonathon] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [MacKintosh, Fred C.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands	University of Gottingen; University of California System; University of California Santa Barbara; University of Munich; University of Munich; Princeton University; Princeton University; Massachusetts Institute of Technology (MIT); Yale University; Vrije Universiteit Amsterdam	Schmidt, CF (corresponding author), Univ Gottingen, Drittes Phys Inst, D-37077 Gottingen, Germany.; Schmidt, CF; MacKintosh, FC (corresponding author), Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.; MacKintosh, FC (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands.	christoph.schmidt@phys.uni-goettingen.de; fcmack@gmail.com	Broedersz, Chase/AAL-5908-2021; Schmidt, Christoph F/G-3787-2011; Howard, Jonathon/J-7492-2016; MacKintosh, Fred C/A-9450-2008; MacKintosh, Frederick/AAB-9332-2021	Schmidt, Christoph F/0000-0003-2864-6973; Howard, Jonathon/0000-0003-0086-1196; MacKintosh, Fred C/0000-0002-2607-9541; MacKintosh, Frederick/0000-0002-2607-9541; Fakhri, Nikta/0000-0003-1261-7465; , Chase/0000-0001-7283-3704	Lewis-Sigler fellowship; German Excellence Initiative via the program "NanoSystems Initiative Munich"; Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG) Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB); Human Frontier Science Program Fellowship; European Research Council [340528]; DFG Collaborative Research Center [SFB 937]; Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organization for Scientific Research (NWO); NSF [PHY-1066203, PHY11-25915]; NIH [R13GM085967, P50GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM085967, P50GM068763] Funding Source: NIH RePORTER	Lewis-Sigler fellowship; German Excellence Initiative via the program "NanoSystems Initiative Munich"; Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG) Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)(German Research Foundation (DFG)); Human Frontier Science Program Fellowship(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); DFG Collaborative Research Center(German Research Foundation (DFG)); Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organization for Scientific Research (NWO); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lippincott-Schwartz, U. Seifert, G. Berman A. El-Hady, B. Machta, and J. Gore for discussions. This research was supported be a Lewis-Sigler fellowship (C.P.B.) the German Excellence Initiative via the program "NanoSystems Initiative Munich" (C.P.B.), and the Cluster of Excellence and Deutsche Forschungsgemeinschaft (DFG) Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) (C.F.S.); a. Human Frontier Science Program Fellowship (N.F.): the European Research Council Advanced Grant PF7 ERC-2013-AdG, Project 340528 (C.F.S) the DFG Collaborative Research Center SFB 937 (Project A2), and a research program of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organization for Scientific Research (NWO). This work was initiated at the Aspen Center for Physics which is supported by NSF grant PHY-1066203 and was further supported in part by the NSF under grant NSF PHY11-25915 Experiments with Chlamydomonas flagella were performed during the 2011 Physiology Course at the Marine Biological Laboratory, Woods Hole, MA, supported. in part by NIH grants R13GM085967 and P50GM068763.	Alberts B., 2010, MOL BIOL CELL; Alper J, 2013, METHOD ENZYMOL, V524, P343, DOI 10.1016/B978-0-12-397945-2.00019-6; Antoniades I, 2014, DEV CELL, V28, P70, DOI 10.1016/j.devcel.2013.12.003; ARAGON SR, 1985, MACROMOLECULES, V18, P1868, DOI 10.1021/ma00152a014; BARNES BG, 1961, J ULTRA MOL STRUCT R, V5, P453, DOI 10.1016/S0022-5320(61)80019-1; Battle C, 2015, P NATL ACAD SCI USA, V112, P1410, DOI 10.1073/pnas.1421845112; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Boltzmann L, 1872, WIEN BER, V66, P275, DOI DOI 10.1007/978-3-322-84986-1_3; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bustamante C, 2005, PHYS TODAY, V58, P43, DOI 10.1063/1.2012462; Cates ME, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/4/042601; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Egolf DA, 2000, SCIENCE, V287, P101, DOI 10.1126/science.287.5450.101; Feynman R. P., 1966, FEYNMAN LECT PHYS, VI; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Ma R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.048101; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861; Seifert U, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040602; Sekimoto K, 1997, J PHYS SOC JPN, V66, P1234, DOI 10.1143/JPSJ.66.1234; Shannon C. E., 1949, MATH THEORY COMMUNIC; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Wan KY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238103; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Zia RKP, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07012	35	168	171	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					604	607		10.1126/science.aac8167	http://dx.doi.org/10.1126/science.aac8167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126047	Green Accepted			2022-12-28	WOS:000374998600049
J	Sholl, DS; Lively, RP				Sholl, David S.; Lively, Ryan P.			Seven chemical separations to change the world	NATURE			English	Editorial Material							STRATEGIES; ENERGY		[Sholl, David S.; Lively, Ryan P.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Sholl, DS (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	david.sholl@chbe.gatech.edu						Humphrey J. L., 1997, SEPARATION PROCESS T; Interagency Working Group on Social Cost of Carbon (US Govt.), 2013, SOC COST CARB REG IM; Jordens A, 2013, MINER ENG, V41, P97, DOI 10.1016/j.mineng.2012.10.017; Kim J, 2013, SEP SCI TECHNOL, V48, P367, DOI 10.1080/01496395.2012.712599; Koros WJ, 2012, AICHE J, V58, P2624, DOI 10.1002/aic.13888; Massari S, 2013, RESOUR POLICY, V38, P36, DOI 10.1016/j.resourpol.2012.07.001; Oak Ridge National Laboratory, 2005, MAT SEP TECHN EN EM; Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029; US Dept. Energy Advanced Manufacturing Office, 2015, BANDW STUD EN US POT; Xu LR, 2012, J MEMBRANE SCI, V423, P314, DOI 10.1016/j.memsci.2012.08.028	10	1751	1783	152	1196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					435	437		10.1038/532435a	http://dx.doi.org/10.1038/532435a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	27121824				2022-12-28	WOS:000374815900020
J	Zhou, YH; Zheng, MH				Zhou, Yong-Hai; Zheng, Ming-Hua			A neonate with dyspnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zhou, Yong-Hai] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat, Wenzhou 325000, Zhejiang, Peoples R China; [Zhou, Yong-Hai] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China; [Zheng, Ming-Hua] Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Hepatol, Wenzhou 325000, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Hepatol, Wenzhou 325000, Zhejiang, Peoples R China.	zhengmh@wmu.edu.cn	Zheng, Ming-Hua/H-5584-2019	Zheng, Ming-Hua/0000-0003-4984-2631				Kotecha S, 2012, EUR RESPIR J, V39, P820, DOI 10.1183/09031936.00066511; Mielniczuk M, 2012, ANAESTH INTENSIVE TH, V44, P232; van den Hout L, 2009, PEDIATR SURG INT, V25, P733, DOI 10.1007/s00383-009-2425-8	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2016	353								i2361	10.1136/bmj.i2361	http://dx.doi.org/10.1136/bmj.i2361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RW	27126592				2022-12-28	WOS:000375483900005
J	[Anonymous]				[Anonymous]			The strike in numbers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2016	353								i2405	10.1136/bmj.i2405	http://dx.doi.org/10.1136/bmj.i2405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RW	27125897				2022-12-28	WOS:000375483900010
J	[Anonymous]				[Anonymous]			George Alberti: Laid back, iconoclastic, irreverent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2016	353								i2331	10.1136/bmj.i2331	http://dx.doi.org/10.1136/bmj.i2331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RR	27121293				2022-12-28	WOS:000375483300005
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 UK research paper of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOUBLE-BLIND					nigel.hawkes1@btinternet.com						Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Davey C, 2015, THORAX, V70, P288, DOI 10.1136/thoraxjnl-2014-205127; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2211	10.1136/bmj.i2211	http://dx.doi.org/10.1136/bmj.i2211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RF	27112164				2022-12-28	WOS:000375482000002
J	Swain, DP; Benoit, HP; Cox, SP; Cadigan, NG				Swain, Douglas P.; Benoit, Hugues P.; Cox, Sean P.; Cadigan, Noel G.			Comment on "Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery"	SCIENCE			English	Editorial Material							NATURAL MORTALITY	Pershing et al. (Science, 13 November 2015, p. 809) concluded that recent warming in the Gulf of Maine contributed to the collapse of Gulf of Maine cod. We argue that this conclusion is based on a flawed analysis of the population dynamics of this cod stock. We believe that understanding the potential role of climate change in the collapse of this stock requires more defensible analyses.	[Swain, Douglas P.; Benoit, Hugues P.] Fisheries & Oceans Canada, Gulf Fisheries Ctr, Moncton, NB E1C 9B6, Canada; [Cox, Sean P.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Cadigan, Noel G.] Mem Univ Newfoundland, Ctr Fisheries Ecosyst Res, Inst Marine, St John, NF A1C 5R3, Canada	Fisheries & Oceans Canada; Simon Fraser University; Memorial University Newfoundland	Benoit, HP (corresponding author), Fisheries & Oceans Canada, Gulf Fisheries Ctr, Moncton, NB E1C 9B6, Canada.	hugues.benoit@dfo-mpo.gc.ca	Brooks, ELIZABETH/AAD-2502-2020	Legault, Christopher/0000-0002-0328-1376; Cadigan, Noel/0000-0002-5922-1014; Brooks, Elizabeth N/0000-0002-9142-4372				Cadigan N. G., 2015, CAN J FISH AQUAT SCI, P1; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Deroba JJ, 2015, ICES J MAR SCI, V72, P19, DOI 10.1093/icesjms/fst237; Jiao Y, 2012, ICES J MAR SCI, V69, P105, DOI 10.1093/icesjms/fsr184; Northeast Fisheries Science Center, 2013, 55 NE REG STOCK ASS; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Swain D. P., 2015, 2015080 DFO CAN SCI; Swain DP, 2015, MAR ECOL PROG SER, V519, P165, DOI 10.3354/meps11012	8	13	13	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284								10.1126/science.aad9346	http://dx.doi.org/10.1126/science.aad9346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102473				2022-12-28	WOS:000374479700035
J	Misra, M; Sagar, P; Friedmann, AM; Ryan, DP; Sgroi, DC				Misra, Madhusmita; Sagar, Pallavi; Friedmann, Alison M.; Ryan, Daniel P.; Sgroi, Dennis C.			Case 12-2016: An 8-Year-Old Boy with an Enlarging Mass in the Right Breast	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECRETORY CARCINOMA; PREPUBERTAL GYNECOMASTIA; CANCER; EXCESS; HYBRIDIZATION; FUSION; GAIN; GENE		[Misra, Madhusmita; Friedmann, Alison M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sagar, Pallavi] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ryan, Daniel P.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Misra, Madhusmita; Friedmann, Alison M.] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Sagar, Pallavi] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Ryan, Daniel P.] Harvard Univ, Sch Med, Dept Pediat Surg, Cambridge, MA 02138 USA; [Sgroi, Dennis C.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Misra, M (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Misra, M (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA.		Misra, Madhusmita/X-8807-2018; Sgroi, Dennis/AAV-2487-2021	Misra, Madhusmita/0000-0002-9405-2981; 	Genentech	Genentech(Roche HoldingGenentech)	Dr. Misra reports receiving grant support to her institution from Genentech. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2015, EP PATH CAUS GYN; Binder G, 2005, J CLIN ENDOCR METAB, V90, P484, DOI 10.1210/jc.2004-1566; BOTTA G, 1982, VIRCHOWS ARCH A, V395, P145, DOI 10.1007/BF00429608; Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677; Brinton LA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt465; Deepinder F, 2012, EXPERT OPIN DRUG SAF, V11, P779, DOI 10.1517/14740338.2012.712109; Demura M, 2007, HUM MOL GENET, V16, P2529, DOI 10.1093/hmg/ddm145; Diallo R, 2003, HUM PATHOL, V34, P1299, DOI 10.1016/S0046-8177(03)00423-4; Fukami M, 2011, J CLIN ENDOCR METAB, V96, pE1035, DOI 10.1210/jc.2011-0145; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Henley DV, 2007, NEW ENGL J MED, V356, P479, DOI 10.1056/NEJMoa064725; Herz H, 2000, ANN ONCOL, V11, P1343, DOI 10.1023/A:1008387800525; Hoda S. A., 2014, ROSENS BREAST PATHOL; Janes SE, 2006, BREAST, V15, P273, DOI 10.1016/j.breast.2005.05.003; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; KRAUSZ T, 1989, HISTOPATHOLOGY, V14, P25, DOI 10.1111/j.1365-2559.1989.tb02111.x; Lapid O, 2015, BREAST J, V21, P219, DOI 10.1111/tbj.12393; Lee SG, 2014, ONCOL LETT, V8, P683, DOI 10.3892/ol.2014.2213; Longo Osvaldo Anibal, 1999, Breast J, V5, P65, DOI 10.1046/j.1524-4741.1999.005001065.x; Makretsov N, 2004, GENE CHROMOSOME CANC, V40, P152, DOI 10.1002/gcc.20028; Mathur R, 1997, HORM RES, V48, P95, DOI 10.1159/000185497; MCDIVITT RW, 1966, J AMER MED ASSOC, V195, P388, DOI 10.1001/jama.195.5.388; MIES C, 1993, AM J SURG PATHOL, V17, P715, DOI 10.1097/00000478-199307000-00009; OBERMAN HA, 1972, CANCER, V30, P470, DOI 10.1002/1097-0142(197208)30:2<470::AID-CNCR2820300226>3.0.CO;2-6; OBERMAN HA, 1980, AM J SURG PATHOL, V4, P465, DOI 10.1097/00000478-198010000-00006; OHANLON DM, 1995, AM J SURG, V170, P24, DOI 10.1016/S0002-9610(99)80246-3; ROSEN PP, 1991, ARCH PATHOL LAB MED, V115, P141; Shozu M, 2003, NEW ENGL J MED, V348, P1855, DOI 10.1056/NEJMoa021559; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Vidal-Sicart S, 2012, J ONCOL, V2012, DOI 10.1155/2012/361341; Volpe CM, 1999, AM SURGEON, V65, P250; Weiss JR, 2005, CANCER EPIDEM BIOMAR, V14, P20, DOI 10.1158/1055-9965.EPI-05-0414	32	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1565	1574		10.1056/NEJMcpc1503831	http://dx.doi.org/10.1056/NEJMcpc1503831			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7IA	27096583				2022-12-28	WOS:000374383900012
J	Tian, XL; Verho, T; Ras, RHA				Tian, Xuelin; Verho, Tuukka; Ras, Robin H. A.			Moving superhydrophobic surfaces toward real-world applications	SCIENCE			English	Editorial Material							DURABILITY		[Tian, Xuelin; Verho, Tuukka; Ras, Robin H. A.] Aalto Univ, Dept Appl Phys, Puumiehenkuja 2, Espoo 02150, Finland	Aalto University	Ras, RHA (corresponding author), Aalto Univ, Dept Appl Phys, Puumiehenkuja 2, Espoo 02150, Finland.	robin.ras@aalto.fi	Ras, Robin/F-7680-2010; Tian, Xuelin/C-3424-2008	Ras, Robin/0000-0002-2076-242X; Tian, Xuelin/0000-0001-6178-2067				Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Butt HJ, 2014, CURR OPIN COLLOID IN, V19, P343, DOI 10.1016/j.cocis.2014.04.009; Callies M, 2005, SOFT MATTER, V1, P55, DOI 10.1039/b501657f; Deng B, 2010, ADV MATER, V22, P5473, DOI 10.1002/adma.201002614; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; Milionis A, 2016, ADV COLLOID INTERFAC, V229, P57, DOI 10.1016/j.cis.2015.12.007; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Pierce E, 2008, COLLOID SURFACE A, V323, P73, DOI 10.1016/j.colsurfa.2007.09.032; Steele A, 2012, J APPL POLYM SCI, V125, pE445, DOI 10.1002/app.36312; Tian Y, 2014, ADV MATER, V26, P6872, DOI 10.1002/adma.201400883; Verho T, 2011, ADV MATER, V23, P673, DOI 10.1002/adma.201003129; Wang HX, 2011, ANGEW CHEM INT EDIT, V50, P11433, DOI 10.1002/anie.201105069; Xu QF, 2011, ACS APPL MATER INTER, V3, P3508, DOI 10.1021/am200741f; Zimmermann J, 2008, ADV FUNCT MATER, V18, P3662, DOI 10.1002/adfm.200800755	14	461	477	46	595	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					142	143		10.1126/science.aaf2073	http://dx.doi.org/10.1126/science.aaf2073			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124437				2022-12-28	WOS:000373681600020
J	Malinow, R				Malinow, Roberto			DEPRESSION Ketamine steps out of the darkness	NATURE			English	Editorial Material							D-ASPARTATE ANTAGONIST; SYNAPTIC-TRANSMISSION; RECEPTOR ANTAGONIST; ANTIDEPRESSANT; POTENTIATION; BLOCKADE	The way in which ketamine exerts its antidepressant effects has been perplexing. Evidence that a metabolite of the drug is responsible, and acts on a different target from ketamine, might be the key to an answer. SEE ARTICLE P.481	[Malinow, Roberto] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Malinow, Roberto] Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Malinow, R (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.; Malinow, R (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu			NIA NIH HHS [R01 AG032132] Funding Source: Medline; NIMH NIH HHS [R01 MH091119, R01 MH049159] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159, R01MH091119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Carrier N, 2013, NEUROPHARMACOLOGY, V70, P27, DOI 10.1016/j.neuropharm.2012.12.009; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DiazGranados N, 2010, J CLIN PSYCHIAT, V71, P1605, DOI 10.4088/JCP.09m05327blu; Ebert B, 1997, EUR J PHARMACOL, V333, P99, DOI 10.1016/S0014-2999(97)01116-3; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; McGirr A, 2015, PSYCHOL MED, V45, P693, DOI 10.1017/S0033291714001603; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Styron W., 1990, DARKNESS VISIBLE MEM; Trevino K, 2014, ANN CLIN PSYCHIATRY, V26, P222; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	16	22	22	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					477	478		10.1038/nature17897	http://dx.doi.org/10.1038/nature17897			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27144350	Green Accepted			2022-12-28	WOS:000376443100028
J	Portman, DS				Portman, Douglas S.			Wired for sex	NATURE			English	Editorial Material							BRAIN; CONNECTOME		[Portman, Douglas S.] Univ Rochester, Dept Biomed Genet, Rochester, NY 14642 USA; [Portman, Douglas S.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Portman, DS (corresponding author), Univ Rochester, Dept Biomed Genet, Rochester, NY 14642 USA.; Portman, DS (corresponding author), Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA.	douglas.portman@rochester.edu		Portman, Douglas/0000-0003-2686-8839				Bergan JF, 2014, ELIFE, V3, DOI 10.7554/eLife.02743; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Frith C, 2004, LANCET NEUROL, V3, P577, DOI 10.1016/S1474-4422(04)00875-0; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kohl J, 2013, CELL, V155, P1610, DOI 10.1016/j.cell.2013.11.025; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Oren-Suissa M, 2016, NATURE, V533, P206, DOI 10.1038/nature17977; Ryan DA, 2014, CURR BIOL, V24, P2509, DOI 10.1016/j.cub.2014.09.032; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	11	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					188	189		10.1038/nature17898	http://dx.doi.org/10.1038/nature17898			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144358				2022-12-28	WOS:000376007200038
J	Rossant, J				Rossant, Janet			Implantation barrier overcome	NATURE			English	Editorial Material							HUMAN BLASTOCYST; RHESUS-MONKEY; STEM-CELLS; MOUSE; LINEAGES		[Rossant, Janet] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Rossant, J (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada.; Rossant, J (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada.	janet.rossant@sickkids.ca						Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; ENDERS AC, 1986, AM J ANAT, V177, P161, DOI 10.1002/aja.1001770205; LUCKETT WP, 1975, AM J ANAT, V144, P149, DOI 10.1002/aja.1001440204; Petropoulos S., 2016, CELL; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Shahbazi M. N., 2016, NATURE CELL BIOL; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]	10	12	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					182	183		10.1038/nature17894	http://dx.doi.org/10.1038/nature17894			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144361				2022-12-28	WOS:000376007200033
J	Phillips, N				Phillips, Nicky			CHINA Building an innovator	NATURE			English	Editorial Material									[Phillips, Nicky] Nat Publishing Grp, Sydney, NSW, Australia		Phillips, N (corresponding author), Nat Publishing Grp, Sydney, NSW, Australia.							Dang JW, 2015, CHINA ECON REV, V35, P137, DOI 10.1016/j.chieco.2015.03.012; Roth E, 2015, CHINA EFFECT GLOBAL	2	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S32	S33		10.1038/533S32a	http://dx.doi.org/10.1038/533S32a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144607	Bronze			2022-12-28	WOS:000375473900006
J	Scielzo, SA; Stone, L; Kazi, S				Scielzo, Shannon A.; Stone, Langdon; Kazi, Salahuddin			Update in Rheumatology: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Scielzo, Shannon A.; Stone, Langdon; Kazi, Salahuddin] Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Scielzo, SA (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shannon.scielzo@utsouthwestern.edu	Scielzo, Shannon/AAA-6657-2021	Scielzo, Shannon/0000-0002-9541-9677				O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W61	W64		10.7326/M16-0223	http://dx.doi.org/10.7326/M16-0223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136234				2022-12-28	WOS:000375744000013
J	Allen, OKH				Allen, Orlanda K. H.			Barbara Cushnaghan OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2425	10.1136/bmj.i2425	http://dx.doi.org/10.1136/bmj.i2425			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129357				2022-12-28	WOS:000375484100010
J	Hurley, R				Hurley, Richard			ILLICIT DRUG POLICY Consider legalising drugs despite UN treaties, says influential commission	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						Caulkins JP, LONG RUN TRENDS INCA; Commission on Narcotic Drugs, 2016, PREP SPEC SESS GEN A; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2015, PUBL HLTH RIGHTS APP; UNGASS, 2016, CONTR STAK; UNGASS, 2016, CONTR UN ENT; United Nations General Assembly, 1998, 20 SPEC SESS WORLD D; United Nations Office on Drugs and Crime, WORLD DRUG REP 2014; United Nations Office on Drugs and Crime, 1971, CONV PSYCH SUBST; United Nations Office on Drugs and Crime, 1988, UN CONV ILL TRAFF NA; United Nations Office on Drugs and Crime, 1961, SINGL CONV NARC DRUG	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2474	10.1136/bmj.i2474	http://dx.doi.org/10.1136/bmj.i2474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130078				2022-12-28	WOS:000375484100019
J	Iacobucci, G				Iacobucci, Gareth			Troubled mental health trust is still putting patients at risk, warns CQC	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, 2016, SO HLTH NHS FDN TRUS; Iacobucci G, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6749	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2483	10.1136/bmj.i2483	http://dx.doi.org/10.1136/bmj.i2483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2RY	27130235				2022-12-28	WOS:000375484100023
J	Serio, T				Serio, Tricia			Speak up about subtle sexism in science	NATURE			English	Editorial Material									[Serio, Tricia] Univ Arizona, Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Serio, T (corresponding author), Univ Arizona, Mol & Cellular Biol, Tucson, AZ 85721 USA.	tserio@email.arizona.edu	Serio, Tricia/GPP-7129-2022						0	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					415	415		10.1038/532415a	http://dx.doi.org/10.1038/532415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27121804	Bronze			2022-12-28	WOS:000374815900010
J	Chen, JH				Chen, Jonathan H.			The Patient You Least Want to See	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chen, Jonathan H.] Stanford Univ, Dept Med, Div Gen Med Disciplines, Stanford, CA 94305 USA	Stanford University	Chen, JH (corresponding author), Stanford Univ, Dept Med, Div Gen Med Disciplines, Stanford, CA 94305 USA.	jonc101@stanford.edu		Chen, Jonathan H./0000-0002-4387-8740	NIEHS NIH HHS [K01 ES026837] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Chen JH, 2016, JAMA INTERN MED, V176, P259, DOI 10.1001/jamainternmed.2015.6662; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; National Center on Addiction and Substance Abuse at Columbia University, 2012, ADD MED CLOS GAP SCI	4	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1701	1702		10.1001/jama.2016.0221	http://dx.doi.org/10.1001/jama.2016.0221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115373	Green Accepted			2022-12-28	WOS:000374759300013
J	Galloway, A; Saveliev, A; Lukasiak, S; Hodson, DJ; Bolland, D; Balmanno, K; Ahlfors, H; Monzon-Casanova, E; Mannurita, SC; Bell, LS; Andrews, S; Diaz-Munoz, MD; Cook, SJ; Corcoran, A; Turner, M				Galloway, Alison; Saveliev, Alexander; Lukasiak, Sebastian; Hodson, Daniel J.; Bolland, Daniel; Balmanno, Kathryn; Ahlfors, Helena; Monzon-Casanova, Elisa; Mannurita, Sara Ciullini; Bell, Lewis S.; Andrews, Simon; Diaz-Munoz, Manuel D.; Cook, Simon J.; Corcoran, Anne; Turner, Martin			RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence	SCIENCE			English	Article							MESSENGER-RNA; CYCLIN-E; PROLIFERATION; RECOMBINATION; COORDINATION; PROGRESSION; STABILITY; TARGET; E2F	Progression through the stages of lymphocyte development requires coordination of the cell cycle. Such coordination ensures genomic integrity while cells somatically rearrange their antigen receptor genes [in a process called variable-diversity-joining (VDJ) recombination] and, upon successful rearrangement, expands the pools of progenitor lymphocytes. Here we show that in developing B lymphocytes, the RNA-binding proteins (RBPs) ZFP36L1 and ZFP36L2 are critical for maintaining quiescence before precursor B cell receptor (pre-BCR) expression and for reestablishing quiescence after pre-BCR-induced expansion. These RBPs suppress an evolutionarily conserved post-transcriptional regulon consisting of messenger RNAs whose protein products cooperatively promote transition into the S phase of the cell cycle. This mechanism promotes VDJ recombination and effective selection of cells expressing immunoglobulin-m at the pre-BCR checkpoint.	[Galloway, Alison; Saveliev, Alexander; Lukasiak, Sebastian; Hodson, Daniel J.; Ahlfors, Helena; Monzon-Casanova, Elisa; Mannurita, Sara Ciullini; Bell, Lewis S.; Diaz-Munoz, Manuel D.; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Hodson, Daniel J.] Univ Cambridge, Dept Haematol, Clifford Allbutt Bldg,Biomed Campus,Hills Rd, Cambridge CB2 0AH, England; [Bolland, Daniel; Corcoran, Anne] Babraham Inst, Lab Nucl Dynam, Cambridge CB22 3AT, England; [Balmanno, Kathryn; Cook, Simon J.] Babraham Inst, Lab Signalling, Cambridge CB22 3AT, England; [Monzon-Casanova, Elisa] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Lukasiak, Sebastian] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Mannurita, Sara Ciullini] Univ Florence, Meyer Childrens Hosp, Dept Neurosci Psychol Pharmacol & Child Hlth NEUR, Child Hlth Sect, Florence, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England.	martin.turner@babraham.ac.uk	Diaz-Munoz, Manuel D/H-2080-2018; Mannurita, Sara Ciullini/AAA-5395-2019; Diaz-Munoz, Manuel D./AAB-6518-2020; Bolland, Daniel/AAE-5185-2020; Hodson, Daniel J/K-6817-2016; Turner, Martin/N-9976-2014	Diaz-Munoz, Manuel D/0000-0002-9227-7474; Mannurita, Sara Ciullini/0000-0002-4498-6209; Diaz-Munoz, Manuel D./0000-0002-9227-7474; Bolland, Daniel/0000-0003-3674-9913; Hodson, Daniel J/0000-0001-6225-2033; Balmanno, Kathryn/0000-0002-6417-3889; Cook, Simon/0000-0001-9087-1616; Saveliev, Alexander/0000-0003-0840-4774; Monzon-Casanova, Elisa/0000-0001-6617-6138; Ahlfors, Helena/0000-0002-8183-0895; Turner, Martin/0000-0002-3801-9896; Galloway, Alison/0000-0001-8780-0382; Bell, Lewis/0000-0002-9412-7066	Biotechnology and Biological Sciences Research Council; Medical Research Council (MRC); GlaxoSmithKline; MRC; Bloodwise; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H322, BBS/E/B/000C0407, 976494, BBS/E/B/0000M983, BBS/E/B/0000H190, BB/J00152X/1, BBS/E/B/000C0417, BBS/E/B/00001206, BB/C506121/1] Funding Source: researchfish; Medical Research Council [MC_PC_12009, MR/M008584/1, G0601618] Funding Source: researchfish; BBSRC [BBS/E/B/000C0407, BBS/E/B/0000H190, BBS/E/B/000C0417, BB/J00152X/1, BBS/E/B/0000H322] Funding Source: UKRI; MRC [MR/M008584/1, G0601618] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloodwise; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Vogel, R. Newman, C. Tiedje, and S. Bell for advice and comments on the manuscript; L. Matheson, A. Stark, and R. Venigalla for technical advice; S. Bell, K. Bates, D. Sanger, N. Evans, and The Babraham Institute's Biological Support Unit, Flow Cytometry Core Facility, and Next Generation Sequencing Facility for expert technical assistance; J. Ule and T. Curk for help with iCLIP; L. Dolken for the gateway-compatible psi-check vector; and R. Brink, D. Kioussis, and M. Reth for mice. This work was funded by the Biotechnology and Biological Sciences Research Council, a Medical Research Council (MRC) Collaborative Award in Science and Engineering (CASE) studentship with GlaxoSmithKline, a MRC centenary award (A.G.), and project grants from Bloodwise. D.J.H. was supported by a MRC Clinician Scientist Fellowship. The data from this study are tabulated in the main paper and in the supplementary materials. Sequencing data from the RNA sequencing and iCLIP experiments have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) and are accessible under GEO Series accession number GSE78249 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78249). Zfp36l1<SUP>fl</SUP>, Zfp36l2<SUP>fl</SUP>, and ROSA26<SUP>L1</SUP> mice are available from The Babraham Institute under a material transfer agreement.	Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hausburg MA, 2015, ELIFE, V4, DOI 10.7554/eLife.03390; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Johnson K, 2012, J IMMUNOL, V188, P6084, DOI 10.4049/jimmunol.1200368; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Leone G, 1999, P NATL ACAD SCI USA, V96, P6626, DOI 10.1073/pnas.96.12.6626; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Mukherjee N, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r12; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Oki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04012; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Thompson BJ, 2015, J EXP MED, V212, P723, DOI 10.1084/jem.20150002; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	31	94	96	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					453	459		10.1126/science.aad5978	http://dx.doi.org/10.1126/science.aad5978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102483	Green Accepted			2022-12-28	WOS:000374479700046
J	Dy, AJ; Collins, JJ				Dy, Aaron J.; Collins, James J.			Engineering Models to Scale	CELL			English	Editorial Material							PATTERN-FORMATION	Developing organisms can regulate and scale patterns to achieve consistent proportions despite immense changes in size. In this issue, Cao et al. build a model system, using engineered E. coli, to understand how regulatory dynamics can produce pattern scaling without the need for a morphogen gradient.	[Dy, Aaron J.; Collins, James J.] MIT, Dept Biol Engn, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dy, Aaron J.; Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dy, Aaron J.; Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Collins, JJ (corresponding author), MIT, Dept Biol Engn, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	jimjc@mit.edu	/H-7052-2016	/0000-0003-0319-5416				Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Calder WA., 1984, SIZE FUNCTION LIFE H; Cao YXL, 2016, CELL, V165, P620, DOI 10.1016/j.cell.2016.03.006; Dzialowski EM, 2004, J EXP BIOL, V207, P597, DOI 10.1242/jeb.00792; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Payne S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.55; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112	8	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					516	517		10.1016/j.cell.2016.04.017	http://dx.doi.org/10.1016/j.cell.2016.04.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104972	Green Submitted, Bronze			2022-12-28	WOS:000374636800009
J	Smith, JM				Smith, Jeanette M.			Pueblo Series, Acoma Raymond Jonson	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		GARMAN E, 1976, ART R JONSON PAINTER, V199, pR13; MCCAULEY EA, 1980, R JONSON EARLY YEARS, P1	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1432	1433		10.1001/jama.2015.14203	http://dx.doi.org/10.1001/jama.2015.14203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115254				2022-12-28	WOS:000373873800001
J	Takasato, M; Er, PX; Chiu, HS; Maier, B; Baillie, GJ; Ferguson, C; Parton, RG; Wolvetang, EJ; Roost, MS; Lopes, SMCD; Little, MH				Takasato, Minoru; Er, Pei X.; Chiu, Han S.; Maier, Barbara; Baillie, Gregory J.; Ferguson, Charles; Parton, Robert G.; Wolvetang, Ernst J.; Roost, Matthias S.; Lopes, Susana M. Chuva de Sousa; Little, Melissa H.			Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis (vol 526, pg 564, 2015)	NATURE			English	Correction													Wolvetang, Ernst jurgen/D-6644-2017; Takasato, Minoru/K-2035-2014; Parton, Robert/C-5673-2009; Baillie, Gregory/F-9478-2013	Wolvetang, Ernst jurgen/0000-0002-2146-6614; Takasato, Minoru/0000-0002-0458-7414; Parton, Robert/0000-0002-7494-5248; Baillie, Gregory/0000-0002-6130-250X				Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695	1	76	77	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					238	238		10.1038/nature17982	http://dx.doi.org/10.1038/nature17982			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2UG	27120161	Bronze			2022-12-28	WOS:000452218700001
J	Greer, N; Bolduc, J; Geurkink, E; Rector, T; Olson, K; Koeller, E; MacDonald, R; Wilt, TJ				Greer, Nancy; Bolduc, Jennifer; Geurkink, Eric; Rector, Thomas; Olson, Kimberly; Koeller, Eva; MacDonald, Roderick; Wilt, Timothy J.			Pharmacist-Led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care	ANNALS OF INTERNAL MEDICINE			English	Review							MEDICATION-THERAPY MANAGEMENT; BLOOD-PRESSURE CONTROL; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK REDUCTION; CONTROLLED DIABETES-MELLITUS; CLUSTER-RANDOMIZED-TRIAL; CLINICAL PHARMACIST; PHARMACEUTICAL CARE; COST-EFFECTIVENESS; HEART-FAILURE	Background: Increased involvement of pharmacists in patient care may increase access to health care and improve patient outcomes. Purpose: To determine the effectiveness and harms of pharmacist-led chronic disease management for community-dwelling adults. Data Sources: MEDLINE, Cochrane Library, CINAHL, and International Pharmaceutical Abstracts from 1995 through February 2016, and reference lists of systematic reviews and included studies. Study Selection: 65 patient populations in 63 studies conducted in the United States of any design reported outcomes of pharmacist-led chronic disease management versus a comparator for community-dwelling adults in the United States. Studies set in retail pharmacies were excluded. Data Extraction: Data extraction done by a single investigator was confirmed by a second investigator; risk of bias was assessed by 2 investigators; and strength of evidence was determined by consensus. Data Synthesis: Pharmacist-led care was associated with similar numbers of office visits, urgent care or emergency department visits, and hospitalizations (moderate-strength evidence) and medication adherence (low-strength evidence) compared with usual care (typically continuing a prestudy visit schedule). Pharmacist-led care increased the number or dose of medications received and improved study-selected glycemic, blood pressure, and lipid goal attainment (moderate-strength evidence). Mortality and clinical events were similar (low-strength evidence). Evidence on patient satisfaction was mixed and insufficient. The reporting of harms was limited. Limitations: Interventions were heterogeneous. Studies were typically short-term and designed to assess physiologic intermediate outcomes rather than clinical events. Reporting of many clinical outcomes of interest was limited, and often they were not the study-defined primary end points. Conclusion: Pharmacist-led chronic disease management was associated with effects similar to those of usual care for resource utilization and may improve physiologic goal attainment. Further research is needed to determine whether increased medication utilization and goal attainment improve clinical outcomes.	[Greer, Nancy; Bolduc, Jennifer; Geurkink, Eric; Rector, Thomas; Olson, Kimberly; Koeller, Eva; MacDonald, Roderick; Wilt, Timothy J.] Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, One Vet Dr, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Greer, N (corresponding author), Vet Affairs Med Ctr 111 O, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA.	nancy.greer@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative [09-009]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative(US Department of Veterans Affairs)	Grant Support: By the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative (#09-009).	Adler DA, 2004, GEN HOSP PSYCHIAT, V26, P199, DOI 10.1016/j.genhosppsych.2003.08.005; Aspinall SL, 2013, APPL HEALTH ECON HEA, V11, P653, DOI 10.1007/s40258-013-0057-6; Aspinall SL, 2012, AM J KIDNEY DIS, V60, P371, DOI 10.1053/j.ajkd.2012.04.013; Bogden PE, 1997, J GEN INTERN MED, V12, P158, DOI 10.1007/s11606-006-5023-7; Borenstein JE, 2003, PHARMACOTHERAPY, V23, P209, DOI 10.1592/phco.23.2.209.32096; Boudreau DM, 2002, ANN PHARMACOTHER, V36, P585, DOI 10.1345/aph.1A259; Brummel AR, 2013, POPUL HEALTH MANAG, V16, P28, DOI 10.1089/pop.2012.0023; Bucaloiu Ion D, 2007, Manag Care Interface, V20, P26; Capoccia KL, 2004, AM J HEALTH-SYST PH, V61, P364, DOI 10.1093/ajhp/61.4.364; Carter BL, 2008, J CLIN HYPERTENS, V10, P260, DOI 10.1111/j.1751-7176.2008.07434.x; Carter BL, 2015, CIRC-CARDIOVASC QUAL, V8, P235, DOI 10.1161/CIRCOUTCOMES.114.001283; Carter BL, 2009, ARCH INTERN MED, V169, P1996, DOI 10.1001/archinternmed.2009.358; Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962; Chung N, 2014, J MANAG CARE SPEC PH, V20, P914, DOI 10.18553/jmcp.2014.20.9.914; Clause S, 2001, AM J HEALTH-SYST PH, V58, P1143, DOI 10.1093/ajhp/58.12.1143; Cohen LB, 2011, DIABETES EDUCATOR, V37, P801, DOI 10.1177/0145721711423980; Cooney D, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0052-2; Ellis SL, 2000, PHARMACOTHERAPY, V20, P1508, DOI 10.1592/phco.20.19.1508.34852; Erickson SR, 1997, PHARMACOTHERAPY, V17, P140; Finley PR, 2002, AM J HEALTH-SYST PH, V59, P1518, DOI 10.1093/ajhp/59.16.1518; Finley PR, 2003, PHARMACOTHERAPY, V23, P1175, DOI 10.1592/phco.23.10.1175.32760; Fox D, 2009, J AM PHARM ASSOC, V49, P192, DOI 10.1331/JAPhA.2009.09016; Gattis WA, 1999, ARCH INTERN MED, V159, P1939, DOI 10.1001/archinte.159.16.1939; Gourley G A, 1998, J Am Pharm Assoc (Wash), V38, P586; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Gums TH, 2015, J AM SOC HYPERTENS, V9, P569, DOI 10.1016/j.jash.2015.05.005; Heisler M, 2012, CIRCULATION, V125, P2863, DOI 10.1161/CIRCULATIONAHA.111.089169; Heisler M, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-95; HEPLER CD, 1987, AM J PHARM EDUC, V51, P369; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hirsch JD, 2014, CLIN THER, V36, P1244, DOI 10.1016/j.clinthera.2014.06.030; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Ip EJ, 2013, AM J HEALTH-SYST PH, V70, P877, DOI 10.2146/ajhp120238; Irons BK, 2012, PHARM PRACT, V10, P25; Jaber LA, 1996, ANN PHARMACOTHER, V30, P238, DOI 10.1177/106002809603000305; Jacobs M, 2012, J AM PHARM ASSOC, V52, P613, DOI 10.1331/JAPhA.2012.10183; Jameson JP, 2010, AM J MANAG CARE, V16, P250; Johnson KA, 2010, ANN PHARMACOTHER, V44, P1877, DOI 10.1345/aph.1P380; KELLY C, 2000, J MANAGE CARE PHARM, V6, P488, DOI DOI 10.18553/JMCP.2000.6.6.488; Konzem SL, 1997, PHARMACOTHERAPY, V17, P576; Kulchaitanaroaj P, 2012, PHARMACOTHERAPY, V32, P772, DOI 10.1002/j.1875-9114.2012.01103.x; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; Magid DJ, 2013, CIRC-CARDIOVASC QUAL, V6, P157, DOI 10.1161/CIRCOUTCOMES.112.968172; Magid DJ, 2011, AM J MANAG CARE, V17, pE96; Malone DC, 2001, MED CARE, V39, P113, DOI 10.1097/00005650-200102000-00002; Malone DC, 2000, PHARMACOTHERAPY, V20, P1149, DOI 10.1592/phco.20.15.1149.34590; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; Mazzolini Timothy A, 2005, J Manag Care Pharm, V11, P763; McAdam-Marx Carrie, 2015, J Manag Care Spec Pharm, V21, P452; Miller AE, 2008, PHARMACOTHERAPY, V28, P553, DOI 10.1592/phco.28.5.553; Murray MD, 2007, ANN INTERN MED, V146, P714, DOI 10.7326/0003-4819-146-10-200705150-00005; Odegard PS, 2005, ANN PHARMACOTHER, V39, P433, DOI 10.1345/aph.1E438; Okamoto MP, 2001, PHARMACOTHERAPY, V21, P1337, DOI 10.1592/phco.21.17.1337.34424; Olson KL, 2009, AM J MANAG CARE, V15, P497; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Padiyara RS, 2011, J MANAGE CARE PHARM, V17, P456, DOI 10.18553/jmcp.2011.17.6.456; Pai AB, 2009, PHARMACOTHERAPY, V29, P1433, DOI 10.1592/phco.29.12.1433; Pai AB, 2009, HEMODIAL INT, V13, P72, DOI 10.1111/j.1542-4758.2009.00328.x; Pape GA, 2011, ARCH INTERN MED, V171, P1480, DOI 10.1001/archinternmed.2011.417; Polgreen LA, 2015, HYPERTENSION, V66, P1145, DOI 10.1161/HYPERTENSIONAHA.115.06023; Ralston JD, 2014, APPL CLIN INFORM, V5, P232, DOI 10.4338/ACI-2013-10-RA-0079; Rothman RL, 2005, AM J MED, V118, P276, DOI 10.1016/j.amjmed.2004.09.017; Salvo MC, 2012, ANN PHARMACOTHER, V46, P29, DOI 10.1345/aph.1Q512; Santschi V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000718; Scott DM, 2006, AM J HEALTH-SYST PH, V63, P2116, DOI 10.2146/ajhp060040; Shane-McWhorter L, 2005, PHARMACOTHERAPY, V25, P96, DOI 10.1592/phco.25.1.96.55623; Shane-McWhorter L, 2015, J AM PHARM ASSOC, V55, P516, DOI 10.1331/JAPhA.2015.14285; Skinner JS, 2015, DIABETES EDUCATOR, V41, P459, DOI 10.1177/0145721715587563; Smith MC, 2013, PHARMACOTHERAPY, V33, P736, DOI 10.1002/phar.1273; Solomon D K, 1998, J Am Pharm Assoc (Wash), V38, P574; Spence MM, 2014, J MANAG CARE SPEC PH, V20, P1036, DOI 10.18553/jmcp.2014.20.10.1036; Straka RJ, 2005, PHARMACOTHERAPY, V25, P360, DOI 10.1592/phco.25.3.360.61601; Stroup J, 2003, AM J PHARM EDUC, V67, DOI 10.5688/aj670391; Taveira TH, 2014, DIABETES RES CLIN PR, V105, P327, DOI 10.1016/j.diabres.2014.05.013; Taveira TH, 2011, ANN PHARMACOTHER, V45, P1346, DOI 10.1345/aph.1Q212; Taveira TH, 2010, DIABETES EDUCATOR, V36, P109, DOI 10.1177/0145721709352383; Taylor CT, 2003, AM J HEALTH-SYST PH, V60, P1123, DOI 10.1093/ajhp/60.11.1123; Viswanathan M, 2015, JAMA INTERN MED, V175, P76, DOI 10.1001/jamainternmed.2014.5841; Vivian EM, 2002, PHARMACOTHERAPY, V22, P1533, DOI 10.1592/phco.22.17.1533.34127; Zillich AJ, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2014.11.027	81	70	69	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					30	+		10.7326/M15-3058	http://dx.doi.org/10.7326/M15-3058			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27111098				2022-12-28	WOS:000379215800005
J	Chung, KF				Chung, Kian Fan			Dupilumab: a potential new treatment for severe asthma	LANCET			English	Editorial Material							ADULTS		[Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Expt Studies Unit, London SW7 2AZ, England; [Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, Biomed Res Unit, London SW3 6LY, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Expt Studies Unit, London SW7 2AZ, England.; Chung, KF (corresponding author), Royal Brompton & Harefield NHS Trust, Biomed Res Unit, London SW3 6LY, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426				Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Shaw DE, 2015, EUR RESPIR J, V46, P1308, DOI 10.1183/13993003.00779-2015; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; Wenzel S., 2016, LANCET; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	10	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					3	4		10.1016/S0140-6736(16)30311-7	http://dx.doi.org/10.1016/S0140-6736(16)30311-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP9PM	27130690				2022-12-28	WOS:000378828400004
J	Spatz, ES; Krumholz, HM; Moulton, BW				Spatz, Erica S.; Krumholz, Harlan M.; Moulton, Benjamin W.			The New Era of Informed Consent Getting to a Reasonable-Patient Standard Through Shared Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Spatz, Erica S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, One Church St,Ste 200, New Haven, CT 06510 USA; [Spatz, Erica S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Moulton, Benjamin W.] Harvard Univ, Sch Publ Hlth, Informed Med Decis Fdn, Healthwise Res & Advocacy, 665 Huntington Ave, Boston, MA 02115 USA	Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Spatz, ES (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, One Church St,Ste 200, New Haven, CT 06510 USA.	erica.spatz@yale.edu	, Harlan/AAI-2875-2020		AHRQ HHS [K12HS023000, K12 HS023000] Funding Source: Medline; NHLBI NIH HHS [U01 HL105270-05, U01 HL105270] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; AHRQ [5K12HS023000-05] Funding Source: Federal RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], DEC MEM SCREEN LUNG; Centers for Disease Control and Prevention, 2010, CDC NCHS NAT HOSP DI; Elwyn G, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S14; Hopper KD, 1998, SURGERY, V123, P496, DOI 10.1067/msy.1998.87236; Krumholz HM, 2010, JAMA-J AM MED ASSOC, V303, P1190, DOI 10.1001/jama.2010.309; Stacey D, 2014, COCHRANE DATABASE SY, V1	6	123	126	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2016	315	19					2063	2064		10.1001/jama.2016.3070	http://dx.doi.org/10.1001/jama.2016.3070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9PN	27099970	Green Accepted, Bronze			2022-12-28	WOS:000375975300010
J	Savage, N				Savage, Neil			START-UPS A sense of enterprise	NATURE			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					S10	S12		10.1038/533S10a	http://dx.doi.org/10.1038/533S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL2OE	27144602	Bronze			2022-12-28	WOS:000375473900001
J	Stewart-Jones, GBE; Soto, C; Lemmin, T; Chuang, GY; Druz, A; Kong, R; Thomas, PV; Wagh, K; Zhou, TQ; Behrens, AJ; Bylund, T; Choi, CW; Davison, JR; Georgiev, IS; Joyce, MG; Do Kwon, Y; Pancera, M; Taft, J; Yang, YP; Zhang, BS; Shivatare, SS; Shivatare, VS; Lee, CCD; Wu, CY; Bewley, CA; Burton, DR; Koff, WC; Connors, M; Crispin, M; Baxa, U; Korber, BT; Wong, CH; Mascola, JR; Kwong, PD				Stewart-Jones, Guillaume B. E.; Soto, Cinque; Lemmin, Thomas; Chuang, Gwo-Yu; Druz, Aliaksandr; Kong, Rui; Thomas, Paul V.; Wagh, Kshitij; Zhou, Tongqing; Behrens, Anna-Janina; Bylund, Tatsiana; Choi, Chang W.; Davison, Jack R.; Georgiev, Ivelin S.; Joyce, M. Gordon; Do Kwon, Young; Pancera, Marie; Taft, Justin; Yang, Yongping; Zhang, Baoshan; Shivatare, Sachin S.; Shivatare, Vidya S.; Lee, Chang-Chun D.; Wu, Chung-Yi; Bewley, Carole A.; Burton, Dennis R.; Koff, Wayne C.; Connors, Mark; Crispin, Max; Baxa, Ulrich; Korber, Bette T.; Wong, Chi-Huey; Mascola, John R.; Kwong, Peter D.			l Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G	CELL			English	Article							BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; RECOGNITION; POTENT; VULNERABILITY; MATURATION; SUPERSITE; EVOLUTION; ANTIGENS	The HIV-1-envelope (Env) trimer is covered by a glycan shield of similar to 90 N-linked oligosaccharides, which comprises roughly half its mass and is a key component of HIV evasion from humoral immunity. To understand how antibodies can overcome the barriers imposed by the glycan shield, we crystallized fully glycosylated Env trimers from clades A, B, and G, visualizing the shield at 3.4-3.7 angstrom resolution. These structures reveal the HIV-1-glycan shield to comprise a network of interlocking oligosaccharides, substantially ordered by glycan crowding, that encase the protein component of Env and enable HIV-1 to avoid most antibody-mediated neutralization. The revealed features delineate a taxonomy of N-linked glycan-glycan interactions. Crowded and dispersed glycans are differently ordered, conserved, processed, and recognized by antibody. The structures, along with glycan-array binding and molecular dynamics, reveal a diversity in oligosaccharide affinity and a requirement for accommodating glycans among known broadly neutralizing antibodies that target the glycan-shielded trimer.	[Stewart-Jones, Guillaume B. E.; Soto, Cinque; Lemmin, Thomas; Chuang, Gwo-Yu; Druz, Aliaksandr; Kong, Rui; Thomas, Paul V.; Zhou, Tongqing; Bylund, Tatsiana; Choi, Chang W.; Georgiev, Ivelin S.; Joyce, M. Gordon; Do Kwon, Young; Pancera, Marie; Taft, Justin; Yang, Yongping; Zhang, Baoshan; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lemmin, Thomas] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wagh, Kshitij; Korber, Bette T.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, POB 1663, Los Alamos, NM 87544 USA; [Behrens, Anna-Janina; Crispin, Max] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, S Parks Rd, Oxford OX1 3QU, England; [Davison, Jack R.; Bewley, Carole A.] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Shivatare, Sachin S.; Shivatare, Vidya S.; Lee, Chang-Chun D.; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA 02142 USA; [Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Baxa, Ulrich] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Electron Microscopy Lab, Ft Detrick, MD 21702 USA; [Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Academia Sinica - Taiwan; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Scripps Research Institute	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Wagh, Kshitij/ABB-5002-2020; Do Kwon, Young/A-6957-2010; Mascola, John/AAI-7193-2021; Crispin, Max/AAG-4098-2020; Zhou, Tongqing/A-6880-2010; Shivatare, Sachin S/G-7264-2017; Lemmin, Thomas/AAO-7849-2021; Wu, Chung-Yi/K-8334-2018; Davison, Jack R/L-8151-2019	Do Kwon, Young/0000-0002-1188-7458; Crispin, Max/0000-0002-1072-2694; Zhou, Tongqing/0000-0002-3935-4637; Shivatare, Sachin S/0000-0002-7512-752X; Davison, Jack R/0000-0002-6803-304X; Bewley, Carole/0000-0003-2203-0852; Korber, Bette/0000-0002-2026-5757; Lemmin, Thomas/0000-0001-5705-4964; Baxa, Ulrich/0000-0002-7263-5078	Intramural Research Program of the Vaccine Research Center; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH); International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill AMP; Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; UK Department for International Development; United States Agency for International Development (USAID); International AIDS Vaccine Initiative Neutralizing Antibody Center CAVD grant; Scripps Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) grant [1UM1AI100663]; Duke CHAVI-ID grant [UM1 AI100645]; Swiss National Foundation of Science Fellowship [148914]; Academia Sinica; Ministry of Science and Technology [MOST 104-0210-01-09-02, 103-2321-B-001-004]; NIH [R01 AI072155]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38];  [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, UM1AI100663, ZICAI005113, ZICAI005112, ZIAAI005023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK032103] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; Bill AMP; Melinda Gates Foundation(CGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; UK Department for International Development; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); International AIDS Vaccine Initiative Neutralizing Antibody Center CAVD grant; Scripps Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) grant; Duke CHAVI-ID grant; Swiss National Foundation of Science Fellowship; Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. O'Connor for NMR support, J. Stuckey for assistance with graphics, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center for discussions and comments on the manuscript. We thank Acellera for assistance with molecular dynamics simulations. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), and from the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium. IAVI's work is made possible by support from many donors, including the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation; the UK Department for International Development; and the United States Agency for International Development (USAID). The contents of this manuscript do not necessarily reflect the views of USAID or the US Government. The full list of IAVI donors is available at http://www.iavi.org. A.-J.B. and M. Crispin were supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center CAVD grant (Glycan characterization and Outer Domain glycoform design) and the Scripps Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) grant 1UM1AI100663. K.W. and B.K. were supported by the Duke CHAVI-ID grant UM1 AI100645. T.L. was supported by the Swiss National Foundation of Science Fellowship 148914. V.S.S., C.-C.D.L., C.-Y.W., and C.-H.W. were supported by Academia Sinica and Ministry of Science and Technology grants MOST 104-0210-01-09-02 and 103-2321-B-001-004. C.-H.W. was supported by NIH grant R01 AI072155. The Frederick National Laboratory for Cancer Research, National Institutes of Health, is supported under contract HHSN261200800001E. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HANOVER JA, 1980, J BIOL CHEM, V255, P3600; Helle F, 2011, VIRUSES-BASEL, V3, P1909, DOI 10.3390/v3101909; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Shivatare SS, 2016, NAT CHEM, V8, P338, DOI [10.1038/NCHEM.2463, 10.1038/nchem.2463]; Sommerstein R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005276; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Varki A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005462; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	46	283	287	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					813	826		10.1016/j.cell.2016.04.010	http://dx.doi.org/10.1016/j.cell.2016.04.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27114034	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000375800300011
J	Siemieniuk, RAC; Alonso-Coello, P; Guyatt, GH				Siemieniuk, Reed A. C.; Alonso-Coello, Pablo; Guyatt, Gordon H.			Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia Response	ANNALS OF INTERNAL MEDICINE			English	Letter							METAANALYSIS		[Siemieniuk, Reed A. C.; Guyatt, Gordon H.] McMaster Univ, Hamilton, ON, Canada; [Alonso-Coello, Pablo] Inst Invest Biomed St Pau, CIBER Epidemiol & Salud Publ, Barcelona, Spain	McMaster University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Siemieniuk, RAC (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Rover C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0091-1	4	2	2	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					636	637		10.7326/L15-0583	http://dx.doi.org/10.7326/L15-0583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136220				2022-12-28	WOS:000375744000034
J	Cooper, J; Roberts, W				Cooper, June; Roberts, William			Katherine Nola Williams OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2422	10.1136/bmj.i2422	http://dx.doi.org/10.1136/bmj.i2422			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27130154				2022-12-28	WOS:000375484100008
J	El-Awady, N				El-Awady, Nadia			SHARED KNOWLEDGE IS KEY TO A KINGDOM	NATURE			English	Editorial Material																			0	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					S16	S18		10.1038/532S16a	http://dx.doi.org/10.1038/532S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK3KQ	27135101	Bronze			2022-12-28	WOS:000374815900004
J	Kressin, NR; Gunn, CM; Battaglia, TA				Kressin, Nancy R.; Gunn, Christine M.; Battaglia, Tracy A.			Content, Readability, and Understandability of Dense Breast Notifications by State	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							LEGISLATION		[Kressin, Nancy R.] Boston Univ, Sch Med, Vet Affairs Boston Healthcare Syst, 801 Massachusetts Ave, Boston, MA 02118 USA; [Gunn, Christine M.; Battaglia, Tracy A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Kressin, NR (corresponding author), Boston Univ, Sch Med, Vet Affairs Boston Healthcare Syst, 801 Massachusetts Ave, Boston, MA 02118 USA.	nkressin@bu.edu		Gunn, Christine/0000-0003-3340-2834; Kressin, Nancy/0000-0003-2767-4286				Freer PE, 2015, BREAST CANCER RES TR, V153, P455, DOI 10.1007/s10549-015-3534-9; Kutner M, HLTH LITERACY AM ADU; LAYTON JR, 1980, J READING, V24, P239; Roman L, 2014, J WOMENS HEALTH, V23, P57, DOI 10.1089/jwh.2013.4397; Shoemaker, PATIENT ED MAT ASSES; Slanetz PJ, 2015, NEW ENGL J MED, V372, P593, DOI 10.1056/NEJMp1413728	6	52	52	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1786	1788		10.1001/jama.2016.1712	http://dx.doi.org/10.1001/jama.2016.1712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115382	Bronze			2022-12-28	WOS:000374759300027
J	Vetter, C; Devore, EE; Wegrzyn, LR; Massa, J; Speizer, FE; Kawachi, I; Rosner, B; Stampfer, MJ; Schernhammer, ES				Vetter, Celine; Devore, Elizabeth E.; Wegrzyn, Lani R.; Massa, Jennifer; Speizer, Frank E.; Kawachi, Ichiro; Rosner, Bernard; Stampfer, Meir J.; Schernhammer, Eva S.			Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; HEALTH; QUESTIONNAIRE; OBESITY; STRESS; REPRODUCIBILITY; CHRONOTYPE; VALIDITY; IMPACT	IMPORTANCE Prospective studies linking shift work to coronary heart disease (CHD) have been inconsistent and limited by short follow-up. OBJECTIVE To determine whether rotating night shift work is associated with CHD risk. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 189 158 initially healthy women followed up over 24 years in the Nurses' Health Studies (NHS [1988-2012]: N = 73 623 and NHS2 [1989-2013]: N = 115 535). EXPOSURES Lifetime history of rotating night shift work (>= 3 night shifts per month in addition to day and evening shifts) at baseline (updated every 2 to 4 years in the NHS2). MAIN OUTCOMES AND MEASURES Incident CHD; ie, nonfatal myocardial infarction, CHD death, angiogram-confirmed angina pectoris, coronary artery bypass graft surgery, stents, and angioplasty. RESULTS During follow-up, 7303 incident CHD cases occurred in the NHS (mean age at baseline, 54.5 years) and 3519 in the NHS2 (mean age, 34.8 years). In multivariable-adjusted Cox proportional hazards models, increasing years of baseline rotating night shift work was associated with significantly higher CHD risk in both cohorts. In the NHS, the association between duration of shift work and CHD was stronger in the first half of follow-up than in the second half (P=.02 for interaction), suggesting waning risk after cessation of shift work. Longer time since quitting shift work was associated with decreased CHD risk among ever shift workers in the NHS2 (P<.001 for trend). [GRAPHICS] CONCLUSIONS AND RELEVANCE Among women who worked as registered nurses, longer duration of rotating night shift work was associated with a statistically significant but small absolute increase in CHD risk. Further research is needed to explore whether the association is related to specific work hours and individual characteristics.	[Vetter, Celine; Devore, Elizabeth E.; Speizer, Frank E.; Rosner, Bernard; Stampfer, Meir J.; Schernhammer, Eva S.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Vetter, Celine; Devore, Elizabeth E.; Speizer, Frank E.; Rosner, Bernard; Stampfer, Meir J.; Schernhammer, Eva S.] Harvard Univ, Sch Med, Boston, MA USA; [Wegrzyn, Lani R.; Stampfer, Meir J.; Schernhammer, Eva S.] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Massa, Jennifer; Stampfer, Meir J.] Harvard Univ, Dept Nutr, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Speizer, Frank E.] Harvard Univ, Dept Environm Hlth, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kawachi, Ichiro] Harvard Univ, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Rosner, Bernard] Harvard Univ, Dept Biostat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Schernhammer, Eva S.] Med Univ Vienna, Dept Epidemiol, Ctr Publ Hlth, Vienna, Austria	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Medical University of Vienna	Vetter, C (corresponding author), Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	celine.vetter@channing.harvard.edu	Schernhammer, Eva S/L-7898-2018; Vetter, Celine/U-1036-2019	Schernhammer, Eva S/0000-0002-4337-9415; Vetter, Celine/0000-0002-3752-1067	Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health [5R01OH009803, UM1CA186107, UM1CA176726, R01HL034594]; German Research Foundation [VE 835/1-1]; NATIONAL CANCER INSTITUTE [UM1CA186107, UM1CA176726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH009803] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This research was supported by Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health grants 5R01OH009803 (to Dr Schernhammer), UM1CA186107, UM1CA176726, and R01HL034594. Dr Vetter was additionally supported by a fellowship from the German Research Foundation (VE 835/1-1).	Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6; Baron KG, 2014, INT REV PSYCHIATR, V26, P139, DOI 10.3109/09540261.2014.911149; Bernstein AB, 2003, DHHS PUBLICATION, V2004-1031; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Costa G, 1996, APPL ERGON, V27, P9, DOI 10.1016/0003-6870(95)00047-X; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Fujishiro K, 2015, OCCUP ENVIRON MED, V72, P690, DOI 10.1136/oemed-2014-102311; Harrington JM, 2001, OCCUP ENVIRON MED, V58, P68, DOI 10.1136/oem.58.1.68; Hoffmann B, 2015, OCCUP ENVIRON MED, V72, P687, DOI 10.1136/oemed-2014-102640; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hublin C, 2010, EUR J EPIDEMIOL, V25, P315, DOI 10.1007/s10654-010-9439-3; Jensen MK, 2014, NAT REV ENDOCRINOL, V10, P659, DOI 10.1038/nrendo.2014.155; Juda M, 2013, J BIOL RHYTHM, V28, P141, DOI 10.1177/0748730412475042; Kantermann T, 2010, SLEEP BIOL RHYTHMS, V8, P95, DOI 10.1111/j.1479-8425.2010.00432.x; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; Knutsson A, 1989, Scand J Soc Med Suppl, V44, P1; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Leclerc A, 2010, EUR J EPIDEMIOL, V25, P285, DOI 10.1007/s10654-010-9456-2; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Redline S, 2011, CIRCULATION, V124, P2049, DOI 10.1161/CIRCULATIONAHA.111.062190; Roenneberg T, 2012, SLEEP BIOL RHYTHMS, V10, P75, DOI 10.1111/j.1479-8425.2012.00541.x; Rose G, 1982, CARDIVOSCULAR SURVEY; Ruger M, 2009, REV ENDOCR METAB DIS, V10, P245, DOI 10.1007/s11154-009-9122-8; Standsfeld SA, 2002, STRESS HEART PSYCHOS, P21; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; VYAS MV, 2012, BMJ-BRIT MED J, V345, P4800; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26	36	219	227	2	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1726	1734		10.1001/jama.2016.4454	http://dx.doi.org/10.1001/jama.2016.4454			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK2QK	27115377	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000374759300020
J	Kump, L				Kump, Lee			Mineral clues to past volcanism	SCIENCE			English	Editorial Material									[Kump, Lee] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kump, L (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	lkump@psu.edu						Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Dessert C, 2003, CHEM GEOL, V202, P257, DOI 10.1016/j.chemgeo.2002.10.001; Fischer A.G., 1981, BIOTIC CRISES ECOLOG, P103, DOI DOI 10.1016/B978-0-12-519640-6.50012-0; Holland HD., 1984, CHEM EVOLUTION ATMOS; Jagoutz O, 2016, P NATL ACAD SCI USA, V113, P4935, DOI 10.1073/pnas.1523667113; Kent DV, 2008, P NATL ACAD SCI USA, V105, P16065, DOI 10.1073/pnas.0805382105; McKenzie NR, 2016, SCIENCE, V352, P444, DOI 10.1126/science.aad5787; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776	9	2	2	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					411	412		10.1126/science.aaf6612	http://dx.doi.org/10.1126/science.aaf6612			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102466				2022-12-28	WOS:000374479700025
J	Guglani, S				Guglani, Sam			The Notes: encounters with medicine	LANCET			English	Editorial Material									[Guglani, Sam] Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	Guglani, S (corresponding author), Cheltenham Gen Hosp, Ctr Oncol, Cheltenham GL53 7AN, Glos, England.	sam@medicineunboxed.org						Heaney Seamus, 2002, FINDERS KEEPERS SELE; Miller A., 1961, DEATH SALESMAN	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1497	1497		10.1016/S0140-6736(16)30170-2	http://dx.doi.org/10.1016/S0140-6736(16)30170-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27115961				2022-12-28	WOS:000373741600011
J	Snyder, A				Snyder, Alison			Willard Cates, Jr Obituary	LANCET			English	Biographical-Item																		CATES W, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1506	1506		10.1016/S0140-6736(16)30136-2	http://dx.doi.org/10.1016/S0140-6736(16)30136-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27115969	Bronze			2022-12-28	WOS:000373741600018
J	Smith, GD				Smith, George Davey			A fatter, healthier but more unequal world	LANCET			English	Editorial Material							OBESITY		[Smith, George Davey] Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England	University of Bristol	Smith, GD (corresponding author), Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England.	julia.mackay@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475				Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bourdieu Pierre, 1999, WEIGHT WORLD; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Goda T, 2017, SOC INDIC RES, V130, P1051, DOI 10.1007/s11205-015-1222-0; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Krishna A, 2015, AM J CLIN NUTR, V101, P598, DOI 10.3945/ajcn.114.100073; Pontzer H, 2016, CURR BIOL, V26, P410, DOI 10.1016/j.cub.2015.12.046; Razak F, 2015, JAMA-J AM MED ASSOC, V314, P2164, DOI 10.1001/jama.2015.15666; Richmond RC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001618; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Subramanian SV, 2013, INT J EPIDEMIOL, V42, P1410, DOI 10.1093/ije/dyt017; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Varbo A, 2015, CIRC RES, V116, P665, DOI 10.1161/CIRCRESAHA.116.304846	16	22	22	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1349	+		10.1016/S0140-6736(16)00588-2	http://dx.doi.org/10.1016/S0140-6736(16)00588-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI0WH	27115799	hybrid, Green Submitted			2022-12-28	WOS:000373217500007
J	Gao, J; Barzel, B; Barabasi, AL				Gao, Jianxi; Barzel, Baruch; Barabasi, Albert-Laszlo			Universal resilience patterns in complex networks (vol 530, pg 307, 2016)	NATURE			English	Correction													Barabasi, Albert-Laszlo/S-6474-2017; Gao, Jianxi/I-1300-2013	Gao, Jianxi/0000-0002-3952-208X; Barabasi, Albert/0000-0002-4028-3522				Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948	1	13	14	27	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					238	238		10.1038/nature18019	http://dx.doi.org/10.1038/nature18019			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27144362	Bronze			2022-12-28	WOS:000381472100042
J	Duan-Porter, W; Goldstein, KM; McDuffie, JR; Hughes, JM; Clowse, MEB; Klap, RS; Masilamani, V; LaPointe, NMA; Nagi, A; Gierisch, JM; Williams, JW				Duan-Porter, Wei; Goldstein, Karen M.; McDuffie, Jennifer R.; Hughes, Jaime M.; Clowse, Megan E. B.; Klap, Ruth S.; Masilamani, Varsha; LaPointe, Nancy M. Allen; Nagi, Avishek; Gierisch, Jennifer M.; Williams, John W., Jr.			Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; SELF-MANAGEMENT EDUCATION; LOW-GLYCEMIC-INDEX; QUALITY-OF-LIFE; CLINICAL-TRIALS; KNEE OSTEOARTHRITIS; GENDER-DIFFERENCES; AFRICAN-AMERICANS	Systematic reviews (SRs) have the potential to contribute uniquely to the evaluation of sex and gender differences (termed "sex effects"). This article describes the reporting of sex effects by SRs on interventions for depression, type 2 diabetes mellitus, and chronic pain conditions (chronic low back pain, knee osteoarthritis, and fibromyalgia). It includes SRs published since 1 October 2009 that evaluate medications, behavioral interventions, exercise, quality improvement, and some condition-specific treatments. The reporting of sex effects by primary randomized, controlled trials is also examined. Of 313 eligible SRs (86 for depression, 159 for type 2 diabetes mellitus, and 68 for chronic pain), few (n = 29) reported sex effects. Most SRs reporting sex effects used metaregression, whereas 9 SRs used subgroup analysis or individual-patient data meta-analysis. The proportion of SRs reporting the sex distribution of primary studies varied from a low of 31% (n = 8) for low back pain to a high of 68% (n = 23) for fibromyalgia. Primary randomized, controlled trials also infrequently reported sex effects, and most lacked an adequate sample size to examine them. Therefore, all SRs should report the proportion of women enrolled in primary studies and evaluate sex effects using appropriate methods whenever power is adequate.	Durham Vet Affairs Med Ctr, Durham, NC USA; [Clowse, Megan E. B.] Duke Univ, Sch Med, 200 Trent Dr,7 Baker House, Durham, NC 27710 USA; [Hughes, Jaime M.] Univ N Carolina, Campus Box 7200, Chapel Hill, NC 27599 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Durham Vet Affairs Med Ctr, Hlth Adm Hlth Serv Res & Dev, 411 West Chapel Hill St,Suite 600, Durham, NC 27701 USA; [Duan-Porter, Wei; McDuffie, Jennifer R.; Masilamani, Varsha; Nagi, Avishek] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev, 411 West Chapel Hill St,Suite 600, Durham, NC 27701 USA; [Goldstein, Karen M.; Gierisch, Jennifer M.] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev, 508 Fulton St, Durham, NC 27705 USA; [Klap, Ruth S.] Vet Affairs West Los Angeles Med Ctr, 11301 Wilshire Blvd,Bldg 206,Room 231, Los Angeles, CA 90073 USA; [LaPointe, Nancy M. Allen] Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA; [Williams, John W., Jr.] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev, 411 West Chapel Hill St,Suite 500, Durham, NC 27701 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Duan-Porter, W (corresponding author), Durham Vet Affairs Med Ctr, Hlth Adm Hlth Serv Res & Dev, 411 West Chapel Hill St,Suite 600, Durham, NC 27701 USA.	wei.duan-porter@duke.edu	Gierisch, Jennifer/GLU-1269-2022	, Nancy/0000-0002-6390-8337; Goldstein, Karen/0000-0003-4419-5869; Hughes, Jaime/0000-0001-6410-0068	Veterans Affairs Office of Academic Affiliations [TPM 21-022]; Veterans Health Administration Health Services Research Development [13-263]	Veterans Affairs Office of Academic Affiliations; Veterans Health Administration Health Services Research Development	By the Veterans Affairs Office of Academic Affiliations (fellowship support TPM 21-022; Dr. Duan-Porter) and the Veterans Health Administration Health Services Research & Development (Career Development Award 13-263; Dr. Goldstein).	Agency for Healthcare Research and Quality, 2015, METH GUID EFF COMP E; Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Alabas OA, 2012, EUR J PAIN, V16, P1211, DOI 10.1002/j.1532-2149.2012.00121.x; Anderson RM, 2005, ETHNIC DIS, V15, P671; Anthony Marietta, 2002, J Womens Health Gend Based Med, V11, P601, DOI 10.1089/152460902760360559; Arksey H, 2003, HEALTH SOC CARE COMM, V11, P335, DOI 10.1046/j.1365-2524.2003.00433.x; Arslanian-Engoren C, 2005, WOMEN HEALTH, V42, P53, DOI 10.1300/J013v42n02_04; Attridge M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub3; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Bailey KR, 2007, MAYO CLIN PROC, V82, P158; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Bellary S, 2008, LANCET, V371, P1769, DOI 10.1016/S0140-6736(08)60764-3; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P473, DOI 10.1017/S0140525X97591497; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Bhat VM, 2008, STROKE, V39, P2439, DOI 10.1161/STROKEAHA.107.510073; Biesheuvel-Leliefeld KEM, 2015, J AFFECT DISORDERS, V174, P400, DOI 10.1016/j.jad.2014.12.016; Blauwet LA, 2007, MAYO CLIN PROC, V82, P166; Blonde L, 2015, CURR MED RES OPIN, V31, P1993, DOI 10.1185/03007995.2015.1082991; Bower P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f540; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Braun SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068135; Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259; Calati R, 2013, J AFFECT DISORDERS, V147, P1, DOI 10.1016/j.jad.2012.11.053; Carter GC, 2012, DEPRESS ANXIETY, V29, P340, DOI 10.1002/da.21918; Cawston H, 2013, EUR SPINE J, V22, P1996, DOI 10.1007/s00586-013-2804-7; Centers for Disease Control and Prevention, 2015, AMB HLTH CAR DAT AMB; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Crowley MJ, 2013, AM HEART J, V166, P179, DOI 10.1016/j.ahj.2013.04.004; Cuijpers P, 2014, DEPRESS ANXIETY, V31, P941, DOI 10.1002/da.22328; Cuijpers P, 2014, J AFFECT DISORDERS, V159, P118, DOI 10.1016/j.jad.2014.02.026; Cuijpers P, 2012, DEPRESS ANXIETY, V29, P855, DOI 10.1002/da.21985; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Di Loreto C, 2003, DIABETES CARE, V26, P404, DOI 10.2337/diacare.26.2.404; Dreeks JJ, COCHRANE HDB SYSTEMA, pChapter 9; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Driessen E, 2010, CLIN PSYCHOL REV, V30, P25, DOI 10.1016/j.cpr.2009.08.010; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Esposito K, 2011, DIABETES OBES METAB, V13, P594, DOI 10.1111/j.1463-1326.2011.01380.x; Esposito K, 2012, DIABETES OBES METAB, V14, P228, DOI 10.1111/j.1463-1326.2011.01512.x; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-00004; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Fakhoury WKH, 2010, PHARMACOLOGY, V86, P44, DOI 10.1159/000314690; Farkas RH, 2013, NEW ENGL J MED, V369, P689, DOI 10.1056/NEJMp1307972; Forte ML, 2015, AHRQ PUBLICTION; Foulkes MA, 2011, J WOMENS HEALTH, V20, P829, DOI 10.1089/jwh.2010.2527; Frank E, 2011, PSYCHOL MED, V41, P151, DOI 10.1017/S0033291710000553; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gary TL, 2009, ARCH INTERN MED, V169, P1788, DOI 10.1001/archinternmed.2009.338; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Gibiino S, 2014, INT J NEUROPSYCHOPH, V17, P1, DOI 10.1017/S1461145713000746; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Groop PH, 2014, DIABETES OBES METAB, V16, P560, DOI 10.1111/dom.12281; Gucciardi E, 2013, PATIENT EDUC COUNS, V92, P235, DOI 10.1016/j.pec.2013.03.007; Hawthorne K, 1997, BRIT J GEN PRACT, V47, P301; Hay EM, 2006, BRIT MED J, V333, P995, DOI 10.1136/BMJ.38977.590752.0B; He SY, 2014, TUMOR BIOL, V35, P2095, DOI 10.1007/s13277-013-1278-x; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; Hurley MV, 2007, ARTHRIT RHEUM-ARTHR, V57, P1211, DOI 10.1002/art.22995; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; Jenkinson CM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3170; Johansen OE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-3; Johnson RE, 2007, SPINE, V32, P1578, DOI 10.1097/BRS.0b013e318074f890; Johnson SM, 2003, J WOMEN HEALTH GEN-B, V12, P449, DOI 10.1089/154099903766651577; Kao MJ, 2012, ARCH GERONTOL GERIAT, V54, P317, DOI 10.1016/j.archger.2011.05.018; Kim ESH, 2008, J AM COLL CARDIOL, V52, P672, DOI 10.1016/j.jacc.2008.05.025; Kokras N, 2011, EXPERT OPIN DRUG MET, V7, P213, DOI 10.1517/17425255.2011.544250; Kramer CK, 2013, LANCET DIABETES ENDO, V1, P28, DOI 10.1016/S2213-8587(13)70006-8; Lamanna C, 2011, DIABETES OBES METAB, V13, P221, DOI 10.1111/j.1463-1326.2010.01349.x; Lapane KL, 2013, DRUG AGING, V30, P527, DOI 10.1007/s40266-013-0081-0; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Leon AC, 2009, COMPUT STAT DATA AN, V53, P603, DOI 10.1016/j.csda.2008.06.010; Lichtman JH, 2015, CIRC-CARDIOVASC QUAL, V8, pS31, DOI 10.1161/CIRCOUTCOMES.114.001612; Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313; Mancini M, 2012, INT CLIN PSYCHOPHARM, V27, P298, DOI 10.1097/YIC.0b013e3283589a3f; Mann AH, 1998, BRIT J GEN PRACT, V48, P875; McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C; Melloni C, 2010, CIRC-CARDIOVASC QUAL, V3, P135, DOI 10.1161/CIRCOUTCOMES.110.868307; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Miaskowski C, 2000, PROG PAIN RES MANAG, V17, P209; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; National Institutes of Health, 2015, INCL WOM MIN CLIN RE; O'Hare JP, 2004, DIABETIC MED, V21, P1357, DOI 10.1111/j.1464-5491.2004.01373.x; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Pardue M. L., 2001, EXPLORING BIOL CONTR; Parikh M, 2013, J AM COLL SURGEONS, V217, P527, DOI 10.1016/j.jamcollsurg.2013.04.023; Poole H, 2007, EUR J PAIN, V11, P878, DOI 10.1016/j.ejpain.2007.01.006; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rosal MC, 2011, DIABETES CARE, V34, P838, DOI 10.2337/dc10-1981; Rose MJ, 1997, SPINE, V22, P2246, DOI 10.1097/00007632-199710010-00009; Roshanaei-Moghaddam B, 2011, DEPRESS ANXIETY, V28, P560, DOI 10.1002/da.20829; Rubenstein LV, 2009, VA EVIDENCE BASED SY; Ryan RE, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-16; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; Schweikert B, 2006, J RHEUMATOL, V33, P2519; Schweizer A, 2010, DIABETES OBES METAB, V12, P485, DOI 10.1111/j.1463-1326.2010.01215.x; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Sim K, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv076; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Smeets RJEM, 2008, PAIN, V134, P263, DOI 10.1016/j.pain.2007.04.021; Soares CN, 2014, J CLIN PSYCHOPHARM, V34, P57, DOI 10.1097/JCP.0000000000000049; Springer KW, 2012, SOC SCI MED, V74, P1817, DOI 10.1016/j.socscimed.2011.05.033; Strand V, 2015, J PAIN RES, V8, P217, DOI 10.2147/JPR.S83076; Taichman DB, 2016, JAMA-J AM MED ASSOC, V315, P467, DOI 10.1001/jama.2015.18164; Thota AB, 2012, AM J PREV MED, V42, P525, DOI 10.1016/j.amepre.2012.01.019; Thrasher J, 2015, POSTGRAD MED, V127, P419, DOI 10.1080/00325481.2015.1027132; Toobert DJ, 2011, TRANSL BEHAV MED, V1, P416, DOI 10.1007/s13142-010-0011-1; Toobert DJ, 2011, ANN BEHAV MED, V41, P310, DOI 10.1007/s12160-010-9256-7; Toobert DJ, 2003, DIABETES CARE, V26, P2288, DOI 10.2337/diacare.26.8.2288; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; von Wolff A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-61; Wang GF, 2015, OBES SURG, V25, P199, DOI 10.1007/s11695-014-1391-y; Waterschoot FPC, 2014, PAIN, V155, P179, DOI 10.1016/j.pain.2013.10.006; Weinberger AH, 2010, J WOMENS HEALTH, V19, P1727, DOI 10.1089/jwh.2009.1784; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114; Yip YB, 2007, PATIENT EDUC COUNS, V65, P113, DOI 10.1016/j.pec.2006.06.019	121	19	20	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					184	+		10.7326/M15-2877	http://dx.doi.org/10.7326/M15-2877			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27111355	Green Accepted			2022-12-28	WOS:000380583300007
J	Pellicer, A; Galliano, D				Pellicer, Antonio; Galliano, Daniela			Hysteroscopy before IVF: can it improve outcomes?	LANCET			English	Editorial Material							IN-VITRO FERTILIZATION; PERSONALIZED EMBRYO-TRANSFER; IMPLANTATION FAILURE; OFFICE HYSTEROSCOPY; UTERINE CAVITY		[Pellicer, Antonio; Galliano, Daniela] IVI, I-00197 Rome, Italy		Pellicer, A (corresponding author), IVI, I-00197 Rome, Italy.	apellicer@ivi.es	Pellicer, Antonio/AAA-6005-2020	Pellicer, Antonio/0000-0002-8254-863X				Diez-Juan A, 2015, FERTIL STERIL, V104, P534, DOI 10.1016/j.fertnstert.2015.05.022; El-Toukhy T, 2016, LANCET; Fatemi HM, 2010, HUM REPROD, V25, P1959, DOI 10.1093/humrep/deq150; Franasiak JM, 2015, FERTIL STERIL, V104, P1364, DOI 10.1016/j.fertnstert.2015.10.012; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kilic Y, 2013, ARCH GYNECOL OBSTET, V287, P577, DOI 10.1007/s00404-012-2584-z; Negm SMM, 2012, J MINIM INVAS GYN, V19, P503, DOI 10.1016/j.jmig.2012.03.021; Ruiz-Alonso M, 2014, HUM REPROD, V29, P1244, DOI 10.1093/humrep/deu070; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Smit JG, 2016, LANCET, P00231	11	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2578	2579		10.1016/S0140-6736(16)00549-3	http://dx.doi.org/10.1016/S0140-6736(16)00549-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	27132054				2022-12-28	WOS:000378390500006
J	Lane, R				Lane, Richard			Jean-Paul Moatti: charismatic French leader in global health	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2191	2191		10.1016/S0140-6736(16)30270-7	http://dx.doi.org/10.1016/S0140-6736(16)30270-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27145709				2022-12-28	WOS:000376820800021
J	Spaun, B; Changala, PB; Patterson, D; Bjork, BJ; Heckl, OH; Doyle, JM; Ye, J				Spaun, Ben; Changala, P. Bryan; Patterson, David; Bjork, Bryce J.; Heckl, Oliver H.; Doyle, John M.; Ye, Jun			Continuous probing of cold complex molecules with infrared frequency comb spectroscopy	NATURE			English	Article							VIBRATIONAL-SPECTRA; MICROWAVE-SPECTRUM; INTERNAL-ROTATION; RADICAL CATIONS; FORCE-FIELD; NITROMETHANE; NAPHTHALENE; BAND; RAMAN; APPROXIMATION	For more than half a century, high-resolution infrared spectroscopy has played a crucial role in probing molecular structure and dynamics. Such studies have so far been largely restricted to relatively small and simple systems, because at room temperature even molecules of modest size already occupy many millions of rotational/vibrational states, yielding highly congested spectra that are difficult to assign. Targeting more complex molecules requires methods that can record broadband infrared spectra (that is, spanning multiple vibrational bands) with both high resolution and high sensitivity. However, infrared spectroscopic techniques have hitherto been limited either by narrow bandwidth and long acquisition time(1), or by low sensitivity and resolution(2). Cavity-enhanced direct frequency comb spectroscopy (CE-DFCS) combines the inherent broad bandwidth and high resolution of an optical frequency comb with the high detection sensitivity provided by a high-finesse enhancement cavity(3,4), but it still suffers from spectral congestion(5). Here we show that this problem can be overcome by using buffer gas cooling(6) to produce continuous, cold samples of molecules that are then subjected to CE-DFCS. This integration allows us to acquire a rotationally resolved direct absorption spectrum in the C-H stretching region of nitromethane, a model system that challenges our understanding of large-amplitude vibrational motion(7-9). We have also used this technique on several large organic molecules that are of fundamental spectroscopic and astrochemical relevance, including naphthalene(10), adamantane(11) and hexamethylenetetramine(12). These findings establish the value of our approach for studying much larger and more complex molecules than have been probed so far, enabling complex molecules and their kinetics to be studied with orders-of-magnitude improvements in efficiency, spectral resolution and specificity.	[Spaun, Ben; Changala, P. Bryan; Bjork, Bryce J.; Heckl, Oliver H.; Ye, Jun] Univ Colorado, Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA; [Spaun, Ben; Changala, P. Bryan; Bjork, Bryce J.; Heckl, Oliver H.; Ye, Jun] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Patterson, David; Doyle, John M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University	Spaun, B; Ye, J (corresponding author), Univ Colorado, Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA.; Spaun, B; Ye, J (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	Spaun@jila.colorado.edu; Ye@jila.colorado.edu	Heckl, Oliver/M-5348-2017; Ye, Jun/C-3312-2011	Heckl, Oliver/0000-0003-2879-1564; Ye, Jun/0000-0003-0076-2112	DARPA SCOUT; AFOSR; NIST; NSF-JILA PFC; NSF; HQOC; NRC; Humboldt Fellowship; NSF GRFP [DGE1144083]	DARPA SCOUT; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIST(National Institute of Standards & Technology (NIST) - USA); NSF-JILA PFC; NSF(National Science Foundation (NSF)); HQOC; NRC(National Research Centre (NRC)); Humboldt Fellowship(Alexander von Humboldt Foundation); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	We acknowledge funding from DARPA SCOUT, AFOSR, NIST and NSF-JILA PFC for this research. J.M.D. and D.P. acknowledge funding from the NSF and HQOC. B.S. is supported through an NRC Postdoctoral Fellowship. O.H.H. is partially supported through a Humboldt Fellowship. P.B.C. is supported by the NSF GRFP (award no. DGE1144083). We thank J. Baraban for input and discussion. We thank D. Perry for providing us with G. O. Sorensen's original nitromethane ground state data.	Adler F, 2010, OPT EXPRESS, V18, P21861, DOI 10.1364/OE.18.021861; Adler F, 2009, OPT LETT, V34, P1330, DOI 10.1364/OL.34.001330; Albert S, 2011, FARADAY DISCUSS, V150, P71, DOI 10.1039/c0fd00013b; ATKINSON R, 1992, J PHYS CHEM REF DATA, V21, P1125, DOI 10.1063/1.555918; BAKKE A, 1979, Z NATURFORSCH A, V34, P579, DOI 10.1515/zna-1979-0510; Bemish RJ, 1998, J CHEM PHYS, V109, P8968, DOI 10.1063/1.477579; BISTRICIC L, 1995, SPECTROCHIM ACTA A, V51, P1643, DOI 10.1016/0584-8539(95)01416-R; Brown GG, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2919120; Brubach JB, 2010, AIP CONF PROC, V1214, P81, DOI 10.1063/1.3326356; Brumfield BE, 2012, J PHYS CHEM LETT, V3, P1985, DOI 10.1021/jz300769k; Buckingham GT, 2013, J PHYS CHEM A, V117, P10047, DOI 10.1021/jp400702p; Bunker, 1998, MOL SYMMETRY SPECTRO; Caro GMM, 2004, ASTRON ASTROPHYS, V413, P209, DOI 10.1051/0004-6361:20031447; Cavagnat D, 1997, J CHEM PHYS, V106, P7946, DOI 10.1063/1.473807; COX AP, 1972, J CHEM SOC FARAD T 2, V68, P1060, DOI 10.1039/f29726801060; Davis S, 1997, J CHEM PHYS, V107, P5661, DOI 10.1063/1.474259; Dawadi MB, 2015, J MOL SPECTROSC, V315, P10, DOI 10.1016/j.jms.2014.11.009; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; Fleisher AJ, 2014, J PHYS CHEM LETT, V5, P2241, DOI 10.1021/jz5008559; Foltynowicz A, 2013, APPL PHYS B-LASERS O, V110, P163, DOI 10.1007/s00340-012-5024-7; Gagliardi G., 2014, CAVITY ENHANCED SPEC; GORSE D, 1993, J PHYS CHEM-US, V97, P4262, DOI 10.1021/j100119a005; Griffith P.R., 2007, FOURIER TRANSFORM IN, V2nd; Halonen M, 1998, J PHYS CHEM A, V102, P9124, DOI 10.1021/jp982372o; HAZRA A, 1995, J MOL SPECTROSC, V173, P300, DOI 10.1006/jmsp.1995.1235; HAZRA A, 1994, J MOL SPECTROSC, V164, P20, DOI 10.1006/jmsp.1994.1054; HEWETT KB, 1994, J CHEM PHYS, V100, P4077, DOI 10.1063/1.466345; HILL JR, 1991, J PHYS CHEM-US, V95, P3037, DOI 10.1021/j100161a019; Hudson BS, 2005, J PHYS CHEM A, V109, P3418, DOI 10.1021/jp0503213; JENKINS TE, 1980, SPECTROCHIM ACTA A, V36, P259, DOI 10.1016/0584-8539(80)80128-0; Jensen JO, 2004, SPECTROCHIM ACTA A, V60, P1895, DOI 10.1016/j.saa.2003.09.024; JONES WJ, 1968, PROC R SOC LON SER-A, V304, P135, DOI 10.1098/rspa.1968.0078; Karpushenkava LS, 2009, J MOL STRUC-THEOCHEM, V913, P43, DOI 10.1016/j.theochem.2009.07.016; Maslowski P, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.021802; MCKEAN DC, 1976, J MOL SPECTROSC, V61, P184, DOI 10.1016/0022-2852(76)90241-1; MITRA SS, 1959, CAN J CHEM, V37, P553, DOI 10.1139/v59-076; Nesbitt DJ, 1996, J PHYS CHEM-US, V100, P12735, DOI 10.1021/jp960698w; Pal C, 1997, J MOL STRUCT, V407, P165, DOI 10.1016/S0022-2860(96)09647-0; Park GB, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3597774; Patterson D, 2012, MOL PHYS, V110, P1757, DOI 10.1080/00268976.2012.679632; Patterson D, 2010, PHYS CHEM CHEM PHYS, V12, P9736, DOI 10.1039/c002764b; PECHUKAS P, 1984, J PHYS CHEM-US, V88, P828, DOI 10.1021/j150648a043; PIMENTEL GC, 1952, J CHEM PHYS, V20, P270, DOI 10.1063/1.1700390; Pirali O, 2015, J MOL SPECTROSC, V315, P37, DOI 10.1016/j.jms.2015.02.004; Pirali O, 2013, PHYS CHEM CHEM PHYS, V15, P10141, DOI [10.1039/c3cp44305a, 10.1039/c3cρ44305a]; Pirali O, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3666853; Piskorski J, 2014, CHEMPHYSCHEM, V15, P3800, DOI 10.1002/cphc.201402502; Ramachandran G, 2006, J MOL STRUC-THEOCHEM, V766, P125, DOI 10.1016/j.theochem.2006.03.025; ROHART F, 1975, J MOL SPECTROSC, V57, P301, DOI 10.1016/0022-2852(75)90033-8; SELLERS H, 1985, J AM CHEM SOC, V107, P6487, DOI 10.1021/ja00309a011; Shinohara H, 1998, J MOL STRUCT, V442, P221, DOI 10.1016/S0022-2860(97)00335-9; Sorensen G. O., 1983, Symmetries and Properties of Non-Rigid Molecules. A Comprehensive Survey. Proceedings of an International Symposium, P219; SORENSEN GO, 1983, J MOL STRUCT, V97, P77, DOI 10.1016/0022-2860(83)90179-5; SZCZEPANSKI J, 1993, J CHEM PHYS, V98, P4494, DOI 10.1063/1.465009; TANNENBAUM E, 1956, J CHEM PHYS, V25, P42, DOI 10.1063/1.1742845; Thorpe MJ, 2008, APPL PHYS B-LASERS O, V91, P397, DOI 10.1007/s00340-008-3019-1; Thorpe MJ, 2006, SCIENCE, V311, P1595, DOI 10.1126/science.1123921; Townes C.H., 2013, MICROWAVE SPECTROSCO; Udem T, 1999, PHYS REV LETT, V82, P3568, DOI 10.1103/PhysRevLett.82.3568; VALA M, 1994, J PHYS CHEM-US, V98, P9187, DOI 10.1021/j100088a017; WATSON JKG, 1977, VIBRATIONAL SPECTRA, V6, pCH1	61	81	82	8	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2016	533	7604					517	+		10.1038/nature17440	http://dx.doi.org/10.1038/nature17440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM6EJ	27144351	Green Submitted			2022-12-28	WOS:000376443100037
J	Bevan, G				Bevan, Gerald			Jerome Gerald Lewis OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		LEWIS JG, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2435	10.1136/bmj.i2435	http://dx.doi.org/10.1136/bmj.i2435			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129887				2022-12-28	WOS:000375484100011
J	Mendoza, N; Prasad, P				Mendoza, Neil; Prasad, Paritosh			Pulmonary nodules in a man with a history of bone marrow transplantation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; FUNGAL-INFECTIONS; DIAGNOSTIC-VALUE; ASPERGILLOSIS; BIOPSY; LUNG; CT; RECOMMENDATIONS; COMPLICATION; MALIGNANCIES		[Mendoza, Neil; Prasad, Paritosh] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA	University of Rochester	Prasad, P (corresponding author), Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA.	paritosh_prasad@urmc.rochester.edu						Aktas AR, 2015, THORAC CANCER, V6, P151, DOI 10.1111/1759-7714.12156; Ananthakrishnan L, 2009, AM J ROENTGENOL, V192, P676, DOI 10.2214/AJR.08.1837; Austin JHM, 1996, RADIOLOGY, V200, P327, DOI 10.1148/radiology.200.2.8685321; Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278; BARRIO JL, 1986, AM REV RESPIR DIS, V134, P1094, DOI 10.1164/arrd.1986.134.5.1094; Borhani AA, 2009, RADIOGRAPHICS, V29, P981, DOI 10.1148/rg.294095020; CARIGNAN S, 1995, RADIOLOGY, V197, P53, DOI 10.1148/radiology.197.1.7568853; Chamilos G, 2005, CLIN INFECT DIS, V41, P60, DOI 10.1086/430710; Chellapandian D, 2015, J CLIN ONCOL, V33, P501, DOI 10.1200/JCO.2014.58.0480; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; DODD GD, 1992, RADIOLOGY, V184, P65, DOI 10.1148/radiology.184.1.1609104; Georgiadou SP, 2011, CLIN INFECT DIS, V52, P1144, DOI 10.1093/cid/cir122; Gulbahce HE, 2004, AM J CLIN PATHOL, V121, P205, DOI 10.1309/4HYN1DEA718RDM6T; Gupta S, 2010, HEMATOL ONCOL, V28, P75, DOI 10.1002/hon.923; Hwang GL, 2005, J COMPUT ASSIST TOMO, V29, P228, DOI 10.1097/01.rct.0000159867.20193.fa; Kim SW, 2015, ANN HEMATOL, V94, P153, DOI 10.1007/s00277-014-2172-3; Lamoth F, 2012, CLIN INFECT DIS, V54, P633, DOI 10.1093/cid/cir897; Loren AW, 2003, BONE MARROW TRANSPL, V31, P145, DOI 10.1038/sj.bmt.1703806; Morales IJ, 2003, J PEDIAT HEMATOL ONC, V25, P89, DOI 10.1097/00043426-200301000-00019; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Onishi A, 2012, J CLIN MICROBIOL, V50, P7, DOI 10.1128/JCM.05267-11; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Rouce RH, 2014, CURR OPIN HEMATOL, V21, P476, DOI 10.1097/MOH.0000000000000083; Ruggiero P, 2014, J CLIN MICROBIOL, V52, P288, DOI 10.1128/JCM.02787-13; Scarsbrook AF, 2005, CLIN RADIOL, V60, P47, DOI 10.1016/j.crad.2004.08.016; Sirvent-von Bueltzingsloewen A, 2002, BONE MARROW TRANSPL, V29, P21, DOI 10.1038/sj.bmt.1703331; SPRINGMEYER SC, 1982, AM REV RESPIR DIS, V126, P763; White P, 1997, BONE MARROW TRANSPL, V20, P681, DOI 10.1038/sj.bmt.1700957; Wingard JR, 2012, BLOOD, V120, P1791, DOI 10.1182/blood-2012-02-378976	29	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2016	353								i1805	10.1136/bmj.i1805	http://dx.doi.org/10.1136/bmj.i1805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RW	27126192				2022-12-28	WOS:000375483900002
J	Watts, G				Watts, Geoff			Profile Tolullah Oni: public health specialist with a global ambition	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1712	1712		10.1016/S0140-6736(16)30267-7	http://dx.doi.org/10.1016/S0140-6736(16)30267-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	27116269				2022-12-28	WOS:000374541900014
J	Aschemann-Witzel, J				Aschemann-Witzel, Jessica			Waste not, want not, emit less	SCIENCE			English	Editorial Material							FOOD WASTE		[Aschemann-Witzel, Jessica] Aarhus Univ, Dept Management, MAPP Ctr, DK-8000 Aarhus C, Denmark	Aarhus University	Aschemann-Witzel, J (corresponding author), Aarhus Univ, Dept Management, MAPP Ctr, DK-8000 Aarhus C, Denmark.	jeaw@mgmt.au.dk	Aschemann-Witzel, Jessica/ABD-5432-2020; Aschemann-Witzel, Jessica/HDN-4575-2022	Aschemann-Witzel, Jessica/0000-0002-6737-3659; 				Aschemann-Witzel J, 2015, SUSTAINABILITY-BASEL, V7, P6457, DOI 10.3390/su7066457; Buzby JC, 2012, FOOD POLICY, V37, P561, DOI 10.1016/j.foodpol.2012.06.002; Evans D., 2014, FOOD WASTE HOME CONS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization, 2013, FOOD WAST FOOTPR IMP; Hoolohan C, 2013, ENERG POLICY, V63, P1065, DOI 10.1016/j.enpol.2013.09.046; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Papargyropoulou E, 2014, J CLEAN PROD, V76, P106, DOI 10.1016/j.jclepro.2014.04.020; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; QUESTED TE, 2013, SI RESOURCEFUL BEHAV, V79, P43; Stuart T., 2009, WASTE UNCOVERING GLO; Van Boxstael S, 2014, FOOD CONTROL, V37, P85, DOI 10.1016/j.foodcont.2013.08.043; Wikstrom F, 2014, J CLEAN PROD, V73, P100, DOI 10.1016/j.jclepro.2013.10.042	13	54	55	6	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					408	409		10.1126/science.aaf2978	http://dx.doi.org/10.1126/science.aaf2978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ8RH	27102464				2022-12-28	WOS:000374479700023
J	Hawkes, N				Hawkes, Nigel			Diabetes team finalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2183	10.1136/bmj.i2183	http://dx.doi.org/10.1136/bmj.i2183			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106035				2022-12-28	WOS:000374999700003
J	Maile, C				Maile, Christopher			Ian John Davis OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2300	10.1136/bmj.i2300	http://dx.doi.org/10.1136/bmj.i2300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106746				2022-12-28	WOS:000374999700006
J	Mayor, S				Mayor, Susan			Risk of stroke after transient ischaemic attack is lower than previously thought, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Amarenco P, 2016, NEW ENGL J MED, V374, P1533, DOI 10.1056/NEJMoa1412981	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2320	10.1136/bmj.i2320	http://dx.doi.org/10.1136/bmj.i2320			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27106286				2022-12-28	WOS:000374999700011
J	Pillai, PS; Molony, RD; Martinod, K; Dong, H; Pang, IK; Tal, MC; Solis, AG; Bielecki, P; Mohanty, S; Trentalange, M; Homer, RJ; Flavell, RA; Wagner, DD; Montgomery, RR; Shaw, AC; Staeheli, P; Iwasaki, A				Pillai, Padmini S.; Molony, Ryan D.; Martinod, Kimberly; Dong, Huiping; Pang, Iris K.; Tal, Michal C.; Solis, Angel G.; Bielecki, Piotr; Mohanty, Subhasis; Trentalange, Mark; Homer, Robert J.; Flavell, Richard A.; Wagner, Denisa D.; Montgomery, Ruth R.; Shaw, Albert C.; Staeheli, Peter; Iwasaki, Akiko			Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease	SCIENCE			English	Article							A-VIRUS-INFECTION; DENDRITIC CELLS; TOLERANCE; MICE; VACCINATION; RESPONSES; IMMUNITY; GENES; MOUSE	Influenza A virus (IAV) causes up to half a million deaths worldwide annually, 90% of which occur in older adults. We show that IAV-infected monocytes from older humans have impaired antiviral interferon production but retain intact inflammasome responses. To understand the in vivo consequence, we used mice expressing a functional Mx gene encoding a major interferon-induced effector against IAV in humans. In Mx1-intact mice with weakened resistance due to deficiencies in Mavs and Tlr7, we found an elevated respiratory bacterial burden. Notably, mortality in the absence of Mavs and Tlr7 was independent of viral load or MyD88-dependent signaling but dependent on bacterial burden, caspase-1/11, and neutrophil-dependent tissue damage. Therefore, in the context of weakened antiviral resistance, vulnerability to IAV disease is a function of caspase-dependent pathology.	[Pillai, Padmini S.; Molony, Ryan D.; Dong, Huiping; Pang, Iris K.; Tal, Michal C.; Solis, Angel G.; Bielecki, Piotr; Flavell, Richard A.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Martinod, Kimberly; Wagner, Denisa D.] Harvard Univ, Boston Childrens Hosp, Sch Med, Program Cellular & Mol Med, Boston, MA USA; [Mohanty, Subhasis; Shaw, Albert C.] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, 333 Cedar St, New Haven, CT 06520 USA; [Trentalange, Mark] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Homer, Robert J.] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA; [Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, Sect Rheumatol, 333 Cedar St, New Haven, CT 06520 USA; [Staeheli, Peter] Univ Med Ctr Freiburg, Inst Virol, Inst Med Mikrobiol & Hyg, Hermann Herder Str 11, D-79104 Freiburg, Germany; [Flavell, Richard A.; Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA; [Tal, Michal C.] Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Yale University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Yale University; Yale University; Yale University; Yale University; University of Freiburg; Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Martinod, Kimberly/K-4742-2019; Iwasaki, Akiko/Z-1591-2019; Shaw, Albert/AAD-2567-2021; homer, robert/P-3884-2019	Martinod, Kimberly/0000-0002-1026-6107; Iwasaki, Akiko/0000-0002-7824-9856; Shaw, Albert/0000-0003-4970-7640; homer, robert/0000-0002-2055-5885; Montgomery, Ruth/0000-0002-8661-4454; Tal, Michal/0000-0003-2550-6246	NIH [AI081884, AI062428, AI064705, HHSN272201100019C, K24 AG02489, T32 AI007019-36, T32 AI007019-38, T32 AI055403, 5T32HL066987-13, F31 AG039163, R01HL102101, R01HL125501, K24 AG042489, P30 AG21342]; Deutsche Forschungsgemeinschaft (DFG) [SFB1160/P13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125501, T32HL066987, R01HL102101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064705, R01AI081884, T32AI007019, R01AI062428, R56AI062428, T32AI055403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, F31AG039163, K24AG042489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Sequence data has been publicly released to the general scientific community (NCBI Sequence Read Archive ID SRR3216492). This study was supported by NIH awards AI081884, AI062428, and AI064705 (to A.I.); HHSN272201100019C (to A.C.S. and R.R.M); K24 AG02489 (to A.C.S.); T32 AI007019-36 (to P.S.P.); T32 AI007019-38 and T32 AI055403 (to R.D.M.); 5T32HL066987-13 (to K.M.); F31 AG039163 (to M.T.); R01HL102101 and R01HL125501 (to D.D.W.); K24 AG042489 (to A.C.S); P30 AG21342 (Claude D. Pepper Older Americans Independence Center at Yale) (to A.C.S.); and grant SFB1160/P13 from the Deutsche Forschungsgemeinschaft (DFG) (to P.S.). A.I. and R.A.F. are investigators of the Howard Hughes Medical Institute.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Canaday DH, 2010, J CLIN IMMUNOL, V30, P373, DOI 10.1007/s10875-010-9374-9; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Kaminski MM, 2012, J GEN VIROL, V93, P555, DOI 10.1099/vir.0.039065-0; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13; Mohanty S, 2015, J INFECT DIS, V211, P1174, DOI 10.1093/infdis/jiu573; Moritoh K, 2009, JPN J VET RES, V57, P89; Pang IK, 2013, P NATL ACAD SCI USA, V110, P13910, DOI 10.1073/pnas.1303275110; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Sridharan A, 2011, AGE, V33, P363, DOI 10.1007/s11357-010-9191-3; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Vanhooren V, 2013, AGEING RES REV, V12, P8, DOI 10.1016/j.arr.2012.03.010; Vela A, 2012, J BIOL CHEM, V287, P42564, DOI 10.1074/jbc.M112.385146; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671	35	162	168	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					463	466		10.1126/science.aaf3926	http://dx.doi.org/10.1126/science.aaf3926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102485	Green Accepted			2022-12-28	WOS:000374479700048
J	Freeman, KH				Freeman, Katherine H.			Geoffrey Eglinton (1927-2016)	NATURE			English	Biographical-Item									[Freeman, Katherine H.] Penn State Univ, Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Freeman, KH (corresponding author), Penn State Univ, Geosci, University Pk, PA 16802 USA.	khf4@psu.edu	Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				EGLINTON G, PUBLICATION LIST	1	0	0	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					314	314		10.1038/532314a	http://dx.doi.org/10.1038/532314a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ7WU	27127818	Bronze			2022-12-28	WOS:000374424700018
J	Liu, YS; Beyer, A; Aebersold, R				Liu, Yansheng; Beyer, Andreas; Aebersold, Ruedi			On the Dependency of Cellular Protein Levels on mRNA Abundance	CELL			English	Review							QUANTITATIVE PROTEOMIC ANALYSIS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ABSOLUTE PROTEIN; MASS-SPECTROMETRY; GLOBAL ANALYSIS; COPY-NUMBER; IN-VIVO; REGULATORY VARIATION	The question of how genomic information is expressed to determine phenotypes is of central importance for basic and translational life science research and has been studied by transcriptomic and proteomic profiling. Here, we review the relationship between protein and mRNA levels under various scenarios, such as steady state, long-term state changes, and short-term adaptation, demonstrating the complexity of gene expression regulation, especially during dynamic transitions. The spatial and temporal variations of mRNAs, as well as the local availability of resources for protein biosynthesis, strongly influence the relationship between protein levels and their coding transcripts. We further discuss the buffering of mRNA fluctuations at the level of protein concentrations. We conclude that transcript levels by themselves are not sufficient to predict protein levels in many scenarios and to thus explain genotype-phenotype relationships and that high-quality data quantifying different levels of gene expression are indispensable for the complete understanding of biological processes.	[Liu, Yansheng; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Beyer, Andreas] Univ Cologne, Cellular Networks & Syst Biol, CECAD, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne; University of Zurich	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.; Beyer, A (corresponding author), Univ Cologne, Cellular Networks & Syst Biol, CECAD, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Aebersold, R (corresponding author), Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.	andreas.beyer@uni-koeln.de; aebersold@imsb.biol.ethz.ch	Beyer, Andreas/AAQ-5519-2020; Liu, Yansheng/E-4786-2018; Beyer, Andreas/A-3352-2009	Beyer, Andreas/0000-0002-3891-2123; Liu, Yansheng/0000-0002-2626-3912; Beyer, Andreas/0000-0002-3891-2123	European Research Council (ERC) [616441-DISEASEAVATARS]; German Federal Ministry of Education and Research (BMBF); German Research Foundation (DFG) [CRC680]; Swiss National Science Foundation (SNSF) [3100A0-688]; SystemsX.ch; Swiss Initiative for Systems Biology; European Union via ERC [AdG-233226, AdG-670821]	European Research Council (ERC)(European Research Council (ERC)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SystemsX.ch; Swiss Initiative for Systems Biology; European Union via ERC	We regret that we could not cite all the relevant papers in the research field. Y.L was supported by the European Research Council (ERC, consolidator grant number 616441-DISEASEAVATARS). A.B. was supported by the German Federal Ministry of Education and Research (BMBF; grants: Sybacol & PhosphoNetPPM), as well as the German Research Foundation (DFG; grant CRC680). R.A. was funded by grants from the Swiss National Science Foundation (SNSF #3100A0-688), SystemsX.ch, the Swiss Initiative for Systems Biology, and by the European Union via ERC AdG-233226, Proteomics v3.0, and AdG-670821 Proteomics 4D.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albert FW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004692; An E, 2014, MOL CELL PROTEOMICS, V13, P2687, DOI 10.1074/mcp.M113.034371; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Aviner R, 2014, NAT PROTOC, V9, P751, DOI 10.1038/nprot.2014.051; Aviner R, 2013, GENE DEV, V27, P1834, DOI 10.1101/gad.219105.113; Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Bader DM, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145844; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Black MB, 2014, TOXICOL SCI, V137, P385, DOI 10.1093/toxsci/kft249; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; Chai Q, 2014, J BIOL CHEM, V289, P11342, DOI 10.1074/jbc.M114.557348; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Cheng Z, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156423; Chu D, 2011, NUCLEIC ACIDS RES, V39, P6705, DOI 10.1093/nar/gkr300; Claydon AJ, 2012, MOL CELL PROTEOMICS, V11, P1551, DOI 10.1074/mcp.O112.022186; Darmanis S, 2016, CELL REP, V14, P380, DOI 10.1016/j.celrep.2015.12.021; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Eichelbaum K, 2014, MOL CELL PROTEOMICS, V13, P792, DOI 10.1074/mcp.M113.030916; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Flory MR, 2006, PROTEOMICS, V6, P6146, DOI 10.1002/pmic.200600159; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Friedel CC, 2009, MOL BIOSYST, V5, P1271, DOI 10.1039/b911233b; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Gedeon T, 2012, BIOPHYS J, V103, P377, DOI 10.1016/j.bpj.2012.06.025; Geiger T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001090; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Grun D, 2014, CELL REP, V6, P565, DOI 10.1016/j.celrep.2014.01.001; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Jovanovic M, 2010, NAT METHODS, V7, P837, DOI [10.1038/NMETH.1504, 10.1038/nmeth.1504]; Juschke C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r133; KELLERMAN KA, 1990, GENE DEV, V4, P1936, DOI 10.1101/gad.4.11.1936; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li JJ, 2015, SCIENCE, V347, P1066, DOI 10.1126/science.aaa8332; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2013, MOL CELL PROTEOMICS, V12, P1900, DOI 10.1074/mcp.M112.025783; Liu YS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145728; Liu Y, 2013, EXPERT REV MOL DIAGN, V13, P811, DOI 10.1586/14737159.2013.845089; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Ludwig C, 2014, NEW DEV MASS SPECTR, V1, P80; Ludwig C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013987; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mather WH, 2013, BIOPHYS J, V104, P2564, DOI 10.1016/j.bpj.2013.04.049; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; McManus J, 2015, MOL BIOSYST, V11, P2680, DOI 10.1039/c5mb00310e; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muzzey D, 2014, GENOME RES, V24, P963, DOI 10.1101/gr.166322.113; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Neymotin B, 2014, RNA, V20, P1645, DOI 10.1261/rna.045104.114; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Peshkin L, 2015, DEV CELL, V35, P383, DOI 10.1016/j.devcel.2015.10.010; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Schubert OT, 2015, CELL HOST MICROBE, V18, P96, DOI 10.1016/j.chom.2015.06.001; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selevsek N, 2015, MOL CELL PROTEOMICS, V14, P739, DOI 10.1074/mcp.M113.035550; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shaik AA, 2014, J PROTEOME RES, V13, P5536, DOI 10.1021/pr5005136; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Teo GS, 2014, J PROTEOME RES, V13, P29, DOI 10.1021/pr400855q; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; Tyanova S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10259; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang Z, 2015, GENOME BIOL EVOL, V7, P1155, DOI 10.1093/gbe/evv059; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wei YN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0608-2; Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419	158	1314	1329	15	220	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2016	165	3					535	550		10.1016/j.cell.2016.03.014	http://dx.doi.org/10.1016/j.cell.2016.03.014			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK0XW	27104977	Green Accepted, Bronze			2022-12-28	WOS:000374636800014
J	Martin, SA; Sinsky, CA				Martin, Stephen A.; Sinsky, Christine A.			The map is not the territory: medical records and 21st century practice	LANCET			English	Editorial Material							PRIMARY-CARE; PATIENT SAFETY; HEALTH; DOCUMENTATION; IMPLEMENTATION; GUIDELINES; HISTORY; PAYMENT; POLICY	Documentation of care is at risk of overtaking the delivery of care in terms of time, clinician focus, and perceived importance. The medical record as currently used for documentation contributes to increased cognitive workload, strained clinician-patient relationships, and burnout. We posit that a near verbatim transcript of the clinical encounter is neither feasible nor desirable, and that attempts to produce this exact recording are harmful to patients, clinicians, and the health system. In this Viewpoint, we focus on the alternative constructions of the medical record to bring them back to their primary purpose-to aid cognition, communicate, create a succinct account of care, and support longitudinal comprehensive care-thereby to support the building of relationships and medical decision making while decreasing workload.	[Martin, Stephen A.] Harvard Med Sch, Ctr Primary Care, Boston, MA 02115 USA; [Martin, Stephen A.] Barre Family Hlth Ctr, Barre, MA USA; [Martin, Stephen A.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Sinsky, Christine A.] Amer Med Assoc, Med Associates Clin & Hlth Plans, Chicago, IL 60610 USA	Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; American Medical Association	Martin, SA (corresponding author), Harvard Med Sch, Ctr Primary Care, Boston, MA 02115 USA.	stmartin@gmail.com	Martin, Stephen A/L-9381-2013	Martin, Stephen A/0000-0002-0356-5440				Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Baron RJ, 2010, NEW ENGL J MED, V362, P1632, DOI 10.1056/NEJMon0910793; Beasley JW, 2011, J AM BOARD FAM MED, V24, P745, DOI 10.3122/jabfm.2011.06.100255; Behforouz HL, 2014, NEW ENGL J MED, V371, P1277, DOI 10.1056/NEJMp1404846; Berenson RA, 2011, NEW ENGL J MED, V364, P1892, DOI 10.1056/NEJMp1102099; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Borges Jorge Luis, 1998, COLLECTED FICTIONS; Carroll L, 1893, SYLVIE BRUNO CONCLUD; Centers for Medicare and Medicaid services, 2012, EL PROF EP MEAN US C; Centers for Medicare & Medicaid Services, 2016, BETT CAR SMART SPEND; Edwards ST, 2014, BMJ QUAL SAF, V23, P406, DOI 10.1136/bmjqs-2013-002194; Fritz F, 2015, J AM MED INFORM ASSN, V22, P479, DOI 10.1093/jamia/ocu038; Gottlieb LM, 2015, AM J PREV MED, V48, P215, DOI 10.1016/j.amepre.2014.07.009; Harman JS, 2012, J GEN INTERN MED, V27, P962, DOI 10.1007/s11606-012-2001-0; Hill RG, 2013, AM J EMERG MED, V31, P1591, DOI 10.1016/j.ajem.2013.06.028; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Iezzoni LI, 1999, NEW ENGL J MED, V341, P365, DOI 10.1056/NEJM199907293410511; Kassirer JP, 1998, NEW ENGL J MED, V339, P1697, DOI 10.1056/NEJM199812033392308; Kleinman A, 2012, LANCET, V380, P1550, DOI 10.1016/S0140-6736(12)61870-4; Korzybski A., 1933, SCI SANITY, V1933, P747; Kuhn T, 2015, ANN INTERN MED, V162, P301, DOI 10.7326/M14-2128; Nguyen L, 2014, INT J MED INFORM, V83, P779, DOI 10.1016/j.ijmedinf.2014.06.011; Mandl KD, 2014, JAMA-J AM MED ASSOC, V312, P2499, DOI 10.1001/jama.2014.15064; May C, 2006, SOC SCI MED, V62, P1022, DOI 10.1016/j.socscimed.2005.07.003; Rothberg MB, 2014, JAMA-J AM MED ASSOC, V311, P2175, DOI 10.1001/jama.2014.3415; Saver BG, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001902; Schoen C, 2012, HEALTH AFFAIR, V31, P2805, DOI 10.1377/hlthaff.2012.0884; Shah UK, 2015, JAMA INTERN MED, V175, P884, DOI 10.1001/jamainternmed.2015.1100; Sinsky CA, 2014, ANN INTERN MED, V160, P727, DOI 10.7326/M13-2589; Sinsky CA, 2013, ANN INTERN MED, V159, P782, DOI 10.7326/0003-4819-159-11-201312030-00012; Walker J, 2014, NEW ENGL J MED, V370, P6, DOI 10.1056/NEJMp1310132; Zullig LL, 2013, JAMA-J AM MED ASSOC, V310, P2611, DOI 10.1001/jama.2013.282818	32	29	29	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					2053	2056		10.1016/S0140-6736(16)00338-X	http://dx.doi.org/10.1016/S0140-6736(16)00338-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6EQ	27125861				2022-12-28	WOS:000385954800034
J	Toh, S; Hampp, C; Reichman, ME; Graham, DJ; Balakrishnan, S; Pucino, F; Hamilton, J; Lendle, S; Iyer, A; Rucker, M; Pimentel, M; Nathwani, N; Griffin, MR; Brown, NJ; Fireman, BH				Toh, Sengwee; Hampp, Christian; Reichman, Marsha E.; Graham, David J.; Balakrishnan, Suchitra; Pucino, Frank; Hamilton, Jack; Lendle, Samuel; Iyer, Aarthi; Rucker, Malcolm; Pimentel, Madelyn; Nathwani, Neesha; Griffin, Marie R.; Brown, Nancy J.; Fireman, Bruce H.			Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs	ANNALS OF INTERNAL MEDICINE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; RANDOMIZED CLINICAL-TRIALS; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR OUTCOMES; MINI-SENTINEL; DIABETES-MELLITUS; METAANALYSIS; COHORT; ASSOCIATION; DISEASE	Background: Recent postmarketing trials produced conflicting results about the risk for hospitalized heart failure (hHF) associated with dipeptidyl peptidase-4 (DPP-4) inhibitors, creating uncertainty about the safety of these antihyperglycemic agents. Objective: To examine the associations of hHF with saxagliptin and sitagliptin. Design: Population-based, retrospective, new-user cohort study. Setting: 18 health insurance and health system data partners in the U.S. Food and Drug Administration's Mini-Sentinel program. Patients: Patients aged 18 years or older with type 2 diabetes who initiated therapy with saxagliptin, sitagliptin, pioglitazone, second-generation sulfonylureas, or long-acting insulin products from 2006 to 2013. Measurements: Hospitalized HF, identified by International Classification of Diseases, Ninth Revision, Clinical Modification codes 402.x1, 404.x1, 404.x3, and 428.xx recorded as the principal discharge diagnosis. Results: 78 553 saxagliptin users and 298 124 sitagliptin users contributed an average of 7 to 9 months of follow-up data to 1 or more pairwise comparisons. The risk for hHF was not higher with DPP-4 inhibitors than with the other study drugs. The hazard ratios from the disease risk score (DRS)-stratified analyses were 0.83 (95% CI, 0.70 to 0.99) for saxagliptin versus sitagliptin, 0.63 (CI, 0.47 to 0.85) for saxagliptin versus pioglitazone, 0.69 (CI, 0.54 to 0.87) for saxagliptin versus sulfonylureas, and 0.61 (CI, 0.50 to 0.73) for saxagliptin versus insulin. The DRS-stratified hazard ratios were 0.74 (CI, 0.64 to 0.85) for sitagliptin versus pioglitazone, 0.86 (CI, 0.77 to 0.95) for sitagliptin versus sulfonylureas, and 0.71 (CI, 0.64 to 0.78) for sitagliptin versus insulin. Results from the 1: 1 propensity score-matched analyses were similar. Results were also similar in subgroups of patients with and without prior cardiovascular disease and in a subgroup defined by the 2 highest DRS deciles. Limitation: Residual confounding and short follow-up. Conclusion: In this large cohort study, a higher risk for hHF was not observed in users of saxagliptin or sitagliptin compared with other selected antihyperglycemic agents.	[Toh, Sengwee; Iyer, Aarthi; Rucker, Malcolm; Pimentel, Madelyn; Nathwani, Neesha] Harvard Univ, Sch Med, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Toh, Sengwee; Iyer, Aarthi; Rucker, Malcolm; Pimentel, Madelyn; Nathwani, Neesha] Harvard Pilgrim Hlth Care Inst, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Hampp, Christian] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, White Oak CDER Off Bldg 22,Room 2441, Silver Spring, MD 20993 USA; [Reichman, Marsha E.] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, White Oak CDER Off Bldg 22,Room 3462, Silver Spring, MD 20993 USA; [Graham, David J.] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, White Oak CDER Off Bldg 22,Room 4314, Silver Spring, MD 20993 USA; [Balakrishnan, Suchitra] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, White Oak CDER Off Bldg 22,Room 3145, Silver Spring, MD 20993 USA; [Pucino, Frank] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, White Oak CDER Off Bldg 22,Room 3204, Silver Spring, MD 20993 USA; [Griffin, Marie R.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Suite 2600,1500 21st Ave South, Nashville, TN 37212 USA; [Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Med Ctr North D3100, Nashville, TN 37232 USA; VA Tennessee Valley Hlth Care Syst, Nashville, TN USA; [Hamilton, Jack; Lendle, Samuel; Fireman, Bruce H.] Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Kaiser Permanente	Toh, S (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA.; Toh, S (corresponding author), Harvard Pilgrim Hlth Care Inst, 401 Pk Dr,Suite 401, Boston, MA 02215 USA.	darren_toh@harvardpilgrim.org	Toh, Sengwee/D-7567-2017; Hampp, Christian/I-1143-2019	Toh, Sengwee/0000-0002-5160-0810; Hampp, Christian/0000-0002-1094-6364; Hamilton, Jack/0000-0001-7544-9388	U.S. Department of Health and Human Services [HHSF223200910006I, HHSF22301004T, HHSF22301007T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER	U.S. Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the FDA through the U.S. Department of Health and Human Services (contract HHSF223200910006I, HHSF22301004T, and HHSF22301007T).	[Anonymous], 2010, GUID CLIN INV MED PR; Behrman RE, 2011, NEW ENGL J MED, V364, P498, DOI 10.1056/NEJMp1014427; Chen DY, 2015, INT J CARDIOL, V181, P200, DOI 10.1016/j.ijcard.2014.12.029; Curtis LH, 2012, PHARMACOEPIDEM DR S, V21, P23, DOI 10.1002/pds.2336; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Evans B, HIPAA COMMON RULE CO; Fireman B, 2012, PHARMACOEPIDEM DR S, V21, P282, DOI 10.1002/pds.2337; Fu AZ, 2016, DIABETES CARE; Glynn RJ, 2012, PHARMACOEPIDEM DR S, V21, P138, DOI 10.1002/pds.3231; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kim SC, 2014, ACTA DIABETOL, V51, P1015, DOI 10.1007/s00592-014-0663-2; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; McAlister FA, 2008, EUR J HEART FAIL, V10, P703, DOI 10.1016/j.ejheart.2008.05.013; McGraw D, 2012, PHARMACOEPIDEM DR S, V21, P18, DOI 10.1002/pds.2319; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; Monami M, 2014, NUTR METAB CARDIOVAS, V24, P689, DOI 10.1016/j.numecd.2014.01.017; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Parsons LS, 2001, 26 ANN SAS US GROUP; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Psaty BM, 2014, NEW ENGL J MED, V370, P2165, DOI 10.1056/NEJMp1401664; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Selby J, 2010, PROTOCOL ACTIVE SURV; US Food and Drug Administration, 2008, GUID IND DIAB MELL E; US Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2008, DIABETES MELLITUS DE; Voors AA, 2011, HEART, V97, P774, DOI 10.1136/hrt.2009.183624; Weir DL, 2014, JACC-HEART FAIL, V2, P573, DOI 10.1016/j.jchf.2014.04.005; Wu SY, 2014, CARDIOVASC THER, V32, P147, DOI 10.1111/1755-5922.12075; Yu OHY, 2015, DIABETES CARE, V38, P277, DOI 10.2337/dc14-1459; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X	36	84	87	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2016	164	11					705	+		10.7326/M15-2568	http://dx.doi.org/10.7326/M15-2568			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO1AI	27110660	Green Accepted			2022-12-28	WOS:000377510100002
J	Wang, WM; Kryczek, I; Dostal, L; Lin, H; Tan, LJ; Zhao, LL; Lu, FJ; Wei, S; Maj, T; Peng, DJ; He, G; Vatan, L; Szeliga, W; Kuick, R; Kotarski, J; Tarkowski, R; Dou, YL; Rattan, R; Munkarah, A; Liu, JR; Zou, WP				Wang, Weimin; Kryczek, Ilona; Dostal, Lubomir; Lin, Heng; Tan, Lijun; Zhao, Lili; Lu, Fujia; Wei, Shuang; Maj, Tomasz; Peng, Dongjun; He, Gong; Vatan, Linda; Szeliga, Wojciech; Kuick, Rork; Kotarski, Jan; Tarkowski, Rafal; Dou, Yali; Rattan, Ramandeep; Munkarah, Adnan; Liu, J. Rebecca; Zou, Weiping			Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer	CELL			English	Article							IMMUNE CHECKPOINT BLOCKADE; TUMOR MICROENVIRONMENT; ANTITUMOR IMMUNITY; REDUCED SURVIVAL; FIBROBLASTS; CISPLATIN; GLUTATHIONE; METABOLISM; RESISTANCE; RELEVANCE	Effector T cells and fibroblasts are major components in the tumor microenvironment. The means through which these cellular interactions affect chemoresistance is unclear. Here, we show that fibroblasts diminish nuclear accumulation of platinum in ovarian cancer cells, resulting in resistance to platinum-based chemotherapy. We demonstrate that glutathione and cysteine released by fibroblasts contribute to this resistance. CD8(+) T cells abolish the resistance by altering glutathione and cystine metabolism in fibroblasts. CD8(+) T-cell-derived interferon (IFN)gamma controls fibroblast glutathione and cysteine through upregulation of gamma-glutamyl-transferases and transcriptional repression of system xc(-) cystine and glutamate antiporter via the JAK/STAT1 pathway. The presence of stromal fibroblasts and CD8(+) T cells is negatively and positively associated with ovarian cancer patient survival, respectively. Thus, our work uncovers a mode of action for effector T cells: they abrogate stromal-mediated chemoresistance. Capitalizing upon the interplay between chemotherapy and immunotherapy holds high potential for cancer treatment.	[Wang, Weimin; Tan, Lijun; He, Gong; Liu, J. Rebecca] Univ Michigan, Dept Obstet & Gynecol, Sch Med, Ann Arbor, MI 48109 USA; [Wang, Weimin; Kryczek, Ilona; Lin, Heng; Lu, Fujia; Wei, Shuang; Maj, Tomasz; Peng, Dongjun; Vatan, Linda; Szeliga, Wojciech; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Dostal, Lubomir] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Zhao, Lili; Kuick, Rork] Univ Michigan, Dept Biostat, Sch Med, Ann Arbor, MI 48109 USA; [Kotarski, Jan; Tarkowski, Rafal] Med Univ Lublin, Dept Gynecol Oncol & Gynecol 1, PL-20081 Lublin, Poland; [Dou, Yali] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Rattan, Ramandeep; Munkarah, Adnan] Henry Ford Hlth Syst, Dept Womens Hlth Serv, Detroit, MI 48202 USA; [Liu, J. Rebecca; Zou, Weiping] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Grad Program Tumor Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical University of Lublin; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Liu, JR (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Sch Med, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.; Liu, JR; Zou, WP (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Grad Program Tumor Biol, Ann Arbor, MI 48109 USA.	rliu@med.umich.edu; wzou@med.umich.edu	Tarkowski, Rafał/GQQ-9740-2022; Maj, Tomasz/ABH-9964-2020	Maj, Tomasz/0000-0002-8431-1361; Rattan, Ramandeep/0000-0002-3532-6057	Department of Defense [W81XWH-10-1-0865]; NIH [CA123088, CA099985, CA156685, CA171306, CA190176, CA193136, 5P30CA46592, U24 DK097153]; Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA211016, R01CA123088, R01CA171306, R01CA099985, R01CA152470, P30CA046592, R01CA193136, R01CA156685, R01CA190176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported (in part) by the Department of Defense (W81XWH-10-1-0865), the NIH grants (CA123088, CA099985, CA156685, CA171306, CA190176, CA193136, and 5P30CA46592), the Ovarian Cancer Research Fund, and Marsha Rivkin Center for Ovarian Cancer Research. This work utilized Metabolomics Core Services supported by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan. We thank Kathleen Cho for her intellectual support. We thank D. Postiff, M. Vinco, R. Craig, and J. Barikdar for their assistance. We thank Chunhai Ruan and Charles F. Burant at the Metabolomics Core, Ted J. Huston at the Department of Earth and Environmental Sciences, Peng Huang at the University of Texas, and Stephen B. Howell at the University of California San Diego for their support. We appreciate the support from Barbara and Don Leclair.	Binder DC, 2015, TRENDS MOL MED, V21, P463, DOI 10.1016/j.molmed.2015.05.007; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dabrowiak JC, 2002, DRUG METAB DISPOS, V30, P1378, DOI 10.1124/dmd.30.12.1378; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kroning R, 2000, CANCER CHEMOTH PHARM, V45, P43, DOI 10.1007/PL00006741; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Lushchak V.I., 2012, J AMINO ACIDS, V2012; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Soussi T, 2010, HUM MUTAT, V31, P1020, DOI 10.1002/humu.21313; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	32	229	238	5	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2016	165	5					1092	1105		10.1016/j.cell.2016.04.009	http://dx.doi.org/10.1016/j.cell.2016.04.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM6QT	27133165	Green Accepted, Bronze			2022-12-28	WOS:000376478200011
J	Raccuglia, P; Elbert, KC; Adler, PDF; Falk, C; Wenny, MB; Mollo, A; Zeller, M; Friedler, SA; Schrier, J; Norquist, AJ				Raccuglia, Paul; Elbert, Katherine C.; Adler, Philip D. F.; Falk, Casey; Wenny, Malia B.; Mollo, Aurelio; Zeller, Matthias; Friedler, Sorelle A.; Schrier, Joshua; Norquist, Alexander J.			Machine-learning-assisted materials discovery using failed experiments	NATURE			English	Article							METAL-ORGANIC FRAMEWORKS; CRYSTAL-STRUCTURE; SELENITES; SOLIDS	Inorganic-organic hybrid materials(1-3) such as organically templated metal oxides(1), metal-organic frameworks (MOFs)(2) and organohalide perovskites(4) have been studied for decades, and hydrothermal and (non-aqueous) solvothermal syntheses have produced thousands of new materials that collectively contain nearly all the metals in the periodic table(5-9). Nevertheless, the formation of these compounds is not fully understood, and development of new compounds relies primarily on exploratory syntheses. Simulation-and data-driven approaches (promoted by efforts such as the Materials Genome Initiative(10)) provide an alternative to experimental trial-and-error. Three major strategies are: simulation-based predictions of physical properties (for example, charge mobility(11), photovoltaic properties(12), gas adsorption capacity(13) or lithium-ion intercalation(14)) to identify promising target candidates for synthetic efforts(11,15); determination of the structure-property relationship from large bodies of experimental data(16,17), enabled by integration with high-throughput synthesis and measurement tools(18); and clustering on the basis of similar crystallographic structure (for example, zeolite structure classification(19,20) or gas adsorption properties(21)). Here we demonstrate an alternative approach that uses machine-learning algorithms trained on reaction data to predict reaction outcomes for the crystallization of templated vanadium selenites. We used information on 'dark' reactions-failed or unsuccessful hydrothermal syntheses-collected from archived laboratory notebooks from our laboratory, and added physicochemical property descriptions to the raw notebook information using cheminformatics techniques. We used the resulting data to train a machine-learning model to predict reaction success. When carrying out hydrothermal synthesis experiments using previously untested, commercially available organic building blocks, our machine-learning model outperformed traditional human strategies, and successfully predicted conditions for new organically templated inorganic product formation with a success rate of 89 per cent. Inverting the machine-learning model reveals new hypotheses regarding the conditions for successful product formation.	[Raccuglia, Paul; Elbert, Katherine C.; Adler, Philip D. F.; Falk, Casey; Wenny, Malia B.; Mollo, Aurelio; Friedler, Sorelle A.; Schrier, Joshua; Norquist, Alexander J.] Haverford Coll, 370 Lancaster Ave, Haverford, PA 19041 USA; [Zeller, Matthias] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA	Haverford College; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Friedler, SA; Schrier, J; Norquist, AJ (corresponding author), Haverford Coll, 370 Lancaster Ave, Haverford, PA 19041 USA.	sorelle@cs.haverford.edu; jschrier@haverford.edu; anorquis@haverford.edu	Adler, Philip D F/I-5767-2014	Adler, Philip D F/0000-0002-4114-5076; Wenny, Malia/0000-0002-0704-8184	Ohio Board of Reagents [CAP-491]; Youngstown State University; National Science Foundation [DMR-1307801]; Direct For Mathematical & Physical Scien [1662030, 1337296] Funding Source: National Science Foundation; Division Of Materials Research [1307801] Funding Source: National Science Foundation	Ohio Board of Reagents; Youngstown State University; National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Y. Huang, G. Martin-Noble and D. Reilley for data entry and J. H. Koffer for synthetic efforts. M.Z. acknowledges support for the purchase of a diffractometer by the National Science Foundation (DMR 1337296), the Ohio Board of Reagents grant CAP-491 and from Youngstown State University. This work was supported by the National Science Foundation (DMR-1307801). A.J.N. and J.S. each acknowledge the Henry Dreyfus Teacher-Scholar Award program.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 2013, JCHEM 6 1 3; Barakat N, 2006, INT J COMPUTATIONAL, V2, P59; Beran GJO, 2015, ANGEW CHEM INT EDIT, V54, P396, DOI 10.1002/anie.201409823; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U; Colon YJ, 2014, CHEM SOC REV, V43, P5735, DOI 10.1039/c4cs00070f; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; Ferey G, 2001, CHEM MATER, V13, P3084, DOI 10.1021/cm011070n; FEREY G, 1995, J FLUORINE CHEM, V72, P187, DOI 10.1016/0022-1139(94)00406-6; Fernandez M, 2014, J PHYS CHEM LETT, V5, P3056, DOI 10.1021/jz501331m; Gaultois MW, 2013, CHEM MATER, V25, P2911, DOI 10.1021/cm400893e; Groom CR, 2014, ACTA CRYSTALLOGR B, V70, P776, DOI 10.1107/S2052520614015923; Hachmann J, 2014, ENERG ENVIRON SCI, V7, P698, DOI 10.1039/c3ee42756k; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hastie T., 2009, ELEMENTS STAT LEARNI; HAUSHALTER RC, 1992, CHEM MATER, V4, P31, DOI 10.1021/cm00019a012; Hautier G, 2010, CHEM MATER, V22, P3762, DOI 10.1021/cm100795d; Holdren J. P., 2014, TECHNICAL REPORT; Joachims T., 1998, PROC 10 EUROPEAN C M, P137, DOI DOI 10.1007/BFB0026683; Kalidindi SR, 2015, ANNU REV MATER RES, V45, P171, DOI 10.1146/annurev-matsci-070214-020844; Leach A., 2007, INTRO CHEMOINFORMATI; Li Y, 2014, CHEM REV, V114, P7268, DOI 10.1021/cr500010r; Martin RL, 2013, J PHYS CHEM C, V117, P12159, DOI 10.1021/jp401920y; Olshansky JH, 2014, INORG CHEM, V53, P12027, DOI 10.1021/ic501736r; R Development Core Team, 2009, R LANG ENV STAT COMP; Rao CNR, 2006, CHEM SOC REV, V35, P375, DOI 10.1039/b510396g; Rao CNR, 2000, J AM CHEM SOC, V122, P2810, DOI 10.1021/ja993892f; Riniker S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-26; Sokolov AN, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1451; Stranks SD, 2015, NAT NANOTECHNOL, V10, P391, DOI [10.1038/NNANO.2015.90, 10.1038/nnano.2015.90]; Thakur TS, 2015, ANNU REV PHYS CHEM, V66, P21, DOI 10.1146/annurev-physchem-040214-121452; Thangavelu SG, 2015, CRYST GROWTH DES, V15, P3481, DOI 10.1021/acs.cgd.5b00549; Ustun B, 2006, CHEMOMETR INTELL LAB, V81, P29, DOI 10.1016/j.chemolab.2005.09.003; Wicker JGP, 2015, CRYSTENGCOMM, V17, P1927, DOI 10.1039/c4ce01912a; Yang SJ, 2009, J PHYS CHEM C, V113, P21721, DOI 10.1021/jp907017u; Zhao JC, 2014, CHINESE SCI BULL, V59, P1652, DOI 10.1007/s11434-014-0120-1; Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x	39	733	777	121	1535	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 5	2016	533	7601					73	+		10.1038/nature17439	http://dx.doi.org/10.1038/nature17439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2OE	27147027				2022-12-28	WOS:000375473900041
J	Pike, W; Mackenzie, E				Pike, William; Mackenzie, Elizabeth			Catherine Provan Pike OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2016	353									10.1136/bmj.i2547	http://dx.doi.org/10.1136/bmj.i2547			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL4AR	27145930				2022-12-28	WOS:000375575500019
J	Ma, AD; Burstein, HJ				Ma, Alice D.; Burstein, Harold J.			Update in Hematology and Oncology: Evidence Published in 2015	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ma, Alice D.] Univ N Carolina, Div Hematol Oncol, 170 Manning Dr,CB 7305, Chapel Hill, NC 27599 USA; [Burstein, Harold J.] Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute	Ma, AD (corresponding author), Univ N Carolina, Div Hematol Oncol, 170 Manning Dr,CB 7305, Chapel Hill, NC 27599 USA.							Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Ribas A, 2015, NEW ENGL J MED, V373, P1490, DOI 10.1056/NEJMp1510079	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					W32	W36		10.7326/M16-0214	http://dx.doi.org/10.7326/M16-0214			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	27136229				2022-12-28	WOS:000375744000008
J	Blaser, MJ				Blaser, Martin J.			Antibiotic use and its consequences for the normal microbiome	SCIENCE			English	Editorial Material							GUT MICROBIOTA; ADIPOSITY	Anti-infectives, including antibiotics, are essentially different from all other drugs; they not only affect the individual to whom they are given but also the entire community, through selection for resistance to their own action. Thus, their use resides at the intersection of personal and public health. Antibiotics can be likened to a four-edged sword against bacteria. The first two edges of the antibiotic sword were identified immediately after their discovery and deployment in that they not only benefit an individual in treating their infection but also benefit the community in preventing the spread of that infectious agent. The third edge was already recognized by Alexander Fleming in 1945 in his Nobel acceptance speech, which warned about the cost to the community of antibiotic resistance that would inevitably evolve and be selected for during clinical practice. We have seen this cost mount up, as resistance curtails or precludes the activities of some of our most effective drugs for clinically important infections. But the fourth edge of the antibiotic sword remained unappreciated until recently, i.e., the cost that an antibiotic exerts on an individual's own health via the collateral damage of the drug on bacteria that normally live on or in healthy humans: our microbiota. These organisms, their genes, metabolites, and interactions with one another, as well as with their host collectively, represent our microbiome. Our relationship with these symbiotic bacteria is especially important during the early years of life, when the adult microbiome has not yet formed.	[Blaser, Martin J.] NYULMC, Dept Med, Div Translat Med, New York, NY 10016 USA; [Blaser, Martin J.] NYULMC, Dept Microbiol, New York, NY 10016 USA; [Blaser, Martin J.] Dept Vet Affairs Nev York Harbor Med Ctr, New York, NY 10010 USA		Blaser, MJ (corresponding author), NYULMC, Dept Med, Div Translat Med, New York, NY 10016 USA.; Blaser, MJ (corresponding author), NYULMC, Dept Microbiol, New York, NY 10016 USA.; Blaser, MJ (corresponding author), Dept Vet Affairs Nev York Harbor Med Ctr, New York, NY 10010 USA.	martin.blaser@nyumc.org	Blaser, Martin/ABF-6878-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI122285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER; NIAID NIH HHS [U01AI122285, U01 AI122285] Funding Source: Medline; NIDDK NIH HHS [R01 DK090989, R01DK090989] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Azad MB, 2014, INT J OBESITY, V38, P1290, DOI 10.1038/ijo.2014.119; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P3633, DOI 10.1210/jc.2015-2696; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zimmerman D.R., 1986, J ANIM SCI, V62, P6, DOI [10.2527/1986.62Supplement_36s, DOI 10.2527/1986.62SUPPLEMENT_36S]	15	427	456	12	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					544	545		10.1126/science.aad9358	http://dx.doi.org/10.1126/science.aad9358			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126037	Green Accepted			2022-12-28	WOS:000374998600035
J	Dyer, C				Dyer, Clare			High Court is expected to hear challenges to junior doctor contract in June	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I1915	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2472	10.1136/bmj.i2472	http://dx.doi.org/10.1136/bmj.i2472			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129728				2022-12-28	WOS:000375484100017
J	Gensollen, T; Iyer, SS; Kasper, DL; Blumberg, RS				Gensollen, Thomas; Iyer, Shankar S.; Kasper, Dennis L.; Blumberg, Richard S.			How colonization by microbiota in early life shapes the immune system	SCIENCE			English	Review							REGULATORY T-CELLS; GERM-FREE MICE; INNATE LYMPHOID-CELLS; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; INFANT GUT MICROBIOME; ANTIBIOTIC EXPOSURE; BACTERIAL-COLONIZATION; EOSINOPHILIC ESOPHAGITIS; DIFFERENTIAL INDUCTION; COMMENSAL MICROBIOTA	Microbial colonization of mucosal tissues during infancy plays an instrumental role in the development and education of the host mammalian immune system. These early-life events can have long-standing consequences: facilitating tolerance to environmental exposures or contributing to the development of disease in later life, including inflammatory bowel disease, allergy, and asthma. Recent studies have begun to define a critical period during early development in which disruption of optimal host-commensal interactions can lead to persistent and in some cases irreversible defects in the development and training of specific immune subsets. Here, we discuss the role of early-life education of the immune system during this "window of opportunity," when microbial colonization has a potentially critical impact on human health and disease.	[Gensollen, Thomas; Iyer, Shankar S.; Blumberg, Richard S.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Div Gastroenterol Hepatol &, Boston, MA USA; [Kasper, Dennis L.] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Blumberg, RS (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Div Gastroenterol Hepatol &, Boston, MA USA.	rblumberg@partners.org		/0000-0002-9834-5490	Symbiotic Biotherapies; NIH [DK44319, R21 AI090102]; Harvard Digestive Diseases Center [DK0034854]; U.S. Department of Defense [W81XWH-15-1-0368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK044319, R37DK044319] Funding Source: NIH RePORTER	Symbiotic Biotherapies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	D.L.K. is an inventor on patents licensed to Symbiotic Biotherapies by Brigham and Women's Hospital and Harvard Medical School related to RSA of B. fragilis and its use as an immunomodulator for treating immune-mediated diseases. D.L.K. and R.S.B. are paid consultants for Symbiotic Biotherapies. R.S.B. is supported by NIH grant DK44319 and the Harvard Digestive Diseases Center (DK0034854). D.L.K. is supported by NIH grant R21 AI090102 and the U.S. Department of Defense (W81XWH-15-1-0368).	ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; ABRAMS GD, 1963, LAB INVEST, V12, P355; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azad MB, 2014, INT J OBESITY, V38, P1290, DOI 10.1038/ijo.2014.119; Baptista AP, 2013, MUCOSAL IMMUNOL, V6, P511, DOI 10.1038/mi.2012.90; Barclay AR, 2009, J PEDIATR-US, V155, P421, DOI 10.1016/j.jpeds.2009.03.017; BAUER H, 1963, AM J PATHOL, V42, P471; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Boursi B, 2015, EUR J ENDOCRINOL, V172, P639, DOI 10.1530/EJE-14-1163; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; CRABBE PA, 1970, LAB INVEST, V22, P448; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; El Aidy S, 2013, GUT MICROBES, V4, P118, DOI 10.4161/gmic.23362; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; GORDON HA, 1961, ACTA ANAT, V44, P210; GORDON HA, 1966, ACTA ANAT, V64, P367, DOI 10.1159/000142843; GUSTAFSSON BE, 1970, SCAND J GASTROENTERO, V5, P309; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; KAWAGUCHI M, 1993, P NATL ACAD SCI USA, V90, P8591, DOI 10.1073/pnas.90.18.8591; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lexmond WS, 2014, AM J GASTROENTEROL, V109, P646, DOI 10.1038/ajg.2014.12; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mai XM, 2010, CLIN EXP ALLERGY, V40, P1230, DOI 10.1111/j.1365-2222.2010.03532.x; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MATSUMOTO S, 1992, GASTROENTEROLOGY, V103, P1777, DOI 10.1016/0016-5085(92)91434-6; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mosconi I, 2013, MUCOSAL IMMUNOL, V6, P1157, DOI 10.1038/mi.2013.12; Natividad JMM, 2013, APPL ENVIRON MICROB, V79, P7745, DOI 10.1128/AEM.02470-13; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Nuttall G. H. F., 1896, PHYIOLOGICAL CHEM, V21, P109; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pasteur Louis., 1885, CR HEBD ACAD SCI, V100, P68; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; PLEASANTS JR, 1959, ANN NY ACAD SCI, V78, P116, DOI 10.1111/j.1749-6632.1959.tb53099.x; Probert CSJ, 2007, IMMUNOL REV, V215, P215, DOI 10.1111/j.1600-065X.2006.00480.x; Rajavelu P, 2012, AM J PHYSIOL-GASTR L, V302, pG645, DOI 10.1152/ajpgi.00223.2011; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Reyniers James A., 1946, LOBUND REPT, V1, P1; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Sommer F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0614-4; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stockinger S, 2011, CELL MOL LIFE SCI, V68, P3699, DOI 10.1007/s00018-011-0831-2; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; UMESAKI Y, 1993, IMMUNOLOGY, V79, P32; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Dieren JM, 2007, INFLAMM BOWEL DIS, V13, P1146, DOI 10.1002/ibd.20164; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847	100	874	919	24	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					539	544		10.1126/science.aad9378	http://dx.doi.org/10.1126/science.aad9378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126036	Green Accepted			2022-12-28	WOS:000374998600034
J	Sahl, SJ; Balzarotti, F; Keller-Findeisen, J; Leutenegger, M; Westphal, V; Egner, A; Lavoie-Cardinal, F; Chmyrov, A; Grotjohann, T; Jakobs, S				Sahl, Steffen J.; Balzarotti, Francisco; Keller-Findeisen, Jan; Leutenegger, Marcel; Westphal, Volker; Egner, Alexander; Lavoie-Cardinal, Flavie; Chmyrov, Andriy; Grotjohann, Tim; Jakobs, Stefan			Comment on "Extended-resolution structured illumination imaging of endocytic and cytoskeletal dynamics"	SCIENCE			English	Editorial Material							FLUORESCENCE MICROSCOPY; OPTICAL RESOLUTION; NANOSCOPY; PROTEIN; LIGHT; REVEALS; LIMIT; GFP	Li et al. (Research Articles, 28 August 2015, aab3500) purport to present solutions to longstanding challenges in live-cell microscopy, reporting relatively fast acquisition times in conjunction with improved image resolution. We question the methods' reliability to visualize specimen features at sub-100-nanometer scales, because the mandatory mathematical processing of the recorded data leads to artifacts that are either difficult or impossible to disentangle from real features. We are also concerned about the chosen approach of subjectively comparing images from different super-resolution methods, as opposed to using quantitative measures.	[Sahl, Steffen J.; Balzarotti, Francisco; Keller-Findeisen, Jan; Leutenegger, Marcel; Westphal, Volker; Grotjohann, Tim; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany; [Egner, Alexander] Laser Lab Gottingen, Hans Adolf Krebs Weg 1, D-37077 Gottingen, Germany; [Lavoie-Cardinal, Flavie] Inst Univ Sante Mentale Quebec, Cellular & Mol Neurosci Res Axis, 2601 Chem Canardiere, Quebec City, PQ G1J 2G3, Canada; [Chmyrov, Andriy] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Chmyrov, Andriy] Tech Univ Munich, Chair Biol Imaging, Ismaningerstr 22, D-81675 Munich, Germany; [Jakobs, Stefan] Univ Gottingen, Fac Med, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen; Laval University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Gottingen	Sahl, SJ; Balzarotti, F; Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany.; Jakobs, S (corresponding author), Univ Gottingen, Fac Med, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	ssahl@mpibpc.mpg.de; fbalzar@mpibpc.mpg.de; sjakobs@mpibpc.mpg.de	Jakobs, Stefan/F-4898-2012; Chmyrov, Andriy/A-2472-2010	Jakobs, Stefan/0000-0002-8028-3121; Chmyrov, Andriy/0000-0003-0265-019X; Egner, Alexander/0000-0001-5248-3858; Balzarotti, Francisco/0000-0003-1471-8120; Keller-Findeisen, Jan/0000-0003-2753-0848				Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; Frohn JT, 2000, P NATL ACAD SCI USA, V97, P7232, DOI 10.1073/pnas.130181797; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Hell SW, 2004, CURR OPIN NEUROBIOL, V14, P599, DOI 10.1016/j.conb.2004.08.015; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Rittweger E, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/14001; Schwentker MA, 2007, MICROSC RES TECHNIQ, V70, P269, DOI 10.1002/jemt.20443; Testa I, 2012, NEURON, V75, P992, DOI 10.1016/j.neuron.2012.07.028; Vandenberg W, 2015, CELL TISSUE RES, V360, P151, DOI 10.1007/s00441-014-2109-0	17	34	35	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285								10.1126/science.aad7983	http://dx.doi.org/10.1126/science.aad7983			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK5ZA	27126030				2022-12-28	WOS:000374998600028
J	Wise, J				Wise, Jacqui			Yoga may improve asthma symptoms, Cochrane review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Yang ZY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010346.pub2	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2016	353								i2462	10.1136/bmj.i2462	http://dx.doi.org/10.1136/bmj.i2462			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RY	27129481				2022-12-28	WOS:000375484100014
J	Klein, R; Klein, BEK				Klein, Ronald; Klein, Barbara E. K.			Body Fat Distribution and Diabetic Retinopathy in People With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; POPULATION; OBESITY	IMPORTANCE The association between obesity and diabetic retinopathy (DR) is equivocal, possibly owing to the strong interrelation between generalized and abdominal obesity leading to a mutually confounding effect. To our knowledge, no study in Asia has investigated the independent associations of these 2 parameters with DR to date. OBJECTIVE To investigate the associations of generalized (defined by body mass index [BMI], calculated as weight in kilograms divided by height in meters squared) and abdominal obesity (assessed by waist to hip ratio [WHR]) with DR in a clinical sample of Asian patients with type 2 diabetes mellitus. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional clinic-based study was conducted at the Singapore National Eye Centre, a tertiary eye care institution in Singapore, from December 2010 to September 2013. We recruited 498 patients with diabetes. After exclusion of participants with ungradable retinal images and type 1 diabetes, 420 patients (mean [SD] age, 57.8 [7.5] years; 32.1% women) were included in the analyses. EXPOSURES Body mass index and WHR as waist/hip circumference (in centimeters). MAIN OUTCOMES AND MEASURES The presence and severity of DR were graded from retinal images using the modified Airlie House Classification into none (n = 189), mild-moderate (Early Treatment Diabetic Retinopathy Study scale score, 20-41; n = 125), and severe DR (Early Treatment Diabetic Retinopathy Study scale score >= 53; n = 118). The associations of BMI and WHR with DR were assessed using multinomial logistic regression models adjusting for age, sex, traditional risk factors, and mutually for BMI and WHR. RESULTS Among the total of 420 patients, the median (interquartile range) for BMI and WHR were 25.7 (5.7) and 0.94 (0.08), respectively. In multivariable models, BMI was inversely associated with mild-moderate and severe DR(oddsratio[OR], 0.90 [95% CI, 0.84-0.97] and OR, 0.92 [95% CI, 0.85-0.99] per 1-unit increase, respectively), while WHR was positively associated with mild-moderate and severe DR(OR, 3.49[95% CI, 1.50-8.10] and OR, 2.68 [95% CI, 1.28-5.62] per 0.1-unit increase, respectively) in women(Pf or interaction = .006). Nosex-specific associations were found between BMI and DR(P for interaction >.10). CONCLUSIONS AND RELEVANCE In Asian patients with type 2 diabetes, a higher BMI appeared to confer a protective effect on DR, while higher WHR was associated with the presence and severity of DR in women. Our results may inform future clinical trials to determine whether WHR is a more clinically relevant risk marker than BMI for individuals with type 2 diabetes.	[Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Klein, R (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, 610 Walnut St,417WARF, Madison, WI 53726 USA.	kleinr@epi.ophth.wisc.edu						BALLARD DJ, 1986, DIABETES CARE, V9, P334, DOI 10.2337/diacare.9.4.334; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Klein R, 1997, ARCH INTERN MED, V157, P650, DOI 10.1001/archinte.157.6.650; Lipska KJ, 2016, JAMA-J AM MED ASSOC, V315, P1034, DOI 10.1001/jama.2016.0299; Man REK, 2016, JAMA OPHTHALMOL, V134, P251, DOI 10.1001/jamaophthalmol.2015.5103; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063	7	8	9	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2016	315	16					1778	+		10.1001/jama.2016.3849	http://dx.doi.org/10.1001/jama.2016.3849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK2QK	27115379				2022-12-28	WOS:000374759300024
J	Lenzer, J				Lenzer, Jeanne			PROFILE Otis Brawley-one of the first to question the value of screening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2301	10.1136/bmj.i2301	http://dx.doi.org/10.1136/bmj.i2301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27117310				2022-12-28	WOS:000375482500006
J	Wise, J				Wise, Jacqui			Weekend admission to psychiatric hospital is not linked to increased risk of death	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Patel R, 2016, BRIT J PSYCHIAT, V209, P29, DOI 10.1192/bjp.bp.115.180307; Rimmer A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5624; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2016	353								i2342	10.1136/bmj.i2342	http://dx.doi.org/10.1136/bmj.i2342			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DL2RF	27114473				2022-12-28	WOS:000375482000005
J	Barnett, R				Barnett, Richard			Case histories Systemic lupus erythematosus	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1711	1711		10.1016/S0140-6736(16)30266-5	http://dx.doi.org/10.1016/S0140-6736(16)30266-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ9OD	27116268				2022-12-28	WOS:000374541900013
J	Newby, G; Bennett, A; Larson, E; Cotter, C; Shretta, R; Phillips, AA; Feachem, RGA				Newby, Gretchen; Bennett, Adam; Larson, Erika; Cotter, Chris; Shretta, Rima; Phillips, Allison A.; Feachem, Richard G. A.			The path to eradication: a progress report on the malaria-eliminating countries	LANCET			English	Review							PLASMODIUM-FALCIPARUM MALARIA; IMPORTED MALARIA; STRATEGIES; FEASIBILITY; SYSTEMS; DISEASE	In the past several years, as worldwide morbidity and mortality due to malaria have continued to decrease, the global malaria community has grown increasingly supportive of the idea of malaria eradication. In 2015, three noteworthy global documents were released-the WHO's Global Technical Strategy for Malaria 2016-2030, the Roll Back Malaria Partnership's Action and Investment to defeat Malaria 2016-2030, and From Aspiration to Action: What Will It Take to End Malaria?-that collectively advocate for malaria elimination and eradication and outline key operational, technical, and financial strategies to achieve progress toward malaria eradication. In light of this remarkable change in global attitudes toward malaria elimination and eradication, and as the malaria community debates how and when to embark on this ambitious goal, it is important to assess current progress along the path to eradication. Although low-income, high-burden countries are often the focus when discussing the substantial challenges of eradication, the progress toward elimination in middle-income, low-burden countries is a major driver of global progress and deserves better recognition. Additionally, although global support and guidance is essential for success, malaria elimination and eradication efforts will ultimately be driven at the country level and achieved in a collaborative manner, region by region. In this Review, we examine the present status of the 35 malaria-eliminating countries, summarise existing national and regional elimination goals and the regional frameworks that support them, and identify the most crucial enabling factors and potential barriers to achieving eradication by a theoretical end date of 2040.	[Newby, Gretchen; Bennett, Adam; Larson, Erika; Cotter, Chris; Shretta, Rima; Phillips, Allison A.; Feachem, Richard G. A.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Newby, G (corresponding author), Univ Calif San Francisco, Global Hlth Sci, Mission Hall,550 16th St, San Francisco, CA 94158 USA.	gretchen.newby@ucsf.edu			Malaria Elimination Initiative of the Global Health Group at the University of California, San Francisco - Bill & Melinda Gates Foundation	Malaria Elimination Initiative of the Global Health Group at the University of California, San Francisco - Bill & Melinda Gates Foundation	The authors are supported by the Malaria Elimination Initiative of the Global Health Group at the University of California, San Francisco, whose funding for this work comes from a grant from the Bill & Melinda Gates Foundation. The funders had no role in the design or writing of this manuscript, or the decision to submit the manuscript for publication. The authors were not paid to write this report. The corresponding author had full access to all material included in the manuscript and had the final responsibility for the decision to submit for publication. We thank Alistair Dawson, Roly Gosling, Jimee Hwang, and Cara Smith Gueye of the UCSF Global Health Group for their review of the report and helpful feedback.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; APMEN, 2015, US AS PAC MAL EL NET; Asia Pacific Leaders Malaria Alliance, 2014, TASK FORC PROGR REP; Asia Pacific Leaders Malaria Alliance, 2015, APLMA MAL EL ROADM; Asia Pacific Leaders Malaria Alliance, 2015, APLMA UN WE DEF MAL; Baird JK, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0531-0; Bill & Melinda Gates Foundation, 2015, MIDDL E OFF LIV LIV; Cao J L, 2014, INT J PHOTOENERGY, V2014, P1, DOI DOI 10.1371/J0URNAL.PMED.1001642; CDC Foundation, 2015, CONS AIMS EL MAL HIS; CDC Foundation, 2015, MAL ZER ALL MAL FREE; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Coleman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105980; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Danis K, 2013, TRAVEL MED INFECT DI, V11, P8, DOI 10.1016/j.tmaid.2013.01.001; E8 Secretariat, 2015, 8 SECRETARIAT ELIMIN; E8 Secretariat, 2015, E8 SECR EL 8 CONC NO; Ejov M, 2014, REGIONAL FRAMEWORK P; Feachem RGA, 2009, SHRINKING MALARIA MA; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gasimov E., 2015, UDPATE MALARIA ELIMI; Gates B, 2014, WE CAN ERADICATE MAL; Gates B, 2015, ASPIRATION ACTION WI; Global Malaria Programme, 2007, GLOB MAL PROGR MAL E; Global Malaria Programme, 2014, GLOB MAL PROGR WORLD; Gosling J, 2015, AM J TROP MED HYG, V93, P135, DOI 10.4269/ajtmh.14-0255; Gueye CS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-286; Herrera S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003700; HM Treasury Department for International Development The Rt Hon Justine Greening MP and The Rt Hon George Osborne MP, 2015, NEWS STORY CHANCELLO; Hsiang MS, 2010, LANCET, V375, P1586, DOI 10.1016/S0140-6736(10)60350-9; Kelly GC, 2012, TRENDS PARASITOL, V28, P297, DOI 10.1016/j.pt.2012.04.002; Koita K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-219; Kumar K, 2013, FINANCING MALARIA EL; Liu J, 2013, LANCET GLOB HEALTH, V1, pE2, DOI 10.1016/S2214-109X(13)70002-0; Malaria Eradication Scientific Alliance (MESA), 2015, US; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Moyes CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002780; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Office of the UN Secretary-General's Special Envoy for Financing the Health Millennium Development Goals and for Malaria, 2015, OFF UN SECR GEN SPEC; Ohrt C, 2015, AM J TROP MED HYG, V93, P145, DOI 10.4269/ajtmh.14-0257; Organizacion Panamericana de la Salud, 2014, PAR IN CAM HAC CERT; Regional Steering Committee for the Regional Artemisinin Initiative, 2013, REG STEER COMM REG A; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Roll Back Malaria Partnership, 2014, AS PAC MAL EL NETW A; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Roll Back Malaria Partnership Secretariat, 2015, ACT INV DEF MAL 2016; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Southern African Development Community, 2012, MAL EL 8 E8, V8; Sturrock HJW, 2015, AM J TROP MED HYG, V93, P139, DOI 10.4269/ajtmh.14-0256; Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; The Executive Board of Health Ministers' Gulf Cooperation Council, 2010, AR PEN FREE MAL IN; Whittaker MA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-221; WHO, 2015, GLOB TECHN STRAT MAL; WHO Regional Office for Europe, 2005, TASHK DECL MOV MAL C; Wickremasinghe R, 2016, MAINTAINING ZERO UPD; World Health Organization, 2015, REG HUB GREAT MEK SU; World Health Organization, 2015, STRAT MAL EL GREAT M; World Health Organization Regional Offi ce for Europe, 2015, MAL FREE EUR REG END; Zelman B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1171-3; Zelman B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115714	62	75	77	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2016	387	10029					1775	1784		10.1016/S0140-6736(16)00230-0	http://dx.doi.org/10.1016/S0140-6736(16)00230-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9OD	27116283	Bronze			2022-12-28	WOS:000374541900030
J	Gulland, A				Gulland, Anne			Government's pledges on mental health are not backed with funding, says spending watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Audit Office, 2016, MENT HLTH SERV PREP	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2330	10.1136/bmj.i2330	http://dx.doi.org/10.1136/bmj.i2330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK5ZL	27106912				2022-12-28	WOS:000374999700013
J	Somers, K				Somers, Krishna			Mildred Hilario Genesio de Souza OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2016	353								i2302	10.1136/bmj.i2302	http://dx.doi.org/10.1136/bmj.i2302			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK5ZL	27105889				2022-12-28	WOS:000374999700007
J	Rocklov, J				Rocklov, Joacim			Misconceptions of global catastrophe	NATURE			English	Editorial Material							PERCEPTIONS; WEATHER		[Rocklov, Joacim] Umea Univ, Umea Ctr Global Hlth Res, Unit Epidemiol & Global Hlth, S-90187 Umea, Sweden	Umea University	Rocklov, J (corresponding author), Umea Univ, Umea Ctr Global Hlth Res, Unit Epidemiol & Global Hlth, S-90187 Umea, Sweden.	joacim.rocklov@umu.se		Rocklov, Joacim/0000-0003-4030-0449				Bernauer T, 2016, NAT CLIM CHANGE, V6; Egan PJ, 2016, NATURE, V532, P357, DOI 10.1038/nature17441; Egan PJ, 2012, J POLIT, V74, P796, DOI 10.1017/S0022381612000448; Hanigan Ivan, 2006, Int J Health Geogr, V5, P38, DOI 10.1186/1476-072X-5-38; IPCC, 2013, CLIMATE CHANGE 2022; Matthews HD, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014010; Rappaport J, 2007, REG SCI URBAN ECON, V37, P375, DOI 10.1016/j.regsciurbeco.2006.11.004; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Stern N, 2016, NATURE, V530, P407, DOI 10.1038/530407a; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6	10	3	3	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					317	318		10.1038/532317a	http://dx.doi.org/10.1038/532317a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ7WU	27127820				2022-12-28	WOS:000374424700020
J	[Anonymous]				[Anonymous]			A Harvey Anniversary: 1616-1916 (Reprinted from JAMA vol 66, pg 1200-1201, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1916, JAMA, V66, P1200	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1524	1524		10.1001/jama.2015.17081	http://dx.doi.org/10.1001/jama.2015.17081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27115281				2022-12-28	WOS:000373873800029
J	Alley, RB				Alley, Richard B.			A heated mirror for future climate	SCIENCE			English	Editorial Material							EOCENE; EVOLUTION		[Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Alley, Richard B.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Alley, RB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.; Alley, RB (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.	rba6@psu.edu						Aze T, 2014, GEOLOGY, V42, P739, DOI 10.1130/G35637.1; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Lunt DJ, 2011, NAT GEOSCI, V4, P775, DOI [10.1038/NGEO1266, 10.1038/ngeo1266]; Penman DE, 2014, PALEOCEANOGRAPHY, V29, P357, DOI 10.1002/2014PA002621; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Secord R, 2012, SCIENCE, V335, P959, DOI 10.1126/science.1213859; Sluijs A, 2014, CLIM PAST, V10, P1421, DOI 10.5194/cp-10-1421-2014; Svensen H, 2010, J GEOL SOC LONDON, V167, P433, DOI 10.1144/0016-76492009-125; Turner SK, 2016, EARTH PLANET SC LETT, V435, P1, DOI 10.1016/j.epsl.2015.11.027; Wing SL, 2013, AM J BOT, V100, P1234, DOI 10.3732/ajb.1200554; Zeebe RE, 2016, NAT GEOSCI, V9, P325, DOI 10.1038/NGEO2681; Zeebe RE, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0006	13	9	9	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					151	152		10.1126/science.aaf4837	http://dx.doi.org/10.1126/science.aaf4837			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	27124443				2022-12-28	WOS:000373681600026
J	Ranasinghe, I; Parzynski, CS; Freeman, JV; Dreyer, RP; Ross, JS; Akar, JG; Krumholz, HM; Curtis, JP				Ranasinghe, Isuru; Parzynski, Craig S.; Freeman, James V.; Dreyer, Rachel P.; Ross, Joseph S.; Akar, Joseph G.; Krumholz, Harlan M.; Curtis, Jeptha P.			Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation An Observational Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							DUAL-CHAMBER; SURGICAL REVISION; COMPETING RISK; MORTALITY; ICD; REGISTRY; DATABASE; OUTCOMES; IMPACT; LONGEVITY	Background: Long-term nonfatal outcomes after implantable cardioverter-defibrillator (ICD) placement are poorly defined. Objective: To determine the long-term risk for ICD-related complications requiring reoperation or hospitalization and reoperation for reasons other than complications, and to assess associated patient and device characteristics. Design: Observational cohort study of ICD implantations from the National Cardiovascular Data Registry ICD registry linked with Medicare fee-for-service claims data. Setting: 1437 U.S. hospitals. Patients: 114 484 patients aged 65 years or older (mean, 74.8 years [SD, 6.2]; 72.4% male) receiving an ICD for the first time from 2006 to 2010 (single-chamber, 19.8%; dual-chamber, 41.3%; cardiac resynchronization therapy with a defibrillator [CRT-D], 38.9%). Measurements: Rate and cumulative incidence of ICD-related complications requiring reoperation or hospitalization and reoperation for reasons other than complications. Results: During a median follow-up of 2.7 years (interquartile range, 1.8 to 3.9 years), 40 072 patients died, representing 12.6 (95% CI, 12.5 to 12.7) deaths per 100 patient-years of follow-up. When the risk for death was accounted for, there were 6.1 (CI, 6.0 to 6.2) ICD-related complications per 100 patient-years that required reoperation or hospitalization and 3.9 (CI, 3.8 to 4.0) reoperations per 100 patient-years for reasons other than complications. Overall, 10 patients had complications or reoperation per 100 patient-years of follow-up. Younger age at implantation (65 to 69 vs. >85 years) (hazard ratio [HR], 1.55 [CI, 1.43 to 1.69]), receipt of a CRT-D device (HR, 1.38 [CI, 1.31 to 1.45]) versus a single-chamber device, female sex (HR, 1.16 [CI, 1.12 to 1.21]), and black race (HR, 1.14 [CI, 1.05 to 1.23]) were associated with the greatest increased risks for ICD-related complications. Limitation: The analysis was limited to Medicare fee-for-service patients aged 65 years or older. Conclusion: Patients have a high rate of device-related complications and reoperation for other causes after ICD implantation. Risks of ICD implantation and strategies to reduce them should be actively considered before implantation.	Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; Yale Univ, New Haven, CT 06510 USA; [Ranasinghe, Isuru] Queen Elizabeth Hosp, Discipline Med, Level 5B,29 Woodville Rd, Woodville South, SA 5011, Australia; [Parzynski, Craig S.; Freeman, James V.; Dreyer, Rachel P.; Ross, Joseph S.; Akar, Joseph G.; Krumholz, Harlan M.; Curtis, Jeptha P.] Ctr Outcomes Res & Evaluat, 1 Church St, New Haven, CT 06510 USA	Yale University	Ranasinghe, I (corresponding author), Queen Elizabeth Hosp, Discipline Med, Level 5B,29 Woodville Rd, Woodville South, SA 5011, Australia.	isuru.ranasinghe@adelaide.edu.au	, Harlan/AAI-2875-2020; Kuschyk, Jürgen/Q-2150-2015	Ross, Joseph/0000-0002-9218-3320; Ranasinghe, Isuru/0000-0003-0982-1561; Dreyer, Rachel/0000-0003-2861-1383	National Health and Medical Research Council; National Heart Foundation of Australia (early career fellowship); National Heart, Lung, and Blood Institute [K23 HL118147-01, 1U01HL105270-03]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; American College of Cardiology NCDR	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia (early career fellowship)(National Heart Foundation of Australia); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; American College of Cardiology NCDR	Financial Support: By the National Health and Medical Research Council and the National Heart Foundation of Australia (early career fellowship; Dr. Ranasinghe); the National Heart, Lung, and Blood Institute (grant K23 HL118147-01 to Dr. Freeman and grant 1U01HL105270-03 [Center for Cardiovascular Outcomes Research at Yale-New Haven Hospital] to Drs. Krumholz and Curtis); the National Institute on Aging (grant K08 AG032886; Dr. Ross); the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program (Dr. Ross); and the American College of Cardiology NCDR (salary support; Dr. Curtis).	Al-Khatib SM, 2011, JAMA-J AM MED ASSOC, V305, P43, DOI 10.1001/jama.2010.1915; Al-Khatib SM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P240, DOI 10.1161/CIRCEP.108.777888; Anderson KP, 2009, CIRCULATION, V119, P1069, DOI 10.1161/CIRCULATIONAHA.108.841452; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Biffi M, 2008, EUROPACE, V10, P1288, DOI 10.1093/europace/eun240; Boriani G, 2013, EUROPACE, V15, P1453, DOI 10.1093/europace/eut133; Brignole M, 2009, EUROPACE, V11, P1129, DOI 10.1093/europace/eup174; Dewland TA, 2011, J AM COLL CARDIOL, V58, P1007, DOI 10.1016/j.jacc.2011.04.039; Duray GZ, 2009, EUROPACE, V11, P297, DOI 10.1093/europace/eun322; Eckstein J, 2008, CIRCULATION, V117, P2727, DOI 10.1161/CIRCULATIONAHA.107.740670; Ezekowitz JA, 2007, ANN INTERN MED, V147, P251, DOI 10.7326/0003-4819-147-4-200708210-00007; Ezzat VA, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000198; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hauptman PJ, 2013, JAMA INTERN MED, V173, P571, DOI 10.1001/jamainternmed.2013.3171; Hlatky MA, 2002, AM HEART J, V144, P397, DOI 10.1067/mhj.2002.125496; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Kleemann T, 2007, CIRCULATION, V115, P2474, DOI 10.1161/CIRCULATIONAHA.106.663807; Kramer DB, 2014, HEART RHYTHM, V11, P216, DOI 10.1016/j.hrthm.2013.10.046; Kramer DB, 2013, CIRC-CARDIOVASC QUAL, V6, P488, DOI 10.1161/CIRCOUTCOMES.111.000054; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Landolina M, 2011, CIRCULATION, V123, P2526, DOI 10.1161/CIRCULATIONAHA.110.015024; Lee DS, 2007, J AM COLL CARDIOL, V49, P2408, DOI 10.1016/j.jacc.2007.02.058; Lee DS, 2010, J AM COLL CARDIOL, V55, P774, DOI 10.1016/j.jacc.2009.11.029; MacFadden DR, 2012, ANN INTERN MED, V156, P195, DOI 10.7326/0003-4819-156-3-201202070-00007; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Peterson PN, 2013, JAMA-J AM MED ASSOC, V309, P2025, DOI 10.1001/jama.2013.4982; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Trivedi AN, 2006, J AM COLL CARDIOL, V47, P417, DOI 10.1016/j.jacc.2005.08.068	31	54	54	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					20	+		10.7326/M15-2732	http://dx.doi.org/10.7326/M15-2732			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	27135392				2022-12-28	WOS:000379215800004
J	Hamilton, DP				Hamilton, Douglas P.			Fresh solutions to the four-body problem	NATURE			English	Editorial Material							CENTRAL CONFIGURATIONS; MASSES		[Hamilton, Douglas P.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Hamilton, DP (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	dphamil@astro.umd.edu						Albouy A., 1996, CONT MATH, V198, P131, DOI [10.1090/conm/198/02494, DOI 10.1090/CONM/198/02494]; Alvarez-Ramirez M, 2013, APPL MATH COMPUT, V219, P5996, DOI 10.1016/j.amc.2012.12.036; Erdi B, 2016, CELEST MECH DYN ASTR, V125, P33, DOI 10.1007/s10569-016-9672-5; Long YM, 2002, ARCH RATION MECH AN, V162, P25, DOI 10.1007/s002050100183; Pina E, 2010, CELEST MECH DYN ASTR, V108, P73, DOI 10.1007/s10569-010-9291-5	5	10	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					187	188		10.1038/nature17896	http://dx.doi.org/10.1038/nature17896			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144360				2022-12-28	WOS:000376007200037
J	Ye, LB; Van Eps, N; Zimmer, M; Ernst, OP; Prosser, RS				Ye, Libin; Van Eps, Ned; Zimmer, Marco; Ernst, Oliver P.; Prosser, R. Scott			Activation of the A(2A) adenosine G-protein-coupled receptor by conformational selection	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DYNAMIC PROCESS; EQUILIBRIUM; BINDING; LANDSCAPES; RHODOPSIN; INSIGHTS; STATES	Conformational selection and induced fit are two prevailing mechanisms(1,2) to explain the molecular basis for ligand-based activation of receptors. G-protein-coupled receptors are the largest class of cell surface receptors and are important drug targets. A molecular understanding of their activation mechanism is critical for drug discovery and design. However, direct evidence that addresses how agonist binding leads to the formation of an active receptor state is scarce(3). Here we use F-19 nuclear magnetic resonance to quantify the conformational landscape occupied by the adenosine A(2A) receptor (A(2A)R), a prototypical class A G-protein-coupled receptor. We find an ensemble of four states in equilibrium: (1) two inactive states in millisecond exchange, consistent with a formed (state S-1) and a broken (state S-2) salt bridge (known as 'ionic lock') between transmembrane helices 3 and 6; and (2) two active states, S-3 and S-3', as identified by binding of a G-protein-derived peptide. In contrast to a recent study of the beta(2)-adrenergic receptor(4), the present approach allowed identification of a second active state for A(2A)R. Addition of inverse agonist (ZM241385) increases the population of the inactive states, while full agonists (UK432097 or NECA) stabilize the active state, S-3', in a manner consistent with conformational selection. In contrast, partial agonist (LUF5834) and an allosteric modulator (HMA) exclusively increase the population of the S-3 state. Thus, partial agonism is achieved here by conformational selection of a distinct active state which we predict will have compromised coupling to the G protein. Direct observation of the conformational equilibria of ligand-dependent G-protein-coupled receptor and deduction of the underlying mechanisms of receptor activation will have wide-reaching implications for our understanding of the function of G-protein-coupled receptor in health and disease.	[Ye, Libin; Prosser, R. Scott] Univ Toronto, Dept Chem, UTM, 3359 Mississauga Rd North, Mississauga, ON L5L 1C6, Canada; [Ye, Libin; Van Eps, Ned; Zimmer, Marco; Ernst, Oliver P.; Prosser, R. Scott] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Zimmer, Marco] Univ Stuttgart, Dept Tech Biochem, 31 Allmandring, D-70569 Stuttgart, Baden Wurttembe, Germany; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University of Stuttgart; University of Toronto	Prosser, RS (corresponding author), Univ Toronto, Dept Chem, UTM, 3359 Mississauga Rd North, Mississauga, ON L5L 1C6, Canada.; Ernst, OP; Prosser, RS (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Ernst, OP (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	oliver.ernst@utoronto.ca; scott.prosser@utoronto.ca		Van Eps, Ned/0000-0001-9178-1436	Natural Sciences and Engineering Research Council of Canada [261980]; Canada Excellence Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Excellence Research Chair Program	This work was supported by the Natural Sciences and Engineering Research Council of Canada, research discovery award grant number 261980 (to R.S.P.) and the Canada Excellence Research Chair Program (to O.P.E., who is the Anne and Max Tanenbaum Chair in Neuroscience at the University of Toronto). We thank T. Kobayashi and R. Grisshammer for providing plasmids with A<INF>2A</INF>R sequence. We thank J. Wells, S. Larda, and F. Huang from the University of Toronto, as well as S. Furness, B. K. Kobilka, and R. Sunahara for their suggestions and comments.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Helgstrand M, 2000, J BIOMOL NMR, V18, P49, DOI 10.1023/A:1008309220156; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Kumar S, 2000, PROTEIN SCI, V9, P10; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Mazzoni MR, 2000, MOL PHARMACOL, V58, P226, DOI 10.1124/mol.58.1.226; Meiler J, 2003, J BIOMOL NMR, V26, P25, DOI 10.1023/A:1023060720156; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ruiz MD, 2014, J MED CHEM, V57, P3623, DOI 10.1021/jm4011669; Schafer CT, 2015, J BIOL CHEM, V290, P4304, DOI 10.1074/jbc.M114.603134; SCORER CA, 1994, BIO-TECHNOL, V12, P181, DOI 10.1038/nbt0294-181; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; SYKES BD, 1974, P NATL ACAD SCI USA, V71, P469, DOI 10.1073/pnas.71.2.469; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Weikl TR, 2014, PROTEIN SCI, V23, P1508, DOI 10.1002/pro.2539; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Ye LB, 2015, J BIOMOL NMR, V62, P97, DOI 10.1007/s10858-015-9922-y	37	208	210	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2016	533	7602					265	+		10.1038/nature17668	http://dx.doi.org/10.1038/nature17668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM0BJ	27144352				2022-12-28	WOS:000376007200054
J	Lui, HS; Zhang, JS; Makinson, SR; Cahill, MK; Kelley, KW; Huang, HY; Shang, YL; Oldham, MC; Martens, LH; Gao, FY; Coppola, G; Sloan, SA; Hsieh, CL; Kim, CC; Bigio, EH; Weintraub, S; Mesulam, MM; Rademakers, R; Mackenzie, IR; Seeley, WW; Karydas, A; Miller, BL; Borroni, B; Ghidoni, R; Farese, RV; Paz, JT; Barres, BA; Huang, EJ				Lui, Hansen; Zhang, Jiasheng; Makinson, Stefanie R.; Cahill, Michelle K.; Kelley, Kevin W.; Huang, Hsin-Yi; Shang, Yulei; Oldham, Michael C.; Martens, Lauren Herl; Gao, Fuying; Coppola, Giovanni; Sloan, Steven A.; Hsieh, Christine L.; Kim, Charles C.; Bigio, Eileen H.; Weintraub, Sandra; Mesulam, Marek-Marsel; Rademakers, Rosa; Mackenzie, Ian R.; Seeley, William W.; Karydas, Anna; Miller, Bruce L.; Borroni, Barbara; Ghidoni, Roberta; Farese, Robert V., Jr.; Paz, Jeanne T.; Barres, Ben A.; Huang, Eric J.			Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation	CELL			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; NEURONAL CEROID-LIPOFUSCINOSIS; OBSESSIVE-COMPULSIVE DISORDER; NETWORK ANALYSIS; DEMENTIA; MUTATION; CELLS; C1Q; TRANSCRIPTOME; ORGANIZATION	Microglia maintain homeostasis in the brain, but whether aberrant microglial activation can cause neurodegeneration remains controversial. Here, we use transcriptome profiling to demonstrate that deficiency in frontotemporal dementia (FTD) gene progranulin (Grn) leads to an age-dependent, progressive upregulation of lysosomal and innate immunity genes, increased complement production, and enhanced synaptic pruning in microglia. During aging, Grn(-/-) mice show profound microglia infiltration and preferential elimination of inhibitory synapses in the ventral thalamus, which lead to hyperexcitability in the thalamocortical circuits and obsessive-compulsive disorder (OCD)-like grooming behaviors. Remarkably, deleting C1qa gene significantly reduces synaptic pruning by Grn(-/-) microglia and mitigates neurodegeneration, behavioral phenotypes, and premature mortality in Grn(-/-) mice. Together, our results uncover a previously unrecognized role of progranulin in suppressing aberrant microglia activation during aging. These results represent an important conceptual advance that complement activation and microglia-mediated synaptic pruning are major drivers, rather than consequences, of neurodegeneration caused by progranulin deficiency.	[Lui, Hansen; Zhang, Jiasheng; Cahill, Michelle K.; Huang, Hsin-Yi; Shang, Yulei; Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Makinson, Stefanie R.; Paz, Jeanne T.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Makinson, Stefanie R.; Seeley, William W.; Karydas, Anna; Miller, Bruce L.; Paz, Jeanne T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Kelley, Kevin W.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA; [Martens, Lauren Herl] FORUM Pharmaceut, Waltham, MA 02451 USA; [Gao, Fuying; Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Sloan, Steven A.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Hsieh, Christine L.] Univ Calif San Francisco, Immunol Sect, San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Hsieh, Christine L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Kim, Charles C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Bigio, Eileen H.; Weintraub, Sandra; Mesulam, Marek-Marsel] Northwestern Univ, Feinberg Sch Med, Northwestern Alzheimer Dis Ctr, Chicago, IL 60611 USA; [Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Mackenzie, Ian R.] Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Seeley, William W.; Karydas, Anna; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94158 USA; [Borroni, Barbara] Univ Brescia, Neurol Unit, Ctr Ageing Brain & Neurodegenerat Disorders, I-25100 Brescia, Italy; [Ghidoni, Roberta] IRCCS Ist Ctr San Giovanni Dio, Mol Markers Lab, I-25100 Brescia, Italy; [Farese, Robert V., Jr.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA; [Huang, Eric J.] San Francisco VA Med Ctr, Pathol Serv 113B, San Francisco, CA 94121 USA; [Lui, Hansen] UC Berkeley UCSF Joint Med Program JMP, Sch Publ Hlth, Berkeley, CA 94720 USA; [Huang, Hsin-Yi] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10002, Taiwan; [Kim, Charles C.] Verily, Mountain View, CA 94043 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; Mayo Clinic; University of British Columbia; University of British Columbia; University of California System; University of California San Francisco; University of Brescia; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; National Taiwan University; National Taiwan University Hospital	Huang, EJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.; Huang, EJ (corresponding author), San Francisco VA Med Ctr, Pathol Serv 113B, San Francisco, CA 94121 USA.	eric.huang2@ucsf.edu	Huang, Eric J./AAH-7997-2019; Ghidoni, Roberta/K-4507-2016; Borroni, Barbara/AAN-4105-2020	Huang, Eric J./0000-0002-5381-3801; Ghidoni, Roberta/0000-0002-7691-1957; Huang, Hsin-Yi/0000-0003-0062-3091; Sloan, Steven/0000-0001-7769-7684; Kim, Charles/0000-0001-6474-8227	NIH [AG013854, P50 AG023501, P01 AG019724, P30 AI027763, P30 DK063720]; Italian Ministry of Health (Ricerca Corrente); JPB Foundation; Department of Veterans Affairs Career Development Award [BX002690, BX001108, RX002133]; Consortium for Frontotemporal Dementia Research (CFR); Bluefield Project; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS078118, P30NS062691, R01NS096369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013854, P01AG019724, P50AG023501] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001108, I01RX002133, I01BX002978, I01BX002690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); JPB Foundation; Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); Consortium for Frontotemporal Dementia Research (CFR); Bluefield Project; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Ivy Hsieh for immunogold EM, Eric Bennett, Jordan Sorokin, and John Huguenard for their feedback on the Matlab code for analyzing the multi-unit recording in the thalamus, and Dr. Jennifer Cotter for critical comments on the manuscript. This work has been supported by NIH AG013854 (E.H.B.), P50 AG023501 and P01 AG019724 (B.L.M. and W.W.S.), P30 AI027763 and P30 DK063720 (C.C.K.), Italian Ministry of Health (Ricerca Corrente, R.G.), JPB Foundation (B.A.B.), Department of Veterans Affairs Career Development Award-2 (C.L.H.), Merit Awards BX002690 (C.L.H.) BX001108 (E.J.H.), and RX002133 (E.J.H.), and Consortium for Frontotemporal Dementia Research (CFR) and the Bluefield Project (B.L.M, W.W.S., and E.J.H.). Special thanks to Dr. Laura Mitic and Dr. Rodney Pearlman for their unwavering support.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Burguiere E, 2015, CURR OPIN NEUROBIOL, V30, P59, DOI 10.1016/j.conb.2014.08.008; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; Cotman SL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0366-z; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fitzgerald KD, 2011, J AM ACAD CHILD PSY, V50, P938, DOI 10.1016/j.jaac.2011.06.011; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; SMYTH MD, 1994, NEUROBIOL AGING, V15, P609, DOI 10.1016/0197-4580(94)00055-7; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029	41	379	381	0	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2016	165	4					921	935		10.1016/j.cell.2016.04.001	http://dx.doi.org/10.1016/j.cell.2016.04.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DL7DN	27114033	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000375800300019
J	Sandborn, WJ; Feagan, BG; Wolf, DC; D'Haens, G; Vermeire, S; Hanauer, SB; Ghosh, S; Smith, H; Cravets, M; Frohna, PA; Aranda, R; Gujrathi, S; Olson, A				Sandborn, William J.; Feagan, Brian G.; Wolf, Douglas C.; D'Haens, Geert; Vermeire, Severine; Hanauer, Stephen B.; Ghosh, Subrata; Smith, Heather; Cravets, Matthew; Frohna, Paul A.; Aranda, Richard; Gujrathi, Sheila; Olson, Allan		TOUCHSTONE Study Grp	Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; SPHINGOSINE 1-PHOSPHATE; ORAL FINGOLIMOD; THERAPY; FTY720; RECEPTORS; EFFICACY; PROTEIN; TRIAL	BACKGROUND Ozanimod (RPC1063) is an oral agonist of the sphingosine-1-phosphate receptor subtypes 1 and 5 that induces peripheral lymphocyte sequestration, potentially decreasing the number of activated lymphocytes circulating to the gastrointestinal tract. METHODS We conducted a double-blind, placebo-controlled phase 2 trial of ozanimod in 197 adults with moderate-to-severe ulcerative colitis. Patients were randomly assigned, in a 1: 1: 1 ratio, to receive ozanimod at a dose of 0.5 mg or 1 mg or placebo daily for up to 32 weeks. The Mayo Clinic score was used to measure disease activity on a scale from 0 to 12, with higher scores indicating more severe disease; subscores range from 0 to 3, with higher scores indicating more severe disease. The primary outcome was clinical remission (Mayo Clinic score <= 2, with no subscore >1) at 8 weeks. RESULTS The primary outcome occurred in 16% of the patients who received 1 mg of ozanimod and in 14% of those who received 0.5 mg of ozanimod, as compared with 6% of those who received placebo (P = 0.048 and P = 0.14, respectively, for the comparison of the two doses of ozanimod with placebo). Differences in the primary outcome between the group that received 0.5 mg of ozanimod and the placebo group were not significant; therefore, the hierarchical testing plan deemed the analyses of secondary outcomes exploratory. Clinical response (decrease in Mayo Clinic score of >= 3 points and >= 30% and decrease in rectal-bleeding subscore of >= 1 point or a subscore <= 1) at 8 weeks occurred in 57% of those receiving 1 mg of ozanimod and 54% of those receiving 0.5 mg, as compared with 37% of those receiving placebo. At week 32, the rate of clinical remission was 21% in the group that received 1 mg of ozanimod, 26% in the group that received 0.5 mg of ozanimod, and 6% in the group that received placebo; the rate of clinical response was 51%, 35%, and 20%, respectively. At week 8, absolute lymphocyte counts declined 49% from baseline in the group that received 1 mg of ozanimod and 32% from baseline in the group that received 0.5 mg. The most common adverse events overall were anemia and headache. CONCLUSIONS In this preliminary trial, ozanimod at a daily dose of 1 mg resulted in a slightly higher rate of clinical remission of ulcerative colitis than placebo. The trial was not large enough or of sufficiently long duration to establish clinical efficacy or assess safety.	[Sandborn, William J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Smith, Heather; Cravets, Matthew; Frohna, Paul A.; Aranda, Richard; Gujrathi, Sheila; Olson, Allan] Receptos, San Diego, CA USA; [Feagan, Brian G.] Univ Western Ontario, Robarts Res Inst, Robarts Clin Trials, London, ON, Canada; [Feagan, Brian G.] Univ Western Ontario, Dept Med, London, ON, Canada; [Ghosh, Subrata] Univ Calgary, Calgary, AB, Canada; [Wolf, Douglas C.] Atlanta Gastroenterol Associates, Atlanta, GA USA; [D'Haens, Geert] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Vermeire, Severine] Univ Hosp Gasthuisberg, Leuven, Belgium; [Hanauer, Stephen B.] Northwestern Univ, Evanston, IL USA	University of California System; University of California San Diego; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Calgary; University of Amsterdam; KU Leuven; University Hospital Leuven; Northwestern University	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr,MC 0956, La Jolla, CA 92093 USA.	wsandborn@ucsd.edu	Fadieienko, Galyna/T-5967-2019; Feagan, Brian/G-3292-2011; Ghosh, Subrata/AAC-2676-2021; Gearry, Richard B/H-3959-2019; Iakovlev, Aleksei A/O-4837-2015; Filip, Rafal/O-4277-2019; Sandborn, William/ABE-8342-2020; Vasyliuk, Serhii/H-9737-2018	Fadieienko, Galyna/0000-0003-0881-6541; Ghosh, Subrata/0000-0002-1713-7797; Gearry, Richard B/0000-0002-2298-5141; Iakovlev, Aleksei A/0000-0003-1697-8989; Filip, Rafal/0000-0002-5954-151X; Isaacs, Kim/0000-0002-6433-876X; Vasyliuk, Serhii/0000-0002-6738-6951; Lowenberg, Mark/0000-0002-4975-9945; Delgado, Jorge -Shmuel/0000-0002-8632-2945; Vermeire, Severine/0000-0001-9942-3019; Mylytsia, Kostiantyn/0000-0001-8187-8111; katz, seymour/0000-0002-3492-9200	Receptos	Receptos	Funded by Receptos	[Anonymous], 2015, GIL PACK INS; Brinkmann V, 2006, CURR OPIN PHARMACOL, V6, P244, DOI 10.1016/j.coph.2005.12.004; Cohen JA, 2016, LANCET NEUROL, V15, P373, DOI 10.1016/S1474-4422(16)00018-1; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Francis G, 2014, MULT SCLER J, V20, P471, DOI 10.1177/1352458513500551; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Jain N, 2012, NEUROLOGY, V78, P672, DOI 10.1212/WNL.0b013e318248deea; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Mosli MH, 2015, AM J GASTROENTEROL, V110, P802, DOI 10.1038/ajg.2015.120; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Scott FL, 2016, BR J PHARM	22	273	282	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2016	374	18					1754	1762		10.1056/NEJMoa1513248	http://dx.doi.org/10.1056/NEJMoa1513248			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL0RY	27144850	Green Published, Bronze			2022-12-28	WOS:000375341500008
J	Desai, S; Hatfield, LA; Hicks, AL; Chernew, ME; Mehrotra, A				Desai, Sunita; Hatfield, Laura A.; Hicks, Andrew L.; Chernew, Michael E.; Mehrotra, Ateev			Association Between Availability of a Price Transparency Tool and Outpatient Spending	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; COST; CHALLENGES; PROVIDERS	IMPORTANCE There is increasing interest in using price transparency tools to decrease health care spending. OBJECTIVE To measure the association between offering a health care price transparency tool and outpatient spending. DESIGN, SETTING, AND PARTICIPANTS Two large employers represented in multiple market areas across the United States offered an online health care price transparency tool to their employees. One introduced it on April 1, 2011, and the other on January 1, 2012. The tool provided users information about what they would pay out of pocket for services from different physicians, hospitals, or other clinical sites. Using a matched difference-indifferences design, outpatient spending among employees offered the tool (n=148 655) was compared with that among employees from other companies not offered the tool (n=295 983) in the year before and after it was introduced. EXPOSURE Availability of a price transparency tool. MAIN OUTCOMES AND MEASURES Annual outpatient spending, outpatient out-of-pocket spending, use rates of the tool. RESULTS Mean outpatient spending among employees offered the tool was $2021 in the year before the tool was introduced and $2233 in the year after. In comparison, among controls, mean outpatient spending changed from $1985 to $2138. After adjusting for demographic and health characteristics, being offered the tool was associated with a mean $59 (95% CI, $25-$93) increase in outpatient spending. Mean outpatient out-of-pocket spending among those offered the tool was $507 in the year before introduction of the tool and $555 in the year after. Among the comparison group, mean outpatient out-of-pocket spending changed from $490 to $520. Being offered the price transparency tool was associated with a mean $18 (95% CI, $12-$25) increase in out-of-pocket spending after adjusting for relevant factors. In the first 12 months, 10% of employees who were offered the tool used it at least once. CONCLUSIONS AND RELEVANCE Among employees at 2 large companies, offering a price transparency tool was not associated with lower health care spending. The tool was used by only a small percentage of eligible employees.	[Desai, Sunita; Hatfield, Laura A.; Hicks, Andrew L.; Chernew, Michael E.; Mehrotra, Ateev] Harvard Univ, Sch Med, Boston, MA USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Hatfield, Laura A./I-6835-2019; Mehrotra, Ateev/AAO-8454-2021	Hatfield, Laura A./0000-0003-0366-3929; Mehrotra, Ateev/0000-0003-2223-1582	Laura and John Arnold Foundation; Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School	Laura and John Arnold Foundation; Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School	This work was supported by a grant from the Laura and John Arnold Foundation and the Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School.	Aliferis L, 2015, JAMA INTERN MED, V175, P11, DOI 10.1001/jamainternmed.2014.6793; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Brot-Goldberg ZC, 2015, 21632 NBER; Catalyst for Payment Reform, 2013, NAT SCOR PAYM REF; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Ghosh D., 2012, JT STAT METINGS, P3455; Higgins A, 2016, AM J MANAG CARE, V22, P126; Hussey PS, 2013, ANN INTERN MED, V158, P27, DOI 10.7326/0003-4819-158-1-201301010-00006; Kullgren JT, 2013, JAMA-J AM MED ASSOC, V309, P2437, DOI 10.1001/jama.2013.6557; Mehrotra A, 2014, INQUIRY-J HEALTH CAR, V51, DOI 10.1177/0046958014561496; Mehrotra A, 2012, HEALTH AFFAIR, V31, P843, DOI 10.1377/hlthaff.2011.1181; Meisel ZF, 2016, HEALTHCARE-J DEL SCI, V4, P3, DOI 10.1016/j.hjdsi.2015.06.004; Moukheiber Z., 2015, FORBES; Neprash HT, 2015, JAMA INTERN MED, V175, P1932, DOI 10.1001/jamainternmed.2015.4610; Newman D., 2016, SPENDING SHOPPABLE S; Robinson JC, 2015, JAMA INTERN MED, V175, P1783, DOI 10.1001/jamainternmed.2015.4588; Robinson JC, 2013, HEALTH AFFAIR, V32, P1392, DOI 10.1377/hlthaff.2013.0188; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sinaiko AD, 2016, HEALTH AFFAIR, V35, P662, DOI 10.1377/hlthaff.2015.0746; Sinaiko AD, 2011, NEW ENGL J MED, V364, P891, DOI 10.1056/NEJMp1100041; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Whaley C, 2014, JAMA-J AM MED ASSOC, V312, P1670, DOI 10.1001/jama.2014.13373; Wu SJ, 2014, HEALTH AFFAIR, V33, P1391, DOI 10.1377/hlthaff.2014.0168; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980	24	64	64	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1874	1881		10.1001/jama.2016.4288	http://dx.doi.org/10.1001/jama.2016.4288			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK9XF	27139060	Bronze			2022-12-28	WOS:000375284400016
J	Stark, A; Donahue, TR; Reber, HA; Hines, OJ				Stark, Alexander; Donahue, Timothy R.; Reber, Howard A.; Hines, O. Joe			Pancreatic Cyst Disease A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PAPILLARY-MUCINOUS NEOPLASMS; FINE-NEEDLE-ASPIRATION; INTERNATIONAL-CONSENSUS-GUIDELINES; FLUID CARCINOEMBRYONIC ANTIGEN; ATYPICAL EPITHELIAL-CELLS; OVARIAN-TYPE STROMA; LONG-TERM OUTCOMES; FOLLOW-UP; ENDOSCOPIC ULTRASOUND; CLINICOPATHOLOGICAL FEATURES	IMPORTANCE Cystic lesions of the pancreas are common and increasingly detected in the primary care setting. Some patients have a low risk for developing a malignancy and others have a high risk and need further testing and interventions. OBSERVATIONS Pancreatic cystsmay be intraductal mucinous neoplasms, mucinous cystic neoplasms, serous cystadenomas, solid pseudopapillary neoplasms, cystic variations of pancreatic neuroendocrine tumors, pancreatic ductal adenocarcinomas, or 1 of several types of nonneoplastic cysts. Mucinous (intraductal mucinous neoplasm or mucinous cystic neoplasm) lesions have malignant potential and should be distinguished from serous lesions (serous cystadenomas) that are nearly always benign. Symptomatic patients or those having high-risk features on initial imaging (eg, main pancreatic duct dilatation, a solid component, or mural nodule) require further evaluation with advanced imaging, possibly followed by surgical resection. Advanced imaging includes endoscopic ultrasound with cyst fluid analysis and cytology to confirm the type of cyst and determine the risk of malignancy. Small cysts (size < 3 cm) in asymptomatic patients without any suspicious featuresmay be observed with serial imaging because the risk for malignancy is low. CONCLUSIONS AND RELEVANCE The management of pancreatic cysts requires risk stratification for malignant potential based on the presence or absence of symptoms and high-risk features on cross-sectional imaging. Because pancreatic cysts are becoming more frequently diagnosed, clinicians should have a systematic approach for establishing a diagnosis and determining which patients require treatment.	[Stark, Alexander; Donahue, Timothy R.; Reber, Howard A.; Hines, O. Joe] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, 10833 Le Conte Ave,72-180 CHS, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hines, OJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, 10833 Le Conte Ave,72-180 CHS, Los Angeles, CA 90095 USA.	joehines@mednet.ucla.edu	Stark, Alexander/AAV-3823-2021		National Institutes of Health [P01CA163200]; Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This review study was supported by grant P01CA163200 from the National Institutes of Health and through funding from the Hirshberg Foundation for Pancreatic Cancer Research.	Anand N, 2013, CLIN GASTROENTEROL H, V11, P913, DOI 10.1016/j.cgh.2013.02.010; Ardengh JC, 2014, SCAND J GASTROENTERO, V49, P114, DOI 10.3109/00365521.2013.854830; Attasaranya S, 2007, J PANCREAS, V8, P553; Baba T, 2004, PANCREAS, V29, P212, DOI 10.1097/00006676-200410000-00006; Bae SY, 2012, DIGEST LIVER DIS, V44, P257, DOI 10.1016/j.dld.2011.09.010; Bordelanou L, 2008, J AM COLL SURGEONS, V206, P1154, DOI 10.1016/j.jamcollsurg.2007.12.040; Brugge WR, 2004, GASTROENTEROLOGY, V126, P1330, DOI 10.1053/j.gastro.2004.02.013; Chang Hong, 2010, Int J Med Sci, V7, P309; Charfi S, 2009, CANCER CYTOPATHOL, V117, P203, DOI 10.1002/cncy.20024; Chaudhari VV, 2008, J COMPUT ASSIST TOMO, V32, P757, DOI 10.1097/RCT.0b013e318157b100; Chung JW, 2013, PANCREAS, V42, P230, DOI 10.1097/MPA.0b013e31826ae31a; Cizginer S, 2013, PANCREAS, V42, P728, DOI 10.1097/MPA.0b013e3182953d4b; Cizginer S, 2011, PANCREAS, V40, P1024, DOI 10.1097/MPA.0b013e31821bd62f; Correa-Gallego C, 2013, ANN SURG ONCOL, V20, P4348, DOI 10.1245/s10434-013-3207-z; Das A, 2008, AM J GASTROENTEROL, V103, P1657, DOI 10.1111/j.1572-0241.2008.01893.x; de Jong K, 2010, CLIN GASTROENTEROL H, V8, P806, DOI 10.1016/j.cgh.2010.05.017; Donahue TR, 2010, PANCREAS, V39, P1271, DOI 10.1097/MPA.0b013e3181e1d6f4; Fernandez-del Castillo C, 2003, ARCH SURG-CHICAGO, V138, P427; Ferrone CR, 2009, ARCH SURG-CHICAGO, V144, P448, DOI 10.1001/archsurg.2009.36; Fritz S, 2012, SURGERY, V152, pS74, DOI 10.1016/j.surg.2012.05.025; Fritz S, 2012, ANN SURG, V256, P313, DOI 10.1097/SLA.0b013e31825d355f; Gaujoux S, 2012, SURGERY, V151, P518, DOI 10.1016/j.surg.2011.09.037; Gaujoux S, 2011, J AM COLL SURGEONS, V212, P590, DOI 10.1016/j.jamcollsurg.2011.01.016; Genevay M, 2011, ANN SURG, V254, P977, DOI 10.1097/SLA.0b013e3182383118; Goh BKP, 2008, J AM COLL SURGEONS, V206, P17, DOI 10.1016/j.jamcollsurg.2007.06.312; Goh BKP, 2007, J SURG ONCOL, V95, P640, DOI 10.1002/jso.20735; Goh BKP, 2006, WORLD J SURG, V30, P1553, DOI 10.1007/s00268-005-0749-7; Goh BKP, 2014, AM J SURG, V208, P202, DOI 10.1016/j.amjsurg.2013.09.031; Hackert T, 2015, ANN SURG, V262, P875, DOI 10.1097/SLA.0000000000001462; HAMMEL P, 1995, GASTROENTEROLOGY, V108, P1230, DOI 10.1016/0016-5085(95)90224-4; Hoffman RL, 2015, J AM COLL SURGEONS, V220, P1087, DOI 10.1016/j.jamcollsurg.2015.02.013; Jacobs AK, 2013, J AM COLL CARDIOL, V61, P213, DOI 10.1016/j.jacc.2012.09.025; Jang JY, 2008, ANN SURG ONCOL, V15, P199, DOI 10.1245/s10434-007-9603-5; Kang MJ, 2011, CLIN GASTROENTEROL H, V9, P87, DOI 10.1016/j.cgh.2010.09.008; Kavuturu S, 2013, J PANCREAS, V14, P250, DOI 10.6092/1590-8577/1229; Kawakubo K, 2014, CLIN GASTROENTEROL H, V12, P486, DOI 10.1016/j.cgh.2013.06.032; Kawamoto S, 2013, AM J ROENTGENOL, V200, pW283, DOI 10.2214/AJR.12.8941; Kazanjian KK, 2008, ARCH SURG-CHICAGO, V143, P1166, DOI 10.1001/archsurg.143.12.1166; Keswani RN, 2012, PANCREAS, V41, P813, DOI 10.1097/MPA.0b013e318243a276; Khannoussi W, 2012, PANCREATOLOGY, V12, P198, DOI 10.1016/j.pan.2012.03.056; Khashab MA, 2013, PANCREAS, V42, P717, DOI 10.1097/MPA.0b013e3182883a91; Khurana B, 2003, AM J ROENTGENOL, V181, P119, DOI 10.2214/ajr.181.1.1810119; Kim KW, 2014, ANN SURG, V259, P72, DOI 10.1097/SLA.0b013e31829385f7; Kirkpatrick IDC, 2007, ABDOM IMAGING, V32, P119, DOI 10.1007/s00261-006-9080-5; Kosmahl M, 2002, MODERN PATHOL, V15, P154, DOI 10.1038/modpathol.3880507; Kwong WT, 2016, CLIN GASTROENTEROL H, V14, P865, DOI 10.1016/j.cgh.2015.11.013; Kwong WT, 2015, DIGEST DIS SCI, V60, P2800, DOI 10.1007/s10620-015-3679-8; Lee SE, 2008, ANN SURG ONCOL, V15, P2089, DOI 10.1245/s10434-008-9959-1; Leeds JS, 2013, PANCREATOLOGY, V13, P263, DOI 10.1016/j.pan.2013.02.009; Leung KK, 2009, ANN SURG ONCOL, V16, P2818, DOI 10.1245/s10434-009-0502-9; Lim SJ, 2005, SURGERY, V138, P672, DOI 10.1016/j.surg.2005.07.033; Madura JA, 1997, SURGERY, V122, P786, DOI 10.1016/S0039-6060(97)90088-X; Matsubara S, 2012, PANCREAS, V41, P1241, DOI 10.1097/MPA.0b013e31824f5970; Megibow AJ, 2001, ABDOM IMAGING, V26, P640, DOI 10.1007/s00261-001-0024-9; Morales-Oyarvide V, 2014, CANCER CYTOPATHOL, V122, P435, DOI 10.1002/cncy.21403; Moriya T, 2011, J GASTROINTEST SURG, V15, P762, DOI 10.1007/s11605-011-1437-6; Murakami Y, 2006, SURGERY, V140, P448, DOI 10.1016/j.surg.2006.03.017; Nadig SN, 2012, PANCREAS, V41, P441, DOI 10.1097/MPA.0b013e318229b9b8; Nagula S, 2010, J GASTROINTEST SURG, V14, P1997, DOI 10.1007/s11605-010-1281-0; Ngamruengphong S, 2013, DIGEST LIVER DIS, V45, P920, DOI 10.1016/j.dld.2013.05.002; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Ohtsuka T, 2012, SURGERY, V151, P76, DOI 10.1016/j.surg.2011.07.009; Othman MO, 2012, DIGEST LIVER DIS, V44, P844, DOI 10.1016/j.dld.2012.06.005; Park JW, 2014, PANCREATOLOGY, V14, P131, DOI 10.1016/j.pan.2013.12.006; Park WGU, 2011, PANCREAS, V40, P42, DOI 10.1097/MPA.0b013e3181f69f36; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P1759, DOI 10.1111/j.1572-0241.2007.01224.x; Pitman MB, 2013, CANCER CYTOPATHOL, V121, P29, DOI 10.1002/cncy.21242; Pitman MB, 2008, PANCREATOLOGY, V8, P277, DOI 10.1159/000134276; Pitman MB, 2010, CANCER CYTOPATHOL, V118, P434, DOI 10.1002/cncy.20118; Rautou PE, 2008, CLIN GASTROENTEROL H, V6, P807, DOI 10.1016/j.cgh.2007.12.021; Rockacy MJ, 2013, CLIN GASTROENTEROL H, V11, P425, DOI 10.1016/j.cgh.2012.12.008; Sahani DV, 2011, AM J ROENTGENOL, V197, pW53, DOI 10.2214/AJR.10.5866; Sahani DV, 2006, RADIOLOGY, V238, P560, DOI 10.1148/radiol.2382041463; Sahora K, 2013, ANN SURG, V258, P466, DOI 10.1097/SLA.0b013e3182a18f48; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Scheiman JM, 2015, GASTROENTEROLOGY, V148, P824, DOI 10.1053/j.gastro.2015.01.014; Schmidt CM, 2007, ANN SURG, V246, P644, DOI 10.1097/SLA.0b013e318155a9e5; Shami VM, 2007, PANCREAS, V34, P466, DOI 10.1097/mpa.0b013e318033fa12; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; Spinelli KS, 2004, ANN SURG, V239, P651, DOI 10.1097/01.sla.0000124299.57430.ce; Springer S, 2015, GASTROENTEROLOGY, V149, P1501, DOI 10.1053/j.gastro.2015.07.041; Sunkara S, 2012, BRIT J RADIOL, V85, pE1140, DOI 10.1259/bjr/20695686; Tada M, 2006, CLIN GASTROENTEROL H, V4, P1265, DOI 10.1016/j.cgh.2006.07.013; Talamini MA, 1998, ANN SURG, V227, P896, DOI 10.1097/00000658-199806000-00013; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Tanaka S, 2010, RADIOLOGY, V254, P965, DOI 10.1148/radiol.09090992; Thornton GD, 2013, PANCREATOLOGY, V13, P48, DOI 10.1016/j.pan.2012.11.313; Tien YW, 2008, ANN SURG ONCOL, V15, P193, DOI 10.1245/s10434-007-9613-3; Tipton SG, 2006, BRIT J SURG, V93, P733, DOI 10.1002/bjs.5334; Uehara H, 2011, J GASTROENTEROL, V46, P657, DOI 10.1007/s00535-010-0343-0; Vege SS, 2015, GASTROENTEROLOGY, V148, P819, DOI 10.1053/j.gastro.2015.01.015; Vege SS, 2015, GASTROENTEROLOGY, V148, pe12, DOI DOI 10.1053/J.GASTRO.2015.01.015; Walsh RM, 2008, SURGERY, V144, P677, DOI 10.1016/j.surg.2008.06.013; Walsh RM, 2002, SURGERY, V132, P628, DOI 10.1067/msy.2002.127543; Woo SM, 2009, BRIT J SURG, V96, P405, DOI 10.1002/bjs.6557; Wu BU, 2014, AM J GASTROENTEROL, V109, P121, DOI 10.1038/ajg.2013.334; Wu RI, 2014, CANCER CYTOPATHOL, V122, P412, DOI 10.1002/cncy.21385; Xourafas D, 2015, SURGERY, V157, P473, DOI 10.1016/j.surg.2014.09.028; Yamao K, 2011, PANCREAS, V40, P67, DOI 10.1097/MPA.0b013e3181f749d3; Yang F, 2009, AM J SURG, V198, P210, DOI 10.1016/j.amjsurg.2008.07.062; Zhan XB, 2013, J DIGEST DIS, V14, P191, DOI 10.1111/1751-2980.12027; Zhang XM, 2002, RADIOLOGY, V223, P547, DOI 10.1148/radiol.2232010815; Zhong N, 2012, CLIN GASTROENTEROL H, V10, P192, DOI 10.1016/j.cgh.2011.09.029	104	135	149	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2016	315	17					1882	1893		10.1001/jama.2016.4690	http://dx.doi.org/10.1001/jama.2016.4690			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK9XF	27139061				2022-12-28	WOS:000375284400017
J	Safarian, S; Rajendran, C; Muller, H; Preu, J; Langer, JD; Ovchinnikov, S; Hirose, T; Kusumoto, T; Sakamoto, J; Michel, H				Safarian, Schara; Rajendran, Chitra; Mueller, Hannelore; Preu, Julia; Langer, Julian D.; Ovchinnikov, Sergey; Hirose, Taichiro; Kusumoto, Tomoichirou; Sakamoto, Junshi; Michel, Hartmut			Structure of a bd oxidase indicates similar mechanisms for membrane-integrated oxygen reductases	SCIENCE			English	Article							RADICAL CATALYTIC INTERMEDIATE; SITE-DIRECTED MUTAGENESIS; AEROBIC RESPIRATORY-CHAIN; CYTOCHROME-C-OXIDASE; HEME ACTIVE-SITE; ESCHERICHIA-COLI; QUINOL OXIDASE; AZOTOBACTER-VINELANDII; TERMINAL OXIDASES; BINUCLEAR CENTER	The cytochrome bd oxidases are terminal oxidases that are present in bacteria and archaea. They reduce molecular oxygen (dioxygen) to water, avoiding the production of reactive oxygen species. In addition to their contribution to the proton motive force, they mediate viability under oxygen-related stress conditions and confer tolerance to nitric oxide, thus contributing to the virulence of pathogenic bacteria. Here we present the atomic structure of the bd oxidase from Geobacillus thermodenitrificans, revealing a pseudosymmetrical subunit fold. The arrangement and order of the heme cofactors support the conclusions from spectroscopic measurements that the cleavage of the dioxygen bond may be mechanistically similar to that in the heme-copper-containing oxidases, even though the structures are completely different.	[Safarian, Schara; Rajendran, Chitra; Mueller, Hannelore; Preu, Julia; Langer, Julian D.; Michel, Hartmut] Max Planck Inst Biophysics, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany; [Ovchinnikov, Sergey] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Hirose, Taichiro; Kusumoto, Tomoichirou; Sakamoto, Junshi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Kawazu 680-4, Iizuka, Fukuoka 8208502, Japan; [Rajendran, Chitra] Univ Regensburg, Fac Biol & Preclin Med, Univ Str 31, D-93051 Regensburg, Germany	University of Washington; University of Washington Seattle; Kyushu Institute of Technology; University of Regensburg	Michel, H (corresponding author), Max Planck Inst Biophysics, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	hartmut.michel@biophys.mpg.de		Langer, Julian David/0000-0002-5190-577X; Ovchinnikov, Sergey/0000-0003-2774-2744; Safarian, Schara/0000-0002-0232-1612	Max Planck Society; Japan Society for the Promotion of Science [25440050]; National Institutes of Health [R01GM092802]; Deutsche Forschungsgemeinschaft (Cluster of Excellence Macromolecular Complexes Frankfurt); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (Cluster of Excellence Macromolecular Complexes Frankfurt); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft (Cluster of Excellence Macromolecular Complexes Frankfurt), by a Grant-in-Aid for Scientific Research (C) (25440050 to IS.) from the Japan Society for the Promotion of Science, and by the National Institutes of Health (grant R01GM092802). We thank the staff of beamline X10SA of the Swiss Light Source for assistance. Parts of the experiments were performed on beamlines ID29, ID23.1, and 10232 at the European Synchrotron Radiation Facility, Grenoble, France. We are grateful to beamline scientists for providing assistance; D. Baker for support during model building; and R. Gennis, U. Ermler, R. Murali, and A. Resemann for scientific discussion and expertise. Coordinates and structure factors have been deposited under PDB accession codes 5DOQ and 5IR6.	Allen JP, 1998, FEBS LETT, V438, P5, DOI 10.1016/S0014-5793(98)01245-9; Allen RJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-946; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Belevich I, 2005, P NATL ACAD SCI USA, V102, P3657, DOI 10.1073/pnas.0405683102; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berney M, 2014, MBIO, V5, DOI 10.1128/mBio.01275-14; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Edwards SE, 2000, FEMS MICROBIOL LETT, V185, P71, DOI 10.1111/j.1574-6968.2000.tb09042.x; FANG H, 1989, J BIOL CHEM, V264, P8026; Giuffre A, 2014, BBA-BIOENERGETICS, V1837, P1178, DOI 10.1016/j.bbabio.2014.01.016; Hoeser J, 2014, FEBS LETT, V588, P1537, DOI 10.1016/j.febslet.2014.03.036; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; KITA K, 1984, J BIOL CHEM, V259, P3375; Lu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep10333; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; MILLER MJ, 1983, J BIOL CHEM, V258, P9159; Mogi T, 2006, BIOCHEMISTRY-US, V45, P7924, DOI 10.1021/bi060192w; Mogi T, 2006, BIOCHEMISTRY-US, V45, P15785, DOI 10.1021/bi0615792; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Paulus A, 2012, J BIOL CHEM, V287, P8830, DOI 10.1074/jbc.M111.333542; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Sakamoto J, 1996, FEMS MICROBIOL LETT, V143, P151, DOI 10.1016/0378-1097(96)00312-6; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; SPINNER F, 1995, BIOCHEM J, V308, P641, DOI 10.1042/bj3080641; Sun J, 1996, BIOCHEMISTRY-US, V35, P2403, DOI 10.1021/bi9518252; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; Yang K, 2007, BIOCHEMISTRY-US, V46, P3270, DOI 10.1021/bi061946+	30	95	98	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					583	586		10.1126/science.aaf2477	http://dx.doi.org/10.1126/science.aaf2477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	27126043	Green Accepted			2022-12-28	WOS:000374998600044
J	Schwamm, LH; Jaff, MR; Dyer, KS; Gonzalez, RG; Huck, AE				Schwamm, Lee H.; Jaff, Michael R.; Dyer, K. Sophia; Gonzalez, R. Gilberto; Huck, Amelia E.			Case 13-2016: A 49-Year-Old Woman with Sudden Hemiplegia and Aphasia during a Transatlantic Flight	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATENT FORAMEN OVALE; TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; MAY-THURNER SYNDROME; ADULTS RISK-FACTORS; TO-NEEDLE TIMES; CRYPTOGENIC STROKE; VENOUS THROMBOEMBOLISM; ENDOVASCULAR THERAPY; DIAGNOSTIC-YIELD		[Schwamm, Lee H.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Jaff, Michael R.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Huck, Amelia E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Schwamm, Lee H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Jaff, Michael R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Huck, Amelia E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Dyer, K. Sophia] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Dyer, K. Sophia] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston Medical Center; Boston University	Schwamm, LH (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.; Schwamm, LH (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.				Lundbeck; Penumbra; Genentech; Cardinal Health; Volcano Corporation	Lundbeck(Lundbeck Corporation); Penumbra; Genentech(Roche HoldingGenentech); Cardinal Health; Volcano Corporation	Dr. Gonzalez reports receiving payment for providing expert testimony related to neuroimaging in stroke diagnosis; Dr. Schwamm, receiving consulting fees from Lundbeck and Penumbra and grant support from Genentech; and Dr. Jaff, serving as an uncompensated advisor for Abbott Vascular, Boston Scientific, Cordis Corporation, Covidien Vascular, and Medtronic Vascular, serving as an uncompensated member of a data and safety monitoring board for EKOS Corporation and as a compensated member of a data and safety monitoring board for Novella, and receiving consulting fees from Cardinal Health and Volcano Corporation. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2012, NEW ENGL J MED, V367, P1450; Ay H, 2002, STROKE, V33, P286, DOI 10.1161/hs0102.101544; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Chew HK, 2006, ARCH INTERN MED, V166, P458; Cramer SC, 2004, STROKE, V35, P46, DOI 10.1161/01.STR.0000106137.42649.AB; Doyen D, 2014, CHEST, V146, P967, DOI 10.1378/chest.14-0100; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Health and Human Services of Massachusetts, STROK POINT ENTR PLA; Health and Human Services of Massachusetts, DES PRIM STROK SERV; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Ji RJ, 2013, JAMA NEUROL, V70, P51, DOI 10.1001/jamaneurol.2013.575; Katsanos AH, 2014, STROKE, V45, P3352, DOI 10.1161/STROKEAHA.114.007109; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kibbe MR, 2004, J VASC SURG, V39, P937, DOI 10.1016/j.jvs.2003.12.032; Kiernan TJ, 2009, STROKE, V40, P1502, DOI 10.1161/STROKEAHA.108.527366; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Leifer D, 2011, STROKE, V42, P849, DOI 10.1161/STR.0b013e318208eb99; Leslie-Mazwi TM, 2016, JAMA NEUROL, V73, P43, DOI 10.1001/jamaneurol.2015.3000; Liberman AL, 2014, STROKE, V45, P2324, DOI 10.1161/STROKEAHA.114.005539; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P315, DOI 10.1038/nrneurol.2014.72; Mahnken AH, 2007, INVEST RADIOL, V42, P529, DOI 10.1097/RLI.0b013e318036b42b; Mousa AY, 2013, ANN VASC SURG, V27, P984, DOI 10.1016/j.avsg.2013.05.001; National Health Service, SYMPT SIGNS STROK; Philbrick JT, 2007, J GEN INTERN MED, V22, P107, DOI 10.1007/s11606-006-0016-0; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Raju S, 2006, J VASC SURG, V44, P136, DOI 10.1016/j.jvs.2006.02.065; Ruff IM, 2014, STROKE, V45, P504, DOI 10.1161/STROKEAHA.113.004073; Schwamm LH, 2005, CIRCULATION, V111, P1078, DOI 10.1161/01.CIR.0000154252.62394.1E; Smith Eric E, 2008, Crit Pathw Cardiol, V7, P173, DOI 10.1097/HPC.0b013e318184e2bc; Tomkowski WZ, 2007, THROMB HAEMOSTASIS, V97, P191, DOI 10.1160/PH06-10-0601; Tsimafeyeu IV, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-30; ZACHARSKI LR, 1986, BLOOD, V68, P394	38	4	4	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1671	1680		10.1056/NEJMcpc1501151	http://dx.doi.org/10.1056/NEJMcpc1501151			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	27119240				2022-12-28	WOS:000374843400011
J	Wise, J				Wise, Jacqui			Concern over arsenic in infants' rice products rises after US study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Karagas MR, 2016, JAMA PEDIATR, V170, P609, DOI 10.1001/jamapediatrics.2016.0120	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2016	353								i2365	10.1136/bmj.i2365	http://dx.doi.org/10.1136/bmj.i2365			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2RJ	27118563				2022-12-28	WOS:000375482500015
J	Lamichhaney, S; Han, F; Berglund, J; Wang, C; Almen, MS; Webster, MT; Grant, BR; Grant, PR; Andersson, L				Lamichhaney, Sangeet; Han, Fan; Berglund, Jonas; Wang, Chao; Almen, Markus Sallman; Webster, Matthew T.; Grant, B. Rosemary; Grant, Peter R.; Andersson, Leif			A beak size locus in Darwin's finches facilitated character displacement during a drought	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; EVOLUTION; HYBRIDIZATION; ADAPTATION; MUTATION; HEIGHT; MOUSE	Ecological character displacement is a process of morphological divergence that reduces competition for limited resources. We used genomic analysis to investigate the genetic basis of a documented character displacement event in Darwin's finches on Daphne Major in the Galapagos Islands: The medium ground finch diverged from its competitor, the large ground finch, during a severe drought. We discovered a genomic region containing the HMGA2 gene that varies systematically among Darwin's finch species with different beak sizes. Two haplotypes that diverged early in the radiation were involved in the character displacement event: Genotypes associated with large beak size were at a strong selective disadvantage in medium ground finches (selection coefficient s = 0.59). Thus, a major locus has apparently facilitated a rapid ecological diversification in the adaptive radiation of Darwin's finches.	[Lamichhaney, Sangeet; Han, Fan; Berglund, Jonas; Wang, Chao; Almen, Markus Sallman; Webster, Matthew T.; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Grant, B. Rosemary; Grant, Peter R.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Uppsala University; Princeton University; Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.; Andersson, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.; Andersson, L (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA.	leif.andersson@imbim.uu.se	Grant, Peter/HIR-3733-2022	Han, Fan/0000-0002-8091-443X	NSF (USA); Knut and Alice Wallenberg Foundation; Swedish Research Council [80576801, 70374401]	NSF (USA)(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank A. Garcia-Dorado, P. Hedrick, and M. Pettersson for advice concerning statistical analysis, and J. Pettersson and U. Gustafsson for expert technical assistance. NSF (USA) funded the collection of material under permits from the Galapagos and Costa Rica National Parks Services and the Charles Darwin Research Station, and in accordance with protocols of Princeton University's Animal Welfare Committee. The project was supported by the Knut and Alice Wallenberg Foundation. Sequencing was performed by the SNP & SEQ Technology Platform, supported by Uppsala University and Hospital, SciLifeLab, and Swedish Research Council grants 80576801 and 70374401. Computer resources were supplied by UPPMAX. The Illumina reads have been submitted to the short reads archive (www.ncbi.nlm.nih.gov/sra) with accession numbers PRJNA263122 and PRJNA301892. Raw tree files for constructing Fig. 1, C and D, have been submitted to the TreeBASE database with submission ID S18636 (http://purl.org/phylo/treebase/phylows/study/TB2:S18636). Author contributions: P.R.G. and B.R.G. collected the material; L.A., P.R.G., and B.R.G. conceived the study; L.A. and M.T.W. led the bioinformatic analysis of data; S.L., F.H., J.B., and C.W. performed the bioinformatic analysis with contributions from M.S.A.; and L.A., S.L., B.R.G., and P.R.G. wrote the paper with input from the other authors. All authors approved the manuscript before submission.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Arnegard ME, 2014, NATURE, V511, P307, DOI 10.1038/nature13301; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; Frischknecht M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140749; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant P. R., 2014, 40 YEARS EVOLUTION D, DOI DOI 10.2307/J.CTT5HHNCC; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2016, BIOL J LINN SOC, V117, P812, DOI 10.1111/bij.12702; GRANT PR, 1994, EVOLUTION, V48, P297, DOI 10.1111/j.1558-5646.1994.tb01313.x; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Liu KJ, 2015, P NATL ACAD SCI USA, V112, P196, DOI 10.1073/pnas.1406298111; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Pfennig D. W., 2012, EVOLUTIONS EDGE COMP; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; Tobias JA, 2014, NATURE, V506, P359, DOI 10.1038/nature12874; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	25	151	151	11	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2016	352	6284					470	474		10.1126/science.aad8786	http://dx.doi.org/10.1126/science.aad8786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ8RH	27102486				2022-12-28	WOS:000374479700050
